View - City of Lathrop
View - City of Lathrop
View - City of Lathrop
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
MEDICAL MARIJUANA<br />
INFORMATIONAL BINDER<br />
TABLE OF CONTENTS<br />
A Federal Government Information<br />
DOJ DEA website page for Controlled Substances Act CSA<br />
DOJ letter to <strong>City</strong> <strong>of</strong> Eureka815 11<br />
DOJ letter to <strong>City</strong> <strong>of</strong> Chico701 11<br />
DOJ memo from James Cole629 ll<br />
DOJ letter to St <strong>of</strong> Washington414 ll<br />
DOJ letter to <strong>City</strong> <strong>of</strong> Oakland211<br />
DOJ letter to <strong>City</strong> <strong>of</strong> Oakland12 08 10<br />
DOJ Memo from David Ogden10 19 09<br />
B State <strong>of</strong> California lnformation<br />
Gaidelines for the Security and Non Diversion <strong>of</strong> Marijuana Grown for<br />
Medical Use Guidelines<br />
Medical Marijuana Program MMP website page<br />
Health Safety Code Article 2 Marijuana Section 11357 11369<br />
Health<br />
11362 7ll362 83<br />
Safety Code Article 25 Medical Marijuana Program Section<br />
C Health and Medical Publications and Reports on Marijuana<br />
Center for Medicinal Cannabis Research Report 2010<br />
Anesthesia Journal Cannabis for Chronic Pain 2004<br />
Journal <strong>of</strong> Pain and Symptom Management Article 2010<br />
National Institute on Drug Abuse Marijuana Abuse<br />
National Institute on Drug Abuse Marijuana Facts for Parent<br />
National Institute on Drug Abuse Marijuana Facts for Teens<br />
Science Daily Cannabis Damages Young Brains 2009<br />
Office <strong>of</strong> National Drug Control Policy Marijuana As Medicine 2003<br />
Eye Care America Marijuana in the Treatment <strong>of</strong> Glaucoma<br />
Page 1 <strong>of</strong> 2
D Information from Groups in Support <strong>of</strong> Marijuana<br />
1800 Medical Marijuana com Legal States for Medical Marijuana<br />
Perkel com Marijuana Telling Teenagers the Truth about Smoking Pot<br />
1800 Medical Marijuana com Benefits <strong>of</strong> Medical Marijuana<br />
California NORMAL<br />
Recent Research on Medical Marijuana<br />
California NORMAL Local Medical Marijuana Cultivation Possession<br />
Guidelines<br />
Medical MJ org Addictive Properties <strong>of</strong> Commonly Use Drugs website<br />
page<br />
Medical Marijuana ProCon org<br />
E Information from Groups in Opposition <strong>of</strong> Marijuana<br />
Coalition for a<br />
Drug<br />
Free California List<br />
California Police Chiefs Association<br />
<strong>of</strong> <strong>City</strong> County Moratoria<br />
Marijuana Talking Points<br />
Bans<br />
California Police Chiefs Association White Paper on Marijuana<br />
Dispensaries 2009<br />
Friends <strong>of</strong> the DEA<br />
2009<br />
Marijuana Dispensaries and the Federal Government<br />
General Barry McCaffrey Ret<br />
and Medicine<br />
Marijuana Children The Work Place<br />
Page 2 <strong>of</strong> 2
A Federal Government Information<br />
DOJ DEA website page for Controlled Substances<br />
Act CSA<br />
DOJ letter to <strong>City</strong> <strong>of</strong> Eureka815 11<br />
DOJ letter to <strong>City</strong> <strong>of</strong> Chico701 11<br />
DOJ memo from James Cole629 11<br />
DOJ letter to St <strong>of</strong> Washington414 11<br />
DOJ letter to <strong>City</strong> <strong>of</strong> OaklandZ11<br />
DOJ letter to <strong>City</strong> <strong>of</strong>Oal land12 OS 10<br />
DOJ Memo from David Ogden 10 19 09
M<br />
21 USC Codes Page 1 <strong>of</strong> 1<br />
ed caaa<br />
i<br />
Home<br />
Title 21 Regulations Codified CSA 21 US Codes<br />
Contact Us Site Map Search<br />
Registration<br />
RePOrting<br />
nformatior ancf Lec al Rescrurces t d<br />
caf1Ct1<br />
Info<br />
Legal Resources<br />
Inside Diversion Control<br />
s<br />
t<br />
t<br />
ua<br />
A<br />
Title 21 United States Code USC<br />
Controlled Substances Act<br />
SubchapterI Control And Enforcement<br />
Part A<br />
Introductory Provisions<br />
I<br />
Section<br />
Section 801 Congressional findings and declarations controlled substances<br />
801a Congressional findings and declarations psychotropic substances<br />
Section 802 Definitions<br />
Section 803 Repealed Pub L95 137 Section1b Oct 18 1977 91 Stat 1169<br />
Part B Authority to Control Standards And Schedules<br />
Section 811 Authority and criteria for classification <strong>of</strong> substances<br />
Section 812 Schedules <strong>of</strong> controlled substances<br />
Section 813 Treatment <strong>of</strong> controlled substance analogues<br />
Section 814 Removal <strong>of</strong> exemption <strong>of</strong> certain drugs<br />
Part C Registration <strong>of</strong> Manufacturers Distributors and Dispensers <strong>of</strong> Controlled<br />
Substances<br />
II<br />
411dfiltfllS OY<br />
U<br />
II I<br />
Section 821 Rules and regulations<br />
Section 822 Persons required to register<br />
Section 823 Registration requirements<br />
Section 824 Deniai revocation orsuspension <strong>of</strong> registration<br />
Section 825 Labeling and packaging<br />
Section 826 Production quotas for controlled substances<br />
Section 827 Records and reports <strong>of</strong> registrants<br />
Section 628 Order forms<br />
Section 829 Prescriptions<br />
Section 830 Regulation <strong>of</strong> listed chemicais and certain machines<br />
Section 831 Additional requirements relating to online pharmacies and telemedicine<br />
Part D Offenses And Penalties<br />
I<br />
Section 841 Prohibited acts A<br />
Section 842 Prohibited acts B<br />
Section 843 Prohibited acts C<br />
http www<br />
deadiversion usdoj gov 21 cfr 21usc index html 929 2011
i<br />
I<br />
i<br />
i<br />
US Department <strong>of</strong> Justice<br />
Unr7edSlrrlesAnornep<br />
Na daeriv Dish Ic1 <strong>of</strong>Cali wnia<br />
Ncllnda Hnag<br />
Iln IedSr<strong>of</strong>tl Aflonmp<br />
lldi Flaor idaul8uild uS<br />
esn coid Go e Areu<br />
Bor 35055<br />
Son Frencimo Coli onda 9Jl0 J9<br />
JIS J36d2q0<br />
F945 JSI JJ6 73<br />
A is zot<br />
1<br />
Robert S Wall<br />
iU F<br />
Director<strong>of</strong>ConununityDevelopment tl I<br />
<strong>City</strong> <strong>of</strong> Euteka t ut F 74<br />
531 K Street<br />
I<br />
t<br />
Eareka CA 955D1 1146<br />
Dear blr Well<br />
I write in response to your letter duted August 8 201l seeking guida tce regarding<br />
ncdical cannabis growing facilities infl e Cir <strong>of</strong> Evreka Califomia<br />
As the Department lias slated on many oecasions Congress tasde ermined fliat<br />
marijuana is a controlled suhstance Congresspl ced marijuana in Schedule I <strong>of</strong> We Controlled<br />
Substances Ac CSA and as such growing distributing and possessing marijuana in any<br />
rApacity otlier then as part <strong>of</strong> a federally nuthorized research progTam is a viola6on <strong>of</strong> federal<br />
law regardless <strong>of</strong> state laws pettnitting suchar tivities<br />
The prosecution <strong>of</strong> indiviJuals and organizations involved in ihe trede <strong>of</strong> nny illega drugs<br />
and the disruption <strong>of</strong> drug trafficking organiz itions is a core priority <strong>of</strong> the Deparhnent Tlus<br />
core piioriry includes prosecution <strong>of</strong> 6usiuess euterprises thac wilawtully aiarkeL and sell<br />
marijuana As stated in the Octoher 2009 Ogden Memoruidum and reitereted recently in ihe<br />
2011 Cole Memorandum tl e Deparunent does not focus its limi ed resources on seriously il<br />
individuals who use marijuana as pari <strong>of</strong> a medically recommended treaiment regimeu in<br />
con pliance tvilhst te law fiowcvec individttals and orgatuzations who are in the business <strong>of</strong><br />
i<br />
cultivating selling or distributing marijua ia and those who knowingly faci itnte such actjviUes<br />
are in violation <strong>of</strong> the Convolled Substances Act and are subject to federal enforcement even if<br />
such nclivities are permitted undcr stalc laH<br />
Consistent with federal law Uie Depvtment maintains the authoriry to pursue criminal or<br />
civil actions for any CSA violationswl enever tlie Department detennines that such legel action<br />
is warranted This ineludes bul is not limited to actions to enforce tl e criminat provisions <strong>of</strong> ihe<br />
CSA such as Title 21 Section S41 malcing it illegal to mnnufacture distributc or possess with<br />
intent to distribut any conirolled substance including niazijuana Titte 21 Section 856 making it<br />
unlawFul to Imowingly open lease rent muintain or usc property for the manufacturing storing<br />
or dislri6ution oFcontrolled substances and7itle 2l Section S46 making it illegaf to conspire to<br />
commit any <strong>of</strong> the crimes set Fortl in the CS Federal money laupdering and reJated statutes<br />
that prohibit a variety <strong>of</strong> different types <strong>of</strong> financial activity involving the movement <strong>of</strong> drug
I<br />
Robert S Wall<br />
Augusl 15 20 1<br />
Page 2<br />
proceeds may ikewise beuilized The gove rnment may also porsue civil injunctions and the<br />
forfaiture <strong>of</strong> drug praceeds property raceable to such proceeds and property used to facilitate<br />
drug violations<br />
The Departmen is concemed a6ovt die Ciry <strong>of</strong> Eurel as creation <strong>of</strong>a licensing scheme<br />
that permits large scele industrint mariju na culEivation processing and distribution as it<br />
authori2es conduct cantrary ta federaf taw an3 threatens tl e Federal governmenl s eSoru to<br />
regulate the possession manufacturing and trdfficking <strong>of</strong> controlled substances Individuals who<br />
elect to operate any such facili6es wiU 6e doing so in violation oFfederal law OtLers who<br />
knowingly facilitnte the actions <strong>of</strong> these individuals including propeiry owners landlords and<br />
finnnciers should also tcnow Uiat lheir conduc t vio ates federel law if the Ciry <strong>of</strong> Eureka were to<br />
pmceed this <strong>of</strong>fice tivould consider injunetive actions civil fines criminal prosecution and the<br />
forfeiture <strong>of</strong> any property used to facilitateaiolation <strong>of</strong> Uie CSA As tlie Attomey Generat hns<br />
repeatedly sta ed de Depazipte<br />
<strong>of</strong> JusGce remains frimly comn itted 10 enforcing the CSA in<br />
all states<br />
matter<br />
1 hope this letter assists the <strong>City</strong> <strong>of</strong> Eureka in muking informed decisions regnrding flris<br />
Very truly yours<br />
r1<br />
T<br />
Melinda Haag<br />
United St tes Attomey<br />
Northern Districl <strong>of</strong> California<br />
cc<br />
David Tyson <strong>City</strong> Manager<br />
Mike FCnighi Assistant Cify Monager<br />
<strong>City</strong> Attorney
Jul V1 2011 14 17 From US AiTORNEY 96 654 2874 T459 P002 003 F304<br />
US DEPARTMENT OF NSTtCE<br />
nSy<br />
i UnrtedStatesAttorney<br />
a<br />
Eastern Drstrici <strong>of</strong> CaTfornia<br />
a<br />
Nenjantin 6 Wogr er<br />
Jnifed 1alesAq rney<br />
koben TMsui<br />
Unitcd Stntes Courthouse<br />
Ph nc514 554 70<br />
501 I Svtc4 Sme IG 100 Fuz 916 554 2900<br />
Socramento CA 95814 TTD 97fd554 2fl55<br />
July 1 2011<br />
Mayor Ann Schwab<br />
<strong>City</strong> <strong>of</strong> Chico<br />
PO Box 3420<br />
Chico CA 9592 7<br />
Dear Mayor Schwab<br />
It has come to my Artention that the <strong>City</strong> <strong>of</strong> Chico is considering an ordinance whicl would<br />
authorize permits for two medica marijuana cultivation facilities each up to 10 000 square feet<br />
Tlvs etter isvrinen to ensure there is no conftuion regarding the US Departmem <strong>of</strong> lustice<br />
position regerding munScipal ordinances and state Iaws that purport to estabiish proposed marijuana<br />
cultivation or licensing programs<br />
Congress has determined that marijuana is a eontrolled substance Conaess placed marijuana<br />
in Schedule I <strong>of</strong> the Controlled SubstanCes Act CSA and as such growing distributing and<br />
possessing marijuana in any capaciTy otl er than as part <strong>of</strong> a federally authorized research prram is<br />
a violation <strong>of</strong> federal law regardless <strong>of</strong> state laws permirting such acuviries The Deparm ent <strong>of</strong><br />
Justice is firmly commined to enforcing the CSA in all states As stated in the October 2009<br />
memorandum from thenTeputy Attomey General llat d Ogden and in the memorandum issued<br />
esterday by Deputy Artorney General James Cole while the Department does not focus its limited<br />
resowces on prosecuting seriously ili indi duals who use mazijuana as part <strong>of</strong> a medically<br />
recommended treatment regimen in compliarice witYt state law we will enforee the CSA viSorously<br />
ainst individvals andor anizations that parucipate in unlav ful manufacnuing and distribution<br />
activiry involving marijuana even if such activities aze permirted under staTe law<br />
Consistent with federal law the Depar ment maintains the authoriry to pursue crir nal or civil<br />
actions for euy CSA violations whenever ihe Department determines that such legat action is<br />
vvazranted This inchzdes but is not imited to actions to enforce the criminal provisions <strong>of</strong> the CSA<br />
such as Title 21 United Scates Code Secuon 841 making it illegal to manufaccure distribute nr<br />
possess with intent to distriUute any controlled substance including marijuana Title 31 United States<br />
Code Section86 making it unlawful to nowingly open lease rent maintain or use property for<br />
the manufaciwing storing or distribution <strong>of</strong> convolledsub tances and Title 21 tinited Stutes Code<br />
1
Jul D1 2011 14 17 From US ATTORNEY 016 554 2874 i459 P003 03 P304<br />
Secdon 8A6 mal ing it illegal to conspire to commit any <strong>of</strong> the crimes set forrh in the CSA Federal<br />
mney aundering and reJated statutes which prohibit a variety <strong>of</strong>different types <strong>of</strong>financial acti iry<br />
involving the movement <strong>of</strong> drug proceeds may like vise Ue utilized The government may also pursue<br />
ci 71 injunctions and the forfeittue <strong>of</strong> drug proceeds property traceable to such proceeds and<br />
property used to facilitate drug violations<br />
The Department is concemed about the proposed ordinance in the <strong>City</strong> <strong>of</strong> Chico as it would<br />
authorize conduct contrary to federal law and threatens tl e federal govemment s effons to regulate<br />
the possession manufacnuing and uafficking <strong>of</strong> controlled sutscances Individuals who elect to<br />
operate industrial marijuana cultivationfcilities will be doing so in violation <strong>of</strong> feder l law Others<br />
who knowingly facilitate such industria eultivation activities including property owners landlords<br />
and financiers should also know tkia their conduct violates federal law<br />
Ilope this letter assisFs you in making informed decisions regarding a proposed ordinance<br />
which would permit the estalalishment <strong>of</strong> significant marijuana culuvation faciliries in the Ciry <strong>of</strong><br />
Chico<br />
Very truly yours<br />
Be unin B Wagner1<br />
United States Attorney<br />
Eastcrn District <strong>of</strong> Califomia<br />
cc<br />
Kamala D Harris Attorney Creneral <strong>of</strong> the State <strong>of</strong> Califomia<br />
Mike Ramsey Burte Counry Disuict Attomcy<br />
David Burkland Chico <strong>City</strong> Manager<br />
Lori J Barker Chico <strong>City</strong> Attomey<br />
Z
US Departinent <strong>of</strong>Jstice<br />
OfFice <strong>of</strong> the Deputy Attorney General<br />
Nfirhingron 00 X15J0<br />
June 29 2011<br />
MEMORANDUM FOR UNITED STAT<br />
FROM James M Cole V<br />
Deputy Attom<br />
General<br />
SUBIECT<br />
Cuidance Regazding the Ogden Memo in Jurisdictions<br />
Seekin to Authorize Mariivana for Medical Use<br />
Over the last several months somc <strong>of</strong> you have requested the Department s assistance in<br />
responding to inquiries from State and local govemments seeking guidance about the<br />
DepartmenCs position on enforcement <strong>of</strong> the Controlled Substances Act CSA in jurisdictions<br />
ihat have under consideration or have implemented legislation that would sanction and regulate<br />
he commercial cultivation and distribution <strong>of</strong> marijuana purpor edly for medical use Some <strong>of</strong><br />
these jurisdictions have considered approving the cultivation <strong>of</strong> large quantitiea <strong>of</strong> marijuana or<br />
broadening the regulation andta ation <strong>of</strong> the substance You may have seen letters responding<br />
to these inquiries by several United States Attorneys Those letters are entirely consistent with<br />
the October 2009 memorandum issued by Deputy Anomey General David Ogden to federal<br />
prosecutors in States that have enacted laws authorizing the medical use <strong>of</strong> marijuana the<br />
Ogden Memo<br />
The Department <strong>of</strong> Justice is commined to the enforcement <strong>of</strong> the Controlled Substances<br />
Act in all States Congress has determincd that marijuana is a dangerous drug and that the illegal<br />
distribution and sale <strong>of</strong> marijuana is a serious crime that provides a significant sounce <strong>of</strong> revenue<br />
to arge scale criminal enterprises gangs and cartels The Ogden Memorandum provides<br />
guidance to you in deploying your resources to enforce the CSA as part <strong>of</strong> the exercise <strong>of</strong> the<br />
broad discretion you are given ro address federal criminal matters within your disficts<br />
A number <strong>of</strong> states have enacted some form <strong>of</strong> legislation relating to the medical use <strong>of</strong><br />
maryjuana Awordingly the Ogden Memo reiterated to you that prosecution <strong>of</strong> significant<br />
trafTickers <strong>of</strong> illegal drugs including marijuana remains a core priority but advised that it is<br />
likely not an efficient use <strong>of</strong> federal resources to focus enforcement efforts on individuals with<br />
cancer or other serious illnesses who use marijuana as part <strong>of</strong> a recommended treatment regimen<br />
consis ent with applicable state law or theit caregivers The enn caregiver as used in the<br />
memorandum mean just thaC individuals providing care to individuals with cancer or other<br />
serious illnesses not commercial operations cultivating selling or disiributing marijuana<br />
The DepartmenPs view <strong>of</strong> the efficient use <strong>of</strong> limited federal resources as articulated in<br />
the Ogden Memorandum has not changed There has however been an increase in the scope <strong>of</strong>
Memorandum for United States Attorneys Page 2<br />
Subject Guidance Regarding the Ogden Memo in Jurisdictions<br />
Seeking to Authorize Marijuana for Medical Use<br />
commercial cultivatioq sale distribution and use <strong>of</strong> mazijuana for purported medical puiposes<br />
For example within the past 12 months several jurisdictions have considered or enacted<br />
legislation to authorize multiple Iarge scale privately operated indusfial marijuana cultivation<br />
centers Some <strong>of</strong> hese planned facilities have revenue projec ions <strong>of</strong> millions <strong>of</strong> dollazs based<br />
on the planned cultivation <strong>of</strong> tens <strong>of</strong> thousands <strong>of</strong>cam abis plants<br />
The Ogden Memorandum was never intended to shield such activities from federal<br />
enforcement action and prosewtion even where those activities purport to comply with state<br />
law Persons who aze in the business <strong>of</strong> cultivating selling ordis ribu ing marijuana and those<br />
who knowingly facili ate such activi ies are in violation <strong>of</strong> he Controlled Substances Act<br />
regardless <strong>of</strong> state law Consistent with resource cons raints and the discretion you may exercise<br />
in your dis ric such persons aze subject to federal enforcement action including poten ial<br />
prosecution State laws or local ordinances are not a defense to civil or criminal enforcement <strong>of</strong><br />
federal law with respect to such conduct including enforcement <strong>of</strong> the CSA Those who engage<br />
in transac ions imolving the proceeds <strong>of</strong> such ac ivity may also be in viola ion <strong>of</strong> federal money<br />
laundering statu es andoher federal financial laws<br />
The Department <strong>of</strong> Justice is tasked with enforcing existing federal criminal laws in all<br />
sta es and enforcement <strong>of</strong> he CSA has long been and remains a core prionty<br />
cc Lanny A Breuer<br />
Assistant Attomey General Criminal Division<br />
B Todd Jones<br />
United States Attomey<br />
District <strong>of</strong> Minnesota<br />
Chair AGAC<br />
Michele M Leonhart<br />
Administrator<br />
Drug Enforcement Administration<br />
H Marshall Jarzett<br />
Direc or<br />
Executive Office for United States Attomeys<br />
Kevin L Perkins<br />
Assistant Director<br />
Criminal Investiga ive Division<br />
Federal Bureau <strong>of</strong> Investigations
US Department <strong>of</strong> Justice<br />
k uN<br />
UnitedStatesAttorney<br />
Eas eDistrict <strong>of</strong> Wnshingio<br />
Suite 340 77 omas S Foley U S Courfhouse 509 353 1767<br />
P O Bax 1491 Fns 509 353 1766<br />
Spokrrse Warhiagton 99210 1494<br />
Honorable Chrisrine Gregoire<br />
Washington State Governor<br />
PO Box 40002<br />
Olympia Washington 98504 0002<br />
April 14 2011<br />
Re<br />
Medical Marijuana Legislativc Proposals<br />
Deaz Honorable Govemor Gregoire<br />
We write in response to your letter dated April 13 2011 seeking guidance from the<br />
Attomey General and our two <strong>of</strong>fices concerning the practical effect <strong>of</strong> the legslation currently<br />
being considered by the Washington State Legislature conceming medical marijuana We<br />
understand that the proposals being considered by theIegislature would establish a licensing<br />
scheme for marijuana growers and dispensaries and for processors <strong>of</strong>marijuaoa infused foods<br />
among other provisions We have consulted with the Attomey General and the Depury Attorney<br />
General about the proposed legislation This letter is written to enswe there is no confusion<br />
regarding the bepartment <strong>of</strong> Justice<br />
view <strong>of</strong> such a licensing scheme<br />
As the Department has stated on many occasions Congess has determined that<br />
marijuana is a controlled substance Congress placed marijuana in Schedule I <strong>of</strong> the Controlled<br />
Substances Act CSA and as such growing distribu6ng and possessing marijuana in any<br />
capacity other than as part <strong>of</strong> a federally authorized research program is a violation <strong>of</strong> federal<br />
law regazdless <strong>of</strong> state laws permitting such acrivities<br />
The prosecution <strong>of</strong> individuals and organizations involved in the trade <strong>of</strong> any illegal drugs<br />
and the disruption <strong>of</strong> drug trafficking organizations is a core priority <strong>of</strong> the Deparhnent This<br />
core priority includes prosecution <strong>of</strong> business enterprises that unlawfully market and sell<br />
marijuana Accordingly while the Department does not focus its limited resources on seriously<br />
ill individuals who use marijuana as part <strong>of</strong> a medically recommcnded treatment regimen in<br />
compliance with state law as stated in the October 2009 Ogden Memorandum we maintain the<br />
authoriry to enforce the CSA vigorously against individuals and organizations that participate in<br />
unlawful manufacturing and distribution acrivity involving marijuana even if sucb activities are<br />
pernvtted under state law The DepartmenYs investigative and prosecutorial resources will<br />
continue to be direcYed toward these objectives
Honorable Christine Gregoire<br />
April 14 201<br />
Page 2<br />
Consistent with fcderal law the Department maintains the authority to pursue criminal or<br />
civil actions for any CSA viola ions whcnevcr thc Department determines that such legal action<br />
is warranted This includes but is not limited to actions to enforce thc criminal provisions <strong>of</strong> thc<br />
CSA such as<br />
21 USC 841 making it illegal to manufacture disvibute or<br />
possess with intent to distribute any controllcd substance including<br />
marijuana<br />
21 USC 856 making it unlawful to knowingly open lease<br />
rent maintain or use property for the manufacturing storing or<br />
distribution <strong>of</strong> controlled substances<br />
21 USC 860 making it unlawful to distributc or manufacture<br />
controlled substances within 000 fect <strong>of</strong> schools collcges<br />
playgrounds and public housing facilities and within 100 feet <strong>of</strong><br />
any youth centcrs public swimming pools and vidco arcadc<br />
facilities<br />
21 USC 843 making it unlawful to usc any communication<br />
facility to commit felony violations <strong>of</strong> thc CSA and<br />
21USC 846 making it illcgal to conspirc ro commit any <strong>of</strong><br />
the crimes set forth in the CSA<br />
In additiontederal money laundering and related statutcs which prohibit a variety <strong>of</strong> different<br />
typcs <strong>of</strong> financial activity involving the movement <strong>of</strong> drug procccds may likewise be utilized<br />
Thc Govcmmcnt may also pursuc civil injunctions and the forfeiturc <strong>of</strong> drug proceeds property<br />
traccable to such proceeds and property uscd to facilitate drug violations<br />
The Washington legislative proposals will create a liccnsing schcmc that permits<br />
largo scale marijuana cultivation and distribution This would authorize conduct contrary to<br />
fcderal law and thus would undcrminc the federal govemmcn s cfforts to regulate thc<br />
possession manufacturing and trafficking <strong>of</strong> concrolled substanccs Accordinely the<br />
Department could consider civil and criminal legal rcmedies regarding those who sct up<br />
marijuana growing facilities and dispcnsaries as they will be doing so in violation <strong>of</strong> federal law<br />
Otl ers who knowingly facilitate the actions <strong>of</strong> the licensees including property owners<br />
landlords and financiers should also know that their conduc violates federal law In addition<br />
state cmployces who conductcd activities mandated by the Washington lcgislativc proposals<br />
would not be immune from liability undcr the CSA Potential actions the Department cou d<br />
consSdcr include injunctivc actions to prcvent cultivation and distribution <strong>of</strong> marijuana and other<br />
associatcd violations <strong>of</strong> the CSA civil fines criminal prosccution and the forfciture <strong>of</strong> any
Honorable Christine Gregoire<br />
April 14 20I I<br />
Page 3<br />
property used to facilitate a violation <strong>of</strong> the CSA As the Attomey General has repeatedly stated<br />
the Department <strong>of</strong> Justice remains fumly committed to enforcing the CSA in all states<br />
We hope this letter assists the State <strong>of</strong> Washington and potential licensees in making<br />
informed decisions regarding the cultivation manufacture and distribution <strong>of</strong> marijuana<br />
Very hvly yours<br />
G<br />
Je Durkan Michael C Om7sby<br />
Unite States Attomey United States Attomey<br />
Westem Disuict <strong>of</strong> Washington<br />
Eastern District <strong>of</strong> Washington
US Department <strong>of</strong> Justice<br />
United States Attorney<br />
Northern District <strong>of</strong>California<br />
Me lnda Haag<br />
IIYh Floor Fede Bvllding 415J 436 7200<br />
UnUedSmles AUOmey 450 Golden Cate Avenue Box 36055<br />
San Fsancisco CapJamla 9410J FifX 415J 436 7134<br />
February I 2011<br />
John A Russo Esq<br />
Oakiand <strong>City</strong> Attorney<br />
i Frank Ogawa Plaza 6th Floor<br />
Oakland California 94612<br />
Dear Mr Russo<br />
I write in response to your letter dated January 14 2011 seeking guidance from the<br />
Attomey General regazding the <strong>City</strong> <strong>of</strong> Oakland Medical Cannabis Cultivarion Ordinance The<br />
US Deparhnent <strong>of</strong> 7ustice is familiaz with the <strong>City</strong> s solicitation <strong>of</strong> applications for pertnits to<br />
operate industrial cannabis cultivation and manufacturing facilities pursuant to Oaklaud<br />
Ordinance No 13033 Oakland Ordinance I have consulted with the Attomey General and the<br />
Deputy Attorney Creneral about the Oakland Ordinance This letter is written to ensure there is<br />
no confusion regazding the Department <strong>of</strong> Justice<br />
view <strong>of</strong> such facilities<br />
As the Department has stated on many occasions Congress has detemuned that<br />
marijuana is a controlled substauce Congress placed marijuana in Schedule I <strong>of</strong> the Controlled<br />
Substances Act CSA and as such growing disllibuting and possessing marijuana in any<br />
capacity other than as part <strong>of</strong> a federally authorized reseazch program is a violation <strong>of</strong> federa<br />
law regardless <strong>of</strong> state laws pemutting such activities<br />
The prosecution <strong>of</strong> individuals and organizations involved in the trade <strong>of</strong> any illegal drugs<br />
and the disruption <strong>of</strong> drugtr cking organizations is a core priority <strong>of</strong> the Department 11ris<br />
core priority includes prosecution <strong>of</strong> business enterprises that unlaw ully market and sell<br />
marijuana Accordingly while ihe Department does not focus its limited resources on seriously<br />
ill individuals who use marijuana as part <strong>of</strong> a medically recouunended treatrnent regimen in<br />
compliance with state law as stated in the October 2009 Ogden Memorandum we will enforce<br />
the CSA vigorously against individuals and organizations that participate in unlawfiil<br />
manufaciuring and distribution activiTy involving marijuana even if such ac6vities are permitted<br />
under state law The DepartmenYs inves6gative and prosecutorial resources will continue to be<br />
directed toward these objectives<br />
Consistent with federat law the Department maintains the authority to pursue crimival or<br />
civil actions for any CSA violations whenever the Department determines that such legal action<br />
is warranted Tlils includes but is not limited to actions to enforce the criminal provisions <strong>of</strong> the<br />
CSA such as Title 2 Section 841 making it IIlegal to manufacture distribute or possess with<br />
intent to dishibute any controlled substance including marijuana Title 21 Secfion 856 making it
John A Russo<br />
Febauary 1 2011<br />
Page 2<br />
unlawful to lmowingly open lease rent maintain or use property for the manufacturing storing<br />
or distribution <strong>of</strong> controlled substances and Title 21 Section 846 making it illegal to conspire to<br />
commit any <strong>of</strong> the crimes set forth in the CSA Federal money laundering and related statutes<br />
which prohibit a variety <strong>of</strong> different types <strong>of</strong> financial activity involving the movement <strong>of</strong> drug<br />
proceeds may likewise be ufllized The government may also pursue civil injuncfions and ihe<br />
forfeiture <strong>of</strong> drug proceeds property traceable to such proceeds and property used to facIlitate<br />
drug violations<br />
The Department is concemed about the Oakland Ordinance s creation <strong>of</strong> a licensing<br />
scheme that pernuts lazge scale industrial marijuana culdvation and manufacturing as it<br />
authorizes conduct contrary to federal law and threatens the federal govemmenYs efforts to<br />
regulate the possession manufacturing and trafFicking <strong>of</strong> controlled substances Accordingly<br />
the DeQar ent is carefully considering civil and criminal legal remedies regazding those who<br />
seek to set up industrial marijuana growing wazehouses in Oakland pwsuant to licenses issued by<br />
the <strong>City</strong> <strong>of</strong> Oakland Individuals who elect to operate industrial cannabis cultivarion and<br />
manufacturing facilities will be doing so in violation <strong>of</strong> federal law Others who knowingly<br />
facilitate the actions <strong>of</strong> the licensees inciuding property owners landlords and financiers should<br />
atso know that theu conduct violates federal law Potential acdons the Departrnent is<br />
considering include injunctive actions to prevent cultivation and distribution <strong>of</strong> marijuana and<br />
other associated violalions <strong>of</strong> the CSA civil Fmes criminal prosecution and the forfeiture <strong>of</strong> any<br />
property used to facilitate a violation <strong>of</strong> the CSA As the Attorney General has repeatedly stated<br />
the Department <strong>of</strong> Justice remains finnly committed to enforcing the CSA in all states<br />
I hope this letter assists the <strong>City</strong> <strong>of</strong> Oakland and potential licensees in making informed<br />
decisions regarding the cufrivation manufacture and distribution <strong>of</strong> marijuana<br />
Very truly yours<br />
Melinda Haag<br />
United States Attorney<br />
Northem Dishict <strong>of</strong> California<br />
cc<br />
Kamala D Harris Attorney General <strong>of</strong> the State <strong>of</strong> Califotnia<br />
Nancy E OMalley Alameda County District Attorney
12 21 2010 17 00 5102084965 DA RM 213 PA6E 02l04<br />
December 8 2010<br />
Mayor Eiect Jean Quan<br />
Oakland <strong>City</strong> Hall<br />
Frank Ogawa Plaza<br />
Oakland CA 94fi07<br />
Dear Mayor Elect Quan<br />
Congratulations on your election f hope this letter finds you weli I look forward to<br />
joining together in our work towards a safe healthy and thriving Oakland in the New<br />
Year<br />
I am writing to you regarding akland s Ordinance amending Title 5 oE the Oakland<br />
Municipal Code Entitled Business Licenses And Regulatipns to add Chapter581<br />
pertaining to Medical Cannabis Cultivation Facility Permitting and amending the master<br />
tee schedule Ordinance No 9336 as Amended to establish regulatory fees regarding<br />
this activiiy The Alameda County District Attorney s Office has a long standing policy<br />
<strong>of</strong> declining to issue advisory opinions as to the legality <strong>of</strong> any particular conduct To<br />
that end this le8er is not nor should it be interpretedas an aduisory opinion on the<br />
legality <strong>of</strong> the Ordinance ar any part contained therein<br />
I make the point that this ce haS always taken a very reasonable approach to<br />
enforcement <strong>of</strong> the marijuana laws in light <strong>of</strong> the Gompassionate lJse Act and the<br />
Medical Marijuana Program As a cancer survivor myself I certainly understand the<br />
6enefits for those in need <strong>of</strong> themdicinal use <strong>of</strong> marijuana in uariousfrms This<br />
reasonable policy and approach should not be taken as an endorsement <strong>of</strong> the<br />
Ordinance or as a deciaration that those engaging in conduct outside the parameters<br />
<strong>of</strong> the law as it pertains to marijuana will be ignored<br />
Earlier this year my 5tafF was in discussion with Council staff regarding legal concerns<br />
the As Office had with the Ordinance if it passed At that time we were told that with<br />
respect ta the Ordinance Council would wait untii the outcome <strong>of</strong> Proposition 19<br />
Obviously Prop 19 failed to pass it is my understanding that Councii is now moving<br />
forvvard with your Ordinance This letter is being written to alert you to legal concems<br />
still held by the Alameda County District Attorney sOce regarding the Ordinance<br />
particularly in light <strong>of</strong> recenk case law opinions regarding the Compassionate Use Act<br />
CUA and the Medi al Marijuana Program Act MMP<br />
The CUA and MMP define primary caregiver as the individual designated by the<br />
person exempted under this section who has consistently assumed responsibility for the<br />
housing health or safety <strong>of</strong> that person emphasis is mine The definition beoomes
12 21 2010 17 00 5102084965 DA RM 213 PAGE 03 04<br />
very significant in terms <strong>of</strong> who is aliowed by California lew to cultivate and provide<br />
marijuana to others I would point out that mos recently the California Court <strong>of</strong><br />
Appeals in People v Hochanadel210 176Cal App 4th 997 relying on the<br />
Califomie Supreme Court case <strong>of</strong> People v Mentch 2008 45 Cal 4th 274 found that<br />
operators <strong>of</strong> storefront medical manjuana dispensary were not primary caregivers<br />
exempted from liability for certain narcotics <strong>of</strong>fenses under Compassionate Use Act and<br />
Medical Marijuana Program Act despite them being designated as such by medical<br />
marijuana patients who purchased medical marijuana from them The Court found that<br />
where there was no evidence <strong>of</strong> an existing established relationship providing for<br />
housing health or safety indepanden <strong>of</strong> the administration <strong>of</strong> inedical marijuana the<br />
dispensary operators did not qualify as caregivers under the legal definition set forth in<br />
the law The MMP set limits on the number <strong>of</strong> plants that could be possessed or<br />
cultivated The same section <strong>of</strong> the code but a different subsection authorizes<br />
possession and or cultivation in amoun s for reasonable use for the patient In sfriking<br />
down the limits language as it pertains to medicinal use or cuftivation for medicinal<br />
use the Supreme Court did not extend its ruling to HS Sections 11359 and 11360<br />
possession for sale and sale <strong>of</strong> marijuana outside the CUA and MMP See Peapfe v<br />
Kelly 2010 24 Cal 4 10D8<br />
7he Alameda County District Attorney soce makes the point that enactment <strong>of</strong> this<br />
Ordinance does nt provide a defense over and above the defense provided by the<br />
Campassionate Use Act Health and Safety Code section 11362 5 aka Prop 215 or the<br />
Medical Marijuana Program Mealth and Safety Code sections 113 2J et seq to any<br />
criminal charge In other words n<strong>of</strong>wifhstanding pronouncements by city <strong>of</strong>ficials or the<br />
enactment <strong>of</strong> the Ordinance he prosecuting agency in Alameda County is not<br />
pro iding any assurances that activities authorized by the Ordinance but not authorized<br />
under state law or federal law are permissible Persons should not rely s<strong>of</strong>efy upon<br />
pronouncements by city <strong>of</strong>fcials or enactment <strong>of</strong> the rdinsnce as providing any legal<br />
or equiYable defense to a criminal prosecution Nor should persons rely on<br />
pronouncements <strong>of</strong> city <strong>of</strong>ficials or the Ordinance as an accurate inferpretation <strong>of</strong> the<br />
state laws regarding marijuana cultivation possession sale etc and or the defenses<br />
available to those charges<br />
In California as you know culti ation <strong>of</strong> marijuana for medicinal or compassionate use<br />
must benot for pr<strong>of</strong>it The law is quite specific in what can and cannot be the basis <strong>of</strong><br />
exchange <strong>of</strong> money from the primary caregiver and the patient as it pertains to<br />
marijuana Potentiel difficulties might arise in assessing the appropriate amount <strong>of</strong><br />
taxes that can be imposed on transactions undertaken by these large scale marijuana<br />
growing operations This concern is not only with potential difficulties in cases <strong>of</strong> tax<br />
evasion but also persons relying on the Ordinance may 6e placed at risk <strong>of</strong> prosecution<br />
for tax evasion due o the lack <strong>of</strong> clear guidelines in assessing when and how much tax<br />
need be paid<br />
One important caveat is Yhat notwithstanding the language <strong>of</strong> Section581 100 it<br />
remains an open question whether public <strong>of</strong>ficers or public employees who aid and<br />
abet or conspire to violate state or federal laws in furtherance <strong>of</strong> a city ordinance are
12 21 2010 17 00 5102084965 DA RM 213 PAGE 04<br />
exempt from criminal liability<br />
The District Attorney s Office will uphold and enforce the laws <strong>of</strong> this 5tate As is the<br />
policy in this Office alleged violations <strong>of</strong> the law will be reviewed on a by case<br />
basis<br />
Thank you for your attention to these issues I am not providing to you an advisory<br />
opinion on the legality <strong>of</strong> your Ordinance hat is the purview <strong>of</strong> your <strong>City</strong> Attorney<br />
Mowever if you would like to discuss this further please don t hesitate to contact me<br />
5incerely yaurs<br />
Nancy EOMalley<br />
District Attorney<br />
Cc <strong>City</strong> Attorney John Russo
LS1epartment <strong>of</strong>Jstice<br />
f<br />
Oflice <strong>of</strong> the Deputy Attorne General<br />
r np r r tc wrn<br />
October 19 20U9<br />
Mt 10R 1NDUi lESF LF TLDitiI 1Ft STA f1SAT CORNT YS<br />
a<br />
FRO vI<br />
llavid 1 Ogdcav<br />
leputy Attorney General<br />
SCRJEiC7<br />
Im esti ations and Prosccutiuns it Statcs<br />
Authurizine thc lcdical Usc <strong>of</strong> Ntariivana<br />
1 memorandum pro ides clarificafion andgiidance to fedcral prosecutors in Stares<br />
tlia ha e enacted laws authorizing the medical use <strong>of</strong> mnrijuana These lnw s an in their<br />
substan ieroci ions end in the extern uf statu regulutonucrsight both amonn he enacting<br />
States and an ong locul jurisdictiuns ithi thosc Statcs Kather than decdoping diftcrcnt<br />
euidclines for e ery possihle arinnt <strong>of</strong> state and local law this memorandum pro idcs uniform<br />
uidunce to focus fed rl incestig ticros nnd prosccutions in thesc States on cure icdcral<br />
rNurccmcnt priorities<br />
Il cfepartmcm ul Justirc is committcd to the enfurccmcnt <strong>of</strong>ilc Controlled Substances<br />
Zet in ull Sts Congress has determincd diat mnrijuana is a dangerous drug and the illegal<br />
istribution ad salc ol marijuanu is serious crime andro ides a signilicant tiource <strong>of</strong>re enue<br />
to large sc ile criminal rntcrprises gangs and cartels One timeh example underscores thc<br />
im ortancr nl our clCotts tu prosecute significant marijuanaualTickers marijuana distrihution in<br />
hc l nited Statcs remains the sint le largest source <strong>of</strong> revenuefor the YIexican carids<br />
l he1epanment is also committed to mxkin efficirnt nd rational use <strong>of</strong> its limited<br />
incsti ati e and prosccutorial resources In general Ui ited Stdtes Attorne s arc vested witl<br />
nlenar uthorit ilh regard to federel criminal matters aithin theirdistricts US 49 9001<br />
Incrcising this authorittnit d Smtcs Attorncys ar invcsic b statutc xnd dclegation from<br />
th ttornc ienrrul tiith the broadest discretion in the rserciseot such authoriri d fhis<br />
uulhunt shauldn1 ourse br cxrrcised consistent cith Departmrnt priurities mdui linc<br />
Ihc prascc ition ufsi nilicanttial ficl crs ufillcgal trugs includin muriivana and ihc<br />
Jisruption oC illegal diu manuf ctu inc unhafticl ing netv orlcs eontinucs to be t corc riurit<br />
in thrIcpartmcnt s ctfl rt against nm and dangerous drugs and thc cpanmrnt s<br />
imestigati c and prusecuturinl resow ces should he dircctedto ards thrse objecti es s a<br />
encrnl muucr pursuit <strong>of</strong> thcsc prinrilics should not tiicus icdcral resnurccs in ourSatcs on
Memorandum for Selected United Statcs Attorneys Page 2<br />
Subject Investigations and Prosecutions in States Authorizing the Medical Use <strong>of</strong> Marijuana<br />
indi idualsHhose actions are in clear and wiambiguous compliance with existing state laws<br />
pro iding for the medical use <strong>of</strong> mazijuana For example prosecution <strong>of</strong> individuals with cancer<br />
or other scrious illnesses who use marijuana as part <strong>of</strong> a recommended treatment regimen<br />
consistent with applicable state lav or those caregivers in clear and unambiguous compliance<br />
ith existing state law who provide such individuals wth marijuana is unlikely to be an efficient<br />
use <strong>of</strong> limited federal resources On the other hand prosecution <strong>of</strong> commercial enterprises that<br />
unla fully market and sell marijuana for pr<strong>of</strong>it continues to be an enforcement priority <strong>of</strong> the<br />
Department To be sure claims <strong>of</strong> compliance with state or local law may mask operations<br />
inconsistent with the terms conditions or purposes <strong>of</strong> those taws and federal law enforcement<br />
should not be deterred by such assertions when otherwise pursuing the Depattment s core<br />
enforcement priorities<br />
Tpically when any <strong>of</strong> the following characteristics is present the conduct vill not be in<br />
clear and unambiguous compliance with applicable state law and may indicate illegal drug<br />
tralficking activity <strong>of</strong> potential federal interest<br />
unla ul possession or unla tifiul use <strong>of</strong> firearms<br />
iolencc<br />
sales to minors<br />
financial and marketing activities inconsistent with the terms conditions or purposes <strong>of</strong><br />
state law including evidence <strong>of</strong> money laundering activity and or financial gains or<br />
exeessive amounts <strong>of</strong> cash inconsistent with purported compliance ith state or local law<br />
amoients <strong>of</strong> marijuana inconsistent with purported compliance with state or ocal law<br />
illegal possession or sale <strong>of</strong> other controlled substances or<br />
tics to other criminal enterprises<br />
Of course no State can authorizevio ations <strong>of</strong> federal law and the list <strong>of</strong> factors above is<br />
not intended to describeehaustively when a federal prosecution may berarranted<br />
Accordingly in prosecutions undertl e Controlled Substances Act federal prosecutors aze not<br />
expccted roei arge rove or otherwise establish any state law violations Indeed this<br />
memorandum does not alter in vrv way the DepartmenYs authority to enforce federal law<br />
including laws prohibiting the manufacture production distribution possession or use <strong>of</strong><br />
marijuana on federal property This guidance regarding resource allocation does not legalize<br />
marijuana or provide a legal defense to a violation <strong>of</strong> federa law nor is it intended to create any<br />
pri ileges benefits or rights substantive or procedural enforceable by am individual party or<br />
imess in any administrative civil or criminal matter Nor does clear and unambiguous<br />
compliance with state la or the absence <strong>of</strong> one or a11 <strong>of</strong> the above factors create a legal defense<br />
to a violation <strong>of</strong> the Controlled Substanccs Act Rather this memorandum is intended soiely as a<br />
guide to the xercise <strong>of</strong> investigative and prosecutorial discretion
Memorandum for Selected linited States Attorneys Page 3<br />
Subject lnvestigations and Prosecutions in States Authorizing the Medical Use <strong>of</strong> Marijuana<br />
Finally nothing herein precludcs investigation or prosecution where there is a reasonable<br />
basis to believe that compfiance with state law is being invoked as a pretext for the production or<br />
distribution <strong>of</strong> marijuana for purposes not authorized by state law Nor does this guidance<br />
preclude investigation or prosecution eeen when there is clear and unambiguous compliance<br />
with existing state lav in particular circumstances where investigation or prosecution othenvise<br />
serves important federal interests<br />
Your <strong>of</strong>fices should continue to review marijuana cases for prosecution on a by case<br />
basis consistent with the guidance on resource allocation and federal priorities set forth herein<br />
the consideration <strong>of</strong> requests for federal assistance from state and loca law enforcement<br />
authorities and the Principles <strong>of</strong> Federa Prosccution<br />
cc All United States Attorneys<br />
Lanny A Breuer<br />
Assistant Attorney General<br />
Crimina llivision<br />
B Todd Jones<br />
lnite States Attomey<br />
District <strong>of</strong> Minnesota<br />
Chair Attorney GeneraPs Advisory Committee<br />
Michele M Leonhazt<br />
Acting Administrator<br />
Drug Enforcement Administration<br />
H Marshafl Jarrett<br />
Director<br />
rxecuti<br />
Office for United States Attorneys<br />
Kc in L Perkins<br />
Assistant Director<br />
Criminal Investigative Division<br />
Federal Bureau <strong>of</strong>Im esti ation
B State <strong>of</strong> California lnformation<br />
Guidelines for the Security and Non Diversion <strong>of</strong><br />
Marijuana Grown for Medical Use Guidelines<br />
Medical Marijuana Program MMP website page<br />
Health Safety Code Article 2 Marijuana<br />
Section 11357 11369<br />
Health Safety Code Article 25 Medical<br />
Marijuana Program<br />
Section 711362 83
EDMUND G BROWN JR<br />
Attorney General 04<br />
G<br />
o T<br />
p<br />
libcn<br />
RNr<br />
uN rinw<br />
F<br />
A<br />
9 u<br />
r L F<br />
1 Jh<br />
o y<br />
2<br />
DEPARTMENT OF JUSTICE<br />
State <strong>of</strong> California<br />
GUIDELINES FOR THE SECURITY ANDNON<br />
DIVERSION<br />
OF MARIJUANA GROWN FOR MEDICAL USE<br />
August 2008<br />
In 1996 California voters approved an initiative that exempted certain patients and their<br />
primary caregivers from criminal liability under state law for the possession and cultivation <strong>of</strong><br />
marijuana In 2003 the Legislature enacted additional legislation relating to medical marijuana<br />
One <strong>of</strong> those statutes requires the Attorney General to adopt guidelines to ensure the security and<br />
nondiversion <strong>of</strong> marijuana grown for medical use Health Sa Code 11362 81d To<br />
fulfill this mandate this Office is issuing the following guidelines to 1 ensure that marijuana<br />
grown for medical purposes remains secure and does not find its way tonon patients or illicit<br />
markets 2 help law enforcement agencies perform their duties effectively and in accordance<br />
with California law and 3 help patients and primary caregivers understand how they may<br />
cultivate transport possess and use medical marijuana under California law<br />
L<br />
SUMMARY OF APPLICABLE LAW<br />
A<br />
California Penal Provisions Relating to Marijuana<br />
The possession sale cultivation or transportation <strong>of</strong> marijuana is ordinarily a crime under<br />
California law See eg 11357 possession <strong>of</strong> marijuana is a misdemeanor 11358<br />
cultivation <strong>of</strong> marijuana is a felony Veh Code 23222 possession <strong>of</strong> less than 1 oz <strong>of</strong><br />
marijuana while driving is a misdemeanor 11359 possession with intent to sell any<br />
amount <strong>of</strong> marijuana is a felony l 1360 transporting selling or giving away marijuana<br />
in Califomia is a felony under 285 grams is a misdemeanor 11361 selling or<br />
distributing inarijuana to minors or using a minor Yo transport sell or give away<br />
marijuana is a felony<br />
B Proposition 215 The Compassionate Use Act <strong>of</strong> 1996<br />
On November 5 1996 California voters passed Proposition 215 which decriminalized the<br />
cultivation and use <strong>of</strong> marijuana by seriously ill individuals upon a physician<br />
recommendation<br />
1362 5 Proposition 215 was enacted to ensure that seriously ill<br />
Californians have the right to obtain and use marijuuia for medical purposes where that<br />
medical use is deemed appropriate and has been recommended by a physician who has<br />
determined that the person<br />
health would benefit from the use <strong>of</strong> marijuana and to<br />
ensure that patients and their primary caregivers who obtain and use marijuana for<br />
Unlessotk erwise noted all stat tory refereoces are to the Heal h Safety Code<br />
1
medical purposes upon the recommendation <strong>of</strong> a physician are not subject to criminal<br />
prosecutionorsanction ll362 5b1AB<br />
The Act further states that Section 11357 relating to the possession <strong>of</strong> marijuana and<br />
Section 11358 relating to the cultivation <strong>of</strong> marijuana shall not apply to a patient or to a<br />
patienYs primary caregiver who possesses or cultivates marijuana for the personal medical<br />
purposes <strong>of</strong> the patient upon the written or verbal recommendation or approval <strong>of</strong> a<br />
physician 11362 5d Courts have found an implied defense to the transportation <strong>of</strong><br />
medical marijuana when the quantity transported and the method timing and distance <strong>of</strong><br />
the transportation are reasonably related to the patienYs current medical needs People<br />
vTppet 1997 56Cal App 4th 1532 1551<br />
C Senate Bill 420 The Medical Marijuana Program Act<br />
On January 1 2004 Senate Bill 420 the Medical Marijuana Program Act MMP became<br />
law 711362 83 The MMP among other things requires the California<br />
Department <strong>of</strong> Public Health DPH to establish and maintain a program for the voluntary<br />
registration <strong>of</strong> qualified medical marijuana patients and their primary caregivers through a<br />
statewide identiFication card system Medical marijuana identification cards are intended<br />
to help law enforcement <strong>of</strong>ficers identify and verify that cardholders are able to cultivate<br />
possess and transport certain amounts <strong>of</strong> marijuana without being subject to arrest under<br />
specific conditions 11362J1 e 11362 78<br />
It is mandatory that all counties participate in the identification card program by<br />
a providing applications upon request to individuals seeking to join the identification<br />
card program b processing completed applications c maintaining certain records<br />
d following state implementarion protocols and e issuing DPH identification cards to<br />
approved applicants and designated primary caregivers 11362 71b<br />
Participation by patients and primary caregivers in the identification card program is<br />
voluntary However because identification cards <strong>of</strong>fer the holder protection from arrest<br />
are issued only after verification <strong>of</strong> the cardholder s status as a qualified patient or primary<br />
caregiver and are immediately verifiable online or via telephone they represent one <strong>of</strong> the<br />
best ways to ensure the security andnon diversion <strong>of</strong> marijuana grown for medical use<br />
In addition to establishing the identification card program the MMP also de mes certain<br />
terms sets possession guidelines for cardholders and recognizes a qualified right to<br />
collective and cooperative cultivation <strong>of</strong> inedical marijuana 11362 7 11362 77<br />
11362 775<br />
D<br />
Taxability <strong>of</strong> Medical Marijuana Transactions<br />
In February 2007 the California State Board <strong>of</strong> Equalization BOE issued a Special<br />
Notice confinning its policy <strong>of</strong> taacing medical marijuana transactions as well as its<br />
requirement that businesses engaging in such transactions hold a Seller s Permit<br />
http www boe ca gov news<br />
medse11er2007 pdf According to the Notice having a<br />
Seller s Pernut does not allow individuals to make unlawful sales but instead merely<br />
provides a way to remit any sales and use taxes due BOE further clarified its policy in a<br />
2
June 2007 Special Notice that addressed several frequently asked questions concerning<br />
taxation <strong>of</strong> inedical marijuana transactionshttp www boe ca gov news<br />
173 pdf<br />
E<br />
Medical Board <strong>of</strong> California<br />
The Medical Board <strong>of</strong> California licenses investigates and disciplines Califomia<br />
physicians Bus Pro Code 2000 et seq Although state law prohibits punishing a<br />
physician simply for recommending marijuana for treatment <strong>of</strong> a serious medical condition<br />
11362 5c the Medical Board can and does take disciplinary action against physicians<br />
who fail to comply with accepted medical standards when recommending marijuana In a<br />
May 13 2004 press release the Medical Board clarified that these accepted standards are<br />
the same ones that a reasonable and prudent physician would follow when recommending<br />
or approving any medication They include the following<br />
1 Taking a history and conducting a good faith examination <strong>of</strong> the patient<br />
2 Developing a treatment plan with objectives<br />
3 Providing informed consent including discussion <strong>of</strong> side effects<br />
4 Periodically reviewing the treatmenYs efficacy<br />
5 Consultations as necessary and<br />
6 Keeping proper records supporting the decision to recommend the use <strong>of</strong><br />
medical marijuana<br />
http www mbaca gov board media releases 2004 OS 13 marijuana hhnl<br />
Complaints about physicians should be addressed to the Medical Board1800 633 2322<br />
orwww mbaca gov which investigates and prosecutes alleged licensing violations in<br />
conjunction with the Attorney GeneraPs Office<br />
F<br />
The Federal Cantrolled Substauces Act<br />
Adopted in 1970 the Controlled Substances Act CSA established a federa<br />
regulatory system designed to combat recreational drug abuse by making it unlawful to<br />
manufacture distribute dispense or possess any controlled substance 21USC 801<br />
et seq Gonzales v Oregon 2006 546 US 243 271 273 The CSA reflects the federal<br />
governmenYs view that marijuana is a drug with no currently accepted medical use<br />
21USC 812 b1 Accordingly the manufacture distribution or possession <strong>of</strong><br />
marijuana is a federal criminal <strong>of</strong>fense Id at 841 a1 844 a<br />
The incongruity between federal and state law has given rise to understandable<br />
confusion but no legal conflict exists merely because state law and federal law treat<br />
marijuana differently Indeed California s medical marijuana laws have been challenged<br />
unsuccessfully in court on the ground that they are preempted by the CSA Coainty <strong>of</strong> Scn<br />
Diego v Sarz Diego NORML July 31 2008 Ca1 Rptr3d 2008 WL 2930117<br />
Congress has provided that states are free to regulate in the area <strong>of</strong> controlled substances<br />
including marijuana provided that state law does not positively conflict with the CSA 21<br />
USC 903 Neither Proposition 215 nor the MMP conflict with the CSA because in<br />
adopting these laws California did not legalize medical marijuana but instead exercised<br />
the state<br />
reserved powers to not punish certain marijuana <strong>of</strong>fenses under state law when a<br />
physician has recommended its use to treat a serious medical condition See <strong>City</strong> <strong>of</strong><br />
Gm den Grove v Superior Coz rt Kha 2007 157 Ca1 App 4th 355 371 373 381 382<br />
3
In light <strong>of</strong> California s decision to remove the use and cultivation <strong>of</strong> physician<br />
recommended marijuana from the scope <strong>of</strong> the state<br />
drug laws this Office recommends<br />
that state and local law enforcement <strong>of</strong>ficers not arrest individuals or seize marijuana<br />
under federal law when the <strong>of</strong>ficer determines from the facts available that the cultivation<br />
possession or transportation is permitted under California s medical marijuana laws<br />
II<br />
DEFINITIONS<br />
A<br />
Physician<br />
RecommendaHon Physicians may not prescribe marijuana because<br />
the federal Food and Drug Administration regulates prescription drugs and under the<br />
CSA marijuana is a Schedule I drug meaning that it has no recognized medical use<br />
Physicians may however lawfully issue a verbal or written recommendation under<br />
California law indicating that marijuana would be a beneficial treatment for a serious<br />
medical condition 11362 5d Conant v Walters 9th Cir 2002 309 F3d 629 632<br />
B Primary Caregiver A primary caregiver is a person who is designated by a<br />
qualified patient and has consistently assumed responsibility for the housing health os<br />
safety <strong>of</strong> the patient 11362 5e Califomia courts have emphasized the consistency<br />
element <strong>of</strong> the patient caregiver relationship Althoughaprimary caregiver who<br />
consistently grows and supplies medicinal marijuana for a section 1 1362 5 patient is<br />
serving a health need <strong>of</strong> the patient someone who merely maintains a source <strong>of</strong><br />
marijuana does not automatically become the party who has consistenUy assumed<br />
responsibility for the housing health or safety <strong>of</strong> that purchaser People ex rel Lungren<br />
v Per 1997 59 Ca1 App 4th 1383 1390 1400 A person may serve as primary<br />
caregiver to more than one patient provided that the patients and caregiver all reside in<br />
the same<br />
city or county 11362 7d2 Primary caregivers also may receive certain<br />
compensation for their services 11362 765 c A primary caregiver who receives<br />
compensation for actual expenses including reasonable compensation incurred for<br />
services provided to enable a patient to use marijuana under this article or for<br />
payment forout <strong>of</strong> pocket expenses incuned in providing those services or both shall<br />
not on the sole basis <strong>of</strong> that fact be subject to prosecution for possessing or transporting<br />
marijuana<br />
C Qualified Patient A qualified patient is a person whose physician has<br />
recommended the use <strong>of</strong> marijuana to treat a serious illness including cancer anorexia<br />
AIDS chronic pain spasticity glaucoma arthritis migraine or any other illness for which<br />
marijuanaprovidesrelie 11362 5b1A<br />
D Recommending Physician A recommending physician is a person who<br />
1 possesses a license in good standing to practice medicine in California 2 has taken<br />
responsibility for some aspect <strong>of</strong> the medical care treatment diagnosis counseling or<br />
referral <strong>of</strong> a patient and 3 has complied with accepted medical standards as described<br />
by the Medical Board <strong>of</strong> California in its May 13 2004 press release that a reasonable and<br />
prudent physician would follow when recommending or approving medical marijuana for<br />
the treatment <strong>of</strong> his or her patient<br />
4
III<br />
GUIDELINES REGARDING INDI VIDUAL QUALIFIED PATIENTS AND PRIMARY CAREGIVERS<br />
A<br />
State Law Compliance Guidelines<br />
1 Physician Recommendation Patients must have a written or verbal<br />
recommendation for medical marijuana from a licensed physician 11362 5d<br />
2 State <strong>of</strong> California Medical Marijuana Identification Card Under the<br />
MMP qualified patients and their primary caregivers may voluntarily apply for a<br />
card issued by DPH identifying them as a person who is authorized to use possess<br />
or transport marijuana grown for medical purposes To help law enforcement<br />
<strong>of</strong>ficers verify the cardholder s identity each card bears a unique identification<br />
number and a verification database is available onlinewww calmmp<br />
gov In<br />
addition the cards contain the name <strong>of</strong> the county health department that approved<br />
the application a24 hour verification telephone number and an expiration date<br />
11362 71a 11362 735 a34 11362 745<br />
3 Pro<strong>of</strong> <strong>of</strong> Qualified Patient Status Although verbalreco<br />
nmendations aze<br />
technically permitted under Proposition 215 patients should obtain and carry<br />
written pro<strong>of</strong> <strong>of</strong> their physician recommendations to help them avoid arrest A<br />
state identification card is the best form <strong>of</strong> pro<strong>of</strong> because it is easily verifiable and<br />
provides immunity from arrest if certain conditions are met see sectionIII B4<br />
below The next best forms <strong>of</strong> pro<strong>of</strong> are a city or county issued patient<br />
identification cazd or a written recommendation from a pbysician<br />
4 Possession Guidelines<br />
a MMP Qualified patients and primary caregivers who possess a state<br />
issued identification card may possess 8 oz <strong>of</strong> dried marijuana and may<br />
maintain no more than 6 mature or 12 immature plants per qualified patient<br />
11362 7a But ifa qualified patient or primary caregiver has a<br />
doctor s recommendation tbat this quantity does not meet the qualified<br />
patient s medical needs the qualified patient or primary caregiver may<br />
possess an amount <strong>of</strong> marijuana consistent with the patienYs needs<br />
11362 77b Only the dried mature processed flowers or buds <strong>of</strong> the<br />
female cannabis plant should be considered when determining allowable<br />
quantities <strong>of</strong> inedical marijuana for pwposes <strong>of</strong> the MMP 11362 77d<br />
b Local Possession Guidelines Counties and cities may adopt<br />
regulations that allow qualified patients or primary caregivers to possess<br />
On May 22 2008 Califomia s Second District Court <strong>of</strong> Appeal severed Health Safery Code I 1362 77<br />
from the MMP on the ground that the statate<br />
possession guidelines were an unconstiWtiooal amendment <strong>of</strong><br />
Proposition 215 which does not quantify the marijua a patient may possess See People n Kel y 2008 163<br />
Cal AppAth 124 77 Ca1 Rptr3d 390 The Third District Court <strong>of</strong> Appeal recently reached a similar conclusioni<br />
People v Phomphah dv July 31 2008 Cal Rptr3d 2008 WL 2931369 The Califomia Supreme Court has<br />
gran ed review in Kelly and the Attorney General intends to seek review in Phomphakdy<br />
5
medical marijuana in amounts that exceed the MMP s possession<br />
guidelines 11362 77 c<br />
c Proposition 215 Qualified patients claiming protection under<br />
Proposition 215 may possess an amount <strong>of</strong> marijuana that is reasonably<br />
related fo their current medical needs People v Ti ippet 1997 56<br />
Ca1 App 4th 1532 1549<br />
B<br />
Enforcement Guidelines<br />
1 Location <strong>of</strong> Use Medical marijuana may not be smoked a where<br />
smoking is prohibited by law b at or within 1000 feet <strong>of</strong> a school recreation<br />
center or youth center unless the medical use occurs within a residence c on a<br />
school bus or d in a moving inotor vehicle or boat 11362 79<br />
2 Use <strong>of</strong> Medical Marijua in the Workplace or at Correctional<br />
Facilities The medical use <strong>of</strong> marijuana need not be accommodated in the<br />
workplace during work hours or at anyjail correctional facility or other penal<br />
institution 11362 785 a Ross v RagingWire Telecomms Inc 2008 42<br />
Ca1 4th 920 933 under the Fair Employment and Housing Act an employer may<br />
terminate an employee who tests positive for marijuana use<br />
3 Criminal Defendants Probationers and Parolees Criminal defendants<br />
and probationers may request court approval to use medical marijuana while they<br />
are released on bail ar probation The court s decision and reasoning must be<br />
stated on the record and in the minutes <strong>of</strong> the court Likewise parolees who are<br />
eligible to use medical marijuana may request that they be allowed to continue<br />
such use during the period <strong>of</strong> parole The written conditions <strong>of</strong> parole must reflect<br />
whether the request was granted or denied 11362 795<br />
4 State <strong>of</strong> California Medical Marijuana Identification Cardholders<br />
When a person invokes the protections <strong>of</strong> Proposition 215 or the MMP and he or<br />
she possesses a state medical marijuana identification card <strong>of</strong>ficers should<br />
a Review the identi6cation card and verify its validity either by calling<br />
the telephone number printed on the card or by accessing DPH s card<br />
verification websitehrip www calmmp<br />
gov and<br />
b If the card is valid and not being used fraudulently there are no other<br />
indicia <strong>of</strong> illegal activity weapons illicit drugs or excessive amounts <strong>of</strong><br />
cash and the person is within the state or local possession guidelines the<br />
individual should be released and the marijuana should not be seized<br />
Under the MMP no person or designated primary cazegiver in possession<br />
<strong>of</strong> a valid state medical marijuana identification card shall be subject Yo<br />
arrest for possession transportation delivery or culfivation <strong>of</strong> inedical<br />
marijuana 11362 71e Furtherastate or local law enforcement<br />
agency or <strong>of</strong>ficer shall not refuse to accept an identification card issued by<br />
the department unless the state or local law enforcement agency or <strong>of</strong>ficer<br />
6
has reasonable cause to believe that the information contained in the card is<br />
false or fraudulent or the card is being used fraudulently I 1362 78<br />
5<br />
Non<br />
Cardholders When a person claims protection under Proposition<br />
215 or the MMP and only has a locally issuedie non state patient identification<br />
card or a written or verbal recommendation from a licensed physician <strong>of</strong>ficers<br />
should use their sound pr<strong>of</strong>essional judgment to assess the validity <strong>of</strong> the person<br />
medical use claim<br />
a Officers need not abandon their search or investigation The standard<br />
search and seizure rules apply to the enforcement <strong>of</strong>marijuana related<br />
violations Reasonable suspicion is required for detention while probable<br />
cause is required for search seizure and arrest<br />
b Officers should review any written documentation for validity It may<br />
contain the physician<br />
name telephone number address and license<br />
number<br />
c If the <strong>of</strong>ficer reasonably believes that the medical use claim is valid<br />
based upon the totality <strong>of</strong> the circumstances including the quantity <strong>of</strong><br />
marijuana packaging for sale the presence <strong>of</strong> weapons illicit drugs ar<br />
large amounts <strong>of</strong> cash and the person is within the state or local possession<br />
guidelines or has an amount consistent with their current medical needs the<br />
person should be released and the marijuana should not be seized<br />
d Alternatively if the <strong>of</strong>ficer has probable cause to doubt the validity <strong>of</strong> a<br />
person<br />
medical marijuana claim based upon the facts and circumstances<br />
the person may be arrested and the marijuana may be seized It will then be<br />
up to the person to establish his or her medical marijuana defense in court<br />
e Officers are not obligated to accept a person<br />
claim <strong>of</strong> having a verbal<br />
physician<br />
recommendation that cannot be readily verified with the<br />
physician at the time <strong>of</strong> detention<br />
6<br />
Exceeding Possession Guidelines If a person has what appears to be valid<br />
medical marijuana documentation but exceeds the applicable possession<br />
guidelines identified above all marijuana may be seized<br />
7<br />
Return <strong>of</strong> Seized Medical Marijuana If a person whose marijuana is<br />
seized by law enforcement successfully establishes a medical marijuana defense in<br />
court or the case is not prosecuted he or she may file a motion for return <strong>of</strong> the<br />
marijuana If a court grants the motion and orders the return <strong>of</strong> marijuana seized<br />
incident to an arrest the individual or entity subject to the order must return the<br />
property State law enforcement <strong>of</strong>ficers who handle controlled substances in the<br />
course <strong>of</strong> their <strong>of</strong>ficial duties are immune from IiabiIity under fhe CSA 21USC<br />
885 d Once the marijuana is returned federal authorities are free to exercise<br />
jurisdiction over it 21USC 812 c10 844 a <strong>City</strong> <strong>of</strong> Garden Grove v<br />
Super ior Court Kha 2007 157Ca1 App 4th 355 369 386 391<br />
7
IV<br />
GUIDELINES REGARDING COLLECTIVES AND COOPERATIVES<br />
Under California law medical marijuana patients and primary caregivers may associate<br />
within the State <strong>of</strong> California in order collectively or cooperatively to cultivate marijuana for<br />
medical purposes 11362 775 The following guidelines are meant to apply to qualified<br />
patients and primary caregivers who come together to collectively or cooperatively cultivate<br />
physician<br />
recommended marijuana<br />
A<br />
Business Forms Any group that is collectively or cooperatively cultivating and<br />
distributing marijuana for medical purposes should be organized and operated in a manner<br />
that ensures the security <strong>of</strong> the crop and safeguards against diversion fornon medical<br />
purposes The following are guidelines to help cooperatives and collectives operate within<br />
the law and to help law enforcement determine whether they are doing so<br />
1<br />
Statutory Cooperatives A cooperative must file articles <strong>of</strong> incorporation<br />
with the state and conduct its business for Uie mutual benefit <strong>of</strong> its members<br />
Corp Code 12201 12300 No business may call iYselfacooperative or co<br />
op unless it is properly organized and registered as such a corporation under the<br />
Corporations or Food and Agricultural Code Id at 12311 b Cooperative<br />
corporations are democratically controlled and are not organized to make a pr<strong>of</strong>it<br />
for themselves as such or for their members as such but primarily for their<br />
members as patrons Id at 12201 The earnings and savings <strong>of</strong> the business<br />
must be used for the general welfare <strong>of</strong> its members or equitably distributed to<br />
members in the form <strong>of</strong> cash properiy credits or services Ibid Cooperatives<br />
must follow strict rules on organization articles elections and distribution <strong>of</strong><br />
earnings and must report individual transactions from individual members each<br />
year See id at 12200 et seq Agricultural cooperatives are likewise nonpr<strong>of</strong>it<br />
corporate entities since they are not organized to make pr<strong>of</strong>it for themselves as<br />
such or for their members as such but only for their members as producers<br />
Food Agric Code 54033 Agricultural cooperatives shaze many<br />
characterisUcs with consumer cooperatives See eg id at 54002 et seq<br />
Cooperatives should not purchase marijuana from or sell tonon members<br />
instead they should only provide a means for facilitating or coordinating<br />
transactions between members<br />
2 Collectives California law does not define collectives but the dictionary<br />
defines them as a business farm etc jointly owned and operated by the members<br />
<strong>of</strong> a group Random House Unabridged Dictio tary Randoin House Inc<br />
OO 2006 Applying this definition a collective should be an organization that<br />
merely facilitates the collaborative efforts <strong>of</strong> patient and caregiver members<br />
including the allocation oFcosts and revenues As such a collective is not a<br />
statutory entity but as a practical matter it might have to organize as some form <strong>of</strong><br />
business to carry out its activities The collective should not purchase marijuana<br />
from or sell tonon members instead it should only provide a means for<br />
facilitating or coordinating transactions between members
B<br />
Guidelines for the Lawful Operation <strong>of</strong> a Cooperative or Collective<br />
Collectives and cooperatives should be organized with sufficient structure to ensure<br />
securitynon diversion <strong>of</strong> marijuana to illicit markets and compliance with all state and<br />
local laws The following are some suggested guidelines and practices for operating<br />
collective growing operations to help ensure lawful operation<br />
1<br />
Non Pr<strong>of</strong>it Operation Nothing in Proposition 21 S or the MMP authorizes<br />
collectives cooperatives or individuals to pr<strong>of</strong>it from the sale or distribution oP<br />
marijuana Seeeg 11362 765 a nothing in this section shali authorize<br />
any individual or group to cultivate or distribute marijuana for pr<strong>of</strong>iY<br />
2 Business Licenses Sales Tax and Seller s Permits The State Board <strong>of</strong><br />
Equalization has determined that medical marijuana Yransactions are subject to<br />
sales tax regardless <strong>of</strong> whether the individual or group makes a proFit and those<br />
engaging in transactions involving medical marijuana must obtain a Seller s<br />
Permit Some cities and counties also require dispensing collectives and<br />
cooperatives to obtain business licenses<br />
3<br />
Membership Application and Verification When a patient or primary<br />
caregiver wishes to join a collective or cooperative the group can help prevent the<br />
diversion <strong>of</strong> marijuana fornon medical use by having potential members complete<br />
a written membership application The following application guidelines should be<br />
followed to help ensure that marijuana grown for medical use is not diverted to<br />
illicit markets<br />
a Verify the individual s status as a gualified patient or primary caregiver<br />
Unless he or she has a valid sfate medical marijuana identification card this<br />
should involve personal contact with the recommending physician or his or<br />
her agent verification <strong>of</strong> the physician<br />
identity as well as his or her state<br />
licensing status Verification <strong>of</strong> primary caregiver status should include<br />
contact with the qualified patient as well as validation <strong>of</strong> the patient s<br />
recommendation Copies should be made <strong>of</strong> the physician<br />
recommendation or identifieation card if any<br />
b Have the individual agree not to distribute marijuana tonon members<br />
c Have Yhe individual agree not to use the marijuana for other than<br />
medical purposes<br />
d Maintain membership records on site or have them reasonably<br />
available<br />
e Track when members medical marijuana recommendation and or<br />
identification cards expire and<br />
Enforce conditions <strong>of</strong> inembership by excluding members whose<br />
identification card or physician recommendation are invalid or have<br />
expired or who are caught diverting marijuana fornon medical use<br />
9
4<br />
Collectives Should Acquire Possess and Distribute Only Lawfully<br />
Cultivated Marijuana Collectives and cooperatives should acquire marijuana<br />
only from their constituent members because only marijuana grown by a qualified<br />
patient or his or her prunary caregiver may lawfully be transported by or<br />
distributed to other members <strong>of</strong> a collective or<br />
cooperative 11362 765<br />
11362 775 The collective or cooperative may then allocate it to other members <strong>of</strong><br />
the group Nothing allows marijuana to be purchased from outside the collective or<br />
cooperative for distribution to its members Instead the cycle should be a closed<br />
circuit <strong>of</strong> marijuana cultivation and consumption with no purchases or sales to or<br />
fromnon members To help prevent diversion <strong>of</strong> inedical marijuana to non<br />
medical markets collectives and cooperatives should document each member s<br />
contribution <strong>of</strong> labor resources or money to the enterprise They also should track<br />
and record the source <strong>of</strong> their marijuana<br />
5 Distribution and Sales toNon Members are Prohibited State law<br />
allows primary caregivers to be reimbursed for certain services including<br />
marijuana cultivation but nothing allows individuals or groups to sell or distribute<br />
marijuana tonon members Accordingly a collective or cooperative may not<br />
distribute medical marijuana to any person who is not a member in good standing<br />
<strong>of</strong> the organization A dispensing collective or cooperative may credit its members<br />
for marijuana they provide to the collective which it may then allocate to other<br />
members 11362 765 c Members also may reimburse the collective or<br />
cooperative for marijuana that has been allocated to them Any monetary<br />
reimbursement that members provide to the collective or cooperative should only<br />
be an amount necessary to cover overhead costs and operating expenses<br />
6 Permissible Reimbursements and Allocations Marijuana grown at a<br />
collective or cooperative for medical purposes may be<br />
a Provided free to qualified patients and primary caregivers who are<br />
members <strong>of</strong> the collective or cooperative<br />
b Provided in exchange for services rendered to the entity<br />
c Allocated based on fees that are reasonably calculated to cover<br />
overhead costs and operating expenses or<br />
d Any combination <strong>of</strong> the above<br />
7<br />
Possession and Cultivation Guidelines If a person is acting as primary<br />
caregiver to more than one patient under section 11362 7d2 he or she may<br />
aggregate the possession and cultivation limits for each patient For example<br />
applying the MMP s basic possession guidelines if a caregiver is responsible for<br />
three patients he or she may possess up to 24 oz <strong>of</strong> marijuana 8 oz per patient<br />
and may grow 18 mature or 36 iinmature plants Similarly collectives and<br />
cooperafives may cultivaCe and Cransport marijuana in aggregate amounts tied to its<br />
membership numbers Any patient or primary caregiver exceeding individual<br />
possession guidelines should have supporting records readily available when<br />
a Operating a location for cultivation<br />
b Transporting the group s medical marijuana and<br />
c Operating a location for distribution to members <strong>of</strong> the collective or<br />
cooperative<br />
10
8 Security Collectives and cooperatives should provide adequate securily to<br />
ensure that patients are safe and that the surrounding homes or businesses are not<br />
negatively impacted by nuisance activity such as loitering or crime Further to<br />
maintain security prevent fraud and deter robberies collectives and cooperatives<br />
should keep accurate records and follow accepted cash handling practices<br />
including regular bank runs and cash drops and maintain a general ledger <strong>of</strong> cash<br />
transactions<br />
C Enforcement Guidelines Depending upon the facts and circumstances<br />
deviations from the guidelines outlined above or other indicia that marijuana is not for<br />
medical use may give rise to probable cause for arrest and seizure The following are<br />
additional guidelines to help identify medical marijuana collectives and cooperatives that<br />
aze operating outside <strong>of</strong> state law<br />
1 Storefront Dispensaries Although medical marijuana dispensaries<br />
have been operating in Callfornia for years dispensaries as such are not<br />
recognized under the law As noted above the only recognized group entities are<br />
cooperatives and collectives I 1362 775 It is the opinion <strong>of</strong> this Office that a<br />
properly organized and operated collective or cooperative that dispenses medical<br />
marijuana through a storefront may be lawful under California law but that<br />
dispensaries that do not substantially comply with the guidelines set forth in<br />
sectionsIVA and B above are likely operating outside the protections <strong>of</strong><br />
Proposition 215 and the MMP and that the individuals operating such entities may<br />
be subject to anest and criminal prosecution under California law For example<br />
dispensaries that merely require patients to complete a form summarily designating<br />
the business owner as their primary caregiver and then <strong>of</strong>fering marijuanai<br />
exchange for cash donations are likely unlawful Perori supra 59<br />
Ca1 App 4th at p 1400 cannabis club owner was not the primary caregiver to<br />
thousands <strong>of</strong> patients where he did not consistently assume responsibility for their<br />
housing health or safety<br />
2<br />
Indicia <strong>of</strong> Unlawful Operation When investigatiog collectives or<br />
cooperatives law enforcement oFficers should be alert for signs <strong>of</strong> mass production<br />
or illegal sales including a excessive amounts <strong>of</strong> marijuana b excessive<br />
amounts <strong>of</strong> cash c failure to follow local and state laws applicable to similar<br />
businesses such as maintenance <strong>of</strong> any required licenses and payment <strong>of</strong> any<br />
required taxes induding sales taxes d weapons e illicit drugs purchases<br />
from or sales or distribution tonon members or g distribution outside <strong>of</strong><br />
California<br />
I1
Medical Marijuana Program Page 1 <strong>of</strong> 1<br />
hNec6ical Marijuar<br />
Prog m<br />
Aedical Marijuana Program MMP was estabiished to provide a voluntary medical marijuana identification card issuance and<br />
re try program for qualified patients and their caregroers The web based registry system allows law enforcement and the public to<br />
verify the validity <strong>of</strong> qualified patient or caregiver s card as authonzation to possess grow transport and or use Medical Marijuana in<br />
California To facilitate the verification <strong>of</strong> authorized cardholders the verification database is available on the internet at<br />
www calmmp<br />
qov<br />
In 2003 Senate Bill SB 420 Chapter 875 Statutes <strong>of</strong> 2003 was passed as an extension and clarification <strong>of</strong> Proposition 215 the<br />
Compassionate Use Act <strong>of</strong> 1996 The Medical Marijuana Program within CDPH is administered through a patient s county <strong>of</strong><br />
residence Upon obtaining a recommendation from their physician for use <strong>of</strong> inedicinai marijuana patients and their primary<br />
caregivers may apply for and be issued a Medical Marijuana Identification Card Senate Bill 420 aiso required that the MMP be fully<br />
supported through the card application processing fees Both the state and the counties have authority to cover their costs for the<br />
program through these appiication fees<br />
Regulations Statutes Program Information<br />
Senate Bill 420<br />
Contact MMP<br />
Compassionate Use Act<br />
County Program Location and Hours<br />
Health and Safety Code<br />
Verification <strong>of</strong> Medical Marijuana ID card<br />
Data Statistics Appeals<br />
Patient Primary Caregiver<br />
and Medi Cal Card Data<br />
Forms<br />
Participating Counties PDF New Window<br />
Card Data by County and Fiscal Year PDF New Window<br />
MMP Fact Sheet PDF New Window<br />
County Implementation Schedule PDF New Window<br />
ding<br />
Fees<br />
Pro9ram Revenues Expenditures and Loan Repayment PDF<br />
New Window<br />
Patient Advocacy Groups and Information<br />
Americans for Safe Access<br />
CA Norml<br />
Marijuana Policy Projed<br />
Office <strong>of</strong> Attorney General<br />
Organization<br />
Health Information and Strategic Planning<br />
Vital Records Registration Branch<br />
Vital Records Issuance and Preservation Branch<br />
Public Health Policy and Research Branch<br />
Public Health Informati s Branch<br />
HISP Administrative Support Branch<br />
Responsibilities<br />
Dispensaries Cooperatives and Collectives<br />
Patient Responsibilities<br />
Primary Caregiver Responsibilities<br />
Physician Responsibilities<br />
Legal Representative Responsibilities<br />
County Responsibilities<br />
State Responsibilities<br />
Last modified on928 2011 211 PM<br />
http www cdph<br />
gov programs mmp Pages Medical<br />
20Marijuana 20Program aspx 929 2011
CA Codes hsa11357 11362 9 Page 1 <strong>of</strong> 9<br />
HEALTH AND SAFETY CODE<br />
SECTION 11357 11362 9<br />
11357<br />
a Except as authorized by law every person who possesses<br />
any concentrated cannabis shall be punished by imprisonment in the<br />
county jail for a period <strong>of</strong> not more than one year or by a fine <strong>of</strong><br />
not more than five hundred dollars 500 or by both such fine and<br />
imprisonment or shall be punished by imprisonment in the state<br />
prison<br />
b Except as authorized by law every person who possesses not<br />
more than 285 grams <strong>of</strong> marijuana other than concentrated cannabis<br />
is guilty <strong>of</strong> an infraction punishable by a fine <strong>of</strong> not more than one<br />
hundred dollars 100<br />
c Except as authorized by law every person who possesses more<br />
than 285 grams oE marijuana other than concentrated cannabis shall<br />
be punished by imprisonment in the county jail for a period <strong>of</strong> not<br />
more than six months or by a fine <strong>of</strong> not more than five hundred<br />
dollars 500 or by both such fine and imprisonment<br />
d Except as authorized by law every person 18 years <strong>of</strong> age or<br />
over who possesses not more than 285 grams <strong>of</strong> marijuana other than<br />
concentrated cannabis upon the grounds <strong>of</strong> or within any school<br />
providing instruction in kindergarten or any <strong>of</strong> grades 1 through 12<br />
during hours the school is open for classes or school related<br />
programs is guilty <strong>of</strong> a misdemeanor and shall be punished by a fine<br />
<strong>of</strong> not more than five hundred dollars 500 or by imprisonment in<br />
the county jail for a period <strong>of</strong> not more than 10 days or both<br />
e Except as authorized by law every person under the age <strong>of</strong> 18<br />
who possesses not more than 285 grams <strong>of</strong> marijuana other than<br />
concentrated cannabis upon the grounds <strong>of</strong> or within any school<br />
providing instruction in kindergarten or any <strong>of</strong> grades 1 through 12<br />
during hours the school is open for classes or school related<br />
programs is guilty <strong>of</strong> a misdemeanor and shall be subject to the<br />
following dispositions<br />
1 A fine <strong>of</strong> not more than two hundred fifty dollars 250 upon<br />
a finding that a first <strong>of</strong>fense has been committed<br />
2 A fine <strong>of</strong> not more than five hundred dollars 500 or<br />
commitment to a juvenile hall ranch camp Eorestry camp or secure<br />
juvenile home for a period <strong>of</strong> not more than 10 days or both upon a<br />
finding that a second or subsequent <strong>of</strong>fense has been committed<br />
11357<br />
a Except as authorized by law every person who possesses<br />
any concentrated cannabis shall be punished by imprisonment in the<br />
county jail for a period <strong>of</strong> not more than one year or by a fine <strong>of</strong><br />
not more than five hundred dollars 500 or by both such fine and<br />
imprisonment or shall be punished by imprisonment pursuant to<br />
subdivision h <strong>of</strong> Section 1170 <strong>of</strong> the Penal Code<br />
b Except as authorized by law every person who possesses not<br />
more than 285 grams <strong>of</strong> marijuana other than concentrated cannabis<br />
is guilty <strong>of</strong> an infraction punishable by a fine <strong>of</strong> not more than one<br />
hundred dollars 100<br />
c Except as authorized by law every person who possesses more<br />
than 285 grams <strong>of</strong> marijuana other than concentrated cannabis shall<br />
be punished by imprisonment in a county jail for a period <strong>of</strong> not<br />
more than six months or by a fine <strong>of</strong> not more than five hundred<br />
dollars 500 or by both such fine and imprisonment<br />
d Except as authorized by law every person 18 years <strong>of</strong> age or<br />
over who possesses not more than 28 5 grams <strong>of</strong> marijuana other than<br />
concentrated cannabis upon the grounds <strong>of</strong> or within any school<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 2011
11357 11362 9 Page 2 <strong>of</strong> 9<br />
CA Codeshsc<br />
providing instruction in kindergarten or any <strong>of</strong> grades 1 through 12<br />
during hours the school is open for classes or school related<br />
programs is guilty <strong>of</strong> a misdemeanor and shall be punished by a fine<br />
o not more than five hundred dollars 500 or by imprisonment in a<br />
county jail for a period <strong>of</strong> not more than 10 days or both<br />
e Except as authorized by law every person under the age <strong>of</strong> 18<br />
who possesses not more than 285 grams <strong>of</strong> marijuana other than<br />
concentrated cannabis upon the grounds <strong>of</strong> or within any school<br />
providing instruction in kindergarten or any <strong>of</strong> grades 1 through 12<br />
during hours the school is open for classes or school related<br />
programs is guilty <strong>of</strong> a misdemeanor and shall be subject to the<br />
following dispositions<br />
1 A fine <strong>of</strong> not more than two hundred fifty dollars 250 upon<br />
a finding that a first <strong>of</strong>fense has been committed<br />
2 A fine <strong>of</strong> not more than five hundred dollars 500 or<br />
commitment to a juvenile hall ranch camp forestry camp or secure<br />
juvenile home for a period <strong>of</strong> not more than 10 days oz both upon a<br />
finding that a second or subsequent <strong>of</strong>fense has been committed<br />
11358 Every person who plants cultivates harvests dries or<br />
processes any marijuana or any part there<strong>of</strong> except as otherwise<br />
provided by law shall be punished by imprisonment in the state<br />
prison<br />
11358 Every person who plants cultivates harvests dries or<br />
processes any marijuana or any part there<strong>of</strong> except as otherwise<br />
provided by law shall be punished by imprisonment pursuant to<br />
subdivision h <strong>of</strong> Section 1170 <strong>of</strong> the Penal Code<br />
11359 Every person who possesses for sale any marijuana except as<br />
otherwise provided by law shall be punished by imprisonment in the<br />
state prison<br />
11359 Every person who possesses for sale any marijuana except as<br />
otherwise provided by law shall be punished by imprisonment<br />
pursuant to subdivision h <strong>of</strong> Section 1170 <strong>of</strong> the Penal Code<br />
11360<br />
a Except as otherwise provided by this section or as<br />
authorized by law every person who transports imports into this<br />
state sells furnishes administers or gives away or <strong>of</strong>fers to<br />
transport import into this state sell furnish administer or give<br />
away or attempts to import into this state or transport any<br />
marijuana shall be punished by imprisonment in the state prison for a<br />
period <strong>of</strong> two three or four years<br />
b Except as authorized by law every person who gives away<br />
<strong>of</strong>fers to give away transports <strong>of</strong>fers to transport or attempts to<br />
transport not more than 285 grams <strong>of</strong> marijuana other than<br />
concentrated cannabis is guilty <strong>of</strong> a misdemeanor and shall be<br />
piu by a fine <strong>of</strong> not more than one hundred dollars 100 In<br />
any case in which a person is arrested for a violation <strong>of</strong> this<br />
subdivision and does not demand to be taken before a magistrate such<br />
person shall be released by the arresting <strong>of</strong>ficer upon presentation<br />
<strong>of</strong> satis actory evidence <strong>of</strong> identity and giving his written promise<br />
to appear in court as provided in Section 853 6 <strong>of</strong> the Penal Code<br />
and shall not be subjected to booking<br />
http www leginfoca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 2011
CA Codes hsa1 1 3571 1 362 9 Page 3 <strong>of</strong>9<br />
11360<br />
a Except as otherwise provided by this section or as<br />
authorized by law every person who transports imports into this<br />
state sells furnishes administers or gives away or <strong>of</strong>fers to<br />
transport import into this state sell furnish administer or give<br />
away or attempts to import into this state or transport any<br />
marijuana shall be punished by imprisonment pursuant to subdivision<br />
h <strong>of</strong> Section 1170 <strong>of</strong> the Penal Code for a period <strong>of</strong> two three or<br />
four years<br />
b Except as authorized by law every person who gives away<br />
<strong>of</strong>fers to give away transports <strong>of</strong>fers to transport or attempts to<br />
transport not more than 285 grams <strong>of</strong> marijuana other than<br />
concentrated cannabis is guilty <strong>of</strong> a misdemeanor and shall be<br />
punished by a fine <strong>of</strong> not more than one hundred dollars 100 In<br />
any case in which a person is arrested for a violation <strong>of</strong> this<br />
subdivision and does not demand to be taken before a magistrate such<br />
person shall be released by the arresting <strong>of</strong>ficer upon presentation<br />
<strong>of</strong> satisfactory evidence <strong>of</strong> identity and giving his written promise<br />
to appear in court as provided in Section 853 6 <strong>of</strong> the Penal Code<br />
and shall not be subjected to booking<br />
11361<br />
a Every person 18 years <strong>of</strong> age or over who hires employs<br />
or uses a minor in unlawfully transporting carrying selling<br />
giving away preparing for sale or peddling any marijuana who<br />
unlawfully sells or <strong>of</strong>fers to se11 any marijuana to a minor or who<br />
furnishes administers or gives or <strong>of</strong>fers to furnish administer<br />
or give any marijuana to a minor under 14 years <strong>of</strong> age or who<br />
induces a minor to use marijuana in violation <strong>of</strong> law shall be<br />
punished by imprisonment in the state prison for a period <strong>of</strong> three<br />
five or seven years<br />
b Every person 18 years <strong>of</strong> age or over who furnishes<br />
administers or gives or <strong>of</strong>fers to furnish administer or give any<br />
marijuana to a minor 14 years <strong>of</strong> age or older shall be punished by<br />
imprisonment in the state prison for a period <strong>of</strong> three four or five<br />
years<br />
11361 5<br />
a Records <strong>of</strong> any court <strong>of</strong> this state any public or<br />
private agency that provides services upon referral under Section<br />
1000 2 <strong>of</strong> the Penal Code or <strong>of</strong> any state agency pertaining to the<br />
arrest or conviction <strong>of</strong> any person for a violation <strong>of</strong> subdivision<br />
b c d or e <strong>of</strong> Section 11357 or subdivision b <strong>of</strong> Section<br />
11360 shall not be kept beyond two years from the date <strong>of</strong> the<br />
conviction or from the date <strong>of</strong> the arrest if there was no<br />
conviction except with respect to a violation <strong>of</strong> subdivision e <strong>of</strong><br />
Section 11357 the records shall be retained until the <strong>of</strong>fender<br />
attains the age <strong>of</strong> 18 years at which time the records shall be<br />
destroyed as provided in this section Any court or agency having<br />
custody <strong>of</strong> the records shall provide for the timely destruction <strong>of</strong><br />
the records in accordance with subdivision c The requirements <strong>of</strong><br />
this subdivision do not apply to records <strong>of</strong> any conviction occurring<br />
prior to January 1 1976 or records <strong>of</strong> any arrest not followed by a<br />
conviction occurring prior to that date<br />
b This subdivision applies only to records <strong>of</strong> convictions and<br />
arrests not followed by conviction occurring prior to January 1<br />
1976 for any <strong>of</strong> the following <strong>of</strong>fenses<br />
1 Any violation <strong>of</strong> Section 11357 or a statutory predecessor<br />
there<strong>of</strong><br />
2 Unlawful possession <strong>of</strong> a device contrivance instrument or<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 1<br />
1 001 2000 file 929 20l 1
CA Codes hsc 1 1 3571 1 362 9 Page 4 <strong>of</strong> 9<br />
paraphernalia used for unlawfully smoking marijuana in violation <strong>of</strong><br />
Section 11364 as it existed prior to January 1 1976 or a statutory<br />
predecessor there<strong>of</strong><br />
3 Unlawful visitation or presence in a room or place in which<br />
marijuana is being unlawfully smoked or used in violation <strong>of</strong> Section<br />
11365 as it existed prior to January 1 1976 or a statutory<br />
predecessor there<strong>of</strong><br />
4 Unlawfully using or being under the influence <strong>of</strong> marijuana in<br />
violation <strong>of</strong> Section 11550 as it existed prior to January 1 1976<br />
or a statutory predecessor there<strong>of</strong><br />
Any person subject to an arrest or conviction for those <strong>of</strong>fenses<br />
may apply to the Department <strong>of</strong> Justice for destruction <strong>of</strong> records<br />
pertaining to the arrest or conviction if two or more years have<br />
elapsed since the date <strong>of</strong> the conviction or since the date <strong>of</strong> the<br />
arrest if not followed by a conviction The application shall be<br />
submitted upon a form supplied by the Department <strong>of</strong> Justice and shall<br />
be accompanied by a fee which shall be established by the<br />
department in an amount which will defray the cost <strong>of</strong> administering<br />
this subdivision and costs incurred by the state under subdivision<br />
c but which shall not exceed thirty seven dollars and fifty cents<br />
37 50 The application form may be made avai2able at every local<br />
police or sheriff<br />
department and from the Department <strong>of</strong> Justice and<br />
may require that information which the department determines is<br />
necessary for purposes <strong>of</strong> identification<br />
The department may request but not require the applicant to<br />
include aself<br />
administered fingerprint upon the application If the<br />
department is unable tosu ficiently identify the applicant for<br />
purposes <strong>of</strong> this subdivision without the fingerprint or without<br />
additional fingerprints it shall so notify the applicant and shall<br />
request the applicant to submit any fingerprints which may be<br />
required to effect identification including a complete set if<br />
necessary or alternatively to abandon the application and request<br />
a refund <strong>of</strong> all or a portion <strong>of</strong> the fee submitted with the<br />
application as provided in this section If the app2icant fails or<br />
refuses to submit fingerprints in accordance with the department s<br />
request within a reasonable time which shall be established by the<br />
department or if the applicant requests a refund <strong>of</strong> the fee the<br />
department shall promptly mail a refund to the applicant at the<br />
address specified in the application or at any other address which<br />
may be specified by the applicant However if the department has<br />
notified the applicant that election to abandon the application will<br />
result in forfeiture <strong>of</strong> a specified amount which is a portion <strong>of</strong> the<br />
fee the department may retain a portion <strong>of</strong> the fee which the<br />
department determines will defray the actual costs <strong>of</strong> processing the<br />
application provided the amount <strong>of</strong> the portion retained shall not<br />
exceed ten dollars 10<br />
Upon receipt <strong>of</strong> a sufficient app2ication the Department <strong>of</strong><br />
Justice shall destroy records <strong>of</strong> the department if any pertaining<br />
to the arrest or conviction in the manner prescribed by subdivision<br />
c and shall notify the Federal Bureau <strong>of</strong> Investigation the law<br />
enforcement agency which arrested the applicant and if the<br />
applicant was convicted the probation department which investigated<br />
the applicant and the Department <strong>of</strong> Motor vehicles <strong>of</strong> the<br />
application<br />
c Destruction <strong>of</strong> records <strong>of</strong> arrest or conviction pursuant to<br />
subdivision a or b shall be accomplished by permanent<br />
obliteration <strong>of</strong> all entries or notations upon the records pertaining<br />
to the arrest or conviction and the record shall be prepared again<br />
so that it appears that the arrest or conviction never occurred<br />
However where 1 the only entries upon the record pertain to the<br />
arrest or conviction and 2 the record can be destroyed without<br />
necessarily effecting the destruction <strong>of</strong> other records then the<br />
document constituting the record shall be physically destroyed<br />
d Notwithstanding subdivision a or b written transcriptions<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc<br />
boup 1 1001 12000 file 929 2011
11357 11362 9 Page 5 <strong>of</strong> 9<br />
CA Codeshsc<br />
<strong>of</strong> oral testimony in court proceedings and published judicial<br />
appellate reports are not subject to this section Additionally no<br />
records shall be destroyed pursuant to subdivision a if the<br />
defendant or a codefendant has filed a civil action against the peace<br />
<strong>of</strong>ficers or law enforcement jurisdiction which made the arrest or<br />
instituted the prosecution and if the agency which is the custodian<br />
<strong>of</strong> those records has received a certified copy <strong>of</strong> the complaint in<br />
the civil action until the civil action has finally been resolved<br />
Immediately following the final resolution <strong>of</strong> the civil action<br />
records subject to subdivision a shall be destroyed pursuant to<br />
subdivision c if more than two years have elapsed from the date <strong>of</strong><br />
the conviction or arrest without conviction<br />
11361 7 a Any record subject to destruction or permanent<br />
obliteration pursuant to Section 11361 5 or more than two years <strong>of</strong><br />
age or a record <strong>of</strong> a conviction for an <strong>of</strong>fense specified in<br />
subdivision a or b <strong>of</strong> Section 11361 5 which became final more<br />
than two years previously shall not be considered to be accurate<br />
relevant timely or complete for any purposes by any agency or<br />
person The provisions <strong>of</strong> this subdivision shall be applicable for<br />
purposes <strong>of</strong> the Privacy Act <strong>of</strong> 1974 5 USC Section 552a to the<br />
fullest extent permissible by law whenever any information or recorfl<br />
subject to destruction or permanent obliteration under Section<br />
11361 5 was obtained by any state agency local public agency or any<br />
public or private agency that provides services upon referral under<br />
Section 1000 2 <strong>of</strong> the Penal Code and is thereafter shared with or<br />
disseminated to any agency <strong>of</strong> the federal government<br />
b No public agency shall alter amend assess condition deny<br />
limit postpone quali y revoke surcharge or suspend any<br />
certificate franchise incident interest license opportunity<br />
permit privilege right or title <strong>of</strong> any person because <strong>of</strong> an arrest<br />
or conviction for an <strong>of</strong>fense specified in subdivision a or b <strong>of</strong><br />
Section 11361 5 or because <strong>of</strong> the facts or events leading to such an<br />
arrest or conviction on or after the date the records <strong>of</strong> such<br />
arrest or conviction are required to be destroyed by subdivision a<br />
<strong>of</strong> Section 11361 5 or two years from the date <strong>of</strong> such conviction or<br />
arrest without conviction with respect to arrests and convictions<br />
occurring prior to January 1 1976 As used in this subdivision<br />
public agency includes but is not limited to any state county<br />
city and county city public or constitutional corporation or<br />
entity district local or regional political subdivision or any<br />
department division bureau <strong>of</strong>fice board commission or other<br />
agency there<strong>of</strong><br />
c Any person arrested or convicted for an <strong>of</strong>fense specified in<br />
subdivision a or b <strong>of</strong> Section 11361 5 may two years from the<br />
date <strong>of</strong> such a conviction or from the date <strong>of</strong> the arrest if there<br />
was no conviction indicate in response to any question concerning<br />
his prior criminal record that he was not arrested or convicted for<br />
such <strong>of</strong>fense<br />
d The provisions <strong>of</strong> this section shall be applicable without<br />
regard to whether destruction or obliteration <strong>of</strong> records has actually<br />
been implemented pursuant to Section 12361 5<br />
11362 As used in this article felony <strong>of</strong>fense and <strong>of</strong>fense<br />
punishable as a felony refer to an <strong>of</strong>fense for which the law<br />
prescribes imprisonment in the state prison as either an alternative<br />
or the sole penalty regardless <strong>of</strong> the sentence the particular<br />
defendant received<br />
http www leginfo ca gov cgi bin<br />
displaycode sec6on hsc group 11001 12000 file 929 2011
CA Codes hsc 1 1 357 1 1 362 9 Page 6 <strong>of</strong> 9<br />
11362 As used in this article felony <strong>of</strong>fense and <strong>of</strong>fense<br />
punishable as a felony refer to an <strong>of</strong>fense prior to July 1 2011<br />
for which the law prescribes imprisonment in the state prison or for<br />
an <strong>of</strong>fense on or after July 1 2011 imprisonment in either the<br />
state prison or pursuant to subdivision h <strong>of</strong> Section 1170 <strong>of</strong> the<br />
Penal Code as either an alternative or the sole penalty regardless<br />
<strong>of</strong> the sentence the particular defendant received<br />
11362 5 a This section shall be known and may be cited as the<br />
Compassionate Use Act <strong>of</strong> 1996<br />
b 1 The people <strong>of</strong> the State <strong>of</strong> California hereby find and<br />
declare that the purposes <strong>of</strong> the Compassionate Use Act <strong>of</strong> 1996 are as<br />
follows<br />
A To ensure that seriously ill Californians have the right to<br />
obtain and use marijuana for medical purposes where that medical use<br />
is deemed appropriate and has been recommended by a physician who has<br />
determined that the person<br />
health would benefit from the use <strong>of</strong><br />
marijuana in the treatment <strong>of</strong> cancer anorexia AIDS chronic pain<br />
spasticity glaucoma arthritis migraine or any other illness for<br />
which marijuana provides relief<br />
B To ensure that patients and their primary caregivers who<br />
obtain and use marijuana for medical purposes upon the recommendation<br />
<strong>of</strong> a physician are not subject to criminal prosecution or sanction<br />
C To encourage the federal and state governments to implement a<br />
plan to provide for the safe and affordable distribution <strong>of</strong> marijuana<br />
to all patients in medical need <strong>of</strong> marijuana<br />
2 Nothing in this section shall be construed to supersede<br />
legislation prohibiting persons from engaging in conduct that<br />
endangers others nor to condone the diversion <strong>of</strong> marijuana for<br />
nonmedical purposes<br />
c Notwithstanding any other provision <strong>of</strong> law no physician in<br />
this state shall be punished or denied any right or privilege for<br />
having recommended marijuana to a patient for medical purposes<br />
d Section 11357 relating to the possession <strong>of</strong> marijuana and<br />
Section 11358 relating to the cultivation <strong>of</strong> marijuana shall not<br />
apply to a patient or to a patient s primary caregiver who<br />
possesses or cultivates marijuana for the personal medical purposes<br />
<strong>of</strong> the patient upon the written or oral recommendation or approval <strong>of</strong><br />
a physician<br />
e For the purposes <strong>of</strong> this section primary caregiver means<br />
the individual designated by the person exempted under this section<br />
who has consistently assumed responsibility for the housing health<br />
or safety <strong>of</strong> that person<br />
11362 9 a 1 It is the intent <strong>of</strong> the Legislature that the state<br />
commission objective scientific research by the premier research<br />
institute <strong>of</strong> the world the University <strong>of</strong> California regarding the<br />
efficacy and safety <strong>of</strong> administering marijuana as part <strong>of</strong> inedical<br />
treatment If the Regents <strong>of</strong> the University <strong>of</strong> California by<br />
appropriate resolution accept this responsibility the University <strong>of</strong><br />
California shall create a program to be known as the California<br />
Marijuana Research Program<br />
2 The program shall develop and conduct studies intended to<br />
ascertain the general medical safety and efficacy <strong>of</strong> marijuana and<br />
if found valuable shall develop medical guidelines for the<br />
appropriate administration and use <strong>of</strong> marijuana<br />
b The program may immediately solicit proposals for research<br />
projects to be included in the marijuana studies Program<br />
requirements to be used when evaluating responses to its solicitation<br />
http<br />
wwwleginfo ca gov cgi bin<br />
displaycode section hsc group 1 1 0012000 file 929 2011
CA Codes hsc 1 1 357 1 1 362 9 Page 7 <strong>of</strong> 9<br />
for proposals shall include but not be limited to all <strong>of</strong> the<br />
following<br />
1 Proposals shall demonstrate the use <strong>of</strong> key personnel<br />
including clinicians or scientists and support personnel who are<br />
prepared to develop a program <strong>of</strong> research regarding marijuana s<br />
general medical efficacy and safety<br />
2 Proposals shall contain procedures for outreach to patients<br />
with various medical conditions who may be suitable participants in<br />
research on marijuana<br />
3 Proposals shall contain provisions for a patient registry<br />
4 Proposals shall contain provisions for an information system<br />
that is designed to record information about possible study<br />
participants investigators and clinicians and deposit and analyze<br />
data that accrues as part <strong>of</strong> clinical trials<br />
5 Proposals shall contain protocols suitable for research on<br />
marijuana addressing patients diagnosed with the acquired<br />
immunodeficiency syndrome AIDS or the human immunode iciency virus<br />
HIV cancer glaucoma or seizures or muscle spasms associated with<br />
a chronic debilitating condition The proposal may also include<br />
research on other serious illnesses provided that resources are<br />
available and medical inEormation justifies the research<br />
6 Proposals shall demonstrate the use <strong>of</strong> a specimen laboratory<br />
capable <strong>of</strong> housing plasma urine and other specimens necessary to<br />
study the concentration <strong>of</strong> cannabinoids in various tissues as well<br />
as housing specimens for studies <strong>of</strong> toxic effects <strong>of</strong> marijuana<br />
7 Proposals shall demonstrate the use <strong>of</strong> a laboratory capable <strong>of</strong><br />
analyzing marijuana provided to the program under this section for<br />
purity and cannabinoid content and the capacity to detect<br />
contaminants<br />
c In order to ensure objectivity in evaluating proposals the<br />
program shall use a peer review process that is modeled on the<br />
process used by the National Institutes <strong>of</strong> Health and that guards<br />
against funding research that is biased in favor <strong>of</strong> or against<br />
particular outcomes Peer reviewers shall be selected for their<br />
expertise in the scientific substance and methods <strong>of</strong> the proposed<br />
research and their lack <strong>of</strong> bias or conflict <strong>of</strong> interest regarding<br />
the applicants or the topic <strong>of</strong> an approach taken in the proposed<br />
research Peer reviewers shall judge research proposals on several<br />
criteria foremost among which shall be both <strong>of</strong> the following<br />
1 The scientific merit <strong>of</strong> the research plan including whether<br />
the research design and experimental procedures are potentially<br />
biased for or against a particular outcome<br />
2 Researchers expertise in the scientific substance and methods<br />
oE the proposed research and their lack <strong>of</strong> bias or conflict <strong>of</strong><br />
interest regarding the topic <strong>of</strong> and the approach taken in the<br />
proposed research<br />
d If the program is administered by the Regents oE the<br />
University <strong>of</strong> California any grant research proposals approved by<br />
the program shall also require review and approval by the research<br />
advisory panel<br />
e It is the intent <strong>of</strong> the Legislature that the program be<br />
established as follows<br />
1 The program shall be located at one or more University <strong>of</strong><br />
California campuses that have a core oE faculty experienced in<br />
organizing multidisciplinary scientific endeavors and in particular<br />
strong experience in clinical trials involving psychopharmacologic<br />
agents The campuses at which research under the auspices <strong>of</strong> the<br />
program is to take place shall accommodate the administrative<br />
<strong>of</strong>fices including the director <strong>of</strong> the program as well as a data<br />
management unit and facilities for storage <strong>of</strong> specimens<br />
2 When awarding grants under this section the program shall<br />
utilize principles and parameters <strong>of</strong> the other well tested statewide<br />
research programs administered by the University <strong>of</strong> California<br />
modeled after programs administered by the National Institutes <strong>of</strong><br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 2011
CA Codes hsc 1 1357<br />
1362 9 Page 8 <strong>of</strong> 9<br />
Health including peer review evaluation <strong>of</strong> the scientific merit <strong>of</strong><br />
applications<br />
3 The scientific and clinical operations <strong>of</strong> the program shall<br />
occur partly at University <strong>of</strong> California campuses and partly at<br />
other postsecondary institutions that have clinicians or scientists<br />
with expertise to conduct the required studies Criteria for<br />
selection <strong>of</strong> research locations shall include the elements listed in<br />
subdivision b and additionally shall give particular weight to<br />
the organizational plan leadership qualities <strong>of</strong> the program<br />
director and plans to involve investigators and patient populations<br />
from multiple sites<br />
4 The funds received by the program shall be allocated to<br />
various research studies in accordance with a scientific plan<br />
developed by the Scientific Advisory Council As the first wave <strong>of</strong><br />
studies is completed it is anticipated that the program will receive<br />
requests for funding <strong>of</strong> additional studies These requests shall be<br />
reviewed by the Scientific Advisory Council<br />
5 The size scope and number <strong>of</strong> studies funded shall be<br />
commensurate with the amount <strong>of</strong> appropriated and available program<br />
funding<br />
f All personnel involved in implementing approved proposals<br />
shall be authorized as required by Section 11604<br />
g Studies conducted pursuant to this section shall include the<br />
greatest amount oE new scientific research possible on the medical<br />
uses <strong>of</strong> and medical hazards associated with marijuana The program<br />
shall consult with the Research Advisory Panel analogous agencies in<br />
other states and appropriate federal agencies in an attempt to avoid<br />
duplicative research and the wasting <strong>of</strong> research dollars<br />
h The program shall make every effort to recruit qualified<br />
patients and qualified physicians from throughout the state<br />
i The marijuana studies shall employ state <strong>of</strong> the art research<br />
methodologies<br />
j The program shall ensure that all marijuana used in the<br />
studies is <strong>of</strong> the appropriate medical quality and shall be obtained<br />
from the National Institute on Drug Abuse or any other federal agency<br />
designated to supply marijuana for authorized research If these<br />
federal agencies fail to provide a supply <strong>of</strong> adequate quality and<br />
quantity within six months <strong>of</strong> the effective date <strong>of</strong> this section the<br />
Attorney General shall provide an adequate supply pursuant to<br />
Section 11478<br />
k The program may review approve or incorporate studies and<br />
research by independent groups presenting scientifically valid<br />
protocols for medical research regardless <strong>of</strong> whether the areas <strong>of</strong><br />
study are being researched by the committee<br />
1 1 To enhance understanding <strong>of</strong> the efficacy and adverse<br />
effects <strong>of</strong> marijuana as a pharmacological agent the program shall<br />
conduct focused controlled clinical trials on the usefulness <strong>of</strong><br />
marijuana in patients diagnosed with AIDS or HIV cancer glaucoma<br />
or seizures or muscle spasms associated with a chronic debilitating<br />
condition The program may add research on other serious illnesses<br />
provided that resources are available and medical information<br />
justifies the research The studies shall focus on comparisons <strong>of</strong><br />
both the efficacy and saEety <strong>of</strong> inethods <strong>of</strong> administering the drug to<br />
patients including inhalational tinctural and oral evaluate<br />
possible uses <strong>of</strong> marijuana as a primary or adjunctive treatment and<br />
develop further information on optimal dosage timing mode <strong>of</strong><br />
administration and variations in the effects <strong>of</strong> different<br />
cannabinoids and varieties <strong>of</strong> marijuana<br />
2 The program shall examine the safety <strong>of</strong> marijuana in patients<br />
with various medical disorders including marijuana s interaction<br />
with other drugs relative safety <strong>of</strong> inhalation versus oral forms<br />
and the effects on mental function in medically ill persons<br />
3 The program shall be limited to providing for objective<br />
scientific research to ascertain the efficacy and safety <strong>of</strong> marijuana<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 2011
CA Codes hsc 1 1 3571 1 362 9 Page 9 <strong>of</strong> 9<br />
as part <strong>of</strong> inedical treatment and should not be construed as<br />
encouraging or sanctioning the social or recreational use oE<br />
marijuana<br />
m 1 Subject to paragraph 2 the program shall prior to any<br />
approving proposals seek to obtain research protocol guidelines from<br />
the National Institutes <strong>of</strong> Health and shall if the National<br />
Institutes <strong>of</strong> Health issues research protocol guidelines comply with<br />
those guidelines<br />
2 If after a reasonable period <strong>of</strong> time <strong>of</strong> not less than six<br />
months and not more than a year has elapsed from the date the program<br />
seeks to obtain guidelines pursuant to paragraph 1 no guidelines<br />
have been approved the program may proceed using the research<br />
protocol guidelines it develops<br />
n In order to maximize the scope and size <strong>of</strong> the marijuana<br />
studies the program may do any <strong>of</strong> the following<br />
1 Solicit apply for and accept funds from foundations private<br />
individuals and all other funding sources that can be used to<br />
expand the scope or timeframe <strong>of</strong> the marijuana studies that are<br />
authorized under this section The program shall not expend more than<br />
5 percent <strong>of</strong> its General Fund allocation in efforts to obtain money<br />
from outside sources<br />
2 include within the scope <strong>of</strong> the marijuana studies other<br />
marijuana research projects that are independently funded and that<br />
meet the requirements set forth in subdivisions a to c<br />
inclusive In no case shall the program accept any funds that are<br />
<strong>of</strong>fered with any conditions other than that the funds be used to<br />
study the efficacy and safety <strong>of</strong> marijuana as part oE medical<br />
treatment Any donor shall be advised that funds given for purposes<br />
<strong>of</strong> this section will be used to study both the possible benefits and<br />
detriments <strong>of</strong> marijuana and that he or she will have no control over<br />
the use <strong>of</strong> these funds<br />
o 1 Within six months <strong>of</strong> the effective date <strong>of</strong> this section<br />
the program shall report to the Legislature the Governor and the<br />
Attorney General on the progress <strong>of</strong> the marijuana studies<br />
2 Thereafter the program shall issue a report to the<br />
Legislature every six months detailing the progress <strong>of</strong> the studies<br />
The interim reports required under this paragraph shall include but<br />
not be limited to data on all <strong>of</strong> the following<br />
A The names and number <strong>of</strong> diseases or conditions under study<br />
B The number <strong>of</strong> patients enrolled in each study by disease<br />
C Any scientifically valid preliminary findings<br />
p If the Regents <strong>of</strong> the University <strong>of</strong> California implement this<br />
section the President <strong>of</strong> the University <strong>of</strong> California shall appoint<br />
a multidisciplinary Scienti ic Advisory Council not to exceed 15<br />
members to provide policy guidance in the creation and<br />
implementation <strong>of</strong> the program Members shall be chosen on the basis<br />
<strong>of</strong> scientific expertise Members <strong>of</strong> the council shall serve on a<br />
voluntary basis with reimbursement for expenses incurred in the<br />
course <strong>of</strong> their participation The members shall be reimbursed for<br />
travel and other necessary expenses incurred in their performance <strong>of</strong><br />
the duties o the council<br />
q No more than 10 percent <strong>of</strong> the total funds appropriated may be<br />
used for all aspects <strong>of</strong> the administration <strong>of</strong> this section<br />
r This section shall be implemented only to the extent that<br />
funding for its purposes is appropriated by the Legislature in the<br />
annual Budget Act<br />
http waweginfoca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 20ll
CA Codes hsa11362 7ll362 83 Page I <strong>of</strong> 10<br />
HEALTH AND SAFETY CODE<br />
SECTION 711362 83<br />
11362 7 For purposes <strong>of</strong> this article the following definitions<br />
shall apply<br />
a Attending physician means an individual who possesses a<br />
license in good standing to practice medicine or osteopathy issued by<br />
the Medical Board <strong>of</strong> California or the Osteopathic Medical Board <strong>of</strong><br />
California and who has taken responsibility for an aspect <strong>of</strong> the<br />
medical care treatment diagnosis counseling or referral <strong>of</strong> a<br />
patient and who has conducted a medical examination <strong>of</strong> that patient<br />
before recording in the patient s medical record the physician<br />
assessment o whether the patient has a serious medical condition and<br />
whether the medical use <strong>of</strong> marijuana is appropriate<br />
b Department means the State Department <strong>of</strong> Aealth Services<br />
c Person with an identification card means an individual who<br />
is a qualified patient who has applied for and received a valid<br />
identification card pursuant to this article<br />
d Primary caregiver means the individual designated by a<br />
qualified patient or by a person with an identification card who has<br />
consistently assumed responsibility for the housing health or<br />
safety <strong>of</strong> that patient or person and may include any <strong>of</strong> the<br />
following<br />
1 In any case in which a qualified patient or person with an<br />
identification card receives medical care or supportive services or<br />
both from a clinic licensed pursuant to Chapter1commencing with<br />
Section 1200 <strong>of</strong> Division 2 a health care facility licensed pursuant<br />
to Chapter2commencing with Section 1250 <strong>of</strong> Division 2 a<br />
residential care facility for persons with chroniclife<br />
threatening<br />
illness licensed pursuant to Chapter 301 commencing with Section<br />
1568 01 <strong>of</strong> Division 2 a residential care facility for the elderly<br />
licensed pursuant to Chapter 32 commencing with Section 1569 <strong>of</strong><br />
Division 2 a hospice or a home health agency licensed pursuant to<br />
Chapter8commencing with Section 1725 <strong>of</strong> Division 2 the owner or<br />
operator or no more than three employees who are designated by the<br />
owner or operator <strong>of</strong> the clinic facility hospice or home health<br />
agency if designated as a primary caregiver by that qualified<br />
patient or person with an identification card<br />
2 An individual who has been designated as a primary caregiver<br />
by more than one qualified patient or person with an identification<br />
card i every qualified patient or person with an identification<br />
card who has designated that individual as a primary caregiver<br />
resides in the same city or county as the primary caregiver<br />
3 An individual who has been designated as a primary caregiver<br />
by a qualified patient or person with an identification card who<br />
resides in a city or county other than that <strong>of</strong> the primary caregiver<br />
if the individual has not been designated as a primary caregiver by<br />
any other qualified patient or person with an identification card<br />
e A primary caregiver shall be at least 18 years <strong>of</strong> age unless<br />
the primary caregiver is the parent <strong>of</strong> a minor child who is a<br />
quali ied patient or a person with an identification card or the<br />
primary caregiver is a person otherwise entitled to make medical<br />
decisions under state law pursuant to Sections 6922 7002 7050 or<br />
7120 <strong>of</strong> the Family Code<br />
f Qualified patient means a person who is entitled to the<br />
protections <strong>of</strong> Section 11362 5 but who does not have an<br />
identification card issued pursuant to this article<br />
g Identification card means a document issued by the State<br />
Department <strong>of</strong> Health Services that document identifies a person<br />
authorized to engage in the medical use <strong>of</strong> marijuana and the person<br />
designated primary caregiver if any<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 2011
711362 83 Page 2 <strong>of</strong> 10<br />
CA Codeshsc<br />
h Serious medical condition means<br />
conditions<br />
1 Acquired immune deficiency syndrome AIDS<br />
2 Anorexia<br />
3 Arthritis<br />
4 Cachexia<br />
5 Cancer<br />
6 Chronic pain<br />
7 Glaucoma<br />
all o the following medical<br />
8 Migraine<br />
9 Persistent muscle spasms including but not limited to<br />
spasms associated with multiple sclerosis<br />
10 Seizures including but not limited to seizures associated<br />
with epilepsy<br />
11 Severe nausea<br />
12 Any other chronic or persistent medical symptom that either<br />
A Substantially limits the ability <strong>of</strong> the person to conduct one<br />
or more major life activities as defined in the Americans with<br />
Disabilities Act <strong>of</strong> 1990 Public Law 101 336<br />
B If not alleviated may cause serious harm to the patient s<br />
safety or physical or mental health<br />
i Written documentation means accurate reproductions <strong>of</strong> those<br />
portions <strong>of</strong> a patient s medical records that have been created by the<br />
attending physician that contain the information required by<br />
paragraph 2 <strong>of</strong> subdivision a <strong>of</strong> Section 11362 715 and that the<br />
patient may submit to a county health department or the county s<br />
designee as part <strong>of</strong> an application for an identification card<br />
11362 71 a 1 The department shall establish and maintain a<br />
voluntary program for the issuance <strong>of</strong> identification cards to<br />
qualified patients who satisfy the requirements <strong>of</strong> this article and<br />
voluntarily apply to the identification card program<br />
2 The department shall establish and maintain a 24 hour<br />
toll free telephone number that will enable state and ocal law<br />
enforcement <strong>of</strong>ficers to have immediate access to information<br />
necessary to verify the validity <strong>of</strong> an identification card issued by<br />
the department until a cost effective Internet Web based system can<br />
be developed for this purpose<br />
b Every county health department or the county s designee<br />
shall do all <strong>of</strong> the following<br />
1 Provide applications upon request to individuals seeking to<br />
join the identi ication card program<br />
2 Receive and process completed applications in accordance with<br />
Section 11362 72<br />
3 Maintain records <strong>of</strong> identification card programs<br />
4 Utilize protocols developed by the department pursuant to<br />
paragraph 1 <strong>of</strong> subdivision d<br />
5 Issue identification cards developed by the department to<br />
approved applicants and designated primary caregivers<br />
c The county board <strong>of</strong> supervisors may designate another<br />
health related governmental or nongovernmental entity or organization<br />
to perform the functions described in subdivision b except for an<br />
entity or organization that cultivates or distributes marijuana<br />
d The department shall develop all <strong>of</strong> the following<br />
1 Protocols that shall be used by a county health department or<br />
the county s designee to implement the responsibilities described in<br />
subdivision b including but not limited to protocols to confirm<br />
the accuracy <strong>of</strong> information contained in an application and to<br />
protect the confidentiality <strong>of</strong> program records<br />
2 Application forms that shall be issued to requesting<br />
applicants<br />
3 An identification card that identifies a person authorized to<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 20ll
CA Codeshsc<br />
711362 83 Page 3 <strong>of</strong> 10<br />
engage in the medical use <strong>of</strong> marijuana and an identification card<br />
that identifies the person<br />
designated primary caregiver if any<br />
The two identification cards developed pursuant to this paragraph<br />
shall be easily distinguishable rom each other<br />
e No person or designated primary caregiver in possession <strong>of</strong> a<br />
valid identification card shall be subject to arrest for possession<br />
transportation delivery or cultivation <strong>of</strong> inedical marijuana in an<br />
amount established pursuant to this article unless there is<br />
reasonable cause to believe that the information contained in the<br />
card is false or falsified the card has been obtained by means <strong>of</strong><br />
Eraud or the person is otherwise in violation <strong>of</strong> the provisions <strong>of</strong><br />
this article<br />
f It shall not be necessary for a person to obtain an<br />
identification card in order to claim the protections <strong>of</strong> Section<br />
11362 5<br />
11362 715<br />
a A person who seeks an identification card shall pay<br />
the fee as provided in Section 11362 755 and provide all <strong>of</strong> the<br />
following to the county health department or the county s designee on<br />
a form developed and provided by the department<br />
1 The name <strong>of</strong> the person and pro<strong>of</strong> <strong>of</strong> his or her residency<br />
within the county<br />
2 Written documentation by the attending physician in the person<br />
s medical records stating that the person has been diagnosed with a<br />
serious medical condition and that the medical use <strong>of</strong> marijuana is<br />
appropriate<br />
3 The name <strong>of</strong>fice address <strong>of</strong>fice telephone number and<br />
California medical license number <strong>of</strong> the person<br />
attending<br />
physician<br />
4 The name and the duties <strong>of</strong> the primary caregiver<br />
5 A government issued photo identification card <strong>of</strong> the person<br />
and <strong>of</strong> the designated primary caregiver if any If the applicant is<br />
a person under 18 years <strong>of</strong> age a certified copy <strong>of</strong> a birth<br />
certificate shall be deemed sufficient pro<strong>of</strong> <strong>of</strong> identity<br />
b If the person applying for an identification card lacks the<br />
capacity to make medical decisions the application may be made by<br />
the person<br />
legal representative including but not limited to any<br />
<strong>of</strong> the following<br />
1 A conservator with authority to make medical decisions<br />
2 An attorney in fact under a durable power <strong>of</strong> attorney for<br />
health care or surrogate decisionmaker authorized under another<br />
advanced health care directive<br />
3 Any other individual authorized by statutory or decisional law<br />
to make medical decisions for the person<br />
c The legal representative described in subdivision b may also<br />
designate in the application an individual including himself or<br />
herself to serve as a primary caregiver for the person provided<br />
that the individual meets the definition <strong>of</strong> a primary caregiver<br />
d The person or legal representative submitting the written<br />
information and documentation described in subdivision a shall<br />
retain a copy there<strong>of</strong><br />
11362 72<br />
a Within 30 days <strong>of</strong> receipt <strong>of</strong> an application for an<br />
identification card a county health department or the county s<br />
designee shall do all <strong>of</strong> the following<br />
1 For purposes <strong>of</strong> processing the application verify that the<br />
in ormation contained in the application is accurate If the person<br />
is less than 18 years <strong>of</strong> age the county health department or its<br />
designee shall also contact the parent with legal authority to make<br />
medical decisions legal guardian or other person or entity with<br />
legal authority to make medical decisions to verify the information<br />
2 veriEy with the Medical Board <strong>of</strong> California or the Osteopathic<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 2011
CA Codeshsc<br />
711362 83 Page 4 <strong>of</strong> 10<br />
Medical Board <strong>of</strong> California that the attending physician has a<br />
license in good standing to practice medicine or osteopathy in the<br />
state<br />
3 Contact the attending physician by facsimile telephone or<br />
mail to confirm that the medical records submitted by the patient are<br />
a true and correct copy <strong>of</strong> those contained in the physician<br />
<strong>of</strong>fice<br />
records when contacted by a county health department or the county<br />
s designee the attending physician shall confirm or deny that the<br />
contents <strong>of</strong> the medical records are accurate<br />
4 Take a photograph or otherwise obtain an electronically<br />
transmissible image <strong>of</strong> the applicant and <strong>of</strong> the designated primary<br />
caregiver if any<br />
5 Approve or deny the application If an applicant who meets the<br />
requirements <strong>of</strong> Section 11362 715 can establish that an<br />
identification card is needed on an emergency basis the county or<br />
its designee shall issue a temporary identification card that shall<br />
be valid for 30 days from the date <strong>of</strong> issuance The county or its<br />
designee may extend the temporary identification card for no more<br />
than 30 days at a time so long as the applicant continues to meet<br />
the requirements <strong>of</strong> this paragraph<br />
b If the county health department or the county s designee<br />
approves the application it shall within 24 hours or by the end <strong>of</strong><br />
the next working day <strong>of</strong> approving the application electronically<br />
transmit the following information to the department<br />
1 A unique user identification number <strong>of</strong> the applicant<br />
2 The date <strong>of</strong> expiration <strong>of</strong> the identification card<br />
3 The name and telephone number <strong>of</strong> the county health department<br />
or the county s designee that has approved the application<br />
c The county health department or the county s designee shall<br />
issue an identification card to the applicant and to his or her<br />
designated primary caregiver if any within five working days <strong>of</strong><br />
approving the application<br />
d In any case involving an incomplete application the applicant<br />
shall assume responsibility for rectifying the deficiency The<br />
county shall have 14 days from the receipt <strong>of</strong> information from the<br />
applicant pursuant to this subdivision to approve or deny the<br />
application<br />
11362 735<br />
a An identification card issued by the county health<br />
department shall be serially numbered and shall contain all <strong>of</strong> the<br />
following<br />
1 A unique user identification number <strong>of</strong> the cardholder<br />
2 The date o expiration <strong>of</strong> the identification card<br />
3 The name and telephone number <strong>of</strong> the county health department<br />
or the county s designee that has approved the application<br />
4 7a 24 hour toll free telephone number to be maintained by the<br />
department that will enable state and local law enforcement<br />
<strong>of</strong>ficers to have immediate access to information necessary to verify<br />
the validity <strong>of</strong> the card<br />
5 Photo identification <strong>of</strong> the cardholder<br />
b A separate identification card shall be issued to the person<br />
designated primary caregiver if any and shall include a photo<br />
identification <strong>of</strong> the caregiver<br />
11362 74<br />
a The county health department or the county s designee<br />
may deny an application only for any <strong>of</strong> the following reasons<br />
1 The applicant did not provide the information required by<br />
Section 21362 715 and upon notice <strong>of</strong> the deficiency pursuant to<br />
subdivision d <strong>of</strong> Section 11362 72 did not provide the information<br />
within 30 days<br />
2 The county health department or the county s designee<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 1 1 0012000 file 929 2011
711362 83 Page 5 <strong>of</strong> 10<br />
CA Codeshsc<br />
determines that the information provided was false<br />
3 The applicant does not meet the criteria set forth in this<br />
article<br />
b Any person whose application has been denied pursuant to<br />
subdivision a may not reapply for six months from the date <strong>of</strong><br />
denial unless otherwise authorized by the county health department or<br />
the county s designee or by a court <strong>of</strong> competent jurisdiction<br />
c 7ny person whose application has been denied pursuant to<br />
svbdivision a may appeal that decision to the department The<br />
county health department or the county s designee shall make<br />
available a telephone munber or address to which the denied applicant<br />
can direct an appeal<br />
11362 745 a An identification card shall be valid for a period<br />
<strong>of</strong> one year<br />
b Upon annual renewal <strong>of</strong> an identification card the county<br />
health department or its designee shall verify all new information<br />
and may verify any other information that has not changed<br />
c The county health department or the county s designee shall<br />
transmit its determination <strong>of</strong> approval or denial <strong>of</strong> a renewal to the<br />
department<br />
11362 755<br />
a The department shall establish application and<br />
renewal fees for persons seeking to obtain or renew identification<br />
cards that are sufficient to cover the expenses incurred by the<br />
department including the startup cost the cost <strong>of</strong> reduced fees for<br />
Medi Cal beneficiaries in accordance with subdivision b the cost<br />
<strong>of</strong> identifying and developing a cost effective Internet web based<br />
system and the cost <strong>of</strong> maintaining the 24 hour toll free telephone<br />
number Each county health department or the county s designee may<br />
charge an additional fee for all costs incurred by the county or the<br />
county s designee for administering the program pursuant to this<br />
article<br />
b Upon satisfactory pro<strong>of</strong> <strong>of</strong> participation and eligibility in<br />
the Medi Cal program a Medi Cal beneficiary shall receive a 50<br />
percent reduction in the fees established pursuant to this section<br />
11362 76 a A person who possesses an identification card shall<br />
1 Within seven days notify the county health department or the<br />
county s designee <strong>of</strong> any change in the person<br />
attending physician<br />
or designated primary caregiver if any<br />
2 Annually submit to the county health department or the county<br />
s designee the following<br />
A Updated written documentation <strong>of</strong> the person<br />
serious medical<br />
condition<br />
B The name and duties <strong>of</strong> the person<br />
designated primary<br />
caregiver if any for the forthcoming year<br />
b If a person who possesses an identification card fails to<br />
comply with this section the card shall be deemed expired If an<br />
identification card expires the identification card <strong>of</strong> any<br />
designated primary caregiver <strong>of</strong> the person shall also expire<br />
c If ttxe designated primary caregiver has been changed the<br />
previous primary caregiver shall return his or her identification<br />
card to the department or to the county health department or the<br />
county s designee<br />
d If the owner or operator or an employee <strong>of</strong> the owner or<br />
operator oE a provider has been designated as a primary caregiver<br />
pursuant to paragraph 1 <strong>of</strong> subdivision d <strong>of</strong> Section 11362 7 <strong>of</strong><br />
the qualified patient or person with an identification card the<br />
http hvww leginfo ca gov cgi bin<br />
displaycode secrion hsc group 1 1001 12000 file 929 2011
711362 83 Page 6 <strong>of</strong> 10<br />
CA Codeshsc<br />
owner or operator shall notify the county health department or the<br />
county s designee pursuant to Section 11362 715 iE a change in the<br />
designated primary caregiver has occurred<br />
11362 765 a Subject to the requirements <strong>of</strong> this article the<br />
individuals specified in subdivision b shall not be subject on<br />
that sole basis to criminal liability under Section 1135 7 11358<br />
11359 11360 11366 11366 5 or 11570 However nothing in this<br />
section shall authorize the individual to smoke or otherwise consume<br />
marijuana unless otherwise authorized by this article nor shall<br />
anything in this section authorize any individual or group to<br />
cultivate or distribute marijuana for pr<strong>of</strong>it<br />
b Subdivision a shall apply to all <strong>of</strong> the following<br />
1 A qualified patient or a person with an identification card<br />
who transports or processes marijuana for his or her own personal<br />
medical use<br />
2 A designated primary caregiver who transports processes<br />
administers delivers or gives away marijuana for medical purposes<br />
in amounts not exceeding those established in subdivision a <strong>of</strong><br />
Section 11362 77 only to the qualified patient <strong>of</strong> the primary<br />
caregiver or to the person with an identification card who has<br />
designated the individual as a primary caregiver<br />
3 Any individual who provides assistance to a qualified patient<br />
or a person with an identification card or his or her designated<br />
primary caregiver in administering medical marijuana to the<br />
qualified patient or person or acquiring the skills necessary to<br />
cultivate or administer marijuana for medical purposes to the<br />
qualified patient or person<br />
c A primary caregiver who receives compensation for actual<br />
expenses including reasonable compensation incurred for services<br />
provided to an eligible qualified patient or person with an<br />
identification card to enable that person to use marijuana under this<br />
article or for payment for out <strong>of</strong> pocket expenses incurred in<br />
providing those services or both shall not on the sole basis <strong>of</strong><br />
that fact be subject to prosecution or punishment under Section<br />
11359 or 11360<br />
11362 768 a This section shall apply to individuals specified in<br />
subdivision b <strong>of</strong> Section 11362 765<br />
b No medical marijuana cooperative collective dispensary<br />
operator establishment or provider who possesses cultivates or<br />
distributes medical marijuana pursuant to this article shall be<br />
located within a 600 foot radius <strong>of</strong> a school<br />
c The distance specified in this section shall be the horizontal<br />
distance measured in a straight line from the property line <strong>of</strong> the<br />
school to the closest property line <strong>of</strong> the lot on which the medical<br />
marijuana cooperative collective dispensary operator<br />
establishment or provider is to be located without regard to<br />
intervening structures<br />
d This section shall not apply to a medical marijuana<br />
cooperative collective dispensary operator establishment or<br />
provider that is also a licensed residential medical or elder care<br />
facility<br />
e This section shall apply only to a medical marijuana<br />
cooperative collective dispensary operator establishment or<br />
provider that is authorized by law to possess cultivate or<br />
distribute medical marijuana and that has a storefront or mobile<br />
retail outlet which ordinarily requires a local business license<br />
f Nothing in this section shall prohibit a city county or city<br />
and county from adopting ordinances or policies that further<br />
restrict the location or establishment <strong>of</strong> a medical marijuana<br />
cooperative collective dispensary operator establishment or<br />
provider<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 2011
ll362 711362 83 Page 7 <strong>of</strong> 10<br />
CA Codeshsc<br />
g Nothing in this section shall preempt local ordinances<br />
adopted prior to January 1 2011 that regulate the location or<br />
establishment <strong>of</strong> a medical marijuana cooperative collective<br />
dispensary operator establishment or provider<br />
h For the purposes <strong>of</strong> this section school means any public or<br />
private school providing instruction in kindergarten or grades 1 to<br />
12 inclusive but does not include any private school in which<br />
education is primarily conducted in private homes<br />
11362 77<br />
a A qualified patient or primary caregiver may possess<br />
no more than eight ounces <strong>of</strong> dried marijuana per qualified patient<br />
In addition a qualified patient or primary caregiver may also<br />
maintain no more than six mature or 12 immature marijuana plants per<br />
qualified patient<br />
b If a qualified patient or primary caregiver has a doctor s<br />
recommendation that this quantity does not meet the qualified patient<br />
s medical needs the qualified patient or primary caregiver may<br />
possess an amount <strong>of</strong> marijuana consistent with the patient s needs<br />
c Counties and cities may retain or enact medical marijuana<br />
guidelines allowing qualified patients or primary caregivers to<br />
exceed the state limits set forth in subdivision a<br />
d Only the dried mature processed flowers <strong>of</strong> female cannabis<br />
plant or the plant conversion shall be considered when determining<br />
allowable quantities <strong>of</strong> marijuana under this section<br />
e The Attorney General may recommend modifications to the<br />
possession or cultivation limits set forth in this section These<br />
recommendations if any shall be made to the Legislature no later<br />
than December l 2005 and may be made only after public comment and<br />
consultation with interested organizations including but not<br />
limited to patients health care pr<strong>of</strong>essionals researchers law<br />
enforcement and local governments Any recommended modification<br />
shall be consistent with the intent <strong>of</strong> this article and shall be<br />
based on currently available scientific research<br />
f A qualified patient or a person holding a valid identification<br />
card or the designated primary caregiver <strong>of</strong> that qualified patient<br />
or person may possess amounts <strong>of</strong> marijuana consistent with this<br />
article<br />
11362 775 Qualified patients persons with valid identification<br />
cards and the designated primary caregivers <strong>of</strong> qualified patients<br />
and persons with identification cards who associate within the State<br />
<strong>of</strong> California in order collectively or cooperatively to cultivate<br />
marijuana for medical purposes shall not solely on the basis <strong>of</strong> that<br />
fact be subject to state criminal sanctions under Section 11357<br />
11358 11359 11360 11366 11366 5 or 11570<br />
11362 78 A state or local law enforcement agency or <strong>of</strong>ficer shall<br />
not refuse to accept an identification card issued by the department<br />
tnless the state or local law enforcement agency or <strong>of</strong>ficer has<br />
reasonable cause to believe that the information contained in the<br />
card is false or fraudulent or the card is being used fraudulently<br />
11362 785<br />
a Nothing in this article shall require any<br />
accommodation <strong>of</strong> any medical use <strong>of</strong> marijuana on the property or<br />
premises <strong>of</strong> any place <strong>of</strong> employment or during the hours <strong>of</strong> employment<br />
or on the property or premises <strong>of</strong> any jail correctional facility<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 2011
CA Codes hsc<br />
l1362 711362 83 Page 8 <strong>of</strong> 10<br />
or other type <strong>of</strong> penal institution in which prisoners reside or<br />
persons under arrest are detained<br />
b Notwithstanding subdivision a a person shall not be<br />
prohibited or prevented from obtaining and submitting the written<br />
information and documentation necessary to apply for an<br />
identification card on the basis that the person is incarcerated in a<br />
jail correctional facility or other penal institution in which<br />
prisoners reside or persons under arrest are detained<br />
c Nothing in this article shall prohibit a jail correctional<br />
facility or other penal institution in which prisoners reside or<br />
persons under arrest are detained from permitting a prisoner or a<br />
person under arrest who has an identification card to use marijuana<br />
for medical purposes under circiunstances that will not endanger the<br />
health or safety <strong>of</strong> other prisoners or the security <strong>of</strong> the Eacility<br />
d Nothing in this article shall require a governmental private<br />
or any other health insurance provider or health care service plan<br />
to be liable for any claim for reimbursement for the medical use <strong>of</strong><br />
marijuana<br />
11362 79 Nothing in this article shall authorize a qualified<br />
patient or person with an identification card to engage in the<br />
smoking <strong>of</strong> inedical marijuana under any <strong>of</strong> the following<br />
circumstances<br />
a In any place where smoking is prohibited by law<br />
b In or within 1000 feet <strong>of</strong> the grounds <strong>of</strong> a school recreation<br />
center or youth center unless the medical use occurs within a<br />
residence<br />
c On a<br />
schoolbus<br />
d While in a motor vehicle that is being operated<br />
e While operating a boat<br />
11362 795<br />
a 1 Any criminal defendant who is eligible to use<br />
marijuana pursuant to Section 11362 5 may request that the court<br />
confirm that he or she is allowed to use medical marijuana while he<br />
or she is on probation or released on bail<br />
2 The court s decision and the reasons for the decision shall be<br />
stated on the record and an entry stating those reasons shall be<br />
made in the minutes <strong>of</strong> the court<br />
3 During the period <strong>of</strong> probation or release on bail if a<br />
physician recommends that the probationer or defendant use medical<br />
marijuana the probationer or defendant may request a modification o<br />
the conditions <strong>of</strong> probation or bail to authorize the use <strong>of</strong> inedical<br />
marijuana<br />
4 The court s consideration <strong>of</strong> the modification request<br />
authorized by this subdivision shall comply with the requirements <strong>of</strong><br />
this section<br />
b 1 Any person who is to be released on parole from a jail<br />
state prison school road camp or other state or local institution<br />
<strong>of</strong> confinement and who is eligible to use medical marijuana pursuant<br />
to Section 11362 5 may request that he or she be allowed to use<br />
medical marijuana during the period he or she is released on parole<br />
A parolee s written conditions <strong>of</strong> parole shall reflect whether or not<br />
a request for a modification <strong>of</strong> the conditions <strong>of</strong> his or her parole<br />
to use medical marijuana was made and whether the request was<br />
granted or denied<br />
2 During the period <strong>of</strong> the parole where a physician recommends<br />
that the parolee use medical marijuana the parolee may request a<br />
modification <strong>of</strong> the conditions <strong>of</strong> the parole to authorize the use <strong>of</strong><br />
medical marijuana<br />
3 Any parolee whose request to use medical marijuana while on<br />
parole was denied may pursue an administrative appeal <strong>of</strong> the<br />
decision Any decision on the appeal shall be in writing and shall<br />
http www leginfo cagov cgi bin displaycode section hsc group 11001 12000 file 929 2011
CA Codeshsc<br />
711362 83 Page 9 <strong>of</strong> 10<br />
reflect the reasons for the decision<br />
4 The administrative consideration <strong>of</strong> the modification request<br />
authorized by this subdivision shall comply with the requirements <strong>of</strong><br />
this section<br />
11362 8 No pr<strong>of</strong>essional licensing board may impose a civil penalty<br />
or take other disciplinary action against a licensee based solely on<br />
the fact that the licensee has performed acts that are necessary or<br />
appropriate to carry out the licensee<br />
role as a designated primary<br />
caregiver to a person who is a qualified patient or who possesses a<br />
lawful identification card issued pursuant to Section i1362 72<br />
Iowever this section shall not apply to acts performed by a<br />
physician relating to the discussion or recommendation <strong>of</strong> the medical<br />
use <strong>of</strong> marijuana to a patient These discussions or recommendations<br />
or both shall be governed by Section 11362 5<br />
11362 81 a A person specified in subdivision b shall be<br />
subject to the following penalties<br />
1 For the irst <strong>of</strong>fense imprisonment in the county jail for no<br />
more than six months oraine not to exceed one thousand dollars<br />
1000 or both<br />
2 For a second or subsequent <strong>of</strong>fense imprisonment in the county<br />
jail for no more than one year or a fine not to exceed one thousand<br />
dollars1000 or both<br />
b Subdivision a applies to any <strong>of</strong> the following<br />
i A person who fraudulently represents a medical condition or<br />
fraudulently provides any material misinEOrmation to a physician<br />
county health department or the county s designee or state or local<br />
law enforcement agency or <strong>of</strong>ficer for the purpose <strong>of</strong> falsely<br />
obtaining an identification card<br />
2 A person who steals or fraudulently uses any person<br />
identification card in order to acquire possess cultivate<br />
transport use produce or distribute marijuana<br />
3 A person who counterfeits tampers with or fraudulently<br />
produces an identification card<br />
4 A person who breaches the confidentiality requirements <strong>of</strong> this<br />
article to information provided to or contained in the records <strong>of</strong><br />
the department or <strong>of</strong> a county health department or the county s<br />
designee pertaining to an identification card program<br />
c In addition to the penalties prescribed in subdivision a<br />
any person described in subdivision b may be precluded from<br />
attempting to obtain or obtaining or using an identification card<br />
for a period <strong>of</strong> up to six months at the discretion <strong>of</strong> the court<br />
d In addition to the requirements <strong>of</strong> this article the Attorney<br />
General shall develop and adopt appropriate guidelines to ensure the<br />
security and nondiversion <strong>of</strong> marijuana grown for medical use by<br />
patients qualified under the Compassionate Use act <strong>of</strong> 1996<br />
11362 82 If any section subdivision sentence clause phrase or<br />
portion <strong>of</strong> this article is for any reason held invalid or<br />
unconstitutional by any court <strong>of</strong> competent jurisdiction that portion<br />
shall be deemed a separate distinct and independent provision and<br />
that holding shall not affect the validity <strong>of</strong> the remaining portion<br />
there<strong>of</strong><br />
11362 93 Nothing in this article shall prevent a city or other<br />
local governing body from adopting and enforcing laws consistent with<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 20ll
CA Codes hsa I 1362 7ll362 83 Page 10 <strong>of</strong> 10<br />
this article<br />
http www leginfo ca gov cgi bin<br />
displaycode section hsc group 11001 12000 file 929 2011
C Health and Medical Publications and<br />
Reports on Marijuana<br />
Center for Medicinal Cannabis Research Report<br />
2010<br />
Anesthesia Journal Cannabis for Chronic Pain<br />
2004<br />
Journal <strong>of</strong> Pain and Symptom Management<br />
Article 2010<br />
National Institute on<br />
Drug Abuse<br />
Abuse<br />
National Institute on<br />
Drug Abuse<br />
Facts for Parent<br />
Marijuana<br />
Marijuana<br />
National Institute on<br />
Drug Abuse Marijuana<br />
Facts for Teens<br />
Science Daily Cannabis Damages Young<br />
Brains 2009<br />
Office <strong>of</strong> National Drug Control Policy<br />
Marijuana As Medicine 2003<br />
Eye<br />
Care America Marijuana<br />
<strong>of</strong> Glaucoma<br />
in the Treatment
I<br />
CMCR<br />
I Center for Medicinal Cannabis Research<br />
N<br />
JI N<br />
F N<br />
0<br />
Universiry oF Cali fornia<br />
ETER FORI<br />
ANNABIS ESE C<br />
Report to the Legislature and Governor <strong>of</strong> the Sta e <strong>of</strong>California<br />
presenting findings pursuant io 58847 which created the CMCR and provided state funding<br />
Director<br />
Igor Grant MD<br />
University <strong>of</strong>California San Diego<br />
Co Directors<br />
J Hampton Atkinson MD<br />
Andrew Mattison Ph D<br />
University <strong>of</strong> California San Diego<br />
Thomas J Coates Ph D<br />
University <strong>of</strong>California Los Angeles<br />
Deceased<br />
3d<br />
UC SanDiega Prepared February il 2010 University <strong>of</strong> California www cmccucsd edu<br />
FFEALTH SCIENCES
Objective<br />
In 1999 the California legislature passed and Governor Gray Davis signed 56847 which commis<br />
sioned the University <strong>of</strong> California to establish a scientific research program to expand the public<br />
scientific knowledge on purported therapeutic usages <strong>of</strong> marijuana<br />
We hereby submit this report <strong>of</strong> our scientific findings pursuant to this objective<br />
WWW CMCR UCSD EDU FEBRUAFV 11 2010
Table <strong>of</strong> Contents<br />
ExecutiveSummary 2<br />
Summary<strong>of</strong> Results to Date2<br />
OtherCMCR Activities3<br />
Condusion 4<br />
MissionStatement4<br />
Scientific and Legislative Precursors <strong>of</strong> the CMCR5<br />
Discovery <strong>of</strong>Cannabis Receptors in the Brain5<br />
ScientificReports5<br />
LegislativeOrigins5<br />
CMCRReview Process6<br />
GMCR Vision for Cannabis Therepeutics Research 7<br />
Stagel Smoked Cannabis7<br />
Stage 11Non Smoked Preparations7<br />
Stage lll Molecules To Target Endocannabinoid System7<br />
Overview <strong>of</strong> Research Program8<br />
Studies in Pain and Other Neurologic Conditions8<br />
Synopsis <strong>of</strong> CMCR Published Clinical Study Results10<br />
The Effect <strong>of</strong> Cannabis on Neuropathic Pain inHIV Related Peripheral<br />
Neu ropa thy<br />
10<br />
Placebo Controlled Double Blind Trial <strong>of</strong> Medicinal Cannabis in Painful HIV<br />
Neuropathy<br />
10<br />
4 Double BlindPlacebo Controlled CrossoverTrial <strong>of</strong> the Antinociceptive Effects<br />
<strong>of</strong>Smoked Marijuana on Subjects with Neuropathic Pain 11<br />
4nalgesic Efficacy <strong>of</strong>Smaked Cannabis 11<br />
Short Term Effects <strong>of</strong> Cannabis Therapy on Spasticiry in Multiple Sclerosis 12<br />
Uaporization asaSmokeless DeliverySystem 11<br />
Recently Completed And Ongoing Studies13<br />
Sleep and Medicinal Cannabis 13<br />
Impact <strong>of</strong>Repeated Cannabis Treatments on<br />
DrivingAbilities 13<br />
Efficacy<strong>of</strong>lnhaled Cannabis in Diabetic Painful Peripheral Neuropathy 13<br />
The Analgesic Effect <strong>of</strong> Vaporized Cannabis on Neuropathic Pain 13<br />
CompletedPre Clinical Studies14<br />
Mechanisms <strong>of</strong>Cannabinoid Analgesia 14<br />
annabinoids in Fear Extinction 14<br />
Effects <strong>of</strong> Cannabis Therapy on Endogenous Cannabinoids 14<br />
Effec s <strong>of</strong>Medicinal Cannabis on CD4lmmuniry in AIDS<br />
I S<br />
DiscontinuedStudies15<br />
Summary And Future Directions16<br />
CMCRRoster17<br />
CMCRSupported Publications18<br />
Results<strong>of</strong> CMCR Studies 18<br />
PublishedAbstracts 18<br />
OtherCMCRions 19<br />
Supported Publica<br />
CENTER FOR MEDIUNAL CANNABIS RESEARCH UNNER9TV OF CALIFOflNIA
Research should continue into the physiological effects <strong>of</strong> synthetic and<br />
plant derived cannabinoids and the natural function <strong>of</strong> cannabinoids found<br />
in the body<br />
Institure<strong>of</strong>Medicine 1999<br />
The question <strong>of</strong> whether marijuana has any legitimate medical purpose<br />
should be determined by sound science and medicine<br />
Asa Hutchinson Former DEA Administrator 2001<br />
The scientific community the medical community in particular is divided<br />
on the real therapeutic effectiveness <strong>of</strong> marijuana Some are quick to say<br />
that opening the door to medical marijuana would be a step toward outright<br />
legalization <strong>of</strong> the substance But none <strong>of</strong> that should matter to physi<br />
cians or scientists It is not a question <strong>of</strong> defending general public policy on<br />
marijuana or even all illegal drugs It is not a question <strong>of</strong> sending a symbolic<br />
message about drugs It is not a question <strong>of</strong> being afraid that young people<br />
will use marijuana if it is approved as a medicine The question and the only<br />
question for physicians as pr<strong>of</strong>essionals is whether to what extent and in<br />
what circumstances marijuana serves a therapeutic purpose<br />
Canadian Senate Special Committee On Illegal Drugs Cannabis Summary Report 2002<br />
Although the indications for some conditionseg HIV wasting and<br />
chemotherapy induced nausea and vomiting have been well documented<br />
less information is available about other potential medical uses Additional<br />
research is needed to clarify marijuana s therapeutic properties and deter<br />
mine standard and optimal doses and routes <strong>of</strong> delivery<br />
American College <strong>of</strong> Physicians 2008<br />
The Center for Medicinal Cannabis Research is currently conducting<br />
scientific studies to determine the efficacy <strong>of</strong> marijuana in treating various<br />
ailments Until that research is concluded however most <strong>of</strong> what the public<br />
hears from marijuana activists is little more than a compilation <strong>of</strong> anecdotes<br />
John Wa ters Former Director <strong>of</strong> the White House Office <strong>of</strong> National Drug Control Policy 2002<br />
WWW CMCR UCSD EDU FEBRUAIiY ii 2010<br />
i
Executive Summary<br />
The Genter for Medicinal Cannabis Research CMCR at the University <strong>of</strong> California was created in 2000<br />
to conduct clinical andpre clinical studies <strong>of</strong> cannabinoids including smoked marijuana to provide<br />
evidence one way or the other to answer the question Does marijuana have therapeutic value To<br />
accomplish this objective the CMCR issued calls for applications from researchers at leading California<br />
institutions developed a close working relationship with state and federal agencies to gain regulatory<br />
approvals estabtished panels <strong>of</strong>nationally recognized experts to rigorously review the merit <strong>of</strong> appli<br />
cations and funded carefully designed studies that have now been published in high impact scientific<br />
journals making significant contributions to the available literature on cannabis and the cannabinoids<br />
Summary <strong>of</strong> Results to Date<br />
In total the CMCR has approved fifteen clinical studies including seven clinical trials <strong>of</strong> which five have<br />
completed and two are in progress The CMCR has also approved fourpre clinical studies all <strong>of</strong> which<br />
have completed<br />
By design CMCR clinical studies focused on conditions identified by the Institute <strong>of</strong> Medicine for which<br />
cannabis might have potential therapeutic effects based on current scientific knowledge Institute <strong>of</strong><br />
Medicine 1999 To date four CMCR funded studies have demonstrated that cannabis has analgesic<br />
effects in pain conditions secondary to injuryeg spinal cord injury or disease eg HIV disease HIV<br />
drug therapy <strong>of</strong> the nervous system This result is particularly important because three <strong>of</strong> these CMCR<br />
studies utilized cannabis as an add on treatment for patients who were not receiving adequate benefit<br />
from a wide range <strong>of</strong> standard pain relieving medications This suggests that cannabis may provide<br />
a treatment option for those individuals who do not respond or respond inadequately to currently<br />
available therapies The efficacy <strong>of</strong> cannabis in treaiment ref actory patients also may suggest a novel<br />
mechanism <strong>of</strong> action not fully exploited by current therapies In addition to nerve pain CMCR has<br />
also supported a study on muscle spasticity in Multiple Sclerosis MS Such spasticity can be painful<br />
and disabling and some patients do not benefit optimally from existing treatments The results <strong>of</strong> the<br />
CMCR study suggest that cannabis reduces MS spasticity at least in the short term beyond the benefit<br />
available from usual medical care<br />
Table 1 Clinical Studies Published or Submitted for Publication<br />
Donald Abrams MD<br />
UC San Francisco<br />
Donald Abrems MD<br />
UC San Francisco<br />
JodyCorey BloomMD Ph D<br />
UC San Diego<br />
Ronald EilisMD Ph D<br />
UC San Diego<br />
Mark WallaceMD<br />
UC San Diego<br />
Barth Wilsey MD<br />
UC Davis<br />
Cannabis forTreatment <strong>of</strong>HIV Related Peripheral<br />
Neuropathy<br />
Vaporization as a Smokeless Cannabis Delivery System<br />
Short Term Effects <strong>of</strong> Cannabis Therepy on Spasticity in MS<br />
Placebo controlled Double Blind Trial <strong>of</strong> Medicinal Cannabis<br />
in Painful HIV Neuropathy<br />
Analgesic Efficacy <strong>of</strong> Smoked Cannabis<br />
Double BlindPla ebo Controlled Trial <strong>of</strong> Smoked Marijuana<br />
on Neuropathic Pain<br />
2 CENTER FOF MEOICINAL CANNABIS RESEARCH UNIVERSITY OF CALIFORNIA
To date six <strong>of</strong> the studies have published or are in the process <strong>of</strong> publishing results in respected medi<br />
cal journals garnering national and international attention from other researchers media outlets<br />
governmental agencies and the generel public see Table 1 These results have helped to bring togeth<br />
er accomplished international experts on cannabis and cannabinoids and foster scientific dialog on the<br />
possible utility <strong>of</strong> cannabis as a therepeutic agent<br />
Adverse side effects experienced by participants included cough nausea dizziness sedation and<br />
changes in cognition However these effects were typically mild and resolved rapidly after treatment<br />
Currently approved analgesics are not without side effects and the effects observed in CMCR studies<br />
tended to be no worse than would be expected with other potent analgesics Following the conclusion<br />
<strong>of</strong> the two studies currently in progress CMCR will have exhausted its available funding for clinical work<br />
though the CMCR will continue to maintain a sample bank and to consult with researchers and policy<br />
makers as needed<br />
The majority <strong>of</strong> CMCR studies that have been discontinued were cancer studies that experienced diffi<br />
culty in recruiting participants Many severely ill individuals were reluctant to volunteer for a rigorous<br />
research protocol where the experimental treatment addressed disease symptomsie nausea pain<br />
but did not affect tumor growth directly Other factors such as requirement that patients have stable<br />
pain scores over a period <strong>of</strong> time leading into the study prohibition from driving for che duration <strong>of</strong><br />
the study and difficulty in providing cannabis for home administration may also have played a role in<br />
the lack <strong>of</strong> success in recruiting this population A further impediment to participation in CMCR stud<br />
ies particularly in cancer patients was the inability <strong>of</strong> CMCR Co continue to provide study drug beyond<br />
the study period to patients who find active treatment beneficial Additionally some individuals<br />
already were using cannabis to treat pain or other symptoms and so had less incentive to participate in<br />
research<br />
The CMCR portfolio also included basic science studies in animals and in human cellspre clinical<br />
research This research was supported because it had the potential to provide insights into therepeutic<br />
use <strong>of</strong> cannabinoids in human disease One study provided evidence by way <strong>of</strong> iecordings <strong>of</strong> nerve cell<br />
activity and in awake animals <strong>of</strong> analgesic effects <strong>of</strong> cannabis like compounds on head and facial pain<br />
suggesting that clinical trials <strong>of</strong> cannabis might be warranted in patients with headache or other facial<br />
pain Another study reported that cannabis did not interfere with the function <strong>of</strong> blood celis involved<br />
with immunity an important finding considering potential therapeutic use <strong>of</strong> cannabis compounds will<br />
be in persons with chronic illnesses<br />
Other CMCR Activities<br />
In addition to the research<br />
CMCR has also functioned as a catalyst for discussion and examination <strong>of</strong><br />
the potential development <strong>of</strong> cannabis as medicine In July 2002 CMCR sponsored a workshop Future<br />
Directions in Cannabinoid Therapeutics featuring presentations by intellectual and scientific leaders<br />
in the field <strong>of</strong> cannabinoid science from around the world CMCR hosted a second meeting in summer<br />
2004 to address recent progress in science that would be likely to lead to clinical trials <strong>of</strong> new cannabi<br />
noid compounds Future Directions in Cannabinoid Therapeutics II From the Bench to the Clinic<br />
brought together the major stakeholders in the development <strong>of</strong> cannabinoid therepeutics in order<br />
to survey laboratory compounds that are most promising for testing in human trials and to confront<br />
potential stumbling blocks to testing and development <strong>of</strong>these compounds A special issue <strong>of</strong> the<br />
journal Neuropharmacology 2005 was dedicated to publishing the research presented at this meeting<br />
W WWCMCR UCSD EDU FEBRUARV I7 2010 3
Executive Summc ry cont l<br />
CMCR researchers have also published two literature reviews on the neuropsycholo9ical effects <strong>of</strong><br />
cannabis use in order to better understand the potential hazards <strong>of</strong> cannabis use in short and long term<br />
treatment settings Grant et al 2003 Gonzalez et al 2002 see reference list<br />
Conclusion<br />
As a result <strong>of</strong> the vision and foresight <strong>of</strong> the California State Legislature Medical Marijuana Research Act<br />
SB847 the CMCR has successfully conducted the first clinical trials <strong>of</strong> smoked cannabis in the United<br />
States in more than 20 years As a result <strong>of</strong> this program <strong>of</strong> systematic research we now have reason<br />
able evidence that cannabis is a promising treatment in selected pain syndromes caused by injury or<br />
diseases <strong>of</strong> the nervous system and possibly for painful muscle spasticity due to multiple sclerosis<br />
Obviously more research will be necessary to elucidate the mechanisms <strong>of</strong> action and the full therapeu<br />
tic potential <strong>of</strong> cannabinoid compounds Meanwhile the knowledge and new findings from the CMCR<br />
provide a strong science based context in which policy makers and the public can discuss the place <strong>of</strong><br />
these compounds in medical care<br />
Mission Statement<br />
The Center for Medicinal Cannabis Research CMCR will conduct high quality scientific studies intend<br />
ed to ascertain the general medical safety and efficacy <strong>of</strong> cannabis products and examine alternative<br />
forms <strong>of</strong> cannabis administration The Center will be seen as a model resource for health policy plan<br />
ning by virtue <strong>of</strong> its close collaboration with federal state and academic entities<br />
4 CENTEP FOR MEDICINAI CANNABIS RESEARCH UNIVEPSITY OF CAUFOFNIA
Scientific and Legislative Precursors <strong>of</strong> the CMCR<br />
Discovery <strong>of</strong> Cannabis Receptors in the Brain<br />
During the late 1980 s and early 1990 s a series <strong>of</strong> significant scientific breakthroughs revealed anin built<br />
system <strong>of</strong> cannabinoid receptors and cannabinoid signaling molecules in the human brain Cannabinoid<br />
receptors are located throughout the central nervous system and peripherel tissues and are implicated<br />
in nervous system excitability movement analgesia neuroprotection and feeding behaviors including<br />
newborn suckling<br />
Scientific Reports<br />
Following this period <strong>of</strong> scientific discovery and expanded understanding <strong>of</strong>the physiological basis <strong>of</strong><br />
cannabinoid action there was renewed interest in potential therapeutic applications <strong>of</strong> cannabinoid<br />
chemicals The National Institutes <strong>of</strong> Health Ad Hoc Group <strong>of</strong> Experts and the Institute <strong>of</strong> Medicine follow<br />
ing thorough review <strong>of</strong>the existing scientific literature identified medical conditions warranting further<br />
research regarding the possible therapeutic effects <strong>of</strong> marijuana Medical evidence for likely therapeutic<br />
benefit was identified in the areas <strong>of</strong> appetite stimulation neurological and movement disorders analge<br />
sia and nausea and vomiting<br />
1997 National Institutes <strong>of</strong> Health Workshop on the Medical Utility <strong>of</strong> Marijuana<br />
1999 Institute <strong>of</strong> Medicine Report Marijuana and Medicine Assessing the Science Base<br />
Available through the CMCR websire athttp<br />
Ocmccucsd edu geninfo marijuana htm<br />
Legislative Origins<br />
7he triggering event which led to the creation <strong>of</strong> the CMCR was the passage by the people <strong>of</strong> California<br />
in 1996 <strong>of</strong> Proposition 215 the Compassionate Use Act which approved the medical use <strong>of</strong> marijuana<br />
although at that time the exact role the substance should play in patient care remained ambigu<br />
ous Following that in 1999 the Legislature <strong>of</strong> California passed Senate Bill SB 847 authored by then<br />
Assemblyman later Senator John Vasconcellos after extensive negotiations with then Attorney General<br />
Dan Lungren providing he bipartisan legitimacy that enabled this bill to obtain the required two thirds<br />
vote in each house <strong>of</strong> the California legislature 56847 proposed subject to the approval <strong>of</strong> the Board<br />
<strong>of</strong> Regents <strong>of</strong> the University <strong>of</strong> California to create a three year program overseeing objective hi9h<br />
quality medical research that would enhance understanding <strong>of</strong> the efficacy and adverse effects <strong>of</strong><br />
marijuana as a pharmacological agent stressing that the projed should not be construed as encour<br />
aging or sanctioning the social or recreational use <strong>of</strong> marijuana In August 2000 the Center for Medici<br />
nal Cannabis Research was established at the University <strong>of</strong> California to carry out this mission In 2003<br />
after CMCR had demonstrated its ability to carry out the proposed progrem <strong>of</strong> research SB295 was<br />
approved to remove the3year program limitation included in the founding legislation<br />
1996 California voters pass the Compassionate Use Act <strong>of</strong> 1996<br />
1999 California State Legislature passes the Medical Marijuana Resea ch Act <strong>of</strong> 1999 5B647<br />
2000 Center for Medicinal Cannabis Research is established as a state funded research center at the University <strong>of</strong><br />
California to solicit review and support clinical and limited preclinical research<br />
2000 CMCR issued its first call for proposals<br />
2003 5B295 is passedre authorizing the CMCR to continue indefinitely<br />
W WWCMCR IICSD EDU FEBRUARV 11 2010 5
CMCR Review Process<br />
In order to evaluate the scientific validity <strong>of</strong>the proposals submitted the CMCR engaged<br />
senior scientists from around the nation to serve as a Scientific Review Board SRB Studies<br />
recommended for funding by the Scientific Review Board were then submitted for review to<br />
the Research Advisory Panel <strong>of</strong> California RAP C the Office <strong>of</strong> Public Health and Science <strong>of</strong><br />
the federal Department <strong>of</strong> Health and Human Services DHHS the Food and Drug Administra<br />
tion FDA the National Institute on Drug Abuse NIDA and the Drug Enforcement Adminis<br />
tration DEA Upon final approval from each <strong>of</strong> the above agencies studies were authorized<br />
to order cannabis cigarettes from NIDA and io begin recruiting patients This process is<br />
described in Figures 1 and 2<br />
Figure L CMCR Scientific Review<br />
Application reviewed intetnally<br />
Appiication assigned 3 SRB<br />
reviewersfordetailedcritique<br />
Applicationsentt<strong>of</strong>ull5R8<br />
SRBmemberssubmitcritiquestoCMCN<br />
to cirwlare ta entire SRB<br />
ielephone meeting <strong>of</strong> entire SRB<br />
Each protocol is reviewed and scored evisions<br />
Necessary modifications including<br />
budget are diswssed<br />
CMCR Director communicates review to<br />
Investigaton<br />
Results<br />
Recommended<br />
Invite Investigator<br />
revisions<br />
Deferred<br />
Suggest major<br />
for next<br />
round<br />
NOiRecommended<br />
proposal Declined<br />
Figure 2 CMCR Regulatory Approval Process<br />
p SFBApproval<br />
Review<br />
qevisions<br />
Statt<strong>of</strong><br />
Calilorrtia<br />
RAPC DHHS NIDA<br />
Review pevisions RevisedAppwved Pevisions<br />
i<br />
ProPOSals<br />
Neview DNHS<br />
Review FDA<br />
FDA<br />
INDN<br />
DEAHQ<br />
DEALOCaI<br />
DEA<br />
Inspectian<br />
Review<br />
Appwval<br />
Order Pmdact<br />
Begln Studie5<br />
fi<br />
CENTER fOR MEDIUNAL CANNABIS FESEARCH UNNERSITV OF CALIFORNIA
CMCR Vision for Cannabis Therapeutics Research<br />
CMCR envisions its role in the investigation <strong>of</strong> cannabis and cannabinoid compounds in three main<br />
research domains involving smoked cannabisnon smoked preparations and eventually new pharmaceu<br />
tical drug candidates formulated to act directly on the endocannabinoid system<br />
Stage 1 Smoked Cannabis<br />
Develop state and federal review process and solicit proposals for initial studies<br />
Conductwell designed rigorously controlled clinical trials <strong>of</strong> smoked cannabis Until alternative<br />
delivery systems and new molecules are available smoked cannabis <strong>of</strong>fers the most efficient delivery<br />
<strong>of</strong> cannabinoids for clinical trials<br />
Cannabis cigarettes are provided by the National Institute on Drug Abuse NIDA<br />
Work Accomplished<br />
CMCR has developed the scientific and administretive infrastructure to support application review<br />
selection and implementation <strong>of</strong> studies and has developed a rigorous process <strong>of</strong> peer review <strong>of</strong> scien<br />
tific proposals by independent Scientific Review Board CMCR has also established a relationship with<br />
state and federal agencies RAPC DEA FDA DHHS NIDA to facilitate regulatory approval<br />
The CMCR first solicited applications in fall 2000 and has funded fifteen clinical and fourpre clinical<br />
studies throughout California The CMCR has issued five calls for proposals most recently in summer<br />
2006<br />
Stage IINon Smoked Preparations<br />
Explore the safety and effectiveness <strong>of</strong>non smoked forms <strong>of</strong> inedicinal cannabis<br />
Expand trials to include alternative non smoked delivery <strong>of</strong> cannabis preparations<br />
Alternative delivery may include vaporization patches suppositories and alternative oral forms<br />
Work Accomplished<br />
In the area <strong>of</strong>non smoked routes <strong>of</strong> cannabis administretion Dr Donald Abrams study Vaporization<br />
asaSmokeless Cannabis Delivery System has been completed and the results published in the Jour<br />
nal <strong>of</strong> Clinica Pharmacology Therapeutics This study found that vaporization was a safe and effective<br />
mode <strong>of</strong> delivery Two CMCR clinical trials are now in progress utilizing vaporization<br />
Stage 111 Molecules To Target Endocannabinoid System<br />
Stage III represents long term goals for cannabinoid research If the MCR were to continue the long<br />
term research objectives would be to<br />
Collaborate with laboratories around the world who are working on specific molecules both natural<br />
and synthetic to activate modulate or deactivate the body sin built cannabinoid system<br />
Perform Phase I II and III clinical trials on new molecules targeting the endocannabinoid system<br />
WWWCMCfl UCSD EDU FEBFUARY 71 2010
Overview <strong>of</strong> Research Program<br />
Studies in Pain and Other Neurologic Conditions<br />
Chronicpain<br />
on a daily or almost daily basis for six months or longer is one <strong>of</strong> the<br />
most prevalent and disabling conditions in California and in the US generelly Whereas many<br />
types <strong>of</strong> pain are caused by stimulation <strong>of</strong> specialized pain receptors on nerve endings due to<br />
injury <strong>of</strong> tissues neuropathic pain is produced either by direct damage to the central brain<br />
spinal cord or peripheral nervous system itself or by abnormal functioning <strong>of</strong> these systems<br />
Infections diabetes physical trauma strokes and many other diseases can injure the nervous<br />
system with resulting pain which persists even though pain receptors themselves are not<br />
directly activated It is therefore not surprising that neuropathic pain is widespread affect<br />
ing510 <strong>of</strong> the US population Only a few classes <strong>of</strong> inedications are approved for use as<br />
analgesics in these conditions opioids anticonvulsants antidepressants and many patienis<br />
obtain only partial relief even when using combinations <strong>of</strong> all available therapies Among the<br />
most difficult to treat neuropathic pain conditions are those secondary to HIV diabetes and to<br />
physical trauma to the nervous system Because these neuropathic disorders are so prevalent<br />
and treatment alternatives are so limited the CMCR focused on these conditions<br />
A distinguishing scientific feature <strong>of</strong> this program <strong>of</strong> pain research made possible only by the<br />
coordinating function <strong>of</strong> the CMCR is the commonality <strong>of</strong> ineasures and methods across the<br />
research studies This allows for the distinctive advantage <strong>of</strong> comparability <strong>of</strong> results across<br />
studies Additionally when possible we studied treatment <strong>of</strong> the same type <strong>of</strong> pain condition<br />
eg HIV neuropathy in more than one geographic site Finding comparable results at two or<br />
more sites studying the same disease is scientifically important since this suggests that the<br />
results are generally valid rather than being due to chance or the specific characteristics <strong>of</strong> a<br />
single sample <strong>of</strong> patients or <strong>of</strong> a particular team <strong>of</strong> researchers<br />
This research used the gold standard design for assessment <strong>of</strong> therapeutic effects the<br />
rendomized clinical trial In this approach participants are assigned by chance like flipping a<br />
coin to an experimental treatment in this case cannabis or to a placebo an inactive treat<br />
ment The placebo in all <strong>of</strong> our studies was a marijuana cannabis cigarette made with<br />
cannabis from which the active ingredients for exampledelta 9te<br />
rahydrocannabinol<br />
THQ had been removed The cigarette therefore had the appearance and the aroma <strong>of</strong> a<br />
marijuana cigarette but without the crucial chemical ingredients hypothesized to be thera<br />
peutically active Randomization ensures factors which might skew the results like age dura<br />
tion or intensity <strong>of</strong> pain are equally present in both the experimental and placebo condition<br />
Placebo is essential since the expectation <strong>of</strong> pain relief from any treatment is a powerful anal<br />
gesic itself All <strong>of</strong> our protocols used measures <strong>of</strong> pain recommended by expert consensus as<br />
standard in the field For studies <strong>of</strong> smoked cannabis the researchers used a standard timed<br />
method <strong>of</strong> inhalation research using vaporized cannabis used similar state <strong>of</strong> the art technol<br />
ogy Researchers measured blood concentrations <strong>of</strong> the primary active ingredient <strong>of</strong> cannabis<br />
THC allowing estimates <strong>of</strong> relationships between dose concentration and magnitude <strong>of</strong><br />
pain relief<br />
To date the CMCR has completed four studies in the treatment <strong>of</strong> neuropathic pain Two<br />
studies have focused on neuropathic pain resulting from HIV infection or the drugs used to<br />
treat HIV one has focused on neuropathic pain <strong>of</strong> varying causes and one has used an experi<br />
8 CENTEfl FOF MEDICINAL CANNA815 RESEAflCH UNIVERSITV OF CALIFORNIA
mental model <strong>of</strong> neuropathic pain tested in healthy volunteers The results from these four<br />
studies have been convergent with all four demonstrating a significant decrease in pain after<br />
cannabis administration The magnitude <strong>of</strong> effect in these studies expressed as the number <strong>of</strong><br />
patients needed to treat to produce one positive outcome was comparable to current thera<br />
pies Two additional studies involving neuropathic pain are underway<br />
Multiple sclerosis MS is one <strong>of</strong> the most common chronic and disabling diseases <strong>of</strong> the<br />
nervous system Caused by loss <strong>of</strong> the insulating sheath surrounding nerve fibers the dizease<br />
usually begins in young adulthood Although it may initially wax and wane in intensity and be<br />
<strong>of</strong> mild severity it <strong>of</strong>ten steadily progresses causing fatigue loss <strong>of</strong> balance muscle weakness<br />
and muscle spasticity Affecting up to70 <strong>of</strong> people with the disease muscle spasms lead to<br />
pain inability to walk and difficulties with self care causing most <strong>of</strong> the everyday life disabil<br />
ity from this disease There is as yet no cure for M5 Treatments for muscle spasticity are only<br />
partially effective and have side effects which are not easily tolerated making the search for<br />
new therapies <strong>of</strong> high importance Given this background the CMCR identified MS spasticity<br />
as an additional target for therapeutic research As with all CMCR studies the research used<br />
the most rigorous scientific approach to testing therapies a randomized clinical trial supple<br />
mented by modern measurement <strong>of</strong> muscle spasticity everyday function life quality and side<br />
effects Results to date have found a significant improvement in both an objective measure<br />
<strong>of</strong> spasticity and pain intensity in patients whose standard therepy had provided inadequate<br />
relief<br />
W WWCMCR UCSO EDU FEBflUAflY 11 2070 9
Synopsis <strong>of</strong> CMCR Published Clinical<br />
Study Results<br />
The Effect <strong>of</strong> Cannabis on Neuropathic Pain inHIV Related<br />
Peripheral Neuropathy<br />
Donald 1 Abrams MD University <strong>of</strong>California San Francisco<br />
The primary objective <strong>of</strong> this study was to evaluate the efficacy <strong>of</strong> smoked cannabis when used as an<br />
analgesic in persons with neuropathic pain fromHIV associated distal sensory polyneuropathy DSPN<br />
In a double blind randomizedfive day clinical trial patients received either smoked cannabis or place<br />
bo cannabis cigarettes Patients continued on any concurrent analgesic medicationseg gabapentin<br />
amitriptyline narcotics NSAIDs which they were prescribed priorto the trial the dose and amount <strong>of</strong><br />
the medications were recorded daily<br />
The full results <strong>of</strong> this study appear in the journal Neurology Abrams et al 2007 see reference list<br />
In brief 55 patients were randomized and 50 completed the entire trial Smoked cannabis reduced<br />
daily pain by34 compared to17 with placebo The study concluded that a significantly greater<br />
proportion <strong>of</strong> patients who smoked cannabis 52 had a greater than 30 reduction in pain intensity<br />
compared to only 24 in the placebo group This result is clinically important since the threshold <strong>of</strong> a<br />
30o reduction in pain intensity is associated with meaningful improvement in quality <strong>of</strong> life in other<br />
research on pain outcomes<br />
Cannabis appeared to bewell tolerated and there were no safety concerns raised By design all patients<br />
had smoking experience with cannabis There were more side effects in those receiving cannabis than<br />
placebo with the most frequent being sedation anxiety and diuiness but these were all rated as mild<br />
Placebo Controlled Double Blind Trial <strong>of</strong> Medicinal Cannabis in<br />
Painful HIV Neuropathy<br />
Ronald J EllisMD Ph D University <strong>of</strong>California San Diego<br />
The primary objective <strong>of</strong> this study also was to evaluate the efficacy <strong>of</strong> smoked cannabis when used as<br />
an analgesic in persons withHIV associated painful neuropathy In a double blind randomized clinical<br />
trial <strong>of</strong> the short term adjunctive treatment <strong>of</strong> neuropathic pain inHIV associated distai sensory poly<br />
neuropathy participants received either smoked cannabis or placebo cannabis cigarettes A structured<br />
dose escalation titration protocol was used to find an individualized effective safe andwell tolerated<br />
dose for each subject Participants continued on their usual analgesic medications throughout the trial<br />
with the dose and amount <strong>of</strong> these medications being recorded daily<br />
The full results <strong>of</strong> this study were published in thejournal Neuropsychopharmacology Ellis et al 2006<br />
see reference list In brief 34 eligible subjects enrolled and 28 completed both cannabis and placebo<br />
ireatments Among completers pain relief was significantly greater with cannabis than placebo The<br />
proportion <strong>of</strong> subjects achieving at least 30 pain relief was again significantly greater with cannabis<br />
46 compared to placebo 18 It was concluded thai smoked cannabis was generallywell tolereted<br />
and effective when added to concomitant analgesic therapy in patients with medicalfy refractory pain<br />
due toHIV associated neuropathy Once again these results appeared to be relevant to everyday clinical<br />
practice because the magnitude <strong>of</strong> pain relief is associated with that which improves life quality and<br />
also because the benefit was above and beyond that conferred by the patients usual analgesics<br />
As in the study described above side effects were more frequent with cannabis than with placebo with<br />
the most common being sleepiness or sedation fatigue and difficulty with concentration These were<br />
mild for the most part and did not raise safety concerns<br />
10 CENTER FOfl MEOIUNAL CANNABIS FESEAflCH UNNERSITV OF CAIIFORNIA
A Double Blind Placebo Controlled Crossover Trial <strong>of</strong> the<br />
Antinociceptive Effects <strong>of</strong> Smoked Marijuana on Subjects with<br />
Neuropathic Pain<br />
Bar h WilseyMD University <strong>of</strong> Californio Davis<br />
This study<br />
objective was to examine the efficacy <strong>of</strong> two doses <strong>of</strong> smoked cannabis on pain in persons<br />
with neuropathic pain <strong>of</strong> different originseg physical trauma co nerve bundles spinal cord injury<br />
multiple sclerosis diabetes In a double blind randomized clinical trial participants received either low<br />
dose high dose or placebo cannabis cigarettes As customary in CMCR trials participants were allowed<br />
to continue their usual regimen <strong>of</strong> pain medicationseg codeine morphine and others<br />
The full results <strong>of</strong> this study have been published in the Journal <strong>of</strong> Pain Wilsey et al 2008 see refer<br />
ence list Thirty eight patients underwent a standardized procedure for smoking either high dose7h<br />
low dose35 or placebo cannabis <strong>of</strong> these 32 completed all three smoking sessions The study<br />
demonstrated an analgesic response to smoking cannabis with no significant difference between the<br />
low and the high dose cigarettes The study concluded that both low and high cannabis doses were effi<br />
cacious in reducing neuropathic pain <strong>of</strong> diverse causes<br />
Disagreeable or unpleasant side effects were significantly more likely with high dose cigarettes<br />
compared to low dose or placebo whereas there was no difference in these effects between low dose<br />
and placebo sessions There was no indication <strong>of</strong> mood changeseg sadness anxiety fearfulness<br />
Analgesic Efficacy <strong>of</strong> Smoked Cannabis<br />
Mark Wallace MD University <strong>of</strong>California San Diego<br />
This study used an experimental model <strong>of</strong> neuropathic pain to determine whether pain induced by the<br />
injection into the skin <strong>of</strong> capsaicin a compound which is the hot ingredient in chili peppers could be<br />
alleviated by smoked cannabis Another aim <strong>of</strong> the study was to examine the effects <strong>of</strong> dose <strong>of</strong> canna<br />
bis and the time course <strong>of</strong> pain relief In a rendomized double blinded placebo controlled trial volun<br />
teers smoked low medium and high dose cannabis2 48THC by weight or placebo cigarettes<br />
The full results <strong>of</strong>this study were published in he journal Anesthesiology Wallace et al 2007 see refer<br />
ence list Nineteen healthy volunteers were enrolled and 15 completed all four smoking sessions In brief<br />
five minutes after cannabis exposure there was no effect on capsaicin induced pain at any dose By 45<br />
minutes after cannabis exposure there was a significant decrease in capsaicin induced pain with the medi<br />
um dose4and a significant increase in pain with the high dose8There was no significant effect<br />
seen with low dose2h There was a significant inverse relationship between pain perception and plasma<br />
THC In summary this study suggested that there may beatherapeutic window or optimal dose for<br />
smoked cannabis low doses were not effective medium doses decreased pain and higher doses actually<br />
increased pain These results suggest the mechanism<br />
<strong>of</strong> cannabinoid analgesia are complex in some<br />
ways likenon opioid pain relieverseg aspirin ibupr<strong>of</strong>en and in others like opioidseg morphine<br />
WWW CMCR UCSD EDU<br />
FEBRUARY 11 2010 11
Synopsis <strong>of</strong>CVICR Published Clinic nl Sh idy Results cont<br />
Short Term Effects <strong>of</strong> Cannabis Therapy on Spasticity in<br />
Multiple Sclerosis<br />
JodyCorey BloomMD University <strong>of</strong>California San Diego<br />
This objective <strong>of</strong> this study was to determine the potential for smoked cannabis to ameliorate<br />
marked muscle spasticity chronic painful contraction <strong>of</strong> muscles a severe and disabling symptom<br />
<strong>of</strong> multiple sclerosis In a placebo controlled rendomized clinical trial spasticity and global func<br />
tioning was examined before and after treatment with smoked cannabis Patients were allowed to<br />
continue their usual treatments for spasticity and pain while participating in the research<br />
The full results <strong>of</strong>this study are being submitted for publication lnitial results were presented at<br />
the meeting <strong>of</strong> the American College <strong>of</strong> Neuropsychopharmacology in 2007 Thirty patients with<br />
multiple sclerosis were enrolled Compared to placebo cigarettes cannabis was found to signifi<br />
cantly reduce both an objective measure <strong>of</strong> spasticity and pain intensity This study concluded<br />
that smoked cannabis was superior to placebo in reducing spasticity and pain in patients with<br />
multiple sclerosis and provided some benefit beyond currently prescribed treatments<br />
Vaporization asaSmokeless Cannabis Delivery System<br />
Donald Abrams MD University <strong>of</strong>California San Francisco<br />
The aim <strong>of</strong> this study was to evaluate the use <strong>of</strong> a vaporization system the Volcano<br />
VAPORMED Inhalatoren Tuttlingen Germany asasmokeless delivery system for inhaled<br />
cannabis Because <strong>of</strong> concerns regarding the practicality and palatability <strong>of</strong> using cannabis<br />
cigarettes as a siandard treatment there has been an interest in developing alternative deliv<br />
ery systems Participants were randomly assigned to receive low medium or high dose17<br />
34 or68tetrahydrocannabinop cannabis cigarettes delivered by smoking or by the vapor<br />
ization system on six study days<br />
The full results <strong>of</strong> this study have been published in thejournal Clinical Pharmacology Thera<br />
peutics Abrams et al 2007 see reference list Eighteen healthy volunteers were recruited to<br />
participate in the research The analysis indicated that the blood levels <strong>of</strong> vaporized cannabis<br />
are similar to those <strong>of</strong> smoked cannabis over a six hour period However blood concentrations<br />
<strong>of</strong> THC at 30 and 60 minutes after inhalation were significantly higher in vaporized cannabis as<br />
compared to smoked cannabis In addition carbon monoxide levels were significantly reduced<br />
with vaporization compared with smoked cannabis Fourteen participants preferred vaporiza<br />
tion 2 preferred smoking and 2 reported no preference In summary vaporization <strong>of</strong> cannabis<br />
was found to be a safe mode <strong>of</strong> delivery and participants had a preference for vaporization<br />
over smoking as a delivery system in this trial<br />
12 CENTER FOF MEDICINAL CANNABIS RESEARCH UNIVERSITY OF CALIFOHNIA
Recently Completed And Ongoing Studies<br />
Sleep and Medicinal Cannabis<br />
Sean Drummond Ph D University<strong>of</strong>California San Diego<br />
The primary objective <strong>of</strong> this study was to determine the effects <strong>of</strong> cannabis on insomnia and poor<br />
sleep quality which are experienced by up <strong>of</strong>90 <strong>of</strong>HIV infected individuals Participants in this study<br />
were individuals enrolled in the UCSD randomized trial comparing cannabis and placebo as an analge<br />
sic in painfulHIV associated neuropathy see Dr Ellis above<br />
The results <strong>of</strong> this study suggest that cannabis administration during the day does not affect objective<br />
or subjective measures <strong>of</strong> sleep approximately 78 hours after the last use <strong>of</strong> cannabis<br />
Impact <strong>of</strong> Repeated Cannabis Treatments on Driving Abilities<br />
Thomas Marcotte Ph D Universiry<strong>of</strong>Ca ifornia San Diego<br />
The principal aim <strong>of</strong> this study was to examine whether routine administration <strong>of</strong> cannabis in the medi<br />
cal treatment <strong>of</strong>HIV related neuropathy and spasticity associated with multiple sclerosis results in<br />
significant impairment in driving abilities Participants in this study were individuals enrolled in the<br />
randomized clinical trials <strong>of</strong> cannabis for painful HIV neuropathy and for spasticity in multiple sclerosis<br />
conducted at UCSD see Dr Ellis and Dr Corey Bloom above<br />
The results <strong>of</strong> this study are in preparetion Subjects were tested using a computerized driving simulator<br />
commonly used to demonstrate the effects <strong>of</strong> alcohol on driving ability The driving simulator presents<br />
different driving conditions and circumstances and was done at four points before cannabis and at<br />
one three and 18 hours after the final dose in the therapeutic trials These data will provide insights<br />
regarding the real life impact <strong>of</strong> using cannabis as medicine<br />
Efficacy <strong>of</strong> Inhaled Cannabis in Diabetic Painful Peripheral<br />
Neuropathy<br />
Mark WallaceMD Universiry <strong>of</strong>California San Diego<br />
The primary objective <strong>of</strong> this ongoing study is to evaluate the efficacy <strong>of</strong> smoked cannabis when<br />
used as an analgesic in painful neuropathy due to diabetes In a double blind randomized placebo<br />
controlled trial participants will inhale low medium or high dose vaporized cannabis or placebo<br />
Concurrent testing with experimentally induced pain will help identify the potential mechanisms <strong>of</strong><br />
therapeutic effects<br />
This study is actively recruiting its intended sample <strong>of</strong> 20 participants No preliminary results are avail<br />
able at this time<br />
The Analgesic Effect <strong>of</strong> Vaporized Cannabis on Neuropathic Pain<br />
Barth WilseyMD Universiry<strong>of</strong>California Davis<br />
The primary aim <strong>of</strong> this study is to evaluate the analgesic effects <strong>of</strong> vaporized cannabis in patients with<br />
neuropathic pain <strong>of</strong> different origins In a rendomized clinical trial the effects <strong>of</strong> placebo and <strong>of</strong> low and<br />
medium 17 o and35 dose cannabis on clinical pain and on experimentally induced pain will be<br />
assessed As noted above use <strong>of</strong> experimentally induced pain may help identify mechanism <strong>of</strong> actions<br />
This study is beginning to recruit participants No preliminary results are available at this time<br />
WWW CMCR UCSD EDU PEBRUARV 11 2010 13
CompletedPre Clinical Studies<br />
In addition to testing the possible benefits <strong>of</strong> inedicinal cannabis the CMCR supported a small number<br />
<strong>of</strong> laboratory and animal studies which might lead to either developing new treatments in humans or<br />
better understanding the mechanisms <strong>of</strong> therapeutic actions<br />
Mechanisms <strong>of</strong> Cannabinoid Analgesia<br />
Howard Fields MD Ph D University <strong>of</strong>California San Francisco<br />
The aim <strong>of</strong> this study was to determine whether cannabinoids might be a useful class <strong>of</strong> inedication for<br />
migraine and other headaches or facial pain conditions<br />
The full results <strong>of</strong> this study were published in thejournal Pain Papanastassiou et al 2003 see reference<br />
list A cannabis like drug WIN55 212 given to rats under anesthesia showed reduced activity<strong>of</strong> individual<br />
nerve cells transmitting pain whereas giving anotherdrug which blocked cannabis receptors on these nerve<br />
endings reversed this effect Moreover the analgesic effect <strong>of</strong> the cannabis like drug was evident in tests <strong>of</strong><br />
facial pain heat in awake rats This study therefore provided direct scientific evidence at the level <strong>of</strong> both<br />
individual nerve cells and in awake animals <strong>of</strong> analgesic effects <strong>of</strong> cannabis like compounds on head and<br />
facial pain Randomized clinical trials in humans might be conducted to determine ifcannabis could treat<br />
facial pain or headache<br />
Cannabinoids in Fear Extinction<br />
Mark Barad MD Ph D University <strong>of</strong>Califomia Los Angeles<br />
The aim <strong>of</strong> this study was to determine if a cannabis like agent could suppressfear inducing memories or<br />
images that might be the basis for some psychiatric conditions such asPost Traumatic Stress Disorder PTSD<br />
andotheranxietydisorders Therapeuticeffectswerethoughtpossiblebecauseearlierresearchsuggested<br />
that specializedin built cannabinoid receptors in the brain are necessary for suppression <strong>of</strong> normal fears<br />
Tests using three different synthetic cannabis like compounds showed no significant differences in<br />
behavior between mice treated with study drugs and untreated mice treined to fear specific locations<br />
This study suggests that acutely enhancing the brain s internal cannabinoid system does not extinguish<br />
specific fears <strong>of</strong> place memory in animals<br />
Effects <strong>of</strong> Cannabis Therapy on Endogenous Cannabinoids<br />
DanielePiomelli Pharm D Ph D Universiry<strong>of</strong>California Irvine<br />
7he aim <strong>of</strong> this study was to determine the short and longer term effects <strong>of</strong> THC on the naturalin built<br />
system <strong>of</strong> nervous system chemical trensmitters called endocannabinoids which help regulate move<br />
ment cognition pain and other physiological processes Amplification or interference with activity <strong>of</strong><br />
this system could influence outcomes <strong>of</strong> cannabinoid treatment<br />
These experiments contributed preliminary data to work that was later published in the journal Neuropsy<br />
chopharmacology Giuffrida et al 2004 see reference list A synthetic cannabis like compound had no<br />
effects on the levels <strong>of</strong> anandamide an endocannabinoid in blood or in brain tissue from regions involved<br />
in memory motivation movement and wakefulness Chronic but not acute treatment caused a marked<br />
increase in anandamide levels in the brain hippocampus a region crucially involved in learning and memory<br />
This study provides evidence indicating that exposure to cannabis like drugs can alter endocannabinoid<br />
signaling in the brain Alterations in this important signaling system might be involved in mediating the<br />
actions <strong>of</strong> cannabis in humans<br />
14 CENTEH fOP MEDICINAL CANNABIS RESEARCH UNIVEFSITV OF CALIFORNIA
Effects <strong>of</strong> Medicinal Cannabis on CD4 Immunity in AIDS<br />
Rachel5chrier Ph D University <strong>of</strong>California San Diego<br />
The aim <strong>of</strong> this study was to determine if cannabis might suppress the immune system in individuals<br />
with HIV This is an important question since already fregile immunity is characteristic <strong>of</strong> AIDS and other<br />
serious illness where cannabis might be used<br />
Results <strong>of</strong> the study are being prepared for publication Briefly immune system cells CD4 white blood<br />
cells obtained from 15 individuals with AIDS participating in another study were exposed to three<br />
concentrations <strong>of</strong> THC in tests <strong>of</strong> their functional competence There was no evidence <strong>of</strong> acute impair<br />
ment <strong>of</strong> immune function at concentrations achievable in living humans These results parallel other<br />
research showing that short term cannabis administration does not diminish the circulating number <strong>of</strong><br />
this white blood cell essential for immunity<br />
Discontinued Studies<br />
Five clinicaf studies were discontinued before completion because they could not accrue a sufficient<br />
number <strong>of</strong> participants The scientific and safety design <strong>of</strong> two studies one studying the combination<br />
<strong>of</strong> cannabis and opioidseg morphine for cancer pain relief and one on relief <strong>of</strong> muscle spasticity in<br />
multiple sclerosis required either a nine day hospitalization or 16 weeks without driving an automobile<br />
Understandably chronically ill patients were reluctant to bere<br />
hospitalized for research or to surrender<br />
driving privileges for an extended period<br />
Two other cancer studies faced different real Itfe obstades to recruitment One study on cannabis for<br />
severe nausea and vomiting due to chemotherepy could not identify a sufficient number <strong>of</strong> patients<br />
with sufficiently severe nausea lt appeared that currentanti nausea treatments are <strong>of</strong>ten highly effec<br />
tive Alternative or adjunctive therapy may be required only by a minority <strong>of</strong> patients Another project<br />
on cannabis for advanced cancer pain unresponsive to all other analgesics found chat local hospice<br />
agencies were willing to refer potential participants These patients however were <strong>of</strong>ten already smok<br />
ing cannabis for pain control One study <strong>of</strong> cannabis for use at home for neuropathic pain did not elicit<br />
sufficient interest despite outreach to the community through advertisements and focus groups<br />
Although the outcomes <strong>of</strong> these studies is disappointing valua6le lessons were learned in terms <strong>of</strong><br />
design <strong>of</strong> future studies and selection <strong>of</strong> appropriate populations for study<br />
WWW CMCF UCSD EDU FEBRUARY il 2010I5
Summary And Future Directions<br />
Results <strong>of</strong> CMCR studies support the likelihood that cannabis may represent a possible adjunctive<br />
avenue <strong>of</strong> treatment for certain difficult to treat conditions like neuropathic pain and spasticity In<br />
establishing the University <strong>of</strong> California CMCR the California Legislature enabled the creation <strong>of</strong> what is<br />
now arguably a world class resource both forstate <strong>of</strong> the art clinical trials on medicinal cannabis and its<br />
derivatives and for developing knowledge on the potential and limitations <strong>of</strong> cannabinoid therapeutics<br />
for selecced indications By facilitating high caliber clinical trials whose results are published in leading<br />
peer reviewed scientific journals the CMCR is providing physicians and policy makers with solid scien<br />
tific data to inform both medical research and policy decisions As a seasoned and unique resource the<br />
CMCR iswell positioned to inform public health and policy decision makers<br />
Worldwide the merit <strong>of</strong> new therapies is rigorously evaluated by a series <strong>of</strong> clinical trials termed Phase<br />
I Phase II Phase III and Phase IV In Phase I usually involving 20 50 participants several possible doses<br />
<strong>of</strong> a drug are tested safety is assessed and hints <strong>of</strong> therapeutic value are revealed Drug development<br />
then proceeds to Phase II trials which may recruit up to several hundred individuals to more accurately<br />
gauge the efficacy <strong>of</strong> treatment along with determining short term side effects and risks Results from<br />
Phase II trials with smoked cannabis in neuropathic pain form the basis <strong>of</strong> the CMCR s efforts to date In<br />
the next step Phase III trials involving hundreds to several thousand patients are designed to provide<br />
definitive assessment <strong>of</strong> the efficacy <strong>of</strong> new treatment for specific conditions usually by comparing he<br />
newer therapy to the best standard treatment available while also adding to a better understanding<br />
<strong>of</strong> benefit risk relationships Finally Phase IV trials conducted after a treatment is licensed or approved<br />
for general medical use gather additional information on benefits risks and optimal use <strong>of</strong> the therepy<br />
The expertise developed at CMCR iswell suited to contribute to each <strong>of</strong> these phases <strong>of</strong> cannabinoid<br />
research<br />
Were support for the CMCR to continue research might focus on 1 larger placebo controlled stud<br />
ies to generate definitive data on therepeutic meritie Phase III trials 2 to head comparisons<br />
with other current therapies in Phase II or III studies or 3 expanded studies evaluating cannabis as an<br />
adjunc to existing treatment with opioids andnon steroidalanti inflamma ory drugsie Phase II and<br />
III research determining if cannabinoids have an opioid sparing effect that is if they might allow use<br />
<strong>of</strong> lower doses <strong>of</strong> opioids without sacrificing pain relief Other Phase II and III studies might move from<br />
the question <strong>of</strong> efficacy to overall effectiveness that is evaluating 1 alternative delivery systemseg<br />
vaporization that reduce the harmful effects <strong>of</strong> smoking 2 models <strong>of</strong>take home treatment that more<br />
accurately mimic the way drugs are prescribed and 3 long term studies to assess emergent toxici<br />
ties stability <strong>of</strong> treatment effects and possible development <strong>of</strong> tolerance to treatment over time This<br />
research might extend into formal Phase IV trials<br />
Studies also might be conducted onnewly developed synthetic agents which enhance antagonize<br />
or otherwise modulate the cannabinoid system comparing their efficacy to cannabis as a botanical<br />
product In any event the fundamental nature <strong>of</strong> the endocannabinoid system evident by its partici<br />
pation in essential functions like movement pain moods and other behaviors suggests concinuing<br />
clinical research on cannabis might yield important contributions to health care<br />
16 CENTEF FOfl MEDIUNAL CANNABIS RESEAftCH 11NIVER5ITY OF CALIFORNIA
CMCR Roster<br />
James Anthony Ph DMSc<br />
William Breitbart MD<br />
Alan Budney Ph D<br />
Don Cherek Ph D<br />
Steven Childers Ph D<br />
Reena Deutsch Ph D<br />
Wiltiam L Dewey Ph D<br />
Judith Feinberg MD<br />
Richa d Foltin Ph D<br />
Richard Gracely Ph D<br />
Margaret Haney Ph D<br />
Miles Herkenham Ph D<br />
Karl Kieburtz MDMPH<br />
Robert A Parker Sc D<br />
Frank Porreca Ph D<br />
Judith Rabkin Ph DMPH<br />
Srinivasa Raja MD<br />
Richard Rauck MD<br />
Wilfred Van Gorp Ph D<br />
Leslie Weiner MD<br />
Sandra P Welch Ph D<br />
Tanya Wolfson MA<br />
Scientific Review Board<br />
Johns Hopkins University<br />
Memorial Sloan Kettering Cancer Center<br />
University <strong>of</strong> Vermont<br />
University <strong>of</strong> Texas Health Sciences Center<br />
Wake Forest University<br />
University <strong>of</strong> California San Diego<br />
Virginia Commonwealth University<br />
University <strong>of</strong> Cincinnati Holmes Hospital<br />
Columbia University<br />
NIDCR National Institutes <strong>of</strong> Health<br />
Columbia University<br />
National Institute <strong>of</strong> Mental Health<br />
University <strong>of</strong> Rochester<br />
Harvard University<br />
University <strong>of</strong> Arizona<br />
Columbia University<br />
Johns Hopkins University<br />
Wake Forest University<br />
Columbia University<br />
University <strong>of</strong> Southern California<br />
Virginia Commonwealth University<br />
University <strong>of</strong> California San Diego<br />
National Advisory Council<br />
1 Richard Crout MD Crout Consulting<br />
Samuel A Deadwyler Ph D<br />
Dale Gieringer Ph D<br />
Lester Grinspoon MD<br />
Janet Joy Ph D<br />
Lewis Judd MD<br />
Wake Forest University<br />
California NOFML<br />
Pr<strong>of</strong>essor Emeritus Harvard Medical School<br />
Institute <strong>of</strong> Medicine<br />
University <strong>of</strong> California San Diego<br />
AlexandrosMakriyannis Ph D University<strong>of</strong>Connecticut<br />
T Philip Malan MD Ph D<br />
Billy Martin Ph D<br />
CharlesOBrienMD Ph D<br />
John Phair MD<br />
June Machover Reinisch Ph D<br />
Roger A R<strong>of</strong>fmanDSW<br />
Donald P Tashkin MD<br />
Robert Temple MD<br />
Scott Thorpe lD<br />
John Vasconcellos<br />
Tom Vischi<br />
Deceased<br />
Acknowledgement<br />
University <strong>of</strong> Arizona<br />
Virginia Commonwealth University<br />
University <strong>of</strong> Pennsylvania<br />
Northwestern University Medical School<br />
R2 Science Communications Inc<br />
University <strong>of</strong> Washington<br />
University <strong>of</strong> California Los Angeles<br />
Food and Drug Administration<br />
Special Assistant Attorney General State <strong>of</strong> California<br />
Retired California State Senare<br />
Retired Department Health and Human Services<br />
CMCR particularly wishes to acknowledge the contributions <strong>of</strong> Tom Marcotte Ph D as Center<br />
Manager Shondra Neumayer RN and Heather Bentley CCRA as Project Managers and Ben<br />
Gouaux as a Research Associate<br />
WWW CMCR UCSD EDU FEBRUARV 11 2010 17
CMCR Supported Publications<br />
Results <strong>of</strong> CMCR Studies<br />
Abrams Dl lay CA Shade S6 Vizoso H Reda H Press S Kelly ME Rowbotham MC Petersen KL Cannabiz in painful<br />
HIV associated sensory neuropathy A randomized placebo controlled trial Neurology 2007 68 515 521<br />
Abrams DI Vizoso HP Shade SB Jay C Kelly ME Benowitz NL Vaporization as a Smokeless Cannabis Delivery<br />
System A Pilot Study Clin Pharmacol Thei 2007 825 572 578<br />
Ellis R Toper<strong>of</strong>f W Vaida F van den Brande G Gonzales J Gouaux B Bentley H Atkinson 1H Smoked Medicinal<br />
Cannabis for Neuropathic Pain in HIV A Randomized Crossover Clinical Trial Neuropsychopharmacology 2008<br />
343 672 680<br />
Giuffrida A Leweke FM Gerth CW Schreiber D Koethe D Faulhaber 1 Klosterkotter J PiomelliD2004 Cerebrospi<br />
nal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms<br />
Neuropsychopharmacology 29 2108 2114<br />
Papanastassiou AM Fields HL Meng ID 2004 Local application <strong>of</strong> the cannabinoid receptor agonist WIN S5<br />
212 to spinal trigeminal nucleus caudalis differentially affects nociceptive andnon noci eptive neurons Pain<br />
107 3 267 75<br />
Wallace M Schu teis G Atkinson 1H Wolfson T Lazzaretto D Bentley H Gouaux B Abramson I Dose dependent<br />
Effects <strong>of</strong> Smoked Cannabis on Capsaicin induced Pain and Hyperalgesia in Healthy Volunteers Anesthesiology<br />
107 51 785 796 November 2007<br />
Wilsey B Marcotte T Tsodikov A Millman J Bentley H Gouaux B Fishman 5 April 2008 A Randomized Placebo<br />
Controlled Crossover Trial <strong>of</strong> Cannabis Cigarettes in Neuropatbic PainJoumal <strong>of</strong>Pain96506 521<br />
Published Abstracts<br />
Abrams D Jay C Vizoso H Shade S Reda H Press 5 Kelley ME Rowbotham M Petersen K Smoked Canna<br />
bis Therepy for HIV Related Painful Peripheral Neuropathy Results <strong>of</strong> a Randomized Placebo Controlled Clinical<br />
Trial 2nd Annual Meeting <strong>of</strong>the International Association for Cannabis as Medicine 2005<br />
Abrams Dl Jay C Petersen K Shade S Vizoso H Reda H Benowitz N Rowbotham M The Effects <strong>of</strong> Smoked Canna<br />
6is in Painful Peripheral Neuropathy and Cancer Pain Refractory to Opioids Proceedings <strong>of</strong>the International Asso<br />
ciation <strong>of</strong> Cannabis as Medicine Cologne 2003p28<br />
Abrams D Vizoso H Shade S Jay C Kelley ME Benowitz N Vaporization as a Smokeless Cannabis Delivery System<br />
A Pilot Study 2nd Annual Meeting <strong>of</strong>the International Association for Cannabis as Medicine 2005<br />
Corey Bloom J Wolfson T Gamst A Jin 5 Marcotte T Bentley H Gouaux 6 Short Term Effects <strong>of</strong> Medicinal Canna<br />
bis on Spasticity in Multiple Sclerosis Poster presented at the 60th Annual Meeting <strong>of</strong> the American Academy ot<br />
Neurology Chicago IL 2008<br />
Jay C Shade S Vizoso H Reda H Petersen K Rowbotham M Abrams D The Effect <strong>of</strong> Smoked Marijuana on Chronic<br />
Neuropathic and Experimentally Induced Pain in HIV Neuropathy Results <strong>of</strong> an Open Label Pilot Study Proceed<br />
ings 11th Conference on fletroviruses and OpportunisticIfections abstract 496p243 2004<br />
Lopez C Toper<strong>of</strong>f W van den Brande G Tapert 5 Atkinson JH Drummond SPA Increased Sleep Disturbances in<br />
Patients withHIV Related Neuropathy 2005 Annual Meeting <strong>of</strong>the Associated Pr<strong>of</strong>essional Sleep Societies<br />
Marcotte T Rosenthal T Corey Bloom 1 Roberts E Lampinen 5 Allen W The Impact <strong>of</strong> Cognitive Deficits and<br />
Spasticity on Driving Simulator Performance in Multiple Sclerosis Proceedings <strong>of</strong> the Third International Driving<br />
Symposium on Human Factors in Driver Assessment Training and Vehicle Design 2005<br />
Schrier R Soto P Hamlat C Durand D Ceci K Ellis R 2004 3 Effects <strong>of</strong> in Vitro Cannabinoids onTcell Responses<br />
<strong>of</strong> HIV Infected Patients Poster presented at the 70th Sociery on Neuroimmune Pharmarology Conference Santa<br />
Fe NM<br />
IB<br />
CENTEF FOR MEDICINAL CANNABIS RESEARCH UNIVERSITY OF CALIFORNIA
OtherCMCR Supported Publications<br />
t Darmani NA Izzo AA Degenhardt B Valenti M Scaglione G Capasso R Sorrentini I Di Marzo V 2005<br />
Involvement <strong>of</strong> the cannabimimetic compoundNpalmitoyl<br />
ethanolamine in inflammatory and neuro<br />
pathic conditions Review <strong>of</strong> the available pre clinical data and first human studies Neuropharmacology<br />
48 1154 1163<br />
t Fattore L Spano S Cossu G Deiana 5 Fadda P Fratta W 2005 Cannabinoid C81 antagonist SR 147716A<br />
attenuates reinstatement <strong>of</strong> heroinself<br />
administration in heroin abstinent rats Neuropha macology 48<br />
1097 1104<br />
t Fride E Ponde D Breuer A Hanus L 2005 Peripheral but not centrel effects <strong>of</strong> cannabidiol derivatives<br />
Mediation by C61 and unidentified receptors Neurophaimacology 48 11V1129<br />
t Fu J Oveisi F Gaetani S Lin E Piomelli D2005<br />
Oleoylethanolamide an endogenous PPAR alpha agonist<br />
lowers body weight and hyperlipidemia in obese rats Neuropharmacology 48 1147 1153<br />
t Grant I 2005 Foreword by Igor Grant MD Director Center for Medicinal Cannabis Research CMCR<br />
Neuropharmacology 48 7067<br />
Grant I Cahn BR 2005 Cannabis and Endocannabinoid modulators Therapeutic Promises and Challenges<br />
Clinical Neuroscience Research524185 799<br />
Grant I Gonzalez R Carey C Natarejan L Wolfson T 2003 Non acute residual neurocognitive effects <strong>of</strong><br />
cannabis use Ameta analysis study lournal <strong>of</strong> the International Neuropsychological Society 9 679 689<br />
Gonzalez R Carey C Grant I Nonacute Residuaq Neuropsychological Effects <strong>of</strong> Cannabis Use A Qualitative<br />
Analysis and Systemic Review 1 Clin Pharmacol 2002 42485 575<br />
t Hillard U Jarrahian A 2005 Accumulation <strong>of</strong> anandamide Evidence for cellular diversity Neuropharmacol<br />
agy 486 1072 1078<br />
Ilan A Gevins A Role K Vizoso H Abrams D The Cognitive Neuropysiological Effects <strong>of</strong> Medicinal Mari<br />
juana in HIV Patients with Peripheral Neuropathy 2nd Annual Meeting <strong>of</strong> the International Association for<br />
Cannabis as Medicine 2005<br />
tLupicaCR RiegelAC 2005<br />
Endocannabinoidreleasefrommidbraindopamineneurons<br />
apotentialsubstrate<br />
for cannabinoid receptor antagonist treatment <strong>of</strong> addiction Neuropharmacology 48 17OS 1116<br />
tMakriyannisA<br />
MechoulamR PiomelliD 2005<br />
Therapeuticopportunitiesthroughmodulation<strong>of</strong>theendo<br />
cannabinoid system Neuropharmacology 486 7068 1071<br />
t Pacher P Batkai S Kunos G 2005 Blood pressure regulation by endocannabinoids and their receptors<br />
Neuropharmacolagy 48 7130 1738<br />
t Pertwee RG Thomas A Stevenson LA Maor Y Mechoulam R 2005 Evidence that7hydroxy 4dimethyl<br />
heptyl<br />
cannabidiol activates a non CBI CB2non TRPVI target in the mouse vas deferens Neurophar<br />
macology 48 1139 7146<br />
t Salim K Schneider U Burstein S Hoy L Karst M 2005 Pain measurements and side effect pr<strong>of</strong>ile <strong>of</strong> the novel<br />
cannabinoid ajulemit acid Neuiopharmacology 48 7164 1171<br />
t Ueda N Tsuboi K Lambert DM 2005 A secondNacylethanolamine hydrolase in mammalian tissues<br />
Neuropharmacology 48 1079 1085<br />
t Zhuang SY Bridges D Grigore ko E McCloud 5 Boon A Hampson R Deadwyler SA 2005 Cannabinoids<br />
produce neuroprotection by reducing intracellular calcium release from ryanodine sensitive stores Neurop<br />
harmacology 48 1086 1096<br />
tConrents <strong>of</strong>CMCF special issueothejournal Neuropharmacology<br />
W WWCMCR UCS EDU FEHRUARY 11 1010 19
Y<br />
UCSanDiego<br />
HEALTH SCIENCES<br />
Universiry<strong>of</strong>California<br />
www cmcr ucsd edu
Anaest esia 2004 59 pages 440 452<br />
Initial experiences with medicinal extracts <strong>of</strong> cannabis<br />
for chronic pain Results from 34 N <strong>of</strong> 1 studies<br />
William Notcutt Mario Price Roy Miller Samantha Newport Cheryl Philiips<br />
Susan Simmons and Cathy Sansom<br />
1 Cons dmnt Annestlietist 2 Seriior Phnmm ist 3 Specinlist Registrnr Annestlresin 4 ResenrcH Assistnnt<br />
i Registered Nuvse Depnrtroent <strong>of</strong> Anaesd esiq Jnnies Pnget NospirnlLaeuesl<strong>of</strong>r Rond Crea Yam oufh Norfolk<br />
NR 31<br />
6LA UK<br />
Summary<br />
Three Cannabis Based Medicinal Extracts CBMEs for sublingual use became available in 2000<br />
Aotal <strong>of</strong> 34 N <strong>of</strong> 1 studies were undertaken using his novel herapy for patients with chronic<br />
mairily neuropathic pain and associaced symptonu ro explore efficacy olerability safery and<br />
dosages Three CBMEs 49 Tetrahydrocannabinol THC Cannabidiol CBD and a 1 1 mix<br />
ture <strong>of</strong> them both were given over a 12 week penod After an initial open label period the<br />
CBMEs were used in a randomised double blind placebo controlled crossover rial Extracts<br />
which contained THC proved most eH ecdve in symptom concroi Regimeas for the use <strong>of</strong> the<br />
subfingual spray emerged and a wide range <strong>of</strong> dosing requirements was observed Side effec s were<br />
commoq reflecting a leaming curve for both patient and study eam These were generally<br />
acceptable and Gtde different to those seen when other psycho accive agents are used for chronic<br />
paia These ini ial experiences with CBME open the way ro more detailed and extensive smdies<br />
Keywords<br />
neuropathic<br />
CnnnnGis Def n 9re<br />
rahyArocnnnnbinoL CannaGidiol Multiple sderosia<br />
Pnin chmnic<br />
Conespondenre YVilliaii Notcutr<br />
Email willinni no au tajpagetnl suk<br />
Arrepted i Ocro6er 2003<br />
Cannabis has been used for five millennia for he 1 The absence <strong>of</strong> reliable and standardised<br />
reatment <strong>of</strong> many conditions including pain inftamma preparations<br />
tion neuralgia migraine and dysmenorrhoea It has also Marerials obtained om mntrolled sources having<br />
been used as an anticonvulsant msde relaxant and Eor reliable standardised tomposition and prepared to<br />
restlessness and aiixiery in cerminal illness 12j However pharmaceuuca standards have not previously been<br />
1971 it was<br />
by deemed to be <strong>of</strong> liccle medical use and available<br />
was removed from he formulary UK The synthe ic<br />
cannabinoid nabdone was subsequendy in roduced for 2 Difi ieulries with deGvery methods<br />
the treacmen <strong>of</strong> chemotherapy induced intractable Smoking is an efficienc method <strong>of</strong> pa ient titration and<br />
nausea<br />
and vomiting delivery bu modem medicine does not accept the<br />
More recendy basic science research has revealed che inhalation <strong>of</strong> carcinogenic smoke om buxning dried<br />
Endocannabinoid system 2 thereby providing a ration plant matenal as a method <strong>of</strong> delivenng a therapeutic<br />
ale for clinical research Concunently there has been an agenc Not only are there health nsks 4SJ but under<br />
explosion <strong>of</strong> anecdotal evidence Gom patients <strong>of</strong> the taking quality clinical research using this approach is<br />
therapeutic efTects <strong>of</strong> cannabis<br />
almost impossible<br />
A few single dose clinical studies on the ure oE cannabis As an oIly substance cannabis is difficult m nebulise<br />
for were<br />
pain conducred in the 1970s but the condusions and as such is imtable to the laryra and trachea<br />
drawn are debatable 3 Very litde has been undertaken Equipment for heating cannabis m produce a vapour for<br />
since because <strong>of</strong> four major obstacles<br />
inhalation is available recreationally<br />
o zoon eiackweuamn9 m
Anaesthesia 2004 59 pages 440 452 W Not utt et al<br />
Cannabrs based medicinal extracts<br />
Whilst the oral route is oen used recreadonally the Yharmaceuticals We chose to investigate a 1 1 mixmre<br />
onset <strong>of</strong> ef ec is slow over<br />
one and a half hours <strong>of</strong> THC and CBD for chronic pain and ro compare it<br />
absorption is very variable and there is a significan first with placebo THC alone and CBD alone Two recently<br />
pass eH ect This makes accurate and rapid ticration compleced CBME smdies 14 15 were run in parallel<br />
difficult for a<br />
patient<br />
with chronic pain although this with this study as pazt <strong>of</strong> the initial development program<br />
may become a practical<br />
route for the pa ient<br />
who is The primary objective <strong>of</strong> this study was to identify the<br />
stabilised and who a<br />
requires<br />
constant intake oE cacmabi thezapeutic windows <strong>of</strong> three CBMEs The secondary<br />
noid Rectal administration has also been suggesced objectives were o study the effects <strong>of</strong> three CBMEs <strong>of</strong><br />
as a<br />
possibility but ptobably corifers no advantages over the varying constituent composition on patients suffering<br />
oral route<br />
with chronic reErac ory pain or defects <strong>of</strong> neurological<br />
The subGngual<br />
rouce was first descdbed by Marshall in function to study safety and rolerabiliry parameters for<br />
1897 t It provides the possibility <strong>of</strong> acceptable rapid these CBMEs and to determine the approaches ro more<br />
absorption for titration combined with the absence <strong>of</strong> a exrensive and de aIled studies<br />
first pass effec No clinical smdies had previously been<br />
ndertaken on this rouce <strong>of</strong> administration<br />
Methods<br />
3 PoGtical and legal difficulties The smdy was approved by the Local Research Ethics<br />
It is only recendy that the issues <strong>of</strong> the recreational and Committee and by the Medicines Control Agency and<br />
the medicinal use <strong>of</strong> cannabis have been disentangled in was conducced underaDoctors and llentisa Exemp<br />
the minds <strong>of</strong> the public the medical pr<strong>of</strong>ession<br />
and senior tions DDX Gcence lluring the ime <strong>of</strong> the smdy the<br />
politicians267 CBMEs remained classified as Schedule 1 drugs This<br />
required that the patients and the invesdgating team be<br />
ects Gcensed by he CIK Home Off ce in London Each<br />
<strong>of</strong> acu e psycho active other prychologi panent gave written informed consen a the start <strong>of</strong> the<br />
effects2891Oj that have been smdy The stud underwent independen external audic<br />
4 Side ef<br />
The possibility<br />
cal and physical side<br />
observed with recrea ional cannabis se have discouraged<br />
cli tical study<br />
The smdy cannabinoids<br />
The caruiabinoids were derived direcdy Erom standardised<br />
Single chemical or plant extract<br />
cloned plants and were prepared to medicinalsandards<br />
It has been suggested that the presence <strong>of</strong> cannabidiol Each extract contained 95 <strong>of</strong> the specified cannabi<br />
CBll amelioraces the psycho acdve eflects <strong>of</strong> 09 noid s the remainder being a mixture oE other plant<br />
tetrahydrocannabinol THC ll Patients have self chemicals minor cannabinoids terpenes and Ravonoids<br />
reporred chat they prefer milder forms <strong>of</strong> cannabis that The materials were prepared as a sublingual spray and<br />
have a significan<br />
CBD con suggests each ac uadon delivered 25 mg <strong>of</strong> THC 25 mg CBD<br />
that pa ients prefer plant cannabis to dronabinol an oral or 25 mg THC 25 mg CBD THC CBD or<br />
synthetic form <strong>of</strong> THC when used for the control <strong>of</strong> matching placebo in Ot ml The first six patients recei<br />
nausea and vomiting associated wi h chemotherapy ved che spray as an aerosol delivery system excipients<br />
712 Similarly patien s<br />
who had used cannabis for their tetraf3uoroe hane 80a ethanol 20Sbsequent pa chronic pain prior<br />
to<br />
trying nabilone a syn hetic used a pump ac ion spray excipients ethanol 50<br />
analogue <strong>of</strong> THC prefened the formez 13 propylene glycol 50<br />
There may be sevetal reasons for this difference CBD<br />
blocks the mecabolism <strong>of</strong> THC m 11 hydro cy THC Patien selection<br />
which is more<br />
psycho ac ive than THC and may produce Patients were either recruited om he local Pain ielief<br />
dysphoria 2 Alcernatively it may simply be that patiencs CGnic or direcdy referred by ge eral practitioners or<br />
find dtiation easier with smoked cannabis It is unknown hospital consultants Several volunceered direcdy with he<br />
whether any other ingredients <strong>of</strong> plant cannabis contrib agreement <strong>of</strong> their general practitioners<br />
ute ro this effect<br />
The patien s were all over 18 years old with chronic<br />
It was decided to investigate he poten ial benefits <strong>of</strong> stable pain poorly responsive to other modalities <strong>of</strong><br />
whole planc<br />
extracts ra her than pure THC alone control Painoher symptoms and medicarion use had o<br />
Pharmaceutical grade Cannabis Based Medicinal Extracts be stable over the 4 weeks preceding che start <strong>of</strong> the<br />
CBMEs derived from cloned plants yielding standard study Patients were required co abstain om ddving<br />
ised quan ities <strong>of</strong> cannabinoids for sublingual use during the study and also<br />
contracepcion<br />
required m ensure adequace<br />
in 2000 om GW<br />
became available for clinical sudy<br />
o zooa eia kweurmny m
I<br />
I<br />
I<br />
W Not utt et al<br />
Cannabs based medional exVacts<br />
Anaes hesia 2004 59 pages 440 452<br />
Patients with significan cardiovascular disease oral Ti IC CBll or placebo At he start <strong>of</strong> each week<br />
disease or any oher serious sys emic disorders titration under supervision was under aken as on the first<br />
were<br />
exduded Patients with any history <strong>of</strong> schizophrenia day <strong>of</strong> the open label period Each CBME was Chen given<br />
other<br />
psychoses oher significant psychiatric disorder or<br />
again in random order over the next 4 weeks Therefore<br />
any problem with drug or alcohol misuse<br />
dependency each patient received each CBME and placebo for nvo<br />
were also excluded 0 llepression secondary co their separate1week penods<br />
chroriic pain was not an exdusion facror Randomisation was undenaken externally and che<br />
Patiena with a<br />
past history <strong>of</strong> sigruficant recreational tchedule supplied to GW Pharmaceuticals Un 66nding<br />
cannabis use or who were continuing ro use the drug in occurred at completion <strong>of</strong> each patient s study<br />
this manner ere excluded Padents who had current or<br />
previous expenence <strong>of</strong> using cannabinoids as a medicine Cannabinoid escape medication<br />
illicit plant cannabis or nabilone were included Seven Gequent urers <strong>of</strong> illicic cannabis for eympmm<br />
The racionale for recruiting patients who were non control prior o the smdy were<strong>of</strong>ered the THC CBll<br />
naYve ro cannabis was<br />
mixture as escape medicanon dunng che crossover period<br />
The CBME preparations the delivery sysrem and he This was o ensure that they did not retum ro their use <strong>of</strong><br />
sublingual roure were new and untried in patients There illicit cannabis when receiving inefIective medicanon<br />
was no information on Gkely dose rann e<br />
These panents would have knowledge <strong>of</strong> the benefits Patient assessment<br />
eflects and side effeces <strong>of</strong> cannabinoids They would At he fint visit a full medical hisrory was obtained<br />
therefore be appropriarely prepared and able co recognise including an assessment <strong>of</strong> che pain and associated symp<br />
these ef ects early<br />
toms the past management and the current dmg therapy<br />
Some qualitadve comparison with their preceding The previous use <strong>of</strong> cannabis recreational and medicinal<br />
cannabinoid use and effect migh be achievable<br />
determining equency type effec iveness and side As more<br />
experience grew cannabinoid patients was explored Futther relevant informaboo was obtained<br />
were recruited om local medical records and the patient s general<br />
practicionrr A physical examinanon was undertaken<br />
The study design Fig 1 Basic haematology urea electrolyces and Gver function<br />
An IV <strong>of</strong> 1 methodology was used Two weeks <strong>of</strong> tests were pedormed and repeared a the end <strong>of</strong> the smdy<br />
baseline assessments were followed by a 4h supervised Depression was assessed with che Beck llepression<br />
titration wich open label 1HC CBD CBME use was Invenrory BDI wtilch was applied at each visic Thu was<br />
connnued at home for a 2week run in penod A supplemented by the General Health Quescionnaire 28<br />
schedule <strong>of</strong> assessments was undertaken before and after GHQ28 a three poinrs during the study Fig 1 16<br />
each penod Throughout the study patients kept a daily Up to five significant pain or other symproms were<br />
diary <strong>of</strong> their worst two symproms each measured with a<br />
no ninated by the panent and the severiry <strong>of</strong> each was<br />
standard 10 cm visual analogue scale VAS and also <strong>of</strong> assessed at each visit using a standard VAS The patients<br />
their sleep and any side experienced<br />
were familiansed ith he assessmenc procedures and the<br />
If ehe patien s showed some benefit in one or more <strong>of</strong> daily dianes to be completed at home The seventy <strong>of</strong> he<br />
cheir assessments chey muld proceed<br />
to che8week two worst symptoms was measured in the mottung at<br />
randoaused double blind placebo controlled crossover midday and in the evening on a dady basis The<br />
part <strong>of</strong> he study Each week for the first 4 weeks hey remai ung index symptoms were used to broaden the<br />
randomly received a difE THC CBll assessment <strong>of</strong> individual clinical efEectiveness Duration <strong>of</strong><br />
IWEEk<br />
Superv sN smB<br />
BBSB Lne<br />
Run ln<br />
crosco roaumeen<br />
cros onoa eisen<br />
aiweek emm aea<br />
penomoi<br />
TXC<br />
ceo<br />
zx zea<br />
u J rncceo<br />
0 2 9<br />
waceeo<br />
5 6<br />
1 I<br />
aeax aneom sae<br />
pe oasm<br />
TXC<br />
eeo<br />
NCwo<br />
waceea<br />
9 B 9 10 11 1Y<br />
nme sneaw 1 1 1 1<br />
1<br />
IGH028 t I I<br />
I<br />
Figure i Thesrucmre <strong>of</strong> che smdy<br />
442<br />
moa eiack veucei n g m
Anaesthesa 2004 59 pages 440 452 W Notcutt et al Cannaba based medional extracts<br />
Results<br />
sleep houcs and quality <strong>of</strong> sleep Good Fair Poor were benefies seen the occunence <strong>of</strong>side effeca etc Similady<br />
recorded for each night Appetite<br />
bowel fonctioq a comparison <strong>of</strong> he efFectiveness <strong>of</strong> the three CBMEs and<br />
bladder fimction and activity levels were also monitored placebo was under aken<br />
Yacients were Eully briefed on the possible psycho Where clinical benefit could be shown for individual<br />
active side effects and the likely seven mos common pacients hey were ot ered the opportunity to con inue<br />
were iden ifiedi the diary These were presenred<br />
in the into a long rerm safety extension study CBME SAFEX<br />
form <strong>of</strong> he<br />
question Throughouc the day have you Ic had been a requiremen <strong>of</strong> the Local 2esearch Ethics<br />
experienced any <strong>of</strong> the following please tick Dry Commitree for the patients to be able ro continue<br />
mouth Time disrortion Dizziness Panic aixiety attacks trea ment unless cGnical pharmaceutical or regulatory<br />
Drowsiness High Strange feeling Hallucinations requiremen s deemed otherwise<br />
Patiena were also asked ro record any other side efCects<br />
or new<br />
sympmms that they expedenced whether or not<br />
they felt this was associa ed wich he medication Vo<br />
attempt was made o investigare tolerance dependency or Patients<br />
other longer term psychiattic ef ects<br />
A total <strong>of</strong> 34 patiencs ere studied Demographic details<br />
The use <strong>of</strong> concoautanc medication was monirored underlying diagnosis main problem symproms and<br />
Patients were asked not m change heir re ular medica previous medicinal use <strong>of</strong> cannabis are shown in Table l<br />
tion withouc prior discussion wi The high number <strong>of</strong> female padents ref3ected he<br />
maintenance oE a constant<br />
pharmacological background prevalence <strong>of</strong> multiple sclerosis The patients have been<br />
was considered impor an Non<br />
grouped for analysis Fig 2<br />
for was<br />
breakthrough pai allowed and documented Only seven pacients used THC CBD as rescue<br />
However by definicion most<br />
patients were getting very medication during the crossover part <strong>of</strong> the study Group<br />
litde benefit from their previously prescribed medication CRM Therefore data from these panenrs have only<br />
been included for the assessment <strong>of</strong> the run in periods<br />
Cannabinoid administration The first two patients had inadequate daca fmm the<br />
The patien s underwent4h dosing sessions a the hospital baseGne period<br />
Fig 1 whenever a new CBME was incroduced Initially Out <strong>of</strong> the toal oE 34 24 patients complered he<br />
one<br />
spray was given every 15 min This interval had been crossover penod without cannabinoid rescue medication<br />
determined om studies <strong>of</strong> the use <strong>of</strong> the spray in<br />
healthy Group NoRM Fig 2 They provide the comparadve<br />
voluneeers Thisiterval was changed<br />
to 30 min afrer the information on effects and side effects<br />
fiat six<br />
pa ients<br />
had been smdied One patient who experienced a vasovagal episode<br />
Throughout these itrations vital signs<br />
and side wntinued single blind without the THC periods for the<br />
were monitored ac<br />
regular intervals Tesrs <strong>of</strong> psychomotor remainder <strong>of</strong> the crossover period Therefore only data on<br />
and cognitive func pedormed before the start and dosage used are induded Table 2<br />
after 3hTrail Making Tests A B17 Adulc Memory Two patients were withdrawn from the study Table 2<br />
and Informacion Processing Battery AMIPB 18 One failed ro mlerare he 1HC CBD at the lowesc<br />
had received between nvo<br />
dose during he run in and che other could not cope with<br />
At the end oE 4 h patients<br />
and four sprays two and eight sprays for the first six the smdy requirements<br />
pauencs depending on their response etFects and side<br />
efi ec s The patienrs were then discharged home with a Dose titration sessions<br />
rela ive if in a clinically satisfacrory state They were given The inicial rate oE citration was roo rapid for cwo <strong>of</strong> che<br />
a supply oF the test CBME During the initial2week first six patiena who developed dysphoria and light<br />
mn in<br />
penod patients were contacred daily for 7 days or headedness Both recovered Eully over che following 2 h<br />
longer as necessary A all imes a member <strong>of</strong> he ream Subsequently the in erval between sprays was changed<br />
was available for con ac in an<br />
emergency ro answer from 15 to 30 min This gave the patiencs adequate<br />
etc<br />
questions opportunity o tenninare heir itration safely if they<br />
stareed to experience side efEects<br />
Data analysis<br />
The rests <strong>of</strong> psychomotor and mgnitive function Trail<br />
1his smdy was primarily observational and each patient s Tests and AMIPB yielded unexpectedly equivocal<br />
data were evaluated individually The use <strong>of</strong> placebo and results requiring a more detailed analysis than planned<br />
blinding was ro provide greater rigour w the observa There were <strong>of</strong>ren improvements in performance aer<br />
tional da Data om the individual N <strong>of</strong> 1sudies have CBME 19 Therefore the resulcs will be presented<br />
been aggregated o give<br />
an indica ion <strong>of</strong> the scale oE he separately<br />
C 2004 Blackwell Pubhshing Lttl<br />
3
W Notcutt et al<br />
Canna6is based medicinai eztracts Anaesthesa 2004 59 pages 440 52<br />
Table 1<br />
Pa iene details<br />
Site <strong>of</strong> pain Site <strong>of</strong> pain Prev Rescue Global<br />
No Sex A9e Dia9nosis<br />
Years symptom 51 symptom 52 cann use CBME outcome<br />
1 M 51 MS 12 Lum6ar pain Leg spasms 3 CRM 2<br />
2 M 43 Spinal cord tethering IamineROmy 13 Low lumbar pain Posterior leg pain L 3 CRM 3<br />
3 F 58 MS 6 Thigh pain L spasms Hip pain L 2 CRM 3<br />
4 M 55 Low back sciatica post laminectomy 36 Lum6ar pain Posterior le9 pain B 3 CRM 2<br />
5 F 53 MS 71 Whole le9 pain Ne k arm L pain Z CRM Z<br />
6 F 52 MS 15 Knee pain B Head facelpain 1 CRM 0<br />
7 F 33 Disc degeneration laminotomy z 2 35 Posterior thigh R Low back pain 0 NoRM 1<br />
8 F 44 M5 post cystecfomy ileostomy 78 Urethral pain Pelvic floor pain 1 NoRM 3<br />
9 F 51 MS 7 Thigh L lower legs pain Chest tightness<br />
N None<br />
10 F 50 MS 15 Leg pain R Right leg spasm 1 None X<br />
11 F 53 Spinal fusion 18 Posterior leg pain B Low back pain 2 NoRM 3<br />
12 F 55 MS 10 Lower le9 pain Lumbar pain 0 NoRM 0<br />
13 F 32 Degenerative Dis pos laminotomy 6 Leg B pain Back pain 0 NoRM 2<br />
14 M 64 Paraplegia AV malformation <strong>of</strong> mrd 10 Leg pain B foot R 4abbing pain 1 NoRM 2<br />
15 F 46 MS 13 Legpain Sa ro ilia pain 0 None 3<br />
16 M 4 MS 10 Leg spasms Bladder urgency<br />
1 NoRM 3<br />
17 F 41 MS 23 Leg spasms Hip pain R 1 NoRM 2<br />
18 M 50 6rachial Plexus Avulsion injury 14 Arm R aching pain Arm shooting pains 0 NoRM 1<br />
79 M 48 Femoral Plexopathy from phenol inj 7 Lumbar pain Leg scmtum L pain 2 NoRM 2<br />
20 F 30 LamineROmy L15 x 2 9 Wmbar pain Leg L pain 0 NoRM 1<br />
21 F 46 MS 3 ftetro orbital pain 8 Arm R pain 1 NoRM 3<br />
22 M 53 MS 4 Legs spaAicity Leg B pain 1 NoRM i<br />
23 M 48 4<br />
Myopathy<br />
Leg B pain Upper arms 3 NoRM 2<br />
24 F 35 CRP51 post ankle trauma 9 Ankle R aching pain Ankle R stab6ing pain 0 NoRM 1<br />
ZS F Z6 CRP51 4 Neck arm ache Neck scapula N NoRM 1<br />
shooting pain<br />
26 F 41 20<br />
Polyarthralgia<br />
Spinal pain Knee pain B 2 NoRM 0<br />
27 F 26 Disc degeneration post discectomy 5 Lumbar pain Posterior leg pain L 0 NoRM 1<br />
28 F 47 MS 7 Neck thorax pain Arm pain R 0 NoRM 2<br />
29 F 56 Raditulopathy cervical fusion 11 Arms CS Inter 0 NoRM 2<br />
30 F M Diffuse systemic Atrophy 11 Jaw pain<br />
Tremor in limbs 2 NoRM 2<br />
31 F 50 MS 10 Neck pain Lower leg pain B 0 NoRM 2<br />
32 F 66 MS 3 Leg pain B Hand pain B 0 NoRM 0<br />
33 M 62 Massive Trauma Left Arm 26 Lateral forearm pain L Wrist allodynia L 1 NoRM 1<br />
34 M 38 Stiff Man Syndrome 75 Hands wrisis pain Buttocks hips pain 3 CRM 2<br />
MS Multiple Sdemsis CRPS Complex Re9ional Pain Syndrome ft ftight L Left B Bilateral<br />
Previous medicinal cannabis use 3 frequent 2 sometimes 1 occasional 0 none N nabilone<br />
Resme CBME CRM Resme CBME group NoRM No Rescue CBME group None athers<br />
Glo6al Outmme3Subrtantial 2 Moderate 1 Some 0 No Benefit X Didn t omplete<br />
xe ne<br />
2 Patlantv<br />
Sixreen <strong>of</strong> the 34 patients had a decrease in VAS <strong>of</strong><br />
greater than 50 for either S1 or S2Of hese 10 patients<br />
zev um had a greater than 50 reduction in VAS for both S1<br />
LBMEfteaweMeElntlon CRMgmup<br />
NoCBMENeatu<br />
MeClcaEOn NeftMgaup<br />
tPeEen kt5<br />
and Sz<br />
Of he 34 padents 32 recorded the VAS <strong>of</strong> 1 and 52 at<br />
rar c midday on each day <strong>of</strong> the baseline and run in penods<br />
2 weeks each The results have been aggregaced Fig 4<br />
and the median and inrerquartile range presented<br />
za na<br />
Figure 2 The progress <strong>of</strong> che 34 paciena ehrough che smdy Crossover period symptom control<br />
Uuring the crossover period the cumulative S1 scores for<br />
Run in pedod symptom control<br />
24 patients in group NokZM measured three times The wo main sympmms S1 S2<br />
were measured VAS median inrerquartile range were placebo SA2873<br />
ac che start and at completion <strong>of</strong> the2week run in period CBD 545 3674 THC 463 lJ4606 and<br />
for all 34 patients The scores were aggregared and the THC CBD 4A2658 p 001 overall cest for<br />
median and interquartile ranges are shown Fig 3 significance Fnedman THC CBll and THC were<br />
n<br />
r Zp04 Blaceweli Publrshing ttl
Anaesthesa 2004 59 pa9es 440 152 W Notwtt e al Cannabis based medional extracts<br />
Table 2 Uecails <strong>of</strong> the patienu who either failed ro complece che stady or for whom che<br />
andomizanon mde was broken<br />
PatientlD<br />
Reason<br />
N9<br />
Very frail from M5 Could not tolerate the lowest dose <strong>of</strong> the spray during the open label period and hecame too sedated<br />
She was withdrawn at this point<br />
N70 Travel to the study entre was too distressing for her 3 weeks into the rossover part <strong>of</strong> the study she was withdrawn<br />
The randomization was broken There had heen no evidence <strong>of</strong> benefit during the crossover period<br />
k75<br />
She experienced a vasova9al episode during titration with THC Her vital signs had been checked 10 min previously and<br />
refleaed the pre dosing resulu She recovered uneventfully and was able to retum home about 2 h latec 7he THC periods<br />
<strong>of</strong> the crossover period were omitted and she continued single 61ind<br />
19 He be ame very depressed and distressed towards fheed ot the crossover period having had no benefit for 5 weeks<br />
following initial success Breaking the randomization code it was discovered tfiat only the 7HC CeD period had been beneficial<br />
He continued the last Z weeks single hlind whi<br />
induded the semnd THC CBD period Later we leamed that he was on the<br />
verge <strong>of</strong> divorcing his wife who had a psychiatric disorder coincidental to the study<br />
W32<br />
She had an episode <strong>of</strong> abdominal pain and vomiting in week 2 <strong>of</strong> the crossover period Randomization was 6roken A diagnosis<br />
<strong>of</strong> gastroenteritis was made A break from the medi aiion was allowed and she then continued single hlind<br />
Q<br />
N 9 Sl<br />
a10<br />
N 8 Q S2 c 8<br />
7<br />
6<br />
oi 5<br />
c 4 cm<br />
a 3 Q 4<br />
c 2<br />
c<br />
1<br />
a 2<br />
0<br />
Baseline<br />
Run in<br />
0<br />
F T C P<br />
Figure 3 Change in med an inmrquarcile range VAS for CBME<br />
sympmm St 5 recorded at the start baseline and a com<br />
pletion <strong>of</strong> he2week mn in penod for 34 patiencs wich open<br />
label THC<br />
m<br />
N<br />
ia<br />
e<br />
CBU<br />
6<br />
Sl<br />
O S2<br />
Figure 5 Crossover period aggregated symprom Sl and S2<br />
VAS measured 3 cimes day mediannerquar ile ange for<br />
che four pairs oE weeks For each CBME and placebo F<br />
THC CBD T THQ C CBD P Placebo<br />
51<br />
261750 50331688 408133543 and 428<br />
SZ<br />
233 51 respectively p 001 overall est for<br />
N s<br />
significance Friedman THC and THC CBll were<br />
5<br />
significandy better tha placebo p 001 and<br />
o<br />
p OA54 Wilmxort with Bonferroni correction<br />
a<br />
2<br />
Of these 24 paden s nine had a deaease in VAS <strong>of</strong><br />
more than 50 for either 51 or S2 when using one <strong>of</strong> he<br />
o hree active preparations compazed with placebo All<br />
Baseline<br />
Rumin<br />
ne experienced this with THC and or THC CBD<br />
hese three patients also achievcd his reduction with<br />
Figure 4 Change in median VAS recorded in che daily dianes at Of<br />
noon for symptom Sl S2 incerquartile range during CBll<br />
2 weeks base line period and 2 weeks open label THC CBD<br />
Paciencs 3 co 34<br />
EfFectiveness <strong>of</strong> inedication in comparison<br />
with mn in THC CBD<br />
both significandy betrer chan placebo p 05 and At the weekly visit the patients were asked ro compare<br />
p 01 Wilcoxon with Banferroni correction Fig 5 their current test medication with che THC CBD<br />
Similarly the S2 scores median interquartile range received during the initia run in penod <strong>of</strong> the smdy<br />
for placebo CBll THC and THC CBll were 495 Fourteen <strong>of</strong> 24 patienes in group NoRNI found he<br />
445<br />
moa eiaaweureom g ce
W Notcutt et al<br />
Cannabis 6ased medional extracts<br />
Anaez hesia 2004 59 pages 440 52<br />
c<br />
Range<br />
er 75<br />
t Median<br />
o 25<br />
Range<br />
W100 W 100 f<br />
J<br />
N a F 80 0<br />
o<br />
Z<br />
LL<br />
O<br />
60<br />
0 40<br />
qp<br />
o o<br />
20<br />
0<br />
Base Line<br />
CBME PERIOD<br />
A<br />
Run In<br />
Z<br />
LL 20<br />
O<br />
z o p<br />
60<br />
o<br />
op<br />
o<br />
Range<br />
o75<br />
t Median i<br />
o25o i<br />
Range<br />
F T C P<br />
CBME PERIOD<br />
Figure 7 Percentage <strong>of</strong> mghu when sleep was <strong>of</strong> good<br />
Figure 6 Percenrage <strong>of</strong> nigh c when sleep was <strong>of</strong> good quahq for 24 pa ien s Group NoAM comparing the 14 days <strong>of</strong><br />
qualiry Eor 32 patiena 3 ro 34 rompanng the 14 day each CBME used during the crossover penods median incer<br />
baseline and run in<br />
penods medianin erquartile range range 9uaaile range range<br />
o<br />
THC CBD nine patiena and or the THC eight<br />
9<br />
pa ients as or<br />
equal<br />
more effective Cor symptom control a 8<br />
Four <strong>of</strong> these patients also Eound CBD as effective as the 7<br />
onginal medication No patient found che placebo as E 6<br />
effective as the odginal medication<br />
i a 5<br />
y 4<br />
QuaGty <strong>of</strong> sleep N 3<br />
percentage oE nights thae each padent described as<br />
y 2<br />
good quality sleep were compazed<br />
Eor che baseline and<br />
o<br />
the iun in periods The res les Erom 32 <strong>of</strong> 34 patiena are<br />
presented median IQR range The median IQEZ rose F T C P<br />
om 134 35J 0 to 535 714 25 Fig 6<br />
CBME<br />
Similarly the percen age<strong>of</strong> good ni hts was calcula<br />
ted for he 24<br />
patien s <strong>of</strong> group NoRM for the Figwe 8 Uuration oEslerp in hours mean SU for 24 panena<br />
crossover<br />
part <strong>of</strong> he study comparing the hree diflerent CBMEs Group NoRM wmparing he 14 days oF each CBME used<br />
during he crossover periods F THC CBD T THQ<br />
and placebo median QR range Fig 7 The median C CBU P Placebo<br />
IQR Eor THC CBll was 554 78 345 for THC<br />
was 429 572 357 for CBD was 369 47 9 286<br />
and for placebo 170 35J 36 p 001 overall sleep dura ion in hours for THC CBll THC CBD and<br />
eest for significance Friedman THC CBll THC placebo were 68 13 6J 13 64 14 and 63l6<br />
and CBU were all significandy better than placebo respecuvely Pig S<br />
P 001 p 001 and p 05 respectively<br />
Wilcoxon with Bonfeaoni correction<br />
General Health Questionnaire 28 GHQ28<br />
The GHQ28 assesses he patient s health in general over<br />
Duradon <strong>of</strong> sleep che preceding few weeks It has four mmponents<br />
The duration <strong>of</strong> sleep for each <strong>of</strong> the 24 patients in group Somatic Symptoms Aivciety Ineomrtia Social Dys<br />
NoKM for each <strong>of</strong> the CBMEs and placebo during the Funcdon Severe llepression and it is recognised that<br />
crossover<br />
part <strong>of</strong> the study was calculated The mean SD these are not independent <strong>of</strong> each other The lower the<br />
6<br />
2004 BlackwellPUbbshing Ltl
Anaesthesia 2004 59 pages 440 452 W Notcutt et al Cannabis based med mal extracts<br />
Table 3 Median valoes inrerquart<br />
range range <strong>of</strong> the four elements the rotal smre and the caseness <strong>of</strong> the GHQ28 and <strong>of</strong> che<br />
BDI at the start the end <strong>of</strong> the mn in and a the end <strong>of</strong> the study<br />
Generel Health Questionnaire GHQ28<br />
Somatic Anziety So ial Severe Total<br />
Period Symptoms Insomnia Dysfunction Uepression Maximum 84 Caseness BDI<br />
easeline 85 1345 192 9 1155 181 913575 181 3 121 20 36 44 23 69 11 13 175 Z5 0 16 267 9J 423<br />
End <strong>of</strong> Run In 5 64 10 5 8290 785 11 1 650 10 18 26 13 36 8p 2 61 90 7 16 25 430<br />
End <strong>of</strong> Study 6p5 14 17 784 130 795 170 15650 120 24 5315165 412 4105 140 B Q0 4J5 420<br />
score the healtMer the pauent<br />
The median scores<br />
interquartile range rangeJ for the 24 patients in group<br />
V 30<br />
NoRM measured ac<br />
the start at the end oE the run in o 25<br />
period and ac the end <strong>of</strong> the smdy are shown Table 3 20<br />
The Caseness derived from the patienc s score is an<br />
15<br />
indication <strong>of</strong> psychological psychiatric disturbance<br />
m 5<br />
Depression<br />
Q<br />
For the 24 pa ients in N<br />
group IVoRM the median IQR <strong>of</strong><br />
FF F T C P<br />
he BDI score measured at the start at the end <strong>of</strong> the run in<br />
period and at comple ion <strong>of</strong> he study are shown Table 3 Figwe 9 Box and whisker ploc <strong>of</strong> the medianin erquattile<br />
Four een patients changed the severity <strong>of</strong> their depression range range number oEsprays day used by 25 patien s Group<br />
between the start and he end <strong>of</strong> the study Seven NoRM pacienc 15 The lasc 4 days <strong>of</strong> ehe mn in penod<br />
pa ients<br />
and the last 4 days <strong>of</strong> each <strong>of</strong> che pairs <strong>of</strong> weeks <strong>of</strong> each CBME<br />
moderate mild three patiena moderate 9 aurtimal<br />
ere averaged FF RuniHQCBU F THC CBD<br />
two<br />
patients severe moderate one patient severe a T THC C CBD P Placebo<br />
mild one patient minimal mild BDI score Minimal<br />
09 Mild 10 16 Moderate 17 29 Severe 30 63<br />
commonest side efEec<br />
occurred during the run in<br />
Daily intake o CBME period and the 2 weeks <strong>of</strong> use <strong>of</strong> each CBME and<br />
At the start <strong>of</strong> he run in period each <strong>of</strong> the padents placebo during crossover are shown Fig 10 Unfortu<br />
titrated themselves to their optimum dose over a period <strong>of</strong> narely data on the incidence <strong>of</strong> the designared side effects<br />
several days The amount was pardy determined by he eg dry mouth drowsiness dunng the baseline period<br />
onse <strong>of</strong> side efIects and partly the in<br />
improvement was subs antially incomplece due to an enor in data<br />
symproms lluring he crossover pedod he patients collec ion and is not presented<br />
reached heir optimum dose more quickly<br />
Drowsiness and euphoda dysphoria high were com<br />
The wo<br />
patients who used six or more sprays as a mon in the East 2 weeks <strong>of</strong> the run in period while patients<br />
single dose found ic difficulc ro retain sublingually because ried co find an appropriate dose and were more equent<br />
<strong>of</strong> saGvation This caused some <strong>of</strong> he CBME m be wi h CBMEscon aining THC Dizziness followed a sunilar<br />
swallowed cheoretically altering the absorp ion proEile pattem but was less <strong>of</strong> a problem Episodes <strong>of</strong> panic and<br />
Across the 34 patients there was a range<br />
<strong>of</strong> use <strong>of</strong> between acuciety were infrequent They were commonest during che<br />
one and eight sprays as a single dose<br />
run in period and noc exclusive ro those who were<br />
For 25 patients Group NoRM patient 15 the cannabinoid ntive Time disrortion was infrequent but<br />
average daily in days <strong>of</strong>he run occuned with CBMEs contauilng THC Halluciriadon was<br />
in and each pair <strong>of</strong> CBME treatment weeks during he recorded by only one patient and was not repotced as severe<br />
crossover<br />
period was calculaced median IQR range The most common rymptom hat patients complained <strong>of</strong><br />
Fig 9 TFus assumed a level <strong>of</strong> stabiliry in the dose used was a dry mouth Fig 10 However most patients were<br />
towards the end <strong>of</strong> each week<br />
taking other mediwtions which could contribute to chis<br />
indicated by the high occurrence when using placebo<br />
y<br />
35<br />
Side effects Some padents experienced a stinging sensation on use<br />
In cheir daily diaries the patients recorded episodes <strong>of</strong> the <strong>of</strong> the spray particularly wich the ial formulation<br />
seven specified side effects For 24 patients Group Many did not like the taste No subling al mucosal<br />
PIoRM the number <strong>of</strong> on<br />
days which the hree changes were observed<br />
2004 Blackwell Publrshing Lttl
W Notcutt ei al<br />
Cannabiz based medicmal extracts<br />
Anaesthes<br />
2004 59 pagez 440 452<br />
PREVALENCE OF COMMONESTSIDE EFFECTS<br />
25<br />
20<br />
wt5 17 deyS Figure 10 Prevalence <strong>of</strong> daily<br />
814<br />
episodes oE dry mouch drowsiness and<br />
dey5<br />
dysphoria euphoda high during<br />
o<br />
mn in 14 days and crossover periods<br />
Z 7 7 days None No episodes<br />
5<br />
7 days Epfsodes on S1 <strong>of</strong> days<br />
814 days Episodes on 50 <strong>of</strong><br />
O<br />
days FF Run In THC CBU<br />
FF F T C P FF F T C P FF F T C P<br />
F THC CBD T THC<br />
Dry Mouth Drowsiness DysphorialEuphoria c Csv P Ptacebo<br />
None<br />
Patient 15 had a vasovagal episode during<br />
a dosing prefereoce5<br />
session It occurred 1 h aer he third spray when using<br />
THC for the first ime as revealed on immediare The 28 paciena who obtained benefi were asked which<br />
unblinding Table 2 The reaction was probably due CBME they had prefened Eleven preEerred THC<br />
to a combination <strong>of</strong> prolonged sittmg and excessive CBD 14 found THC and THC CBD equally satisFac<br />
IVo other cardiovascular side effec<br />
were obser tory two preferred THC and one found THC and CBD<br />
dosing<br />
ved for any patients<br />
equally satisfactory<br />
A change in neural func ion was observed in two At the end <strong>of</strong> each individual study the senior clinician<br />
patients xho had had previous spinal surgery One had a made a clinical asseesment <strong>of</strong> the overall benefi for each<br />
retum <strong>of</strong> an absent ankle reftex pauent 11 The second patient to decide on progression to the safety extension<br />
patient 2 discovered that touch sensation reappeared in smdy This subjective assessmen included he concrol <strong>of</strong><br />
a previously anaesthe ic fifth lumbar dermatome He also symptoms Sl and S2 and other identif ed symp oms<br />
found chat his abiliry<br />
to mai ain an erection sleep mood and GHQ28 Table 1<br />
was<br />
dramatically improved leading to the acciden al preg<br />
nancy o his partner and bir h <strong>of</strong> a daughter<br />
Distussion<br />
No other side effects relared ro the use <strong>of</strong> CBME<br />
emerged dunng che smdy<br />
This was the first clinicalsudy <strong>of</strong>boh the use <strong>of</strong> CBMEs<br />
The patients were weighed at the beginning and the and <strong>of</strong> their delivery via the sublingual rou e The<br />
end oF he study in normal clothing The median change objectives were ro ob ain an initial indica ion <strong>of</strong> the<br />
in weight or 27 <strong>of</strong> 34 patients interquartile range efEicacy safety and tolerability We had no firm know<br />
range was OS kg 2 m 06 kg56 to 4 kg Of the ledge <strong>of</strong> the exrent <strong>of</strong> the therapeutic ef ect he Gkely<br />
remainin seven two patien s eeraunated the study early dose range ehe frequenty and pattem <strong>of</strong> administration<br />
and data the incidence <strong>of</strong> and threshold for side eflects or he<br />
one<br />
pacient<br />
was paraplegic and unweighable<br />
were unrecorded on four<br />
tolerabiliry <strong>of</strong> the CBME spray<br />
Full blood count urea and electrolytes and Gverfl ncdon<br />
ests remained within noxmal limits for 33 patients One Designing the study<br />
patienc had transien changes<br />
in alanine transaminase and In designing he study si c major fac ors were taken into<br />
alkaline phosphatase wMch may have been related mhe consideration<br />
use <strong>of</strong>ery hromycin for a vaginal abscess 1 Chronic pain is ahe<br />
erogeneous problem with mul During the 3 months <strong>of</strong> the study other events and vadable pathophysiological mechanisms coexisting in<br />
occurred which were unassociated with CBME but the paden and varying over ime llifI eren mechanisms<br />
would be Gkely to have an effect on outcomes significant Eor pain genesis probably ecist wi hin a single clinical<br />
marical disharmony two husband made redundant diagnostic group leading to the eed for difCerent<br />
one wife undergoing chemocherapy one pregnancy treatment strate es 20 21<br />
and misdiagnosis <strong>of</strong> a major geneuc abnoxmaliry one 2 There has been a pressure o use cannabinoids in<br />
flare up <strong>of</strong> MS one other two The randomization pa ients for whom all other therapy has failed These<br />
was broken for two patiena and boh continued single are usually the most difficult and complex padena to<br />
blind Table 2<br />
smdy<br />
J 200a Blackwell Pubirshing Lid
Anaesthesa 2004 59 pages 440 452 W Notcutt et al Cannabis based medional eatracts<br />
3 The efEec <strong>of</strong> cannabinoids on pain is Gkely to be ae padents to individually customise heir usage to difl erent<br />
vadable sites in he nervous<br />
system ranging om the endpoints<br />
neurone to<br />
pedpheral<br />
he cerebral mrtex<br />
Comparisons <strong>of</strong> results across groups <strong>of</strong> patien s canno<br />
4 Previous and current therapy is usually hererogeneous reach the same level <strong>of</strong> sta istical significance as with<br />
5 DifEerences benveen healthy volunceers and patients in homogeneous parallel group studies Therefore the<br />
side ef ec pr<strong>of</strong>de were anncipaced analyses undertaken are anatempt to summarise some<br />
6 Differences in cherapeucic dose effect and inside effect<br />
<strong>of</strong> the data om the 34 individual studies Furthermore<br />
pr<strong>of</strong>de benveen patients were expected<br />
morphine and many ocher psycho active drugs because <strong>of</strong> he failure <strong>of</strong> past symptom controL The<br />
For multiple sclerosis MS the ae iology <strong>of</strong> the pain attention from the study ream futther compGcaces the<br />
may be central neuropathic somatic muscle spasm evalua ion It was no surprising that all but one patient<br />
and spasticity visceral muscle spasm eg bladder could show some benefit at the end <strong>of</strong> che run in period<br />
mechanical spinal mechanical immobility Therefore the daca only allows for generaliza ions to be<br />
or even<br />
as see wi<br />
h he patients were desperate o participare in the study<br />
unrelated ro MS The pain may be markedly aggravared drawq hereby providing information for individual<br />
by psycho social factors such as depression immobility clinical practice and for he design <strong>of</strong> fumre and more<br />
einployment loss burden on the family and variable focussedsudies<br />
progression <strong>of</strong> the disease To these must be added the The progress <strong>of</strong> patients inasceady state in the<br />
effecrs <strong>of</strong> a vadety <strong>of</strong> other problems including defects subsequent extension study will complement he inor<br />
<strong>of</strong> vision co ordination strength sensation bladder mation given here paper in prepara ion Future smdies<br />
contml and sexual function<br />
night give tighter indications <strong>of</strong> cl e Gkely success <strong>of</strong><br />
There were three specific reasons for on<br />
focussing CBMEs in neating the specific sympcoms <strong>of</strong> specific<br />
patien s with MS Firs ly there is ex ensive anecdotal diseases although we are still far from being able to<br />
evidence <strong>of</strong> he benefi s <strong>of</strong> illicit cannabis Eor symprom predict accurarely he outcome <strong>of</strong> most therapy in chronic<br />
mntrol in his disease Secondly there is a perception that pain<br />
cannabinoids should be used for reating neuropaehic The 1week periods <strong>of</strong> the crossover patt were too<br />
paiq although there is no strong evidence to support this short However periods <strong>of</strong> 2 weeks or more would have<br />
opinion<br />
We herefore saw no reason to exclude othea extended this study unacceptably Alcematively we could<br />
with a<br />
vanety <strong>of</strong> other incraceable pain problems All have eliminaced one or more CBMEs However as we<br />
patients exhibited multiple pains <strong>of</strong> neuro<br />
nociceptive had no hard evidence on the optimum CBME we<br />
pathic and or unceetain pa<br />
hophysiology Two patients compromised We did not include washout periods as<br />
nominated a<br />
symp om hat was no specifically painful cannabinoids have a long half life in the body even<br />
tremor bladder urgency Third it was expedien<br />
ro though their clinical effect may only last a Eew hours<br />
focus on this group o obcain agreement to ini iate studies<br />
<strong>of</strong> CBMEs However choosing the mos intraccable Dosing<br />
problems for the clinical crial <strong>of</strong> a new drug for pain is far tllchough healchy volunteers in the Phase 1 smdies could<br />
from ideal tolerare titraeion at 15 min incervals our patiena proved<br />
With all hese diff culties we decided that a classical differen This vindicated our use at the beginning <strong>of</strong><br />
or crossover<br />
parallel group study was inappropriace 22 thesudy <strong>of</strong> patients who had previous experience oF<br />
We<br />
op ed to use anN oE 1 approach which has been medicinal cannabis use<br />
descdbed as a developei sool and has been recommen 1 general patienrs initially itrated o the linut <strong>of</strong><br />
ded for scudying new therapy in chronic pain 23 24 and rolerability drowsiness dysphoria rather than benefi<br />
cannabinoids 7 The method has already been used by The tescs <strong>of</strong> psychomo or and cognitive function served<br />
others for the scudy <strong>of</strong> the medicinal use <strong>of</strong> cannabinoids mairily as a reassurance for discharging he patien s home<br />
in individuals 25 26 19 The wide range <strong>of</strong> dosage parallels tha seen wi h<br />
The pacienrs are smdied as individuals but with the morphine and many other psycho active drugs<br />
gour <strong>of</strong> double blind placebo controlled As the smdy progressed the ins mctions for home<br />
crossover<br />
echniques Each individual patient scudy stands by itself usage <strong>of</strong> the CBMEs evolved Because <strong>of</strong> our concems<br />
and indeed is much closer co<br />
everyday clinical practice over safety we instructed pa ienes ro initially use as a<br />
than is he classical parallel<br />
trial <strong>of</strong> a new pharmacolo single dose 30 SO less chan they had received during<br />
treatment It<br />
gical<br />
allows both for the hererogeneity <strong>of</strong> the citration sessioa They were allowed to use ehe CBME<br />
patients and their varied responses The cap ure <strong>of</strong> daca up m 6 times per day as required Over the days the<br />
can be individualised allowing a variety <strong>of</strong> endpoines panents dosage and pattem <strong>of</strong>use was customised ro their<br />
Variable dosing patterns are acceptable enabling the need from their response For example some might<br />
8 2004 Blackwell PubLShing Ltl<br />
9
W No cutt et al<br />
Anaesthesia 2004 59 pages 440 452<br />
Cannabis based medinnal extracts<br />
and con<br />
were mos prevalent during the run in period as patien s<br />
prefer a higher dose at night With expenence<br />
fidznce the<br />
patients quickly moved ro heir optimum learnt eo titrare themselves to an appropriare level<br />
dosing schedule IZealistically the weekly periods oF che study were too<br />
short to allow time for the patients ro fully customise their<br />
Pain and other symptoms<br />
No az empt has been made to analyse<br />
use and their side ef ect managemen<br />
effects <strong>of</strong> the Drowsiness and dizziness induced by the CBMEs were<br />
CBME on speci6c pain sympmms<br />
The VAS scores do common but manageable for all but one pacient<br />
not difCerenciate between improvements due co direct Table 2 It was used o positive advantage at night time<br />
eEfects on neuralpa hways efEects on sleep and mood and to improve sleep as wi h mcyclic antidepressants<br />
the benefi oE the supporuve environment <strong>of</strong> the study morphine etc<br />
Equally some padents found the smdy tiring eedious and Dysphoria and mild euphoria were common during the<br />
uscrating whilst others experienced domestic upheavals mn in period Some patienrs were pleased to experience a<br />
ec<br />
feeling <strong>of</strong> relasation and well being especially if they had<br />
ihe overall ttends seen with the use <strong>of</strong> THC and had a bad day wi h pain Soaie found he distancing effect<br />
THC CBD were encouraging We anticipated that beneficial However no patient wanted to exchange the<br />
CBD would have litde effect by itself in his study but it disabling efCect <strong>of</strong> chronic pain for that <strong>of</strong> immobility<br />
may have other cherapeu ic roles par iculady<br />
in inRam from being dysphorideuphoric<br />
mamry pain 14 27J At the sart <strong>of</strong> the srudy and before che dose titracion<br />
All eigh patients with residual pain associated with che sessions the padents were briefed about the possibility <strong>of</strong><br />
failure <strong>of</strong> spinal surgery obtained benefit and tis is panic attacks We had no iri ormation about their<br />
an<br />
exciting prospect for Eurther smdy in this notoriously incidence or at what point they might appear No severe<br />
dif icult group<br />
to reat<br />
panic attacks occurred although some bewme amcious at<br />
the onset <strong>of</strong> dysphoria It may be chat these are pnmarily<br />
Sleep and mood<br />
a feacure <strong>of</strong> uncontrolled dosing particularly in he novice<br />
The CBME seemed ro have litde effect on he recorded<br />
recreational user<br />
number <strong>of</strong> hours <strong>of</strong> sleep However che change in quality A dry mouth was a coaunon oral problem However<br />
om poor or fair to good was unexpectedly high many panencs were using oher drugs which could<br />
The quality <strong>of</strong> sleep is a subjective global<br />
assessmen and contribuce to this effect No specific oral lesions were<br />
includes duration depth and disturbance It is more seen although they have occuaed in patiena m other<br />
important Eor the pauent<br />
than duration alone Others studies GW Pharmaceucicals<br />
have analysed nocturia 15 and shown a reduction in its Cannabis is known ro etimula<br />
appetite<br />
However<br />
equency wich the use <strong>of</strong> THC The efLeca oE CBMEs only one patient showed a substantial increase in weigh<br />
he The loss <strong>of</strong> Sb kg by ano her probably ref3ec ed<br />
on sleep may prove<br />
o be one <strong>of</strong>the major benefits oE<br />
use <strong>of</strong> cannabinoids in chronic pain and MS substandal marital disharmony<br />
The GHQ28 indicated that the useoCBME had had a<br />
broad efIect even though i was only applied<br />
on three<br />
preferenees<br />
occasions across the study The changes in the Caseness<br />
<strong>of</strong> the GHQ28 and in che BDI show valuable improve The irtitial open label Utration with THC CBD proved<br />
men in mood o be a guide to the optimum dose <strong>of</strong> THC Although<br />
CBD and placebo had limited efFect panena did not<br />
Side efI ects<br />
titrare themselves much fur her than they had wi h the<br />
eflects <strong>of</strong> cannabinoids are the original THC CBD Prior o the smdy we had expected<br />
The psycho active side<br />
main focus <strong>of</strong> objection ro this group <strong>of</strong> drugs<br />
We o find that heTHC CBD mixture would be opumal<br />
specifically targetted he common acute side etFeccs by that we would see more side eEfects with THC and that<br />
recording their daily<br />
occurrence Whilst we did not CBD alone would be almost ineffective Whilsc chere was<br />
measure intensity<br />
or duration directly the daily a preference for THQCBD the differences were not as<br />
occur<br />
rence gives an indicatio <strong>of</strong> prevalence Fig 10<br />
marked as we antidpated The lack <strong>of</strong> effect <strong>of</strong> CBD by<br />
Pa ients were ee ro record any other perceived effects itself may just reHect either the narrow range <strong>of</strong> pain<br />
However except for the oral effects <strong>of</strong> the spray itself no problems smdied and or the need for a subscancially<br />
other side effects emerged<br />
higher dose <strong>of</strong> CBD<br />
In conclusion chis study has been a fiat step in gaining<br />
In general the side effects were manageable tolerable<br />
and similar ro those seen cfinically with most other confidence in the use <strong>of</strong> CBMEs THC and THC CBD<br />
prycho ac ive drugs used in pain management They were effec<br />
ive in relieving pain and improving sleep in a<br />
450<br />
i004 BlackweU Pubhshing Ld
W Notcutt et aL Cannabis based medional extracts<br />
Anaesthesia 2004 59 pages 440 52<br />
small grouP <strong>of</strong> pa ien s As expenence was gained<br />
in che dosing the spray proved eary and convenient for he 1510Lhem<br />
pa ients ro use They were able to medicate in public JYJ Watson S Brnson J eds Mnrijunnn nnd MeAi ine<br />
Assusing tlie Srienre Bnse Washing on UQ Insnture <strong>of</strong><br />
without at www nap edu books<br />
030907155<br />
Side eEEec s were not substantially diH eren m those seen<br />
hcrnl<br />
wi h most oher psycho active drugs used in pain g Mi deman M Lewis R Madure M Sherwood J Muller J<br />
managemenL<br />
Tnggering myocardial infa cion by nanjuana Cirndn ion<br />
Stodying CBMEs in pauents with a wider variety <strong>of</strong> 2001 103 2805 9<br />
pain problems exploring specific areas and deepening Che 9ohns A Prychiacric efTeas <strong>of</strong> cannabis BritisH Jmmml <strong>of</strong><br />
clinical expenence are the next steps The uses<br />
potential PsycHintry 2001 178 116 22<br />
in a variety oE other non pain areas neuro protection 10 Rey JM Tennanc CC Cannabis and mencal healch<br />
dicorial Bnnsh Med nl ounm12002 325 1783 4<br />
psychiatric disease Wmour therapy inf3ammation AIDS E<br />
etc are exciting prospects for he future ow that we ll Zuardi A Shirakawa I Finkelfarb E Kamiol I Action <strong>of</strong><br />
have some confidence and m<br />
experience the se oE hese Cannabidiol on he amciery and ocher effeca produced<br />
by THC in normal subjec<br />
Pryrhoplinrrcm ology 1982 76<br />
materials<br />
245 50<br />
12 Vinaguerra V Moore T Brennan E Inhala ion manjuana<br />
Aeknowledgements<br />
as an anti eme ic for cancer chemotherapy ti ew YorkJam al<br />
<strong>of</strong> Medirine 1988 10 525 7<br />
The smdy was desigtted by members <strong>of</strong> he team Ttis has<br />
3 Noccucc WG Price M Chapman G CGnical ezpenence<br />
been supported in planning in adrtunistration liceasing with nabilone For chronic pain PlinmmceuticalSienres 1997<br />
etc and m evalua by GW Pharmaceuticals who 3I1 551<br />
provided the cannabis exnacts free <strong>of</strong> charge The fiat 14 Wade DT Robson P House H Makela P Aram J<br />
year <strong>of</strong> the was<br />
smdy financed om local funds with A preliminary concrolled scudy ro dreenrune whecher whole<br />
support<br />
om the MS Society Subsequendy<br />
i was plant cannabis ex racts can miprove mttac able neurogemc<br />
necessary to ob ongoing fimding for research stafI rymp oms Cliniml Rehabdimtion 2003 17 18 26<br />
15 Brady CM UasGup<br />
R Wiseman OJ Dalmn CM Berkley<br />
from GW Pharma euCicals<br />
KJ Fowler CJ The effea <strong>of</strong> cannabis based medicinal<br />
Dr Malcolm Adams Dean School <strong>of</strong> Health PoLcy<br />
exttact on lower urinary raa dysfunaion in advanred mul<br />
and Practice University <strong>of</strong> Eas AngGa Norwich advised<br />
sdemvs preliminary resul<br />
Abs racts <strong>of</strong> Associadon <strong>of</strong><br />
on he N <strong>of</strong> 1 methodology the res6 o<br />
psychological gtish Neurologisu Aucumn Mee ing Newcasde Universiry<br />
use the analysis <strong>of</strong> results and provided the randomisation meecing at Uurham 12 14 Sepcember 2001 Joumnl <strong>of</strong><br />
schedule Ms Kerry Jeavons Medical Student helped Newology Neurosurgery nnd Psychiatry 002 72 133 42<br />
wi h analysis <strong>of</strong> he Side ect Data 16 Rabins PV Brooks BR Emotronaldsmrbance in mulciple<br />
Finally the managemen and many other members <strong>of</strong> sderosis pauenes validiry <strong>of</strong> che General Healeh Quescion<br />
the staf oE he James Paget Hospi al have provided naire GH Psycliologiml Medi ine 1981 Il 425 7<br />
to<br />
support he 17 Reican iM Validity <strong>of</strong> he Trail Making Tesc as an indi<br />
project<br />
canon <strong>of</strong> orgamc bain damage Percepnmi nnd Nlo or Skills<br />
1958 6 271 i<br />
R2fef2 ICe5 18 Coughlan AK Tlre Adu6 Neniop anA Lfommtion Proressing<br />
Bnttery AMIPB Test Mnruml Leeds AK Coughlan<br />
1 Ivenen L Snyder SH 77ie Sden<br />
<strong>of</strong> MnnJunnn Oxfocd<br />
9 Nomutt W Pnce M Miller R Newporc S Sansom C<br />
Oxford University Press 2000<br />
Simmons S Medicinal cannabis ex aas in chroni pain<br />
2 Morgan DR rdTiempeutic Uses <strong>of</strong> Cnnnnbis London 5 Cognitive Eunc ion and blood cannabinoid levels<br />
Hanvood Academic 799Z<br />
Abstracu <strong>of</strong> Mee ing <strong>of</strong> the Incernational Assoaadon <strong>of</strong><br />
3 Campbell FA Tramer MR Carroll D Reynolds UJM<br />
Cannabis as Med cine Jmirnnl <strong>of</strong> Cnnnabis T7ternpeutia 1985<br />
Moore RA McQuay HJ Are cannabinoids an effective and 2 9 8<br />
safe reatment oprion in he management <strong>of</strong> pain A qual<br />
ZO Loeser JU The futt re will pain be abolished or ust pain<br />
itative sysremaeic rcview Bntish MeAicnl Journnl 2001 323<br />
specialists PALV CLnital UpAntes 2000 8 6 hetp<br />
3<br />
www iasp pain org VCU00 6hmil<br />
4 Henry JA Oldfield WLG Kon OM Companng cannabis z Hansson PT Lacerenza M Marchemm P Aspects <strong>of</strong><br />
wich obacco Brirish Medirnl Jmimnl 2003 326 942 3<br />
clinical and experimental neuropach<br />
pain the chnical<br />
5 Iversen L Comparing cannabis wi h obacco Ari hmetic<br />
perspeaive In Hansson P Fields H HIll R Marchettini P<br />
does noc add up British NeAirnl Jmnnal 2003 327 165<br />
eds Progress in Pnin Resemdi nnd Mnnagemenl Vol 21<br />
6 House <strong>of</strong> Lords Selea Comrttittee Cannabis The scientific<br />
Neumpa hic PainPa<br />
hophysiology and Trea menc Seatde<br />
and medical evidence Hmae <strong>of</strong> LorAs Sele Conimittee on ASP Press 2000<br />
Snence nridTe Hriology Nintli Reporthepwww parliame c<br />
9 20a4 Blackwell Publrshing lttl<br />
451
W Notcutt et al<br />
Can a6is based medional ex<br />
Anaesthesa204 59 pages 440 452<br />
racts<br />
22 Fine PG Conaolled chnical dnig tnals creacing<br />
a new 26 HoldcroC A Smi h M Jacklin A cr nl Pain relief wich oral<br />
cannabinoids in Eam ial Mediteiranean fever Annrst6esin<br />
paradigrn Pnin 2002 95 794<br />
23 Guyatt GH Keller JL Jeaschke A Rosenbloocn U Adathi 7997 52 483 6<br />
JU Newhouse MT The N<strong>of</strong> 1 Randomised Controlled 27 MalEai M Gallily R Sumanwalla P ri nLihe non<br />
Tnal dinical usefidness Aunnis uf lnrernnl MrAici ie 1990<br />
prychoacnve cannabis consntuent cannabidiol s an oral ann<br />
9 arthdcic herapeu ic in munne collagen induced arthricis<br />
Brirish Proreedings <strong>of</strong> he Nntionnl Amdenry <strong>of</strong> Scienres <strong>of</strong> die<br />
112 293<br />
24 Johannessen T Conerolled trials m single sub eccs<br />
ilediml Joumnl 1991 303 173 4 Uriited Smtes <strong>of</strong> Anin im 2000 97 9561<br />
25 Marryn CN Illis LS Thom J Nabilone in the reamient <strong>of</strong><br />
mol iple sderosis Lnncer 1995 345 579<br />
QSZ<br />
d 2004 8iacewell Publrshmg td
Iol 39 No 2 FeMuary 20I0<br />
Jourrc l oJPin ad Synep6om Man gemen 167<br />
Original Article<br />
Multicenter Double Blind Randomized<br />
Placebo Controlled Parallel Group Study<br />
<strong>of</strong> the Efficacy Safery and Tolerability<br />
<strong>of</strong> THC CBD Extract and THC Extract in<br />
Patients with Intractable Cancer Related Pain<br />
Jeremy R Johnson MB ChB Mary Burnell Nugent MB BChir<br />
Dominique Lossignol vIB ChB MRCG DRCOG<br />
Elena Doina Ganae Motan MD Richard Potts BSt Hons MICR and<br />
Marie T Fallon vIB ChB MD FRCP E FRCP Glasg<br />
Swent Hospice RJ Shrewsbury Shro shi e nd Sl Luke s HasQ ceMBN Turnthapel<br />
Plymou6h Unated Kangdom Associ tio rz Hospitalaere De BrusseGsDL Cenlre des Tu rrzeuTS de<br />
lULB BrusteLs Belgaum EmngeacyDe irmenlEDGM Hospit l Sf Ioan cel Nou Sute oa<br />
Rom ania GWPh rma Ltd RPj Ely Cambrfdgeshire and Edirzburgh Can er Researth Centre<br />
MTFUruversity <strong>of</strong> Edinburgh Edanburgh Ueeted Kingdom<br />
Abstract<br />
Thzs study comp red the effic cy <strong>of</strong> atetr hydroc nnabinol cnrwbid oL THQCBD extract<br />
a nanopioid analgesic endocannabinoid systene modul tm and a THC extratt withpl cebo<br />
in relievang pain inptients with dvantedcncer In total 177 patientsuth cancer pain<br />
who experiencedin dequ tenlgesia despite chronit opioid dasing entered truo week<br />
multacen ter double bli tdrndomizedpl cebo<br />
contT011edpar llel group lnal Patients were<br />
rndo raized to THC CBD extr ct n 60 THC extr ct n 58 orpl cebo n 59<br />
The prim ry nalysis <strong>of</strong> change jrom baseline in mean pain Numeric l Rating Scale NRS<br />
scare ws statistic lly signifac ntly in favor ojTHC CBD comp red euith placebo<br />
improvement <strong>of</strong>137 vs 069 vhereas the THC group shomed nonsignific nt<br />
change101 vs 0 69 Twice s many patiencstking THC CBD showed a reduction <strong>of</strong><br />
more thn 30 from baseline pain NRS score mhen comp red with placebo 23 43o vs<br />
12 21a The assoei ted oddsrtio wasst tistic lly sign cny whereas the number <strong>of</strong><br />
THC groxcp responders ws similar to pl cebo 12 23 vs 12 21 and did not reach<br />
tistical signific nce There ms no ch nge from base ine in meda n dose <strong>of</strong>oioid<br />
bckground medic tion ar me n number ajdoses ojbre kthrough meditalian cross<br />
teatment groups Nosi group difjerences mere jound in the NRS sleeyi quality or<br />
navse scores or the pain control assessment However the resu ts from the European<br />
7his study was sponsored by correspondence to Marie T Fallon MD St Co<br />
study medicauon was supplied by GW Pharma lumba s Hospice Chair <strong>of</strong> Palliative Medicine Edin<br />
Ltd and it also funded all sites imolved in the study burgh Cancer Reseazch Centre Crewe Road<br />
by means <strong>of</strong> per patient payments based on recruit Edinburgh EH4 2XR Cni ed Kingdom Email<br />
ment GW Pharma Ltd has funded J R Johnson marie<br />
fallonQedacuk<br />
primary author toaend two conferences to pres<br />
ent the results <strong>of</strong> this study<br />
Atcepted forpub icatian Ju ne 22 2009<br />
GW Phartna Ltd All<br />
Address<br />
O 2010 US Cancer Pain Relief Commi tee 4885 3924 IOjS see fYunt matter<br />
Published by Elsevier Inc 411 rights reserved Aoi<br />
1016<br />
jpainsmiman 2009 06 008
168 fohvasoit et aG o1 39 No 2 Febru ry 2010<br />
Organisation jor Rese rch nd Tre tment ojCancer Quality aJLifeCncer Questionn ire<br />
shorued a morsening innusea and vmaiting with THQCBD compared ruith placebo<br />
P 02 mhere s TNC had no difference P 10 Most drug rel ted adverse evenGs<br />
weremild Yrwderate in seaerity This study shows tht THC CBD extract is efficaciou s fm<br />
reliej <strong>of</strong>pin in patierets with dvancedcncer pain not fully relieoed by strong opioids<br />
f Pain Symptom Manage2010 39 167 179 O 2010 US Cancer Pain Relief Committee<br />
Published lry Elseuier Inc Ali nghts reseived<br />
Key Words<br />
Canterpin tetrahydrocann binol tannabidiol Sativex<br />
InCroduction<br />
and behaviocal activity support the similadty<br />
Cancer pain is a common problem and <strong>of</strong> the endogenous CB anandamide to<br />
THC Both are partial agonists at the CBI re<br />
70 90 <strong>of</strong> patients with advanced cancer ceptoc CBD in contrast binds weakly to CB<br />
experience significant pain Opioids remain<br />
and CB but does show phaRnacological po<br />
he keystone for the tteatment <strong>of</strong> moderate<br />
to severe cancer pain however some patienrs ten12 as a neuval antagonist at each recep<br />
experience inadequace pain relief with opioids<br />
and standard adjuvant analgesics despite dose<br />
tor chat is is silent at such receptors but<br />
an reverse both agonist and inverse agonist<br />
side ellects responses CBD also has shown po3erful anti<br />
adjusvnents and unacceptable<br />
23 inFlammatory immunomodulatory and ana<br />
are common<br />
a<br />
Cannabis contains 60 or more cannabinoids<br />
oxidant properUes in vitro It is a TRPVl<br />
anilloid receptor agonist in its own right<br />
CBs The main ones include delta 9tetrahy<br />
drocannabinol THC and cannabidiol hile modulating anandamide by inhibiting<br />
both its reuptake and hydrolysis Addidon<br />
CBD4 There is evidence that both THC<br />
ally CBD increases adenosine A2A receptor<br />
and CBD show promise in relieving cancer<br />
related pain Sativex THC CBD<br />
an endo signalin<br />
by inhibition <strong>of</strong> the adenosine trans<br />
porter Both THC and CBD have shown anal<br />
cannabinoid system modulator is produced by<br />
gesic efficaty in animal models In this<br />
GW Pharma Ltd United Kingdom it is de<br />
rived from strains <strong>of</strong>Cnnabis sativ L<br />
study both a THC CBD extract and a THG<br />
planrs<br />
only extract were compared against placebo<br />
developed to produce high and reproducible<br />
to ascertain if the indusion <strong>of</strong> CBD provided<br />
yields <strong>of</strong> principal CBs THC and CBD with<br />
a different efficacy or safety pr<strong>of</strong>ile<br />
minor amounts <strong>of</strong> other GBs and terpenes in<br />
Campbell et al published a litelature re<br />
a solution containing ethanol propylene gly etv <strong>of</strong> ine randomized controlled trials<br />
col and peppermint oil flavoring The named<br />
CBs cons iute at least 90o <strong>of</strong> the rotal CB<br />
performed using CBs any route <strong>of</strong> administra<br />
con<br />
tion in patients with acute chronic nonmalig<br />
tent <strong>of</strong> the extracts<br />
nant or cancer pain Five studies that were<br />
CBs act<br />
primarily through specific CB recep<br />
tors CB receprors are predominandy distrib described i four reports comprised 128<br />
patients with cancer pain62 All <strong>of</strong> the ui<br />
uted in the cenval nervous system and CB2<br />
s conducted in padents with cancer pain<br />
receptors are located primarily in the periph<br />
ery including the immune system The ere placebo tonu trials Four <strong>of</strong> the tri<br />
prin<br />
als found CB as effecrive as codeine but with<br />
cipal pharmacological effects <strong>of</strong> THG include<br />
analgesia<br />
muscle rela cation antiemesis dose limiting side effects Thus CBs have dem<br />
appe<br />
tite sdmulation and psychoactivity CBD has onstrated efficacy comparable to selected<br />
shown anticonwlsant muscle relaxant anxio<br />
opioids<br />
THC CBD is the first endocannabinoid sys<br />
lytic neuroprotective antioxidant and anti<br />
temmod<br />
latortoundergoclinicaldevelopment<br />
psychotic activiry and has been also shown to<br />
for pain It has been approved in Canada for the<br />
reduce the anxiety and psychoactive effeccs <strong>of</strong><br />
THC Preliminary rests <strong>of</strong> relief <strong>of</strong> neuropathic pain<br />
pharmacology<br />
in muluple sderosis
Uol 39 No 2 Febru ry 2010<br />
THQCBD for Tre tmenl <strong>of</strong> Cncer Re1 led Pain 169<br />
and persistent background cancerrelared pain for assessment randomizauon and dose intro<br />
The formulation is an oromucosa spray<br />
that al duction to one <strong>of</strong> the three treatrnent arms<br />
lows fle ble individualized dosing Patients THC CBD exvact THC extract or placebo<br />
self titra<br />
their overall dose and pattern <strong>of</strong> dos Fig 1 in a 1 treatment allocation rauo<br />
ing according to their response to and toler Patients were reviewed after710 days Visit<br />
ance <strong>of</strong> the medicine with administration <strong>of</strong> 2 and at the end <strong>of</strong> study 14 20 days or<br />
approximarely 812 sprays day that is withdrawal Visit 3 During the medica ion<br />
22 32 mg day THC and 20 30mg day CBD dosing period the patients condnued to mm<br />
This study assessed the analgesic efficacy <strong>of</strong> plete the daily smdy diaries with the aforemen<br />
THC CBD and THC ext acts compared with<br />
tioned information and the number <strong>of</strong> doses<br />
that <strong>of</strong> placebo in the management <strong>of</strong> patients <strong>of</strong> study medication taken The relevan regu<br />
with at least severe<br />
moderately cancervrelated latory authorides and research ethics commit<br />
pain despite appropriate pharmacological tees approved the study<br />
management<br />
The study medication was delivered using<br />
a pump action oromucosal spray Each 100<br />
L actuation <strong>of</strong> the pump containing the<br />
THQCBD extract delivered a dose containing<br />
Methods<br />
27 mg THC and 25 mg CBD Each 00L ac<br />
This ttvo two day baseline and two mation <strong>of</strong> the pump containing the THC ex<br />
week veatment multicenter double blind tract delivered a dose containing 27 mg<br />
randomized placebo controlled parallel CHC and each actuauon <strong>of</strong> placebo delivered<br />
group study evaluared the efficacy<br />
<strong>of</strong> only excipients plus mlorants The mascimum<br />
THC CBD extract and THC extract in the anal permitted dose <strong>of</strong> all study medication was<br />
gesic management <strong>of</strong> padents with moderate eight actuations in any three hour period and<br />
to severe cancerrelated pain There was 48 actuations in any 24hour period<br />
a<br />
nvo day baseline period Adult male or Patients self titrated to their opdmal dose<br />
female patienrs who had been using strong over the seven days <strong>of</strong> Week 1 based on effi<br />
opioids for at least one week to relieve pain as cacy tolerability and the maximum permitted<br />
sociated with incurable malignancy<br />
and who dose Pauents could increase the total number<br />
gave written informed consent were screened <strong>of</strong> splays each day by a maximum <strong>of</strong> 50 until<br />
for study entry Eligible patients recorded they either had satisfactory relief <strong>of</strong> their symp<br />
a<br />
pain severity<br />
score <strong>of</strong> 4 or above on a010 toms or developed unwanted effeccs such as<br />
Numerical Rating Scale NRS on both days intoxication high The total number <strong>of</strong><br />
<strong>of</strong> the two day baseline period<br />
Patients were<br />
sprays was spread over the day with a minimum<br />
exduded if they had cancers affecting the <strong>of</strong> 15 minutes benveen any nvo sprays f un<br />
oral cavity radiotherapy to the floor <strong>of</strong> the wanted effects developed on a new number<br />
or cardiovascular dis <strong>of</strong> sprays the patient would not take any fur<br />
mouth major psychiatric<br />
orders epilepsy renal or hepatic impairment ther sprays for three to four hours The pauent<br />
or if they were pregnant lactating or not using would then go back to taking their further<br />
adequare contraception Patients who had re sprays at a similar level to the previous day<br />
ceived therapies expected to confound the Oce the patient had found he maximum<br />
smdy outcome epidural analgesia within 48<br />
number <strong>of</strong> sprays per day that they rolerated<br />
hours <strong>of</strong> screening pallia ive radio chemo well or the number that provided good symp<br />
or hormonal therapy within cwo weeks <strong>of</strong> tom relief they continued with approacimately<br />
screening<br />
or CBswi days <strong>of</strong> random the same number <strong>of</strong> sprays per day for the<br />
ization were also excluded Patients taking remainder <strong>of</strong> the study<br />
levodopa sildenafil or fentany or patients The coprimary endpoints were the change<br />
with a<br />
hypersensitivity ro CBs were excluded from baseline in NRS pain score and use <strong>of</strong><br />
on safety grounds PaUents completed a study breakthrough analgesia The NRS a widely<br />
diary recording pain score three dmes daily used and validated measure <strong>of</strong> pain severity<br />
and background medication and all addiuonal is capable <strong>of</strong> showing clinically and stadstically<br />
breakthrough analgesia on each day during significant changes in pain disorders The<br />
the baseline period Patients hen returned IVRS question indicate your level <strong>of</strong> pain
170 Johnsaa et aL Yal 39 No 2 February 2010<br />
Screened n 192<br />
2day baseline period<br />
Randomized n 177<br />
2week treatment penod<br />
THC CBD THC extract Placebo<br />
n60 n58 n59<br />
Withdrawn12 Withdrawn13 Withdravm n8<br />
Adverse event W Adverse event 7 Ativerse event 3<br />
ConseMwiihdrawal Consentwtthtlrawel 2 Cansentwithdravrel 2<br />
ONer 1 Sponsor tlecision 1 Olher 3<br />
Prorocol vlotation 1<br />
Other 2<br />
Completedn48 Completed n 45 Completed n 51<br />
ITT population n 177<br />
Safety population n 177<br />
Fig 1 Study design Consolidated Standards <strong>of</strong> Reporung Trials CONSORT diagram ITT inten to ireat<br />
was answered by patients three times daily in represents the pain intensity The Total BPI<br />
the morning on waking atlnchtime and in for Question 9 is the unweighted sum <strong>of</strong> the<br />
the evening before retiring using the anchors seven assessmencs and represents the effect<br />
0 no<br />
pain and 10 very bad pain Pa <strong>of</strong> pain The EORTC QL C30 cancer ques<br />
were allowed to use their breakthrough analge tionnaire consisrs <strong>of</strong> 30 quesuons that cover<br />
sia as<br />
required and this was recorded daily in global health status functional scales eg<br />
the diary Patients maintained background physical functioning and symptoms eg<br />
medication for the duration <strong>of</strong> the smdy The fatigue<br />
secondary endpoints included the use <strong>of</strong> opi<br />
Adverse events AEs and use oE concomi<br />
oid background medication pa ient assess tant medications were reported by patients at<br />
ments <strong>of</strong> sleep quality nausea memory study visits throughout the trial Predefined<br />
concentration and appetite over the previous categories for determining the intensity and<br />
24 hours<br />
using diary ARSsihe Brief Pain the relationship to study medicauon were<br />
Inventory Short Form BPI SF and The Euro used The expert dinical judgment from the<br />
pean Organisation for Research and Treat imestigating study physicians was used in de<br />
ment <strong>of</strong> Cancer EORTC Quality <strong>of</strong> Life termining intensity and causal relationship <strong>of</strong><br />
Questionnaire QLQC30 Version 3 were AEs and serious AEs<br />
completed by patients at Visit 1 and at the The smdy was powered assuming an underly<br />
end <strong>of</strong> the SIUflY 24 25 e BPI ing treatment difference <strong>of</strong> 1 point on an NRS<br />
nine quesuons eight have a single response and a standard deviation SD <strong>of</strong> 16 esti<br />
and Question 9 is subdivided into seven parts mated from previous studies with 80 power<br />
The Total BPI Questions 36 is the and nvo sided 5 significance After allow<br />
un<br />
weighted sum <strong>of</strong> the four pain scores and ing for 15 dropouts 58 subjecrs per groop
al 39 No 2 February 2010<br />
THC CBD for Tiealmeat <strong>of</strong> Cancer<br />
Related Pain 171<br />
were<br />
required For the two coprimary efficacy<br />
jgul<br />
variables NRS pain score and use f break p total <strong>of</strong> 192 patients were screened over 25<br />
through medication the Hochberg method<br />
months leading to 177 patients randomized to<br />
was used to test the globa hypothesis for a treat<br />
treatment Fig 1 at 28 European centers The<br />
ment effect on<br />
pain The null hypothesis was to mean SD duration <strong>of</strong> cancer in these pa<br />
be rejected if either coprimary variable pro<br />
uenrs was 35 years 28 327 32 427<br />
duced two sided P 025 or both produced<br />
and 45 525 years respectively in the<br />
P 05 The daily pain NRS score was the THQCBD THC and placebo groups respec<br />
mean <strong>of</strong> the three daily assessments The tively The mean age gender distribution<br />
change in mean NRS pain score from baseline Previous cannabis use primary disease sites<br />
all days in run in period to the end <strong>of</strong> treat and pain classification were similar among<br />
ment last three days on reatment was ana the three treaUnent groups Table 1 The<br />
lyzed using analysis <strong>of</strong> covariance ANCOVA most common type <strong>of</strong> cancer pain was <strong>of</strong><br />
with baseline pain as a covariare and gr<br />
ouped mixed pathophysiology followed by bone and<br />
smdy center and treavnent as factors The neuropachic pain Table 1 At baseline the<br />
proporuons <strong>of</strong> responders patients with mean dai y dose <strong>of</strong> opioid backgroond medica<br />
30 improvement from baseline to end <strong>of</strong><br />
uon in the whole study population was 271 mg<br />
study NRS pain score wece compared between<br />
<strong>of</strong> oral norphine equivalencs The median oral<br />
treatments Use <strong>of</strong> breakthrough medication<br />
morphine equivalent dose was slighdy lower in<br />
number <strong>of</strong> days <strong>of</strong> use during last three days<br />
the THQCBD group at baseline compared<br />
on treaunent was analyzed using logistic re<br />
with the THC and placebo groups Table 2<br />
gression with a cumulative logit modeL In addi<br />
For all three tteatment groups the predomi<br />
don the change from baseline in mean<br />
nant primary reason for discontinuing the<br />
number <strong>of</strong> doses <strong>of</strong> escape<br />
medicauon was an<br />
study was AEs Fig 1<br />
alyzed using ANCOVA<br />
Tab e 1<br />
Pafi enDe<br />
Demographics<br />
THGCBD THC Placebo Total<br />
Gender rz<br />
Male 38 55 SO 52 32 64 95 54<br />
Female 27 45 28 48 27 46 82 46<br />
Ethnic origin n<br />
Gaucasian 59 98 57 98 58 98 I74 98<br />
Other 12J 2 12 32<br />
Previous cannabis usen 610 610 7l2 19 11<br />
Age years<br />
mean SD 94 Q2 1 613 125 601 123 60 2 Q2 3<br />
Uuration <strong>of</strong> cancer years mean SU 28 83 32 43 45 58 35 4<br />
BMI mean SD 281 42 235 52 241 43 236 46<br />
Primary canrer sires n<br />
Breazt 14 20 S74 9l5 Y9 Q6<br />
Prostate 610 S14 10 t7 24 Q4<br />
Lung 712 916 47 20 11<br />
Pain dassifica ion n<br />
Mixed 31 52 28 48 30 51 89 50<br />
Bo e 16 27 24 41 25 42 65 37<br />
Neuropa hic<br />
11 QB I1 l9 17 29 89 22<br />
Vaceral 14 28 12 21 71 79 37 21<br />
Somafic incident 7I1 9 610 18 10<br />
Baseline morphine equivalents<br />
Median mg B0 12U 0 120 120<br />
Range 06000 01280 06000 06000<br />
Mean Sll 258 4 789 47 188 2 234 49 367 0 886 38 2712 698<br />
is Srcl quartile 30 180 50 213 240 240<br />
BMI body mass index<br />
Onl morphine equivalen<br />
data are sourred mm ReCs 43 4i
172 Johrzson ell Yal 39 No 2 February 2010<br />
Opioid<br />
Table 2<br />
Change in Dose <strong>of</strong> Opioid Background Medication Oral Morphine Equivalents and Strong Opioid<br />
Breakthrough Medica4on<br />
Characteristics THQCBD THC Placebo All<br />
Opioid background medication change From baseline co last 3 days on study medication pauents with data available excluding<br />
3 pa ients receiving intra hecal opioids<br />
e ITC population 60 Q00 58 100 58 98 176 99<br />
Median 0 0 0 0<br />
Range 627 to 300 27 to 1088 1200 to 400 1200 to 1088<br />
Mean f5D 35 108 44 269 152 00 414 201 27 64 160<br />
QI QS 0 QO 0 QO<br />
Opioid background medicntionca egorized change Crom baseline in ornl morphine equiwlents per day<br />
Increasen90 612 6lY 47 16 LO<br />
No changen<br />
41 79 40 77 43 SO 144 78<br />
Decreasen 510 612 713 18 I1<br />
Smng opioid break hrough medication categorized thange from baseline in number oE doses taken<br />
N90 ITTpopulation 22 37 18 Sl 19 32 59 83<br />
Increasen90 49 422 737 13 22<br />
No changea 12 56 l0 56 12 63 84 58<br />
Dn 836 422 0 12 20<br />
17Cincen m tteaqSD standard deviatlon<br />
The mean SD number <strong>of</strong> sprays<br />
taken pet a reduction in pain which was in favor <strong>of</strong><br />
day which had srabilized by the end <strong>of</strong> the first THQCBD extract055 pointsPOA24 but<br />
week Days 17 ending the titrauon phase not for the THC ex ract 024 points<br />
were THG CBD extiact 575514 THC ex<br />
P0204 Sensiuvity analyses <strong>of</strong> the change<br />
tract 834 517 and placebo 961 467 from baseline in the mean NRS scores con<br />
Fig 2 Ove all for the endre treatment pe curred with the primary analysis<br />
riod the mean SD number <strong>of</strong> sprays<br />
used<br />
In thronic pain trials it is recommended<br />
daily in the placebo group 10 88581 was that the percentages <strong>of</strong> pauenrs obtaining re<br />
higher than those in the THQCBD 926 dUCtions in pain intensity <strong>of</strong> at least 30 on<br />
53 and THC groups 547546 a pain NRS responders should be docu<br />
mented A reduction in pain NRS <strong>of</strong> approx<br />
Effic cy imately 30 o is considered to represeni<br />
The mean SD baseline NRS pain scores a clinically important<br />
difference2 the in<br />
were similar<br />
among creatment groups and tent to treat responder analysis approximately<br />
within grouped centers THQCBD extract<br />
twice as many patients in the THC CBD group<br />
568 124 range 233 825 THC exva ct<br />
had a reduction from baseline NRS <strong>of</strong> at least<br />
577133 range 287933 placebo 605 30 compared with the placebo and THC<br />
132 range 35956 The adjusted mean groups THC CBD 23 43 vs THC 12<br />
reduction in NRS ANCOVA for THC CBD 23 placebo 12 21 The odds ratio<br />
THC and placebo groups at the end <strong>of</strong> the for the comparison <strong>of</strong> responders benveen<br />
veatment were 137 Ol and 069 THCCBD and placebo was 281 9 confi<br />
points respecuvely The adjusted mean treao dence interval CI 122 650 P 006<br />
ment difference from placebo was statistically and benveen THC and placebo was 110<br />
significant<br />
for a reduction in pain with the 95 C1 044273P028 Fig 3<br />
THC CBD extract 067 pointsP014 but The number <strong>of</strong> days on which any break<br />
not the THC extract 032 pointsP0245 through medication was used was similar<br />
The ANCOVA did not have normally distrilr among all treatment groups with no signifi<br />
uted residuals but the nonparametric analysis cant differences observed in this clinical trial<br />
gave a similar result The median changes <strong>of</strong> brief duration THQCBD vs placebo<br />
from baseline for THC CBD THC and pla P070 There was a reduction observed in<br />
cebo groups were136100 and060 re<br />
the mean number <strong>of</strong> daily doses <strong>of</strong> all break<br />
spectively<br />
The median difference from through medication THC CBD extract<br />
placebo<br />
was statistically significant<br />
for 019 THC extract014 platebo015
Yo 39 No 2 February 2010<br />
THQCBD far Trea menl oJ Cancer RefnledPi 173<br />
w ts<br />
l r<br />
i<br />
o i 1<br />
i<br />
z<br />
nio T<br />
f<br />
t<br />
A r 1<br />
1 1 1 1<br />
8<br />
1 1<br />
y<br />
f<br />
o s r THC CBD<br />
01<br />
Ey<br />
zC 2<br />
af 0<br />
9L 1 2 3 6 5 fi 8 9 10 11 12 13 1A<br />
Stutly Trealment Oay<br />
1<br />
Place6o<br />
THC<br />
Fig 2 Exposure to study medica ion mean number <strong>of</strong> sprays per day SE<br />
standard error<br />
by the end <strong>of</strong> the smdy period but the <strong>of</strong> patients in the THC CBD group eight pa<br />
difference i change from baseline benveen uents reduced breakthrough doses con<br />
treatment groups was not statistically significant versely the highest proportion <strong>of</strong> increases in<br />
More specifically there was no change from dose was in the placebo group seven pa<br />
baseline to the last three<br />
days <strong>of</strong> treatment in tients which was staustically significandy<br />
the median oral morphine equivalent dose <strong>of</strong> greater than those in the THC CBD group<br />
opioid background medications in 124 78 P004<br />
paaenrs for whom the data were available Most <strong>of</strong> the NRS diary symptom scores and<br />
Doses were increased for 16 patients 10 investigatorvassessed pain control showed no<br />
and reduced for 18 11 these changes significant treavnent differences benveen the<br />
were evenly distributed across the three treat<br />
three groups Table 3 A statisucally signifi<br />
ment groups Table 2 During the baseline cant difference in improvement with placebo<br />
period or last three days on treatment strong was observed in the diary NRS concentradon<br />
opioid breakthrough medicauon was recorded and memory scores whereas the placebo<br />
by 59 patients 33 <strong>of</strong> these 34 58o group showed a mean improvement from<br />
showed no change in the number <strong>of</strong> doses baseline in concentradon score035 and<br />
taken when comparing baseline with last three the THQCBD group showed a deteriorado<br />
days <strong>of</strong> treatment 13 22 increased the<br />
033P02 as did the THC group029<br />
number <strong>of</strong> doses and 12 20 reduced the P03 The memory score showed no<br />
number <strong>of</strong> doses taken A greater proportion change in the placebo group 01 but a dete<br />
rioration in the THC CBD group 063<br />
P045 and in the THC group 066<br />
P053 Similarly the appetite diary NRS<br />
60<br />
N<br />
score showed a mean improvement from base<br />
a so line in the placebo group and there was<br />
rn zm zz smiv aaa<br />
i ap ecao a slight reduction in appetite score in both<br />
t d<br />
THC CBD and THC groups 059 vs 024<br />
a m<br />
J<br />
30 ace P 016 and 059 vs 06 P 056 re<br />
d Zo spectively Table 3<br />
a<br />
ssm asi<br />
The QL C30 showed as expected few dif<br />
10<br />
0<br />
ferences among treatment groups in the nvo<br />
o<br />
week follow p Of the 16 items assessed the<br />
ioi 3oi SO Io 45Fa1m 95 HCCao war oo only statistically significant observations were<br />
ResponseLevel<br />
reductions in cognitive funcuon smre when<br />
Fig 3 Pain0 Numerical Rating<br />
Scale smres re<br />
cOmPared wi h Placebo THC CBD ex rat<br />
sponder analysis ITT anal sis Odds ratio 95 533 vs 368 P 02 THC extract<br />
CI THQCBD vs<br />
placebo Fisher<br />
ezact test 677 vs 368 P OAl and a<br />
worsening <strong>of</strong>
l74 Jahnson el G lol 39 1Uo 2 FeGruary 2010<br />
Tble 3<br />
Primazy and Secondary Endpoints Showing Baseline Score Change from Baseline Treatment Difference and<br />
Stafis4cal Significance <strong>of</strong> the Difference inChang e From Baseline for1IC TT IC and Plac<br />
Comparison with Piacebo<br />
Satistital<br />
Treaunenl Changr Trea ment Significanre<br />
Endpoin Group Baseline From Baseline Dillerence Pvalue<br />
Mean pain severity NRS smre THQCBD 568 137 067 014<br />
oprimary IHC 57 101 082 0245<br />
Placebo 605 Ob7<br />
Brcakthrough medication no <strong>of</strong> THQCBD OR 096 0697<br />
days used mprimary THC OR 120 0555<br />
Placebo<br />
Breakthro gh<br />
daily<br />
medication mean THQCBD 091 019 04 0688<br />
dose THC I10 014 01 0899<br />
Placebo 080 015<br />
Nean sleep quality KRS score THQCBD 433 057 031 0346<br />
THC 46 024 OA2 095<br />
Placebo 417 026<br />
Mean nausea NRS score THQCBD 244 026 049 0110<br />
THC 204 024 046 0126<br />
Placebo 198 OY2<br />
Ytean memory NRS store THCCBD 302 063 065 045<br />
THC 298 066 0fi2 053<br />
Placebo 290 01<br />
Neammcentration URS smre THQCBD 359 033 068 021<br />
THC 353 029 064 028<br />
Placebo 397 035<br />
Nean appetite NRS score THQCBD 483 024 083 016<br />
THC 458 06 066 056<br />
Placebo 498 059<br />
Pain convol assessment THQCBD 50 1 OR 10 0488<br />
proportion wi paimmtro0ed THC 54 2 OR 176 0400<br />
Placebo 36 170<br />
7ean BPISF mtal pain in last 24 THQCBD 20 88 017 104 U619<br />
hours THC 21 29 320 407 048<br />
Placebo 23 48 087<br />
Mean BP1SF total inter erence by THQCBD 46 63 353 484 0325<br />
pain<br />
in last 24 hours THC 39 89 450 58I 0275<br />
Placebo 51 05 131<br />
Nean QLQL30 global health THQGBD 29 74 723 247 0443<br />
status THC 27 05 560 084 0793<br />
Placebo 25 29 477<br />
Mean QL C30 physical IHC CBD 40 84 692 423 0108<br />
fimctioning THC 35 56 894 125 0631<br />
Plarebo 34 14 269<br />
C30 role functioning<br />
THQCBD 29<br />
J1ean QLQ<br />
02 OA2 31 Q415<br />
THC 28 65 012 921 0434<br />
Plare6o 25 00 333<br />
Mean QLQ C30 emotional THGCBD 24 44 70 673 064<br />
Functioning THC 22 41 619 522 0174<br />
Placebo 25 37 098<br />
Mean QLQC30 mgnitive THQCBD 50 57 588 901 022<br />
46 008<br />
fimctioning THC 5632 67 I0<br />
Mean QLQC30 social functioning<br />
Mean QLQ<br />
Placebo 50 85 3fi8<br />
THC CBD 29A2 319 161 0679<br />
THC 29 89 966 808 038<br />
Placebo 25J1 158<br />
C30 fatigue<br />
THGCeD 71 55 392 271 0422<br />
Mean QLQ C30<br />
THC 70 69 136 015 0965<br />
Plarebo 64 56 131<br />
nausea and CHQCBD 25 57 513 856 OA20<br />
vomiting THC 22 18 341 02 U997<br />
Pla ebo 2175 343<br />
lean QLQL30 pain THCGBD 88 62 15 64 634 0107<br />
THC 79 60 15 71 641 0103<br />
Placebo SL64 930<br />
ConGnue
Yol 39 No 2 Febru ry 2010<br />
THC CBD for Treatmen <strong>of</strong> CncervRel tedPin 175<br />
Table 3<br />
Continued<br />
Comp arison with Plac<br />
Sta istical<br />
Trea ment Change Trea men Significance<br />
Endpoint Group Bazeline From Baseline Difference Pvalue<br />
Mean QL iC30 dyspnea THQCBD 40 23 109 080 0846<br />
THC 43 27 421 49 0282<br />
Placebo 84 46 028<br />
Mean QL C30 insomnia THCCBD 5230 615 105 0883<br />
THC 51 15 041 469 0347<br />
Mean QLQ C30 appetire loss<br />
Mean QLQC30 consupation<br />
Mean QLQC80 diarrhea<br />
Placebo 51 41 510<br />
THC CBD 60 34 869 088 0857<br />
THC 54 60 19 lb2 0743<br />
Placebo 59 82 281<br />
THC CBD 50 00 574 797 077<br />
THG 38 33 311 535 0233<br />
Placebo 40 68 23<br />
THC CBD 13 22 215 157 0615<br />
THC 862 056 15 0713<br />
Placebo 12 99 058<br />
Mean QLQC30 finantial THQCBD 58 05 558 170 0714<br />
diculties THC 59 20 893 505 0276<br />
In Cawr oF active vea ment<br />
In fawr oI pla ebo<br />
Placebo 57 06 388<br />
nausea and score<br />
vomiting in the THC retention mmorvrelated pain worsened nau<br />
although ot in the THC only group when sea weakness tumor hemorrhage and somno<br />
mmpared with placebo THC CBD 513 vs<br />
lence were experienced by five padents in the<br />
343 P 02 THC341 vs 343 THC CBD group all <strong>of</strong> which were unrelated<br />
P 10 A trend toward was<br />
improvement to study medication Three events were moderv<br />
seen in both acrive treatment in the<br />
groups are in severity and four evenrs were severe Five<br />
QL C30 pain assessment score THC CBD subjects who received THC experienced the<br />
extract 15 64 vs 930P011 THC ex<br />
nonfatal SAEs <strong>of</strong> inetastases to brain gastric<br />
tract15 71 vs 930 P010 and in the ulcer hemorrhage syncope bronchopneumo<br />
constipadon<br />
score THQCBD574 vs<br />
nia hyperglycemia confusion oral candidia<br />
23 P 08 THC311 vs 23 P023 sis somnolence tremor and disorientauon<br />
All events were unrelated to study medicauon<br />
Safely and with the exception <strong>of</strong> a single episode <strong>of</strong><br />
Toler bility<br />
The active compounds were generally well syncope which was probably related to THC<br />
Two events were moderate in severity and<br />
tolerated and no safety<br />
concerns were identi<br />
eight events were severe No patients from<br />
fied dudng this study Treaunenarelated AEs<br />
he placebo group reported a nonfatal SAE<br />
were<br />
reported by 106 60 patients Com<br />
mon treatment related AEs three or more pa<br />
tients were similar to those seen in other<br />
TI IC CBD clinical trials somnolence dizzi<br />
SClISStOri<br />
ness and nausea mosdy<br />
<strong>of</strong> mild or moderate Unrelieved cancer pain can result in signifi<br />
severity Table4s233 3s The incidence <strong>of</strong><br />
cant distress and disability The results <strong>of</strong><br />
death in this advanced cancer<br />
populadon was this study show hat the THC CBD extract is<br />
similar across treatment groups eight an efficacious adjunctive treatment for can<br />
THQCBD eight THC seve placebo and cervrelated pain in patiencs who are not achiev<br />
all were considered because <strong>of</strong> progression <strong>of</strong> ing an adequate analgesic response to opioids<br />
underlying disease None <strong>of</strong> the cases from This study involved pauents with advanced<br />
the 10 patients who reported nonfatal serious cancer who had a mean diseasedration <strong>of</strong><br />
AEs SAEs raised any<br />
concerns<br />
regarding more than three years and moderate to severe<br />
the safety <strong>of</strong> CBs The nonFatal SAEs <strong>of</strong> urinary levels <strong>of</strong> pain at entry 4 on an NRS pain
776 Johnson el a1 Yoi 39 No 2 Febru ry 2010<br />
Table 4<br />
At baseline the mean daily use <strong>of</strong> opioid<br />
Most Common 1YeavnenaRelated Adverse<br />
background medication was relatively high<br />
Events<br />
Reported by TMree or More Patients<br />
271 mg <strong>of</strong> oral mocphine equivalents The<br />
THC<br />
cha ge in number <strong>of</strong> daily doses <strong>of</strong> break<br />
Destription o THQCBD ez act Placebo<br />
Eei no rzo n through medication between baseline and<br />
end <strong>of</strong> study showed a slight trend toward re<br />
Somnolenre 8ts S4 6lo<br />
Dizziness 7 12 7 12 3 5<br />
duction and no relevant differences benveen<br />
Co son a7 l2 2 treatment groups Only a small number <strong>of</strong> pa<br />
tvausea 6t0 47 a7 tienrs recorded taking svong opioid break<br />
vomidng 35 a7 23<br />
Naised gamma GT 23 59 12 through medicadon in their daily diades<br />
Hyper aema o 0 35 during the baseline period or last three days<br />
Hypocension S5 0 0<br />
on vearment Of these most showed consis<br />
Camma CT gamma gluumyl tans erase<br />
Cn CIOSIng paLtC I1S the changes that did oc<br />
cur showed a trend toward a decrease in the<br />
scale despite ongoing opioid trea menc ARer number oFdoses taken in the THC CBD group<br />
two weeks <strong>of</strong> receiving study medication ad and an increase in the placebo group There<br />
junctive<br />
to all other treatmencs the THC was a large range in the dose <strong>of</strong> background<br />
extract grotip showed a staustically significant oral mocphine equivalent veatmenc These<br />
reducdon in pain severity when compared findings may be a reflecuon <strong>of</strong> different treat<br />
with placebo with a reduction in mean pain ment models used in the participadng coun<br />
NRS scores from baseline <strong>of</strong> 137 points tries and illusvates the need to indude<br />
226o The pain NRS data were not norv<br />
a more specific eligibility criteria <strong>of</strong> minimum<br />
mallydis ributed hence parametric<br />
and non<br />
opioid treatment in fut re studies Less varia<br />
were<br />
parametric analyses conducted This had tion in the existing treavnent regimens would<br />
no influence on the significance <strong>of</strong> the results enhance the interpretauon <strong>of</strong> the efficacy re<br />
The heterogeneity<br />
in the distribution <strong>of</strong> the sult but would make recruivnent to the study<br />
pain scores many large negaUVe and large more challenging<br />
posiuve results combined with consensus Ao statistically significant differences in pa<br />
based recommendations highlight the im tient assessed sleep quality or nausea NRS<br />
portance <strong>of</strong> the responder analysis These rer scores or invesdgator assessed pain control<br />
ommendations are primarily based on the assessment were noted benveen the smdy<br />
results <strong>of</strong> an<br />
analysis <strong>of</strong> relationships benveen medications and placebo There was a signifi<br />
changes in pain intensity and paUent reports cant imprwement in the BPI SF total score<br />
<strong>of</strong> overall improvement<br />
in 10 clinical trials <strong>of</strong> for THC but not for THQCBD Studies <strong>of</strong><br />
chronic pain with patients <strong>of</strong> diverse diagno longer duration in other indications have<br />
ses in which a<br />
clinically relevant response regularly shown that the quality <strong>of</strong> sleep in<br />
was defined as a reduction <strong>of</strong> pain <strong>of</strong> at least the THQCBD group needs to be im<br />
30 Crom baseline to end <strong>of</strong> study proved262zs3 4o The differences benveen<br />
In this current study population 43o <strong>of</strong> pa treatment groups in the memory concentea<br />
tients<br />
taki g<br />
the THC CBD extract achieved uon and appetite NRS diary scores are pardy<br />
a 30 or<br />
greater improvement in their pain attributable to an apparent improvement in<br />
score<br />
equated to a mean improvement <strong>of</strong> the placebo group<br />
271 boxes approximately nvice the number The QL C30 showed few differences be<br />
<strong>of</strong> patients who achieved this response in the nveen study medications and placebo Consid<br />
THC and placebo groups<br />
The results <strong>of</strong> the ering the follow up duration and the patient<br />
responder analysis and the mean change population this is unsurprising There were<br />
from baseline must be interpreted remember marginal improvements in QLQC30 pain<br />
ing that the study medications were adjuncdve scores but significantly reduced cognitive func<br />
to<br />
existing treaunents includingsrong opi Uon scores with the THC CBD and THC<br />
oids for the duradon <strong>of</strong> the triaL Larger veat groups compared with those <strong>of</strong> the placebo<br />
ment differences from placebo may be noted group The stadstically significant worsening<br />
in a<br />
smdy <strong>of</strong> lon er durauon as evident in in the QLQ C30 nausea and vomiung score<br />
other conditions 2 24 seen with the THC CBD extract tompared
PoL<br />
39 Na 2 Februa ry 2010<br />
THC CBD ftrr Treat rrzerel <strong>of</strong> Cscer Rel ted Pin 177<br />
with placebo was not seen in the diary scores THC extract alone This finding is supported<br />
for nausea and is confounded by a median by evidence <strong>of</strong> additional synergy benveen<br />
change <strong>of</strong> 0 benveen the groups making inter THC and CBD CBD may enhance the analge<br />
pretation <strong>of</strong> this result difficult Similarly the sic potenual <strong>of</strong> THC by means <strong>of</strong> potent in<br />
changes in appetite reported in the patient verse agonism at CB2 receprors which may<br />
diaries were not seen in he QL C30<br />
produceanu<br />
inflammatory effects along with<br />
The few staustically significant results <strong>of</strong> the its ability to inhibit immune cell migration<br />
secondary endpoi ts should be interpreted Additionally CBD may modulate the potential<br />
with caution because <strong>of</strong> the multiple analyses unwanted effects <strong>of</strong> THC by means <strong>of</strong> antago<br />
performed on the questionnaire and the nism at CB receptors which potenually<br />
over<br />
lap in content between some <strong>of</strong> the NRS scales would provide a better safety pr<strong>of</strong>ile for the<br />
and questionnaire items However there is THC CBD medicauon in chronic use<br />
a consistent impairment <strong>of</strong> cogniuve function<br />
In conclusion THC CBD extract a nonop<br />
reported by pauenrs in this smdy Although ioid analgesic endocannabinoid system modu<br />
the dinical significance <strong>of</strong> this finding is lator has been shown ro be a use ul adjuncdve<br />
uncleay it warrants further care ul assessment treatment for relief <strong>of</strong> pain in patients with<br />
in long term studies It is accepted that there advanced cancer who experience inadequate<br />
will be limitations and potenual<br />
inaccuracies analgesia despite chronic opioid therapy The<br />
<strong>of</strong> patient completed diary data and future reductions in pain scores were neither because<br />
studies will look to refine this method <strong>of</strong> data oF a change in opioid background medications<br />
completion<br />
nor because <strong>of</strong> an inerease in use <strong>of</strong> break<br />
The AEs seen in this study<br />
were similar to through medication Therefore we can con<br />
those seen in other clinical CIlHI5 2627 33 38 Of clude that the observed reduction in pain<br />
theAEsleadingtopermanentcessation<strong>of</strong>study scores is attributable to the posiuve analgesic<br />
medicauon 17 12o and3respectively for effects <strong>of</strong> THQCBD extract These results are<br />
THC CBD extrnct THC extract and placebo<br />
approximately half were considered to be re<br />
lated to study treatment None <strong>of</strong> the 33 re<br />
ported SAEs raised concerns regarding<br />
treatment<br />
safety The incidence <strong>of</strong> death ACknowlC<br />
was<br />
very encouraging and merit further smdy<br />
pfYtCYIfS<br />
comparable among treatment groups and The authors thank all the patients and their<br />
therewerenotreacmenUrelaleddeaths Despite families who parricipated in this trial Additiorn<br />
some<br />
uncertainty in the total morphine equiva ally the authors acknowledge GW Pharma Ltd<br />
lent dose received by pauenrs the safety pr<strong>of</strong>ile for sponsoring the trial and the following<br />
addsevidencethatthiswasapopulauonwithad invesdgatorsandtheirresearchstafFfortheirparv<br />
vanced disease 13 <strong>of</strong> patients died during the dcipation Dr D Brooks Royal ChesterField<br />
study because <strong>of</strong> their underlying disease<br />
Hospital Chesrerfield UK Dc D Feuer S Bar<br />
The THC CBD and the THC medications tholomew s Hospital London UK Dc R Gaunt<br />
were well tolerated Patients were<br />
fully utrated Rowden Surgery Chippenham UK Dr A Gri<br />
at one week and maintained stable dosing gorescu Institutul Oncologic ProE Alex Tres<br />
throughout the treatment period that is there tioreanu Sos Bucuresu Romania Dc K<br />
was no observed tendency to increase dose GruffyddJones The Box Surgery Corsham<br />
with time This corresponded to a reduction UK Dr E Hall St Helena Hospice Colchester<br />
in pain NRS score over the same period The UK DcJ Hardy The Royal Marsden NHS Trust<br />
clinical response ro pai with THQCBD Sutton UK Dr C Higgs Dorothy House Foun<br />
extract oromucosal spray has not demon daUOnfl adford Upon Avon UK Dv P Hos<br />
strated tolerance in several clinical trials <strong>of</strong> lon kins Mount Vemon Hospiral Northwood UK<br />
ger duration<br />
Dc S Kelly Marie Curie Cenve Belfast UK<br />
There is evidence <strong>of</strong> synergy benveen THC Dr M Leng Roxburgh House Grampian Uni<br />
and morphine in pain and THC may modu versity Hospitals NHS Trust Aberdeen UK Dr<br />
late endogenous opioid rone However in D McKeirh Townhead SurgeryIvine UK Dr<br />
this sudy the THC CBD tombinadon showed D Mosoiu Fiospice Casa Spetantei Brasov<br />
a more<br />
promising efficacy pr<strong>of</strong>ile than the Romania Dc C Nitipir Diagnostic<br />
and
y8 Johnson et aL 01 39 No 2 February 2010<br />
Treatment Centre Foundation Dr Vic or 9 Pernvee RG Neuropharmacology and therapeu<br />
Babes 281 Bucharest Romania Dt W Notcutt uc pocential <strong>of</strong> cannabinoids Addict Biol 2000 5<br />
James Paget Hospital Norfolk UK Dc L Parker<br />
Beehive Surgery Bath UK Dc J Riley Royal<br />
Marsden Hospital Palliative Care Unit London the<br />
UK Dc A S Thomson Atherstone Surgery<br />
Atherstone UK Dc L Trotman Michael Sobell<br />
House Mount Vernon Hospital Northwood<br />
37 46<br />
10 Russo EB Guy GWAale <strong>of</strong> nvo cannabinoids<br />
herapeuuc rationale for combining tetrahydro<br />
annabinol and cannabinol Med Hypotheses 2006<br />
66 234 246<br />
11 Fride E Mechoulam R Pharmacological activity<br />
<strong>of</strong> the cannabinoid receptor agonist anandamide<br />
UK Dr L Vata District Hospital Dr Alexandru a brain consutuent Eur J Phannacol 1993231<br />
Simionescu Onmlogy Department Hune 313 314<br />
doara Romania Dc C Volovat Center <strong>of</strong> Medi<br />
12 Thomas A Baillie GL Phillips AM et aL Canna<br />
cal Oncology Lasi Romania Dc A Wijnberg bidiol displays unexpectedly high potency as an an<br />
Cornhill igeiY Birmingham UK and Dc A tagonist <strong>of</strong> CB 1 and CB 2 receptor agonists in<br />
Wilcock Hayward House HospiceNo Ungham vitro Br Phamiacol 2007 150 613 623<br />
<strong>City</strong> Hospi al Nottingham UK Finally the I3 Matfait Ahl Gallily R Sumariwatla PF e al The<br />
authors acknowledge V Lane Maclagan Health nonpsychoactive cannabis constituent cannabidiol<br />
care Ltd forherassistance in producing<br />
the fitst s an oral anti arthdtic therapeudc in murine colia<br />
gen inducedar hri is Proc Na t Acad Sci USA 2000<br />
draft <strong>of</strong> this manuscri t The authors are<br />
p grateful<br />
97 9561 9566<br />
to Peter Clark statis ician at GW PharmaLd for<br />
14 Hampson AJ Grimaldi M eUcetrod J Wink D<br />
actin as<br />
g<br />
statisucal ediror for this article<br />
Cannabidiol and delta9tetrahydrocannabinol<br />
are neuroprotectivean oxidants Proc Nad Acad<br />
Sci USA 1998 95 8268 8273<br />
CI riCCS<br />
L Glare P Choice <strong>of</strong> opioids<br />
and he WHO ladder lecular<br />
In Davis M Glare P Hardy J eds Opioids in ogues<br />
cancer<br />
pain Oxford UK Ozford University Press 2005<br />
221 234<br />
2 Sco ush Intercollegiate<br />
Guidelines Network 16<br />
Con rol <strong>of</strong> pain in patients<br />
with cancer A National<br />
tio<br />
cannabidiol<br />
Clinical Guideline Edinburgh Scodand SIGN 44<br />
15 Bisogno T Hanus L De Petrorellis L et al Mo<br />
targets for cannabidiol and its synthetic ana<br />
effect on vanilloid VRl receptors and on he<br />
cellular uptake and enrymatic hydrolysis <strong>of</strong> ananda<br />
mide Br Pharmacol 2001 134 845 852<br />
Carrier EJ Auchampach JA Hillard C Inhibi<br />
<strong>of</strong> an equilibrative nucleoside tansporter by<br />
a mechanism <strong>of</strong> cannabinoid immuno<br />
2000179<br />
suppression Proc Nad Acad Sci USA 2006 103<br />
7895 7900<br />
3 Cleeland CS Conin R Ha field AK et al Pain<br />
and its treatment in<br />
outpa ients<br />
with metastadc<br />
17 Pettwee RG Cannabinoid phartnacology he<br />
cam<br />
cec N Engl J<br />
Med 1994 330 592 596 TS 66 years Br J Pharmacol 2006 147 Suppl 1<br />
I63 171<br />
4 House <strong>of</strong> Lords Select Committee on Stience<br />
18 Pertwee RQ Cannabinoid receptors and pain<br />
and Technology<br />
Canrmbis Ihe scientific and<br />
pog Neurobiol 2001 63 569 611<br />
medical evidence 9th Report Session 1997 98<br />
London UK House <strong>of</strong> Lords 1998 Aailable 19 Campbell FA Tamer MR Carroll D et aL Are<br />
from<br />
htp www<br />
padiamencche stationery <strong>of</strong>fice cannabinoids an effecuve and safe treatment op ion<br />
co uk pa Idl fJ9798 ldselect Idsctech<br />
15101 in the management <strong>of</strong> pain A qualitauve systemic<br />
htm Accessed January 4 2008 review BMJ 2001 323 16<br />
5 GW Pharma Ltd Product monograph Sativez 20 Jochimsen PR Lawton RL VerSteeg K Noyes R<br />
Ottawa Canada Health Canada 2007 Available from Effect <strong>of</strong> benzopyranoperidine a delta 9 THC con<br />
http<br />
cpe001321164c6d<br />
cm0014e88ee7a4<br />
net gener on pain Clin Pharmacol Ther 197824<br />
cable rogers comdpdonline<br />
searchRequest<br />
do 223 Accessed March 4 2008<br />
21 Staque M Gan C Machin D Effec <strong>of</strong> a nivo<br />
6 Noyes R Brunk SF Baram DA et aL Malgesic gen analog <strong>of</strong> cevahydrocannabinol on cancer pain<br />
effect <strong>of</strong> delta9tetrahydrocannabinol J Clin Phar Clin Pharmacol Ther1978 234297 401<br />
macol 1975 15 139 143<br />
22 McCormack HM Horne DJ Sheather S Clini<br />
7 Noyes R Brunk SF Avery DA et aL The analge cal applicanons <strong>of</strong> visual analogue scales a critical<br />
sic properties <strong>of</strong> delta 9tevahydro cannabinol and review Psychol Med1988 18 1007 1019<br />
codeine Clin Pharmacol Ther 1975 18 84 89 23 Farrar T Young JPJr LaMoreaux L et al Clin<br />
8 Perlwee RG Pharmacology <strong>of</strong> cannabinoid CB ical importance <strong>of</strong> changes in chronic pain intensity<br />
and CB receptors Pharmawl Ther 1997 74 measured on an 11 poini numerical pain racing<br />
129 180 scale Pain 2001 94 149 158
Yol 39 No 2<br />
February 2010<br />
THC CBD for Tie lmenl <strong>of</strong> CancerRelated Paen 179<br />
24 Cleeland CS Ladinsky JL Serlin RC et al Mul 35 Wade DT Makela PM House H ec aI Long<br />
udimensional measuremen <strong>of</strong> cancer com<br />
pain term use <strong>of</strong> a canrmbis based medicine in the treat<br />
parisons <strong>of</strong> US and Viemamese patienrs J Pain ment <strong>of</strong> spas icity and other sympmms in muluple<br />
Symptom Manage 1988 323 27 sderosis Mult Scler 2006 12 639 645<br />
25 Aaronson NK Ahmedzai 5 Bergman B et aL 36 Bames MP Sativez clinical efficacy and tolera<br />
The for Research and Treat<br />
European Organisation bility in the treatment <strong>of</strong> symptoms <strong>of</strong> muldple scle<br />
ment <strong>of</strong> Cancer QLQ C30 a quality if life insvu rosis and neuropath c pain Expert Opin<br />
mem for use in intemational dinical trials in pharmato her 2006 7607 615<br />
oncology J<br />
Natl Cancer Inst 1993 85 365<br />
376 37 Nurmikko TJ Serpell MG Hoggart B et al Sa<br />
26 Rog DJ Nurmikko TJ Friede T et al Random<br />
ivex successfully treats neuropathic pain character<br />
ized controlled trial <strong>of</strong> cannabis bued medicine in<br />
ised by allodynia a randomised double blind<br />
central pain in multiple sclerosis Neurology 2005 Placebo tonV011ed clinical rial Pain 2007 133<br />
65 812 S19 210 220<br />
27 Berman JS Symonds C Birch R Efficacy <strong>of</strong> Iwo 38 Rog D Nurmikko TJ Young CA Oromucosal<br />
cannabis based medicinal extracts for relief <strong>of</strong> cem<br />
delta 9tetrahrdrocannabino<br />
cannabidiol for neu<br />
val neuropathic pain from brachial plexus awlsion ropathic pain associaced with multiple sclerosis an<br />
resulrs <strong>of</strong> a rdndomised controlled trial Pain 2004<br />
uncontrolled open label 2year excension trial<br />
112 299 306 Clin Ther2007 202068 2099<br />
28 Hochberg Y A shaiper Bonferroni procedure 39 Ripamonti C Dickerson ED Scrategies for the<br />
for multiple tests <strong>of</strong> significance<br />
Biomecrika 1988<br />
creatment <strong>of</strong> cancer pain in the new millennium<br />
75 800 802<br />
Drugs2001 61 955 977<br />
29 Conover 4Vf<br />
Inam RL Analysis <strong>of</strong> covariance 40 Russo E Guy G Robson P Cannabis pain and<br />
using the rank transforntaUOn Biometrics 1982 38<br />
sleep lessons from cherapeuuc dinical trials <strong>of</strong> Sac<br />
7i5 724<br />
ivex cannabis based medkine Chem Biodivers<br />
30 Hodges JL Jr Lehmann EL Estimates <strong>of</strong> loca 2007 41729 1743<br />
uon based on rank tescs Mn Math Staust 1963 34<br />
41 Cox ML Haller VI Welch SP Synergy between<br />
598 611<br />
delta9tevahydrocannabinol and morphine in the<br />
31 Johnson R Wright ST Cannabis based medi<br />
arthriuc rat Eur Pharmacol2007 12125 130<br />
cines on Che treatment <strong>of</strong> cancer pain a Iando<br />
mised double<br />
42 Per wee RG The diverse CBl and CB2 receptor<br />
blind parallel group placebo<br />
controlled comparative smdy <strong>of</strong> he efficiency pharmacology <strong>of</strong> three plant cannabinoids<br />
safety and colerability <strong>of</strong> Sativex and Tecrsnabinex D9<br />
tetrehydrocannabinol cannabidiol and D9 tetra<br />
in<br />
patients ivi h cancervrelated pain J Support<br />
hydrocannabivarin Br J Phartnacol 2008 153<br />
199 215<br />
Oncol 2005 3Suppl321<br />
32 Dworkin RH Turk DC Farrar JT et al Core 43 Twycross R Wilcock A Charlesworth S et al<br />
ou come measures for chronic pain<br />
dinical trials eds Palliative care formulary 2nd ed Oxford UK<br />
IMMPACT recommendations Pain 2005 113 919 Radcliffe Publishing 2002<br />
33 Collin C Davies P MuUboko I et al Rando 44 Fallon M Opioid switching and rota ion In<br />
mised controlled vial <strong>of</strong> cannabis based medicine Sykes N Fallon MC Patt RB eds Clinical pain man<br />
in spasuciry caused by muluple stlerosis Eur J Neu agemenr Cancer pain London UK Hodder Ar<br />
rol 2007 I4290 296 nold 2003 157 165<br />
34 Wade DT Makela P Zobson P e al Do canna 45 Hanks G Cherney N Fallon M Che manage<br />
bis based medicinal exvacts have general or specifit men <strong>of</strong> pain In Doyle D Hanks G Cherny N<br />
effects on<br />
symptoms in muluple sderosis A dou Calman K eds Oxford cextbook <strong>of</strong> palliative medi<br />
ble blind randomized placebocontrolled study cine 3rd ed Ozford UK Oxford Universiry Press<br />
on 160 patients Mult Scler 2004 10 18 2005
I<br />
i<br />
Treatment Research<br />
Trends and Statistics<br />
T Home Research Renort Series Marijuana Abuse<br />
I<br />
Research Report Series<br />
Marijuana Abuse<br />
How Does Marijuana Use Affect<br />
Your Brain and Body<br />
Effects on the Brain<br />
As THC enters the brain it causes the user to feel euphoric orhigh by<br />
acting<br />
on the brain sreard system which is made up <strong>of</strong> regions that<br />
govern the response to pleasurable things like sex and chocolate<br />
as well as<br />
I<br />
to most drugs <strong>of</strong> abuse THC activates the reward system in the same way<br />
that nearly all drugs <strong>of</strong> abuse do by stimuIating<br />
chemical dopamine<br />
brain cells to release the<br />
i<br />
ng with euphoria relaxation is another frequently reported effect in<br />
iman studies Other effects which vary dramatically among different<br />
users include heightened sensory perceptioneg brighter colors<br />
laughter altered perception <strong>of</strong> time and increased appetite After a while<br />
the euphoria subsides and the user may feel sleepy or depressed<br />
Occasionally marijuana use may produce anxiety fear distrust or panic<br />
i<br />
r i i<br />
i i r r<br />
Ii<br />
I<br />
j<br />
i<br />
I<br />
i<br />
i<br />
t<br />
t<br />
Marijuana use impairs a person<br />
ability to form new memories see<br />
Marijuana Memorv and the Hi ocampus and to shift focus THC also<br />
disrupts coordination and balance by binding to receptors in the cerebellum<br />
and basal ganglia parts <strong>of</strong> the brain that regulate balance posture<br />
coordination and reaction time Therefore learning doing complicated<br />
tasks participating in athletics and driving<br />
are also affected<br />
available<br />
Marijuana users who have taken large doses <strong>of</strong> the drug may experience an<br />
M<br />
This report is also<br />
for download<br />
Mariivana Abuse<br />
PDF format 41 M8j<br />
i<br />
i<br />
2
acute psychosis which includes hallucinations delusions and a loss <strong>of</strong> the<br />
NIDA<br />
Pnse <strong>of</strong> personal identity Although the specific causes <strong>of</strong> these symptoms<br />
nain unknown they appear to occur more frequently when a high dose <strong>of</strong><br />
cannabis is consumed in food or drink rather than smoked Such short term<br />
psychotic reactions to high concentrations <strong>of</strong> THC are distinct from longer<br />
lasting schizophrenia like disorders that have been associated with the use<br />
<strong>of</strong> cannabis in wlnerable individuals See Is There a Link Between<br />
Marijuana Use and Mental Illness<br />
DRUG<br />
7NIDA NIH<br />
Order this pubiication<br />
Our understanding <strong>of</strong> marijuana s long term brain effects is limited<br />
Research findings on how chronic cannabis use affects brain structure for<br />
example have been inconsistent It may be that the effects are too subtle for<br />
reliable detection by current techniques A similar challenge arises in<br />
studies <strong>of</strong> the effects <strong>of</strong> chronic marijuana use on brain function Although<br />
imaging studies functional MRI flVIRI in chronic users do show some<br />
consistent alterations the relation <strong>of</strong> these changes to cognitive functioning<br />
is less ctear This uncertainty may stem from confounding factors such as<br />
other drug use residual drug effects which can occur for at least 24 hours<br />
in chronic users or withdrawal symptoms inlong term chronic users<br />
rijuana Memary and the Hippo campus<br />
Memory impairment from marijuana use occurs because THC alters how<br />
information is processed in the hippocampus a brain area responsible for<br />
memory formation<br />
Distribution <strong>of</strong> cannabinoid receptors in the rat brain Brain image reveals<br />
highle els shown in orange and yellow <strong>of</strong> cannabinoid receptors in many<br />
areas including the cortex hippocampus cerebellum and nucleus<br />
mbens ventral striatum<br />
Most <strong>of</strong> theeidence supporting this assertion comes from animal studies<br />
3
i<br />
I<br />
i<br />
I<br />
I<br />
i<br />
For example rats exposed to THC in utero soon after birth or during<br />
2olescence show notable problems with specificlearning memory tasks<br />
r in life Moreover cognitive impairment in adult rats is associated with<br />
structural and functional changes in the hippocampus from THC exposure<br />
during adolescence<br />
As people age they lose neurons in the hippocampus which decreases their<br />
ability to learn new information Chronic THC eacposure may hasten age<br />
related loss <strong>of</strong> hippocampal neurons In one study rats exposed to THC<br />
every day for 8 months approximately 3o percent <strong>of</strong> theirlife span<br />
showed a level <strong>of</strong> nerve cell loss at ii to i2 months <strong>of</strong> age that equaled that<br />
<strong>of</strong> unexposed animals twice their age<br />
An enduring question in the field is whether individuals who quit<br />
marijuana even afterlong term heavy use can recover some <strong>of</strong> their<br />
cognitive abilities One study reports that the ability <strong>of</strong>long term heavy<br />
marijuana users to recall words from a list was still impaired i week after<br />
they quit using but returned to normal by 4 weeks However another study<br />
fouttd that marijuana s effects on the brain can build up and deteriorate<br />
cr tical life skills over time Such effects may be worse in those with other<br />
rtal disorders or simply by virtue <strong>of</strong> the normal aging process<br />
Effects on General Physical Health<br />
Within a few minutes after inhaling marijuana smoke an individual s heart<br />
rate speeds up the bronchial passages relax and become enlarged and<br />
blood vessels in the eyes expand making the eyes look red The heart rate<br />
normally o to 8o beats per minute may increase by 2o to 5o beats per<br />
minute or may even double in some cases Taking other drugs with<br />
marijuana can amplify this effect<br />
Limited evidence suggests that a person<br />
risk <strong>of</strong> heart attack during the<br />
first hour after smoking marijuana is four times his or her usual risk This<br />
observation could be partly explained by marijuana raising blood pressure<br />
in some cases and heart rate and reducing the blood s capacity to carry<br />
oarygen Such possibilities need to be examined more closely particularly<br />
since current marijuana users include adults from the baby boomer<br />
generation who may have other cardiovascular risks that may increase<br />
their wlnerability<br />
j<br />
i<br />
4
Consequences <strong>of</strong>Marijua Abuse<br />
qcute present during intoxicarion<br />
Impairs short term memory<br />
Impairs attention judgment and other cognitive functions<br />
Impairs coordination and balance<br />
Increases heart rate<br />
Psychotic episodes<br />
Persistent lasting langer than intoxication but may not be<br />
permanent<br />
Impairs memory and learning skills<br />
Sleep impairment<br />
Long term cumulative effects <strong>of</strong> chronic abuse<br />
Can ead to addiction<br />
Increases risk <strong>of</strong> chronic cough bronchitis<br />
Increases risk <strong>of</strong> schizophrenia in wlnerable individuals<br />
May increase risk <strong>of</strong> anxiety depression and amotivational<br />
syndrome<br />
These are <strong>of</strong>ten reportedco occurring symptoms disorders with<br />
chronic marijuana use However research has not yet determined<br />
whether marijuana is causal orjust associated with these mental<br />
problems<br />
The smoke <strong>of</strong> marijuana like that <strong>of</strong> tobacco consists <strong>of</strong> a toxicmi cture <strong>of</strong><br />
gases and particulates many <strong>of</strong> which are known to be harmful to the lungs<br />
Someone who smokes marijuana regularly may have many <strong>of</strong> the same<br />
respiratory problems that tobacco smokers do such as daily cough and<br />
phlegm production more frequent acute chest illnesses and a greater risk<br />
<strong>of</strong> lung infections Even infrequent marijuana use can cause burning and<br />
stinging <strong>of</strong> the mouth and throat <strong>of</strong>ten accompanied by a heavy cough One<br />
study found that extra sick days used by frequent marijuana smokers were<br />
<strong>of</strong>ten because <strong>of</strong> respiratory illnesses Polen et al i993<br />
1 addition marijuana has the potential to promote cancer <strong>of</strong> the lungs and<br />
other parts <strong>of</strong> the respiratory tract because it contains irritants and<br />
s
carcinogens up to o percent more than tobacco smoke It also induces<br />
hah levels <strong>of</strong> an enzyme that converts certain hydrocarbons into their<br />
er causing form which could accelerate the changes that ultimately<br />
produce malignant cells And since marijuana smokers generally inhale<br />
more deeply and hold their breath longer than tobacco smokers the lungs<br />
are exposed longer to carcinogenic smoke However while several lines <strong>of</strong><br />
evidence have suggested that marijuana use may lead to lung cancer the<br />
supporting evidence is inconclusive Hashibe et al 2006 The presence <strong>of</strong><br />
an unidentified active ingredient in cannabis smoke having protective<br />
properties if corroborated and properly characterized could help explain<br />
the inconsistencies and modest findings<br />
i r r<br />
i t i t<br />
l<br />
c j<br />
t 1<br />
r<br />
t t<br />
i t<br />
l 1<br />
I<br />
A significant body <strong>of</strong> research demonstrates negative effects <strong>of</strong> THC on the<br />
function <strong>of</strong> various immune cells both in vitro in cells and in vivo with test<br />
animals However no studies to date connect marijuana s suspected<br />
immune system suppression with greater incidence <strong>of</strong> infections or immune<br />
disorders in humans One short3week study found marijuana smoking<br />
to be associated with a few statistically significant negative effects on the<br />
immune function <strong>of</strong> AIDS patients a second small study <strong>of</strong> college students<br />
also suggested the possibility <strong>of</strong> marijuana having adverse effects on<br />
immune system functioning Thus the combined evidence from animal<br />
studies plus the limited human data available seem to warrant additional<br />
research on the impact <strong>of</strong> marijuana on the immune system See The<br />
Science <strong>of</strong> Medical Marijuana<br />
NIDA Home Site Man Search FAQs Accessibilitv Pn FOIA NIH Emplovment Archives<br />
6
ySk o s<br />
3<br />
F<br />
x a<br />
r t<br />
y<br />
t<br />
y<br />
s<br />
s ir rF y Y<br />
t<br />
1F<br />
h SYwr2t<br />
i<br />
Hi<br />
fU U<br />
G<br />
xy qKd<br />
Y<br />
S i i 1<br />
3<br />
a<br />
u<br />
E<br />
C<br />
4<br />
kk<br />
Z<br />
hl S I<br />
A W 1<br />
s af<br />
g<br />
a h<br />
s<br />
yse<br />
f<br />
ts<br />
r<br />
T<br />
a<br />
b d3g<br />
Y v<br />
i is 3 3 r<br />
4 q E3 at F x z<br />
e k w k<br />
r<br />
Ao S e 1<br />
I7b S n SP ai F<br />
a ri a C b r v<br />
y<br />
6s 2 2<br />
J<br />
i<br />
Y w<br />
a<br />
x<br />
u<br />
i<br />
Pk<br />
3<br />
3<br />
ei r 5 f 2 x<br />
ri x v3g<br />
3 k<br />
sP S f sv II a e a<br />
f<br />
Pr<br />
y V i<br />
rnT ACbg<br />
Z t<br />
B<br />
fix<br />
x<br />
p<br />
et<br />
w<br />
n<br />
i<br />
ti<br />
I a3<br />
f<br />
7tx<br />
4<br />
4t<br />
f<br />
Aq<br />
r wro<br />
3 d rr dv a 7t<br />
k e1<br />
Aas Y<br />
5 e<br />
sY s s 1 p o<br />
ui Z<br />
ksi S 1 t i<br />
R<br />
w<br />
ry<br />
9<br />
d<br />
rY xiy<br />
sG elzy 3<br />
t<br />
rt wi F<br />
t<br />
e<br />
i<br />
s<br />
a<br />
z<br />
p<br />
t<br />
Yx<br />
4<br />
Y r<br />
i<br />
QY<br />
x<br />
t<br />
i<br />
4 l<br />
r<br />
3<br />
t S<br />
a r<br />
3ro<br />
a<br />
a<br />
G<br />
i<br />
i<br />
4<br />
n i<br />
e<br />
r t<br />
I<br />
r<br />
i<br />
i<br />
e<br />
a wv x s<br />
P f b t<br />
Rt1I SE<br />
a a<br />
a<br />
b<br />
Xa<br />
waSi x<br />
ik5<br />
x a 4 S S<br />
n y 4t S<br />
s<br />
f<br />
3s 3<br />
Qy oy s<br />
t<br />
c<br />
u<br />
x r<br />
q ffi y<br />
Er x<br />
ab<br />
kY 5 k<br />
x<br />
ta si Spy 7 3<br />
k uw<br />
t P<br />
o<br />
r<br />
2<br />
F xv Sr K Ye<br />
u<br />
x<br />
r<br />
axwr<br />
y xi 3d x<br />
vrt<br />
i<br />
m<br />
x<br />
xg F<br />
ck<br />
y<br />
F<br />
T z<br />
3sx<br />
y<br />
y a smu<br />
3f f<br />
4<br />
riwrsx r d<br />
r<br />
t<br />
L<br />
t<br />
f<br />
e<br />
a x<br />
sfe J r<br />
g<br />
tv C y 8<br />
xz 4 5<br />
a<br />
i<br />
s<br />
k<br />
rs<br />
A<br />
vG<br />
a<br />
xxis 3 c<br />
rb<br />
L<br />
L<br />
kb<br />
Z<br />
5<br />
y 1<br />
latj4<br />
l<br />
it z apxyT4y<br />
F<br />
Y<br />
n<br />
y<br />
i<br />
1E<br />
I<br />
D<br />
W<br />
y<br />
0<br />
1 t F<br />
4yst<br />
k<br />
rui<br />
p A<br />
tt 1 ik I E wa tx fY<br />
i<br />
W<br />
R<br />
r<br />
ti<br />
ar A<br />
i 2<br />
1rn F<br />
F3 1 v<br />
rsmtt ey h f<br />
k<br />
m c s<br />
29<br />
fr<br />
g<br />
q f<br />
pra r<br />
x<br />
rSy<br />
x<br />
ai<br />
a<br />
r
e<br />
gffi<br />
aCr C<br />
4<br />
4r<br />
mt<br />
Fkb r w<br />
r i i<br />
i<br />
i<br />
i<br />
b<br />
r<br />
R<br />
i AL<br />
The oniy way to prevent youriid<br />
dru s s to be opentlht<br />
tm wrn them be awa e cif every<br />
thggoo in your child s life<br />
a k<br />
There s a<br />
dialt oing on If there<br />
is experi atati Tm going to<br />
sn<br />
t<br />
7<br />
E<br />
k<br />
i<br />
t<br />
qt Qatt<br />
a 8<br />
a<br />
at<br />
e<br />
s<br />
k<br />
x<br />
S<br />
m<br />
at<br />
i t sW v<br />
ivf i15 1 x Q<br />
s<br />
ye<br />
c<br />
g<br />
4 5p<br />
x<br />
dw<br />
uYb mg a<br />
gg<br />
p HI fra<br />
t<br />
w r a<br />
i<br />
g e P au e4<br />
J liy L x K<br />
B<br />
f1<br />
M<br />
i ff<br />
n<br />
y<br />
v5 pr<br />
hzm4<br />
a<br />
jf Y<br />
gt4ea<br />
a<br />
e<br />
bn8 Y n a<br />
tj<br />
if YJ l l 3<br />
4<br />
S<br />
ki W tA Y e k<br />
aYx
A Letterto Parents<br />
Marijuana is the illegal drug most <strong>of</strong>ten used in this country<br />
Since 1991 lifetime marijuana use has almost doubled among<br />
8th and lOth grade students and increased by a third among<br />
high school seniors Our research shows that accompanying this<br />
upward pattern <strong>of</strong> use is a significant erosion in antidrug percep<br />
tions and knowledge among young people today As the number<br />
<strong>of</strong> young people who use marijuana has increased the number<br />
who view the drug as harmful has decreased Among high<br />
school seniors surveyed in 2001 current marijuana use has<br />
increased by about 62 percent since 1991 The proportion <strong>of</strong><br />
those seniors who believe regular use <strong>of</strong> marijuana is harmful<br />
has dropped by about 27 percent since 1991<br />
These changes in perception and knowledge may be due to<br />
a decrease in antidrug messages in the media an increase in pro<br />
drug messages through the pop culture and a lack <strong>of</strong> awareness<br />
among parents about this resurgence in druguse most thinking<br />
perhaps that this threat to their children had diminished<br />
Because many parents <strong>of</strong> this generation <strong>of</strong> teenagers used<br />
marijuana when they were in college they <strong>of</strong>ten find it difficult<br />
to talk about marijuana use with their children and to set strict<br />
ground rules against drug use But marijuana use today starts at<br />
a youngerage and more potent forms <strong>of</strong> the drug are available<br />
to these young children Parents need to recognize that marijuana<br />
use is a serious threat and they need to tell their children not<br />
a<br />
to use it<br />
a<br />
W<br />
1
o<br />
ti<br />
0<br />
v0G<br />
en<br />
4<br />
w<br />
d<br />
e<br />
We at the National Institute on Drug Abuse NIDA are<br />
pleased to <strong>of</strong>fer these two short booklets Marijuana Facts for<br />
Teens and Marijuana Facts Parents Need to Know far parents<br />
and their children to review the scientific facts about marijuana<br />
While it is best to talk about drugs when children are young it<br />
is never too late to talk about the dangers <strong>of</strong> drug use<br />
Talking to our children bout drug abuse is not always<br />
easy but it is very important I hope these booklets can help<br />
f14<br />
ffy<br />
Glen R Hanson Ph DDS<br />
Acting Director<br />
National Institute on<br />
Drug Abuse<br />
1
Contents<br />
1 A Letter to Parents<br />
5<br />
What is marijuana<br />
6<br />
What are the current slang terms for marijuana<br />
7<br />
How is marijuana used<br />
7 How many people smoke marijuana<br />
8<br />
How can I tell if my child has been using marijuana<br />
10 Why do young people use marijuana<br />
11<br />
Does using marijuana lead to other drugs<br />
12 What are the effects <strong>of</strong> marijuana<br />
13 What happens after a person smokes marijuana<br />
13 How long does marijuana stay in the user<br />
body<br />
13 Can a user have a bad reaction<br />
14<br />
How is marijuana harmful<br />
14 How does marijuana affect driving<br />
16 What are the long term effects <strong>of</strong> marijuana<br />
19 What about pregnancy<br />
19<br />
What happens if a nursing mother uses marijuana<br />
21<br />
How does marijuana affect the brain<br />
22 Can the drug cause mental illness<br />
22<br />
Do marijuana users lose their motivation<br />
22<br />
Can a person become addicted to marijuana<br />
0<br />
Z4 Are there treatments to help marijuana users<br />
25 Can marijuana be used as medicine G<br />
z<br />
Z6 How can I prevent my child from getting<br />
involved wi marijuana<br />
a<br />
Z7 Talking to your children about marijuana W<br />
Z8<br />
Resources<br />
3 c
I<br />
r<br />
k<br />
t<br />
f<br />
K<br />
r<br />
er<br />
F<br />
dl<br />
a<br />
4<br />
t1<br />
y<br />
i<br />
i i<br />
r<br />
StrO<br />
4<br />
r<br />
II I Ili<br />
r<br />
means ro ffe<br />
t<br />
1<br />
1
QWhat is marijuana Are there different hinds<br />
AMarijuana is a green brown or gray mixture <strong>of</strong> dried<br />
shredded leaves stems seeds and flowers <strong>of</strong> the hemp plant<br />
Cannabis sativa Before the 1960s many Americans had never<br />
heard <strong>of</strong> marijuana but today it is the most <strong>of</strong>ten used illegal<br />
drug in this country<br />
Cannabis is a term that refers to marijuana and other drugs<br />
made from the same plant Strong forms <strong>of</strong> cannabis include sinse<br />
millasin seh me yah hashish hash for short and hash oil<br />
All forms <strong>of</strong> cannabis aremind altering psychoactive drugs<br />
they all contain THCdelta 9tetrahydrocannabinol the main<br />
active chemical in marijuana They also contain more than 400<br />
other chemicals<br />
Marijuana s effect on the user depends on the strength or<br />
potency <strong>of</strong> the THC it contains THC potency has increased since<br />
the 1970s and continues to increase still The strength <strong>of</strong> the drug<br />
is measured by the average amount <strong>of</strong> THC in test samples con<br />
fiscated by law enforcement agencies For the year 2001<br />
Most ordinary marijuana contained on average<br />
5 percent THC<br />
Sinsemilla made from just the buds and flowering tops <strong>of</strong><br />
female plants contained on average 9 percent THC with<br />
a range as high as 25 percent<br />
0<br />
n<br />
x<br />
0<br />
I<br />
x<br />
x y<br />
L<br />
3<br />
G<br />
3
I<br />
i<br />
o<br />
6<br />
a<br />
z<br />
b<br />
W<br />
r<br />
c<br />
IY<br />
r<br />
f<br />
a<br />
L<br />
r<br />
Hashish the sticky resin from the female plant s flowers<br />
had an average <strong>of</strong> 9 percent THC with a range as high<br />
as 19 percent<br />
Hash oil a tar like liquid distilled from hashish had an<br />
average <strong>of</strong> 19 percent THC with a range as high as<br />
27 percent<br />
QWhat are the current slang terms for marijuana<br />
AThere are many different names for marijuana Slang terms<br />
for drugs change quickly and they vary from one part <strong>of</strong> the<br />
country to another They may even differ across sections <strong>of</strong> a<br />
large city<br />
Terms from years ago such as pot herb grass weed Mary<br />
Jane and reefer are still used You might also hear the names<br />
Aunt Mary skunk boom gangster kif or ganja<br />
There are also street names for different strains or brands<br />
<strong>of</strong> marijuana such as Texas tea Maui wowie and Chronic<br />
A recent book <strong>of</strong> American slang lists more than 200 terms for<br />
various kinds <strong>of</strong> marijuana
QHow is fnarijuana used<br />
AMost users roll loose marijuana into a cigarette called a<br />
joint or a nail or smoke it in a pipe Onewell known type <strong>of</strong><br />
water pipe is the bong Some users mix marijuana into foods<br />
or use it to brew a tea Another method is to slice open a cigar<br />
and replace the tobacco with marijuana making what s called<br />
a blunt When the blunt is smoked with a 40 oz bottle <strong>of</strong> malt<br />
liquor it is calledaB40<br />
Lately marijuana cigarettes or blunts <strong>of</strong>ten include crack<br />
cocaine a combination known by various street names such as<br />
primos or woolies Joints and blunts <strong>of</strong>ten are dipped in PCP<br />
and are called happy sticks wicky sticks love boat or tical<br />
QHow many people smohe inarijuana At what<br />
age do children generally start<br />
A recent government survey tells us<br />
Marijuana is the most frequently used illegal drug in the<br />
United States Over 83 million Americans over the age<br />
<strong>of</strong> 12 have tried marijuana at least once<br />
Over 12 million had used the drug in the month before<br />
the survey<br />
s<br />
rt<br />
0<br />
s<br />
0<br />
z<br />
a<br />
7
C<br />
JV<br />
c<br />
z<br />
a<br />
CJV6W6<br />
63<br />
6<br />
The Monitoring the Future Survey which is conducted<br />
yearly includes students from 8th lOth and 12th grades<br />
In 2001 the survey showed that 20 percent <strong>of</strong>8th graders have<br />
tried marijuana at least once and by lOth grade 20 percent are<br />
current users that is used within the past month Among<br />
12th graders nearly 50 percent have tried marijuana hash at<br />
least once and about 22 percent were current users<br />
Other researchers have found that use <strong>of</strong> marijuana and<br />
other drugs usually peaks in the late teens and early twenties<br />
then declines in later years<br />
QHow can I tell if my child has been using<br />
marijuana<br />
AThere are some signs you might be able to see If someone is<br />
high on marijuana he or she might<br />
seem dizzy and have trouble walking<br />
seem silly and giggly for no reason<br />
have very red bloodshot eyes and<br />
have a hard time remembering things that just happened<br />
When the early effects fade the user can become very sleepy<br />
Parents should be aware <strong>of</strong> changes in their child s behavior<br />
although this may be difficult with teenagers Parents should<br />
look for withdrawal depression fatigue carelessness with<br />
grooming hostility and deteriorating relationships with family
aQ<br />
j<br />
Fa ea 4<br />
t<br />
z<br />
n<br />
WS<br />
tht nearl 50 ercent <strong>of</strong><br />
r y P<br />
a<br />
teenagers try mari j uana<br />
before they graduate<br />
5<br />
tr i<br />
g h school
x<br />
0<br />
10<br />
z<br />
a<br />
ti<br />
3<br />
members and friends In addition changes in academic perfor<br />
mance increased absenteeism or truancy lost interest in sports or<br />
other favorite activities and changes in eating or sleeping habits<br />
could be related to drug use However these signs may also indi<br />
cate problems other than use <strong>of</strong> drugs<br />
In addition parents should beavare <strong>of</strong><br />
signs <strong>of</strong> drugs and drug paraphernalia including pipes<br />
and rolling papers<br />
odor on clothes and in the bedroom<br />
use <strong>of</strong> incense and other deodorizers<br />
use <strong>of</strong> eye drops and<br />
clothing posters jewelry etc promoting drug use<br />
QWhy do young people usetia lijuaiia<br />
AChildren and young teens start using marijuana for many rea<br />
sons Curiosity and the desire to fit into a social group are common<br />
reasons Certainly youngsters who have already begun to smoke<br />
cigarettes and or use alcohol are at increased risk for marijuana use<br />
Also our research suggests that the use <strong>of</strong> alcohol and drugs<br />
by other family members plays a strong role in whether children<br />
start using drugs Parents grandparents and older brothers and<br />
sisters in the home are models for children to follow
Some young people who take drugs do not get along with<br />
their parents Some have a network <strong>of</strong> friends who use drugs<br />
and urge them to do the same peer pressure All aspects <strong>of</strong> a<br />
child s environment home school neighborhood help to<br />
determine whether the child will try drugs<br />
Children who become more heavily involved with marijuana<br />
can become dependent making it difficult for them to quit<br />
Others mention psychological coping as a reason for their use<br />
to deal withar iety anger depression boredom and so farth<br />
But marijuana use is not an effective method for coping with<br />
life s problems and staying high can be a way <strong>of</strong> simply not deal<br />
ing with the problems and challenges <strong>of</strong> growing up<br />
Researchers have found that children and teens both male<br />
and female who are physically and sexually abused are at greater<br />
risk than other young people <strong>of</strong> using marijuana and other drugs<br />
and <strong>of</strong> beginning drug use at an early age<br />
QDoes using marijuana lead to other drugs<br />
ALong term studies <strong>of</strong> high school students and their patterns<br />
<strong>of</strong> drug use show that very few young people use other drugs<br />
without first trying marijuana alcohol or tobacco Though few<br />
young people use cocaine for example the risk <strong>of</strong> doing so is<br />
much greater for youth who have tried marijuana than for those<br />
who have never tried it While research has not fully explained<br />
this association growing evidence suggests a combination <strong>of</strong> bio<br />
logical social and psychological factors are involved<br />
30cv<br />
0<br />
v<br />
4 Z<br />
a<br />
11
0<br />
12<br />
z<br />
C<br />
a<br />
d<br />
a<br />
C6G<br />
i<br />
Researchers are examining the possibility that long term<br />
marijuana use may create changes in the brain that make a<br />
person more at risk <strong>of</strong> becoming addicted to other drugs such<br />
as alcohol or cocaine While many young people who use<br />
marijuana do not go on to use other drugs further research is<br />
needed to determine who will be at greatest risk<br />
QWhat are the effects <strong>of</strong> marijuana<br />
AThe effects <strong>of</strong> marijuana on each person depend on the<br />
type <strong>of</strong> cannabis and how much THC it contains<br />
way the drug is taken by smoking or eating<br />
experience and expectations <strong>of</strong> the user<br />
setting where the drug is used and<br />
whether drinking or other drug use is also going on<br />
Some people feel nothing at all when they first try<br />
marijuana Others may feel high intoxicated and or euphoric<br />
It is common for marijuana users to become engrossed with<br />
ordinary sights sounds or tastes and trivial events may seem<br />
extremely interesting or funny Time seems to pass very slowly<br />
so minutes feel like hours Sometimes the drug causes users to<br />
feel thirsty and very hungry an effect called the munchies
QWhat happeris after a person smohes riarijuana<br />
AWithin a few minutes <strong>of</strong> inhaling marijuana smoke the<br />
user will likely feel along with intoxication a dry mouth rapid<br />
heartbeat some loss <strong>of</strong> coordination and poor sense <strong>of</strong> balance<br />
and slower reaction time Blood vessels in the eye expand so the<br />
user<br />
eyes look red<br />
For some people marijuana raises blood pressure slightly<br />
and can double the normal heart rate This effect can be greater<br />
when other drugs are mixed with marijuana but users do not<br />
always know when that happens<br />
As the immediate effects fade usually after 2 to 3 hours<br />
the user may become sleepy<br />
QHow long does marijuana stay in the user<br />
body<br />
ATHC in marijuana is readily absorbed by fatry tissues in vari<br />
ous organs Generally traces metabolites <strong>of</strong> THC can be detected<br />
by standard urine testing methods several days after a smoking<br />
session However in heavy chronic users traces can sometimes<br />
be detected for weeks after they have stopped using marijuana<br />
QCan a user have a bad reaction<br />
AYes Some users especially someone new to the drug or in<br />
a strange setting may suffer acute arixiety and have paranoid<br />
thoughts This is mare likely to happen with high doses <strong>of</strong> THC<br />
These scary feelings will fade as the drug s effects wear <strong>of</strong>f<br />
In rare cases a user who has taken a very high dose <strong>of</strong> the<br />
0<br />
drug can have severe psychotic symptoms and need emergency<br />
z<br />
medical treatment<br />
Other kinds <strong>of</strong> bad reactions can occur when marijuana<br />
is mixed with other drugs<br />
such as PCP or cocaine<br />
W<br />
v<br />
a<br />
13<br />
3
S<br />
Pa<br />
0<br />
b<br />
z<br />
14<br />
Q<br />
a<br />
w<br />
a<br />
QHow is marijuana harmful<br />
AMarijuana can be harmful in a number <strong>of</strong> ways through both<br />
immediate effects and damage to health over time<br />
Marijuana hinders the user<br />
short term memory memory for<br />
recent events and he or she may have trouble handling complex<br />
tasks With the use <strong>of</strong> more potent varieties <strong>of</strong> marijuana even<br />
simple tasks can be difficult<br />
Because <strong>of</strong> the drug s effects on perceptions and reaction time<br />
users could be involved in auto crashes Drug users also may<br />
become involved in risky sexual behaviars which could lead to<br />
the spread <strong>of</strong> HN the virus that causes AIDS<br />
Under the influence <strong>of</strong> marijuana students may find it hard<br />
to study and learn Young athletes could find their performance<br />
is <strong>of</strong>f timing movements and coordination are all affected<br />
by THC<br />
Some <strong>of</strong> the more long range effects <strong>of</strong> marijuana use are<br />
described later in this boohlet<br />
QHow does mariJuana affect driving<br />
AMarijuana affects many skills required for safe driving alert<br />
ness the ability to concentrate coordination and reaction time<br />
Marijuana use can make it difficult to judge distances and react<br />
to<br />
signals and sounds on the road
Fact Marijuana has<br />
f<br />
o<br />
dverse effe<br />
r<br />
s1<br />
cts on many<br />
f<br />
is r drivin<br />
j<br />
g<br />
5<br />
F<br />
Y<br />
ti<br />
y<br />
j<br />
F in<br />
g<br />
g<br />
w i le hi h<br />
r adocar jcier ts<br />
t<br />
r 1<br />
tc<br />
c<br />
1<br />
I
0<br />
16<br />
z<br />
Q<br />
a<br />
Q<br />
Q<br />
a<br />
cL<br />
There are data showing that marijuana can play a role in<br />
crashes When users combine marijuana with alcohol as they<br />
<strong>of</strong>ten do the hazards <strong>of</strong> driving can be more severe than with<br />
either drug alone<br />
A study <strong>of</strong> patients in a shock trauma unit who had been<br />
in traffic accidents revealed that 15 percent <strong>of</strong> those who had<br />
been driving a car or motorcycle had been smoking marijuana<br />
and another 17 percent had both THC and alcohol in their blood<br />
In one study conducted in Memphis TN researchers found<br />
that <strong>of</strong> 150 reckless drivers who were tested for drugs at the<br />
arrest scene 33 percent tested positive for marijuana and 12<br />
percent tested positive for both marijuana and cocaine Data also<br />
show that while smoking marijuana people show the same lack<br />
<strong>of</strong> coordination on standard drunk driver tests as do people<br />
who have had too much to drink<br />
QWhat are the long tenn effects <strong>of</strong> marijuana<br />
AWhile all <strong>of</strong> the long term effects <strong>of</strong> marijuana use are not<br />
yet known there are studies showing serious health concerns<br />
For example a group <strong>of</strong> scientists in California examined the<br />
health status <strong>of</strong> 450 daily smokers <strong>of</strong> marijuana but not tobacco<br />
They found that the marijuana smokers had more sick days and<br />
more doctor visits for respiratory problems and other rypes <strong>of</strong><br />
illness than did a similar group who did not smoke either substance<br />
Findings so far show that the regular use <strong>of</strong> marijuana or<br />
THC may play a role in cancer and problems in the respiratory<br />
and immune systems
Cancer<br />
It is hard to find out whether marijuana alone causes cancer<br />
because many people who smoke marijuana also smoke cigarettes<br />
and use other drugs Marijuana smoke contains some <strong>of</strong> the same<br />
cancer causing compounds as tobacco sometimes in higher con<br />
centrations Studies show that someone who smokes five joints<br />
per day may be taking in as many cancer causing chemicals as<br />
someone who smokes a full pack <strong>of</strong> cigarettes every day<br />
Tobacco smoke and marijuana smoke may work together to<br />
change the tissues lining the respiratory tract Marijuana smoking<br />
could contribute to early development <strong>of</strong> head and neck cancer<br />
in some people<br />
Immune system<br />
Our immune system protects the body from many agents that<br />
cause disease It is not certain whether marijuana damages the<br />
immune system <strong>of</strong> people But both animal and human studies<br />
have shown that marijuana impairs the ability <strong>of</strong>Tcells in the<br />
lungs immune defense system to fight <strong>of</strong>f some infections<br />
Lungs and airways<br />
People who smoke marijuana regularly may develop many<br />
<strong>of</strong> the same breathing problems that tobacco smokers have<br />
such as daily cough and phlegm production more frequent<br />
chest colds a heightened risk <strong>of</strong> lung infections and a greater<br />
tendency toward obstructed airways Cancer <strong>of</strong> the respiratory<br />
tract and lungs may also be promoted by marijuana smoke<br />
since it contains irritants and carcinogens Marijuana smokers<br />
usually inhale more deeply and hold their breath longer which<br />
increases the lungs exposure to carcinogenic smoke Thus puff<br />
for puff smoking marijuana may increase the risk <strong>of</strong> cancer<br />
more than smoking tobacco does<br />
z<br />
1 6<br />
i<br />
a<br />
1 L
I<br />
i<br />
I I 1<br />
I<br />
S<br />
r<br />
b<br />
I<br />
I<br />
a<br />
s<br />
c<br />
1<br />
r<br />
z<br />
i<br />
6<br />
4<br />
k<br />
Y<br />
s<br />
a<br />
W awSii 3<br />
k<br />
vc<br />
b<br />
h<br />
er<br />
u N<br />
tC a<br />
g<br />
z<br />
i<br />
b<br />
4I L ESY<br />
t<br />
r<br />
N Yx<br />
v<br />
y yu k e<br />
3 o<br />
i<br />
a<br />
Y<br />
y<br />
G<br />
4Ki<br />
s<br />
Y<br />
ry<br />
fi A I<br />
f G d 4<br />
o iflll<br />
aspxss<br />
w<br />
vi i<br />
y 1 Y 0<br />
CR
Q What about pregtiancy Will smohirig marijuana<br />
hurt the baby<br />
ADoctors advise pregnant women not to use any drugs because<br />
they might harm the growing fetus One animal study has<br />
linked marijuana use to loss <strong>of</strong> the fetus very early in pregnancy<br />
Some scientific studies have found that babies born to<br />
women who used marijuana during their pregnancy display<br />
altered responses to visual stimulation increased tremors and<br />
a high pitched cry which may indicate problems with nervous<br />
system development During pre and early school years<br />
marijuana exposed children have been reparted to have more<br />
behavioral problems and difficulties with sustained attention<br />
and memory than nonexposed children<br />
Researchers are not certain whether any effects <strong>of</strong> marijuana<br />
during pregnancy persist as the child grows up however<br />
because some parts <strong>of</strong> the brain continue to develop into<br />
adolescence it is also possible that certain kinds <strong>of</strong> problems<br />
will become more evident as the child matures<br />
QWhat happens if a nursing mother uses marijuana<br />
A When a nursing mother uses marijuana some <strong>of</strong> the THC<br />
is passed to the baby in her breast milk This is a matter for<br />
concern since the THC in the mother s milk is much more con<br />
centrated than that in the mother s blood One study has shown<br />
that the use <strong>of</strong> marijuana by a mother during the first month <strong>of</strong><br />
o<br />
breastfeeding can impair the infant s motor development control<br />
<strong>of</strong> muscle movement<br />
Y<br />
z<br />
19
I<br />
i<br />
1<br />
b<br />
a<br />
xr<br />
f p<br />
a 9 1 F f<br />
s<br />
G<br />
r<br />
x<br />
i<br />
C<br />
e<br />
s e 1<br />
St<br />
rs<br />
w<br />
r<br />
r<br />
T<br />
y e<br />
6<br />
p<br />
F ral ro<br />
Pg<br />
r<br />
y<br />
7 r k s<br />
k<br />
u ii<br />
E g t3ti 3 sy c<br />
tHh d a r S 7 v<br />
I<br />
t g tu y<br />
pgtkyzrt<br />
s<br />
G 5<br />
y<br />
P<br />
x<br />
k<br />
r<br />
I<br />
j S<br />
y I i<br />
p<br />
i<br />
ktF<br />
z<br />
4 dr<br />
e c i m e i C<br />
2 T wyay It Yi<br />
t4 V<br />
SmwrI<br />
S<br />
y<br />
Y w S w I<br />
ym<br />
i<br />
r<br />
ay<br />
i
QHow does niarijuana affect the rain<br />
ATHC affects the nerve cells in the part <strong>of</strong> the brain where<br />
memories are formed This makes it hard for the user to recall<br />
recent events such as what happened a few minutes ago It<br />
is hard to learn while high a working short term memory is<br />
required for learning and performing tasks that call for more<br />
than one or two steps<br />
Among a group <strong>of</strong>long time heavy marijuana users in Costa<br />
Rica researchers found that the people had great trouble when<br />
asked to recall a short list <strong>of</strong> words a standard test <strong>of</strong> inemory<br />
People in that study group also found it very hard to focus their<br />
attention on the tests given to them<br />
As people age they narmally lose nerve cells in a region <strong>of</strong><br />
the brain that is important for remembering events Chronic<br />
exposure to THC may hasten the age related loss <strong>of</strong> these nerve<br />
cells In one study researchers found that rats exposed to<br />
THC every day for 8 months about 13 <strong>of</strong> their lifespan<br />
showed a loss <strong>of</strong> brain cells comparable to rats that were twice<br />
their age It is not known whether a similar effect occurs in<br />
humans Researchers are still learning about the many ways that<br />
marijuana could affect the brain<br />
30cY0<br />
u<br />
z<br />
21<br />
n
y 22<br />
z<br />
aa<br />
tV a<br />
ci ca<br />
ac<br />
a<br />
QCan the drug cause mental illness<br />
AScientists do not yet know how the use <strong>of</strong> marijuana relates<br />
to mental illness Among the difficulties in this kind <strong>of</strong> research<br />
are determining whether drug use precedes or follows mental<br />
health problems whether one causes the other and or whether<br />
both are due to other factors such as genetics or environmental<br />
conditions High doses <strong>of</strong> marijuana can induce psychosis<br />
disturbed perceptions and thoughts and marijuana use can<br />
worsen psychotic symptoms in people who have schizophrenia<br />
There is also evidence <strong>of</strong> increased rates <strong>of</strong> depression ar iety<br />
and suicidal thinking in chronic marijuana users However<br />
it is not yet clear whether marijuana is being used in an attempt<br />
toself medicate an already present but otherwise untreated<br />
mental health problem or whether marijuana use leads to men<br />
tal disorders or both<br />
QDo marijuana users lose their rnotivation<br />
ASome frequent long term marijuana users show signs <strong>of</strong><br />
a lack <strong>of</strong> motivation amotivational syndrome Their problems<br />
include not caring about what happens in their lives no desire to<br />
work regularly fatigue and a lack <strong>of</strong> concem about how they look<br />
As a result <strong>of</strong> these symptoms some users tend to perform poorly<br />
in school or at work Scientists are still studying these problems
QCan a person become addicted to marijuana<br />
AYes While not everyone who uses marijuana becomes<br />
addicted when a user begins to seek out and take the drug<br />
compulsively that person is said to be dependent on the drug<br />
or addicted to it In 1999 over 220 000 people entering drug<br />
treatment programs reported marijuana as their primary drug<br />
<strong>of</strong> abuse showing they needed help to stop using<br />
Some heavy users <strong>of</strong> marijuana show signs <strong>of</strong> dependence<br />
because when they do not use the drug they develop withdrawal<br />
symptoms Some subjects in an experiment on marijuana with<br />
drawal had symptoms such as restlessness loss <strong>of</strong> appetite trouble<br />
sleeping weight loss and shaky hands<br />
According to one study marijuana use by teenagers who have<br />
prior serious antisocial problems can quickly lead to dependence<br />
on the drug That study also found that for troubled teenagers<br />
using tobacco alcohol and marijuana progression from their<br />
first use <strong>of</strong> marijuana to regular use was about as rapid as their<br />
progression to regular tobacco use and more rapid than the<br />
progression to regular use <strong>of</strong> alcohol<br />
30c<br />
c<br />
z<br />
a<br />
t<br />
I<br />
23
24<br />
0<br />
z<br />
W<br />
a<br />
QWliat is tolerance for marijuana<br />
ATolerance means that the user needs increasingly larger<br />
doses <strong>of</strong> the drug to get the same desired results that he or she<br />
previously got from smaller amounts Some frequent heavy<br />
users <strong>of</strong> marijuana may develop tolerance for it<br />
QAre there treatments to heip marijuana users<br />
AUp until a few years ago it was hard to find treatment pro<br />
grams specifically for marijuana users Treatments for marijuana<br />
dependence were much the same as therapies for other drug abuse<br />
problems These include behaviaral therapies such as cognitive<br />
behavioral therapy multisystemic therapy individual and group<br />
counseling and regular attendance at meetings <strong>of</strong> support<br />
groups such as Narcotics Anonymous<br />
Recently researchers have been testing different ways to<br />
attract marijuana users to treatment and help them abstain from<br />
drug use There are currently no medications for treating<br />
marijuana dependence Treatment programs focus on counseling<br />
and group support systems From these studies drug treatment<br />
pr<strong>of</strong>essionals are learning what characteristics <strong>of</strong> users are predic<br />
tors <strong>of</strong> success in treatment and which approaches to treatment<br />
can be most helpful<br />
Further progress in treatment to help marijuana users includes<br />
a number <strong>of</strong> programs set up to help adolescents in particular
Some <strong>of</strong> these programs are in university research centers where<br />
most <strong>of</strong> the young clients report marijuana as their drug <strong>of</strong> choice<br />
Others are in independent adolescent treatment facilities Family<br />
physicians are also a good source for information and help in<br />
dealing with adolescents marijuana problems<br />
QCan marijuana be used as medicine<br />
AThere has been much debate in the media about the possible<br />
medical use <strong>of</strong> marijuana Under US law since 1970 marijuana<br />
has been a Schedule I controlled substance This means that the<br />
drug at least in its smoked form has no commonly accepted<br />
medical use<br />
In considering possible medical uses <strong>of</strong> marijuana it is<br />
important to distinguish between whole marijuana and pure<br />
THC or other specific chemicals derived from cannabis Whole<br />
marijuana contains hundreds <strong>of</strong> chemicals some <strong>of</strong> which may<br />
be harmful to health<br />
THC manufactured into a pill that is taken by mouth not<br />
smoked can be used for treating the nausea and vomiting that<br />
go along with certain cancer treatments and is available by<br />
presctiption Another chemical related to THC nabilone has<br />
also been approved by the Food and Drug Administration for<br />
treating cancer patients who suffer nausea The oral THC is also<br />
used to help AIDS patients eat more to keep up their weight<br />
Scientists are studying whether marijuana THC and related<br />
chemicals in marijuana called cannabinoids may have other<br />
medical uses According to scientists more research needs to be<br />
done on marijuana s side effects and potential benefits before it<br />
can be recommended for medical use<br />
o<br />
z<br />
25<br />
c3
i<br />
I<br />
26<br />
0<br />
z<br />
w<br />
a<br />
a<br />
QHow can I prevefit my child from getting involved<br />
with marijuana<br />
AThere is no magic bullet for preventing teenage drug use<br />
But parents can be influential by talking to their children about<br />
the dangers <strong>of</strong> using marijuana and other drugs and remain<br />
actively engaged in their children s lives Even after teenage chil<br />
dren enter high school parents can stay involved in schoolwork<br />
recreation and social activities with their children s friends<br />
Research shows that appropriate parental monitoring can reduce<br />
future drug use even among those adolescents who may be prone<br />
to marijuana use such as those who are rebellious cannot con<br />
trol their emotions and experience internal distress To address<br />
the issue <strong>of</strong> drug abuse in your area it is impartant to get involved<br />
in drug abuse prevention programs in your community or your<br />
child s school Find out what prevention programs you and your<br />
children can participate in together<br />
II<br />
Fq<br />
M<br />
bS
Talking to your children<br />
about marijuana<br />
As this booklet has shown marijuana can pose a particular<br />
threat to the health andwell being <strong>of</strong> children and adolescents at<br />
a critical point in theirlives when they are growing learning<br />
maturing and laying the foundation for their adult years As a<br />
parent your children look to you for help and guidance in<br />
working out problems and in making decisions including the<br />
decision not to use drugs As a role model your decision to not<br />
use marijuana and other illegal drugs will reinforce your mes<br />
sage to your children<br />
There are numerous resources many right in your own<br />
community where you can obtain information so that you can<br />
talk to your children about drugs To find these resources you<br />
can consult your local library school or communiry service<br />
organization<br />
The National Clearinghouse for Alcohol and Drug Information<br />
NCADI <strong>of</strong>fers an extensive collection <strong>of</strong> publications videotapes<br />
and educational materials to help parents talk to their children<br />
about drug nse For more information on marijuana and other<br />
drugs contact National Clearinghouse for Alcohol and Drug<br />
Information PO Box 2345 Rockville MD 208471800<br />
729 6686 TDD number1800 487 4889 and or visit<br />
NIDA s Web site athttp<br />
wwwdrugabuse gov<br />
vz<br />
3W<br />
c<br />
27
x<br />
z<br />
c<br />
a<br />
aca<br />
6<br />
28<br />
Selected Resources and References<br />
National Institute on Drug Abuse NIDA<br />
N1DA s mission is to lead the Nation in bringing he power oE science to bear on<br />
drug abuse and addiction It does so by supparting over 85 <strong>of</strong> the world s<br />
research on drug abuse and ensuring the effective dissemination and use <strong>of</strong> this<br />
research to improve drug abuse and addiction prevention treatment and policy<br />
For general inquiries contact NIDAs public inEormacion <strong>of</strong>fice at 301 443 1124<br />
or visit the NIDA Web si e atwww drugabuse gov andwww marijuana inEo org<br />
NIDA publications are available through the National Clearinghouse on Alcohol<br />
and Drug Information<br />
National Clearinghouse on Alcohol and Drug Information NCADI<br />
NCADl provides access to educational publica ions from N1DA and other Federal<br />
agencies Staff provides assis ance in English and Spanish and has TDD capability<br />
Call1800 729 6686 or visit the NCADI Web site atwww healdi org<br />
Center for Substance Abuse Prevention CSAP<br />
CSAP a part <strong>of</strong> the Substance Abuse and Mental Health Services Administration<br />
provides national leadership in the development <strong>of</strong> policies programs and services<br />
to prevent the onset <strong>of</strong> illegal drug alcohol and obacco use CSAP publications are<br />
available through the NCADI<br />
Cenrer for Substance Abuse 7reatment CSAT<br />
CSAl a part oI the Substance Abuse and Mental Health Services Administration<br />
supports treatinent services research dissemination and adoption and operates<br />
the National Treatment Referral Hodine1800 662 HELP CSAT publications<br />
are available through the NCADI<br />
Feel free to reprint this publication in any quantiry you wish
Be a gvod listener<br />
Give clear nous ir sages abo t<br />
drugs and alcaho<br />
r<br />
Help your child deal with peer<br />
pressure usgs<br />
x<br />
Get to hnw your chiid s friends<br />
tnd parents k<br />
d<br />
M or our child swher ebou<br />
1<br />
y r<br />
5<br />
Supervise teen activities<br />
Maintain an open and honest<br />
m<br />
oae yor child
mm AW<br />
Fact Marijuana e most frequently<br />
usil ga rug in the Un td tates<br />
F early 50 <strong>of</strong>12th graders have<br />
tied marijuana at east one<br />
r<br />
fact Marijuana smokingafct the<br />
bain and eads to impaired short term<br />
mer ory perception judgrner<br />
mr skills<br />
US DEPARTMENT OF HEALTH AND HUMAN SERVECES<br />
NIHPublication No 02 4036<br />
Printed 1995 Revised November 199 2002<br />
Reprinted April 2001
i<br />
a<br />
L<br />
ma luan<br />
A<br />
ty<br />
y q<br />
ewy<br />
ht HF @<br />
Y Jg<br />
Revised<br />
If<br />
r<br />
s<br />
M14<br />
S<br />
tt 4 ti<br />
t<br />
x<br />
t3S<br />
y<br />
ti ar<br />
Ut<br />
I<br />
sy<br />
xv<br />
1J 3<br />
p<br />
e<br />
s<br />
7 ejWd S 1J<br />
R4<br />
k<br />
w<br />
E<br />
pF<br />
ndt<br />
t<br />
i 4<br />
f<br />
ay
i<br />
sk t a a<br />
j<br />
g9<br />
x<br />
t<br />
Y<br />
s<br />
n<br />
s Is z<br />
b<br />
e<br />
i 1P j eg<br />
f 1 g6<br />
g<br />
v<br />
3 2 n<br />
e7<br />
r<br />
M<br />
1 i24<br />
i<br />
f<br />
y<br />
x<br />
y<br />
q<br />
rPa p Yi<br />
I f<br />
ry<br />
trR<br />
S S f<br />
ta b R<br />
egtr<br />
a<br />
tv ii<br />
T 4p iC Q<br />
aab<br />
a<br />
s<br />
ER<br />
yM<br />
t<br />
TI<br />
2e<br />
R<br />
fi aen 2<br />
L<br />
a<br />
y<br />
h f R s<br />
n<br />
R 38<br />
a<br />
a a<br />
S G<br />
k5 t a<br />
6 r<br />
m<br />
s<br />
sgi<br />
3<br />
gas b<br />
z ti<br />
ss<br />
se<br />
s 4 l<br />
g<br />
s<br />
2e a<br />
6r<br />
a<br />
e<br />
x<br />
a<br />
i<br />
r bP<br />
36L G F bg j v a i<br />
C<br />
i<br />
n<br />
I<br />
6 n<br />
i<br />
8<br />
da<br />
4<br />
S 9e<br />
V<br />
aSb Sg<br />
e<br />
z<br />
T<br />
s<br />
b<br />
kac<br />
x<br />
a r r<br />
at<br />
rM1<br />
a r<br />
qa<br />
x<br />
1t<br />
t z t c<br />
a<br />
i<br />
f<br />
qwg<br />
9<br />
aSy<br />
a<br />
a 38x<br />
r<br />
o<br />
9<br />
ii N Y i<br />
ay 4<br />
9 6 Xe<br />
j<br />
waR<br />
V4<br />
rp<br />
fkC 0<br />
w<br />
1n<br />
q<br />
r<br />
nS<br />
wy r<br />
v s r a i9<br />
7<br />
yao a<br />
hE a a 9<br />
3<br />
2<br />
r<br />
y<br />
h<br />
aS<br />
p Sa<br />
8<br />
n<br />
g<br />
3Ri no y<br />
r<br />
v z<br />
1T 1 h y<br />
3 N q f<br />
k<br />
ln sl<br />
u<br />
f Y<br />
X<br />
Q<br />
S<br />
H<br />
t<br />
u<br />
t<br />
3<br />
p<br />
r a w<br />
c<br />
sy<br />
4<br />
SS P<br />
a<br />
y9<br />
i a<br />
g 9a x<br />
I X<br />
ra<br />
II y<br />
a<br />
x<br />
ie<br />
qt<br />
t<br />
z<br />
z s<br />
d<br />
8 e<br />
i<br />
y<br />
f<br />
t 9<br />
S ae ze r<br />
xr I w<br />
h<br />
t YE<br />
as s e<br />
t S v<br />
iw f i I 7<br />
aE L PasaYe<br />
it t a ge 142<br />
xx t<br />
c n 5 I<br />
ao<br />
y<br />
taripy<br />
C<br />
dtat ia<br />
C AiR ua K d fa I T1 A h bRY<br />
b I A<br />
@ a<br />
bi as t x 14qd ya t M<br />
f<br />
e w<br />
t<br />
t 5 s<br />
G<br />
fi<br />
rr a<br />
t i 1 d P x i<br />
E v a r a R<br />
a CS 5<br />
w tt S az Mr x<br />
9a<br />
vu<br />
D
I<br />
Contents<br />
What is marijuana 2<br />
How is marijuana used 4<br />
How long does marijuana stay<br />
in the use<br />
body 5<br />
How many teens smoke marijuana 5<br />
Why do young people use marijuana 5<br />
What happens if you smoke marijuana 6<br />
What are the short term effects <strong>of</strong> marijuana use 8<br />
Does marijuana afFect school sports<br />
or other activities 9<br />
What are the long term effects <strong>of</strong> marijuana use 9<br />
Does marijuana lead to the use <strong>of</strong> other drugs 10<br />
How can you tel if someone has been using marijuana 11<br />
Is marijuana sometimes used as a medicine 11<br />
How does marijuana affect driving 12<br />
If a woman is pregnant and smokes marijuana<br />
will it hurt the baby 12<br />
What does marijuana do to the brain 14<br />
Can people become addicted to marijuana 14<br />
What if a person wants to quit using the drug 16
A<br />
t<br />
b<br />
5 t t F tltykSE<br />
f<br />
7Saa<br />
t k<br />
a x r<br />
v<br />
a<br />
r xr<br />
14<br />
rc<br />
y i 4<br />
YCP x A F8 k<br />
3<br />
4 usi<br />
y<br />
Marijuana is a green brown or gray mixture <strong>of</strong> dried shredded<br />
leaves stems seeds and flowers <strong>of</strong> the hemp plant You may<br />
4x<br />
v<br />
hear marijuana called by street names such as pot herb weed<br />
grass boom Mary Jane gangster or chronic There are more<br />
than 200 slang terms for marijuana<br />
Sinsemillasin seh me yah its a Spanish word<br />
hashish hash for short and hash oil are stronger forms<br />
<strong>of</strong> marijuana<br />
All forms <strong>of</strong> marijuana are mind aLtering In other<br />
words they change how the brain works They all contain THC<br />
delta 9tetrahydrocannabinol the main active chemical in<br />
marijuana They also contain more than 400 other chemicals<br />
Marijuana s effects on the user depend on its strength or<br />
potency which is related to the amount <strong>of</strong> THC it contains<br />
The THC content <strong>of</strong> marijuana has been increasing since<br />
the 1970s<br />
6<br />
tu<br />
SF<br />
B<br />
f ti<br />
x<br />
p<br />
i<br />
e<br />
3 z<br />
y p<br />
i<br />
ya<br />
aw<br />
7<br />
ta<br />
2
s<br />
5u r<br />
s<br />
xY<br />
c<br />
ar<br />
n<br />
a<br />
Ra<br />
ry<br />
a<br />
a<br />
a a<br />
t<br />
a<br />
tY<br />
y52i<br />
a<br />
Mt<br />
1 Lv<br />
y C Y<br />
w rv<br />
Y1Y ly Fe<br />
d<br />
t au<br />
6yt6n<br />
4<br />
a<br />
v<br />
nt<br />
a r<br />
q<br />
J<br />
s<br />
v n c t n<br />
u 9 s s t aY<br />
Yv r<br />
i v<br />
1i e<br />
ti<br />
rt<br />
Yn<br />
3r1<br />
3von<br />
ik<br />
Ft<br />
s<br />
i<br />
v v<br />
z<br />
4 a
tr<br />
p<br />
t<br />
t<br />
I don t think it s<br />
3<br />
Y<br />
cool at all and I<br />
don t see why they<br />
tr to pressure it<br />
on other people<br />
from the videotape<br />
Marijuana What Can<br />
Parents Do<br />
Q How is mar jua<br />
i
Q How Iong does marijuana stay<br />
in the user<br />
body<br />
A<br />
THC in marijuana is strongly absorbed by fatty tissues in<br />
various organs Generally traces metabolites <strong>of</strong> THC can<br />
be detected by standard urine testing methods several days<br />
after a smoking session However in heavy chronic users<br />
traces can sometimes be detected for weeks after they have<br />
stopped using marijuana<br />
A u i u<br />
A<br />
Contrary to poputar belief most teenagers do not use marijuana<br />
Among students surveyed in a yearly nationa survey only about<br />
one in five 10th graders report they are current marijuana users<br />
that is used marijuana within the past month Fewer than<br />
one in four high school seniors is a current marijuana user<br />
ns u<br />
A<br />
There are many reasons why some children and young teens<br />
start smoking marijuana Many young people smoke marijuana<br />
because they see their brothers sisters friends or even older<br />
family members using it<br />
Others may think its cool to use marijuana because<br />
they hear songs about it and see it on TV and in movies<br />
Some teens may fee they need marijuana and other drugs<br />
to help them escape from problems at home at school or<br />
with friends<br />
5
No matter how many shirts and caps you see printed<br />
with the marijuana leaf or how many groups sing about it<br />
remember this You dan t have to use marijuana just because<br />
yau think everybody eLse is doing it<br />
R e u uo<br />
A<br />
The efFects <strong>of</strong>the drug on each person depend on many<br />
factors induding<br />
how strong the marijuana is how much THC it has<br />
what the user expects to happen<br />
where the place the drug is used<br />
how it is taken and<br />
whether the user is drinking alcohol or using<br />
other drugs<br />
Some people fee nothing at all when they smoke<br />
marijuana Others may feet relaxed or high Sometimes<br />
marijuana makes users feel thirsty and very hungry<br />
an effect called the munchies<br />
Some users can get bad effects from marijuana<br />
They may suffer sudden fee ings <strong>of</strong> anxiety and have paranoid<br />
thoughts This is more likely to happen when a more potent<br />
variety <strong>of</strong> marijuana is used<br />
6
I<br />
i<br />
I<br />
11<br />
f<br />
A<br />
x<br />
a<br />
F
A Er o ds s<br />
a<br />
A<br />
The short term efFects <strong>of</strong> marijuana indude<br />
problems with memory and Learning<br />
distorted perception sights sounds time touch<br />
trouble with thinking and problemsolving<br />
loss <strong>of</strong> motor coordination and<br />
increased heart rate<br />
i<br />
r<br />
P<br />
r<br />
tl 11<br />
i<br />
1f<br />
I<br />
f<br />
I<br />
8
These efFects are even greater when other drugs are mixed<br />
with the marijuana and users do not always know what<br />
drugs are given to them<br />
1 u<br />
A<br />
It can Marijuana afFects memory judgment and perception<br />
The drug can make you mess up in school in sports or dubs<br />
or with your friends If you re high on marijuana you are more<br />
likely to make stupid mistakes that could embarrass or even<br />
hurt you If you use marijuana a lot you couLd start to lose<br />
interest in how you look and how you re gettingaong at<br />
school or work<br />
Athletes could find their performance is <strong>of</strong>F timing<br />
movements and coordination are all affected by THC Also<br />
since marijuana can afFect judgment and decisionmaking<br />
its use can Lead to risky sexual behavior resulting in expo<br />
sure to sexually transmitted diseases like HIV the virus that<br />
causes AIDS<br />
A<br />
u<br />
u<br />
A<br />
findings so far show that regular use <strong>of</strong> marijuana or THC<br />
may play a role in some kinds <strong>of</strong> cancer and in problems<br />
with the respiratory and immune systems<br />
Cancer It s hard to know for sure whether regular marijuana<br />
use causes cancer But it is known that marijuana contains<br />
9
some <strong>of</strong> the same and sometimes even more <strong>of</strong> the cancer<br />
causing chemicals found in tobacco smoke Studies show that<br />
someone who smokes five joints per day may be taking in as<br />
many cancer causing chemicais as someone who smokes a full<br />
pack <strong>of</strong> cigarettes every day<br />
Lungs and airways People who smoke marijuana <strong>of</strong>ten<br />
develop the same kinds <strong>of</strong> breathing problems that cigarette<br />
smokers have coughing and wheezing They tend to have<br />
more chest colds than nonusers They are also at greater<br />
risk <strong>of</strong> getting ung infections like pneumonia<br />
Immune system THC may increase the risk <strong>of</strong> developing<br />
infections by inhibiting normaL disease preventing reactions<br />
1 u<br />
i<br />
A<br />
It could Long term studies <strong>of</strong> high schoo students and<br />
their patterns <strong>of</strong> drug use show that very few young people<br />
use other illegal drugs without first trying marijuana Using<br />
marijuana puts children and teens in contact with people<br />
who are users and sellers <strong>of</strong> otF er drugs So there is more <strong>of</strong><br />
a risk that a<br />
marijuana user will be exposed to and urged to<br />
try more drugs<br />
While most young people who use marijuana do not<br />
go on to use other drugs further research is needed to pre<br />
dict who will be at greatest risk<br />
o
dESf<br />
A H iH C<br />
9<br />
A<br />
If someone is high on marijuana he or she might<br />
seem dizzy and have trouble walking<br />
seem silly and giggly for no reason<br />
have very red bloodshot eyes and<br />
have a hard time remembering things that just happened<br />
When the early effects fade over a few hours the user<br />
can become very sleepy<br />
a<br />
u u<br />
u<br />
A<br />
There has been much talk about the possible medical use <strong>of</strong><br />
marijuana Under US law since 1970 marijuana has been a<br />
Schedule I contro led substance This means that the drug at<br />
least in its smoked form has no commonly accepted medical use<br />
THC the active chemicalin marijuana is manufactured<br />
into a pill available by prescription that can be used to treat<br />
the nausea and vomiting that occur with certain cancer treat<br />
ments and to help AIDS patients eat more to keep up their<br />
weight According to scientists more research needs to be<br />
done on marijuana s side effects and potential benefits<br />
before it is used medically with any regularity
Q How does marijuana affect driving<br />
A<br />
Marijuana has serious harmful effects on the skills required to<br />
drive safely alertness the abi ity to concentrate coordination<br />
and the ability to react quickly Marijuana use can make it<br />
difFicult to judge distances and react to signals and sounds<br />
on the road<br />
Marijuana may play a role in car accidents In one<br />
study conducted in Memphis TN researchers found that <strong>of</strong><br />
150 reckless drivers who were tested for drugs at the arrest<br />
scene 33 percent tested positive for marijuana and 12 per<br />
cent tested positive for both marijuana and cocaine Data<br />
have also shown that while smoking marijuana people show<br />
the same lack <strong>of</strong> coordination on standard drunk driver tests<br />
as do people who have had too much to drink<br />
u<br />
u<br />
u<br />
A<br />
Doctors advise pregnant women not to use any drugs because<br />
they could harm the growing fetus One animal study has linked<br />
marijuana use to oss <strong>of</strong> the fetus very early in pregnancy<br />
Other studies have shown increased behavioral prob<br />
lems during infancy and preschool years in children born to<br />
mothers who use marijuana In school these children are<br />
more likely to have problems with decisionmaking memory<br />
and the ability to remain attentive<br />
z
f<br />
I<br />
r<br />
r<br />
h4<br />
d<br />
wr<br />
SAy<br />
x<br />
g<br />
p<br />
tu<br />
bL Iklv<br />
p<br />
an a<br />
l<br />
4<br />
t<br />
a 5<br />
i<br />
P<br />
4 F ir c s<br />
4a<br />
t<br />
4<br />
3 4t a<br />
e<br />
4r<br />
V<br />
r 6 ac o 3<br />
ti<br />
a<br />
rW<br />
i<br />
i<br />
v<br />
e<br />
cw<br />
w z rw 4<br />
Ms Tw<br />
w<br />
a<br />
b<br />
yx<br />
x<br />
3e<br />
tro<br />
f<br />
r<br />
he<br />
I I<br />
h<br />
n<br />
e<br />
ta<br />
in y<br />
r<br />
F<br />
5 Y<br />
I<br />
IS<br />
1<br />
M<br />
I Y<br />
i<br />
Ysi
Researchers are not certain whether health problems<br />
that may be caused by early exposure to marijuana will<br />
remain as the child grows into adulthood However since<br />
some parts <strong>of</strong> the brain continue to develop into adolescence<br />
it is also possib e that certain kinds <strong>of</strong> problems may appear<br />
as the child matures<br />
e s u e e n c c<br />
A<br />
Some studies show that when peopte have smoked large<br />
amounts <strong>of</strong> marijuana for years the drug takes its toll on<br />
mental functions Heavy or daily use <strong>of</strong> marijuana affects<br />
the parts <strong>of</strong> the brain that control memory attention and<br />
learning A working short term memory is needed to earn<br />
and perform tasks that call for more than one or two steps<br />
Smoking marijuana causes some changes in the brain<br />
that are like those caused by cocaine heroin and alcohol<br />
Some researchers believe that these changes may put a per<br />
son more at risk <strong>of</strong> becoming addicted to other drugs such<br />
as cocaine or heroin Scientists are still learning about the<br />
many ways that marijuana could affect the brain<br />
x<br />
A<br />
Yes Long term marijuana use can lead to addiction in some<br />
people That is they cannot control their urges to seek out<br />
and use marijuana even though it negatively affects their<br />
family relationships school performance and recreational<br />
4
u<br />
u<br />
i i r r<br />
I<br />
activities According to one study marijuana abuse by<br />
teenagers who have prior antisocial problems can quickly lead<br />
to addiction In addition some frequent heavy marijuana<br />
users develop tolerance to its efFects This means they need<br />
Larger and larger amounts <strong>of</strong> marijuana to get the same<br />
desired effects as they used to get from smaller amounts<br />
R<br />
r<br />
er<br />
t<br />
A<br />
In 1999 over 220 000 people entering drug treatment pro<br />
grams reported marijuana as their primary drug <strong>of</strong> abuse<br />
However up until a few years ago it was hard to find treat<br />
ment programs specifically for marijuana users<br />
5
Now researchers are testing different ways to he p<br />
marijuana users abstain from drug use There are currently<br />
no medications for treating marijuana addiction Treatment<br />
programs focus on counseling and group support systems<br />
There are also a number <strong>of</strong> programs designed especially<br />
to help teenagers who are abusers Family doctors are also<br />
a good source for information and help in dealing with<br />
ado escent marijuana problems<br />
I6
USDRMENT 3 D BUMAN xY3CES<br />
NIH Publieation No 3 03<br />
s<br />
k<br />
a<br />
a<br />
ta<br />
f<br />
a t x ux<br />
b
Page 1 <strong>of</strong> 2<br />
a<br />
Yc ur source for the Eatest research news<br />
Web address<br />
httpwwwsciencedaily com releases 2009 12<br />
091217115834 htm<br />
Cannabis Damages Young Brains More Than<br />
Originally Thought Study Finds<br />
ScienceDaily Dea 20 2009 Canadian teenagers are among the<br />
largest consumers <strong>of</strong> cannabis warldwide The damaging effects <strong>of</strong><br />
this illicit drug on young brains are worse than originally thought<br />
according to new research by Dr Gabriella Gobbi a psychiatric<br />
researcher from the Research Institute <strong>of</strong> the McGill University<br />
Health Centre The new study published in Neurobiology <strong>of</strong>Disease<br />
suggests that daily consumption <strong>of</strong> cannabis in teens can cause<br />
depression and anxiety and have an irreversible long term effect on<br />
the brain<br />
We wanted to know what happens in the brains <strong>of</strong> teenagers when<br />
they use cannabis and whether they are more susceptible to its<br />
neurological effects than adults explained Dr Gobbi who is also a<br />
Daily consumption <strong>of</strong>cannabis in teens can<br />
pr<strong>of</strong>essor at MeGill University Her study points to an apparent action cause depression and anxiety and have an<br />
<strong>of</strong> cannabis on two important compounds in the brain serotonin and rreversible long term effect on the brain<br />
n<br />
inephrine which are involved in the regulation <strong>of</strong> neurological<br />
Credit iStockphoto Rasmus Rasmussen<br />
functions such as mood control and anxiety<br />
Teenagers who are exposed to cannabis have decreased serotonin transmission which leads to mood disorders as well<br />
as increased norepinephrine transmission which leads to greater long term susceptibility to stress Dr Gobbi stated<br />
Previous epidemiological studies have shown how cannabis consumption can affect behaviour in some teenagers Our<br />
study is one <strong>of</strong> the first to focus on the neurobiological mechanisms at the root <strong>of</strong> this influence <strong>of</strong> cannabis on<br />
depression and anxiety in adolescents confirn ed Dr Gobbi It is also the first study to demonstrate that cannabis<br />
consumption causes more serious damage during adolescence than adulthood<br />
Dr Gabriella Gobbi is a researcher at the neuroscience axis <strong>of</strong> the Research Institute <strong>of</strong> the McGill University Health<br />
Centre and also a psychiatrist and associate pr<strong>of</strong>essor at the Department <strong>of</strong> Psychiatry McGill University<br />
This study was funded by a grant from The Canadian Psychiatric Research Foundation CPRF<br />
This article wasco authored by Dr Francis Rodriguez Bambico Ms Nhu Tram Nguyen and Mr Noam Katz from<br />
fromIR MUHC and the Neurobiological Psychiatry Unit Department <strong>of</strong> Psychiatry McGill UniversiTy<br />
Recommend this story on Facebook TwUter<br />
and Goog e 1<br />
Like 418<br />
z7<br />
Otner bookmarking and sharing tools<br />
More<br />
http<br />
wwwsciencedaily com releases 2009 1<br />
2091 2 1 7 1 15834 htm 912 2011
Page 2 <strong>of</strong> 2<br />
Story Source<br />
The above story is reprinted with editorial adaptations by ScienceDaily staffl from materials provided by<br />
McGill Universih Health Centre via EurekAlert a service <strong>of</strong> AAAS<br />
Need to cite this story in your essay paper or report Use one <strong>of</strong> the following formats<br />
r APA<br />
MLA<br />
McGill University Health Centre 2009 December 20 Cannabis damages young brains more than originally thought<br />
study finds ScienceDaily Retrieved September 12 2011 fromhttp<br />
wwwsciencedaily com<br />
releases 2009 12 091 2 17 1 1 5834 htm<br />
Note If no author is given the source is cited instead<br />
Disclaimer This article is not intended to provide medical advice dingnosis or treatment <strong>View</strong>s expressed here do not<br />
necessarily reflect those <strong>of</strong>ScienceDaily or its staff<br />
http www<br />
sciencedaily com releases 2009<br />
091217ll 5834<br />
htm 912 2011
Medical Marijuana Page 1 <strong>of</strong> 6<br />
Medical Mariivana<br />
raLic<br />
MARIJUANA AS MEDICINE<br />
NTRODUCT ON<br />
New England Governors Summit on Drug Use<br />
October 8 2003<br />
Andrea G Barthwell MD FASAM<br />
Deputy Director Office <strong>of</strong> Demand Reduction<br />
Office <strong>of</strong> National Drug Control Policy<br />
The hoax <strong>of</strong> using a smoked weed as medicine is the Trojan Horse <strong>of</strong> the new millennium The claim that<br />
marijuana can be used as medicine is proving to be one <strong>of</strong> the worst scams drug legalizers have perpetrated<br />
on the American people In reality smoked marijuana is far too complex unstable and harmful a substance<br />
to be approved as a medicine<br />
l ery instance claimed by legalizers as a use for smoked marijuana there exist far better legitimate<br />
scientifically approved medications Any argument supporting a smoked material as a medicine is dubious<br />
ridiculous even The purpose <strong>of</strong> proposals to use marijuana as medicine is simple make marijuana and<br />
other illicif substances more available to individuals and communities in our country<br />
The tangle <strong>of</strong> consequences <strong>of</strong> state or local referenda to make marijuana available for personal use creates<br />
more difficult policy questions and greater public health concerns than the proposed laws would address<br />
Before joining the Bush Adminisfration as Deputy Director for Demand Reduction in the White House Office<br />
<strong>of</strong> National Drug Control Policy ONDCPJ 1 served as Medica Director <strong>of</strong> lnterventrons anot for pr<strong>of</strong>it drug<br />
treatment system in lllinois At lnterventions l ran the largest and oldest adolescent treatmenf sysfem in that<br />
state Children entering treatmenf routinely reported that they heard that pot is medicine<br />
and therefore believed it to be good for them Claims that marijuana is medicine reduce the efficacy <strong>of</strong><br />
prevention efforts<br />
Fortunately modern medical science is close to developing a safe delivery system for the constituent parts<br />
<strong>of</strong> marijuana Marijuana legalizers will no longer be able to exploit the sick and dying as part <strong>of</strong> their attempts<br />
to subvert the medical system undermine the legal system make a laughingstock <strong>of</strong> policy and expose our<br />
children fo dangerous poisons<br />
SCIENCE SHOULD DETERM NE THE PRACTICE OF MEDICINE<br />
7<br />
ical marijuana is a broadly used butill defined term Federal law does not recognize marijuana as a<br />
rn cine Marijuana is listed in Schedule I <strong>of</strong> the Federal Controlled Substances Act CSA which reflects<br />
the fact that marijuana has no currently accepted medical use in treatment in the United States Schedule I<br />
is the most restrictive schedule in the CSA Smoked marijuana delivers harmful and unspecified substances<br />
http neoa org index php view article catid 33Apublic id 18 3Amedical marijuana tmpl compone 912 2011
Medical Marijuana Page 2 <strong>of</strong> 6<br />
to the body cannot be expected to provide a precisely defined drug effect and has a high potential for<br />
abuse In short smoked marijuana is unsafe for use<br />
even under medical supervision<br />
Nevertheless voters in several states have passed referenda making marijuana available for a variety <strong>of</strong><br />
r cal conditions The resulting laws are in conflict with the CSA and with the Federal Food Drug and<br />
Cwmetic Act<br />
Science not public opinion must drive the practice <strong>of</strong> inedicine Political measures aimed at endorsing<br />
marijuana as medicine undercut efforts to ensure that approved medications have undergone rigorous<br />
scientific scrutiny and the Food and Drug Administration FDA approval process Scientists are engaged in<br />
research to determine whether there are indeed potential medical uses for constituents <strong>of</strong> marijuana The<br />
purpose <strong>of</strong> such research is not to develop marijuana as a licensed drug but to investigate rapid onset<br />
delivery systems that do not require inhaling the acrid and potentially carcinogenic smoke <strong>of</strong> a burning weed<br />
WILLOW TREE BARK AND OTHER CRUDE REMEDlES<br />
In the 19th century marijuana was thought to be useful as an analgesic muscle relaxant anticonvulsant<br />
and appetite stimulant It was provided in the form <strong>of</strong> tinctures extracts and elixirs Snake oilsa esmen<br />
extolled the virtues <strong>of</strong> marijuana for asthma bronchitis migraine headaches depression gonorrhea uterine<br />
hemorrhage and dysmenorrhea Treatment responses were unpredictable or nonexistent These marijuana<br />
laced products were subsequently discarded as science developed disease and symptom specific<br />
medicafions<br />
Every American is familiar with aspirin and some know that it was rst found in willow bark from which the<br />
therapeutic agent acetylsalicylic acid was eventually synthesized Surely no physician today would<br />
recommend chewing willow bark much less smoking a piece <strong>of</strong> tree to cure a headache Likewise no<br />
ler imate physician would prescribe smoked opium to relieve the pain <strong>of</strong> cancer when manysemi synthetic<br />
a<br />
ynthetic opioids are currently in use for pain Moreover there is no clamor from legitimate medical<br />
organizations to get a smoked weed on the medications formulary<br />
Marijuana legalizers want to set the clock <strong>of</strong> modern medicine back to a time before the passage <strong>of</strong> the Pure<br />
Food and Drug Act in 1907 when Americans were exposed to a host <strong>of</strong>patent medicine cure alls<br />
everything from vegefable folk remedies to dangerous mixtures with morphine The major component <strong>of</strong><br />
most cures was alcohol which probably explains why people reported that they felt better Claimed<br />
benefifs were erratic and irreproducible The case is the same with marijuana As Dr Mark Krauss <strong>of</strong> the<br />
Connecticut Society <strong>of</strong> Addiction Medicine will explain marijuana cannot be equated with credible<br />
medications The Institute <strong>of</strong> Medicine IOM in its 1999 report commissioned by ONDCP stated<br />
Scientific data indicate the potential therapeutic value <strong>of</strong> cannabinoid drugs primarily<br />
THC for pain relief control <strong>of</strong> nausea and vomiting and appetite stimulation smoked<br />
marijuana however is a crude delivery system that also delivers harmfu<br />
substances<br />
In the 1970s and subsequent years anecdotal claims surfaced that marijuana relieved a number <strong>of</strong> inedical<br />
conditions These claims were investigated in a number <strong>of</strong> studies supported by the National Institutes <strong>of</strong><br />
Health NIH The National Cancer Institute NCI in collaborafion with the National Institute on Drug Abuse<br />
NIDA initiated clrnical trials on a synthetic orally administered form <strong>of</strong>delta 9tetrahydrocannabinol THC<br />
the primary psychoactive ingredient in marijuana In 1985 the FDA approved synthetic THC marketed<br />
under the trade name Marinol0 for nausea associated with cancer chemotherapy<br />
F approval means that the product was subjected to rigorous clinical trials that established its medical<br />
value pr<strong>of</strong>iled its side effects and contraindications established appropriate standards for dosing and<br />
detailed pertinent drug interactions As outlined by the Institute <strong>of</strong> Medicine<br />
http neoa org index php view article catid 3Apublic<br />
I83 Amedical marijuana hnpl compone 912<br />
20l 1
Medical Marijuana Page 3 <strong>of</strong> 6<br />
Under the Federal Food Drug and Cosmetic FDC Act the FDA approves new<br />
drugs for entry into the marketplace after their safety and efficacy are established<br />
through controlled clinical trials FDA approval <strong>of</strong> a drug is the culmination <strong>of</strong> a long<br />
research intensive process <strong>of</strong> drug development which <strong>of</strong>ten takes well over a<br />
decade 2<br />
Institute <strong>of</strong> Medicine Mariivana and Medicine Assessinq the Science Base<br />
Executive Summary visited Oct 5 2003<br />
http books napedu<br />
marimed eshtml<br />
Z Institute <strong>of</strong> Medicine Mariivana and Medicine Assessinp the Science Base Chapter<br />
5 visited Oct 5 2003http books nap edu<br />
marimed ch5 html<br />
For each symptom or disease that marijuana legalizers suggest can be treated with smoked marijuana there<br />
is a variety <strong>of</strong> existing scientifically proven options available to the clinician Among these is Marinol0<br />
Claims that smoking marijuana is more effective than taking Marinol0 remain unproven Interestingly<br />
enough the only property that Marinol0 acks is the capacity 10 create a euphoric mood or high<br />
DRUG USE THRIVES ON MYTHS AND LIES<br />
Legalizers argue that government is oppressive and unjust because elecfed representatives and government<br />
<strong>of</strong>ficials will not let a few people who are at the end <strong>of</strong> their lives smoke a plant material in lieu <strong>of</strong> expert<br />
medical care utilizing prescribed medications This is not in fact the problem The real problem exists where<br />
wealthy advocates for drug legalization misleadwell intentioned and compassionate voters into passing local<br />
referenda to allow the use <strong>of</strong> a smoked weed as medicine These efforts subvert the integrity <strong>of</strong> the scientific<br />
process upon which 21 st century medicine is based<br />
L to Maryland fo see how big and how soon the problems emerge from efforts to construe marrjuana as<br />
medicine On October 1 2003 a Maryland law took effect allowing anyone convicted <strong>of</strong> possessing<br />
marijuana to argue for a maximum penalty <strong>of</strong>a100 fine if the drug was used for medical purposes The ink<br />
was barely dry on the bill before defense attorneys were preparing arguments to defend any marijuana using<br />
criminal who would claim that he or she had a legitimate quasi legitimate or imagined symptom or disease<br />
As The Washinvton Post reported<br />
Defense lawyers would constantly test the law s reach and would be neglecting their<br />
clients if they did not try to find out what physical emotional or psychological pain<br />
causes them to use the drug Sometimes people areself medicating withouf even<br />
realizing it<br />
Self medication hypotheses also support the normalization <strong>of</strong>non dependent drug use 4<br />
In addition to sending the wrong message about drug use these laws will allow attorneys to argue that any<br />
use <strong>of</strong>marijuana can be construed medical Ifany use can be deemed medical and medical marijuana<br />
use carries a maximum fine <strong>of</strong> only 100 marijuana laws are not worth enforcing at all they say<br />
ENVIRONMENTAL FACTORS<br />
As Dr Berthas Madras <strong>of</strong> Harvard Medical School has stafed The environment is a major influence on<br />
w<br />
her a youth will experiment with drugs or develop an aversion to them The big fhreat in fhe<br />
ei ronment <strong>of</strong> drug use today is the active campaign to blur the distinctionbe ween illegal and legal drugs<br />
and corrupt the judgment <strong>of</strong> the American people<br />
http neoa org index php view article catid 33Apublic id 18 3Amedical marijuana tmpl compone 912 2011
Medical Marijuana Page 4 <strong>of</strong> 6<br />
Simply stated alcohol tobacco and the illegal drugs including marijuana are not medicines 5 But by<br />
characterizing the use <strong>of</strong>illegal drugs as quasi legal sanctioned medicinal use legalizers destabilize the<br />
societal norm that drug use is dangerous and drug use is wrong Such attempts to blur the line between the<br />
use <strong>of</strong> an addictive illegal drug and the use <strong>of</strong> a medicine undercut the goals <strong>of</strong> stopping initiation <strong>of</strong> drug<br />
G<br />
and preventing addiction<br />
3 Tim Craig Maryland Starts To Allow Marijuana Court Plea The Washinpton Post October 1 2003 at<br />
801<br />
4 Robert M Dupont Biolonv and the Environment A Rethinkinq <strong>of</strong> Demand Reduction visited<br />
October 5 2003http www<br />
ourdrugfreekids org article 46 htm<br />
5 Id<br />
The key to the environment <strong>of</strong> addiction is a strong focus on the individual who makes the decision to use or<br />
not to use drugs Risk factors as described by Dr Madras can reduce an individual s capacity to make<br />
reasonable responsible decisions However they do not mitigate personal responsibility for such decisions<br />
Individuals are more likely to avoid drug use if they see clear warnings and know they are responsible for<br />
their behaviors The distinction between illegal and legal drugs is important It warns would be users <strong>of</strong> illegal<br />
drugs that the use <strong>of</strong> particular drugs is so dangerous that it is prohibited by criminal law<br />
To the extent that the environment is tolerant or even encouraging <strong>of</strong> the use <strong>of</strong> addicting drugs the rates<br />
<strong>of</strong> use rise Rates <strong>of</strong> the problems resulting from that use also rise To the extent that the environment<br />
rejects in meaningful ways the use <strong>of</strong> addicting substances the levels <strong>of</strong> drug use and resultant problems<br />
decline 6<br />
N ROBIOLOGICAL REWARD PATHWAYS<br />
Dr Madras has shown that over the pasf decade science has made remarkable progress in clarifying the<br />
biological changes elicited by drugs The study <strong>of</strong> brain biology is important because it shows that the human<br />
brain is permanently vulnerable to the siren call <strong>of</strong> addicting substances Vulnerability to drugs is hardwired<br />
into the brain and is deepened by repeated use <strong>of</strong> addicting drugs<br />
The best hope for reducing drug use is in the s<strong>of</strong>tware the brain s operating instructions for deciding to use<br />
or not to use addicting drugs 7 Thirty years <strong>of</strong> prevention research have shown that prevention works best in<br />
an environment where the rules are clear the rules are known and the rules are enforced<br />
6 Id<br />
Id<br />
As Dr Billy Martin <strong>of</strong> Virginia Commonwealth University will tell you science is moving at a rapid pace<br />
There have been major breakthroughs over the last 15 years in understanding the cannabinoid receptor<br />
system Scientists agree fhat the best scienti<br />
course for developing new medications to address a range <strong>of</strong><br />
diseases and symptoms lies in our ability to alter this biological system Regardless <strong>of</strong> what individuals think<br />
marijuana does for them medically medical marijuana will become obso ete very quickly based upon fhe<br />
advances brought about by a process <strong>of</strong> scientific research The advances on cannabinoids administered by<br />
inhalers for example are encouraging<br />
Wt ARE NOT AFRA D OF ANY COMPOUND<br />
http neoa org index php view articl ecatid 3 3Apublic id 183Amedical marijuana tmpl compone 912 2011
Medical Marijuana Page 5 <strong>of</strong> 6<br />
As an American physician with more than 20 years <strong>of</strong> experience 1 have practiced medicine in the most<br />
advanced medical system in the world Americans today receive care in the world s safest most effective<br />
system <strong>of</strong> inedical practice built on a process <strong>of</strong> scientific research testing and oversight that is unequaled<br />
F onents <strong>of</strong> using a smoked plant as a medicine would have you believe that modern medicine is afraid <strong>of</strong><br />
ma ijuana and we are motivated by this fear in our response <strong>of</strong> outrage and incredulousness at attempts to<br />
turn fantasy into reality Medical science does not fear any compound even those with a potential for abuse<br />
lf a substance has a proven capacity to serve a medical purpose then it will be accepted Only if compounds<br />
from marijuana pass the same tests <strong>of</strong> research and scrutiny that any other medication must undergo will<br />
they become part <strong>of</strong> the modern medical arsenal These tests are described as<br />
Phase I studies which test the product for its adverse effects on a small number <strong>of</strong><br />
healthy volunteers<br />
Phase ll studies which probe the drug s effectiveness in patients who have the<br />
disease or condition the product is intended to treat and<br />
Phase lll studies which seek to determine the drug s safety effectiveness and<br />
dosage In these trials hundreds or thousands <strong>of</strong> patients are randomly assigned<br />
freatment either with the tested drug or a control substance most frequently a<br />
placebo<br />
The results <strong>of</strong> Phase III trials are submitfed to the FDA for review by a team <strong>of</strong><br />
chemists physicians epidemiologists and other specialists This group s crucial task<br />
which is frequently shared with an advisory panel <strong>of</strong> outside experts is to judge<br />
whether the trials have demonstrated that the producYs health benefits outweigh its<br />
risks Only products that pass this test may be approved for marketing<br />
These are the tests marijuana has yet to pass Medical science is at risk if we do not defend the proven<br />
process by which medicines are brought fo the market<br />
GRAVE DANGER POSED BYFRAUDS IN WHITE COATS DISTORTING THE TRUTH<br />
Pockets <strong>of</strong>well funded individuals and organizations pursuing a political agenda are behind the efforts to<br />
legalize drugs and are using the pain and suffering <strong>of</strong> patients to gain the attention <strong>of</strong> people in many<br />
communities across the country Many <strong>of</strong> the organizations supporting this effort have in fact been trying to<br />
legalize marijuana and other drugs for over 20 years<br />
It is a well known and established fact that the same people who want to legalize marijuana and other drugs<br />
outright are behrnd fhe medical marijuana movement 9 This is their wedge issue These wealthy<br />
businessmen and aging hippies who are caught up in halcyon memories <strong>of</strong> smoking weed in dorm rooms<br />
during the 60s and 70s are pursuing the same goal decades later<br />
8 FDA and the Druq Development Process How the AqencV Ensures that Druqs are Safe and Effective<br />
visited Oct 5 2003http www fda gov opacom factsheets<br />
justthefacts 17drgdev html<br />
9 See eq Jim McDonough They Just Said No The Washinpton Times Nov 26 2002 reprinted at<br />
http www myfloridacom<br />
government<br />
governorinifiatives drugcontrol editorials<br />
washingtonhtml<br />
Dr Kraus will discuss the medical issues complications and contraindications surroundingso cal ed<br />
medica use <strong>of</strong> this plant In every instance claimed by legalizers as a use for the smoked weed far better<br />
http neoa org index php view article catid 33Apublic id 18 3Amedical marijuana hnpl compone 912 2011
Medical Marijuana Page 6 <strong>of</strong> 6<br />
legitimate and safe alternatives are available Marijuana advocates also claim that the smoked weed is<br />
superior to the constifuent part that has been shown to be responsible for the effects on the brain<br />
Marijuana is composed <strong>of</strong> over 480 different chemicals Our medical system relies on proven scienfific<br />
r 3rch science that is extremely difficult to deliver with a smoked plant containing a variable mixture <strong>of</strong><br />
bw ogically active compounds Dr Martin will tell you the problems associated with the study <strong>of</strong> a plant<br />
material in which no agreement exists on the standardized material<br />
Dr Martin will also explain that those who are inclined to support proposals to use marijuana as medicine do<br />
so without considering the scientific and medical evidence This evidence is necessary before any credible<br />
scientist or physician can recommend the use <strong>of</strong> marijuana as a medicine because a strong justification is<br />
needed when one wants to deliver a medicafion as a plant Dr Martin willaso provide us with the data that<br />
shows that while some who inhale the smoke <strong>of</strong> marijuana do fee better none get better<br />
The rhetorical arguments for marijuana as a medicine are not enough to legitimize it Similarly a few wealthy<br />
individuals putting on white coats and declaring that marijuana is medicine cannot substitute for the FDA<br />
process <strong>of</strong> approving drugs Marijuana must be subjected to the same efficacy and safety standards It is the<br />
opinion <strong>of</strong> the world s finest scientists and physicians however that because marijuana cannot withstand the<br />
rigors <strong>of</strong> science it will never be added to medical treatment formularies Cannabinoid derivatives on the<br />
other hand <strong>of</strong>fer tremendous promise for more specific cannabinoid medications<br />
Many legalizers andwell meaning individuals who support the use <strong>of</strong> this weed for medicine call for its<br />
availability on the basis <strong>of</strong> compassion Dr Kraus is a compassionate physician But Dr Kraus will not allow<br />
his patients to be persuaded that smoking a plant is a reasonable alternative to conventional medicines that<br />
have been deemed to be safe and effective<br />
MP iicine is at its most compassionate when the patient knows that she is getting the best that modern<br />
s ce can provide to ease suffering and cure the cause <strong>of</strong> that suffering In cases where a cure cannot be<br />
<strong>of</strong>fered management <strong>of</strong> disease to prevent progression and preserve function is a highly desired oufcome<br />
Marijuana has none <strong>of</strong> these attributes <strong>of</strong> inedicine and <strong>of</strong>fers none <strong>of</strong> these benefits Marijuana is not<br />
medicine<br />
http neoaorg index php view article catid 33Apublic id 183Amedical marijuana tmpl compone 912 2011
From Saved by Windows Internet Explorer 8<br />
ent Saturday May 01 2010 10 33 AM<br />
ubject<br />
Marijuana in the Treatment <strong>of</strong> Glaucoma<br />
Donate<br />
Ga er1<br />
The Foundation af the Ameriean Academy <strong>of</strong> phthalmology<br />
Eyecare Americasea o<br />
I I i i I<br />
Marijuana in the Treatment <strong>of</strong> Glaucoma<br />
Marijuana is a mixture <strong>of</strong> the dried flowering leaves and tops from the plant<br />
cannabis sativa and it contains over 400 chemicafs A medical use <strong>of</strong><br />
marijuana has been to lower intraocular pressure IOP in patients with primary<br />
open angle glaucoma POAG<br />
CONCLUSIONS<br />
Based on reviews by the National Eye Institute NEI and the Institute <strong>of</strong> Medicine and on available scientifc evidence the Task<br />
Force on Complementary Therapies believes that no scientifc evidence has been found that demonstrates increased benefits<br />
andlor diminished risks <strong>of</strong> marijuana use to treat glaucoma compared with the wide variety <strong>of</strong> pharmaceutical agents now<br />
available<br />
BENEFITS<br />
Initial studies in the 1970s reported that smoked marijuana resulted in lower IOP hours after administration TheNEI sponsored<br />
studies demonstrated that some derivatives <strong>of</strong> marijuana did result in lowering <strong>of</strong> IOP when administered orally intravenously<br />
or by smoking but not when topically applied to the eye The duration <strong>of</strong> the pressure lowering effect is reported to be in the<br />
range <strong>of</strong> 3 to 4 hours Benefts also include euphoria as an acute effect<br />
RISKS<br />
Potentially serious side effects associated with smoking marijuana include an increased heart rate and a decrease in blood<br />
pressure Studies <strong>of</strong>single<br />
administration marijuana use have shown a lowering <strong>of</strong> blood pressure concurrent wilh the lowering<br />
<strong>of</strong> IOP This raises concerns that there may be compromised blood flow to the optic nerve but no data have been published on<br />
the long term systemic and ocular effects from the use <strong>of</strong> marijuana by patients with glaucoma<br />
1
D Information from Groups in Support <strong>of</strong><br />
Marij uana<br />
1800 Medical Marijuana com Legal States for<br />
Medical Marijuana<br />
Perkel com Marijuana Telling Teenagers the<br />
Truth about Smoking Pot<br />
1800 Medical Marijuana com<br />
Marijuana<br />
Benefits <strong>of</strong> Medical<br />
California NORMAL Recent Research on<br />
Medical Marijuana<br />
California NORMAL<br />
Cultivation<br />
Medical<br />
Local Medical Marijuana<br />
Possession Guidelines<br />
MJ org Addictive Properties <strong>of</strong><br />
Commonly Use Drugs website page<br />
Medical Marijuana ProCon org
Legal States for Medical Marijuana Page I <strong>of</strong> 2<br />
Search<br />
Nome Services Uses and Treatment Gallery Blog Legal States News About Us Cont<br />
AAicles<br />
Info<br />
Main Menu You are here Legal States<br />
Home<br />
Services<br />
Legal States for Medical Marijuana<br />
Uses and Treatment<br />
cir<br />
v<br />
Gallery<br />
s<br />
yru<br />
n<br />
w<br />
s<br />
BIOg<br />
i<br />
Legai States<br />
Interactive Map j r<br />
Alaska<br />
Califomia<br />
ryr<br />
w t a<br />
i<br />
e<br />
tui<br />
lorado<br />
j s<br />
Nawan<br />
Maine<br />
ti<br />
b O<br />
i 4<br />
Michigan<br />
1<br />
U<br />
Montana<br />
Nevada<br />
New Jersey<br />
New Mexico<br />
Oregon<br />
Rhode Island<br />
Vermont<br />
Washington<br />
News<br />
out Us<br />
Contact Us<br />
Fourteen states have enacted laws that legalized medical marijuana<br />
State<br />
Year How Passed ID Card Possession Limit<br />
Passed IYes Vote Fee<br />
Alaska 1998 Bailot Measure 8<br />
z5 20 1 oz usable 6 plants<br />
3 mature 3 immature<br />
2 CdI1fOI ni8 1996 Proposition 215<br />
66 33 8 oz usable 18 plants<br />
6 mature 12 immature<br />
3 Colorado 2000 Bailot Amendment g0 2 oz usable 6 plants<br />
20 54<br />
3 mature 3 immature<br />
a Hawaii 2000 Senate 8tll 862 32 25 3 oz usable 7 plants<br />
s House is iz<br />
Senate<br />
s Maine 1999 Ballot Question 2<br />
o<br />
3 mature 4 immature<br />
125 oz usable 6 piants 3<br />
http<br />
1800medicalmarijuana com legal states html 927 2011
Legai States for Medical Marijuana Page 2 <strong>of</strong> 2<br />
90 Off Services mo e 100<br />
s Michigan 2008 Proposal163<br />
25<br />
25 oz usable 12 plants<br />
Montana 2004 Initiative 148 62 50 1 oz usable 6 plants<br />
a Nevada 2000<br />
Ballot Question 9<br />
ss io<br />
g 50 1 oz usable 7 plants<br />
3 mature 4 immature<br />
9 NeW Jersey 2010 Senate Bill 119 48 g0 2 oz usable<br />
14 House 25 13<br />
Senate<br />
io New Mexico 2007 Senate Bill 523 36 0 6 oz usable 16 plants<br />
r 31 House 323<br />
Senate<br />
When you join<br />
our collective<br />
OI egon 1998 6allot Measure 67<br />
you ll receive a 10 55<br />
discount on all our services<br />
4 mature 12 immature<br />
100 24 oz usable 24 plants<br />
20 6 mature 18 immature<br />
and merchandise as well as 2 Rhode 2006 Senate Bill 0710 52 75 10 25 oz usable 12 plants<br />
our medical marijuana<br />
Island<br />
o tiouse 33<br />
Senate<br />
i3 Vermont 2004 Senate Bill76 227 50 2 oz usable 9 plants<br />
HB sas sz 5s<br />
2 mature 7 immature<br />
a Washington 1998 Initiative 692 59 24 oz usable 15 plants<br />
Information taken from<br />
af<br />
f t<br />
u4 yi 7<br />
ti<br />
Check out our Facebook Pa9 e<br />
Follow 1800Mari uana 1 on Twitter<br />
LOCATIONS<br />
and become a fan today<br />
Denver CO<br />
Vail CO<br />
Los Angeles CA<br />
Copyrighi 2010 1800MedicalMarijuanacom<br />
http<br />
1800medicalmarijuana com legal states html 927 2011
Marijuana Telling Teenagers the Truth about Smoking Pot Page 1 <strong>of</strong> 11<br />
r<br />
Marijuana<br />
Telling Teenagers the Truth<br />
about Smoking Pot<br />
a<br />
Lying to Teens about Marijuana does more harm than good<br />
I think iYs wrong for society to lie to teenagers about smoking marijuana I find it frustrating<br />
when I hear ads from places like Partnership for a Drug Free America running<br />
commercials against Pot that just aren t true I don t like it when people warn teens about<br />
using Marijuana and Cocaine when Pot is almost harmless and Cocaine is a dangerous 1<br />
drug When people lie to teens about Marijuana then teens assume they are lying about<br />
other drugs too and I think they are more likely to do drugs they shouldn t do So I think iYs<br />
time to come clean and tell the truth If teens are going to do drugs they should have truthful and accurate<br />
information So I have decided to tell it like it is Best decisions are made when the real facts are presented<br />
For those parents who are reading this in horror I am not trying to get kids to smoke Pot What I am doing here<br />
is trying to tell them the truth and tell you the truth about a widely misunderstood substance This is an<br />
opportunity for everyone to have a better understanding <strong>of</strong> reality If you can t handle reality stop reading this<br />
web page There are plenty <strong>of</strong> other web sites that will tell you what you want to hear This is not one <strong>of</strong> them<br />
How bad is Marijuana Really<br />
As compared to most drugs Pot is the least dangerous Pot is not an addictive drug For those who claim it is<br />
anything is theoretically addictive and there are some people who can become addicted to spring water So to<br />
put it in perspective Pot is less addictive than c<strong>of</strong>fee I have become addicted to c<strong>of</strong>fee myself and have<br />
broken the habit You get mild headaches for a few days I have never had any symptoms for withdrawal from<br />
Pot<br />
Pot will cause some short term memory loss IYs harder to remember a 10 digit phone<br />
number Beer causes the same memory loss as Pot The effect is temporary and wears <strong>of</strong>f<br />
completely Pot has no long term affects on the brain I have been smoking Pot for the last 25<br />
years and I still test as a genius on IQ tests My mental abilities have increased over the<br />
years<br />
Pot will give you the Munchies You may eat more than you would normally If you are on a diet you should<br />
factor this in when deciding to smoke Pot It could cause you to gain weight<br />
Pot is a sexual stimulant It removes a persons inhibitions You are more likely to agree to have sex when you<br />
are stoned You are also more likely to not use birth control while stoned Sometimes people get others stoned<br />
to try to get them to have sex when they normally wouldn t If you are getting stoned with members <strong>of</strong> the<br />
opposite sex be aware <strong>of</strong> this and realize that it can have this effect on you<br />
If anyone asks if you smoke Pot Just say No<br />
Ne r drive while doing any drugs or alcohol or many prescription drugs for that matter Alcohol causes you to<br />
wreck your car Pot has a much lesser effect on driving than alcohol but it has some effect You are more<br />
likely to pull out in front <strong>of</strong> someone or run a red light than lose control <strong>of</strong> the vehicle Pot might also cause you<br />
to get lost Don t drive while stoned<br />
http www perkel com politics issues pot hhn 928 2011
Marijuana Telling Teenagers the Truth about Smoking Pot Page 2 <strong>of</strong> 11<br />
Smoking Pot increases your risk <strong>of</strong> cancer But most people smoke very little Pot If you use Pot moderately<br />
you don t have anything to worry about Moderate means a joint every few days<br />
Pot will give you dry mouth Have something to drink when smoking Pot<br />
The most dangerous thing about Pot is getting caught with it You can go to jail People get very weird about<br />
Pot and you can get in a lot <strong>of</strong> trouble over it So if anyone asks if you ve been smoking Pot Just Say No<br />
aN uvzM<br />
Benefits <strong>of</strong> Marijuana<br />
Marijuana is the safest <strong>of</strong> all drugs It is far safer to smoke a joint than to have a beer Pot is the<br />
drug <strong>of</strong> choice for people who want to get high but be responsible in getting high There are<br />
people who do no drugs at all and thaYs fine But for those <strong>of</strong> you who want to get high and be<br />
responsible Pot is a very good choice<br />
Marijuana make most people more relaxed It relieves the clutter and tension after a hard days<br />
work or school It mellows you out and makes you more relaxed It heightens the imagination<br />
and improves creativity If you have a problem with anger Pot is usually a good drug to reduce<br />
it<br />
Marijuana has other medical benefits It helps reduce problems with glaucoma If you have cancer it reduces<br />
nausea from chemotherapy I had a close friend who died <strong>of</strong> cancer His doctor prescribed Pot even though it<br />
wasn t legal I gave him some and it allowed him to eat food again This was three weeks before he died I<br />
think the Pot gave him another week <strong>of</strong> quality life<br />
M<br />
ana is also safer more effective and has less side effects than many prescription antidepressants<br />
Shortly after mv divorce when I learned that I got a judgement for more that 100 <strong>of</strong> everything I owned my<br />
doctor put me on Pamalor a common antidepressant Pamalor turned me into a zombie and made me<br />
practically impotent I merely existed and felt nothing had no motivation couldn t accomplish anything and<br />
became basically useless After two weeks <strong>of</strong> that I got <strong>of</strong>f it Getting stoned and laid a couple time a week had<br />
a much better result I was alert motivated effective sharp got better sleep happy and alive Not all<br />
antidepressants have this same effect However these drugs are overperscribed and in many cases I think<br />
that an occasional joint is a better alternative to antidepressant drugs<br />
Marijuana is especially good for those with high stress lifestyles The brain has a tendency to lock on to a<br />
problem and your mind gets into a mental loop where you can t stop thinking about work or some other<br />
problem Pot can help you break the cycle and see the problem from a different perspective or allow your mind<br />
to move on and rest allowing you to enjoy life so that you can recover and have a fresh perspective for the next<br />
day<br />
a<br />
x<br />
Marijuana can make you Smarter<br />
Marijuana enhances certain mental abilities Although it cuts into short term memory it reallocates<br />
mental resources allowing you to become more imaginative and to come up with new solutions to<br />
problems that you wouldn t normally think <strong>of</strong> when you re not stoned Much <strong>of</strong> my creative writing<br />
starts from things I though <strong>of</strong> while smoking Pot For example my web page on Teen Ciqarette<br />
Sr inc is a very effective web page that has resulted in thousands <strong>of</strong> kids decided to not<br />
smoKe cigarettes I wrote most <strong>of</strong> it while I was stoned And I came up with the concepts as to<br />
why it would work as a result <strong>of</strong> smoking Pot My smoking Pot has resulted in a decrease in teem<br />
smoking<br />
http www perkel com politics issues pot htm 928 2011
Marijuana Telling Teenagers the Truth about Smoking Pot Page 3 <strong>of</strong> 11<br />
When used correctly and responsibly Pot can actually<br />
increase your ability to find new and innovative solutions<br />
to problems<br />
Thc e are hundreds <strong>of</strong> web sites targeted at discouraging kids from smoking cigarettes and they all have the<br />
same message Smoking causes Cancer and will kill you There s nothing wrong with that message andIm<br />
sure that it reaches a lot <strong>of</strong> teens However a huge number <strong>of</strong> teens still smoke and iYs not because they<br />
haven t got the cancer message Traditional thinking results in repeating the message more times The idea<br />
being is that if these kids actually understood the health issue they would quit smoking This kind <strong>of</strong> reasoning<br />
is an example <strong>of</strong> what is known as thinking inside the box<br />
Marijuana helps you think outside the box This concept <strong>of</strong> thinking out <strong>of</strong> the box is an ability sought after<br />
by corporations who want to hire people with new an innovative ideas and actually invent a better mousetrap<br />
However by having drug testing policies the corporations are actually excluding the very people who they seek<br />
to hire I believe that if some <strong>of</strong> these corporate policy makers were to smoke some Pot themselves they<br />
would realize that Pot when used responsibly actually enhances a persons ability to make strategic decisions<br />
Going back to myanti smoking page and thinking outside the box I want to<br />
now describe the mental processes behind developing this web page while<br />
smoking Pot While I was stoned I wondered why anyone would want to start<br />
smoking cigarettes Although cancer and addiction were reason enough for me<br />
to not smoke obviously there were a lot <strong>of</strong> people who are not like me If<br />
everyone thought like I do no one would smoke I considered the idea that<br />
perhaps there were people who didn t know about cancer and addiction and<br />
quickly dismissed that It seem pretty obvious that everyone has got that<br />
me sage Therefore I reasoned that to continue to repeat the same argument<br />
isi ing to gain ground among those who have already rejected it It was<br />
logical that in order to gain ground I needed to come up with other reasons to<br />
not smoke than those that everyone already knows<br />
People who think in the box would conclude that cancer and death are the<br />
strongest arguments and that if that doesn t work then other issues wouldn t be<br />
important But what these in the box thinkers don t realize is that they are<br />
coloring things from their perspective They are for the most partnon smokers<br />
who have bought the cancer and death argument and wrongly assumes that everyone else thinks like they do<br />
But smokers see things differently Most smokers don t even know why they started smoking because they<br />
can t remember a rational process that caused them to decide to start to smoke ThaYs because most people<br />
smoke because <strong>of</strong> instinctive forces which are more powerful in humans than we would like to admit People<br />
are herd animals and the instinct to be part <strong>of</strong> the herd is more powerful than reasoning And those who<br />
advertise tobacco product know this all too well<br />
My approach on myanti smoking web page was to address the social and lifestyle issues<br />
involved in smoking To expose how the tobacco companies are manipulating your mind and<br />
taking advantage <strong>of</strong> you My web page creates mental defenses in the mind <strong>of</strong> the reader so<br />
that in the future when the reader is being seduced by tobacco that their brains are<br />
programmed to recognize the seduction and to branch to a mental process that causes outrage<br />
that they are being manipulated and results in them not deciding to smoke In addition I made<br />
strong argument about the smokers lifestyle that add many new strong arguments as to why to<br />
no noke in addition to cancer and death The problem with cancer and death is that those are<br />
loi<br />
arm arguments and many young peopie don t respond to it My additional arguments are<br />
short term effects that will start immediately and are more relevant to young people<br />
Am I saying that my web page is better than the addiction cancer and death web pages No I think those<br />
reach most people But my Pot inspired web page reaches a significant number <strong>of</strong> additional teens that the<br />
http www perkel com politics issues pot htm 928 2011
Marijuana Telling Teenagers the Truth about Smoking Pot Page 4 <strong>of</strong> 11<br />
cancer and death pages don t reach My point in this and I hope you as the reader have understood it is that<br />
Fot inspires this kind <strong>of</strong> analytical thinking that results in being able to think outside the box and to come up<br />
with new approaches to problem solving that compliment traditional solutions I hope that I have made it clear<br />
by example that Pot when used correctly and responsibly has a mind enhancing effect But I want to stress to<br />
al a read this that any drug legal or not prescription or not from c<strong>of</strong>fee to LSD should only be used<br />
correctly and responsibly<br />
w<br />
rs<br />
Marijuana can make you Dumber<br />
Pot affects everyone differently Just because Pot has some beneficial effects on me doesn t<br />
mean that it will do the same for you Everyone is different and drugs affect different people in<br />
different ways Obviously if you have tried Marijuana and it had a bad effect on you don t<br />
continue to use it<br />
Marijuana use has been associated with turning teens into mental zombies who lose all<br />
M<br />
motivation They claim that it makes it so that all you want to do is lay around and get high that<br />
you will become like Cheech n Chong There is a real correlation with lazy dopers and Pot but<br />
Im not sure if the Pot makes you a lazy doper or if you are a lazy doper type first and are<br />
therefore attracted to Pot Some people experience fear and paranoia while high on Pot Some people get<br />
headaches Marijuana does compromise certain mental abilities on a short term basis You don t want to<br />
smoke a joint before taking a test Therefore if Pot is messing up your life or you don t have the self control to<br />
use it moderately and appropriately don t use Pot<br />
s<br />
a<br />
Orug Abuse is a Bad Idea<br />
Marijuana is a drug to be used not abused Just because Pot isn t addictive doesn t mean that<br />
you should get stoned every day It doesn t mean that iYs totally safe It doesn t mean that you<br />
should go out and start smoking Pot And just because it makes me more mentally effective<br />
under some circumstances doesn t mean that iYs going to have the same effect on you There<br />
are a lot <strong>of</strong> people who experiences the opposite effect and if your one <strong>of</strong> those Pot isn t for you<br />
Pot affects different people in different ways and if Pot is having a detrimental effect on you you<br />
should not smoke it<br />
M<br />
Handhixak<br />
Drugs <strong>of</strong> all kinds have varying degrees <strong>of</strong> danger You have to be mature and responsible when<br />
experimenting with any drug You should never do a drug that you don t know what the effects are And drugs<br />
should be used in moderation and under the right circumstances You should never do any drug while driving a<br />
car especially alcohol If you are a teenager one beer can make you wreck your car<br />
Many drugs out there are highly addictive The most addictive druq that kills more people than anv other<br />
druq is Tobacco This drug is to be avoided at all costs The addiction to Tobacco is much harder to break if<br />
you get hooked at a young age Besides cancer and death Tobacco will totally change your lifestyle Your<br />
whole life will revolve around scheduling when and where you ll be able to smoke next<br />
LSD is not an addictive drug but it is very mind altering It can be viewed as having similar characteristics as<br />
Pot by much more powerful Mushrooms Mescaline and Peyote are also in thenon addictive psychedelic<br />
class <strong>of</strong> drugs They are similar to the neurotransmitters in the brain and are more mind altering than any other<br />
dr<br />
The experience can have a pr<strong>of</strong>ound effect on you and should be used only with extreme caution<br />
Once you become addicted you can t just quit You<br />
become a slave to the drug Your life revolves around<br />
http www perkel com polities issues pot htm 928 2011
Marijixana Telling Teenagers the Truth about Smoking Pot Page 5 <strong>of</strong> 11<br />
getting it This includes cigarettes<br />
Cocaine and Crack are extremely addictive So is Methamphedamine These drugs are very dangerous in that<br />
they are stimulants and require larger doses to produce the same effects Heroine and Morphine are opiates<br />
ar re also very addictive Valium and Alcohol are depressants and are also addictive Addiction to<br />
de assants take a lot longer that addiction to stimulants and opiates Cocaine and Heroine can hook you from<br />
the first dose Even c<strong>of</strong>fee is addictiveIve had to break that habit a few times myself<br />
I personally avoid all addictive drugs except Alcohol I like to drink some Beer and Wine but I<br />
don t like to get drunk Other people have a different reaction to Alcohol than I do and enjoy<br />
getting drunk Those who enjoy it are more likely to become alcoholic than those who don t<br />
Addiction makes you a slave to the drug and controls your life I never met an addict that was<br />
glad they got addicted If the people who are hooked wish they weren t what would you want to<br />
start<br />
Teens usually have a stronger tendency to follow the crowd than adults do You may find<br />
yourself in a situation where everyone else is doing a drug that you don t want to do You find<br />
yourself tempted because you don t want to go to the trouble to not go along What you may not realize is that<br />
iYs kool to say that you just don t want to do whatever everyone else is doing and not make a big deal out <strong>of</strong> it<br />
Usually the others will just say OK and iYs no big deal In other words you really can Just say No If you don t<br />
want to do a drug don t do it If someone gets pushy about it tell them to fuck <strong>of</strong>f<br />
IYs your Life Be Responsible<br />
Most people will bullshit you about the truth about drugs I have been honest about it here In<br />
fa n being honest at great personal risk because there are a lot <strong>of</strong> people out there who<br />
wo persecute me personally for saying the thingsIm saying here But whatIm saying is the<br />
truth andIm standing by itIm sure that the government particularly the moralists would like to<br />
classify this page as harmful to minors under their new censorship laws would like to see me<br />
shut down and probably jailed This page not harmful to minors iYs helpful to minors Telling<br />
minors lies about drugs is harmful to minors<br />
What I want to make clear to you who read this is that people make choices in their lives that<br />
affect who they are and who they will become If you make the right choices you are more likely to have a<br />
better life than if you make the wrong choices Although you can make all the right choices and still be killed in<br />
a car accident because someone else ran a red light But if you are smart about what you do then the odds are<br />
in your favor<br />
The most important thing a Teenager needs to learn is<br />
how to say NO and mean it<br />
These choices are yours alone and iYs your responsibility to make good choices and make your<br />
life meaningful You may have had a hard beginning and you may have to work hard climbing up<br />
the ladder <strong>of</strong> life to become successful But ultimately you become who you decide to become<br />
and you can choose to be better than what you are raised to be The choices you make are<br />
ultimately yours and you have to be responsible and take your choices seriously If you smoke<br />
cigarettes you will become a smoker If you get pregnant you will become a parent If you get<br />
hOr on Meth you will become a drug addict Its your choice and if you choose to fuck up<br />
yc fe iYs your fault But if you want to become great then you can be great even if you come<br />
from unfortunate conditions And the difference between those who become great and those who<br />
don t is that great people take control <strong>of</strong> their lives take responsibility for their decisions and through pure<br />
force <strong>of</strong> will looking into the future and through self discipline lift themselves up and achieve greatness And<br />
every one <strong>of</strong> you who read this can do the same thing<br />
http www perkel com politics issues pot htm 928 20ll
Marijuana Telling Teenagers the Truth about Smoking Pot Page 6 <strong>of</strong> 11<br />
It s your life f you screw it up you ve screwed it up It s<br />
your fault<br />
Thc was this kid bom to a single mother His father died in a car accident a few months before<br />
he<br />
s born The lived in a trailer in a small hick town in the south His mother went to nursin<br />
P<br />
9 rauri<br />
school and left him to his grandmother for a few iniOiooA<br />
years Then his mother married a drunk and had<br />
another kid The father wouid <strong>of</strong>ten get drunk and get violent The younger brother grew up and<br />
became a Cocaine addict But this kid decided that he was going to rise above his upbringing as<br />
a poor southern white trash stepson <strong>of</strong> a drunk and make something <strong>of</strong> himself He worked hard<br />
and got good grades in school and in 1962 his class went on a trip to Washington where he<br />
shook hands with President Kennedy At that moment that poor kid from Arkansas decided that<br />
some day he was going to be President <strong>of</strong> the United States and he went out and did it If this<br />
kid could become President surely you can decide to grow up and not get hooked on drugs IYs your life and<br />
you can be what you want to be<br />
r<br />
n<br />
i Why Marijuana should be Legal<br />
Legalizing Marijuana would be a benefit to society We as a nation would be improved by it<br />
There are several reasons I make this claim Although Pot has iYs problems iYs benefits for<br />
a<br />
outweigh iYs consequences<br />
If Pot were legal many people would switch from alcohol to Pot I think that a lot <strong>of</strong> Alcohol<br />
abuse come from the fact that it is the only legal drug and therefore is overused Alcohol is highly<br />
addictive physically and psychologically destructive and is a severe drag on society I think that<br />
if Pt were legal that many people would switch to Pot and be much better <strong>of</strong>f I think one side<br />
ef <strong>of</strong> legalizing Pot would be a major reduction in the abuse <strong>of</strong> Alcohol and that the number <strong>of</strong><br />
traffic deaths would drop dramatically<br />
The only reason Pot isn t legal is because there are a lot<br />
<strong>of</strong> people making money because its not legal<br />
Another reason is to save the huge cost in tax dollars wasted in prohibiting Pot and enforcing<br />
drug laws that have no benefit to society If Pot were legal you immediately eliminate the illegal<br />
Pot market and get rid <strong>of</strong> crime associated with Pot money You could also release from jail all<br />
those convicted from Pot related <strong>of</strong>fenses and cut the costs <strong>of</strong> having to build new prisons to<br />
incarcerate normal people Because <strong>of</strong> mandatory drug sentencing laws many states have to<br />
release violent <strong>of</strong>fenders to make room for Pot smokers ThaYs stupid<br />
r<br />
a<br />
qL<br />
y<br />
Pot has many other uses Before the lumber industry lobbied Congress to make Pot illegal<br />
Marijuana known as Hemp was the primary source <strong>of</strong> fiber for the production <strong>of</strong> paper The<br />
United States Constitution is printed on Pot With today s technologies this fiber can be processed into<br />
construction materials that would replace wood products saving our forests and lowering the costs <strong>of</strong><br />
construction while producing byproducts useful in making fuels to run cars and generate electricity Hemp is a<br />
very hearty plant and would be a good cash crop for our nation s farmers<br />
Who opposes legalizing Marijuana and why<br />
There are many types <strong>of</strong> people who oppose legalizing Marijuana for a variety <strong>of</strong> reasons Many<br />
<strong>of</strong> these groups have some very strange reasons and selfish interests Many are just ignorant <strong>of</strong><br />
the facts Here s some <strong>of</strong> the opposition<br />
http www perkel com politics issues pot htm 928 2011<br />
Lit<br />
rv<br />
FiS
Marijuana Telling Teenagers the Truth about Smoking Pot Page 7 <strong>of</strong> 11<br />
The Uninformed<br />
People who believe the misinformation that Pot is harmful to society<br />
The Government Pot has been illegal for so long that no politicians have the political courage to tell the<br />
truth about Pot The ones that do tell the truth are defeated by their opponents that paint them as a<br />
jruggie Many <strong>of</strong> these anti drug politicians are funded by the Alcohol lobby<br />
Religion Anything fun is sin and <strong>of</strong> the Devil Churches might lose members as people figure out that<br />
God can t be that stupid<br />
Moralizers The morally superior who enjoy looking down their noses at the less fortunate<br />
and get a sadistic thrill in putting people in jail<br />
People who do no Drugs These people who don t drink don t smoke in some cases<br />
don t even drink c<strong>of</strong>fee They just don t understand why anyone would want to smoke<br />
anything or do any drug From their perspective the world would be better <strong>of</strong>f if no one did<br />
anything<br />
The Alcohol Lobby Legalizing Pot would seriously cut into the sales <strong>of</strong> Beer Pot would<br />
become the recreational drug <strong>of</strong> choice because it is safer than Beer<br />
The Tobacco Lobby Pot has the ability in some people to help them break the addiction <strong>of</strong> nicotine<br />
Pot smoking could actually reduce the number <strong>of</strong> tobacco addicts<br />
x<br />
People before Lawyers<br />
aw Enforcement There are a lot <strong>of</strong> people who make a living fighting Pot who would have to go get a<br />
real job if Pot were legalized Police departments get a lot <strong>of</strong> funding to fight Marijuana and those funds<br />
could be returned to the taxpayer if Pot were made legal Cops would have to chase robbers rapists and<br />
murderers<br />
Government Agencies Using unconstitutional civil forfeiture laws the government has been able to use<br />
the presence <strong>of</strong> Pot to steal billions <strong>of</strong> dollars <strong>of</strong> private property from the People Drug laws have been<br />
an excuse to circumvent our constitutional right and justify wire tap laws the erosion <strong>of</strong> protection from<br />
illegal searches key recovery encryption and domestic spying If you take a politically unpopular position<br />
like this oneIm taking now the government can plant drugs on you and put you away<br />
Pot Dealers If Pot were legalized then people making money <strong>of</strong>f <strong>of</strong> selling Pot illegally wouid be out <strong>of</strong><br />
business Pot prices would drop to 10 a bale Crime relating to illegal Pot money would vanish<br />
Wood Industry Hemp would become the primary source <strong>of</strong> fiber for paper products as<br />
well as a new source for building materials We wouldn t have to cut down every big tree in<br />
the world<br />
Private Prisons If Pot were legalized the private prison industry would be hurt They<br />
would no longer jail Pot smokers It could free up space for violent criminals<br />
Trial Lawyers Normal people caught with a joint spend billions each year on lawyers to<br />
get them <strong>of</strong>f <strong>of</strong> criminal charges after getting caught with a joint Lawyers get rich <strong>of</strong>f <strong>of</strong> the<br />
Vlarijuana laws If Marijuana were legal this money could be spent sending your kids to college<br />
Mental Hospitals There s a big industry treating people for problems they don t have If you have<br />
insurance you re crazy until the insurance coverage runs out If you smoke Pot then you have mental<br />
problems If Pot were legal some <strong>of</strong> these people would have to get real jobs We should start treating<br />
http www perkel com polirics issues pot htm 928 2011
Marijuana Telling Teenagers the Truth about Smoking Pot Page 8 <strong>of</strong> 11<br />
people who are addicted to 12 step programs<br />
Republicans Pot helps you see reality the way it really is IYs harder to con a Pot smoker on political<br />
issues Once you get stoned iYs harder to want to hate Liberals Queers Blacks Pregnant Teens Draft<br />
Dodgers President Clinton Feminists Lesbians Pot Smokers and other people the Republicans want<br />
you to hate When you re stoned iYs harder to like Newt Gingrich John Ashcr<strong>of</strong>t the KKK the Christian<br />
Coalition Jerry Falwell Pat Buchanan Reverend Sun Myung Moon People who beat Gay s to Death<br />
People who blow up Abortion Clinics and the morally superior in general<br />
Political Cowards Politicians like to pose with police as somebody who is against<br />
drugs promising to lock up all the pot smokers and throw away the key These people<br />
need an artificial issue to be against so they don t have to face real issues like how to<br />
protect the public from crooked lawyers and crooked judges Political cowards cross all<br />
party lines when it comes to pot and includes President Clinton<br />
Others These groups could also be hurt by legalizing Pot Car body shops would get less r<br />
alcoho related wrecks to fix Hospitals would get less alcohol related business as would<br />
alcohol treatment centers and funeral homes It could hurt cemeteries and tombstone<br />
makers as well<br />
tmportant Peopfe for Legalizing Marijuana<br />
There have been several people who have come out in favor <strong>of</strong> legalizing marijuana in the last<br />
year or so These people have shown courage in the face <strong>of</strong> this artificial drug hysteria<br />
r<br />
3overnor Jesse Ventura <strong>of</strong> Minnesota Governor Ventura the first governor elected by the Reform Party is the famousex<br />
w<br />
wrestler Navy Seal who is known for telling it like it is<br />
cs<br />
a<br />
Governor Gary Johnson <strong>of</strong> New Mexico The Republican governor has come out in FF<br />
favor <strong>of</strong> legalizing pot This is an especially brave move for a Republican as the 1<br />
Republican Party has been especially abusive <strong>of</strong> Marijuana users<br />
Hugh Downs ABC News 20co anchor and respected journalist for more than 60 years retired On<br />
his last show he was asked if he had any opinions <strong>of</strong> his own that he d like to express He responded the<br />
marijuana should be legalized<br />
Oppressing Pot Smokers is the Real Crime<br />
The time has come where We the People have to stand up to the government and tell them that<br />
we are no longer going to put up with the jailing and oppression <strong>of</strong> pot smokers and this artificial<br />
war on drugs They teach you that there are three branches <strong>of</strong> government by in fact there are<br />
four branches The fourth branch <strong>of</strong> aovernment is the ueople The time has come for<br />
reasonable people to rise up against the government and to force them to justify the reason for<br />
oppressing pot smokers and drug addicts People in America have been to complacent for to<br />
long and the time has come to stand up and get in their faces and demand satisfaction<br />
x 5<br />
Myths about Marijuana<br />
The most common myth is that Marijuana Leads to Harder Drugs Critics say the medical<br />
http www perkel com politics issues pot htm 928 2011
Marijuana Telling Teenagers the Truth about Smoking Pot Page 9 <strong>of</strong> 11<br />
marijuana movement promotes drug abuse and criminal behavior by ushering young people into<br />
what one judge has called the kindergarten <strong>of</strong> the drug industry They call Pot the gateway drug and say<br />
that once you do Pot that you will need to move on to harder drugs like LSD Heroine and Cocaine to get the<br />
same thrill Sounds good but it just isn t so<br />
Marijuana does not lead to harder drugs<br />
Actually if there is anything that s a gateway drug iYs nicotine Tobacco is the first drug that kids use IYs<br />
illegal for kids and unlike Pot iYs addictive Once a kid is hooked on nicotine they have joined the ranks <strong>of</strong><br />
drug addicts As an addict already its easier for them to move on to other addictive drugs like Alcohol<br />
Cocaine Crack Meth and Heroine<br />
Marijuana on the other hand is the choice <strong>of</strong> the responsible drug user A person who wants to<br />
get high on something that isn t addictive and doesn t have any long term health effects for the<br />
moderate user would likely choose to smoke Pot This is the drug <strong>of</strong> choice for those who don<br />
want to be on the path <strong>of</strong> drug addiction<br />
t s<br />
Another common myth is there is no <strong>of</strong>ficial pro<strong>of</strong> to back the contention that marijuana<br />
can help ease symptoms <strong>of</strong> AIDS cancer multiple sclerosis and other serious<br />
diseases But the reason there is no pro<strong>of</strong> is that the government is actively avoiding the<br />
funding <strong>of</strong> inedical research inYo medical uses <strong>of</strong> Marijuana because they are afraid that they<br />
will indeed discover what doctors already know and it would undermine the laws criminalizing Marijuana and<br />
lead to legalization If you want to read something amusing read the study from National Institute <strong>of</strong> Health<br />
Here s pages and pages documenting the results <strong>of</strong> doing nothing to research the medical benefits <strong>of</strong> smoking<br />
PotIve never seen such a long paper documenting what the government hasn t investigated or tested If the<br />
government weren t afraid <strong>of</strong> legalizing Pot they would Yest it The fact that the government won t do medical<br />
testc on Pot proves that they don t want to know the truth<br />
WhaYs more outrageous is the claims that the government makes about Marijuana when they<br />
refuse to make any medical or scientific tests They claim that smoked Marijuana damages the<br />
brain heart lungs and immune system but they don t know that There have been some tests<br />
done indicating that Marijuana can cause lung cancer even more so than cigarettes But those<br />
test don t take into account that the usage isn t 100th as much as cigarette smokers If the<br />
government wants to make medical ciaims about Pot they should test it and look at the scientific<br />
data I challenge the government to do the research and then we ll talk about reality<br />
t<br />
Twisting Logic<br />
I find it amazing how the anti pot organizations twist logic to try to justify their positions that pot is a dangerous<br />
drug And these people wonder why teenagers don t take their message seriously Teens just aren t that<br />
stupid And when you try to pull stupid logic tricks on teens they resent it and ignore you If they are going to<br />
accuse us <strong>of</strong> being brain damaged the sure aren t setting a very good example <strong>of</strong> what normal is supposed<br />
to be Here some examples <strong>of</strong> tortured logic<br />
90a <strong>of</strong> drug addicts smoked Marijuana first Therefore smoking Marijuana leads to harder<br />
drugs<br />
Wow This is really brilliant Based on that reasoning 99 <strong>of</strong> drug addicts attended church<br />
efore becoming a drug addict Therefore going to church leads to harder drugs What else<br />
did over 90 <strong>of</strong> drug addicts do first Over 90 <strong>of</strong> drug addicts smoked a cigarette most<br />
still do They drank alcohol most still do How about watched television voted for a<br />
Democrat had a pet had sex owned a bicycle chewed gum participated in sports<br />
celebrated Halloween had a religious experience took something that didn t belong to<br />
http www perkel com politics issues pot htm 928 2011
Marijuana Telling Teenagers the Truth about Smoking Pot Page 0 <strong>of</strong> 11<br />
them voted for a Republican told a lie wondered if they might be homosexual or ate too<br />
much white sugar Using the same reasoning all these activities must also lead to harder drugs<br />
There are over 400 chemicals in the marijuana plant<br />
There are over 400 chemicals in every plant There are over 700 chemicals added to American<br />
cigarettes<br />
When a user begins to feel that he or she needs to take the drug to feel well that person is said<br />
to be dependent or addicted to the drug<br />
I supposeIm addicted to aspirin When I get a headache I need aspirin to feel well<br />
Everything that feels good is addictive and there s a 12 step program out there for every<br />
one <strong>of</strong> them And if you don t believe it you re in DENIAL Since they know that Pot isn t<br />
addictive they try to redefine the word addiction and try to make Pot fit the new definition<br />
The fact that the need to twist the definition indicates that they know that Pot doesn t fit the<br />
traditional definition <strong>of</strong> addiction<br />
r r i<br />
Drug addiction occurs when the drug affects the body in a way that causes the body to<br />
become dependent on the drug and causes a negative reaction when the drug is removed<br />
Marijuana LSD and magic mushrooms are examples <strong>of</strong>non addictive drugs Cocaine Heroine<br />
Methamphedamine Alcohol Tobacco and Caffeine are examples <strong>of</strong> addictive drugs Telling lies about<br />
what drugs are addictive is not going to help solve the drug problem<br />
Marijuana Related Links<br />
Medical Organizations Endorsinq Marijuana<br />
Marijuana Policy Project<br />
Cannabis Freedom Fund<br />
What Teens should know about Smoking Cigarettes<br />
Marijuana Special Report New Scientist<br />
Mary Jane s Garden<br />
Anti Marijuana Web Sites<br />
Read Both Sides <strong>of</strong> the Issue<br />
Marijuana Facts for Teens<br />
Marijuana Anonymous<br />
White House statements on MariLana Policy<br />
r<br />
A Ring <strong>of</strong> Cannabis Marijuana and Hemp Related Sites<br />
fPrevious Sitel fRandom Site Next Site<br />
Home Join The Rinq WebRin CID<br />
OOa<br />
Shoopinq EMail Home<br />
http www perkel com politics issues pot htrn 928 20ll
Marijuana Telling Teenagers the Truth about Smoking Pot Page 11 <strong>of</strong> 11<br />
Computer Tytne 1Neb Hr sting<br />
Good Raliable Hasting<br />
Flat Pricing Structrrs<br />
Junk Email Filter<br />
dot eom<br />
Front end SpamFil cring tar your pomain<br />
THE CHURCH OF<br />
REP LIT<br />
If its Reat<br />
We believe in itP<br />
Coovriqh Terms<br />
no<br />
e<br />
i<br />
4<br />
A project <strong>of</strong> the People s leqal Front<br />
1<br />
http www peckel com politics issues pot htm 928 20ll
Benefits <strong>of</strong> Medical Marijuana Page 1 <strong>of</strong> 2<br />
Wedoesday 10 February 2010 01 19<br />
Benefits <strong>of</strong> Medical Marijuana<br />
Written by1800 Medical Marijuana<br />
font size<br />
Print<br />
Rate this item<br />
28 votes<br />
Every day it becomes more difficult to deny the benefits <strong>of</strong> inedical marijuana<br />
Ask anyone who s used it for pain management relating to alife altering illness<br />
Cancer AIDS Glaucoma Multiple Sclerosis and Crohn s disease among others<br />
and they ll tell you how its changed their lives<br />
How smoking or ingesting a natural herb has made managing their pain and side effects a revelation That when<br />
compared to any variety <strong>of</strong> chemically enhanced pharmaceutical <strong>of</strong>ferings the little white pills simply don t measure<br />
up<br />
Take side effects for instance Most prescription drugs come with a multi page rider <strong>of</strong> possible bad things that might<br />
happen with regular use liver damage is almost synonymous with long term use Compare that to marijuana which<br />
studies show have almost no permanent damage with long term use and many patients choose not to smoke Baked<br />
goods butters oils and other natural means make marijuana the easiest medicine to swallow<br />
And medical marijuana doesn t only benefit debilitating illnesses It has also been found to ease the discomfort<br />
surrounding arthritis chronic pain and nausea Many women report success when using marijuana to treat menstrual<br />
cramps and menopausal women have found great success in using marijuana to battle hot flashes mood swings and<br />
chills Currently there are studies being done which indicate that medical marijuana might have a positive effect on<br />
depression and other anxiety related disorders<br />
The bunch <strong>of</strong> stoners stereotype has followed responsible marijuana users around for far too long Like any other<br />
beneflcial drug marijuana can be abused Unlike every other beneficial prescription drug out there it is vir ually<br />
impossible to overdose on marijuana Classifying marijuana as a dangerous drug in the first place is a little like<br />
outlawing black cohosh or ginseng or any <strong>of</strong> the other herbs routinely used in different cultures for healing and pain<br />
management It is an alternative medical course as legitimate as chiropractic medicine and <strong>of</strong>ten used hand in hand<br />
to great results Chiropractic philosophy lines up perfectly with that <strong>of</strong> inedical marijuana your body and nature has<br />
the power to heal<br />
Ultimately thaYs the number one beneft marijuana has to <strong>of</strong>fer it is an herb grown from the earth It is not processed<br />
or refined or chemically enhanced It does not contain an endless list <strong>of</strong> unpronounceable ingredients designed to<br />
carefully manipulate the symptoms <strong>of</strong> your illness Marijuana is a natural medicine whose potential applications have<br />
not yet begun to scratch the surface<br />
Last modified on Wednesday 24 February 201p 07 01<br />
http<br />
1800medicalmarijuana<br />
blog item 3benefits <strong>of</strong><br />
marijuana html tmpl component print 1 927 2011
Benefits <strong>of</strong> Medical Marijuana Page 2 <strong>of</strong> 2<br />
Read 14280 times<br />
Like this Tweet it to your followers<br />
Pubiished in<br />
Medical Marijuana<br />
Tagged under benefits denver medical marijuana colorado california dispensaries<br />
Social sharing<br />
Latest from1800 Medical Marijuana<br />
Medical Marijuana and Cancer Treatment<br />
Medical Marijuana and Epilepsy<br />
Medical Marijuana And Crohn s Disease<br />
Medical Marijuana and Alzheimer s<br />
Is Medical Marijuana Coming to New York<br />
Related items by tag<br />
Medical Marijuana and Cancer Treatment<br />
Medical Marijuana and Epilepsy<br />
Medical Marijuana And Crohn s Disease<br />
Medical Marijuana and Alzheimer s<br />
Is Medical Marijuana Coming to New York<br />
back to toq<br />
http<br />
1800medicalmarijuana<br />
blog iten 3benefits <strong>of</strong><br />
marijuana html tmpl component prinr 1 927 2011
Recent Research on Medical Marijuana NORML Page 1 <strong>of</strong> 4<br />
r<br />
a<br />
Sear iti<br />
i 1 4<br />
Vl L Home Librarv<br />
HealthReoarts Recent<br />
f CheaoVOlcanoVaoorizers<br />
Tc ftesearch on Metlical Marijuana<br />
LICjI Ui1J Vaporizer Units Replacement Par s<br />
Online Free Shipping Over 50<br />
Sign up Recent Research on wwwcsm<br />
Medical Marijuana<br />
Share This Pa9e<br />
h<br />
Select a State<br />
Emerging Clinical Applications For Cannabis<br />
Cannabinoids<br />
A Review <strong>of</strong> he Recent Scientific Literature 2000<br />
State Laws I LevesEtatales Z011 Poreword<br />
Medical Conditions<br />
ODonate Now<br />
IQNORML PAC<br />
Take Action<br />
fiiort7 S<br />
AIZh0fffl8 S<br />
st A<br />
k<br />
UliR SC BCUSiS<br />
ALS<br />
Ghronic Pain<br />
cannabinoid5vstem<br />
eimer s Disease<br />
FAQ S<br />
nic Pain<br />
Fiproinyalqi8<br />
NewS Archive<br />
Fouretta<br />
sSyadrome<br />
ereshleliitus<br />
Dystanla H1V<br />
malaia<br />
LibrarV<br />
ygp2 t18 G HypertEnsiun iso ders r<br />
p<br />
<strong>of</strong> Contents<br />
nas Cancer<br />
Real World Ramifications <strong>of</strong> OiBhetcS Sleep ApneB<br />
3titis C<br />
Cannabis Leqalization and<br />
criminalization<br />
GI DiSotdBrg<br />
rensioninence<br />
RMLTestimonv<br />
Pruritus<br />
InconUnBnGe q<br />
nforcement<br />
4 iole Sclerosis<br />
ks Mariivana Decriminalization<br />
i<br />
000ro5i5<br />
itus<br />
Reports and Commission<br />
matoitl Arthri is<br />
Findin s Ostaoporosis NheumaroldArthriGs pqonea<br />
F Health Reoorts<br />
Recent Research on<br />
Medical Marijuana<br />
Cannabl5 Men al Health<br />
and Contezt The Case For<br />
Reaulation<br />
Breathe Push Puff Pot<br />
Use and Preqnancv A<br />
Review <strong>of</strong> the Literature<br />
As Cancer<br />
Cannabinoids pptarttla<br />
HOpe<br />
nNORML s Mariivana Health<br />
Mytholoov<br />
zjMariivana<br />
Mvth and Facts Despite<br />
asritish Medical<br />
nssociatiods ancet<br />
Su000rts Mariivana Law<br />
aeform<br />
Medical Mariivana Reoorts<br />
Hemo Reoorts<br />
Arrest Reoorts<br />
Economics Reoorts<br />
orivina<br />
and Mariivana treatment<br />
Mariivana CroP Reoorts<br />
ASA<br />
7 i<br />
7hanprutic Usas <strong>of</strong> Medical MadJuana<br />
et es Svndrome<br />
the ongoing political debate regarding the legality <strong>of</strong> inedical<br />
marijuana dinical investigations <strong>of</strong> the therapeutic use <strong>of</strong> cannabinoids are<br />
now more prevalent than at any time in history<br />
For example in February 2010 investigators at the Universitv <strong>of</strong> California<br />
Center for Medicinal Cannabis Research publicly announced the findin s <strong>of</strong> a<br />
series <strong>of</strong> randomized placebo controlled clinical trials on the medical utility<br />
<strong>of</strong> inhaled cannabis The studies which utilized theso called gold standard<br />
FDA clinical trial design concluded that marijuana ought to beafirst line<br />
for patients with neuropathy and other serious illnesses<br />
Among the studies conducted by the Center four assessed smoked<br />
4orua 7estina<br />
marijuana s ability to alleviate neuropathic pain a notoriously difficult to<br />
rooean Drua Laws<br />
treat type <strong>of</strong> nerve pain associated with cancer diabetes HIV AIDS spinal<br />
RML Freedom <strong>of</strong><br />
a<br />
cord injury and many other debilitating conditions Each <strong>of</strong> the trials found<br />
information rteauests<br />
that cannabis consistently reduced patients pain levels to a degree that was<br />
Survevs<br />
Polls<br />
as good or better than currently available medications<br />
OIn The Media<br />
http www norml org index cfm Group ID 7002<br />
Another studY conducted by the Center s investigators assessed the use <strong>of</strong><br />
1032011
1<br />
m<br />
i<br />
r<br />
Recent Research on Medical Marijuana NORML Page 2 <strong>of</strong> 4<br />
NORML Chapters<br />
WOmen S Allidrtce marijuana as a treatmen for patients suffering from multiple sclerosis That<br />
COntaCt OffiCidls study determined that smoked cannabis was superior to placebo in reducing ge5t 420<br />
spasticity and pain in patients with MS and provided some benefit beyond<br />
EvaluOtionS<br />
sonal Use<br />
ut Marijudna currently prescribed treatments 42 Medical Marijana<br />
Card Get Appt Now<br />
Around the globe similarly controlled trials are also taking place<br />
MediCal USe<br />
g16 484 1200<br />
review by researchers in Germany reports that since 2005 there have been<br />
32oe awatons info<br />
OIndustridl U5e<br />
37 controlled studies assessing the safety and efficacy <strong>of</strong> marijuana and its<br />
Leqal ISSUeS<br />
naturally occurring compounds in a total <strong>of</strong>2563 subjects By contrast<br />
most FDA approved drugs go through far fewer trials involving far fewer TrinitV Uraent<br />
Find A awyer subjects Care<br />
Open daily 9am<br />
Contdct Us While much <strong>of</strong> the renewed interest in cannabinoid therapeutics is a result <strong>of</strong> gPm 365 days 10200<br />
PbOUt NORML the discovery <strong>of</strong> the endocannabinoid requlatorv svstem which we describe Trinity PKWY<br />
NORML FoUfldation in detail later in this booklet some <strong>of</strong> this increased attention is also due to www niniCY ucpm<br />
the growing body <strong>of</strong> testimonials from medical cannabis patients and their<br />
TShi1 ts G@dr Physicians Nevertheless despite this influx <strong>of</strong> anecdotal reports much <strong>of</strong> ToVOtaC OffiClal<br />
the modern investigation<br />
Webtnaster Tools<br />
<strong>of</strong> inedical cannabis remains limited o preclinical<br />
Site<br />
animal studies <strong>of</strong> individual cannabinoids eg THC or cannabidiol and or<br />
Discover the 2012<br />
BU5ine55 synthetic cannabinoid agonistseg dronabinol or WIN 55 212 rather<br />
Suppol t2r5 than clinical trial investigations involving whole plant material Because <strong>of</strong> Toyotap Camry<br />
the US government s strong public policy stance against any use <strong>of</strong> Reliable Durable<br />
cannabis the bulk <strong>of</strong> this modern cannabinoid research is predictably taking Learn More<br />
SPY 9ta co min ewcamry<br />
ONORML inks<br />
6nail this paqe place outside the United States www<br />
ane uis oane<br />
Meet others Share Stories<br />
Facebook<br />
MvSoace<br />
7witter<br />
j diaa<br />
y<br />
Stumble Uoon<br />
9rowing<br />
f del icio us<br />
vouTUhe<br />
i Flickr<br />
L Goale<br />
NORML Chaoters<br />
NORML Bloa<br />
oailv nudio Stash<br />
Drug Addietion<br />
As clinical research into the therapeutic value <strong>of</strong> cannabinoids has<br />
TreatmEnt<br />
prolifera ed there are now an estimated 20 oublished oapers in the premier Napa Valley<br />
scientific literature analyzing marijuana and its constituents so too has Alcohol Rehab Sober<br />
investigators unders anding <strong>of</strong> cannabis remarkable capability to combat<br />
Recovery for over 40<br />
disease Whereas researchers in the 1970s 80s and 90s primarily assessed<br />
years<br />
cannabis ability to temporarily alleviate various disease symptoms such<br />
oufrvsRehab com<br />
as the nausea associated with cancer chemotherapy scientists today are<br />
exploring the potential role <strong>of</strong> cannabinoids to modifv disease<br />
Medieal 420 M7<br />
Of particular interest scientists are investigating cannabinoids capacity to<br />
moderate autoimmune disorders such as multiple sclerosis rheumatoid<br />
arthritis and inflammatorv bowel disease as well as their role in the<br />
treatment <strong>of</strong> neurological disorders such as Alzheimer s disease and<br />
amvotrophic lateral sclerosisaka Lou Gehrig s disease In fact in 2009<br />
the American Medical Association AMA resolved for the first time in the<br />
organization s history that marijuana s status as a federal Schedule I<br />
controlled substance be reviewed with the goal <strong>of</strong> facilitating the conduct <strong>of</strong><br />
clinical research and development <strong>of</strong> cannabinoid basetl medicines<br />
Investigators are also studying the anti cancer activities <strong>of</strong> cannabis as a<br />
body <strong>of</strong> preclinical and clinical data concludes that cannabinoids can<br />
reduce the spread <strong>of</strong> specific cancer cells via apoptosis programmed cell<br />
death and by the inhibition <strong>of</strong> angiogenesis the formation <strong>of</strong> new blood<br />
vessels Arguably these latter findings represent far broader and more<br />
significant applica ions for cannabinoid therapeutics than researchers could<br />
have imagined some thirty or even twenty years ago<br />
THE SAFETY PROFILE OF MEDICAL CANNABIS<br />
Evaluation<br />
We match all other<br />
<strong>of</strong>fers If you don t<br />
pass you don t pay<br />
caiiazodoctor va luat on cpm<br />
s<br />
uitnii MF<br />
fipm P5T<br />
FROM TNE BLA6<br />
Cannabinoids have a remarkable safety record particularly when compared World s Larges Drug Policy<br />
to other therapeutically active substances Most significantly the<br />
Reform Conference One Month<br />
Awdy<br />
consumption <strong>of</strong> marijuana regardless <strong>of</strong> quantity or potency cannot oim os oc zoii<br />
induce a fatal overdose According to a 1995 review prepared for the World<br />
Health Organization There are no remrded cases <strong>of</strong> overdose fatalities<br />
Aweses<br />
attributed to cannabis and the estimated lethal dose for humans<br />
extrapolated from animal studies is so high that it cannot be achieved by<br />
U52f5<br />
In 2008 investigators at McGill Universi y Health Centre and McGill<br />
University in Montreal and the University <strong>of</strong> 8ritish Columbia in Vancouver<br />
reviewed 23 clinical investigations <strong>of</strong> inedical cannabinoid drugs typically<br />
oral THC or liquid cannabis extracts and eight observational studies<br />
conducted between 1966 and 2007 Investigators did not find a higher<br />
incidence rate <strong>of</strong> serious adverse events associated with medical cannabinoid<br />
use compared to non controls over these four decades<br />
sce9 Reap d<br />
wnat we sow<br />
Fn 3o sep zoii<br />
A Pot Pardon Plea Prisoner<br />
Seeks Presidential Pardon For<br />
Offenseear Senrence For Firs<br />
ved za 5eU mii<br />
Feds 7o Legal Medical<br />
Marijuana Patients You Don t<br />
Ha e second nmendmen<br />
Riqncs Pe od<br />
Wed 28 Sep Z011<br />
New Vork <strong>City</strong> Police<br />
Commissioner Calls On Officers<br />
http www norml org index cfm Group ID 7002<br />
10 32011
Recent Research on Medical Marijuana NORML Page 3 <strong>of</strong> 4<br />
NORML on That said cannabis should not necessarily be viewed asaharmless<br />
110Nti11 Facebook substance Its active constituents may produce a variety <strong>of</strong> physiological and<br />
To Curb Manjuana Arrests<br />
Tue 2 Sep 2011<br />
euphoric effects As a resul there may be some populations that are<br />
Like<br />
susceptible to increased risks from the use <strong>of</strong> cannabis such as adolescents<br />
oreonant or nursinq mothers and pa ients who have a family history <strong>of</strong><br />
3a5 b41 people like mental illness Patients with heoatitis C decreased lung function such as impact on driving<br />
noRM<br />
aanyne<br />
Stpne<br />
chronic obstructive pulmonarv disease or who have a history <strong>of</strong> heart<br />
disease or stroke may also be at a greater risk <strong>of</strong> experiencing adverse side<br />
effects from marijuana As with any medication patients should consult<br />
thoroughly with their physician before deciding whether the medical use <strong>of</strong><br />
cannabis is safe and appropriate<br />
HOW TO USE THIS REPORT<br />
Learn the truth about poYs<br />
State DUID Laws<br />
Get NORML News for<br />
iPhone and iPotl Touch<br />
Change Marijuana Laws in<br />
Your State Act Nowl<br />
As states continue to approve legislation enabling he physician supervised<br />
use <strong>of</strong> inedical marijuana more patients with varying disease types are<br />
Nearly 200 Studies Support<br />
NOaM on Facebook exploring the use <strong>of</strong> therapeutic cannabis Many <strong>of</strong> these patients and their Medical Cannabist Read<br />
physicians are now discussing this issue for the first time<br />
Them<br />
and are seeking<br />
guidance on whether the therapeutic use <strong>of</strong> cannabis may or may not be<br />
advisable This report seeks to provide this guidance by summarizing the<br />
most recently published scien ific research 2000 2010 on the therapeutic<br />
use <strong>of</strong> cannabis and cannabinoids for 19 dinical indications<br />
Here<br />
Alzheimer s disease<br />
Amvotrophic lateral sclerosis<br />
ChroniC qdin<br />
Diabetes meilitus<br />
Dvstonia<br />
Fibromvalqia<br />
Gastrointestinal disorders<br />
Gliomas other cancers<br />
Heoatitis C<br />
Human Immunodeficiencv Virus<br />
HVPertension<br />
Incontinence<br />
MethicillimresistantSta hvloccus aureus MRSA<br />
Multiole sclerosis<br />
Osteoporosis<br />
Pruritus<br />
Rheumatoid arthritis<br />
Sleeo aonea<br />
Tourette s svndrome<br />
In some <strong>of</strong> these cases modern science is now affirming longtime anecdo al<br />
reports <strong>of</strong> inedical cannabis userseg the use <strong>of</strong> cannabis to alleviate Gi<br />
disorders In other cases this research is highlighting entirely new potential<br />
clinical utilities for cannabinoidseg the use <strong>of</strong> cannabinoids o modify the<br />
progression <strong>of</strong> tliabetes<br />
The conditions pr<strong>of</strong>iled in this report were chosen because patients<br />
frequently inquire about the therapeutic use <strong>of</strong> cannabis to treat these<br />
disorders In addition many <strong>of</strong> the indications included in this report may be<br />
moderated by cannabis therapy In several cases preclinical data and<br />
clinical data indicate that cannabinoids may halt the progression <strong>of</strong> these<br />
diseases in a more efficacious manner than available pharmaceuticals<br />
For patients and their physicians this report can serve as a primer for those<br />
who are considering using or recommending medical cannabis For others<br />
this report can serve as an introduction to the broad range <strong>of</strong> emerging<br />
clinical applications for cannabis and its various compounds<br />
Paul Armentano<br />
Deputy Director<br />
NORML NORML Foundation<br />
Washington DC<br />
January 7 2011<br />
The author would like to acknowledge Drs Dale Gierinqer Dustin Sulak<br />
Gregory Carter Steven Karch and Mitch Earlevwine as well as Bernard<br />
Ellis MPH former NORML interns ohn Lucy Christopher Rasmussen and<br />
http www norml org index cfm Group ID 7002<br />
1032011
Recent Research on Medical Marijuana<br />
NORML Page 4 <strong>of</strong> 4<br />
Rita Bowles for providing research assistance for this report The NORML<br />
Foundation would also like to acknowledge Dale Gieringer Paul Kuhn and<br />
Richard Wolfe for their financial contributions toward the publication <strong>of</strong> this<br />
report<br />
Important and timely publications such as his are only made possible<br />
when concerned citizens become involved with NORML For more information<br />
on joining NORML or making a donation please visit<br />
htto www norml orq ioinTax deduc ible donations in support <strong>of</strong> NORML s<br />
public education campaigns should be made payable to the NORML<br />
Foundation<br />
Share This Page r Z<br />
F<br />
SUBOXONEO Sublinaual Film<br />
buprenorphine and naloxone CIII Now FDA approved find out more at<br />
SUBO ONECOm<br />
updated Apr 06 2011<br />
t 3 4<br />
Site Map Contact Us Support NORML Take Action Library<br />
O 2011 NORML Privacy Statement Site Terms Site by Communicopia and Red Aphid<br />
NORML and Ihe NORML Foundation 1600 K Sireet NW Mezzanine Level Washington OQ 20006 2832<br />
Tel 202 483 5500 Fax 202 483 0057 Email norml@norml org<br />
10<br />
http www norml org index cfm Group ID 7002<br />
3201 I
Local Medical Marijuana Cultivation Possession Guidelines Under California State Law SB 420 Califor Page 1 <strong>of</strong> 6<br />
fdi ated<br />
r<br />
Gr<br />
r<br />
i<br />
z<br />
y<br />
Lc jtf ILlld<br />
a6aosoauro uaen<br />
lariitz<br />
L<br />
SQHYWRE<br />
raNOm<br />
riome<br />
Join California NoRML and Local Medical Marijuana Cultivatian Possession Guidelines Under<br />
hel us continue our work California State Law SB 420<br />
Updated817 2011<br />
Exolanation <strong>of</strong> 5B420 Cultivation Guidelines<br />
Search Site<br />
Anderson Humboldt Sacramento Countv<br />
Arcata Imoerial Beach San Bemardino Countv<br />
Berkelev Kern Countv Citv <strong>of</strong> San Carlos<br />
Biaas Lake Countv Citv <strong>of</strong> San Dieoo<br />
Search Butte Lakeoort San Francisco<br />
Frequently Asked<br />
Questions<br />
Chico Lassen Citv <strong>of</strong> San Mateo<br />
Corninq Live Oak Santa Cruz<br />
Dunsmuir Mendocino Shasta Lake<br />
EI Dorado Nevada Sonoma<br />
Eureka Oakland South Lake Tahoe<br />
Ft Braaa Paradise Tehama<br />
Benefits <strong>of</strong> Legal zation Fresno Reddina Trinitv<br />
M11edical Marijuana Gridlev Rocklin Tulare<br />
Collectives Coops<br />
Delivery Services<br />
Physician Locator<br />
Starting Collectives<br />
List Your<br />
Collective<br />
Patient Guidelines<br />
Local Guidelines<br />
Economic Benefits<br />
Businesses and<br />
Organizations<br />
Legal Tnformation<br />
Legal Referrals<br />
Roseville<br />
Localities NOT listed above adhere to CA state default quidelines which are<br />
6 mature OR 12 immature plan s and 8 oz <strong>of</strong> dried processed marijuana<br />
For guidelines on collectives cooperatives and aggegate grows for multiple<br />
patients see Local California Disoensarv Requlations<br />
NOTE On May 22 2008 the Second District <strong>of</strong> Califomia Court <strong>of</strong>AOOeals ruled that the<br />
state limits on medical marijuana possession and cultivation established under SB 420 are<br />
unconstitutional The court s reasoning would seem to apply only when the SB 420 numbers<br />
are used to limit patients rights but has been interp eted otherwise 6y police who would<br />
prefer to ignore them On January 2i 201Q the Califomia Suoreme Court in essence<br />
affirmed the rulino<br />
Califo nia NORML strongly advises Prop 215 patients to continue following the SB 420<br />
CA Marijuana Laws<br />
guidelines six mature or 12 immature plants and 8 ounces <strong>of</strong> processed marijuana except<br />
Legislative Ne vs<br />
Economics<br />
CA Prisoner Arrest<br />
Da<br />
Federal Medical<br />
Marijuana Cases<br />
CAMP data<br />
Health Info<br />
Student Youth Usage<br />
Studies<br />
where local guidelines speci y more The Supreme Court s recent Kelly decision has been<br />
widely misinterpreted to imply that the limits no longer apply and that patients can<br />
therefore grow as much as they want In fact the Court s decision lets the police arrest<br />
anyone who exceeds the guidelines The only thing it disallows is for the guidelines to be<br />
used as a basis fo conviction inciminaltials<br />
So unless you don t mind being arrested and dragged into court for a felony trial where you<br />
will have to show that the amount <strong>of</strong>marijuana you had was consistent with your medical<br />
needs the best rule <strong>of</strong> thumb is to follow the guidelines The Kelly decision simplyre affirms<br />
the original intent <strong>of</strong> 58 4Z0 which was to establish reasonable guidelines forarest not<br />
automatic limits for guilt<br />
Drug Testing<br />
Below is the latest information CaNORML has about local guidelines check with your local<br />
P1J and Driving government entities for updates and please let us know if this page needs to be updated<br />
Pain Patients Localities NOT listed below adhere to CA state default guidelines <strong>of</strong> 6 mature OR 12<br />
Vaporizers<br />
immature plants and 8 oz <strong>of</strong> dried processed marijuana<br />
Historical Info<br />
About Us<br />
California Chapters<br />
Anderson<br />
On February 18 2011 an ordinance took effect in Anderson that prohibits cultivation either<br />
inside a dwelling or in an outdoor garden limits the growing harvesting and processing <strong>of</strong><br />
medical marijuana to a50 square foot outbuilding that is built to city state and federal<br />
http canorml org prop<br />
loca1215policies html 831 2011
Local Medical Mazijuana Cultivation Possession Guidelines Under California State Law SB 420 Califor Page 2 <strong>of</strong> 6<br />
Coming Events<br />
CaNORML Store<br />
Our Staff<br />
NORML in the News<br />
oin Our Mailing Lists<br />
eMail Us<br />
codes is protected by an audible alarm system and contains electrical plumbing and<br />
ventilation A suit was filed agains the Anderson ordinance on April 15 Z011<br />
Arcata<br />
<strong>City</strong> Council passed an ordinance 11 08 allowing no more than 50 square feet forcul ivation<br />
In addition dispensaries will be prohibited from using more than 25 <strong>of</strong> their property for<br />
cultivation and patients must grow in their own homes which must be mainly residential<br />
space Those with special needs may request more grow space<br />
Berkeley<br />
Measure J7 passed by the voters in 2008 repealed Berkeley s plant and possession limits<br />
Outdoor gardens that are observable are limited to 10 plants<br />
Biggs<br />
Citv code requires marijuana be grown inafully enclosed and secure structure<br />
Butte Co<br />
UPDATE June 22 2011 Butte Countv Citizens fo Comoassionate Use have submitted<br />
12 308 signatures on a referendum petifion to suspend Butte county s cont oversial medical<br />
marijuana ordinance Theodinance is now <strong>of</strong>ficially suspended for 30 days pending<br />
validation <strong>of</strong> the signatures If as seems likely at least 7 600 are valid theodinance will<br />
remain suspended until it can be voted on in the Novemeber election Read more<br />
On May 25 2011 Butte County supervisors passed an ordinance setting permit fees for<br />
aggregate grows at 285 regardless <strong>of</strong> the size and acreage waived for six plants The<br />
ordinance takes effect June 23<br />
Limits are<br />
On lots less than 05 acres no cultivation allowed<br />
On lots between0515 acres 6 mature plants or 12 total plants with a 15 foot setback<br />
Between 15 and 20 acres up to 12 mature or 24 total plants and 100 foot setback<br />
Between 20 and 80 acres up to 24 mature or 48 total plants and Z50 foot setback<br />
Between 80 and 160 acres up to 36 mature or 72 total plants and 500 foot setback<br />
Over 160 acres up to 99 mature plants and 700 foot setback<br />
No outdoor growing would be allowed within thirty 30 feet <strong>of</strong> any occupied residential<br />
structure located on a separate legal parcel and no growing at all within 1000 feet <strong>of</strong> a<br />
school etc Any gardens over 6 plants must register with the Depar ment <strong>of</strong> Development<br />
and pay fees<br />
California NORML is interested in hearing from potential plaintiffs who would like to challenge<br />
the ordinance Write IeqalCa canorml ora<br />
Chico<br />
Chapter 19 77 <strong>of</strong> Chico municipal code allows outdoor residential cultiva ion <strong>of</strong> 50 square<br />
feet per parcel regardless <strong>of</strong> the number <strong>of</strong> patients Plants must be enclosed screened<br />
and 5 feet from the property line Indoor cultivation under SO square feet and IZ00 watts<br />
can take place only with a permit stating outdoor is not possible and the building owner<br />
approves States all marijuana grown must be for personal use only<br />
Corning<br />
The city <strong>of</strong> Corning prohibi s cultivation outdoors or in a residential structure Gardens must<br />
be loca ed in a secure detached structure in the rear yard only removed ten feet from the<br />
property line artd with a six foot solid fence and with a mechanical ventilation system and<br />
security system approved by a Building Official or the Police Dept<br />
Dunsmuir<br />
On May 19 2011 the city <strong>of</strong> Dunsmuir enacted an ordinance Chapter 17 34 <strong>of</strong> city code<br />
that disallows outdoor cultivation and requires anyone growing for more than one person to<br />
submit an affidavit to the city manager A maximum <strong>of</strong> 100 square feet may be grown per<br />
patient not to exceed three patients per parcel Patients must live on the property and<br />
growing must take place in a garage<br />
EI Dorado Co<br />
Sheriff DA policy Indoors 10 flowering plants 10 vegging 1 mother Outdoors 20<br />
sarters or 10 mature plants 1 2 Ib processed marijuana depending on season <strong>of</strong> year<br />
Eureka<br />
On May 3 2011 Eureka city council approved an ordinance that allows personal cultivation<br />
within 50 square feet in area and 10 feet in height or up to 100 feet with an Exemption<br />
Request only in a residence Processing area cannot exceed 20 square feet Also regulates<br />
dispensaries delivery services and labs<br />
Ft Bragg<br />
Cultivation Ordinance allows up to S00 sq feet indoors<br />
http canorml arg prop<br />
loca1215policies hrinl 831 20ll
Local Medical Marijuana Cultivation Possession Guidelines Under California State Law SB 420 Califor Page 3 <strong>of</strong> 6<br />
Join Today<br />
Fresno county On Abm lJS on CaNORML F H A k 0<br />
July 12 2011 Presno County unanimously passed an ordinance to ban dispensaries and Oeon CaNORML Store oin or mau<br />
sharply restrict cultivation It requiresaMedical MJ Cultivation Business License for anyone<br />
seeking to grow in the county Cul ivation can only occur only in a secure locked enclosed<br />
structure in industrial zoning districts if1000 feet from any school park recreation area<br />
aports facility adult business church etc maximum <strong>of</strong> plants is 99<br />
Activists in Fresno are working towards filing a referendum against their ordinanceAtend<br />
the alona with Sabrina Fendick Debby Goldsberrv Melissa Sanchez and Kyndra Miller<br />
Amone interes ed in ioining the efiort can contact Shannon at sluce47C oqmail rom or 559<br />
486 6010<br />
Gridley<br />
The city <strong>of</strong> Gridley has banned outdoor cultivation<br />
Humboldt Co<br />
County guidelines allow patients 100 square feet and 3 Ibs w no plant number limit <strong>City</strong> <strong>of</strong><br />
Fortuna and CHP enforce SB 420 limits 6 mature 12 immature plants 12 Ib Also see<br />
Eureka above<br />
Imperial Beach<br />
On July 7 2011 with a 4 to 1 vote the Imperial Beach <strong>City</strong> Council approved an ordinance<br />
banning collective cultivation <strong>of</strong> inedical marijuana within city limits including in the private<br />
homes <strong>of</strong> qualifed patients Read more<br />
Kem County<br />
On August 9 2011 Kern County Board <strong>of</strong> Supervisors passed an ordinance to limit collective<br />
membership to 3 members and outlaw outdoor cultivation and edibles In addi ion a second<br />
emergency ordinance taking effect immediately disallows more than 12 plants per parcel<br />
Read more<br />
Kern Citizens for Patients Rights is organizing a referendum petition to repeal the county s<br />
repressive ordinances Similar peticion drives have succeeded in overturning or suspending<br />
anti MMJ ordinances in San Diego and Butte County<br />
Interested supporters are invited to contact Kem Citizens for Patient Rights Heather Epps<br />
heooslCa msn com 661 327 3337 or Craig Beresh craiqbereshCa sbcqlobal net or Bakersfield<br />
VORML<br />
Lake Co<br />
On August 23 2011 at 130 PM Lake County Board <strong>of</strong> Supervisors will consider a cultivation<br />
ordinance As it is written permitted gardens on plots 5 acres or larger can have 36 mature<br />
or 72 total plants Personal gardens on plots one acre or less can have 6 mature and 12<br />
immature plants per patient not to exceed 36 total plants Outdoor gardens would be<br />
prohibited near schools and other youth oriented sites Indoor gardens at residences would<br />
be limited to 100 square feet and 1200 watts greenhouses and sheds would have no square<br />
footage limits<br />
The meeting will take place at<br />
LAKE COUNTY COURTHOUSE<br />
255 NORTH FORBES STREET<br />
LAKEPORT CA 95453<br />
htto www co lake caus<br />
Government Boards<br />
<strong>of</strong> Sunervisors BOS Aaen<br />
Lakeport<br />
Cultivation Ordinance<br />
Lassen County<br />
On November 23 2010 Lassen County Ordinance No 575 which prohibits dispensaries and<br />
outdoor cultivation was passed by the Lassen County eoard <strong>of</strong> Supervisors<br />
Live Oak Sutter County<br />
July 20 2011 The city <strong>of</strong> Live Oak in Sutter County is considering banning outdoor<br />
cultivation after holding a public meeting about citizen complaints<br />
Mendocino Co<br />
On March 23 2010 the county enacted an ordinance that would allow gardens <strong>of</strong> up to 99<br />
plants with proper licensing Otherwise it allows 25 plants per parcel More at Mendocino<br />
Medical Mariivana Advisorv Board site<br />
Nevada Co<br />
Cultivation 6 mature female plants or 75 square feet <strong>of</strong> plant canopy previously 10 plants<br />
not to yield more than 2 Ibs Possession 2 Ibs processed marijuana consistent with<br />
patient s recommendation<br />
nie c rsrea c u<br />
http canonnl org<br />
propQoca1215policies hhnl 831 2011
Local Medical Marijuana Cultivation Possession Guidelines Under California State Law SB 420 Califor Page 4 <strong>of</strong> 6<br />
Oakland<br />
Indoors 72 plants in maximum 32 sq ft growing area Outdoors 20 plants no area limit<br />
Weight limit 3 Ibs dried marijuana per patient Collective gardens limited to 3 patients<br />
Dispensaries serving four or more patien s are allowed max 6 mature and 12 immature<br />
plants and 12 pound per patient See Oakland Municipal Code 5 81 101<br />
Paradise<br />
On July 8 2011 the Paradise planning commission approved a draft medical mariivana<br />
ordinance that would limit personal cultivation to 50 square feet within a residential zoning<br />
district and require permits for indoor gardens Collective cultivation could take place in<br />
industrial zones with a permit A requirement that residential gardens be fenced and locked<br />
has been added<br />
Redding<br />
An ordinance passed in 2010 restricts medical marijuana gardens to a maximum <strong>of</strong> 100<br />
square feet <strong>of</strong> canopy or 10 <strong>of</strong> home or garden area Also see Local Ordinances Attack<br />
Patients Riqh to Grow<br />
Rocklin<br />
In January 2011 the city <strong>of</strong> Rotklin passed ordinance 970 Section 1 Chapter 17 81 <strong>of</strong><br />
Rocklin Municipal Code which limits cultivation to 50 square feet and ten feet in height per<br />
residence only within an enclosed structure Marijuana cultivation lighting cannot exceed<br />
1200 watts and the authorized grower must reside in he residence where the marijuana<br />
cultivation occurs Other building and fre codes issues <strong>of</strong> privacy noise odor etc must be<br />
observed With documentation <strong>of</strong> a second patient living on the premises up to 100 square<br />
feet can be grown Penalty for violation is 500 day<br />
Roseville<br />
July Z0 2011 Roseville is holding a meeting about medical marijuana cultivation and is<br />
considering enacting an outdoor ban starting in October CaINORML has written to public<br />
ocials there at the request <strong>of</strong> local patients asking them if they must ban outdoor growing<br />
to adopt language stating Outdoor growing is prohibited where sight or odor presents a<br />
nuisance to neighbors leaving it up to the grower to use a charcoal greenhouse filter<br />
cover aromatic crops like lavender or other measures to address odor<br />
Sacramento County<br />
On August 10 2011 Sacramento County supervisors will hear a revised ordinance that could<br />
regulate dispensaries and ban edibles and outdoor cultivation limit indoor cultivation to 12<br />
mature plants force registration <strong>of</strong> all patient gardens require permits and excessive costs<br />
for patients Read more<br />
San Bernardino County<br />
County code82 02 070 outlaws outdoor cultivation in unincorporated areas <strong>of</strong> San<br />
Bernardino it must occur indoors in a secure locked and fully enclosed structure that<br />
includes solid walls and a ceiling ro<strong>of</strong> or top<br />
<strong>City</strong> <strong>of</strong> San Carlos<br />
San Carlos collective requlation ordinance says a patient may grow medical marijuana for<br />
consumption at their residence It adds All cultivated marijuana must be secured in<br />
structures consisting <strong>of</strong> at least four walls and a ro<strong>of</strong> and 6e held secure to the satisfaction<br />
<strong>of</strong> the police chief<br />
<strong>City</strong> <strong>of</strong> San Diego<br />
Citv Municioal Code allows up to 1 Ib <strong>of</strong> marijuana 24 plants in 64 square feet indoors no<br />
outdoors growing allowed except in enclosed greenhouses<br />
San Francisco<br />
Patients allowed up to 24 plants or 25 square feet <strong>of</strong> canopy dispensary gardens capped at<br />
99 plants in 100 square feet Possession limit 8 oz dried cannabis per patient See p 44 <strong>of</strong><br />
the ordinance<br />
San Francisco has enaded regulations on edibles<br />
<strong>City</strong> <strong>of</strong> San Mateo<br />
San Mateo s city collective ordinance says<br />
Marijuana cultivated and possessed at a private residence must not 6e visible from<br />
adjacent public areas or neighboringpoperties and must be secured within structures<br />
consisting <strong>of</strong> at least four walls and a ro<strong>of</strong> with standa<br />
locks<br />
Santa Cruz<br />
S00 sq ft canopy and up to 99 plan s is allowable under county guidelines<br />
bone fide caregiver<br />
for a patient or a<br />
Sebastopol<br />
In January 2011 Sebastopol city council enacted an ordinance allowing patients and<br />
caregivers fo grow up to 30 plants within 100 square feet at their homes Under the<br />
http canorml org prop<br />
loca1215policies html 831 2011
Local Medical Marijuana Cultivation Possession Guidelines Under Califomia State Law SB 420 I Califor Page 5 <strong>of</strong> 6<br />
ordinance patients and caregivers can possess up to 3 Ibs at the garden site It also allows<br />
two secured 750 square foot gardens for dispensing collectives and two more for non<br />
dispensing patients and caregivers<br />
Shasta Lake<br />
In December 2010 city council adopted an ordinance that allows growing only in residential<br />
or mixed used zoning districts while it would be banned in commercial and industrial<br />
districts The ordinance allows for growing up to 100 square feet inside a garage or adjacent<br />
building but not inside the home<br />
Outdoor growing is limited to 25 square feet on a half acre parcel 60 square feet on a parcel<br />
between half acre and one acre and 240 square feet on parcels larger than one acre<br />
Outdoor grows must also be enclosed in a6foot high non climbable fence with a locking<br />
gate Chain link fences are not allowed according to the ordinance<br />
Sonoma Co<br />
Guidelines permit 3 Ibs for possession maximum 100 square feet cultivation area with 30<br />
plants or fewer approved Sept 2006<br />
South Lake Tahoe<br />
On May 17 2011 the <strong>City</strong> <strong>of</strong> South Lake Tahoe unanimously passed an ordinance to<br />
require that medical marijuana be cultivated in appropriately secured enclosed and<br />
ventilated structures in permitted residential structures only in compliance with the<br />
maximum dimensions permissible for the cultivation <strong>of</strong> inedical marijuana within 10 <strong>of</strong> the<br />
total residence square footage Fines for violations start at S00 day and escalate to S00<br />
with repeat <strong>of</strong>fenses<br />
Enforcement <strong>of</strong> the ordinance would not take effect until after Dec 19 The city plans to hold<br />
two or three workshops to educate growers and property managers on the provisions <strong>of</strong> the<br />
ordinance<br />
Tehama Co<br />
Tehama County Board <strong>of</strong> Supervisors has adopted an ordinance that declares it a public<br />
nuisance for anyone cultivate over 12 mature or 24 immature plants on parcels <strong>of</strong> less than<br />
20 acres The Tehama ordinance bans any cultivation whatsoever within 1000 ft <strong>of</strong> a school<br />
and requires every landlord to register any Prop 215 garden with the city The ordinance<br />
allows hardship exemptions to a requirement that gardens be 100 from property lines<br />
California NORML has joined a lawsuit against the Tehama ordinance see Local Ordinances<br />
Attack Patients Riaht to Grow<br />
Trinity Co<br />
On March 17 2011 Trinity supervisors voted to extend their moratorium on aggregrate<br />
grows on rural residential parcels through Feb 2 2012 The moratorium limits any large<br />
scale operations to nonresidential parcels only that are greater than 30 acres It also sets a<br />
maximum garden size <strong>of</strong>2500 square feet for such operations and a 500 foot property line<br />
setback<br />
The temporary moratorium also limits the size <strong>of</strong> inedical marijuana gardens that may be<br />
grown for personal use within residential areas to 50 square feet on an acre or less 100<br />
square feet on one to fve acres and 250 square feet on parcels greater than five acres It<br />
includes residency requirements calling for individuals upon request to furnish pro<strong>of</strong> that<br />
the property in use is their primary residence An ongoing process is aking place with public<br />
hearings by the Trinity Planning Department<br />
Tulare Co<br />
Chapter 11 <strong>of</strong> Tulare County code requires marijuana be grown within a secure locked and<br />
fully enclosed structure whose exterior is compatible with the exterior appearance <strong>of</strong><br />
structures already constructed or under construction within the immediate area and has an<br />
alarm system and exterior lighting Collectives may grow up to 99 plants within proper<br />
zoning otherwise up to 24 plants at 6 mature or 12 immature plants per patient for only 2<br />
patients Patients may smoke only entirely within a private residence or on the premises <strong>of</strong><br />
a private residence but out <strong>of</strong> public view Violations are crimi al misdemeanors<br />
State Guidelines Under 56 420 Health Safetv Code 11362 71<br />
HSC 11362 77a A qualified patient or primary caregiver may possess no more than eigh<br />
ounces <strong>of</strong> dried marijuana per qualified patient In addition a qualifed patient or primary<br />
caregiver may also maintain no more than six mature or 12 immature marijuana plants per<br />
qualified patient<br />
HSC 11362 77 b If a qualified patient or primary caregiver has a doctor s<br />
recommendation that this quantity does not meet the qualified patient s medical needs the<br />
qualified patient or primary caregiver may possess an amount <strong>of</strong> marijuana consistent with<br />
the patienYs needs<br />
http canorml org<br />
propQoca1215policies hhnl 831<br />
2011
Local Medical Marijuana Cultivation Possession Guidelines Under California State Law SB 420 I Califor Page 6 <strong>of</strong> 6<br />
HSC 11362 77 c Counties and cities may retain or enact medical marijuana guidelines<br />
allowing qualifed patients or primary caregivers to exceed the state limits set forth in<br />
subdivision a<br />
HSC 11362 77 d Only the dried mature processed flowers <strong>of</strong> female cannabis plant or the<br />
plant conversion shall be consideretl when determining allowable quantities <strong>of</strong> marijuana<br />
under this section<br />
5B 420 Enforcement Guidelines<br />
State law SB 420 Health Safety Code 11362 7 which took effect on an 1 2004<br />
protects Prop 215 patients from arrest provided they cultivate no more than 6 mature or 12<br />
immature plants and possess no more than 8 ounces <strong>of</strong> dried marijuanaHSC<br />
11362 77 al<br />
Counties and cities are authorized to establish higher but not lower limits if they wish<br />
HSC 11362 77c Listed above are those localities that have adopted limits above the<br />
state limit<br />
Patients who need more marijuana can be exempted from these limits if they obtain a<br />
physician<br />
statement specifying that they need moreHSC<br />
11362 77 bl While police are <strong>of</strong>ten reluctant to recognize such exemptions they are<br />
helpful in court<br />
Despite supposed protections <strong>of</strong> 5B 420 and Prop 215 patients may still be arrested if law<br />
enforcement suspects they are outside the law for example by being involved in illegal<br />
sales or distribution or growing plants with excessive yields<br />
In general the state Attorney General has given local authorities discretion in how they<br />
enforce Prop 215 as explained in a letter to local law enforcementocials<br />
http canorml org prop<br />
loca1215policies hhn 831 2011
MedicalMJ org Medical Marijuana News and Facts Page 1 <strong>of</strong> 28<br />
Medical<br />
Mariivana<br />
Ne vs<br />
Czechs Will Relative Addictive Properties <strong>of</strong> Various Commonly Used Drugs Top Sto1 leS<br />
Le alize NIedical<br />
Marijuana<br />
Uodates<br />
Medical The Czech MORE<br />
SERiOUS<br />
6<br />
Caroparing pangers <strong>of</strong> Popular Drugs<br />
Luwer score iadicates less serious efEect<br />
On The<br />
W<br />
US NM<br />
Mariivana Republic is on the Despite<br />
Facts<br />
Backeround<br />
llonate<br />
Sueak Out<br />
path toward 5<br />
egalizing medical<br />
mari uana The<br />
4<br />
Praise As<br />
Success<br />
Some Sav<br />
Newsfeed Ministry <strong>of</strong> Health NM Medical<br />
Courtesv <strong>of</strong> said last week it 3<br />
MAPINC<br />
pjans to remove<br />
marijuana<br />
list <strong>of</strong> proscribed<br />
Cannabis<br />
z<br />
Common<br />
Sense for<br />
from its<br />
TheNew<br />
Drue Policv<br />
Mexican 24 Sep<br />
Mana nQ substances and E 2o It Four<br />
Chronic Pain allow It to be LESS years after New<br />
SERIOUS<br />
Mex cos<br />
prescribed by<br />
a<br />
Nimtine Heroin Cocaine Nicohol Caffeina biarijuana Medical<br />
The doctors<br />
OfPEtJUENCE 6 3 A 3 2 1 Cannabis<br />
Coalition for<br />
WfTH6RAIL dt 4 3 3 6 2 1 Pro ram was<br />
M TOtERANCE i 6 3 0 2 1<br />
C is image l align left<br />
ct eated nea ly<br />
QF NFaece arir 3 6 4 2<br />
ca tion true B<br />
4000 New<br />
includes P y INTOXKRTION 1 3 4 6 1 3<br />
Mexico residents<br />
American the end <strong>of</strong> this year<br />
have been<br />
Alliance for ye will SUbmit t0<br />
approved to use<br />
Medical<br />
parliament<br />
Cannab s an Source Dr Jack E Hennin gfield Ph D forNDA Reported by Philip<br />
J the herb as<br />
amended law on<br />
Hilts New York Times Aug 2 1994 Is Nicotine Addictive It Depends medicine and 25<br />
An ericans<br />
addiCtive<br />
nonpr<strong>of</strong>it<br />
for Safe<br />
on Whose Criteria You Use<br />
Access subSt3nCeS which producers have<br />
Image courtesy <strong>of</strong> Dru War Facts<br />
been licensed to<br />
Ai will move sell it to them<br />
JusGce<br />
marihuana from the<br />
New Mexico s<br />
Ansel wines ist <strong>of</strong> banned<br />
y<br />
Patieut<br />
Medical Marijuana News s stem for<br />
Update<br />
OutReach SubStanceS to the regulating those<br />
Inc list <strong>of</strong> those which producers is<br />
Marijuana is medicine for millions <strong>of</strong> patients around the US Click here for medical<br />
being adopted by<br />
California can be prescribed nnriivana news Federal opposition persists in spite <strong>of</strong> successful medical marijuana other states as a<br />
NORML<br />
said Deputy Health programs in several states States cities moving to allow medical use by those in need model for<br />
CannabisMD Minister Martin<br />
allowing<br />
For more information on medical<br />
Ca inabis PlAlXjek pledged<br />
marijuana and other drug policy reform issues check medicinal use <strong>of</strong><br />
out the Common Sense for Dru Policy For the facts about medical marijuana check out marijuana<br />
A<br />
Drue War1acts Medical Mariivana and this CSDP<br />
Nehvork<br />
public service ad on medical without seeing<br />
Medical marijuana annabis to learn more pot dispensaries<br />
Cani abis<br />
already enjoys<br />
pop up on evety<br />
Cc nsumers<br />
Camoaien Political support in street corner as<br />
Chan e Che the CzOCh they have in<br />
Ciimate Republic which Califomia and<br />
For The Latest News Check Out<br />
c a liberalized its drug<br />
SF or<br />
aws last year<br />
Dru Policv Under that law<br />
Stop the<br />
Common Sense for Dru Policv<br />
coto aao<br />
US CA<br />
Dru War possession <strong>of</strong> small OPED Don t<br />
DxCNet amounts <strong>of</strong> pot and Americans Por Safe Access<br />
http www medicalmj org<br />
926 2011
What aze some <strong>of</strong> the pros and cons between smoked andnon smoked medical marijuana Medical Marij Page 1 <strong>of</strong> 2<br />
Medical IVfarijuana<br />
ProCOrvorc<br />
searcn<br />
qLA Print<br />
Clte<br />
ali 42 issucs bout Us FAQs TheoretiCai Hxpertise Teachers Comer Traffic Contact Us onate Donors Sponsore<br />
1f9ColtArp<br />
Rr mn4w4 nar l<br />
minx advcanw<br />
anomt<br />
cn iensn<br />
eA al tdurl upna hlonre Pnga<br />
NonSmokxtltP arl uzna Netlmal Value 8 Risk<br />
las uPtletetl on<br />
t3l2U12o09 Sn8 eU Pe PSl<br />
What are some <strong>of</strong> the pros and cons between smoked and non smoked medical marijuana<br />
PAaalcal Marijuana Home<br />
Featured Resoumes<br />
Soultl marijuana be a<br />
medical option<br />
Genera Reference not clearly pro or con<br />
Method I Description ProS CO05<br />
Top 10 Pros antl Cons 1 Smoking Full Plant Reliet from symptoms is usually Mari7uana smokers have been shown<br />
Ditl Vou Know Buming the Flowering tops obtained in less than a minute to suffer an increased incidence <strong>of</strong><br />
and sometimes the because ihe smoke enters the<br />
Historical Timeline<br />
bronchitis and respiratory intections<br />
leaves and inhaling it into bloodsiream direcity from lhe lungs There coultl be a greater risk <strong>of</strong><br />
Comments<br />
the lungs<br />
cancer <strong>of</strong> the throat and respiratory<br />
Pros Gons by Catagory U2C1<br />
CORE QUESTION<br />
Metlical Value<br />
Diseases<br />
Condinons<br />
Results will <strong>of</strong>ten fade after an hour<br />
2<br />
No smoxeo Jary<br />
Smoking Plant Relief from symptoms is usually Smoking anything can cause severe<br />
Particles obtained in less ihan a minute medical problems although less <strong>of</strong><br />
Public PoliCy<br />
Palients manipulate the because the smoke enters ihe the harmful materials are consumed<br />
RiSks flowered lops and bloodstream directly from the lungs in this method<br />
us covemmen2 and<br />
sometimes leaves <strong>of</strong> the<br />
nneaicai Marijuana plant to make a produd Resutts will <strong>of</strong>ten fade aker an hour<br />
Access to Metlical<br />
that is comprised mainly<br />
or two<br />
Of th0 tfichOmeS <strong>of</strong> th0<br />
Marijuana<br />
plant<br />
cannabinoid<br />
ai iss es<br />
crystals without additional<br />
miwl Composition <strong>of</strong><br />
plant material It is<br />
Nmnjvana<br />
changed into substances<br />
depending upon Ihe<br />
PfOfeC<br />
process known as<br />
i6 Legal Metlical Marijuana<br />
hashish kief bubble<br />
States antl DC<br />
hash and others It is<br />
6 Siateswit Pending then burned in a pipe or<br />
Legislalion ro Legalize<br />
joint and inhaled Some<br />
Metlical Marijuana<br />
people may bake it into<br />
foods<br />
7een Marijuana Use i999<br />
Zoob 3 Vaporization Some peop<br />
greater affecl Some people do not feel that same<br />
oeatns romMa iivana v n Heating marijuana o a lhan by smoking and some palieMS beneficial effects as they do from<br />
Fon npprovea Druqs point where d produces a use less product in ihis method than smoking others say it uses more<br />
3 Peer Reviewetl Studies on vapor a fine mist then by smoking cannabis material than is<br />
nnar jana<br />
inhaling the vapor into the<br />
economicaily feasible for them<br />
lungs The vapor consists Because the cannabinoids enter the<br />
Metlical Marijuana Infogrephic <strong>of</strong> the pianPs bloodsream directly From the lungs The vaporizer needed for this is oo<br />
Opinion Polls Surveys cannabinoitls and is relief from symptoms is usually expensive for some patients Prices<br />
90 Physlcians <strong>View</strong>s on mostly free <strong>of</strong> obtained in less than a minute range from about S30 up to huntlreds<br />
Medical Marijuana<br />
contaminanis without the harmfW toxins in Ihe o dollars for high tech versions The<br />
smoke<br />
marijuana plant materiai must be<br />
PM1armaceutical Drugs Based A vaporizer machine is heated to a cedain tempereture to be<br />
on Cannatis<br />
usually used for this<br />
effective too high and the health<br />
US Govemment Reporis on purpose benefits are negated<br />
Metlical Marijuana<br />
oruq 7ests<br />
Metnods ot<br />
Detecting Cannabis Use<br />
Of hNO<br />
ResWts will <strong>of</strong>ten fade after an hour<br />
or two<br />
Major Court Cases antl 4 Oil The primary beneft <strong>of</strong> this method is The extraction method uses highty<br />
Relatetl Docs Cannabis 8owered tops to convert leaf or inferiorca nabis Flammable gases such as butane<br />
and leaves are fltered into buds into a form that is safer to inhale and can be dangerous as well as too<br />
tearn more<br />
its oils by a method using or consume without ihe tars and complicated for some people<br />
Soume eiograpnies butane gas Some other plant malerials inhaled when<br />
rssary patients may create a smoking The oil some say is messy and<br />
es nrcnive weaker oil using<br />
a difficult to work with<br />
supercrifical carbon Inhalation methods smoking or<br />
e Map<br />
dioxide extraction The oil vaporization usually take effect in Non inhaling eating or drinking it<br />
ptltlitional Resource5<br />
can then be inhaled using less ihan a minute <strong>of</strong>ten takes390 minutes for ihe full<br />
a<br />
pipe or vaporizer<br />
effects to be realized<br />
Get Ireo email uptlates<br />
i r<br />
279 Online Translate Become a Fan U<br />
http<br />
medicalmarijuana procon org view answers php questionlD 000225 926 2011
What are some <strong>of</strong> the pros and cons between smoked andnon smoked medical marijuana Medical Marij Page 2 <strong>of</strong> 2<br />
OK<br />
r4T<br />
a sYrK<br />
conditions applled directly<br />
to the skin<br />
This method can be expensive to<br />
purchase or produce technicians<br />
say they produce less ihan a gram <strong>of</strong><br />
oil from each ounce <strong>of</strong> leaf and<br />
between I antl 3 grams <strong>of</strong> oil from<br />
each ounce<strong>of</strong> bud<br />
5 Tincture This method is usetl mostly by pain This method <strong>of</strong>ten takes 2030<br />
Cannabis flowered tops patienls who say ihe tinctures dull minutes for the full effects to be<br />
and leaves are soaked in the pain without the sirong realized<br />
an alcohol solution psychoactive eHects <strong>of</strong> other<br />
iransferring the THC and methods because ihe tinctures are Many conditions do not find adequate<br />
other cannabinoids to the generally weaker m polency relief trom this product as it is too<br />
liquid The tinclure is then<br />
weak o produce some <strong>of</strong> the desired<br />
used in various ways<br />
effects<br />
adtled to foods and<br />
liquids applied to the skin<br />
The alcohol consumetl in this method<br />
or lhe patient consumes<br />
is undesirable to some<br />
directly by drinking a small<br />
quantity or placing a tew<br />
drops under the tongue<br />
sublingual<br />
6 Butter This method can create a product This method oNen takes 30 90<br />
Cannabis flowered tops that tlelivers long results lasting minules for the fuii effects to be<br />
and Ieaves are simmered several hours realized<br />
in butler or vegetable oil<br />
for several hours Patients can modulate the results 6y Proper doses are diffcWt to<br />
transferring the THC and eating smaller or larger portions and determine and patients <strong>of</strong>len don t<br />
other cannabinoids to the can carry their medicine with them in realize until loo late that iheir portion<br />
butter The solid plant public without being noticed is too strong or too weak<br />
material is then discarded<br />
The butter now a dark Pain patients ciaim this method Eating too much can cause vomiting<br />
shade <strong>of</strong> green is then relieves their symptoms the longest and loss <strong>of</strong> consciousness<br />
used in baking such items<br />
as brownies and cakes or<br />
added to such foods as<br />
spaghetti sauce or soup<br />
The oily base <strong>of</strong> the butter<br />
is needed for the<br />
cannabinoids to properly<br />
adhere<br />
and many patienls use this method<br />
mostly m the evenings to assist with<br />
sleep<br />
Prepared by Medical Marijuana ProCon org Specials thanks to Dale Gieringer <strong>of</strong> California NORML and Jay<br />
Cavanaugh PhD <strong>of</strong> the Amencan Alliance For Medical Cannabis for their input<br />
Raprmbng Poi cy roei lo Gt ProCa org Fovtsn PraCOn org Matla 8 Pess I Dcla ier Prmacy Pollcv<br />
sProConorg z50ifc i3 nonpronf<br />
73JVb5L reNd Smte200cntz don ca CFl9040t<br />
Te13t0 451 3596<br />
http<br />
medicalmarijuana procon org view answers php questionID 000225<br />
926 2011
E Information from Groups in Opposition<br />
<strong>of</strong> Marijuana<br />
Coalition for a<br />
Drug<br />
<strong>City</strong> County Moratoria<br />
Free California List <strong>of</strong><br />
Bans<br />
California Police Chiefs Association<br />
Talking Points<br />
California Police Chiefs Association<br />
on Marijuana Dispensaries 2009<br />
Marijuana<br />
White Paper<br />
Friends <strong>of</strong> the DEA<br />
Marijuana Dispensaries and<br />
the Federal Government 2009<br />
GeneraI Barry McCaffrey Ret Marijuana<br />
Children The Work Place and Medicine
S1oP F<br />
V 0<br />
O<br />
u<br />
DRUG<br />
p<br />
A<br />
FREE<br />
I<br />
C A L I F O R N 1 A<br />
yHWdrugfreecali omia org<br />
youth parents schools law enforcement health care media businesses govemment<br />
non pr<strong>of</strong>ts community groups religious entities freternai and service organizations<br />
United to Protect our Youfh<br />
California <strong>City</strong> and County Listing <strong>of</strong> Illegal Store Front Ordinances<br />
Effective Date Aug 03 2010<br />
Cities With Moratoria 81<br />
Adelanto Moraga South Lake Tahoe<br />
Alameda Morgan Hill Tafr<br />
Alturas National <strong>City</strong> Tahoe <strong>City</strong><br />
Anderson Needles Tehama<br />
Barstow Nevada <strong>City</strong> Temple <strong>City</strong><br />
Baldwin Park Newport Beach Vacaville<br />
Bell Gardens Oceanside Ventura<br />
Calimesa Orange West Sacramento<br />
Camarillo Orinda Westlake Village<br />
Canyon Lake Pacific Grove Winters<br />
Carpinteria Perris Woodland<br />
Chula Vista Pomona Yreka<br />
El Centro Rancho Cordova Yucca Valley<br />
Ferndale<br />
Rancho Palos Verdes<br />
Fillmore<br />
Redwood <strong>City</strong><br />
Fountain Valley Richmond Counties With Moratoria<br />
Galt Rio Vista 10<br />
Guadalupe<br />
Rosamond Colusa<br />
Half Moon Bay Rosemead Glen<br />
Hemet Sacramento Lake<br />
Hughson San Bruno Lassen<br />
Huntington Park San Juan Bautista Nevada<br />
Imperial San Luis Obispo<br />
Placer<br />
Imperial<br />
Ione San Ramon San Diego<br />
La Canada Flintridge Sand <strong>City</strong> San Miguel<br />
Laguna Niguel Santa Clara Tulare<br />
Lancaster<br />
Santa Clarita<br />
Livingston<br />
Lodi<br />
Loma Linda<br />
Mayv ood<br />
Menifee<br />
Montague<br />
Beach San Marino San Bernardino<br />
Santa Ynez<br />
Scotts Valley<br />
Shasta Lake<br />
Signal Hill<br />
Soledad<br />
South Gate
T1oN e<br />
p<br />
O<br />
U<br />
DRUG<br />
O<br />
9<br />
D<br />
FREE I<br />
CALIFORNIA<br />
Cities WiYh Bans<br />
Agoura Hills Covina Indian Wells<br />
Anaheim Antioch Cypress Indio<br />
Apple Valley Davis Inglewood<br />
Arcadia Desert Hot Springs Irwindale<br />
Arroyo Grande Dublin King <strong>City</strong><br />
Atascadero El Cajon Laguna Hills<br />
Auburn El Cerrito La Mirada<br />
Azusa El Monte La Palma<br />
Banning Emeryville La Quinta<br />
Beaumont Encinitas La Verne<br />
Bellflower Escalon Laguna Beach<br />
Beverly Hills Escondido Lake Elsinore<br />
Big Bear Lake Fairfield Lake Forest<br />
Biggs Firebaugh Larkspur<br />
Bishop Folsom La Mesa<br />
Blythe Fontana Lawndale<br />
Brentwood Fortuna Lemon Grove<br />
Buellon Fowler Lemoore<br />
Buena Park Fremont Live Oak<br />
Calabasas Fresno Livermore<br />
Capitola Fullerton Lincoln<br />
Carlsbad Garden Grove Lodi<br />
Cathedral <strong>City</strong> Gardena Lomita<br />
Ceres Gilroy Lompoc<br />
Chico Glendale Los Altos<br />
Chino Glendora Los Banos<br />
Chino Hills GoleYa Manhattan Beach<br />
Chowchilla Grand Terrace Marina<br />
Claremont Gridley Manteca<br />
Clearlake Grover Beach Merced<br />
Cloverdale Hawaiian Gardens Millbrae<br />
Clovis Hawthorne Milpitas<br />
Colma Healdsburg Mission Viejo<br />
Concord Hercules Modesto<br />
Corning Hennosa Beach Monrovia<br />
Corona Hesperia Montague<br />
Corte Madera Hollister Montclair<br />
Costa Mesa Huntington Beach Montebello
S10ry<br />
OP<br />
u<br />
DRUG<br />
9<br />
D<br />
FREE<br />
I<br />
CALIFORNIA<br />
Monterey San Bernardino Yucaipa<br />
Monterey Park San Clemente Yountville<br />
Moorpark<br />
San Gabriel<br />
Murrieta San Jacinto Counties with Bans 9<br />
Newark San Juan Capistrano Amador<br />
Norco San Leandro Contra Costa<br />
Norwalk San Marcos El Dorado<br />
Oakdale San Pablo Madera<br />
Oakley San Rafael Merced<br />
Ontario Santa Ana Placer<br />
Orland Santa Maria Riverside<br />
Oacnard Santee Stanislaus<br />
Pacific Grove Sausalito Sutter<br />
Palm Dale Seal Beach Los Angeles<br />
Palm Desert<br />
Palo Alto<br />
Palos Verdes Estate<br />
Parlier<br />
Pasadena<br />
Paso Robles<br />
Patterson<br />
Petaluma<br />
Pico Rivera<br />
Pinole<br />
Pismo Beach<br />
Pittsburg<br />
Placentia<br />
Pleasant Hill<br />
PleasanYOn<br />
Red Bluff<br />
Redlands<br />
Redondo Beach<br />
Ridgecrest<br />
Riverbank<br />
Riverside<br />
Rocklin<br />
Rohnert Park<br />
Rolling Hills Estates<br />
Seaside<br />
Sierra Madre<br />
Simi Valley<br />
Solvang<br />
Sonoina<br />
South E1 Monte<br />
South San Francisco<br />
Stanton<br />
Suisun <strong>City</strong><br />
Susanville<br />
Temecula<br />
Torrance<br />
Truckee<br />
Turlock<br />
Tuscin<br />
Twentynine Palms<br />
Ukiah<br />
Union <strong>City</strong><br />
Upland<br />
Victorville<br />
Villa Park<br />
Vista<br />
Walnut<br />
Yuba <strong>City</strong>
Marijuana Talking Points<br />
1 California s police chiefs protect over 78 <strong>of</strong> Californians We take our<br />
responsibility very very seriously<br />
2 The legalization <strong>of</strong> marijuana will dramatically increase the public safety<br />
challenges we face<br />
3 Proponents would have you believe otherwise but we all know that s not true<br />
4 The organized criminal combines who are engaged in marijuana cultivation and<br />
distribution will not meekly go away if AB 390 passes they will become<br />
stronger We know this based on what has happened elsewhere It is naive to<br />
think that the major drug cartels who control cultivation in California will meekly<br />
go away Instead they will either use fronts to apply for a Cultivator s license<br />
or because AB 390 reduces the fine for illegal growing <strong>of</strong> marijuana to only<br />
100 keep doing what they have been doing In either case they are not going<br />
away<br />
5 When the Netherlands legalizedso called marijuana cafes in the 1980 s there<br />
were only three organized crime operations in that country Today there are<br />
over 90 as organized criminal enterprises from all over Europe descended on the<br />
Netherlands<br />
6 Here in California we can expect an increase inauto burglaries robberies and<br />
residential burglaries Again we know this because that s what happened in<br />
Alaska when they decriminalized drugs from 1978 to 1990 During that period<br />
there was a dramatic increase in those crimes as users committed crimes to get<br />
money to buy marijuana It s one <strong>of</strong> the reasons Alaska abandoned this failed<br />
experiment<br />
7 Highway fatalities will rise if marijuana is legalized Right now driving under the<br />
influence <strong>of</strong> drugs kills 8000 people a year Under this bill it will be possible to<br />
buy marijuana in every liquor in the state in virtually every supermarket chain<br />
That kind <strong>of</strong> availability will only exponentially increase highway fatalities<br />
8 As police chiefs we feel that any law that would strengthen the hand <strong>of</strong><br />
organized crime increase crime and increase highway fatalities is somehow not<br />
a very good idea<br />
9 President Obama understands that marijuana should not be legalized Dr Sanjay<br />
Gupta at CNN understands that marijuana should not be legalized Ourjob is to<br />
make the Legislature understand the same<br />
thing
WHITE PAPER ON MARIJUANA DISPENSARIES<br />
by<br />
CALIFORNIA POLICE CHIEFS ASSOCIATION<br />
TASK FORCE ON MARIJUANA DISPENSARIES<br />
O 2009 California Police Chiefs Assn<br />
All Rights Reserved
ACKNOWLEDGMENTS<br />
Beyond any question this White Paper is the product <strong>of</strong> a major cooperative effort among<br />
representatives <strong>of</strong> numerous law enforcement agencies and allies who shaze in common the goal <strong>of</strong><br />
bringing to light the criminal nexus and attendant societal problems posed by marijuana dispensaries<br />
that until now have been too <strong>of</strong>ten hidden in the shadows The critical need for this project was first<br />
recognized by the Califomia Police Chiefs Association which put its implementation in the very<br />
capable hands <strong>of</strong> CPCA s Executive Director Leslie McGill <strong>City</strong> <strong>of</strong> Modesto Chief <strong>of</strong> Police Roy<br />
Wasden and <strong>City</strong> <strong>of</strong> El Cerrito Chief <strong>of</strong> Police Scott Kirkland to spearhead More than 30 people<br />
contributed to this project as members <strong>of</strong> CPCA s Medical Marijuana Dispensary Crime Impact<br />
Issues Task Force which has been enjoying the hospitality <strong>of</strong> Sheriff John McGinnis at regulaz<br />
meetings held at the Sacramento County Sheriff s DepartrnenYs Headquarters Office over the past<br />
three years about every three months The ideas for the White Paper s components came from this<br />
group and the text is the collaborative effort <strong>of</strong> numerous persons both on and <strong>of</strong>f the task force<br />
Special mention goes to Riverside County District Attorney Rod Pacheco and Riverside County<br />
Deputy District Attomey Jacqueline Jackson who allowed their Office s fine White Paper on<br />
Medical Marijuana History and Current Complications to be utilized as a partial guide and granted<br />
pemussion to include material from that document Also Attorneys Martin Mayer and Richard<br />
Jones <strong>of</strong> the law firm <strong>of</strong> Jones<br />
Mayer are thanked for preparing the pending legal questions and<br />
answers on relevant legal issues that appeaz at the end <strong>of</strong> this White Paper And I thank recently<br />
retired San Bernardino County Sheriff Gary Penrod for initially assigning me to contribute to this<br />
important work<br />
Identifying and thanking everyone who contributed in some way to this project would be well nigh<br />
impossible since the cast <strong>of</strong> characters changed somewhat over the years and some unknown<br />
individuals also helped meaningfully behind the scenes Ultimately developing a White Paper on<br />
Marijuana Dispensaries became a rite <strong>of</strong> passage for its creators as much as a writing project At<br />
times this daunting and sometimes unwieldy multi year project had many task force members<br />
including the White Paper s editor wondering if a polished final product would ever really reach<br />
fruition But at last it has If any reader is enlightened and spurred to action to any degree by the<br />
White Paper s important and timely subject matter all <strong>of</strong> the work that went into this collaborative<br />
project will have been well worth the effort and time expended by the many individuals who worked<br />
harmoniously to make it possible<br />
Some <strong>of</strong> the other persons and agencies who contributed in a meaningful way to this group venture<br />
over the past three years and deserve acknowledgment for their helpful input and support are<br />
George Anderson California Department <strong>of</strong> Justice<br />
Jacob Appelsmith Office <strong>of</strong> the California Attorney General<br />
John Avila California Narcotics Officers Association<br />
Phebe Chu Office <strong>of</strong> San Bernardino County Counsel<br />
Scott Collins Los Angeles County District Attorney s Office<br />
Cathy Coyne California State Sheriffs Association<br />
Lorrac Craig Trinity County SherifPs Department<br />
Jim Denney Califomia State Sheriffs Association<br />
Thomas Dewey California StaYe University Humboldt Police DeparCment<br />
Dana Filkowski Contra Costa County District Attomey s Office<br />
John Gaines Califomia Departrnent <strong>of</strong>Justice Bureau <strong>of</strong> Narcotics Enforcement<br />
Craig Gundlach Modesto Police Department<br />
John Harlan Los Angeles County District Attorney sOffice Major Narcotics Division<br />
O 2009 California Police Chiefs Assn I All Rights Reserved
Nate Johnson California State University Police<br />
Mike Kanalakis Monterey County Sheriffs Office<br />
Bob Kochly Contra Costa County Office <strong>of</strong> District Attomey<br />
Tommy LaNier The National Marijuana Initiative HIDTA<br />
Carol Leveroni Califomia Peace Officers Association<br />
Kevin McCar hy Los Angeles Police Department<br />
Randy Mendoza Arcata Police Department<br />
Mike Nivens California Highway Patrol<br />
Rick Oules Office <strong>of</strong> the United States Attorney<br />
Mark Pazin Merced County Sheriffs Department<br />
Michael Regan El Cerrito Police Department<br />
Melissa Reisinger California Police Chiefs Association<br />
Kimberly Rios California DeparUnent <strong>of</strong> Justice Conference Planning Unit<br />
Kent Shaw California Department <strong>of</strong>Justice Bureau <strong>of</strong> Nazcotics Enforcement<br />
Crystal Spencer California Department <strong>of</strong> Justice Conference Planning Unit<br />
Sam Spiegel Folsom Police Department<br />
Valerie Taylor ONDCP<br />
Thomas Toller California District Attomeys Association<br />
Martin Vranicaz Jr California District Attorneys Association<br />
Apri122 2009<br />
Dennis Tilton Editor<br />
O 2009 California Police Chiefs Assn II All Rights Reserved
TABLE OF CONTENTS<br />
Paees<br />
ACKNOWLEDGMENTS<br />
ii<br />
EXECUTIVE SUMMARY<br />
ivvi<br />
WHITE PAPER ON MARIJUANA DISPENSARIES<br />
INTRODUCTION1<br />
FEDERAL LAWI2<br />
CALIFORNIA LAW26<br />
LAWS IN OTHER STATES 6<br />
STOREFRONT MARIJUANA DISPENSARIES AND COOPERATNES 67<br />
HOW EXISTING DISPENSARIES OPERATE 78<br />
ADVERSE SECONDARY EFFECTS OF MARINANA DISPENSARIES<br />
AND SIMILARLY OPERATING COOPERATIVES 8<br />
ANCILLARY CRIMES810<br />
OTHER ADVERSE SECONDARY IMPACTS IN THE IMMEDIATE VICINITY OF<br />
DISPENSARIES11<br />
SECONDARY ADVERSE IMPACTS IN THE COMMUNITY AT LARGE 11 14<br />
ULTIMATE CONCLUSIONS REGARDING ADVERSE SECONDARY EFFECTS14<br />
POSSIBLE LOCAL GOVERNMENTAL RESPONSES TO MARINANA DISPENSARIES 14 17<br />
LIABILITY ISSUES18 19<br />
A SAMPLING OF EXPERIENCES WITH MARIJUANA DISPENSARIES 19 30<br />
PENDING LEGAL QUESTIONS 31 39<br />
CONCLUSIONS 40<br />
ENDNOTES 41 44<br />
NON LEGAL REFERENCES 45 49<br />
O 2009 California Police Chiefs Assn iii All Rights Reserved
WHITE PAPER ON MARIJUANA DISPENSARIES<br />
by<br />
CALIFORNIA POLICE CHIEFS ASSOCIATION<br />
TASK FORCE ON MARIJUANA DISPENSARIES<br />
EXECUTIVE SUMMARY<br />
INTRODUCTION<br />
Proposition 215 an initiative authorizing the limited possession cultivation and use <strong>of</strong> marijuana by<br />
patients and their care providers for certain medicinal purposes recommended by a physician without<br />
subjecting such persons to criminal punishment was passed by California voters in 1996 This was<br />
supplemented by the California State Legislature<br />
enactment in 2003 <strong>of</strong> the Medical Marijuana<br />
Program Act SB 420 that became effective in 2004 The language <strong>of</strong> Proposition 215 was codified<br />
in Califomia as the Compassionate Use Act which added section 11362 5 to the California Health<br />
Safety Code Much later the language <strong>of</strong> Senate Bi11420 became the Medical Marijuana Program<br />
Act MMPA and was added to the California Health SaFety Code as section 11362 7 et seq<br />
Among other requirements it purports to direct all California counties to set up and administer a<br />
voluntary identification card system for medical marijuana users and their caregivers Some<br />
counties have already complied with the mandatory provisions <strong>of</strong> the MMPA and others have<br />
challenged provisions <strong>of</strong> the Act or are awaiting outcomes <strong>of</strong> other counties legal challenges to it<br />
before taking affirmative steps to follow all <strong>of</strong> its dictates And with respect to marijuana<br />
dispensaries the reaction <strong>of</strong> counties and municipalities to these nascent businesses has been<br />
decidedly mixed Some have issued pernuts for such enterprises Others have refused to do so<br />
within theirjurisdictions Still others have conditioned permitting such operations on the condition<br />
that Chey noY violate any state or federal law or have reversed course after initially allowing such<br />
activities within their geographical barders by either limiting or refusing to allow any further<br />
dispensaries to open in their community This White Paper explores these matters the apparent<br />
conflicts between federal and California law and the scope <strong>of</strong> both direct and indirect adverse<br />
impacts <strong>of</strong> marijuana dispensaries in local communities It also recounts several examples that could<br />
be emulated <strong>of</strong> what some govemmental <strong>of</strong>ficials and law enforcement agencies have already<br />
instituted in their jurisdictions to limit the proliferation <strong>of</strong> marijuana dispensaries and to mirigate<br />
their negative consequences<br />
FEDERAL LAW<br />
Except for very limited and authorized research purposes federal law through the Controlled<br />
Substances Act absolutely prohibits the use <strong>of</strong> marijuana for any legal purpose and classifies it as a<br />
banned Schedule I drug It cannot be legally prescribed as medicine by a physician And the<br />
federal regulation supersedes any state regulation so that under federal law California medical<br />
marijuana statutes do not provide a legal defense for cultivaYing or possessing marijuana even with<br />
a physician<br />
recommendation for medical use<br />
OO 2009 California Police Chiefs Assn IV All Rights Reserved
CALIFORNIA LAW<br />
Although California law generally prohibits the cultivation possession transportation sa1e or other<br />
transfer <strong>of</strong> marijuana from one person to another since late 1996 after passage <strong>of</strong> an initiative<br />
Proposition 215 later codified as the Compassionate Use Act it has provided a limited affirmative<br />
defense to criminal prosecution for those who cultivate possess or use limited amounts <strong>of</strong> marijuana<br />
for medicinal purposes as qualified patients with a physician<br />
recommendation or their designated<br />
primary caregiver or cooperative Notwithstanding these limited exceptions to criminal culpability<br />
California law is notably silent on any such available defense for a storefront marijuana dispensary<br />
and California Attomey General Edmund G Brown Jr has recenUy issued guidelines that generally<br />
find marijuana dispensaries to be unprotected and illegaldrug trafficking enterprises except in the<br />
rare instance that one can qualify as a true cooperative under California law A primary caregiver<br />
must consistently and regularly assume responsibility for the housing health or safety <strong>of</strong> an<br />
authorized medical marijuana user and nowhere does California law authorize cultivating or<br />
providing marijuana medical ornon medical for pr<strong>of</strong>it<br />
California s Medical Marijuana Program Act Senate Bi11420 provides further guidelines for<br />
mandated county programs for the issuance <strong>of</strong> identification cards to authorized medical marijuana<br />
users on a voluntary basis for the chief purpose <strong>of</strong> giving them a means <strong>of</strong> certification to show law<br />
enfarcement <strong>of</strong>ficers if such persons are investigated for an <strong>of</strong>fense involving marijuana This<br />
system is currently under challenge by the Counties <strong>of</strong> San Bernardino and San Diego and Sheriff<br />
Gary Penrod pending a decision on review by theUS Supreme Court as is California s right to<br />
permit any legal use <strong>of</strong> marijuana in light <strong>of</strong> federal law that totally prohibits any personal<br />
cultivation possession sale transportation or use <strong>of</strong> this substance whatsoever whether for medical<br />
ornon medical purposes<br />
PROBLEMS POSED BY MARIJUANA DISPENSARIES<br />
Marijuana dispensaries are commonly large money making enterprises that will sell marijuana to<br />
most anyone who produces a physician<br />
written recommendation for its medical use These<br />
recoinmendations can be had by paying unscrupulous physicians a fee and claiming to have most<br />
any malady even headaches While the dispensaries will claim to receive only donations no<br />
marijuana will change hands without an exchange <strong>of</strong> money These operations have been tied to<br />
organized criminal gangs foster large grow operations and are <strong>of</strong>tenmulti million dollar pr<strong>of</strong>it<br />
centers<br />
Because they are repositories <strong>of</strong> valuable marijuana crops and large amounts <strong>of</strong> cash several<br />
operators <strong>of</strong> dispensaries have been attacked and murdered by armed robbers both at their storefronts<br />
and homes and such places have been regularly burglarized Drug dealing sales to minors<br />
loitering heavy vehicle and foot traffic in retail areas increased noise and robberies <strong>of</strong> customers<br />
just outside dispensaries are also common ancillary byproducts <strong>of</strong> their operations To repel store<br />
invasions fireanns are <strong>of</strong>ten kept on hand inside dispensaries and firearms are used to hold up their<br />
proprietors These dispensaries are either linked to large marijuana grow operations or encourage<br />
home grows by buying marijuana to dispense And just as destructive fires and unhealthful mold in<br />
residential neighborhoods are <strong>of</strong>ten the result <strong>of</strong> large indoor home grows designed to supply<br />
dispensaries money laundering also naturally results from dispensaries likely unlawful operations<br />
OO 2009 California Police Chiefs Assn v All Rights Reserved
LOCAL GOVERNMENTAL RESPONSES<br />
Local govemmental bodies can impose a moratorium on the licensing <strong>of</strong> marijuana dispensaries<br />
while investigating this issue can ban this type <strong>of</strong> activity because it violates federal law can use<br />
zoning to control the dispersion <strong>of</strong> dispensaries and the attendant problems that accompany them in<br />
unwanted areas and can condition their operation on not violating any federal or state law which is<br />
akin to banning them since their primary activities will always violate federal law as it now exists<br />
and almost surely California law as well<br />
LIABILITY<br />
While highly unlikely local public <strong>of</strong>ficials including county supervisors and city council members<br />
could potentially be charged and prosecuted for aiding and abetting criminal acts by authorizing and<br />
licensing marijuana dispensaries if they do not qualify as cooperatives under California law which<br />
would be a rare occurrence Civil liability could also result<br />
ENFORCEMENT OF MARIJUANA LAWS<br />
While the Drug Enforcement Administration has been very active in raiding large scale marijuana<br />
dispensaries in California in the recent past and arresting and prosecuting their principals under<br />
federal law in selective cases the new US Attorney General Eric Holder Jr has very recently<br />
announced a major change <strong>of</strong> federal position in the enforcement <strong>of</strong> federal drug laws with respect to<br />
marijuana dispensaries It is to target for prosecution only marijuana dispensaries that are exposed<br />
as fronts for drug trafficking It remains to be seen what standards and definitions will be used to<br />
determine what indicia will constitute a drug trafficking operation suitable to trigger investigation<br />
and enforcement under the new federal administration<br />
Some counties like law enforcement agencies in the County <strong>of</strong> San Diego and County <strong>of</strong> Riverside<br />
have been aggressive in confronting and prosecuting the operators <strong>of</strong> marijuana dispensaries under<br />
state law Likewise certain cities and counties have resisted granting marijuana dispensaries<br />
business licenses have denied applications or have imposed moratoria on such enterprises Here<br />
too the future is uncertain and permissible legal action with respect to marijuana dispensaries may<br />
depend on future court decisions not yet handed down<br />
Largely because the majority <strong>of</strong> their citizens have been sympathetic and projected a favorable<br />
attitude toward medical marijuana patients and have been tolerant <strong>of</strong> the cultivation and use <strong>of</strong><br />
marijuana other local public <strong>of</strong>ficials in California cities and counties especially in Northern<br />
California have takenahands <strong>of</strong>f attitude with respect to prosecuting marijuana dispensary<br />
operators or attempting to close down such operations But because <strong>of</strong> the life safety hazards<br />
caused by ensuing fires that have <strong>of</strong>ten erupted in resultant home grow operations and the violent<br />
acts that have <strong>of</strong>ten shadowed dispensaries some attitudes have changed and a few political entities<br />
have reversed course after having previously licensed dispensaries and authorized liberal permissible<br />
amounts <strong>of</strong> marijuana for possession by medical marijuana patients in their jurisdictions These<br />
patienfs have most <strong>of</strong>ten turned out to be young adults who are not sick at all but have secured a<br />
physician<br />
written recommendation for marijuana use by simply paying the required fee demanded<br />
for this document without even first undergoing a physical examination Too <strong>of</strong>ten medical<br />
marijuana has been used as a smokescreen for those who want to legalize it and pr<strong>of</strong>it <strong>of</strong>f it and<br />
storefront dispensaries established as cover for selling an illegal substance for a lucrative return<br />
OO 2009 California Police Chiefs Assn VI All Rights Reserved
WHITE PAPER ON MARIJUANA DISPENSARIES<br />
by<br />
CALIFORNIA POLICE CHIEFS ASSOCIATION<br />
Editor Dennis TiltonMAEdMALitMCJJD<br />
Adjunct Pr<strong>of</strong>essor <strong>of</strong> Criminal Justice Political Science Public Administration Upper Iowa University<br />
Sheriffls Legal Counsel Retired San Bernardino County Sheriffls Department<br />
INTRODUCTION<br />
In November <strong>of</strong> 1996 California voters passed Proposition 215 The initiative set out to make<br />
marijuana available to people with certain illnesses The initiative was later supplemented by the<br />
Medical Marijuana Program Act Across the state counties and municipalities have varied in their<br />
responses to medical marijuana Some have allowed businesses to open and provide medical<br />
marijuana Others have disallowed all such establishments within their borders Several once issued<br />
business licenses allowing medical marijuana stores to operate but no longer do so This paper<br />
discusses the legality <strong>of</strong> both medical marijuana and the businesses that make it available and more<br />
specifically the problems associated with medical marijuana and marijuana dispensaries under<br />
whatever name they operate<br />
FEDERAL LAW<br />
Federal law clearly and unequivocally states that all marijuana related acrivities aze illegal<br />
Consequently all people engaged in such activities are subject to federal prosecution The United<br />
States Supreme Court has ruled that this federal regulation supersedes any state<br />
regulation <strong>of</strong><br />
marijuana even California s Gonzales v Raich 2005 125 SCt 2195 2215 The Supremacy<br />
Clause unambiguously provides that if there is any conflict between federal law and state law<br />
federal law shall prevail Gonzales v Raich sa pra Even more recenUy the 9 Circuit Court <strong>of</strong><br />
Appeals found that there is no fundamental right under the United States Constitution to even use<br />
medical marijuana Raich v Gonzales 9th Cir 2007 500 F3d 850 866<br />
In Goi zales v Ruich the High Court declared that despite the attempts <strong>of</strong> several states to partially<br />
legalize marijuana it continues to be wholly illegal since it is dassified as a Schedule I drug under<br />
federal law As such there aze no exceptions to its illegality 21 USC secs 812 c 841 a1<br />
Over the past thirty years there have been several attempts to have marijuana reclassified to a<br />
different schedule which would permit medical use <strong>of</strong> the drug All <strong>of</strong> these attempts have failed<br />
See Gonzules v Raich 2005 125 SCt 2195 fn 23 The mere categorization <strong>of</strong> marijuana as<br />
medical by some states fails to carve out any legally recognized exception regarding the drug<br />
Marijuana in any form is neither valid nor legal<br />
Clearly the United States Supreme Court is the highest court in the land Its decisions aze final and<br />
binding upon all lower courts The Court invoked the United States Supremacy Clause and the<br />
Commerce Clause in reaching its decision The Supremacy Clause declares that all laws made in<br />
pursuance <strong>of</strong> the Constitution shall be the supreme law <strong>of</strong> the land and shall be legally superior to<br />
any conflicting provision <strong>of</strong> a state constitution or law The Commerce Clause states that the<br />
O 2009 California Police Chiefs Assn 1 All Rights Reserved
Congress shall have power to regulate Commerce with foreign Nations and among the several<br />
States and with the Indian Tribes<br />
Gonzales v Raich addressed the concerns <strong>of</strong> two California individuals growing and using marijuana<br />
under California s medical marijuana statute The Court explained that under the Controlled<br />
Substances Act marijuana is a Schedule I drug and is strictly regulated Schedule I drugs are<br />
categorized as such because <strong>of</strong> their high potential for abuse lack <strong>of</strong> any accepted medical use and<br />
absence <strong>of</strong> any accepted safety for use in medically supervised treatment 21 USC sec 812 b1<br />
The Court ruled that the Commerce Clause is applicable to California individuals growing and<br />
obtaining marijuana for their own personal medical use Under the Supremacy Clause the federal<br />
regulation <strong>of</strong> marijuana pursuant to the Commerce Clause supersedes any state<br />
regulation<br />
including Califomia s The Court found that the California statutes did not provide any federal<br />
defense if a person is brought into federal court for cultivating or possessing marijuana<br />
Accordingly there is no federal exception for the growth cultivation use or possession <strong>of</strong> mazijuana<br />
and all such activity remains illegal California s Compassionate Use Act <strong>of</strong> 1996 and Medical<br />
Marijuana Program Act <strong>of</strong> 2004 do not create an exception to this federal law All marijuana<br />
activity is absolutely illegal and subject to federal regulation and prosecution This notwithstanding<br />
on March 19 2009 US Attomey General Eric Holder Jr announced that under the new Obama<br />
Administration theUS Department <strong>of</strong> Justice plans to target for prosecution only fhose marijuana<br />
dispensaries that use medical marijuana dispensing as a front for dealers <strong>of</strong> illegal drugs<br />
CALIFORNIA LAW<br />
Generally the possession cultivation possession for sale transportation distribution fumishing<br />
and giving away <strong>of</strong> marijuana is unlawful under Califomia state statutory law See Cal Health<br />
Safety Code secs 11357 ll 360 But on November 5 1996 California voters adopted Proposition<br />
215 an initiative statute authorizing the medical use <strong>of</strong> marijuana The initiative added California<br />
Health and Safety code section 11362 5 which allows seriously ill Californians the right to obtain<br />
and use marijuana for medical purposes where that medical use is deemed appropriate and has been<br />
recommended by a physician The codified section is known as the Compassionate Use Act<br />
<strong>of</strong> 1996 Additionally the State Legislature passed Senate Bi11420 in 2003 It became the Medical<br />
Marijuana Program Act and took effect on ianuary 1 2004 This act expanded the definitions <strong>of</strong><br />
patienY and primary caregiver and created guidelines for identification cards It defined the<br />
amount <strong>of</strong> marijuana that patients and primary caregivers can possess It also created a<br />
limited affittnative defense to criminal prosecution Yor qualifying individuals that collectively gather<br />
to cultivate medical marijuana as well as to tha crimes <strong>of</strong> narijuana possession possession for<br />
sale transportation sale furnishing cultivation and maintenance <strong>of</strong> places for storage use or<br />
distribution <strong>of</strong> marijuana for a person who qualifies asapatientaprimary caregiver or as a<br />
member <strong>of</strong> a legally recognized cooperative as those terms are defined within the statutory<br />
scheme Nevertheless there is no provision in any <strong>of</strong> these laws that authorizes or protects the<br />
establishment <strong>of</strong>adispensary or other storefront marijuana distribution operation<br />
Despite their illegality in the federal context the medical marijuana laws in California are specific<br />
The statutes craft narrow affirmative defenses for particular individuals with respect to enumerated<br />
marijuana activity All conduct and people engaging in it that falls outside <strong>of</strong> the statutes<br />
parameters remains illegal under Califomia law Relatively few individuals will be able to asserf the<br />
affirmative defense in the statute To use it a person must beaqualified patient primary<br />
caregiver or a member <strong>of</strong>acooperative Once they are charged with a crime if a<br />
person can prove an applicable legal status they are entitled to assert this statutory defense<br />
OO 2009 California Police Chiefs Assn 2 All<br />
Rights Reserved
Former Califomia Attorney General Bill Lockyer has also spoken abouf inedical marijuana and<br />
strictly construed California law relating to it His <strong>of</strong>fice issued a bulletin to California law<br />
enforcement agencies on June 9 2005 The <strong>of</strong>fice expressed the opinion that Gonzales v Raich did<br />
not address the validity <strong>of</strong> the Califomia statutes and therefore had no effect on California law The<br />
<strong>of</strong>fice advised law enforcement to not change their operating procedures Attorney General Lockyer<br />
made the recommendation that law enforcement neither arrest nor prosecute individuals within the<br />
legal scope <strong>of</strong> California s Compassionate Use Act Now the current California Attomey General<br />
Edmund G Brown Jr has issued guidelines conceming the handling oF issues relating to<br />
Califomia s medical marijuana laws and marijuana dispensaries The guidelines are much tougher<br />
on storefront dispensaries generally finding them to be unprotected illegaldrug trafficking<br />
enterprises if they do not fall within the narrow legal definition <strong>of</strong>acooperative than on the<br />
possession and use <strong>of</strong> marijuana upon the recommendation <strong>of</strong> a physician<br />
When Califomia s medical marijuana laws are strictly construed it appears that the decision in<br />
Gonzales v Ruich does affect CaliFornia law However provided that federal law does not preempt<br />
California law in this area it does appear that the California statutes oPfer some egal protection to<br />
individuals within the legal scope <strong>of</strong> the acts The medical marijuana laws speak to patients<br />
primary caregivers and true collectives These people are expressly mentioned in the statutes and<br />
if their conduct comports to the law they may have some state legal protection for specified<br />
marijuana activity Conversely all marijuana establislunents that fall outside the letter and spirit <strong>of</strong><br />
the statutes including dispensaries and storefront facilities aze not legal These establishments have<br />
no egal protection Neither the former Califomia Attorney GeneraPs opinion nor the current<br />
California Attorney Genera s guidelines present a contrary view Nevertheless without specifically<br />
addressing marijuana dispensaries Attorney General Brown has sent his deputies attorney general to<br />
defend the codified Medical Marijuana Program Act against court challenges and to advance the<br />
position that the state<br />
regulations promulgated to enforce the provisions <strong>of</strong> the codified<br />
Compassionate Use Act Proposition 215 including a statewide database and county identification<br />
card systems for marijuana patients authorized by their physicians to use marijuana are all valid<br />
1 Conduct<br />
California HealYh and Safety Code sections 11362 765 and 11362 775 describe the conduct for<br />
which the affirmative defense is available If a person qualifies asapatient primary caregiver<br />
or is a member <strong>of</strong> a legally recognized cooperative he or she has an affirmative defense to<br />
possessing a defined amount <strong>of</strong> marijuana Under the statutes no more than eight ounces <strong>of</strong> dried<br />
marijuana can be possessed Additionally either six mature or twelve immature plants may be<br />
possessed If a person claims patient or primary caregiver status and possesses more than this<br />
amount <strong>of</strong> marijuana he or she can be prosecuted for drug possession The qualifying individuals<br />
may also cultivate plant harvest dry and or process marijuana but only while still strictly<br />
observing the permitted amount <strong>of</strong> the drug The statute may also provide a limited affirmative<br />
defense for possessing marijuana for sale transporting it giving it away maintaining a marijuana<br />
house knowingly providing a space where marijuana can be accessed and creating a narcotic<br />
nuisance 16<br />
However for anyone who cannot lay claim to the appropriate status under the statutes all instances<br />
<strong>of</strong> marijuana possession cultivation planting harvesting drying processing possession for the<br />
purposes <strong>of</strong> sales completed sales giving away administration transportation maintaining <strong>of</strong><br />
marijuana houses knowingly providing a space for marijuana activity and creating a narcotic<br />
nuisance continue to be illegal under California law<br />
OO 2009 California Police Chiefs Assn 3 All Rights Reserved
2 Patients and Cardholders<br />
A dispensary obviously is not a patient or cardholderAqualified patienY is an individual with a<br />
physician<br />
recommendation that indicates marijuana will benefit the treatment <strong>of</strong> a qualifying<br />
illness CalHS Code secs 11362 5b1A and 11362 7 Qualified illnesses include cancer<br />
anorexia AIDS chronic pain spasticity glaucoma arthritis migraine or any other illness for which<br />
marijuana provides relief A physician<br />
recommendation that indicates medical marijuana will<br />
benefit the treatment <strong>of</strong> an illness is required before a person can claim to be a medical marijuana<br />
patient Accordingly such pro<strong>of</strong> is also necessary before a medical marijuana affirmative defense<br />
can be claimed<br />
Aperson with an identification card means an individual who is a qualified patient who has<br />
applied for and received a valid identification card issued by the State Department <strong>of</strong> Health<br />
Services Cal HS Code secs 11362 7c and ll362 7g<br />
3 Primary Caregivers<br />
The only person or entity authorized to receive compensation For services provided to patients and<br />
cardholders is a primary caregiver CaL HS Code sec 11362 77c However nothing in the law<br />
authorizes any individual or group to cultivate or distribute marijuana for pr<strong>of</strong>it CalHS Code<br />
sec 11362 7b5 a It is important to note tbat it is almost impossible for a storefront marijuana<br />
business to gain true primary caregiver status Businesses that call themselves cooperatives but<br />
function like storefront dispensaries suffer this same fate In People v Mower the court was very<br />
clear that the defendant had to prove he was a primary caregiver in order to raise the medical<br />
marijuana affirn ative defense Mr Mower was prosecuted for supplying two people with<br />
marijuana He claimed he was their primary caregiver under the medical marijuana statutes<br />
claim required him to prove he consistently had assumed responsibility for either one s housing<br />
health or safety before he could assert the defense Emphasis added<br />
The key to being a primary caregiver is not simply that marijuana is provided for a patient s health<br />
the responsibility for the health must be consistent it must be independent <strong>of</strong> inerely providing<br />
marijuana for a qualified person and such a primary caregiver patient relationship must begin before<br />
or contemporaneously with the time <strong>of</strong> assumption <strong>of</strong> responsibility for assisting the individual with<br />
marijuana People v Mentch 2008 45 Cal 4th 274 283 Any relationship a storefront marijuana<br />
business has with a patient is much more likely to be transitory than consistent and to be wholly<br />
lacking in providing for a patienYs health needs beyond just supplying him or her with marijuana<br />
Aprimary caregiver is an individual or facility that has consistently assumed responsibility for<br />
the housing health or safety <strong>of</strong> a patienY over tune CaLHS Code sec 11362 5e<br />
Consistency is the key to meeting this definition A patient can elect to patronize any dispensary<br />
that he or she chooses The patient can visit different dispensaries on a single day or any subsequent<br />
day The statutory definition includes some clinics health care facilities residential care facilities<br />
and hospices But in lighi <strong>of</strong> the holding in People v Mentch szrpra to qualify as a primary<br />
caregiver more aid to a person<br />
health must occur beyond merely dispensing marijuana to a given<br />
customer<br />
Additionally if more than one patient designates the same person as the primary caregiver all<br />
individuals must reside in the same city or county And in most circumstances the primary<br />
caregiver must be at least 18 yeazs <strong>of</strong> age<br />
OO 2009 California Police Chiefs Assn 4 All Rights Reserved<br />
This
The courts have found that the act <strong>of</strong> signing a piece <strong>of</strong> paper declaring that someone is a primary<br />
caregiver does not necessarily make that person one See People ex rel Lungren v Peron 1997 59<br />
Ca1 AppAth 1383 1390 One maintaining a source <strong>of</strong> marijuana supply from which all members <strong>of</strong><br />
the public qualified as permitted medicinal users may or may not discretionarily elect to make<br />
purchases does not thereby become the party who has consistently assumed responsibility for the<br />
housing health or safety <strong>of</strong> that purchaser as section 11362 5e requires<br />
The California Legislature had the opportunity to legalize the existence <strong>of</strong> dispensaries when setting<br />
forth what types <strong>of</strong> facilities could qualify as primary caregivers Those included in the list clearly<br />
show the Legislature<br />
intent to restrict fhe definition to one involving a significant and long term<br />
commitment to the patienYs health safety and welfare The only facilities which the Legislature<br />
authorized to serve as primary caregivers are clinics health care facilities residential care<br />
facilities home health agencies and hospices which actually provide medical care or supportive<br />
services to qualified patients CalHS Code sec 11362 7d1 Any business that cannot prove<br />
that its relationship with the patient meets these requirements is not a primary caregiver<br />
Functionally the business is a drug dealer and is subject to prosecution as such<br />
4 Cooperatives and Co1lecHves<br />
According to the Califomia Attorney General s recently issued Guidelinesfor the Security and Non<br />
Diversio z <strong>of</strong>Mm ijuana GroNnzfor Medical Use unless they meet stringent requirements<br />
dispensaries also cannot reasonably claim to be cooperatives or collectives In passing the Medical<br />
Marijuana Program Act the Legislature sought in part to enhance the access <strong>of</strong> patients and<br />
caregivers to medical marijuana through collective cooperative cultivation programs People v<br />
Urziceanar 2005 132Ca1 App 4th 747 881 The Act added section 11362 775 which provides<br />
that Patients and caregivers who associate within the State <strong>of</strong> California in order collectively or<br />
cooperatively to cultivate marijuana for medical purposes shall not solely on the basis <strong>of</strong> that fact be<br />
subject to state criminal sanctions for the crimes <strong>of</strong> marijuana possession possession for sale<br />
transportation sale furnishing cultivation and maintenance <strong>of</strong> places for storage use or<br />
distribution <strong>of</strong> marijuana However there is no authorization for any individual or group to cultivate<br />
or distribute marijuana for pr<strong>of</strong>it CalHS Code sec 11362 77a If a dispensary is only a<br />
storefront distribution operation open to the general public and there is no indication that it has been<br />
involved with growing or cultivating marijuana far the benefit <strong>of</strong> inembers as anon pr<strong>of</strong>it enterprise<br />
it will not qualify as a cooperative to exempt it from criminal penalties under California s marijuana<br />
laws<br />
Further the common dictionary definition <strong>of</strong> collectives is that they are organizations jointly<br />
managed by those using its facilities or services Legally recognized cooperatives generally possess<br />
the following features control and ownership <strong>of</strong> each member is substantially equal members are<br />
limited to those who will avail themselves <strong>of</strong> the services furnished by the association transfer <strong>of</strong><br />
ownership interests is prohibited or limited capital investment receives either no retum or a limited<br />
return economic benefits pass to the members on a substantially equal basis or on the basis <strong>of</strong> their<br />
patronage <strong>of</strong> the association members are not personally liable for obligations <strong>of</strong> the association in<br />
the absence <strong>of</strong> a direct undertaking or authorization by them death bankruptcy or withdrawal <strong>of</strong><br />
one or moreme nbers does not terminate the association and the services <strong>of</strong> the association are<br />
furnished primarily for the use <strong>of</strong> the members<br />
normally meet this legal definition<br />
Marijuana businesses <strong>of</strong> any kind do not<br />
O 2009 California Police Chiefs Assn 5 All Rights Reserved
Based on the foregoing it is clear that virtually all marijuana dispensaries are not legal entetprises<br />
under either federal or state law<br />
LAWS IN OTHER STATES<br />
esides California at the time <strong>of</strong> publication <strong>of</strong> this White Paper thirteen other states bave enacted<br />
medical marijuana laws on their books whereby to some degree marijuana recommended or<br />
prescribed by a physician to a specified patient may be legally possessed These states are Alaska<br />
Colorado Hawaii Maine Maryland Michigan Montana Nevada New Mexico Oregon<br />
Rhode Island Vermont and Washington And possession <strong>of</strong> marijuana under one ounce has now<br />
been decruninalized in Massachusetts<br />
STOREFRONT MARIJUANA DISPENSARIES AND COOPERATIVES<br />
Since the passage <strong>of</strong> the Compassionate Use Act <strong>of</strong> 1996 many storefront marijuana businesses<br />
have opened in California Some are referred to as dispensaries and some as cooperatives but it is<br />
how they operate that removes them from any umbrella <strong>of</strong> legal protection These facilities operate<br />
as if they are pharmacies Most <strong>of</strong>fer different types and grades <strong>of</strong> marijuana Some <strong>of</strong>fer baked<br />
goods that contain marijuana Monetary donations are collected from the patient or primary<br />
caregiver when marijuana or food items are received The items are not technically sold since that<br />
would be a criminal violation <strong>of</strong> the statutes2 These facilities are able to operate because they<br />
apply for and receive business licenses from cities and counties<br />
Federally all existing storefront marijuana businesses are subject to search and closure since they<br />
violate federal law Their mere existence violates federal law Consequently they have no right to<br />
exist or operate and arguably cities and counties in Califomia have no authority to sanction them<br />
Similarly in California there is no apparent authority for the existence <strong>of</strong> these storefront marijuana<br />
businesses The Medical Marijuana Program Act <strong>of</strong> 2004 allows patients and primarycai to<br />
grow and cultivate marijuana and no one else2 Although CaliFornia Health and Safety Code<br />
section 11362 775 <strong>of</strong>fers some state legal protection for true collectives and cooperatives no parallel<br />
protection exists in the statute for any storefront business providing any narcotic<br />
The common dictionary definition <strong>of</strong> collectives is that they aze organizations jointly managed by<br />
those using its facilities or services Legally recognized cooperatives generally possess the<br />
following features control and ownership <strong>of</strong> each member is substantially equal members are<br />
limited to those who will avail themselves <strong>of</strong> the services furnished by the association transfer <strong>of</strong><br />
ownership interests is prohibited or limited capitalizvestment receives either no retz rn or a limited<br />
reta rn economic benefits pass to the members on a substantially equal basis or on the basis <strong>of</strong> their<br />
patronage <strong>of</strong> the association members are not personally liable for obligations <strong>of</strong> the association in<br />
the absence <strong>of</strong> a direct undertaking or authorization by them death bankruptcy or withdrawal <strong>of</strong> one<br />
or more members does not terminate the association and the services <strong>of</strong> the association are<br />
furnished primarily for the use <strong>of</strong> the members Marijuana businesses <strong>of</strong> any kind do not meet<br />
this legal definition<br />
Actual medical dispensaries are commonly defined as <strong>of</strong>fices in hospitals schools or other<br />
institutions from which medical supplies preparations and treahnents are dispensed Hospitals<br />
hospices home health care agencies and the like are specifically included in the code as primary<br />
caregivers as long as they have consistently assumed responsibility for the housing health or<br />
safety <strong>of</strong> a patient 28<br />
Clearly it is doubtful that any <strong>of</strong> the storefront marijuana businesses currently<br />
O 2009 California Police Chiefs Assn 6 All Rights Reserved
existing in California can claim that status Consequently they are not primary caregivers<br />
and are subject to prosecution under both California and federal laws<br />
HOW EXISTING DISPENSARIES OPERATE<br />
Despite their clear illegality some cities do have existing and operational dispensaries Assuming<br />
arguendo tbat they may operate it may be helpful to review the mechanics <strong>of</strong> the business The<br />
former Green Cross dispensary in San Francisco illustrates how a typical marijuana dispensary<br />
works<br />
A guard or employee may check for medical marijuana cards or physician recommendations at the<br />
entrance Many types and grades <strong>of</strong> marijuana are usually available Although employees are<br />
neither pharmacists nor doctors sales clerks will probably make recommendations about what type<br />
<strong>of</strong> marijuana will best relieve a given medical symptom Baked goods containing marijuana may be<br />
available and sold although there is usually no health pertnit to sell baked goods The dispensary<br />
will give the patient a form to sign declaring that the dispensary is their primary cazegiver a<br />
process fraught with legal difficulties The patient then selects the marijuana desired and is tod<br />
what the contribution will be for the product The California Health Safety Code specifically<br />
prohibits the sale <strong>of</strong> marijuana to a patient so contributions are made to reimburse the dispensary<br />
for its tune and care in making producY available However if a calculation is made based on the<br />
available evidence it is clear that these contributions can easily add up to millions <strong>of</strong> dollars per<br />
year That is a very large cash flow foranon pr<strong>of</strong>iY organization denying any participation in the<br />
retail sale <strong>of</strong> narcotics Before its application to renew its business license was denied by the <strong>City</strong> <strong>of</strong><br />
San Francisco there were single days that Green Cross sold45 000 worth <strong>of</strong> marijuana On<br />
Saturdays Green Cross could sell marijuana to forty three patients an hour The marijuana sold at<br />
the dispensary was obtained from growers who brought it to the store in backpacks A medium<br />
sized backpack would hold approximately16 000 worth <strong>of</strong> marijuana Green Cross used many<br />
different marijuana growers<br />
It is clear that dispensaries are running as if they are businesses not legally valid cooperatives<br />
Additionally they claim to be the prunary caregivers <strong>of</strong> patients This is a spurious claun As<br />
discussed above the term primary caregiver has a very specific meaning and defined legal<br />
qualifications A primary caregiver is an individual who has consistently assumed responsibility<br />
for the housing health or safety <strong>of</strong> a patient 30<br />
The statutory definition includes some clinics<br />
health care facilities residential care facilities and hospices If more than one patient designates the<br />
same person as the primary caregiver all individuals must reside in the same city or county In most<br />
circumstances the primary caregiver must be at least 18 years <strong>of</strong> age<br />
It is almost impossible for a storefront marijuana business to gain true primary caregiver status A<br />
business would have to prove that it consistently had assumed responsibility for a patienYs<br />
housing health or safety The key to being a primary caregiver is not simply that marijuana is<br />
provided for a patienYs health the responsibility for the patienYs health must be consistent<br />
As seen in the Green Cross example a storefront marijuana business relationship with a patient is<br />
most likely transitory In order to provide a qualified patient with marijuana a storefi marijuana<br />
business must create an instant primary caregiver relationship with him The very fact that the<br />
relationship is instant belies any consistency in their relationship and the requirement that housing<br />
health or safety is consistently provided Courts have found that a patienYs act <strong>of</strong> signing a piece <strong>of</strong><br />
paper declaring that someone is a primary caregiver does not necessarily make that person one The<br />
O 2009 California Police Chiefs Assn 7 All Rights Reserved
consistent relationship demanded by the statute is mere fiction if it can be achieved between an<br />
individual and a business that functions like a narcotic retail store<br />
ADVERSE SECONDARY EFFECTS OF MARIJUANA DISPENSARIES<br />
AND SIMILIARLY OPERATING COOPERATIVES<br />
Of great concern are the adverse secondary effects <strong>of</strong> these dispensaries and storefront cooperatives<br />
They are many Besides flouting federal law by selling a prohibited Schedule I drug under the<br />
Controlled Substances Act marijuana dispensaries attract or cause numerous ancillary social<br />
problems as byproducts <strong>of</strong> their operation The most glaring <strong>of</strong> these are other criminal acts<br />
ANCILLARY CRIMES<br />
A ARMED ROBBERIES AND MURDERS<br />
Throughout California many violent crimes have been committed that can be traced to the<br />
proliferation <strong>of</strong> marijuana dispensaries These include armed robberies and murders For example<br />
as far back as 2002 two home occupants were shot in Willits California in the course <strong>of</strong> a home<br />
invasion robbery targeting medical marijuana And a series <strong>of</strong> four armed robberies <strong>of</strong> a<br />
marijuana dispensary in Santa Barbara California occurred through August 10 2006 in which thirty<br />
dollars and fifteen baggies filled with marijuana on display were taken by force and removed from<br />
the premises in the latest holdup The owner said he failed to report the first three robberies because<br />
medical marijuana is such a controversial issue 33<br />
On February 25 2004 in Mendocino County two masked thugs conunitted a home invasion robbery<br />
to steal medical marijuana They held a knife to a65 year old man s throat and though he fought<br />
back managed to get away with large amounts <strong>of</strong> marijuana They were soon caught and one <strong>of</strong> the<br />
men received a sentence <strong>of</strong> six years in state prison And on August 19 200518 year old<br />
Demarco Lowrey was shot in the stomach and bled to death during a gunfight with the business<br />
owner when he and his friends attempted a takeover robbery <strong>of</strong> a storefront marijuana business in the<br />
<strong>City</strong> <strong>of</strong> San Leandro California The owner fought back with the hooded home invaders and a gun<br />
battle ensued Demazco Lowery was hit by gunfire and dumped outside the emergency entrance <strong>of</strong><br />
Children s Hospital Oakland after the shootout He did not survive<br />
Near Haywazd California on September 2 2005 upon leaving a marijuana dispensary a patron <strong>of</strong><br />
the CCA Cannabis Club had a gun put to his head as he was relieved <strong>of</strong> over 250 worth <strong>of</strong> pot<br />
Three weeks later another break in occurred at the Garden <strong>of</strong> Eden Cannabis Club in September <strong>of</strong><br />
2005<br />
Another known marijuana dispensary related murder occurred on November 19 2005<br />
Approximately six gun andbat wielding burglars broke into Les Crane s home in Laytonville<br />
California while yelling This is a raid Les Crane who owned two storefront marijuana<br />
businesses was at home and shot to death He received gunshot wounds to his head arm and<br />
abdomen Another man present at the time was beaten with a baseball bat The murderers left the<br />
home after taking an unknown sum <strong>of</strong>US currency and a stash <strong>of</strong> processed marijuana<br />
Then on January 9 2007 marijuana plant cultivator Rex Farrance was shot once in the chest and<br />
killed in his own home after four masked intruders broke in and demanded money When the<br />
homeowner ran to fetch a firearm he was shot dead The robbers escaped with a small amount <strong>of</strong><br />
OO 2009 California Police Chiefs Assn 8 All Rights Reserved
cash and handguns Investigating <strong>of</strong>ficers counted 109 marijuana plants in various phases <strong>of</strong><br />
cultivation inside the house along with two digital scales and just under 4 pounds <strong>of</strong> cultivated<br />
marijuana<br />
More recenUy in Colorado Ken Gorman a former gubematorial candidate and dispenser <strong>of</strong><br />
marijuana who had been previously robbed over twelve times at his home in Denver was found<br />
murdered by gunshot inside his home He was a prominent proponent <strong>of</strong> inedical marijuana and the<br />
legalization <strong>of</strong> marijuana<br />
B BURGLARIES<br />
In June <strong>of</strong> 2007 after two burglarizing youths in Bellflower California were caught by the<br />
homeowner trying to steal the fruits <strong>of</strong> his indoor marijuana grow he shot one who was running<br />
away and killed him And again in January <strong>of</strong> 2007 Claremont Councilman Corey Calaycay<br />
went on record calling marijuana dispensaries crime magnets after a burglary occurred in one in<br />
Claremont California<br />
On July 17 2006 the El Cerrito <strong>City</strong> Council voted to ban all such marijuana facilities It did so<br />
after reviewing a nineteen page report that detailed a rise in crime near these storefront dispensaries<br />
in other cities The crimes included robberies assaults burglaries murders and attempted<br />
murders Even though marijuana storefront businesses do not currently exist in the <strong>City</strong> <strong>of</strong><br />
Monterey Park Califomia it issued a moratorium on them after studying the issue in August <strong>of</strong><br />
20064 Afrer allowing these establishments to operate within its borders the <strong>City</strong> <strong>of</strong> West<br />
Hollywood California passed a similar moratorium The moratorium was prompted by incidents <strong>of</strong><br />
armed burglary at some <strong>of</strong> the city s eight existing pot stores and complaints from neighbors about<br />
increased pedestrian and vehicle traffic and noise<br />
C TRAFFIC NOISE AND DRUG DEALING<br />
Increased noise and pedestrian traffic including nonresidents in pursuit <strong>of</strong> marijuana and out <strong>of</strong> area<br />
criminals in search <strong>of</strong> prey are commonly encountered just outside marijuana dispensaries as well<br />
as drug related <strong>of</strong>fenses in the vicinity like resales <strong>of</strong> products just obtained inside since these<br />
marijuana centers regularly attract marijuana growers drug users and drug traffickers Sharing<br />
just purchased marijuana outside dispensaries also regularly takes place<br />
Rather than the seriously ill for whom medical marijuana was expressly intended perfecUy<br />
healthy young people frequenting dispensaries are a much mare common sight Patient records<br />
seized by law enforcement <strong>of</strong>ficers from dispensaries during raids in San Diego County California<br />
in December <strong>of</strong> 2005 showed that 72 percent <strong>of</strong> patients were between 17 and 40 years old<br />
Said one admitted marijuana trafficker The people I deal with are the same faces I was dealing<br />
with 12 years ago but now because <strong>of</strong> Senate Bi11420 they are supposedly legit I can totally see<br />
why cops are bummed<br />
Reportedly a security guard sold half a pound <strong>of</strong> marijuana to an undercover <strong>of</strong>ficer just outside a<br />
dispensary in Morro Bay California And the mere presence <strong>of</strong> marijuana dispensaries<br />
encourages illegal growers to plant cultivate and transport ever more marijuana in order to supply<br />
and sell their crops to these storefront operators in the thriving medical marijuana dispensary market<br />
so that the national domestic marijuana yield has been estimated to be 358 billion dollars <strong>of</strong> which<br />
a 138 billion dollar share is California grown It is a big business And although the operators <strong>of</strong><br />
some dispensaries will claim that they only accept monetary contributions for the products they<br />
OO 2009 California Police Chiefs Assn 9 All Rights Reserved
dispense and do not sell marijuana a patron will not receive any marijuana until an amount <strong>of</strong><br />
money acceptable to the dispensary has changed hands<br />
D ORGANIZED CRIME MONEY LAUNDERING AND FIREARMS VIOLATIONS<br />
Increasingly reports have been surfacing about organized crime involvement in the ownership and<br />
operation <strong>of</strong> marijuana dispensaries including Asian and other criminal street gangs and at least one<br />
member <strong>of</strong> the Aimenian Mafia The dispensaries or pot clubs aze <strong>of</strong>ten used as a front by<br />
organized crime gangs to traffic in drugs and launder money One such gang whose temtory<br />
included San Francisco and Oakland California reportedly ran amulti million dollar business<br />
operating ten warehouses in which vast amounts <strong>of</strong> marijuana plants were grown Besides seizing<br />
over9000 marijuana plants during surprise raids on this criminal enterprise<br />
storage facilities<br />
federal <strong>of</strong>ficers also confiscated three firearms which seem to go hand in hand with medical<br />
marijuana cultivation and dispensaries<br />
Marijuana storefront businesses have allowed criminals to flourish in California In the smnmer <strong>of</strong><br />
2007 the <strong>City</strong> <strong>of</strong> San Diego cooperated with federal authorities and served search warrants on<br />
several marijuana dispensary locations In addition to marijuana many weapons were recovered<br />
including a stolen handgun and anM16 assault rifle The National Drug Intelligence Center<br />
reports that marijuana growers are employing attned guards using explosive booby traps and<br />
murdering people to shield their crops Street gangs <strong>of</strong> all national origins are involved in<br />
transporting and distributing marijuana to meet the ever increasing demand for the drug Active<br />
Asian gangs have included members <strong>of</strong> Vietnamese organized crime syndicates who have migrated<br />
from Canada to buy homes throughout the United States to use as grow houses<br />
Some or all <strong>of</strong> the processed harvest <strong>of</strong> marijuana plants nurtured in these homes then wind up at<br />
storefront marijuana dispensaries owned and operated by these gangs Storefront marijuana<br />
businesses are very dangerous enterprises that thrive on ancillary grow operations<br />
Besides fueling marijuana dispensaries some monetary proceeds from the sale <strong>of</strong> harvested<br />
marijuana derived from plants grown inside houses are being used by organized crime syndicates to<br />
fund other legitimate businesses for pr<strong>of</strong>it and the laundering <strong>of</strong> money and to conduct illegal<br />
business operations like prostitution extortion and drug trafficking Money from residential grow<br />
operations is also sometimes traded by criminal gang members for firearms and used to buy drugs<br />
personal vehicles and additional houses for more grow operations and along with the illegal<br />
income derived froin large scale organized crime related marijuana production operations coines<br />
widespread income tax evasion<br />
E POISONINGS<br />
Another social problem somewhat unique to marijuana dispensaries is poisonings both intentional and<br />
unintentional On August 16 2006 the Los Angeles Police Department received two such reports<br />
One involved a security guard who ate a piece <strong>of</strong> cake extended to him from an operator <strong>of</strong> a<br />
marijuana clinic asagift and soon afterward felt dizzy and disoriented The second incident<br />
concerned a UPS driver who experienced similar symptoms after accepting and eating a cookie given<br />
to him by an operator <strong>of</strong> a different marijuana clinic6<br />
OO 2009 California Police Chiefs Assn 10 All Rights Reserved
OTHER ADVERSE SECONDARY IMPACTS IN THE IMNIEDIATE VICINITY OF<br />
DISPENSARIES<br />
Other adverse secondary impacts from the operation <strong>of</strong> marijuana dispensaries include street dealers<br />
lurking about dispensaries to <strong>of</strong>fer a lower price for marijuana to arriving patrons marijuana smoking<br />
in public and in front <strong>of</strong> children in the vicinity <strong>of</strong> dispensaries loitering and nuisances acquiring<br />
marijuana and or money by means <strong>of</strong> robbery <strong>of</strong> patrons going to or leaving dispensaries an increase<br />
in burglaries at or neaz dispensaries a loss <strong>of</strong> trade for other commercial businesses located near<br />
dispensaries the sale at dispensaries <strong>of</strong> other illegal drugs besides marijuana an increase in traffic<br />
accidents and driving under the influence arrests in which marijuana is implicated and the faiture <strong>of</strong><br />
marijuana dispensary operators to report robberies to police<br />
SECONDARY ADVERSE IMPACTS IN THE COMMUNITY AT LARGE<br />
A UNJUSTIFIED AND FICTTTIOUS PHYSICIAN RECOMMENDATIONS<br />
California s legal requirement under California Health and Safety Code section 11362 5 that a<br />
physician<br />
recommendation is required for a patient or caregiver to possess medical marijuana has<br />
resulted in other undesirable outcomes wholesale issuance <strong>of</strong> recommendations by unscrupulous<br />
physicians seeking a quick buck and the proliferation <strong>of</strong> forged or fictitious physician<br />
recommendations Some doctors link up with a marijuana dispensary and take up temporary residence<br />
in a local hotel room where they advertise their appearance in advance and pass out medical<br />
marijuana use recommendations to a line <strong>of</strong> patients at about 150 a pop Other individuals just<br />
make up their own phony doctor recommendations which are seldom if ever scrutinized by<br />
dispensary employees for authenticity Undercover DEA agents fake medical marijuana<br />
sporting<br />
recommendations were readily able to purchase marijuanafi om a clinic Far too <strong>of</strong>ren California s<br />
medical marijuana law is used as a smokescreen for healthy pot users to get their desired drug and for<br />
proprietors <strong>of</strong> marijuana dispensaries to make money <strong>of</strong>f them without suffering any legal<br />
repercussions<br />
On March 11 2009 the Osteopathic Medical Board <strong>of</strong> California adopted the proposed decision<br />
revoking Dr Alfonso Jimenez s Osteopathic Physician<br />
and Surgeon s Certificate and ordering him<br />
to pay74 323 39 in cost recovery Dr Jimenez operated multiple marijuana clinics and advertised<br />
his services extensively on the Internet Based on information obtained from raids on marijuana<br />
dispensaries in San Diego in May <strong>of</strong> 2006 the San Diego Police Department ran two undercover<br />
operations on Dr Jimenez s clinic in San Diego In January <strong>of</strong> 2007 a second undercover operation<br />
was conducted by the Laguna Beach Police Department at Dr Jimenez s clinic in Orange County<br />
Based on the results <strong>of</strong> the undercover operations the Osteopathic Medical Board charged Dr<br />
Jimenez with gross negligence and repeated negligent acts in the treatment <strong>of</strong> undercover operatives<br />
posing as patients After asix day hearing the Administrative Law Judge AL issued her decision<br />
finding that Dr Jimenez violated the standard <strong>of</strong> care by committing gross negligence and repeated<br />
negligence in care treatment and management <strong>of</strong> patients when he among other things issued<br />
medical marijuana recommendations to the undercover agents without conducting adequate medical<br />
examinations failed to gain proper informed consent and failed to consult with any primary care<br />
and or treating physicians or obtain and review prior medical records before issuing medical<br />
marijuana recommendations The ALJ also found Dr Jimenez engaged in dishonesY behavior by<br />
preparing false and or misleading medical records and disseminating false and misleading<br />
advertising to the public including representing himself asaCannabis SpecialisY and Qualified<br />
Medical Marijuana Examiner when no such formal specialty or qualification existed Absent any<br />
O 2009 California Police Chiefs Assn 11 All Rights Reserved
equested administrative agency reconsideration or petition for court review the decision was to<br />
become effective Apri124 2009<br />
B PROLIFERATION OF GROW HOUSES IN RESIDENTIAL AREAS<br />
In recent years the proliferation <strong>of</strong> grow houses in residential neighborhoods has exploded This<br />
phenomenon is country wide and ranges from the purchase for purpose <strong>of</strong> marijuana grow operations<br />
<strong>of</strong> small dwellings to high priced McMansions Mushrooming residential marijuana grow<br />
operations have been detected in California Connecticut Florida Georgia New Hampshire North<br />
Carolina Ohio South Carolina and Texas7 In 2007 alone such illegal operations were detected and<br />
shut down by federal and state law enforcement <strong>of</strong>ficials in 41 houses in California 50 homes in<br />
Florida and 1 homes in New Hampshire7 Since then the number <strong>of</strong> residences discovered to be so<br />
impacted has increased exponentially Part <strong>of</strong> this recent influx <strong>of</strong> illicit residential grow operations is<br />
because the THC richBC bud strain <strong>of</strong> marijuana originally produced in British Columbia can<br />
be grown only in controlled indoor environments and the Canadian market is now reportedly<br />
saturated with the product <strong>of</strong> competing Canadian gangs <strong>of</strong>ten Asian in composition or outlaw<br />
motorcycle gangs like the Hells Angels Typically a gutted house can hold about1000 plants that<br />
will each yield almost half a pound <strong>of</strong> smokable marijuana this collectively nets about 500 pounds <strong>of</strong><br />
usable marijuana per harvest with an average <strong>of</strong> three to four harvests per year With a street value<br />
<strong>of</strong>3000 to5000 per pound for high potency marijuana and such multi<br />
le harvests a successful<br />
grow house can bring in between 45 million and 10 million a year 8 The high potency <strong>of</strong><br />
hydroponically grown marijuana can command a price as much as six times higher than commercial<br />
grade marijuana<br />
C LIFE SAFETY HAZARDS CREATED BY GROW HOUSES<br />
In Humboldt County California structure fires caused by unsafe indoor marijuana grow operations<br />
have become commonplace The city <strong>of</strong> Arcata which sports four marijuana dispensaries was the site<br />
<strong>of</strong> a house fire in which a fan had fallen over and ignited a fire it had been tumed into a grow house<br />
by its tenant Per Arcata Police Chief Randy Mendosa altered and makeshift no code electrical<br />
service connections and overloaded wires used to operatehigh powered grow lights and fans are<br />
common causes <strong>of</strong> the fires Large indoor marijuana growing operations can create such excessive<br />
draws <strong>of</strong> electricity that PGE power pole transformers are commonly blown An average1500<br />
square foot tract house used for growing marijuana can generate monthly electrical bills from1000<br />
to3000 per month From an environmental standpoint the carbon footprint from greenhouse gas<br />
emissions created by large indoor marijuana grow operations should be a major concern for every<br />
community in terms <strong>of</strong> complying with Air Board AB 32 regulations as well as other greenhouse gas<br />
reduction policies Typically air vents are cut into ro<strong>of</strong>s water seeps into carpeting windows are<br />
blacked out holes are cut in floors wiring isjury rigged and electrical circuits are overloaded to<br />
operate grow lights and other apparatus When fires start they spread quickly<br />
The May 31 2008 edition <strong>of</strong> the Los Angeles Times reported Law enforcement <strong>of</strong>ficials estunate that<br />
as many as1000 <strong>of</strong> the7500 homes in this Humboldt County community are being used to cultivate<br />
marijuana slashing into the housing stock spreading building safety problems and sowing<br />
neighborhood discord Not surprisingly in this bastion <strong>of</strong> liberal pot possession rules that authorized<br />
the cultivation <strong>of</strong> up to 99 plants for medicinal purpose most structural fires in the community <strong>of</strong><br />
Arcata have been <strong>of</strong> late associated with marijuana cultivation Chief <strong>of</strong> Police Mendosa clarified<br />
that the actual number <strong>of</strong> marijuana grow houses in Arcata has been an ongoing subject <strong>of</strong> public<br />
debate Mendosa added We know there are numerous grow houses in almost every neighborhood in<br />
and around the city which has been the source <strong>of</strong> constant citizen complaints House fires caused by<br />
OO 2009 California Police Chiefs Assn 12 All Rights Reserved
grower installed makeshifr electrical wiring or tipped electrical fans are now endemic to Humboldt<br />
County<br />
Chief Mendosa also observed that since marijuana has an illicit street value <strong>of</strong> up to3000 per pound<br />
marijuana grow houses have been susceptible to violent armed home invasion robberies Large scale<br />
marijuana grow houses have removed significant numbers <strong>of</strong> affordable houses from the residential<br />
rental market When property owners discover their rentals are being used as grow houses the<br />
residences are <strong>of</strong>ren lefr with major structural damage which includes air vents cut into ro<strong>of</strong>s and<br />
floors water damage to floors and walls and mold The June 9 2008 edition <strong>of</strong> the New York Tin es<br />
shows an unidentified Arcata man tending his indoor grow the man claimed he can make25 000<br />
every three months by selling marijuana grown in the bedroom <strong>of</strong> his rented house Claims <strong>of</strong><br />
ostensible medical marijuana growing pursuant to California s medical marijuana laws are being<br />
advanced as a mostly false shield in an attempt to justify such illicit operations<br />
Neither is fire an uncommon occurrence at grow houses elsewhere across the nation Another<br />
occurred not long ago in Holiday Florida To compound matters further escape routes for<br />
firefighters are <strong>of</strong>ten obstructed by blocked windows in grow houses electric wiring is tampered with<br />
to steal electricity and some residences are even booby trapped to discourage and repel unwanted<br />
intruders<br />
D INCREASED ORGANIZED GANG ACTIVITIES<br />
Along with marijuana dispensaries and the grow operations to support them come members <strong>of</strong><br />
organized criminal gangs to operate and pr<strong>of</strong>it from them Members <strong>of</strong> an ethnic Chinese drug gang<br />
were discovered to have operated 50 indoor grow operations in the San Francisco Bay area while<br />
Cuban American crime organizations have been found to be operating grow houses in Florida and<br />
elsewhere in the South A Vietnamese drug ring was caught operating 19 grow houses in Seattle and<br />
Puget Sound Washington In July <strong>of</strong> 2008 over 55 Asian gang members were indicted for narcotics<br />
trafficking in marijuana and ecstasy including members <strong>of</strong> the Hop Sing Gang that had been actively<br />
operating marijuana grow operations in Elk Grove and elsewhere in the vicinity <strong>of</strong> Sacramento<br />
California<br />
E EXPOSURE OF MINORS TO MARIJUANA<br />
Minors who are exposed to marijuana at dispensaries or residences where marijuana plants are grown<br />
may be subtly influenced to regard it as a generally legal drug and inclined to sample it In grow<br />
houses children are exposed to dangerous fire and health conditions that are inherent in indoor grow<br />
operations Dispensaries also sell marijuana to minors<br />
F IMPAIRED PUBLIC HEALTH<br />
Indoor marijuana grow operations emit a skunk like odor and foster generally unhealthy conditions<br />
like allowing chemicals and fertilizers to be placed in the open an increased carbon dioxide level<br />
within the grow house and the accumulation <strong>of</strong> mold 90 all <strong>of</strong> which are dangerous to any children or<br />
adults who may be living in the residence although many grow houses are uninhabited<br />
OO 2009 California Police Chiefs Assn 13 All Rights Reserved
G LOSS OF BUSINESS TAX REVENUE<br />
When business suffers as a result <strong>of</strong> shoppers staying away on account oFtraffic blight crime and the<br />
undesirability <strong>of</strong> a particular business district known to be frequented by drug users and traffickers<br />
and organized criminal gang members a city s tax revenues necessarily drop as a direct consequence<br />
H DECREASED QUALITY OF LIFE IN DETERIORATING NEIGHBORHOODS<br />
BOTH BUSINESS AND RESIDENTIAL<br />
Marijuana dispensaries bring in the criminal element and loiterers which in turn scare <strong>of</strong>fpotential<br />
business patrons <strong>of</strong> nearby legitimate businesses causing loss <strong>of</strong> revenues and deterioration <strong>of</strong> the<br />
affected business district Likewise empty homes used as grow houses emit noxious odors in<br />
residential neighborhoods project imtating sounds <strong>of</strong> whimng fans and promote the din <strong>of</strong> vehicles<br />
coming and going at all hours <strong>of</strong> the day and night Near harvest time rival growers and other<br />
uninvited enterprising criminals sometimes invade grow houses to beat clip crews to the site and rip<br />
<strong>of</strong>f mature plants ready for harvesting As a result violence <strong>of</strong>ten erupts from confrontations in the<br />
affected residential neighborhood<br />
ULTIMATE CONCLUSIONS REGARDING ADVERSE SECONDARY EFFECTS<br />
On balance any utility to medical marijuana patients in care giving and convenience that marijuana<br />
dispensaries may appear to have on the surface is enom ously outweighed by a much darker reality<br />
that is punctuated by the many adverse secondary effects created by their presence in communities<br />
recounted here These drug distribution centers have even proven to be unsafe for their own<br />
proprietors<br />
POSSIBLE LOCAL GOVERNMENTAL RESPONSES TO MARIJUANA DISPENSARIES<br />
A IMPOSED MORATORIA BY ELECTED LOCAL GOVERNMENTAL<br />
OFFICIALS<br />
While in the process <strong>of</strong> investigating and researching the issue <strong>of</strong> licensing marijuana dispensaries as<br />
an interim measure city councils may enactdate specific moratoria that expressly prohibit the presence<br />
<strong>of</strong> marijuana dispensaries whether for medical use or otherwise and prohibiting the sale <strong>of</strong> marijuana<br />
in any form on such premises anywhere within the incorporated boundaries <strong>of</strong> the city until a<br />
specified date Before such a moratorium s date <strong>of</strong> expiration the moratoriwn may then either be<br />
extended or a city ordinance enacted completely prohibiting or otherwise restricting the establishment<br />
and operation <strong>of</strong> marijuana dispensaries and the sale <strong>of</strong> all marijuana products on such premises<br />
County supervisors can do the same with respect to marijuana dispensaries sought to be established<br />
within the unincorporated areas <strong>of</strong> a county Approximately 80 California cities including the cities<br />
<strong>of</strong> Antioch Brentwood Oakley Pinole and Pleasant Hill and 6 counties including Contra Costa<br />
County have enacted moratoria banning the existence <strong>of</strong> marijuana dispensaries In a novel approach<br />
the <strong>City</strong> <strong>of</strong> Arcata issued a moratorium on any new dispensaries in the downtown area based on no<br />
agricultural activities being permitted to occur there<br />
OO 2009 California Police Chiefs Assn 14 All Rights Reserved
B IMPOSED BANS BY ELECTED LOCAL GOVERNMENTAL OFFICIALS<br />
While the Compassionate Use Act <strong>of</strong> 1996 permits seriously ill persons to legally obtain and use<br />
marijuana for medical purposes upon a physician<br />
recommendation it is silent on marijuana<br />
dispensaries and does not expressly authorize the sale <strong>of</strong> marijuana to patients or primary caregivers<br />
Neither Proposition 215 nor Senate Bi11420 specifically authorizes the dispensing <strong>of</strong> marijuana in any<br />
form from a storefront business And no state statute presently exists that expressly permits the<br />
licensing or operation <strong>of</strong> marijuana dispensaries9 Consequently approximately 39 California cities<br />
including the Cities <strong>of</strong> Concord and San Pablo and 2 counties have prohibited marijuana dispensaries<br />
within their respective geographical boundaries while approximately 24 cities including the <strong>City</strong> <strong>of</strong><br />
Martinez and 7 counties have allowed such dispensaries to do business within their jurisdictions<br />
Even the complete prohibition <strong>of</strong> marijuana dispensaries within a given locale cannot be found to run<br />
afoul <strong>of</strong> current California law with respect to permitted use <strong>of</strong> marijuana for medicinal purposes so<br />
long as the growing or use <strong>of</strong> inedical marijuana by a city or county resident in conformance with state<br />
law is not proscribed<br />
In November <strong>of</strong> 2004 the <strong>City</strong> <strong>of</strong> Brampton in Ontario Canada passed The Grow House Abatement<br />
By law which authorized the city council to appoint inspectors and local police <strong>of</strong>ficers to inspect<br />
suspected grow houses and render safe hydro meters unsafe wiring booby traps and any violation <strong>of</strong><br />
the Fire Code or Building Code and remove discovered controlled substances and ancillary equipment<br />
designed to grow and manufacture such substances at the involved homeowner s cost And afrer<br />
state legislators became appalled at the proliferation <strong>of</strong>for pr<strong>of</strong>it residential grow operations the State<br />
<strong>of</strong> Florida passed the Marijuana Grow House Eradication act House Bill 173 in June <strong>of</strong> 2008 The<br />
governor signed this bill into law making owning a house for the purpose <strong>of</strong> cultivating packaging<br />
and distributing marijuana athird degree felony growing 25 or more marijuana plants a second<br />
degree felony and growing 25 or more marijuana plants in a home with children presenY a first<br />
degree felony It has been estimated that approximately 17 500 marijuana grow operations were<br />
active in late 2007 To avoid becoming a dumping ground for organized crime syndicates who<br />
decide to move their illegal grow operations to a more receptive legislative environment Califomia<br />
and other states might be wise to quickly follow suit with similar bills for it may already be<br />
happening o0<br />
C IMPOSED RESTRICTED ZONING AND OTHER REGULATION BY ELECTED<br />
LOCAL GOVERNMENTAL OFFICIALS<br />
If so inclined rather than completely prohibit marijuana dispensaries through their zoning power city<br />
and county <strong>of</strong>ficials have the authority to restrict owner operators to locate and operateso called<br />
medical marijuana dispensaries in prescribed geographical areas <strong>of</strong> a city or designated<br />
unincorporated areas <strong>of</strong> a county and require them to meet prescribed licensing requirements before<br />
being allowed to do so This is a risky course <strong>of</strong> action though for would be dispensary operators and<br />
perhaps lawmakers too since federal authorities do not recognize any lawful right for the sale<br />
purchase or use <strong>of</strong> marijuana for medical use or otherwise anywhere in the United States including<br />
California Other cities and counties have included as a condition <strong>of</strong> licensure for dispensaries that the<br />
operator shall violate no federal or state law which puts any applicant inaCatch 22 situation<br />
since to federal authorities any possession or sale <strong>of</strong> marijuana is automatically a violation <strong>of</strong> federal<br />
law<br />
Still other municipalities have recenUy enacted or revised comprehensive ordinances that address a<br />
variety <strong>of</strong> inedical marijuana issues For example according to the <strong>City</strong> <strong>of</strong> Arcata Community<br />
OO 2009 California Police Chiefs Assn 15 All Rights Reserved
Development Department in Arcata California in response to constant citizen complaints from what<br />
had become an extremely serious community problem the Arcata <strong>City</strong> Council revised its Land Use<br />
Standards for Medical Marijuana Cultivation and Dispensing In December <strong>of</strong> 2008 <strong>City</strong> <strong>of</strong> Arcata<br />
Ordinance 1382 was enacted It includes the following provisions<br />
Categories<br />
I Personal Use<br />
2 Cooperatives or Collectives<br />
Medical Marijuana for Personal Use An individual qualified patient shall be allowed to cultivate<br />
medical marijuana within his her private residence in conformance with the following standards<br />
1 Cultivation area shall not exceed 50 sauare feet and not exceed ten feet 10 in hei<br />
a<br />
Cultivation lighting shall not exceed 1200 watts<br />
b Gas products COZ butane etc for medical marijuana cultivation or processing is<br />
prohibited<br />
a<br />
Cultivation and sale is prohibited as a Home Occupation sale or dispensing is<br />
prohibited<br />
d Qualified patient shall reside in the residence where the medical marijuanacu tivation<br />
e<br />
occurs<br />
Qualified patient shall not participate in medical marijuana cultivation in any other<br />
residence<br />
f Residence kitchen bathrooms and primary bedrooms shall not be used primarily for<br />
medical marijuana cultivation<br />
g Cultivation area shall comply with the California Building Code 1203 Ventilation or 402 3 Mechanical Ventilation<br />
h<br />
The medical marijuana cultivation azea shall not adversely affect the health or safety<br />
<strong>of</strong> the nearby residents<br />
2<br />
<strong>City</strong> Zoning Administrator my approve up to 100 squaze foot<br />
a<br />
Documentation showing why the 50 square foot cultivation area standard is not<br />
feasible<br />
b<br />
Indude written permission from the property owner<br />
a<br />
<strong>City</strong> Building Official must inspect for California Building Code and Fire Code<br />
d<br />
At a minimum the medical marijuana cultivation area shall be constructed with a 1<br />
hour firewall assembly <strong>of</strong> green board<br />
e<br />
Cultivation <strong>of</strong> inedical marijuana for personal use is limited to detached single family<br />
residential properties or the medical marijuana cultivation area shall be limited to a<br />
garage orself contained outside accessory building thatis secured locked and fully<br />
enclosed<br />
Medical Marijuana Cooperatives or Collectives<br />
1 Allowed with a Conditional Use Permit<br />
2<br />
In Commercial Industrial and Public Facility Zoning Districts<br />
3<br />
Business form must be a cooperative or collective<br />
4<br />
Existing cooperative or collective shall be in full compliance within one year<br />
5 Total number <strong>of</strong> inedical marijuana cooperatives or collectives is limited to four and<br />
ultimately two<br />
6 Special consideration if located within<br />
a<br />
A 300 foot radius from any existing residential zoning district<br />
b<br />
Within 500 feet <strong>of</strong> any other medical narijuana cooperative or collective<br />
OO 2009 California Police Chiefs Assn 16 All Rights Reserved
c<br />
Within 500 feet from any existing public park playground day care or school<br />
7 Source <strong>of</strong> inedical marijuana<br />
a<br />
Permitted Cooperative or Collective On site medical marijuana cultivation shall not<br />
exceed twenty five 25 percent <strong>of</strong> the total floor area but in no case greater than<br />
1500 squaze feet and not exceed ten feet 0 in height<br />
b<br />
Off site Permitted Cultivation Use Pernut application and be updated annually<br />
c<br />
Qualified Patients Medical marijuana acquired from an individual qualified patient<br />
shall received no monetaty remittance and the qualified patient is a member <strong>of</strong> the<br />
inedical marijuana cooperative or collective Collective or cooperative may credit its<br />
members for medical marijuana provided to the collective or cooperative which they<br />
may allocate to other members<br />
8<br />
Operations Manual at a minimum include the following information<br />
a<br />
Staff screening process including appropriate background checks<br />
b Operating hours<br />
c<br />
Site floor plan <strong>of</strong> the facility<br />
d<br />
Security measures located on the premises including but not limited to lighting<br />
alanns and automatic law enforcement notification<br />
e<br />
Screening registration and validation process for qualified patients<br />
f<br />
Qualified patient records acquisition and retention procedures<br />
g Process for tracking medical marijuana quantities and inventory controls including<br />
on site cultivation processing and or medical marijuana products received from<br />
h<br />
outside sources<br />
Measures taken to minimize or <strong>of</strong>fset energy use from the cultivation or processing <strong>of</strong><br />
medical marijuana<br />
i<br />
Chemicals stored used and any effluent discharged into the <strong>City</strong> s wastewater and or<br />
storm water system<br />
9 Operating Standards<br />
a<br />
No dispensing medical marijuana more than twice a day<br />
b Dispense to an individual qualified patient who has a valid verified physician<br />
recommendation The medical marijuana cooperative or collective shall verify that<br />
the physician<br />
recommendation is cunent and valid<br />
c<br />
Display the client rules and or regulations at each building entrance<br />
d Smoking ingesting or consuming medical marijuana on the premises or in the<br />
vicinity is prohibited<br />
e<br />
Persons under the age <strong>of</strong> eighteen 18 are precluded from entering the premises<br />
f<br />
No on site display <strong>of</strong> marijuana plants<br />
g No distribution <strong>of</strong> live plants starts and clones on through Use Pennit<br />
h<br />
Permit the on site display or sale <strong>of</strong> marijuana paraphernalia only through the Use<br />
Pennit<br />
i<br />
Maintain all necessary permits and pay all appropriate taxes Medical marijuana<br />
cooperatives or collectives shall also provide invoices to vendors to ensure vendor s<br />
tax liability responsibility<br />
j Submit an Annual Performance Review Report which is intended to identify<br />
effectiveness <strong>of</strong> Yhe approved Use Pernut Operations Manual and Conditions <strong>of</strong><br />
Approvai as well as the identification and implementation <strong>of</strong> additional procedures as<br />
deemed necessary<br />
k<br />
Monitoring review fees shall accompany the Annual Performance Review Report<br />
for costs associated with the review and approval <strong>of</strong> the report<br />
10<br />
Permit Revocation or Modification A use permit may be revoked or modified for non<br />
compliance with one or more <strong>of</strong> the items described above<br />
OO 2009 California Police Chiefs Assn 17 All Rights Reserved
LIABILITY ISSUES<br />
With respect to issuing business licenses to marijuana storefront facilities a very real issue has<br />
arisen counties and cities are arguably aiding and abetting criminal violations <strong>of</strong> federal law Such<br />
actions clearly put the counties permitting these establishments in very precarious legal positions<br />
Aiding and abetting a crime occurs when someone commits a crime the person aiding that crime<br />
knew the cruninal <strong>of</strong>fender intended to commit the crime and the person aiding the crime intended<br />
to assist the criminal <strong>of</strong>fender in the commission <strong>of</strong> the crime<br />
The legal definition <strong>of</strong> aiding and abetting could be applied to counties and cities allowing marijuana<br />
facilities to open A county that has been informed about the Gonzales v Raich decision knows that<br />
all marijuana activity is federally illegal Furthermore such counties know that individuals involved<br />
in the mazijuana business are subject to federal prosecution When an individual in Califomia<br />
cultivates possesses transports or uses marijuana he or she is committing a federal crime<br />
A county issuing a business license to a marijuana facility knows that the people there are<br />
committing federal crimes The county also knows that those involved in providing and obtaining<br />
marijuana are intentionally violating federal law<br />
This very problem is why some counties arere thinking the presence <strong>of</strong> marijuana facilities in their<br />
communities There is a valid fear <strong>of</strong> being prosecuted for aiding and abetting federal drug crimes<br />
Presently two counties have expressed concern that California s medical marijuana statutes have<br />
placed them in such a precarious legal position Because <strong>of</strong> the serious criminal ramifications<br />
involved in issuing business permits and allowing storefront marijuana businesses to operate within<br />
their borders San Diego and San Bernardino Counties filed consolidated lawsuits against the state<br />
seeking to prevent the State <strong>of</strong> California from enforcing its medical marijuana statutes which<br />
p<strong>of</strong>entially subject them to criminal liability and squarely asserting that California medical<br />
marijuana laws are preempted by federal law in this area After California s medical marijuana laws<br />
were all upheld at the trial level California s Fourth District Cour <strong>of</strong> Appeal found that the State <strong>of</strong><br />
California could mandate counties to adopt and enforce a voluntary medical marijuana identification<br />
card system and the appellate court bypassed the preemption issue by finding that San Diego and<br />
San Bernardino Counties lacked standing to raise this challenge to Califomia s medical marijuana<br />
laws Following this state appellate court decision independent petitions for review filed by the two<br />
counties were both denied by the California Supreme Court<br />
Largely because <strong>of</strong> the quandary that county and city peace <strong>of</strong>ficers in California face in the field<br />
when confronted with alleged medical marijuana with respect to enforcement <strong>of</strong> the total federal<br />
criminal prohibition <strong>of</strong> all marijuana and state exemption from criminal penalties for medical<br />
marijuana users and caregivers petitions for a writ <strong>of</strong> certiorari were then separately filed by the two<br />
counties seeking review <strong>of</strong> this decision by the United States Supreme Court in the consolidated<br />
cases <strong>of</strong> County <strong>of</strong> San Diego County <strong>of</strong>San Bernardino and Ga y Pen od as Sheriff<strong>of</strong> the County<br />
<strong>of</strong> San Bernardino v San Diego Nonn State <strong>of</strong>California and Sandra Shew y Director <strong>of</strong> the<br />
California Department <strong>of</strong>Health Services in herocial capacityCt App Case NoD5333 The<br />
High Court has requested the State <strong>of</strong> California and other interested parties to file responsive briefs<br />
to the two counties and Sheriff Penrod s writ petitions before it decides whether to grant or deny<br />
review <strong>of</strong> these consolidated cases The petitioners would then be entifled to file a reply to any filed<br />
response It is anticipated that theUS Supreme Court will formally grant or deny review <strong>of</strong> these<br />
consolidated cases in late April or early May <strong>of</strong> 2009<br />
OO 2009 California Police Chiefs Assn 18 All Rights Reserved
In another case <strong>City</strong> <strong>of</strong> Gurden Grove v Superior Court 2007 157 Ca1 App 4th 355 although the<br />
federal preemption issue was not squarely raised or addressed in its decision California s Fourth<br />
District Court <strong>of</strong> Appeal found that public policy considerations allowed a city standing to challenge<br />
a state trial court s order directing the return by a city police department <strong>of</strong> seized medical marijuana<br />
to a person determined to be a patient Afrer the court ordered return <strong>of</strong> this federally banned<br />
substance was upheld at the intermediate appellate level and not accepted for review by the<br />
California Supreme Court a petition for a writ <strong>of</strong> certiorari was filed by the <strong>City</strong> <strong>of</strong> Garden Grove to<br />
the US Supreme Court to consider and reverse the state appellate court decision But that petition<br />
was also denied However the case <strong>of</strong> People v Kelly 2008 163 Ca1 App 4th 124 in which a<br />
successful challenge was made to Califomia s Medical Marijuana Program s maximum amounts <strong>of</strong><br />
marijuana and marijuana plants permitted to be possessed by medical marijuana patients CaL HS<br />
Code sec 11362 77 et seq which limits were found at the court <strong>of</strong> appeal level to be without legal<br />
authority for the state to impose has been accepted for review by the California Supreme Court on<br />
the issue <strong>of</strong> whether this law was an unproper amendment to Proposition 215 s Compassionate Use<br />
Act <strong>of</strong> 1996<br />
A SAMPLING OF EXPERIENCES WITH MARIJUANA DISPENSAT2IES<br />
L<br />
MARIJUANA DISPENSARIES THE SAN DIEGO STORY<br />
After the passage <strong>of</strong> Proposition 215 in 1996 law enforcement agency representatives in San Diego<br />
California met many times to formulate a comprehensive strategy <strong>of</strong> how to deal with cases that may<br />
arise out <strong>of</strong> the new law In the end it was decided to handle the matters on a by case basis In<br />
addition questionnaires were developed for patient caregiver and physician interviews At times<br />
patients without sales indicia but large grows were interviewed and their medical records reviewed<br />
in making issuing decisions In other cases where sales indicia and amounts supported a findin <strong>of</strong><br />
sales the cases were pursued At most two cases a month were brought for felony prosecution<br />
In 2003 San Diego County s newly elected District Attorney publicly supported Prop 215 and<br />
wanted her newly created Narcotics Division to design procedures to ensure patients were not caught<br />
up in case prosecutions As many already know law enforcement <strong>of</strong>ficers rarely arrest or seek<br />
prosecution <strong>of</strong> a patient who merely possesses personal use amounts Rather it is those who have<br />
sales amounts in product or cultivation who are prosecuted For the next two years the District<br />
Attorney s Office proceeded as it had before But on the cases where the patient had too many<br />
plants or product but not much else to show sales the DDAs assigned to review the case would<br />
interview and listen to input to respect the patient s and the DA s position Some cases were<br />
rejected and others issued but the case disposition was <strong>of</strong>ten generous and reflectedasin no more<br />
view<br />
All <strong>of</strong> this changed after the passage <strong>of</strong> SB 420 The activists andpro marijuana folks started to<br />
push the envelope Dispensaries began to open for business and physicians started to advertise their<br />
availability to issue recommendations for the purchase <strong>of</strong> inedical marijuana By spring <strong>of</strong> 2005 the<br />
first couple <strong>of</strong> dispensaries openedup but they were discrete This would soon change By fhat<br />
summer 7 to 10 dispensaries were open for business and they were selling marijuana openly In<br />
fact the local police department was doing a smallbuy walk project and one <strong>of</strong> its target dealers said<br />
he was out <strong>of</strong> pot but would go get some from the dispensary to sell to the undercover <strong>of</strong>ficer UC<br />
he did It was the proliferation <strong>of</strong> dispensaries and ancillary crimes that prompted the San Diego<br />
Police Chief the Chief was a Prop 215 supporter who sparred with the Fresno DEA in his prior job<br />
over tbis issue to authorize his <strong>of</strong>ficers to assist DEA<br />
O 2009 California Police Chiefs Assn 19 All Rights Reserved
The Investigatiou<br />
San Diego DEA and its local task force NTF sought assistance from the DA s Office as well as the<br />
US Attomey s Office Though empathetic about being willing to assist the DA s Office was not<br />
sure how prosecutions would fare under the provisions <strong>of</strong> SB 420 The US Attorney had the easier<br />
road but was noncommittal After several meetings it was decided that law enforcement would work<br />
on using undercover operatives UCs to buy so law enforcement could see exactly what was<br />
happening in the dispensaries<br />
The investigation was initiated in December <strong>of</strong> 2005 after NTF received numerous citizen<br />
complaints regarding the crime and traffic associated with medical marijuana dispensaries The<br />
<strong>City</strong> <strong>of</strong> San Diego also saw an increase in crime related to the marijuana dispensaries By then<br />
approximately 20 marijuana dispensaries had opened and were operating in San Diego County and<br />
investigations on 15 <strong>of</strong> these dispensaries were initiated<br />
During the investigation NTF learned that all <strong>of</strong> the business owners were involved in the<br />
transportation and distribution <strong>of</strong> large quantities <strong>of</strong> marijuana marijuana derivatives and marijuana<br />
food products In addition several owners were involved in the cultivation <strong>of</strong> high grade marijuana<br />
The business owners were making significant pr<strong>of</strong>its from the sale <strong>of</strong> these products and not<br />
properly reporting this income<br />
Undercover Task Force Officers TFO s and SDPD Detectives were utilized to purchase marijuana<br />
and marijuana food products from these businesses In December <strong>of</strong> 2005 thirteen state search<br />
warrants were executed at businesses and residences <strong>of</strong> several owners Two additional foliow up<br />
search warrants and a consent search were executed the same day Approximately 977 marijuana<br />
plants from seven indoor marijuana grows 564 88 kilograms <strong>of</strong> marijuana and marijuana food<br />
products one gun and over58 000 US currency were seized There were six arrests made during<br />
the execution <strong>of</strong> these search warrants for various violations including outstanding warrants<br />
possession <strong>of</strong> marijuana for sale possession <strong>of</strong> psilocybin mushrooms obstructing a police <strong>of</strong>ficer<br />
and weapons violations However the owners and clerks were not arrested or prosecuted at this<br />
time just those vho showed up witt weapons or product to sell<br />
Given the fact most owners could claim mistake <strong>of</strong> law as to selling though not a legitimate defense<br />
it could be ajury nullification defense the DA s Office decided not to file cases at that time It was<br />
hoped that the dispensaries would feel San Diego was hostile ground and they would do business<br />
elsewhere Unfortunately this was not the case Over the next few months seven <strong>of</strong> the previously<br />
targeted dispensaries opened as well as a slew <strong>of</strong> others Clearly prosecutions would be necessary<br />
To gear up for there opened and new dispensaries prosecutors reviewed the evidence and sought a<br />
second round <strong>of</strong> UC buys wherein the UC would be buying for themselves and they would have a<br />
second UC present at the time acting as UC1 s caregiver who also would buy This was designed to<br />
show the dispensary was not the caregiver There is no authority in the law for organizations to act<br />
as primary caregivers Caregivers must be individuals who care for a marijuana patient A primary<br />
caregiver is defined by Proposition 215 as codified inHS Code section 11362 5e as For the<br />
purposes <strong>of</strong> this section primary caregiver means the individual designated by the person exempted<br />
under this section who has consistently assumed responsibility for the housing health or safety <strong>of</strong><br />
that person The goal was to show that the stores were only selling marijuana and not providing<br />
care for the hundreds who bought from them<br />
O 2009 California Police Chiefs Assn 20 All Rights Reserved
In addition to the caregiver controlled buys another aim was to put the whole matter in perspective<br />
for the media and the public by going over the data that was found in the raided dispensary records<br />
as well as the crime statistics An analysis <strong>of</strong> the December 2005 dispensary records showed a<br />
breakdown <strong>of</strong> the purported illness and youthful nature <strong>of</strong> the patients The charts and other PR<br />
aspects played out after the second take down in July <strong>of</strong> 2006<br />
The final attack was to reveal the doctors the gatekeepers for medical marijuana for the fraud they<br />
were committing UCs from the local PD went in and taped the encounters to show that the pot docs<br />
did not examine the patients and did not render care at all rather they merely sold a medical MJ<br />
recommendation whose duration depended upon the amount <strong>of</strong> money paid<br />
In April <strong>of</strong> 2006 two state and two federal search warrants were executed at a residence and storage<br />
warehouse utilized to cultivate marijuana Approximately 347 marijuana plants over 21 kilograms<br />
<strong>of</strong> marijuana and2855 US currency were seized<br />
Due to the pressure from the public the United States Attorney s Office agreed to prosecute the<br />
owners <strong>of</strong> the businesses with large indoor marijuana grows and believed to be involved in money<br />
laundering activities The District Attorney s Office agreed to prosecute the owners in the other<br />
investigations<br />
n Tune <strong>of</strong> 2006 a Federal Grand Jury indicted six owners for violations <strong>of</strong> Title 21 USC sections<br />
846 and 841 a1 Conspiracy to Distribute Marijuana sections 846 and 841 a Conspiracy to<br />
Manufacture Marijuana and Title 18 USC Section 2 Aiding and Abetting<br />
In July <strong>of</strong> 2006 11 state and 11 federal search warrants were executed at businesses and residences<br />
associated with members <strong>of</strong> these businesses The execution <strong>of</strong> these search warrants resulted in the<br />
arrest <strong>of</strong> 19 people seizure <strong>of</strong> over 19Q000 in US currency and other assets four handguns one<br />
rifle 405 marijuana plants from seven grows and over 329 kilograms <strong>of</strong> marijuana and marijuana<br />
food products<br />
Following the search warrants two businesses reopened An additional search warrant and consent<br />
search were executed at these respective locations Approximately 20 kilograms <strong>of</strong> marijuana and<br />
32 marijuana plants were seized<br />
As a resu t all but two <strong>of</strong> the individuals arrested on state charges have pled guilty Several have<br />
already been sentenced and a few are still awaiting sentencing All <strong>of</strong> the individuals indicted<br />
federally have also pled guilty and are awaiting sentencing<br />
After the July 2006 search warrants a joint press conference was held with the US Attorney and<br />
District Attorney during which copies <strong>of</strong> a complaint to the medical board photos <strong>of</strong> the food<br />
products which were marketed to children and the charts shown below were provided to the media<br />
Directly after these several combined actions there were no marijuana distribution businesses<br />
operating in San Diego County Law enforcement agencies in the San Diego region have been able<br />
to successfully dismantle these businesses and prosecute the owners As a result medical marijuana<br />
advocates have staged a number <strong>of</strong> protests demanding DEA allow the distribution <strong>of</strong> marijuana<br />
The closure <strong>of</strong> these businesses has reduced crime in the sunounding areas<br />
OO 2009 California Police Chiefs Assn 21 All Rights Reserved
The execution <strong>of</strong> search warrants at these businesses sent a powerful message to other individuals<br />
operating marijuana distribution businesses that they are in violation <strong>of</strong> both federal law and<br />
California law<br />
Press Materials<br />
Reported Crime at Marijuana Dispensaries<br />
From January 1 2005 through June 23 2006<br />
18 t<br />
s<br />
4<br />
y<br />
16 F<br />
II<br />
E<br />
s<br />
14<br />
2<br />
10<br />
t<br />
r<br />
8 M C<br />
6<br />
4<br />
PM1<br />
rk<br />
R<br />
S syirdwz<br />
r s<br />
3<br />
49<br />
E<br />
x<br />
i rr<br />
iC s 4ar<br />
i<br />
k5 Xi<br />
TLx A<br />
r<br />
3 a vin y<br />
a<br />
n c s<br />
d<br />
s<br />
o<br />
4<br />
2<br />
0<br />
tAw<br />
4 L<br />
ti<br />
Y<br />
Burglary Attempted Criminal Attempted Armed Battery<br />
Burglary Threat Robbery Robbery<br />
r<br />
w<br />
r<br />
x<br />
w<br />
Information showing the dispensaries attracted crime<br />
The marijuana dispensaries were targets <strong>of</strong> violent crimes because <strong>of</strong> the amount <strong>of</strong> marijuana<br />
currency and other contraband stored inside the businesses From January I 2005 through June 23<br />
2006 24 violent crimes were reported at marijuana dispensaries An analysis <strong>of</strong> financial records<br />
seized from the marijuana dispensaries showed several dispensaries were grossing over 300 000 per<br />
month from selling marijuana and marijuana food products The majority <strong>of</strong> customers purchased<br />
marijuana with cash<br />
Crime statistics inadequately reflect the actual number <strong>of</strong> crimes committed at the marijuana<br />
dispensaries These businesses were <strong>of</strong>ren victims <strong>of</strong> robberies and burglaries but did not report the<br />
crimes to law enforcement on account <strong>of</strong> fear <strong>of</strong> being arrested for possession <strong>of</strong> marijuana in excess<br />
<strong>of</strong> Prop 215 guidelines NTF and the San Diego Police Department SDPD received nwnerous<br />
citizen compiaints regarding every dispensary operating in San Diego County<br />
Because the complaints were received by various individuals the exact number <strong>of</strong> complaints was<br />
not recorded The following were typical complaints received<br />
high levels <strong>of</strong> traffic going to and from the dispensaries<br />
people loitering in the parking lot <strong>of</strong> the dispensaries<br />
people smoking marijuana in the parking lot <strong>of</strong> the dispensaries<br />
O 2009 California Police Chiefs Assn 22 All Rights Reserved
vandalism near dispensaries<br />
threats made by dispensary employees to employees <strong>of</strong> other businesses<br />
citizens worried they may become a victim <strong>of</strong> crime because <strong>of</strong> their proximity to<br />
dispensaries<br />
In addition the following observations from citizen activisYs assisting in data gathering were made<br />
about the marijuana dispensaries<br />
Identification was not requested for individuals who looked under age 18<br />
Entrance to business was not refused because <strong>of</strong> lack <strong>of</strong> identification<br />
Individuals were observed loitering in the parking lots<br />
Child oriented businesses and recreational areas were situated nearby<br />
Some businesses made no attempt to verify a submitted physician<br />
recommendation<br />
Dispensary Patients By Age<br />
Ages 71 75 4 0<br />
Ages66 70 191Ages 76 80 0 0<br />
Ages61 65 47 2IA9es 81 85 0 0<br />
Ages 56 60 89 3<br />
Ages 51 55 173 6<br />
AgBS46 50 210 7<br />
No Age listed 118 4<br />
Ages 17 20 364 12<br />
Ages41 45 175 6<br />
Ages 36 40 270 9 Ages 21 25 719 23<br />
Ages 31 35 302 10<br />
Ages 26 30 504 17<br />
An analysis <strong>of</strong> patient records seized during search warrants at several dispensaries show that 52<br />
<strong>of</strong> the customers purchasing marijuana were between the ages <strong>of</strong> 17 to 30 63 <strong>of</strong> primary<br />
caregivers purchasing marijuana were betwecn the ages <strong>of</strong> 18 through 30 Only205 <strong>of</strong> customers<br />
submitted a physician<br />
recommendation for AIDS glaucoma or cancer<br />
Why these businesses were deemed to be criminal not compassionate<br />
The medical marijuana businesses were deemed to be criminal enterprises for the following reasons<br />
Many <strong>of</strong> the business owners had 6istories <strong>of</strong> drug and violence related arrests<br />
The business owners were street level marijuana dealers who took advantage <strong>of</strong> Prop 215 in<br />
an attempt to legitimize marijuana sales for pr<strong>of</strong>it<br />
Records or lack <strong>of</strong> records seized during the search wanants showed that all the owners<br />
were not properly reporting income generated from the sales <strong>of</strong> marijuana Many owners<br />
were involved in money laundering and tax evasion<br />
The businesses were selling to individuals without serious medical conditions<br />
There are no guidelines on the amount <strong>of</strong> marijuana which can be sold to an individual For<br />
OO 2009 California Police Chiefs Assn 23 Afl Rights Reserved
example an individual with a physician<br />
recommendation can go to as many marijuana<br />
distribution businesses and purchase as much marijuana as she wants<br />
Califomia law allows an individual to possess 6 mature or 12 immature plants per qualified<br />
person However the San Diego Municipal Code statesacaregiver can only provide care<br />
to 4 people including themselves this translates to 24 mature or 48 immature plants total<br />
Many <strong>of</strong> these dispensaries are operating large marijuana grows with far more plants than<br />
allowed under law Several <strong>of</strong> the dispensaries had indoor marijuana grows inside the<br />
businesses with mature and or immature marijuana plants over the limits<br />
State law allows a qualified patient or primary caregiver to possess no more than eight<br />
ounces <strong>of</strong> dried marijuana per qualified patient However the San Diego Municipal Code<br />
allows prunary caregivers to possess no more than two pounds <strong>of</strong> processed marijuana<br />
Under either law almost every marijuana dispensary had over two pounds <strong>of</strong> processed<br />
marijuana during the execution <strong>of</strong> the search warrants<br />
Some marijuana dispensaries force customers to sign forms designating the business as their<br />
primary caregiver in an attempt to circwnvent the law<br />
2 EXPERIENCES WITH MARIJUANA DISPENSARIES IN RIVERSIDE COUNTY<br />
There were some marijuana dispensaries operating in the County <strong>of</strong> Riverside until the District<br />
Attorney s Office took a very aggressive stance in closing them In Riverside anyone that is not a<br />
qualified patienY or primary caregiver under the Medical Marijuana Program Act who possesses<br />
sells or transports marijuana is being prosecuted<br />
Several dispensary closures illustrate the impact this position has had on marijuana dispensaries For<br />
instance the Palm Springs Caregivers dispensary also known as Palm Springs Safe Access<br />
Collective was searched after a warrant was issued All materials inside were seized and it was<br />
closed down and remains closed The California Caregivers Association was located in downtown<br />
Riverside Very shortly after it opened it was also searched pursuant to a warrant and shut down<br />
The CannaHelp dispensary was located in Palm Desert It was searched and closed down early in<br />
2007 The owner and two managers were than prosecuted for marijuana sales and possession <strong>of</strong><br />
marijuana for the purpose <strong>of</strong> sale However a judge granted their motion to quash the search<br />
warrant and dismissed the chazges The District Attorney s Office then appealed to the Fourth<br />
District Court <strong>of</strong> Appeal Presently the Office is waiting for oral azguments to be scheduled<br />
Dispensaries in the couniy have also been closed by court order The Healing Nations Collective<br />
was located in Corona The owner lied about the nature <strong>of</strong> the business in his application for a<br />
license The city pursued and obtained an injunction that required the business to close The owner<br />
appealed to the Fourth District Court <strong>of</strong> Appeal which ruled against him Ciry <strong>of</strong> Corona v Ronald<br />
Naa lls et al Case No E042772<br />
3 MEDICAL MARIJUANA DISPENSARY ISSUES IN CONTRA COSTA COUNTY<br />
CITIES AND IN OTHER BAY AREA COUNTIES<br />
Several cities in Contra Costa County California have addressed this issue by either banning<br />
dispensaries enacting moratoria against them regulating them or taking a position that they are<br />
simply not a permitted land use because they violate federal law Richmond El Cerrito San Pablo<br />
Hercules and Concord have adopted permanent ordinances banning the establishment <strong>of</strong> marijuana<br />
dispensaries Antioch Brentwood Oakley Pinole and Pleasant Hill have imposed moratoria<br />
against dispensaries Clayton San Ramon and Walnut Creek have not taken any formal action<br />
regarding the establishment <strong>of</strong> marijuana dispensaries but have indicated that marijuana dispensaries<br />
O 2009 California Police Chiefs Assn 24 All Rights Reserved
are not a permitted use in any <strong>of</strong> their zoning districts as a violation <strong>of</strong> federal law Martinez has<br />
adopted a permanent ordinance regulating the establishment <strong>of</strong> marijuana dispensaries<br />
The Counties <strong>of</strong> Alameda Santa Clara and San Francisco have enacted permanent ordinances<br />
regulating the establishment <strong>of</strong> marijuana dispensaries The Counties <strong>of</strong> Solano Napa and Marin<br />
have enacted neither regulations nor bans A brief overview <strong>of</strong> the regulations enacted in<br />
neighboring counties follows<br />
A<br />
Alameda County<br />
Alameda County has a nineteen page regulatory scheme which allows the operation <strong>of</strong> three<br />
permitted dispensaries in unincorporated portions <strong>of</strong> the county Dispensaries can only be located in<br />
commercial or industrial zones or their equivalent and may not be located within1000 feet <strong>of</strong> other<br />
dispensaries schools parks playgrounds drug recovery facilities or recreation centers Permit<br />
issuance is controlled by the Sheriff who is required to work with the Community Development<br />
Agency and the Health Care Services agency to establish operating conditions for each applicant<br />
prior to final selection Adverse decisions can be appealed to the Sheriff and aze ruled upon by the<br />
same panel responsible for setting operating conditions That panel s decision may be appealed to<br />
the Board <strong>of</strong> Supervisors whose decision is final subject to writ review in the Superior Court per<br />
CCP sea 1094 5 Persons violating provisions <strong>of</strong> the ordinance are guilty <strong>of</strong> a misdemeanor<br />
B<br />
Santa Clara Counly<br />
In November <strong>of</strong> 1998 Santa Clara County passed an ordinance permitting dispensaries to exist in<br />
unincorporated portions <strong>of</strong> the county with permits first sought and obtained from the Department <strong>of</strong><br />
Public Health In spite <strong>of</strong> this regulation neither the County Counsel nor the District Attorney s<br />
Drug Unit Supervisor believes that Santa Clara County has had any marijuana dispensaries in<br />
operation at least through 2006<br />
The only permitted activities are the on site cultivation <strong>of</strong> inedical marijuana and the distribution <strong>of</strong><br />
medical marijuana medical marijuana food stuffs No retail sales <strong>of</strong> any products are permitted at<br />
the dispensary Smoking ingestion or consumption is also prohibited on site All doctor<br />
recommendations for medical marijuana must be verified by the County s Public Health<br />
Department<br />
C<br />
San Francisco County<br />
In December <strong>of</strong> 2001 the Board <strong>of</strong> Supervisors passed Resolution No 012006 declaring San<br />
Francisco to beaSanctuary for Medical Cannabis <strong>City</strong> voters passed Proposition S in 2002<br />
directing the city to explore the possibility <strong>of</strong> establishing a medical marijuana cultivation and<br />
dish program run by the city itself<br />
San Francisco dispensaries must apply for and receive a permit from the Department oFPublic<br />
Health They may only operate as a collective or cooperative as defined by California Health and<br />
Safety Code section 11362 7 see discussion in section 4 under California Law above and may<br />
only sell or distribute marijuana to members Cultivation smoking and making and selling food<br />
products may be allowed Permit applications are refened to the Departments <strong>of</strong> Planning Building<br />
Inspection and Police Criminal background checks are required but exemptions could still allow<br />
the operation <strong>of</strong> dispensaries by individuals with prior convictions for violent felonies or who have<br />
had prior permits suspended or revoked Adverse decisions can be appealed to the Director <strong>of</strong><br />
O 2009 California Police Chiefs Assn 25 All Rights Reserved
Public Health and the Board <strong>of</strong> Appeals It is unclear how many dispensaries aze operating in the<br />
city at this time<br />
D<br />
Crime Rates in the Vicinity <strong>of</strong> MariCare<br />
Sheriff s data have been compiled for Calls for Service within a half mile radius <strong>of</strong> 127 Aspen<br />
Drive Pacheco However in research conducted by the El Cerrito Police Department and relied<br />
upon by Riverside County in recently enacting its ban on dispensaries it was recognized that not all<br />
crimes related to medical marijuana take place in or around a dispensary Some take place at the<br />
homes <strong>of</strong> the owners employees or patrons Therefore these statistics cannot paint a complete<br />
picture <strong>of</strong> the impact a marijuana dispensary has had on crime rates<br />
The statistics show that the overall number oF calls decreased3746 in 2005 versus3260 in 2006<br />
However there have been increases in the numbers <strong>of</strong> crimes which appear to be related to a<br />
business which is an attraction to a criminal element Reports <strong>of</strong> commercial burglaries<br />
increased 14 in 2005 24 in 2006 as did reports <strong>of</strong> residential burglaries 13 in 2005 16 in 2006<br />
and miscellaneous burglaries 5 in 2005 21 in 2006<br />
Tender Holistic Care THC marijuana dispensary formerly located on N Buchanan Circle in<br />
Pacheco was forcibly burglarized on June 11 2006 4800 in cash was stolen along with<br />
marijuana hash marijuana food products marijuana pills marijuana paraphernalia and marijuana<br />
plants The total loss was estimated to be16 265<br />
MariCare was also burglarized within two weeks <strong>of</strong> opening in Pacheco On Apri14 2006 a<br />
window was smashed after 11 00pm while an employee was inside the business working late to<br />
get things organized The female employee called 911 and locked herself in an <strong>of</strong>fice while the<br />
intruder ransacked the downstairs dispensary and stole more than 200 worth <strong>of</strong> marijuana<br />
Demetrio Ramirez indicated that since they were just moving in there wasn t much inventory<br />
Reports <strong>of</strong> vehicle thefts increased 4 in 2005 6 in 2006 Disturbance reports increased in nearly all<br />
categories Fights 5 in 2005 7 in 2006 Harassment 4 in 2005 5 in 2006 Juveniles 4 in 2005 21<br />
in 2006 Loitering 11 in 2005 19 in 2006 Verbal 7 in 2005 17 in 2006 Littering reports<br />
increased from 1 in 2005 to 5 in 2006 Public nuisance reports increased from 23 in 2005 to 26 in<br />
2006<br />
These statistics reflect the complaints and concems raised by nearby residents Residents have<br />
reported to the District Attomey s Office as well as to Supervisor Piepho s <strong>of</strong>fice that when calls<br />
are made to the Sheriffls Department the <strong>of</strong>fender has <strong>of</strong>rentimes eft the area before law<br />
enforcement can arrive This has led to less reporting as it appears to local residents to be a futile<br />
act and residents have been advised that law enforcement is understaffed and cannot always timely<br />
respond to all calls for service As a result Pacheco developed a very active visible Neighborhood<br />
Watch program The program became much more active in 2006 according to Doug Stewart<br />
Volunteers obtained radios and began frequently receiving calls directly from local businesses and<br />
residents who contacted them instead <strong>of</strong> law enforcement It is therefore significant that there has<br />
still been an increase in many types <strong>of</strong> calls for law enforcement service although the overall<br />
number <strong>of</strong> calls has decreased<br />
Other complaints from residents included noise odors smoking consuming marijuana in the area<br />
littering and trash from the dispensary loitering near a school bus stop and in the nearby church<br />
parking lot observations that the primary patrons <strong>of</strong> MariCare appear to be individuals under age 25<br />
OO 2009 California Police Chiefs Assn 26 All Rights Reserved
and increased traffic Residents observed that the busiest time for MariCare appeared to be from<br />
400pm to600pm On a typical Friday 66 cazs were observed entering MariCare s facility 49<br />
<strong>of</strong> these were observed to contain additional passengers The slowest fime appeared to be from<br />
100pm to300pm On a typical Saturday 44 cars were counted during this time and 29 <strong>of</strong> these<br />
were observed to have additional passengers MariCare has claimed to serve4000 patients<br />
E<br />
Impact <strong>of</strong> Proposed Ordinance on MedDelivery Dispensary EI Sobrante<br />
It is the position <strong>of</strong> Contra Costa County District Attorney Robert J Kochly that a proposed<br />
ordinance should terminate operation <strong>of</strong> the dispensary in El Sobrante because the land use <strong>of</strong> that<br />
business would be inconsistent with both state and federal law However the Community<br />
Development Department apparently believes that MedDelivery can remain asalegal non<br />
conforming use<br />
F<br />
Banning Versus Regulating Marijuana Dispensaries in Unincorporated<br />
Confra Costa County<br />
It is simply bad public policy to allow the proliferation <strong>of</strong> any type <strong>of</strong> business which is illegal and<br />
subject to being raided by federal and or state authorities In fact eight locations associated with the<br />
New Remedies dispensary in San Francisco and Alameda Counties were raided in October <strong>of</strong> 2006<br />
and eleven Southern California marijuana clinics were raided by federal agents on January 18 2007<br />
The Los Angeles head <strong>of</strong> the federal Drug Enforcement Administration told CBS News after the<br />
January raids that Today s enforcement operations show that these establishments are nothing more<br />
thandrug trafficking organizations bringing cruninal activities to our neighborhoods and drugs near<br />
our children and schools A Lafayette California resident who owned a business that produced<br />
marijuana laced foods and drinks for marijuana clubs was sentenced in federal court to five years<br />
and 10 months behind bars as well asa25Q000 fine Several <strong>of</strong> his employees were also convicted<br />
in that case<br />
As discussed above there is absolutely no exception to the federal prohibition against marijuana<br />
cultivation possession transportation use and distribution Neither California s voters nor its<br />
Legislature authorized the existence or operation <strong>of</strong> marijuana dispensing businesses when given the<br />
opportunity to do so These enterprises cannot fit themselves into the few narrow exceptions that<br />
were created by the Compassionate Use Act and Medical Marijuana Program Act<br />
Further the presence <strong>of</strong> marijuana dispensing businesses contributes substantially to the existence <strong>of</strong><br />
a secondary market for illegal street level distribution <strong>of</strong> marijuana This fact was even recognized<br />
by the United States Supreme Court The exemption for cultivation by patients and caregivers can<br />
only increase the supply <strong>of</strong> marijuana in the California market Tbe likelihood that al such<br />
production will promptly terminate when patients recover or will precisely match the patients<br />
medical needs during their convalescence seems remote whereas the danger that excesses will<br />
satisfy some <strong>of</strong> the admittedly enormous demand for recreational use seems obvious Gonzales v<br />
Raich supra 125 SCt atp 2214<br />
As outlined below clear evidence has emerged <strong>of</strong> such a secondary market in Contra Costa County<br />
In September <strong>of</strong> 2004 police responded to reports <strong>of</strong> two men pointing a gun at cars in<br />
the parking lot at Monte Vista High School during an evening football game dance Two<br />
19 year old Danville residents were located in the parking lot which was full <strong>of</strong> vehicles<br />
and pedestrians and in possession <strong>of</strong> a silver Airs<strong>of</strong>t pellet pistol designed to replicate a<br />
O 2009 California Police Chiefs Assn 27 All Rights Reserved
eal Walthersemi automatic handgun Marijuana hash and hash oil with typical<br />
dispensary packaging and labeling were also located in the car along with a gallon<br />
bottle <strong>of</strong> tequila 14 full a bong with burned residue and rolling papers The young<br />
men admitted to having consumed an unknown amount <strong>of</strong> tequila at the park next to<br />
the school and that they both pointed the gun at passing cars as ajoke They fired<br />
several BBs at a wooden fence in the park when there were people in the area The<br />
owner <strong>of</strong> the vehicle admitted that the marijuana was his and that he was not a medicinal<br />
marijuana user He was able to buy marijuana from his friend Brandon who used a<br />
Proposition 215 card to purchase from a cannabis club in Hayward<br />
In February <strong>of</strong> 2006 Concord police <strong>of</strong>ficers responded to a report <strong>of</strong> a possible drug sale<br />
in progress They arrested a high school senior for two outstanding warrants as he came<br />
to buy marijuana from the cannabis club located on Contra Costa Boulevard The young<br />
man explained that he had a cannabis club card that allowed him to purchase marijuana<br />
and admitted that he planned tore sell some <strong>of</strong> the marijuana to friends He also<br />
admitted to possession <strong>of</strong> nearly 7 grams <strong>of</strong> cocaine which was recovered A21 year old<br />
man was also arrested on an outstanding warrant In his car was a marijuana grinder a<br />
baggie <strong>of</strong> marijuana rolling papers cigars andab1unY hollowed out cigar filled with<br />
marijuana for smoking with one end burned The21 year old admitted that he did not<br />
have a physician<br />
recommendation for marijuana<br />
Also in February <strong>of</strong> 2006 a 17 year old Monte Vista High School senior was charged<br />
with felony furnishing <strong>of</strong> marijuana to a child after giving a4year old boy a marijuana<br />
laced cookie The furnishing occurred on campus during a child development class<br />
In March <strong>of</strong> 2006 police and fire responded to an explosion at a San Ramon townhouse<br />
and found three young men engaged in cultivating and manufactwing honey oil for local<br />
pot clubs Marijuana was also being sold from the residence Honey oil is a concentrated<br />
form <strong>of</strong> cannabis chemically extracted from ground up marijuana with extremely volatile<br />
butane and a special honey oiP extractor tube The butane extraction operation exploded<br />
with such farce that it blew the garage door partia ly <strong>of</strong>f its hinges Sprinklers in the<br />
residence kept the fire from spreading to the other homes in the densely packed residential<br />
neighborhood At least one <strong>of</strong> the men was employed by Ken EsYes owner <strong>of</strong> the<br />
Dragonfly Holistic Solutions pot clubs in Richmond San Francisco and Lake County<br />
They were making the honey oil with marijuana and butane that they brought up from<br />
one <strong>of</strong> Estes San Diego pot clubs after it was shut down by federal agents<br />
Also in March <strong>of</strong> 2006 a16 year old El Cerrito High School student was arrested afrer<br />
selling pot cookies to fellow students on campus many <strong>of</strong> whom became ill At least<br />
four required hospitalization The investigation revealed that the cookies were made with<br />
a butter obtained outside a marijuana dispensary a secondary sale Between March <strong>of</strong><br />
2004 and May <strong>of</strong> 2006 the El Cerrito Police Department conducted seven investigations<br />
at the high school and junior high school resulting in the arrest <strong>of</strong> eight juveniles for<br />
selling or possessing with intent to sell marijuana on or around the school campuses<br />
In June <strong>of</strong> 2006 Moraga police <strong>of</strong>ficers made a traffic stop for suspected driving under<br />
the influence <strong>of</strong> alcohol The car was seen drifring over the double yellow line separating<br />
north and southbound traffic lanes and driving in the bike lane The20 year old driver<br />
denied having consumed any alcohol as he was the designated driver When asked<br />
about his bloodshot watery and droopy eyes the collegejunior explained that he had<br />
OO 2009 California Police Chiefs Assn 28 All Rights Reserved
smoked mazijuana earlier confirmed by blood tests The young man had difficulty<br />
performing field sobriety tests slurred his speech and was ultimately arrested for driving<br />
under the influence He was in possession <strong>of</strong> a falsified California Driver s License<br />
marijuana hash a marijuana pipe a scale and12 288 The marijuana was in packaging<br />
from the Compassionate Collective <strong>of</strong> Alameda County a Hayward dispensary He<br />
explained that he buys the marijuana at Pot Clubs sells some and keeps the rest He<br />
only sells to close friends About3000 to4000 <strong>of</strong> the cash was from playing high<br />
stakes poker but the rest was earned selling marijuana while a freshman at Arizona State<br />
University The18 year old passenger had half an ounce <strong>of</strong> marijuana in her purse and<br />
produced a doctor s recommendation to a marijuana club in Oakland the authenticity <strong>of</strong><br />
which could not be confirmed<br />
Another significant concem is the proliferation <strong>of</strong> marijuana usage at community schools In<br />
February <strong>of</strong> 2007 the Healthy Kids Survey for Alameda and Contra Costa Counties found that<br />
youthful substance abuse is more common in the East Bay s more affluent areas These areas had<br />
higher rates <strong>of</strong> high school juniors who admitted having been high from drugs The regional<br />
manager <strong>of</strong> the study found that the affluent areas had higher alcohol and marijuana use rates USA<br />
Today recently reported that the percentage <strong>of</strong> 12 Grade students who said they had used marijuana<br />
has increased since 2002 from 336 to 36 2 in 2005 and that marijuana was the most used<br />
illicit drug among that age group in 2006 KSDK News Channel 5 reported that high school students<br />
are finding easy access to medical marijuana cards and presenting them to school authorities as a<br />
legitimate excuse for getting high School Resource Officers for Monte Vista and San Ramon<br />
Valley High Schools in Danville have reported finding marijuana in prescription bottles and other<br />
packaging from Alameda County dispensaries Marijuana has also been linked to psychotic<br />
illnesses A risk factor was found to be starting marijuana use in adolescence<br />
For all <strong>of</strong> the above reasons it is advocated by District Attomey Kochly that a ban on land uses<br />
which violate state or federal law is the most appropriate solution for the County <strong>of</strong> Contra Costa<br />
4 SANTA BARBARA COUNTY<br />
According to Santa Barbara County Deputy District Attorney Brian Cota ten marijuana dispensaries<br />
are currently operating within Santa Barbara County The mayor <strong>of</strong> the <strong>City</strong> <strong>of</strong> Santa Barbara who<br />
is an outspoken medical marijuana suppor er has stated that the police must place marijuana behind<br />
every other police priority This has made it difficult for the local District Attomey s Office Not<br />
many marijuana cases come to it for filing The District Attomey s Office would like more<br />
regulations placed on the dispensaries However the majority <strong>of</strong> Santa Barbara County political<br />
leaders and residents are very liberal and do not want anyone to be denied access to medical<br />
marijuana if they say they need it Partly as a result no dispensazies have been prosecuted to date<br />
5 SONOMA COUNTY<br />
Stephan R Passalocqua District Attorney for the County <strong>of</strong> Sonoma has recently reported the<br />
following information related to distribution <strong>of</strong> inedical inarijuana in Sonoma County In 1997 the<br />
Sonoma County Law Enforcement Chiefs Association enacted the following medical marijuana<br />
guidelines a qualified patient is permitted to possess three pounds <strong>of</strong> marijuana and grow 99 plants<br />
in a 100 square foot canopy A qualified caregiver could possess or grow the above mentioned<br />
amounts for each qualified patient These guidelines were enacted afrer Proposition 215 was<br />
overwhelmingly passed by the voters <strong>of</strong> California and afrer two separate unsuccessfixl prosecutions<br />
in Sonoma County Two Sonoma County juries returned not guilty verdicts for three defendants<br />
OO 2009 California Police Chiefs Assn 29 All Rights Reserved
who possessed substantially large quantities <strong>of</strong> marijuana 60 plants in one case and over 900 plants<br />
in the other where they asserted a medical marijuana defense These verdicts and the attendant<br />
publicity demonstrated that the community standards are vastly different in Sonoma County<br />
compared to oYher jurisdicYions<br />
On November 6 2006 and authorized by Senate Bi11420 the Sonoma County Boazd <strong>of</strong> Supervisors<br />
specifically enacted regulations that allow a qualified person holding a valid identification card to<br />
possess up to three pounds <strong>of</strong> dried cannabis a year and cultivate 30 plants per qualified patient No<br />
individual from any law enforcement agency in Sonoma County appeared at the hearing nor did any<br />
representative publicly oppose this resolution<br />
With respect to the People v Sashon Jenkins case the defendant provided verified medical<br />
recommendations for five qualified patients prior to trial At the time <strong>of</strong> arrest Jenkins said that he<br />
had a medical marijuana card and was a care provider for multiple people but was unable to provide<br />
specific documentation Mr Jenkins had approximately 10 pounds <strong>of</strong> dried marijuana and was<br />
growing 14 plants which number <strong>of</strong> plants is consistent with the 2006 Sonoma County Board <strong>of</strong><br />
Supervisors resolution<br />
At a preliminary hearing held In January <strong>of</strong> 2007 the defense called five witnesses who were<br />
pr<strong>of</strong>fered as Jenkins patients and who came to court with medical recommendations Jenkins<br />
also testified that he was their caregiver Afrer the preliminary hearing the assigned prosecutor<br />
conducted a thorough review <strong>of</strong> the facts and the law and concluded that a Sonoma Countyjury<br />
would not returnaguilty verdict in this case Hence no felony information was filed With<br />
respect to the return <strong>of</strong> property issue the prosecuting deputy district attorney never agreed to<br />
release the marijuana despite dismissing the case<br />
Other trial dates aze pending in cases where medical marijuana defenses are being alleged District<br />
Attomey Passalacqua has noted that given the overwhelming passage <strong>of</strong> proposition 215 coupled<br />
with at least one United States Supreme Court decision that has not struck it down to date these<br />
factors present current challenges for law enforcement but that he and other prosecutors will<br />
continue to vigorously prosecute drug dealers within the boundazies <strong>of</strong> the law<br />
6 ORANGE COUNTY<br />
There are 15 marijuana dispensaries in Orange Counry and several delivery services Many <strong>of</strong><br />
the delivery services operate out <strong>of</strong> the <strong>City</strong> <strong>of</strong> Long Beach in Los Angeles County Orange<br />
County served a search warrant on one dispensary and closed it down A decision is being made<br />
whether or not to file criminal charges in Yhat case It is possible that the United States Attorney<br />
will file on that dispensary since it is a branch <strong>of</strong> a dispensary that the federal authorities raided<br />
in San Diego County<br />
The Orange County Board <strong>of</strong> Supervisors has ordered a study by the county s Health Care<br />
Department on how to comply with the Medical Marijuana Program Act The District<br />
Attorney s Office s position is that any activity under the Medical Marijuana Program Act<br />
beyond the mere issuance <strong>of</strong> identification cards violates federal law The District Attorney s<br />
Office has made it clear to County Counsel that if any medical marijuana provider does not meet<br />
a strict definition <strong>of</strong> primary caregiver that person will be prosecuted<br />
OO 2009 California Police Chiefs Assn 30 All Rights Reserved
PENDING LEGAL QUESTIONS<br />
Law enforcement agencies throughout the state as well as their legislative bodies have been<br />
struggling with how to reconcile the Compassionate Use Act CUA Cal Health Safety<br />
Code secs 11362 5 et seq with the federal Controlled Substances Act CSA 21USC sec<br />
801 et seq for some time Pertinent questions follow<br />
QUESTION<br />
1<br />
Is it possible for a storefront marijuana dispensary to be legally operated<br />
under the Compassionate Use Act <strong>of</strong> 1996 Health Sa Code sec 11362 5<br />
and the Medical Marijuana Program Act Health Saf Code secs 11362 7<br />
11362 83<br />
AN5WER<br />
1 Storefront marijuana dispensaries may be legally operated under the CUA<br />
and the Medical Marijuana Program Act D4MPA Cal Health Safety<br />
Code secs 711362 83 as long as they are cooperatives under the<br />
MMPA<br />
ANALYSIS<br />
The question posed does not specify what services or products are available atastorefront<br />
marijuana dispensary The question also does not specify the business structure <strong>of</strong> a<br />
dispensaryAdispensary is <strong>of</strong>ten commonly used nowadays as a generic term for a facility<br />
that distributes medical marijuana<br />
The term dispensary is also used specifically to refer to marijuana facilities that are operated<br />
more like a retail establishment that are open to the public and <strong>of</strong>ten sell medical marijuana to<br />
qualified patients or caregivers By use <strong>of</strong> the term store front dispensary the question may be<br />
presuming that this type <strong>of</strong> facility is being operated For purposes <strong>of</strong> this analysis we will<br />
assume thatadispensary is a generic term that does not contemplate any particular business<br />
structure Based on that assumptionadispensary might provide assistance to a qualified<br />
patient or a person with an identification card or his or her designated primary caregiver in<br />
administering medical marijuana to the qualified patient or person or acquiring the skills<br />
necessary to cultivate or administer marijuana for medical purposes to the qualified patient or<br />
person and be within the permissible limits <strong>of</strong> the CUA and the MMPA Cal Health Safety<br />
Code sec 11362 765b3<br />
1 As the term dispensary is commonly used and understood marijuana dispensaries<br />
would not be permitted under the CUA or the MMPA since they sell medical marijuana and<br />
are not operated as true cooperatives<br />
O 2009 California Police Chiefs Assn 31 All Rights Reserved
The CUA permitsapatienY orapatienYs primary caregiver to possess or cultivate marijuana<br />
for personal medical purposes with the recommendation <strong>of</strong> a physician Cal Health Safety<br />
Code sec 11362 5d Similarly the MMPA provides that patients or designated primary<br />
caregivers who have volunfarily obtained a valid medical marijuana identification card shall not<br />
be subject to arrest for possession transportation delivery or cultivation <strong>of</strong> inedical marijuana in<br />
specified quantities Cal Health Safety Code sea ll362 71 deAstorefront<br />
dispensary would not fit within either <strong>of</strong> these categories<br />
However the MMPA also provides thatqualified patients persons with valid identification<br />
cards and the designated primary caregivers <strong>of</strong> qualified patients and persons with identification<br />
cards who associate within the State <strong>of</strong> California in ardercol ectively or cooperatively to<br />
cultivate marijuana for medical purposes shall not solely on the basis <strong>of</strong> that fact be subject to<br />
state criminal sanctions under section 11357 possession 11358 planting harvesting or<br />
processing 11359 possession for sale I 1360 unlawful transportation importation sale or<br />
gift 11366 opening or maintaining place for trafficking in controlled substances 11366 5<br />
providing place for manufacture or distribution <strong>of</strong> controlled substance Fortifying building to<br />
suppress law enforcement entry or 11570 Buildings or places deemed nuisances subject to<br />
abatement Cal Health Safety Code sec 11362 775 Emphasis added<br />
Since medical marijuana cooperatives are permitted pursuant to the MMPAastorefront<br />
dispensary that would qualify as a cooperative would be permissible under the MMPA Cal<br />
Health<br />
Safety Code sec 11362 775 See also People v Ur iceunu 2005 132 Cal App 4th<br />
747 finding criminal defendant was entitled to present defense relating to operation <strong>of</strong> inedical<br />
marijuana cooperative In granting are trial the appellate court in Urziceane found thaY the<br />
defendant could present evidence which might entitle him to a defense under the MMPA as to<br />
the operation <strong>of</strong> a medical marijuana cooperative including the fact that the cooperative<br />
verified physician recommendations and identities oF individuals seeking medical marijuana and<br />
individuals obtaining medical marijuana paid membership fees reimbursed defendant for his<br />
costs in cultivating the medical marijuana by way <strong>of</strong> donations and volunteered at the<br />
cooperative Id at p 785<br />
Whether or not sales are permitted under Urziceanu and the MMPA is unclear The<br />
Urziceanar Courf did note that the incorporation <strong>of</strong> secYion 11359 relating to marijuana sales<br />
in section 11362 775 allowing the operation <strong>of</strong> cooperatives contemplates the formation and<br />
operation <strong>of</strong> inedicinal marijuana cooperatives that would receive reimbursement for marijuana<br />
and the services provided in conjunction with the provision <strong>of</strong> that marijuana Whether<br />
reimbursemenY may be in the form only <strong>of</strong> donations as were the facts presented in Urziceanu<br />
or whether purchases could be made for medical marijuana it does seem clear that a medical<br />
marijuana cooperative may not makeapr<strong>of</strong>it but may be restricted to being reimbursed for<br />
actual cosYs in providing Yhe marijuana to its members and if there are any pr<strong>of</strong>its these may<br />
have to be reinvested in the cooperative or shared by its members in order for a dispensary to<br />
1<br />
O 2009 California Police Chiefs Assn 32 All Rights Reserved
e truly considered to be operating asacooperative If these requirements aze satisfied as to a<br />
storefront dispensary then it will be permissible under the MMPA Otherwise it will be a<br />
violation <strong>of</strong> both the CUA and the MMPA<br />
QUESTION<br />
2 If the governing body <strong>of</strong> a city county ar city and county approves an ordinance<br />
authorizing and regulating marijuana dispensaries to implement the Compassionate<br />
Use Act <strong>of</strong> 1996 and the Medical Marijuana Program Act can an individual board or<br />
council member be found to be acting illegally and be subject to federal criminal<br />
charges including aiding and abetting or state criminal charges<br />
ANSWER<br />
2<br />
If a city county or city and county authorizes and regulates marijuana<br />
dispensaries individual members <strong>of</strong> the legislative bodies may be held criminally<br />
liable under state or federal law<br />
ANALYSIS<br />
A<br />
Federal Law<br />
Generally legislators <strong>of</strong> federal state and local legislative bodies are absolutely<br />
immune from liability for legislative acts US Const art I sec6Speech and<br />
Debate Clause applicable to members <strong>of</strong> Congress Fed Rules Evid Rule 501<br />
evidentiary privilege against admission <strong>of</strong> legislative acts Tenney v Brandhove<br />
1951 341 US 367 legislative immunity applicable to state legislators Bogan<br />
v Scott Harris 1998 523 US 44 legislative immunity applicable to local<br />
legislators However while federal legislators are absolutely immune from both<br />
criminal and civil liability for purely legislative acts local legislators are only<br />
nnmune from civil liability under federal law United States v Gillock 1980<br />
445 US 360<br />
Where the United States Supreme Court has held that federal regulation <strong>of</strong> marijuana by way <strong>of</strong><br />
the CSA including any medical use <strong>of</strong> marijuana is within Congress Commerce Clause<br />
power federal law stands as a baz to local action in direct violation <strong>of</strong> the CSA Gonzales v<br />
Razch 2005 545 US 1 In fact the CSA itself provides that federal regulations do not<br />
zA is defined as follows An enterprise or organization that is owned or managed<br />
jointly by thOSe wh0 uSe itS faCi11t1eS OC Serv1CeS THE AMERICAN HERITAGE DICTIONARY OF THE<br />
ENC stiLnN unGe by Houghton Mifflin Company 4th Ed 2000<br />
3 Indeed the same conclusion would seem to result from the adoption by state legislators <strong>of</strong> the<br />
MMPA itself in authorizing the issuance <strong>of</strong> inedical marijuana identification cards Cal Health<br />
Safety Code secs 11362 71 et seq<br />
OO 2009 California Police Chiefs Assn 33 All Rights Reserved
exclusively occupy tbe 8eld <strong>of</strong> drug regulation unless there is a positive conflict between that<br />
provision <strong>of</strong> this title the CSA and that state law so that the two cannot consistently stand<br />
together 21USC sec 903<br />
Based on the above provisions then legislative action by local legislators cou d subject the<br />
individnal legislators to federal criminal liability Most likely the only violation <strong>of</strong> the CSA that<br />
could occur as a result <strong>of</strong> an ordinance approved by local legislators authorizing and regulating<br />
medical marijuana would be aiding and abetting a violation <strong>of</strong> the CSA<br />
The elements <strong>of</strong> the <strong>of</strong>fense <strong>of</strong> aiding and abetting a criminal <strong>of</strong>fense are 1 specific intent to<br />
facilitate commission <strong>of</strong> a crime by another 2 guilty knowledge on the part <strong>of</strong> the accused 3<br />
fhat an <strong>of</strong>fense was being committed by someone and 4 that the accused assisted or<br />
participated in the commission <strong>of</strong> an <strong>of</strong>fense United States v Raper 1982 676F2d 841<br />
United States v Staten 1978 581 F2d 878<br />
Criminal aiding and abetting liability under 18USC section 2 requires pro<strong>of</strong> that the<br />
defendants in some way associated themselves with the illegal venture that they participated in<br />
the venture as something that they wished to bring about and that they sought by their actions to<br />
make the venture succeed Central Bank NA v First Interstate BarzlG NA 1994 511 US<br />
164 Mere fumishing <strong>of</strong> company to a person engaged in a crime does not render a companion<br />
an aider or abettor United States v Garguilo 2d Cir 1962 310F2d 249 In order for a<br />
defendant to be an aider and abettor he must know that the activity condemned by law is actually<br />
occurring and must intend to help the perpetrator United States v McDaniel 9th Cir 1976<br />
545 F2d 642 To be guilty <strong>of</strong> aiding and abetting the defendant must willfully seek by some<br />
action <strong>of</strong> his own to make a criminal venture succeed United States v EhrenbergED Pa<br />
1973 354 F Supp 460 cert denied 1974 94 S Ct 1612<br />
The question as posed may presume that the local legislative body has acted in a manner that<br />
affirmatively supports marijuana dispensaries As phrased by Senator Kuehl the question to be<br />
answered by the Attomey General s Office assumes that a local legislative body has adopted an<br />
ordinance that authorizes medical marijuana facilities What if a local public entity adopts an<br />
ordinance that explicitly indicates that it does not authorize legalize or permit any dispensary<br />
that is in violation <strong>of</strong> federal law regarding controlled substances lf the local public entity<br />
grants a permit regulates or imposes locational requirements on marijuana dispensaries with the<br />
announced understanding that it does not thereby allow any illegul activity and that dispensaries<br />
are required to comply with all applicable laws including federal laws then the public entity<br />
should be entifled to expect that all laws will be obeyed<br />
It would seem that a public entiYy is not intentionally acting to encourage or aid acts in violation<br />
<strong>of</strong> the CSA merely because it has adopted an ordinance which regulates dispensaries even the<br />
issuance <strong>of</strong>apermit if it is expressly not allowing violations <strong>of</strong> federallaw cannot necessarily<br />
support a charge or conviction <strong>of</strong> aiding and abetting violation <strong>of</strong> the CSA A public entity<br />
should be entitled to presume that dispensaries will obey all applicable laws and that lawful<br />
business will be conducted at dispensaries For instance dispensaries could very well not engage<br />
in actual medical marijuanadish but instead engage in education and awareness activities<br />
as to the medical effects <strong>of</strong> marijuana the sale <strong>of</strong> other legal products that aid in the suffering <strong>of</strong><br />
OO 2009 California Police Chiefs Assn 34 All Rights Reserved
ailing patients or even activifies directed at effecting a change in the federal laws relating to<br />
regulation <strong>of</strong> marijuana as a Schedule I substance under the CSA<br />
These are examples <strong>of</strong> legitimate business activities and First Amendment protected activities at<br />
that in which dispensaries could engage relating to medical marijuana but not apparently in<br />
violation <strong>of</strong> the CSA Public entities should be entitled to presume that legitimate activities can<br />
and will be engaged in by dispensaries that are permitted and or regulated by local regulations<br />
In fact it seems counterintuitive that local public entities within the state should be expected to<br />
be the watchdogs <strong>of</strong> federal law in the area <strong>of</strong> controlled substances at least local public entities<br />
do not have an affirmative obligation to discem whether businesses are violating federal law<br />
The California Attorney General s Office will note that the State Board <strong>of</strong> Equalization BOE<br />
has already done precisely what has been suggested in the preceding paragraph In a special<br />
notice issued by the BOE this year it has indicated that sellers <strong>of</strong> inedical marijuana must obtain<br />
a seller<br />
permit Seehttp www boe ca gov news<br />
medse11er2007 pdf Special Notice<br />
Important Information for Sellers <strong>of</strong> Medical Marijuana As the Special Notice explicitly<br />
indicates to medical marijuana facilitieshaving a seller<br />
permit does not mean you have<br />
authority to make unlawful sales The permit only provides a way to remit any sales and use<br />
taxes due The pennit states NOTICE TO PERMITTEE You are required to obey all federal<br />
and state laws that regulate or control your business This permit does not allow you to do<br />
otherwise<br />
The above being said however there is no guarantee that criminal charges would not actually be<br />
brought by the federal government or that persons so charged could not be successfully<br />
prosecuted It does seem that arguments contrary to the above conclusions could be persuasive<br />
in convicting local legislators By permitting and or regulating marijuana dispensaries by local<br />
ordinance some legitimacy and credibility may be granted by governmental issuance <strong>of</strong> permits<br />
or authorizing and allowing dispensaries to exist or locate within a jurisdiction<br />
All <strong>of</strong> this discussion then simply demonstrates that individual board or council members can<br />
indeed be found criminally liable wtder federal law for the adoption <strong>of</strong> an ordinance authorizing<br />
and regulating marijuana dispensaries that promote the use <strong>of</strong> marijuana as medicine The<br />
actual likelihood <strong>of</strong> prosecution and its potential success may depend on the particulaz facts <strong>of</strong><br />
the regulation that is adopted<br />
a<br />
Of course the question arises as to how far any such liability be taken Where can the line be<br />
drawn between any permit or regulation adopted specifically with respect to marijuana<br />
dispensaries and other permits or approvals routinely and <strong>of</strong>ten ministerially granted by local<br />
public entities such as building permits or business licenses which are discussedir fi a If local<br />
public entities are held responsible for adopting an ordinance authorizing and or regulating<br />
marijuana dispensaries cannot local public entities also be subject to liability for providing<br />
general public services for the illegal distribution <strong>of</strong> medical marijuana Could a local public<br />
entity that knew a dispensary was dislributing medical marijuana in compliance with state law<br />
be criminally liable if it provided electricity water and trash services to that dispensary How<br />
can such actions really be distinguished from the adoption <strong>of</strong> an ordinance that authorizes and or<br />
regulates marijuana dispensaries<br />
O 2009 California Police Chiefs Assn 35 All Rights Reserved
B<br />
State Law<br />
Similarly under California law aside from the person who directly commits a<br />
crunina <strong>of</strong>fense no other person is guilty as a principal unless he aids and<br />
abets People v Dole 1898 122 Cal 486 People v Stein 1942 55 Cal App 2d<br />
417 A person who innocently aids in the commission <strong>of</strong> the crime cannot be found<br />
guilty People v Fredoni 1910 12 Cal App 685<br />
To authorize a conviction as an aider and abettor <strong>of</strong> crime it must be shown not<br />
only that the person so charged aided and assisted in the commission <strong>of</strong><br />
the <strong>of</strong>fense but also that he abetted the act that is that he criminally or with<br />
guilty knowledge and intent aided the actual perpetrator in the commission <strong>of</strong> the<br />
act People v Terman 1935 4 Cal App 2d 345 To abet another in<br />
commission <strong>of</strong> a crime implies a consciousness <strong>of</strong> guilt in instigating encouraging<br />
promoting or aiding the commission <strong>of</strong> the <strong>of</strong>fense People v Best 1941 43 Cal App<br />
2d 00 Abet implies knowledge <strong>of</strong> the wrongful purpose <strong>of</strong> the perpetrator <strong>of</strong> the<br />
crime People v Stein sacpra<br />
To be guilty <strong>of</strong> an <strong>of</strong>fense committed by another person the accused must not only aid<br />
such perpetrator by assisting or supplementing his efforts but must with knowledge <strong>of</strong><br />
the wrongful purpose <strong>of</strong> the perpetrator abet by inciting or encouraging him People v<br />
Le Grant 1946 76 Cal App 2d 148 72 People v Carlson 1960 177 CaL App 2d<br />
201<br />
The conclusion under state law aiding and abetting would be similar to the analysis above under<br />
federal law Similar to federal law immunities available to local legislators discussed above<br />
state law immunities provide some protection for local legislators Local legislators are certainly<br />
immune from civil liability relating to legislative acts it is unclear however whether they would<br />
also be immune from criminal liability Sterner v Superior Court 50Ca1 App 4th 1771<br />
assuming but finding no California authority relating toacriminal exception to absolute<br />
immunity for legislators under state law Given the apparent state <strong>of</strong> the law local egislators<br />
could only be certain that they would be immune from civil liability and could not be certain that<br />
5 Although the Steiner Court notes thatwell<br />
established federal law supports the exception<br />
when federal case authority is applied in a state law context there may be a different outcome<br />
Federal authorities note that one purpose supporting criminal immunity as to federal legislators<br />
from federal prosecution is the separation <strong>of</strong> powers doctrine which does not apply in the<br />
context <strong>of</strong>federal criminal prosecuYion <strong>of</strong> local legislators However if a state or county<br />
prosecutor brought criminal charges against a local legislator the separation <strong>of</strong> powers doctrine<br />
may bar such prosecution CaL Const art III sec 3 As federal authorities note bribery or<br />
other criminal charges that do not depend upon evidence <strong>of</strong> and cannot be said to further any<br />
Iegislative acts can still be prosecuted against legislators SeeBr v Riddle 4th Cir 1980<br />
631 F2d 272 279 Illegal acts such as bribery are obviously not in aid <strong>of</strong> legislative activity<br />
and legislators can claim no immunity for illegal acts United States v Brewster 408 US 501<br />
indictment for bribery not dependent upon how legislator debated voted or did anything in<br />
chamber or committee prosecution need only show acceptance <strong>of</strong> money for promise to vote<br />
not carrying through <strong>of</strong> vote by legislator United States v Swi sdallllth Cir 1992 971 F2d<br />
O 2009 California Police Chiefs Assn 36 All Rights Reserved
they would be at all immune from criminal liability under state law However there would not<br />
be any criminal violation if an ordinance adopted by a local public entity were in compliance<br />
with the CUA and the MMPA An ordinance authorizing and regulating medical marijuana<br />
would not by virtue solely <strong>of</strong> its subject matter be a violation <strong>of</strong> state law only if the ordinance<br />
itself permitted some activity inconsistent with state law relating to medical marijuana would<br />
there be a violation <strong>of</strong> state law that could subject local legislators to criminal liability under state<br />
law<br />
QUESTION<br />
3 If the governing body <strong>of</strong> a city city and county or county approves an ordinance<br />
authorizing and regulating marijuana dispensaries to iinplement the<br />
Compassionate Use Act <strong>of</strong> 1996 and the Medical Marijuana Program Act and<br />
subsequently a particular dispensary is found to be violating state law regarding<br />
sales and trafficking <strong>of</strong> marijuana could an elected <strong>of</strong>ficial on the goveming body<br />
be guilty <strong>of</strong> state criminal charges<br />
ANSWER<br />
3 Afrer adoption <strong>of</strong> an ordinance authorizing or regulating marijuana dispensaries<br />
elected <strong>of</strong>ficials could not be found criminally liable under state law For the<br />
subsequent violation <strong>of</strong> state law by a particular dispensary<br />
ANALYSIS<br />
Based on the state law provisions referenced above relating to aiding and abetting it does not<br />
seem that a local public entity would be liable for any actions <strong>of</strong> a marijuana dispensary in<br />
violation <strong>of</strong> state law Since an ordinance authorizing andlor regulating marijuana dispensaries<br />
would necessarily only be authorizing and or regulating to the extent already permitted by state<br />
law local elected <strong>of</strong>ficials could not be found to be aiding and abetting a violation <strong>of</strong> state law<br />
In fact the MMPA clearly contemplates local regulation <strong>of</strong> dispensaries Cal Health Safety<br />
Code sec 11362 83 Nothing in this article shall prevent a city or other local goveming body<br />
from adopting and enforcing laws consistent with this article Moreover as discussed above<br />
there may be legislative immunity applicable to the legislative acts <strong>of</strong> individual elected <strong>of</strong>ficials<br />
in adopting an ordinance especially where it is consistent with state law regarding marijuana<br />
dispensaries that dispense crude marijuana as medicine<br />
1531 1549 evidence <strong>of</strong> legislative acts was essential element <strong>of</strong> pro<strong>of</strong> and thus immunity<br />
applies Therefore a criminal prosecution that relates solely to legislative acts cannot be<br />
maintained under the separation <strong>of</strong> powers rationale for legislative immunity<br />
O 2009 California Police Chiefs Assn 37 All Rights Reserved
QUESTION<br />
4<br />
Does approval <strong>of</strong> such an ordinance open the jurisdictions themselves to civil or<br />
criminal liability<br />
ANSWER<br />
4<br />
Approving an ordinance authorizing or regulating marijuana dispensaries may<br />
subject the jurisdicrions to civil or criminal liability<br />
ANALYSIS<br />
Under federal law criminal liability is created solely by statute Dowling v United States<br />
1985 473 US 207 213 Although becoming more rare municipalities have been and still<br />
may be criminally prosecuted for violations <strong>of</strong> federal law where the federal law provides not<br />
just a penalty for imprisonment but a penalty for monetary sanctions See Green Stuart P The<br />
Criminal Prosecution <strong>of</strong>Local Governments 72NC L Rev 1197 1994 discussion <strong>of</strong> history<br />
<strong>of</strong> inunicipal criminal prosecution<br />
The CSA prohibits persons from engaging in certain acts including the distribution and<br />
possession <strong>of</strong> Schedule I substances <strong>of</strong> which marijuana is one 21USC sec 841 A person<br />
for purposes <strong>of</strong> the CSA includes any individual corporation government or govermnental<br />
subdivision or agency business trust partnership association or other lega entity 21CFR<br />
sec 1300 01 34 See also 21CFR sea 1301 02 Any term used in this part shall have the<br />
definition set forth in section 102 <strong>of</strong> the Act 21USC 802 or part 1300 <strong>of</strong> this chapter By<br />
its very terms then the CSA may ba violated by a local public entity If the actions <strong>of</strong> a local<br />
public entity otherwise satisfy the requirements <strong>of</strong> aiding and abetting a violation <strong>of</strong> the CSA as<br />
discussed above then local public entities may indeed be subject to criminal prosecution for a<br />
violation <strong>of</strong> federal law<br />
Under either federal or state law local public entities would not be subject to civil liability for<br />
the mere adoption <strong>of</strong> an ordinance a legislative act As discussed above local legislators are<br />
absolutely immune from civil liability for legislative acts under both federal and state law In<br />
addition there is specific immunity under sfafe law relafing fo any issuance or denial <strong>of</strong> permits<br />
QUESTION<br />
5<br />
Does the issuance <strong>of</strong> a business license to a marijuana dispensary involve any<br />
additional civil or criminal liability far a city or county and its elected governing<br />
body<br />
ANSWER<br />
5 Local public entities will likely not be liabla for the issuance <strong>of</strong> business licenses<br />
to marijuana dispensaries that plan to dispense crude marijuana as medicine<br />
OO 2009 California Police Chiefs Assn 38 All Rights Reserved
ANALYSIS<br />
Business licenses are imposed by cities within the State <strong>of</strong> Califomia <strong>of</strong>tentimes solely for<br />
revenue purposes but are permitted by state law to be imposed for revenue regulatory or For<br />
both revenue and regulatory purposes Cal Gov Code sea 37101 Assuming a business<br />
license ordinance is for revenue purposes only it seems that a local public entity would not have<br />
any liability for the mere collection <strong>of</strong> a tax whether on legal or illega activities However any<br />
liability that would attach would be analyzed the same as discussed above In the end a local<br />
public entity could hardly be said to have aided and abetted the distribution or possession <strong>of</strong><br />
marijuana in violation <strong>of</strong> the CSA by its mere collection <strong>of</strong> a generally applicable tax on all<br />
business conducted within the entity s jurisdiction<br />
OVERALL FINDINGS<br />
All <strong>of</strong> the above further exemplifies the catch 22 in which local public entities are caught in<br />
trying to reconcile the CUA and MMPA on the one hand and the CSA on the other In light <strong>of</strong><br />
the existence <strong>of</strong> the CUA and the MMPA and the resulting fact that medical marijuana is being<br />
used by individuals in California local public entities have a need and desire to re ulate fhe<br />
location and operation <strong>of</strong> inedical marijuana facilities within their jurisdiction 6 io<br />
However because <strong>of</strong> the divergent views <strong>of</strong> the CSA and Califomia law regarding whether there<br />
is any accepted medical use <strong>of</strong> marijuana state and loca legislators as well as local public<br />
entities themselves could be subject to criminal liability for the adoption <strong>of</strong> statutes or<br />
ordinances furthering the possession cultivation distribution transportation and other act<br />
prohibited under the CSA as to marijuana Whether federal prosecutors would pursue federal<br />
criminal charges against state and or local legislators or local public entities remains to be seen<br />
But based on past practices <strong>of</strong> locally basedUS Attorneys who have required seizures <strong>of</strong> large<br />
amounts <strong>of</strong> marijuana before federal filings have been initiated this can probably be considered<br />
unlikely<br />
6 Several compilations <strong>of</strong> research regarding the impacts <strong>of</strong> marijuana dispensaries have been<br />
prepared by the California Police Chiefs Association and highlight some <strong>of</strong> the practical issues<br />
facing local public entities in regulating these facilities Links provided are as fol2ows<br />
Riverside County Office <strong>of</strong> the District AfYorney White Paper Medical Marijuana History<br />
and Current Complications September2006 Recent Information Regarding Marijuana and<br />
Dispensaries EI Cerrito Police Department Memorandum dated January 12 2007 from<br />
Commander M Regan to Scott C Kirkland Chief <strong>of</strong> Police Marijuana Memorandum El<br />
CerriTO Police Department Memorandum dated April 18 2007 from Commander M Regan to<br />
Scott C Kirkland Chief <strong>of</strong> Police Law Enforcement Concerns to Medical Marijuana<br />
Dispensaries Impacts <strong>of</strong> Medical Marijuana Dispensaries oncom nunities between 75 000 and<br />
100 000 population Survey and council agenda report <strong>City</strong> <strong>of</strong> Livermore<br />
O 2009 California Police Chiefs Assn 39 All Rights Reserved
CONCLUSIONS<br />
In light <strong>of</strong> the United States Supreme Court s decision and reasoning in Gonzales v Raich<br />
the United States Supremacy Clause renders Califomia s Compassionate Use Act <strong>of</strong> 1996<br />
and Medical Marijuana Program Act <strong>of</strong> 2004 suspect No state has the power to grant its<br />
citizens the right to violate federal law People have been and continue to be federally<br />
prosecuted for marijuana crimes The authors <strong>of</strong> this White Paper conclude that medical<br />
marijuana is not legal under federal law despite the current California scheme and wait for<br />
the United Stafes Supreme Court to ultimately rule on this issue<br />
Furthermore storefront mazijuana businesses are prey for criminais and create easily<br />
identifiable victuns The people growing marijuana are employing illegal means to protect<br />
their valuable cash crops Many distributing marijuana are hardened criminals Several<br />
are members <strong>of</strong> stepped criminal street gangs and recognized organized crime syndicates<br />
while others distributing marijuana to the businesses are perfect targets for thieves and<br />
robbers They are being assaulted robbed and murdered Those buying and using medical<br />
marijuana are also being victimized Additionally illegalso called medical marijuana<br />
dispensaries have the potential for creating liability issues for counties and cities All<br />
marijuana dispensaries should generally be considered illegal and should not be permitted to<br />
exist and engage in business within a county s or city s borders Their presence poses a clear<br />
violation <strong>of</strong> federal and state law they invite more crime and they compromise the health<br />
and welfare <strong>of</strong>law abiding citizens<br />
O 2009 California Police Chiefs Assn 40 All Rights Reserved
ENDNOTES<br />
US Const art VI cl 2<br />
US Const art I sec 8 cl 3<br />
Gonzales v Raich 2005 125 SCt 2195 at p 2204<br />
Gonzales v Raich See also United States v Oakland Cannabis Btryers Cooperative 2001 121 SCt<br />
1711 1718<br />
Gonzales v Raich 2005 125 SCt 2195 see also lnited Slates v Oakland Cannabis Buyers<br />
Cooperative 121 SCt 1711<br />
6 Josh Meyer Scott GloverUS won t prosecute medical pot sales Los Angeles Times 19 March<br />
2009 available athwww latimes com news local lame medpotl9<br />
2009mar19 04987571 story<br />
See People v Mower 2002 28 Cal 4th 457 463<br />
e Health and Safety Code section ll362 5b 1 A All references hereafrer o the Health and Safety<br />
Code are by section number only<br />
9HS Code sec 113625 a<br />
10HS Code sec I 1362 7 et seg<br />
HS Code sec 11362 7<br />
HS Code secs 71 11362 76<br />
13 HS Code sec 11362 77<br />
14HS Code secs 11362 765 and 11362 775 People v Urziceanu 2005 132 Cal App 4 747 at p 786<br />
15 HS Code sec 11362 77 whether or no this section violates the Califomia ConstiNtion is currendy<br />
under review by the California Supreme Court See People v Kelly 2008 82 Ca1 Rptr3d 167 and People<br />
v Pbomphakdy 2008 SS Cal Rptr 3d 693<br />
16 HS Code secs 11357 11358 11359 1136Q 11366 11366 5 and 11570<br />
HS Code sea ll362 7h gives a more comprehensive list AIDS anorexia arthritis cachexia<br />
cancer chronic pain glaucoma migraine persistent muscle spasms seizures severe nausea and any other<br />
chronic or persistent medical symptom that either substantially limits the ability <strong>of</strong> a person to conduct one<br />
or more lifeac ivities as defined in the ADA or may cause serious harm to the patien s safery or physical<br />
or mental health if not alleviated<br />
1e People v Mower 2002 28 CalAth 457 at p 476<br />
19 Id Emphasis added<br />
Packel Organization and Operation <strong>of</strong>Cooperatives Sth ed Philadelphia American Law Institute<br />
1970 45<br />
Sam Stanton Pot C1ubs Seized Plants NewPresiden Manjuana<br />
Future ls Hazy Sacramendo<br />
Bee 7 December 2008 19A<br />
For a statewide list seehttp canortnl org prop cbclist html<br />
Laura McClure Fuming Over the Pot Clubs Califa nia Lawver Magazine Sune 2006<br />
HS Code sec 11362 765 c see eg People v Urziceanu 132Cal AppAth 747 at p 764<br />
Gonzales v Raieh supru 125 SCt at page 2195<br />
People v C7i ziceanu 2005 132 Ca1 App 4th 747 see alsoHS Code sec 11362 765<br />
Israel Packel 45 Italics added<br />
HS Code sea 11362 7d1<br />
See eg McClure Fuming Over Pot Clubs CalifornraLawyerMagazine June 2006<br />
30HS Code secs 11362 5e and 11362J d123 and e see also People ez rel Lungren v Peron<br />
1997 59Cal App 4th 1383 1395<br />
People Mower 28 CalAth at 476 Emphasis added<br />
Glenda Anderson Laytonville Marijuana Guru Shot to Death 2 Others Beaten in Home No Suspeets but<br />
Officials Believe Killing Related to Pot Growing Santa Rosa Press Democrat 19 November 2005<br />
available athttp wwwl<br />
oressdemocrat com anps obcsdll article All 2001119 NEWSll 190303 1033<br />
33 Medical Marijuana Shop Robbed Santa Barbm<br />
Indepeiident 10 August 2006 available a<br />
httn<br />
independentcom news 2006 a ue10 med ieaIma riiuana shon robbed<br />
34 Mark Scaramella No Good Deed Goes Unpunished Anderson Valley Adverziser 16 June 2004<br />
available athttp www theava com 04 0616 cerelli hfiil<br />
OO 2009 California Police Chiefs Assn 41 All Rights Reserved
js Ricci Graham Police Arrest Suspeci in Deadly San Leandro Pot Club Robbery OaklandTi ibfane S<br />
August 2006 available athttn findarticles com oarticles mi qn4176 is 20060808 ai n16659257<br />
ab Ricci Graham Man Faces Murder Charge in Pot Robbery Oaklaiid Tribime 24 August 2005<br />
available athwww hisl beam com doc 1P2 7021933 html<br />
3 Ricci Graham Another Medical Marijuana Clinic Robbed Oqkland Tribune 10 September 2005<br />
availableathttp findarticles com particles mi an4176 is 20050910 ai n158091 9print<br />
3s Laura Clark Po Dispensary Owner Slain at Home Ckiah DailyJourna I9 November 2007 available at<br />
hwww mariivana com drue war headline news 24910 ca pot dispensarv<br />
ownervslain home html<br />
3B Laura Clark Breaking News Medical Marijuana Supplier Les Crane Killed Ukiah DailyJow 19<br />
November 2005 Laura Clark Les Crane Murder Imestigation ContinuesLkiah Daily Journal 27<br />
November 2005 Glenda Anderson Laytonville Marijuana Guru Shot to Death Santa Rosa Po<br />
Democrat 19 November 2005 Glenda Anderson Pot Activist Likely Knew Killers Police Believe Gunmen<br />
Who Robbed Laytonville Man Familiar With Home Sant Rosa Press Democrat 20 November 2005<br />
available athttn www eaualri hts4all us<br />
contenUview 192 50<br />
40 Mark Scaramella The Mendo Pot Chronicles Anderson Valley Advertiser 3 Oc ober 2007 available at<br />
htto wwwtheava com 04 0616 cerellihtm I<br />
41 Kirk Johnson Killing Highlights Risk <strong>of</strong> Selling Marijuana Even Legally New York Times 13 March<br />
2007 available at<br />
httpJ www vtimescoml2007 03<br />
us<br />
02cannabishtml ex 1 I81880000 en<br />
c609936094adda 0ei 5070<br />
Tami Abdollah Richard Winron Po Theft Claimed in Boy s Shooting Death Los Angeles Times 23<br />
January 2007 available at<br />
http www californiavolicechiefs ore nav tiles mariivana filesibellflower shootine dea h odf<br />
43 Will Bigham Claremont Marijuana Dispensary BurglarizedIn and Valley Daily Bulletin 27 January 2007<br />
available athttp www<br />
dailvbulletin wn ci 5104514<br />
Planning Commission Agenda available athttp www el eelrito ore see also Ala Lopez E Cerri o<br />
Moves to Ban Dispensaries ConG Costa Times 24 June 2006 available at<br />
httpwwwthc m in istrvneUforum a rchive el cerritomoves<br />
bancamiab isclubs 6974 htm<br />
45 Pred Ortega <strong>City</strong> Bans Outlets for Medical Marijuana San Gabriel ValleyTi ibune 17 August 2006<br />
available at<br />
http www lca uk ore Icaforum viewtooic php f6t2436 stam0 sid 1566da l 15 a0da43 facb 17644195cbb<br />
46 Ortega<br />
47 Greg Beato Pot Clubs in Peril Are San Francisco Zoning Boards a Bigger Threat to Medical Manjuana<br />
Than de DEA Reason Magazine February 2007 available at<br />
httwww reason eom news show 118314 html Craig T Steckler Ciry <strong>of</strong>Fremont Police Depm tment<br />
1lemoranderm re Medicnl Marijunnn Dispensaries Potentia Secondarv Impacts 20 June 2006 Tim<br />
Miller Ciry <strong>of</strong>Anaheim Police Department Special Operations Division Memoranduin re Medical<br />
Mar yuana Dispensary MMD Ban Ordinance 13 June 2007<br />
48 Jeff McDonald 15 Held in Raids on Pot Stores San Diego Union Tribune 7 July 2006 available at<br />
http<br />
wwwsienonsandieeo com uniontrib 20060707 news 7m7not html<br />
49 McDonald Beato<br />
i0 CaL HS Code sec 11362 5<br />
Ethan Stewart The Medical Marijuana Movemen Grows in Santa Barbara Emerald Dreams and<br />
Smoky Realities Santa Barbmn Lzdependent 3 May 2007 available at<br />
http<br />
independentcom new5i2007 mav 03 medical mariivaua movement erows santa barbara see also<br />
Adam Ashton DEA Busts Pot Store Day After Council Talk Modesto Bee 28 September 2006<br />
5 McDonald<br />
Stewart<br />
54 Stewart<br />
5i Stewart<br />
sb National DrugIn elligence Center Domesttc Cannabis Cultivation Assessment 2007 Pebruary 2007<br />
available athttu www usdoj<br />
ovMdidoubs2l 224R6 Jaxon Van Derbeken Charlie Goodyear Rachel<br />
Gordon 3 SF Pot Clubs Raided in Probe <strong>of</strong> Organized Cnme San Francisco Chronicle 23 June 2005<br />
available athttp www sfgate con cgi bin article egi file ca2005 06 23<br />
MNGRODDG321 DTL<br />
LAPD report information 2007<br />
O 2009 California Police Chiefs Assn 42 All Rights Reserved
5 Van Derbeken et al<br />
58 Kate Heneroty Medical marijuana iudictment unsealed Jtn ist 24 June 2005 available at<br />
http iurisLlaw pitt edu<br />
paperchase 2005 06 medical marijuana indic ment unsealed hp Sacy Finz 19<br />
Named in Medicinal Pot Indictment More Than9300 Marijuana PlanLS Were Seized in Raids San<br />
Francisco Chroiiicle 24 June 2005 available at<br />
hsfeate condcgi bii article cei file ca2005 06 24<br />
BAGV9DEC4C1 DTL<br />
5 Organized Crime Bahind Medical Marijuana Dispensary in Califomia Pushirigback 29 September 2006<br />
available athttp<br />
pushineback com bloas pushinaback archive 2006 09 29 791 asox Ashton<br />
bo <strong>City</strong> <strong>of</strong> San Diegq Crame Stanstics 2007 available athtto www sandieeo eov<br />
61 National Drug Intelligence Center Marijuano January 2001 available athttp www usdoi eov<br />
b George Anastasia Viet Gangs on the Rise Agaic The Emergiug American Underworld angs<br />
Plant filled Houses a Growing Part <strong>of</strong> Drug Trade Chronrcle <strong>of</strong>Boredom 18 Apri1200 7<br />
63 W ill Bigham Houses Linked to Asian Gangs Inland Valley DailyBu letin 23 September 2007<br />
available ahttn www<br />
dailvbulletin eom newsci 6980682<br />
ba Bigham 23 September 2007<br />
bs Feds Came and Went Now What Humboldt County News 30 June 2008 available at<br />
http new s hum co untvcom archives 2008 6<br />
06 LAPD Report NumberDR<br />
060625000 16 August 2006<br />
6 LAPD Report NumberDR<br />
060625001 16 August 2006<br />
bs Tim Miller Ciry <strong>of</strong>Anaheim Police Department Special Opera ions Division Memorandum re<br />
Marijuana Dispensary MMD Ban Ordinance 25 October 2006 Johnson Gaig T Steckler <strong>City</strong> <strong>of</strong><br />
Fremon Police Department Memorandum re Medical Marijuana Dispensaries Potential Secondary<br />
Impacts 20 June 2006<br />
09 Stewart<br />
Johnson<br />
Ashton<br />
What has the US DEA said about medical marijuana Medical Marijua ProCon org 2005 What<br />
has federal law enforcement said about medica marijuana Medical Marijuana ProCoaorg 2009<br />
available athmedicalmariivanaprocon ore<br />
viewanswersasp questionlD 000630<br />
Jim Avila Marijuana McMansions Cops Say Organized Crime Is Sending Families Into the Suburbs to<br />
Grow Marijuana ABC News 14 June 2007 available athttp abenews eo con print id 3242760<br />
Avila Anastasia DEA Raids Miami Grow House CBSS com 30 April 2008 available a<br />
hUcbsS com<br />
nationaUdea raid miami 2 712958 html<br />
Anastasia<br />
Bigham 23 September 2007Ehan Baron Angel Linked to Grow op The Prorince CNBC 21 May<br />
2005 availableat hvww mapine ore ewstcl v05 n823 a02 html<br />
Bigham 23 September 2007<br />
Bigham 23 September 2007<br />
Hea her Allen Marijuana Grow Houses Flourish as Southwest Florida Marke Drops IieraldTribune com 24 July<br />
2007 available athcom article<br />
20070724MEWS<br />
70724049R<br />
80 Eric Bailey and Tim Reiterman Where Mary Jane is the girl next door Los Angeles Times 31 May<br />
20D8 available athttp articles latimes com 2008 mav 31local me root31<br />
81 Eureka House Fire the Result <strong>of</strong>You know wha Humboldt Cowtry News 7 September 2008 available<br />
athttp news humcountv com written remarks <strong>of</strong> Arcata Police Chief Randy Mendosa 1 March 2009<br />
e Jesse McKinley Marijuana Hotbed Retreats on Medicinal Use New York Times 9 June 2009<br />
availableathttp www ytimes com 2008 06 09 us pot hmlr1em ex 1213329<br />
83 Deputies Fire Damages Holiday Marijuana Grow Home tampabay com 15 February 2008 available at<br />
hbloestampabav com<br />
breakinenews 2008 02 hoidav fire ma html<br />
ft4 Don Ruane Grow Houses Can Impact Utility Bills Public SafetyNews press com 12 April 2008<br />
available at<br />
www news nress com aous abes dll artiele AID 200R0412 NEWS0103<br />
804120394<br />
ei DEA Raids Miami Grow House<br />
86 Sandy Louey Arrests Take Toll onIocal Gang The Sacramento Bee 14 August 2008 available at<br />
http<br />
wwwsacbee com elk rove voinUstorv 1152310 html<br />
Avila<br />
OO 2009 California Police Chiefs Assn 43 All Rights Reserved
88 Scott Glover Morro Bay Pot Dispensary Owner Found Guilty <strong>of</strong> Federal Charges Los Angeles Times 6<br />
August 2008 available ahttp articles latimes com 2008 aue 06 locaUme pot6<br />
B Bailey and Reiterman<br />
90 Janis Ramsay Special Report Grow op House Can Still Be Dream Home Realtor Says The Bmrie<br />
Advance 25 August 2008 available athttp www maoine or dru news v08 n818 a06 html<br />
91 Avila<br />
Bailey and Reiterman<br />
93 Steve Davis Grow Securiry Cannabis Culture Mugazine 6 August 2004 available at<br />
httn www eannab isculturecom articles 3441 html<br />
94 Bailey andRei erman<br />
9 See People v Urziceanu 132Cal App 4th 747<br />
96 <strong>City</strong> <strong>of</strong> Pleasant Hill Presentation to Its Planning Commission by Planning Division Staff on April 24 2007<br />
B4 Office Consolidation By law 361 2004 <strong>of</strong> the <strong>City</strong> <strong>of</strong> Brampto Ontario Canada<br />
98 Bi11 McCollum Landmark Bill Targeting Marijuana Grow Houses Becomes Law Attomey General Bill<br />
McCollum News Release 17 June 2008 available at<br />
http<br />
myfloridalegaLcom<br />
nsf<br />
newsreleases<br />
AFAE7E2BCC16SSD15525746B0070D23B<br />
9B Asian Gangs Move Grow ops The Asian Pacific Post 27 September 2007 available at<br />
http www asianoacificoostcom portal2<br />
ftk080811548063f0115482401d00003 asian eanas move<br />
ops do html<br />
ioo See Asian Gangs Move Grow ops<br />
101 See Does Marijuana Con ribute to Psychotic Ilinesses Current Psychiany Online62 February 2007<br />
10 See eghttp www<br />
californiaroolicechief<br />
ore navfiles research ordinances html<br />
1 National Drug Intelligence Center<br />
row<br />
OO 2009 California Police Chiefs Assn 44 All Rights Reserved
NON LEGAL REFERENCES<br />
Abdollah Tami and Richazd Winton Pot Theft Claimed in Boy s Shooting Death<br />
Los Angeles Times 23 January 2007 Retrieved January 8 2009 from<br />
http www<br />
californiapolicechiefs oranv files marijuana files bellflower shooting<br />
Allen Heather Marijuana Grow Houses Flourish as Southwest Florida Market Drops<br />
HeraldTribune com 24 July 2007 Retrieved January 9 2009 from<br />
http www<br />
heraldtribune com article 20070724 NEWS707240498<br />
Anastasia George Viet Gangs on the Rise Again The Emerging American<br />
Underworld Gangs Plant filled Houses a Growing Part <strong>of</strong> Drug Trade<br />
Chronicle <strong>of</strong>Boredom 18 April 2007 Retrieved January 8 2009 from<br />
httn wwwxanQa com tihailua<br />
584859568 viet gangs on tl erise ain html<br />
Anderson Glenda Laytonville Mazijuana Guru Shot to Death 2 Others Beaten in<br />
Home Santu Rosa Press Democr at 19 November 2005 Retrieved January 8<br />
2009 from<br />
http wwwlpressdemocrat com apsnbcs dll article AID 200511 l9NEWS51 I 190303<br />
Anderson Glenda Pot Activist Likely Knew Killers Police Believe Gunmen Who<br />
Robbed Laytonville Man Familiar With Home Santa Rosa Press Dernocrat<br />
20 November 2005 Retrieved January 8 2009 from<br />
htto www equalri ghts4a11us<br />
contenUview192 50<br />
Ashton Adam DEA Busts Pot Store Day After Council Talk Modesto Bee<br />
28 September 2006<br />
Asian Gangs Move Grow ops The Asian Pacific Post 27 September 2007 Retrieved<br />
January 8 2009 from<br />
http www<br />
asiannacificpost coin porta12<br />
ff8080811548063f0115482401d00003 asian ganQs<br />
move erow ons do html<br />
Avila Jim Marijuana McMansions Cops Say Organized Crime Is Sending Fainilies Into<br />
the Suburbs to Grow Marijuana ABC News 14 June 2007 Retrieved January 8 2009<br />
fromhttp abcnews QO com print id 3242760<br />
Bailey Eric and Tim Reiterman Where Mary Jane Is the Girl Next Door LosAr geles Times<br />
31 May 2008 Retrieved January 8 2009 from<br />
http aticleslatimes com 2008 mav<br />
local<br />
pot31<br />
Baron Ethan Angel Linked to Grow op The Province CNBC 22 May 2005 Retrieved<br />
January 8 2009 fromhtto www mapinc or newstcl v05 n823 a02 html<br />
OO 2009 California Police Chiefs Assn 45 All Rights Reserved
Beato Greg Pot clubs in peril Are San Francisco Zoning Boards a Bigger Threat to Medical<br />
Marijuana Than the DEA Reason Magazine February 2007<br />
Retrieved January 8 2009 fromhwww reason com news show 118314 hmi1<br />
Bigham Will Claremont Marijuana Dispensary Burglarized Inla zd Vulley<br />
Daily Bulletin 27 January 2007 Retrieved January 9 2009 from<br />
http www<br />
dailvbulletin com ci 5104514<br />
Bigham Will Houses Linked to Asian Gangs Inland Valley Daily Bedletin<br />
23 September 2007 Retrieved January 8 2009 from<br />
http www<br />
dailybulletin com newsci 6980682<br />
Brown Edmund G Jr Guidelines foitze Security andNon Diversion <strong>of</strong>Marijuana Grown<br />
for Medical Use August 2008<br />
<strong>City</strong> <strong>of</strong> Pleasant Hill Presentation to Its Planning Commission by Planning Staff<br />
April 24 2007<br />
<strong>City</strong> <strong>of</strong> San Diego Crime Statistics 2007 Retrieved January 9 2009 from<br />
http www sandieeo eov<br />
Clark Laura Breaking News Medical Marijuana Supplier Les Crane Killed Zlkiah Daily Journal<br />
19 November 2005<br />
Clark Laura Les Crane Murder Invesrigation Continues Llkiah Daily Journal 27 November 2005<br />
Clark Laura Pot Dispensary Owner Slain at Home Ukaih Daily Joacrnal<br />
19 November 2005 Retrieved January 9 2009 from<br />
http www mariivana com dru war headline news 24910 ca vot disnensaiv owner slain home html<br />
Davis Steve Grow Security Cannabis Cu ture Magazine 6 August 2004 Retrieved<br />
January 8 2009 fromhttp www<br />
cannabisculture com articles 3441 htm1<br />
DEA Raids Miami Grow House CBS News 30 Apri12008 Retrieved January 8 2009<br />
fromhttp cbs5 com national dea raid miami 2712958 htm1<br />
Deputies Fire Damages Holiday Marijuana Grow House tampabay com 15 February 2008<br />
Retrieved January 8 2009 from<br />
httnblo stampabay com breakin news 2008 02 holiday fire ma html<br />
Does Marijuana Contribute to Psychotic Illnesses Cu re zt Psychiatry Online62<br />
February 2007<br />
Eureka House Fire the Result <strong>of</strong>You know what Humboldt County News<br />
7 September 2008 Retrieved January 8 2009 fromhttp news humcountv com<br />
O 2009 California Police Chiefs Assn 46 All Rights Reserved
Now What Humboldt Counry News 30 June 2008 Retrieved<br />
January 8 2009 fromhttu news humcountv com archives 2008 6<br />
Feds Came and Went<br />
Finz Stacy 19 Named in Medicinal Pot Indictment More Than9300<br />
Marijuana Plants Were Seized in Raids Smi Francisco Chronicle 24 June 2005<br />
Retrieved Januazy 8 2009 from<br />
http sf ate com cei bin article cgi file ca2005 06 24<br />
BAGV9DEC4C1 DTL<br />
Glover Scott Morro Bay Pot Dispensary Owner Found Guilty <strong>of</strong> Federal Charges<br />
Los Ange es Times 6 August 2008 Retrieved January 8 2009 from<br />
lttn www latimes com news locaUla mepot6<br />
2008aue06 0516054 storv<br />
Graham Ricci Man Faces Murder Charge in Pot Robbery Oaklartd Tribune<br />
24 August 2005 Retrieved February 28 2009 from<br />
htto www hiEhbeam com doc 1P2 7021933 html<br />
Graham Ricci Another Medical Marijuana Clinic Robbed Oakland Tribiu2e<br />
10 September 2005 Retrieved February 24 2009 from<br />
htM findarticles com particles mi an4176 is 20050910 ai n15809189 nrint<br />
Graham Ricci Police Arrest Suspect in Deadly San Leandro Pot Club Robbery<br />
Oakland Tribune 8 August 2006 Retrieved February 24 2009 from<br />
http findarticles com particles mi gn4176 is 20060808 ai n16659257<br />
Heneroty Kate Medical Marijuana Indictment Unsealed Jurist 24 June 2005<br />
Retrieved January 8 2009 from<br />
http jurist law nitt edu<br />
panerchase 2005 06 medical mariivana indictment unsealed uhp<br />
Johnson Kirk Killing Highlights Risk <strong>of</strong> Selling Marijuana Even Legally<br />
New York Times 13 March 2007 Retrieved January 8 2009 from<br />
http www nvtimes com 2007 03<br />
us<br />
02cannabis html ex<br />
1181880000 en<br />
c609936094a<br />
dda50 ei 5070<br />
LAPD Report Information 2007<br />
LAPD Report NumberDR<br />
060625000 16 August 2006<br />
LAPD Report NumberDR<br />
060625001 16 August 2006<br />
Lopez Alan El Cemto Moves to Ban Cannabis Clubs Contrn Costa Times 6 January 2008<br />
Retrieved January 8 2009 from<br />
http www tho ministrv neUforum archive el cerrito moves<br />
ban cannabis clubs 6974 htm<br />
OO 2009 California Police Chiefs Assn 47 All Rights Reserved
Louey Sandy Arrests Take Toll on Local Gang 77ie Sacramento Bee 14 August 2008<br />
Rerieved January 8 2009 from<br />
httn<br />
wwwsacbee com elk rove vnrinUstorvll 52310 htm1<br />
McClure Laura Fuming Over the Pot Clubs California Lawyei Magazine June 2006<br />
McCollum Bill Landmark Bill Targeting Marijuana Grow Houses Becomes Law Attorney<br />
General Bill McCollum News Release 17 June 2008 Retrieved January 9 2009 from<br />
http<br />
mvfloridaleeal com<br />
nsf<br />
newsreleases<br />
AFAE7E2BCC 1688D 18525746B0070D23B<br />
McDonald Jef 15 Held in Raids on Pot Stores San Diego Union Tribune 7 July 2006<br />
Retrieved February 24 2009 from<br />
htto<br />
wwwsignonsandiego com uniontrib 20060707 news 7m7pot html<br />
McKinley Jesse Marijuana Hotbed Retreats on Medicinal Use New York Times 9 June 2008<br />
Retrieved March 19 2009 from<br />
httu www nvtimes com 2008 06<br />
us 09pot htmlr1em ex 1213329<br />
Medical Marijuana Shop Robbed Santa Barbara Independent 10 August 2006 Retrieved<br />
January 9 2009 from<br />
http<br />
independentcom news 2006 auQ0medical mariivana shon robbed<br />
Meyer Josh and Scott Glover US Won t Prosecute Medical Pot Sales 19 March 2009<br />
Retrieved March 21 2009 from<br />
http www latimes com news local lame medpot19 2009marI9 04937571 storv<br />
Miller Tim <strong>City</strong> <strong>of</strong>Anaheim Police Deparmzent Special Operations Division Memora zdum<br />
re Medical Marijuana Dispensary MMD Ban Ordinance 25 October 2006<br />
National Drug Intelligence Center Donzestic cannabis cultivation assessment 2007<br />
26 February 2007 Retrieved January 9 2009 from<br />
http www usdojgov ndic pubs2l 22486<br />
Office Consolidation By law 361 2004 <strong>of</strong> the Corporation <strong>of</strong> the <strong>City</strong> <strong>of</strong> Brampton<br />
22 November 2004<br />
Organized Crime Behind MedicaP Marijuana Dispensary in California Ptrshi sgback<br />
29 September 2006 Retrieved January 9 2009 from<br />
http<br />
com blovs pushineback archive 2006 09 29 791 as<br />
Ortega Fred <strong>City</strong> Bans Outlets for Medical Marijuana San Gabriel Valley Tribasne<br />
28 August 2006 Retrieved January 9 2009 from<br />
htt wwwlca<br />
uk ore lcafoium viewtopic hpf6t2436 staart 0sid 15b6da I 15a0da43 facb44195cbb<br />
OO 2009 California Police Chiefs Assn 48 All Rights Reserved
Packel Israel The Organization and Operation <strong>of</strong> Cooperatives 4 ed Philadelphia<br />
American Law Institute 1970<br />
Ramsay Janis Special Report Grow op House Can Still Be Dream Home Realtor Says<br />
The Barrie Advm2ce 25 August 2008 Retrieved January 9 2009 from<br />
httuwww mavincor druenews v08 n818 a06 htm1<br />
Ruane Don Grow Houses Can Impact Utility Bills Public Safety News press com<br />
12 Apri12008 Retrieved 7anuary 9 2009 from<br />
httn www news press com apps pbcs dll article AID 20080412 NEWS0103<br />
804120394<br />
Scaramella Mark The Mendo Pot Chronicles Anderson Yalley Advertiser 3 October 2007<br />
Retrieved January 9 2009 fromhttp www theavacom 07003 mend000t html<br />
Scaramella Mark No Good Deed Goes Unpunished Anderson Va ley Advertiser 16 Tune<br />
2004 Retrieved January 9 2009 fromhttu www theava com 04 0616 cerelli html<br />
Stanton Sam Pot Clubs Seized Plants New President Marijuana<br />
Future Is Hazy<br />
Saci an ento Bee 7 December 2008 19A<br />
Steckler Craig T <strong>City</strong> <strong>of</strong>FremontPolice DepartmentMemorandcnn re Medical Marijuana<br />
Dispensaries Potential Secondary Impacts 20 June 2006<br />
Stewart Ethan 2007 May 3 The Medical Marijuana Movement Grows in Santa Barbara<br />
Emerald Dreams and Smoky Realities Santa Bm bara Indepe 7dent 3 May 2007<br />
Retrieved January 9 2009 from<br />
http<br />
independentcom news 2007 mav 03 medica marijuana movement rows santa barbara<br />
Van Derbeken Jaxon Charlie Goodyear and Rachel Gordon 3 SF pot clubs raided in probe <strong>of</strong><br />
organized crime San Francisco Chronide 23 June 2005 Retrieved January 9 2009 from<br />
http wwwsfgate com cgi bin article cei file ca2005 06 23<br />
MNGRODDG321 DTL<br />
What has federal law enforcement said about medical marijuana Medical Marijuana<br />
ProCon org 2009 Retrieved February 24 2009 from<br />
httn<br />
medicalmariiuana procon ore<br />
viewanswers asp questionID 000630<br />
What has theUS DEA said about medical marijuana Medical Marijuana ProCon org 2005<br />
OO 2009 California Police Chiefs Assn 49 All Rights Reserved
MARIJ UANA DISPENSARI ES<br />
AND THE FEDERAL GOVERNMENT<br />
RECOMMENDATIONS TO THE<br />
OBAMA ADMiNISTRATION<br />
Z DO9
MARIJUANA DISPENSARIES<br />
AND THE FEDERAL GOVERNMENT<br />
RECOMMENDATIONS TO<br />
THE OBAMA ADMINISTRATION<br />
sr<br />
Fri<br />
o<br />
ds<br />
the<br />
DEA<br />
1tF C wr 4 V 4 f alJtt<br />
CADF1<br />
Californlans for Drug Free Youth<br />
1T<br />
ciwFORNiA<br />
fEACCDFFFCEI S<br />
ssbc nnoN<br />
Californians For DRUG FREE Schools<br />
DRUG<br />
T<br />
Q<br />
9<br />
Q<br />
FREE<br />
i<br />
Coalition to End Needless Death<br />
Y<br />
Drug Free<br />
1 on Our Boadways AMERICA<br />
C A L I F O R N I A<br />
Fuundatiun inc
Educating Voices<br />
educating about<br />
the dangers <strong>of</strong> drugs<br />
DNUG FREE SCHOOLS<br />
CQAL1770lJ<br />
HRDI<br />
Human Resources<br />
D2V210prt 2rlt II1StItUt2 IC<br />
INTERNATIONAL COALITION<br />
FOR DRUG DEMAND REDUCTIO<br />
International C Oregonians Against<br />
Scientific and 1 p M fl00d Co811f1011<br />
Legalization <strong>of</strong><br />
Medical Forum 1 111<br />
a<br />
ust one<br />
Aainsf Dru Crime<br />
Marijuana<br />
o<br />
O P 1NE0 C F<br />
lt J<br />
aN r<br />
Yx1<br />
9S SOC nT<br />
k<br />
National Dru Free v<br />
Sa<br />
Jt<br />
WOf Sp IICfgRCC qf W 1<br />
2ipAe NCPC<br />
North Coasul Prevevuon Coali on<br />
euct<br />
SAM DIEGO<br />
l c<br />
1<br />
SAN OIEGURO ALLIANCE<br />
4<br />
FOP OPUGFNEE YOV<br />
M1<br />
SDPC X<br />
n<br />
y<br />
f<br />
1<br />
y<br />
xecNnts<br />
PREVEfiTION<br />
s srcN<br />
COALITIOIV<br />
Sare Our Society From Drugs<br />
cNene<br />
AISO<br />
Dads Against Drug Dealers<br />
Drug Free Schools Coalition <strong>of</strong> New York<br />
Safe<br />
FORUM Fulfilling our Responsibility<br />
unto Mankind<br />
Safety Wellness Advocacy Community Coalition<br />
Approved Medicine for New Jersey
DEFINITIONS<br />
The terms cannabis and marijuana are used interchangeably in this paper to refer to the psychoactive<br />
material in either herbal or resinous form from the Cannobis genus <strong>of</strong> flowering plants<br />
The use <strong>of</strong> the terms medical marijuana and medical marijuana dispensaries in this paper should not be<br />
taken as conferring or acknowledging any validity to the use or distribution <strong>of</strong> cannabis for medical purposes
TABLE OF<br />
CONTENTS<br />
Introduction 6<br />
The Legal Status and Common Practices <strong>of</strong> Cannabis Dispensaries8<br />
Most Cannabis Dispensaries are Illegal Under State Medical Marijuana Laws8<br />
The Operation <strong>of</strong> Cannabis Dispensaries Will Not Generate Scientific Da Leading to a<br />
Meaningful<br />
Assessment <strong>of</strong> Cannabis based Medications<br />
io<br />
Cannabis Dispensaries May Put Seriously III Patients at Risk<br />
ii<br />
Cannabis Dispensaries May Take Advantage <strong>of</strong> Desperate Patients<br />
The Need for Regulatory Protections15<br />
Allowing a Proliferation <strong>of</strong> Cannabis Dispensaries Will Seriously Undercut the FDA Drug<br />
Approval System and Deprive Patients <strong>of</strong> Important Regula ory Protections 15<br />
The Requirements <strong>of</strong> the Food Drug and Cosmetic Act Reduce the Likelihood tha Patients<br />
Will be Exposed<br />
o Harmful or InefFective Products<br />
i5<br />
i4<br />
The Controlled Substances Act Plays a Critical Role in Ensuring hat Properly Tested<br />
Medications are Made Available for Appropriate<br />
Medical Use<br />
i6<br />
Under the CSA Schedule II Placement Does Not Make a Substance Available for Direct Use By Patients 17<br />
PDA Approval is Required in Order for a Specific Finished Medication to be<br />
Marketed and Distributed to Patients 18<br />
TheScientific Process<br />
zo<br />
Crude Herbal Cannabis and Unstandardized Cannabis Preparations Do Not Meet<br />
the Standards <strong>of</strong> Modern Medicine20<br />
Only Recently Has 7echnology Made Possible the Development <strong>of</strong> Modern<br />
Cannabis Derived and Cannabinoid Medica ions<br />
The Administration Should Respect and Support the Proper Workings <strong>of</strong> the Scientific Process<br />
z3<br />
The FDA Has Limi ed Power to Protect Patients Who Seek Medical Treatment<br />
and Advice From Cannabis Dispensaries 25<br />
States Laws and Regulatory Bodies Should Enhance Rather Than Undermine<br />
the Protections Provided by the FDA System<br />
Cannabis Dispensaries Are Not Subject to State Laws and Regulations Applicable<br />
to Entities Operating<br />
in the Health Care Area<br />
z8<br />
Cannabis and Cannabis derived Products Should be Governed by the Quality<br />
Control and Other Testing Procedures Applicable<br />
to All Modern Medications<br />
z9<br />
ZS<br />
The United States International Obligations 31<br />
Good Science Should Also Guide Decisions Implementing Our Obligations<br />
Under International Drug Control Treaties31<br />
The Controlled Substances Act Was Enacted in Part m fulfill Our Obligations<br />
Under the Single Convention and the Proliferation <strong>of</strong> Cannabis Dispensaries<br />
Cannotbe Left Solely to State Control 35<br />
Conclusion 38
INTRODUCTION<br />
In the early weeks <strong>of</strong> his administration President Barack Obama has voiced a number <strong>of</strong> laudable goals<br />
has stressed that Science and the scientific process must inform and guide decisions <strong>of</strong> my Administration<br />
on a wide range <strong>of</strong> issues He has expressed compassion for seriously ill pa ien s and their families With<br />
regard to the use <strong>of</strong> marijuana for medical purposes the president is said to believe that federal resources<br />
should not be used to circumvent state laws Prior to his electionthe Senator Obama noted that any use<br />
<strong>of</strong> marijuana for medical circumstances should take place under strict guidelines in the same way that other<br />
pain relievers or palliative drugs would be prescribed These aspirations are not necessarily inconsistent As<br />
this paper will show each <strong>of</strong> these goals can be met without allowing marijuana dispensaries to multiply free<br />
<strong>of</strong> federal control and intervention<br />
He<br />
The Administration need not fear that Drug Enforcement Agency DEA intervention ino cannabis dispensaries<br />
will conflict with state law indeed dispensaries are in almost all instances not permitted by sta e medical<br />
marijuana laws Nevercheless cannabis dispensaries are proliferating at a rapid rate a cause for concern<br />
given the potential for such operations to take advantage <strong>of</strong> desperate patients and put seriously ill patients at<br />
affirmative risk Local jurisdictions do not have sufficient resources to deal with these abuses<br />
Requiring the<br />
DEA unequivocally to takeahands <strong>of</strong>f approach no matter how egregious the dispensary<br />
practices will not<br />
serve the best interests <strong>of</strong> patients<br />
Uncontrolled proliferation <strong>of</strong> these dispensaries will seriously undercut our Food and Drug Administration<br />
FDA drug approval system and deprive patients <strong>of</strong> important regulatory protections Such a result will defeat<br />
the Administration<br />
avowed desire to support and follow the results <strong>of</strong> sound science<br />
As Presiden Obama<br />
has stressed medical marijuana should be controlled the same as other drugs prescribed by doctors Other<br />
prescription medications such as morphine are subject to a host <strong>of</strong> quality safety and efficacy requirements<br />
Without such requirements wlnerable patients can be exposed to harmful or inefrective products<br />
The Food Drug and Cosmetic Act FDCA and the Controlled Substances Act CSA are carefully integrated<br />
to ensure that patients access to medications is determined by good medical science not politics The FDA<br />
approves specific medical products for marketing and thereafter for distribution to patients based on a<br />
determination <strong>of</strong> those products safety and effectiveness<br />
Through the scheduling pro ess the DEA<br />
a scientific and medical evaluation by the Department <strong>of</strong> Heal h and Human Services the FDA in particular<br />
after<br />
i Office <strong>of</strong> he Press Secretary The White House Memorandum for he Heads <strong>of</strong> Executive Deparxments and Agencies<br />
March 9 zoo9 hereinafter Memorandum at p ihttp Jwww<br />
whitehouse gov<br />
press <strong>of</strong>fice<br />
Memorandum forvthe<br />
Heads <strong>of</strong> Executive Depa rtments and Agencies 3909<br />
2 Montopoli 6 Obama Announces Stem Cell Decision CBS News Political Hotsheet March 9 2oo9 President Obama<br />
remarks in full at p z<br />
3 Egelko 6 Feds Hint No More Raids on Pot tlubs in State San Francisco Chronide A1 Feb 27 2009<br />
4 Town hall meeting in Audubon lowa Nov z4 ioo7 Medical Marijuana ProCOn orghttp<br />
Jmedicalmarijuana procon<br />
org vi ewsource asp IDoo2447<br />
6 z009 Marijuqna Dispensaries<br />
and the Federal Government
determines whether and which restrictions should be placed on basic classes <strong>of</strong> substances that may have<br />
abuse liabili2y Underthis coordinated system only individual products ha have undergone rigorous scien ific<br />
testing can be made available for medical use crude botanical substances such as opium coca and cannabis<br />
cannot be sold to patients<br />
Cannabis dispensaries by distributing herbal cannabis and unapproved cannabis<br />
preparations directly to patients significantly ndermine this system<br />
In addition to maintaining the integrity <strong>of</strong> our domestic drug approval system the United States must uphold its<br />
international treaty obligations Under the Single Convention on Narcotic Drugs which governs the cultivation<br />
distribution and use <strong>of</strong> marijuana the US must prohibit or strictly regulate such activities When Congress<br />
enacted the CSA which is enforced by the DEA it expressly recognized our obligation to adhere to this<br />
and other drug control treaties Again the scientific process should guide our path as we fulfill our global<br />
responsibilities The Administration shouid herefore allow the DEA to determine when and to what extent<br />
federal intervention is required to meet our commitments in this area<br />
zoo9 Marrjuana Dispensaries and the federal Government 7
THE LEGAL STATUS AND COMMON PRACTICES OF<br />
CANNABIS DISPENSARIES<br />
Most Cannabis Dispensaries are Illegal Under State Medical Marijuana Laws<br />
The DEA s intervention into he practices <strong>of</strong> marijuana dispensaries does not circumvent state law or violate<br />
the concept <strong>of</strong> states rights First state legislation relating to the use <strong>of</strong> cannabis for medical purposes is<br />
generally quite limited in scope 7hese laws merely qualify the reach <strong>of</strong> the state<br />
existing criminal legislation<br />
prohibiting the use possession cultivation etc <strong>of</strong> cannabis California s medical marijuana law the oldest in<br />
the nation<br />
clearly illustrates this fact Proposition z15 he California Compassionate Use Act <strong>of</strong> 1g96 CCUA<br />
was enacted by the voters in 1996<br />
The Act renders possession and cultivation <strong>of</strong> cannabis noncriminal under<br />
specified condi ions that is it creates a potential defense against criminal prosecution and conviction The<br />
California Supreme Court has specifically ruled that the Act confers only a limited immunity which operates<br />
by decriminalizing conduct that otherwise would be criminal Such enactments do not fall within the realm<br />
<strong>of</strong> classic states rights<br />
Second in most cases cannabis dispensaries are not actually authorized under these state medical marijuana<br />
laws<br />
In California for example the original CCUA decriminalized the cultivation and possession <strong>of</strong> cannabis<br />
5 See National Organization for the Reform <strong>of</strong> Marijuana laws NORML Active5ate Medical Marijuana Programs http<br />
norml comJindex cfm Group ID 339i In zooq Oregon voters rejected an initiative that would have authorized dispensaries<br />
in thac sxate At present under SB 1085 efrective Jan 1 2006 Oregon permits a patien m registeramarijuana grow<br />
site which can cul ivace cannabis for no more than four pacients<br />
In March zoo9 New Mexico gran ed the first license<br />
for a cannabis dispensary the name and location <strong>of</strong> which are undisdosed See Major Holmes S First medical marijuana<br />
producer in NM approved The Associaced Press March 19 Zoo9 in Michigan dispensaries are springing up even though<br />
the recently enacted medical marijuana law does not authorize xhemhtxp www mlive com news<br />
flinyindexssf zoo9 o3<br />
group to oHer marijuana advic html<br />
6 Calif Health Safeiy Code du36i 5<br />
7 People e Mower 28 Cal 4th 457 47 122Cai Rptcid 326 2002 It is not uncommon for a stace to render certain conduct<br />
noncriminal thatotherwise would be criminal under its laws Seeeg Calif Penal Code sec 6oz n the crime <strong>of</strong> trespass on<br />
another s property is not applicable to persons engaged in lawful labor union activities Calif Insurance Code sec iz9zq b<br />
no individual shall be prosecuted or be subjected o punishment for any crime concerning which she is compelled by<br />
the Insurance Commissioner to estify or produce other evidence J<br />
8 People v Mower supro at p 473 This limited immunity en itles a defendant to raise a defense at trial and o bring a<br />
motion to set aside an indictment or information prior to trial Id at p 470 It does not confer complete immunity from<br />
arrest and prosecution Id at p q7q<br />
9Neither the CCUA nor subsequendy its darifying legislation created other affirmative rights Por example there is<br />
no requirement for any accommodation <strong>of</strong> the use <strong>of</strong> cannabis on the property or premises <strong>of</strong> any place <strong>of</strong> employment or<br />
duringthe hours <strong>of</strong> employment See Calif Heaith SafetyCode pu36z 785 a Fur hermore noching predudes an employer<br />
from discharging an employee who fails a drug test as a result <strong>of</strong> his her use <strong>of</strong> cannabis for medical purposes even ouaide<br />
<strong>of</strong> working hours or the workplace See CaliE Heatth Safety Code jlti362 785 a Ross v Ragingwire Telecommunications<br />
ioo8 44Z CalAth 9zo 7o Cal Rpir 3d 38zpre<br />
employment drug testing These provisions demonstrete that no robust<br />
rights are created by che limited grant <strong>of</strong> immuniiy<br />
8 2009 Marijuana Dispensaries<br />
and the Federal Government
y a patient or by that patient s primary caregiver if the use <strong>of</strong> cannabis was recommended by the patienYs<br />
physician<br />
A primary caregiver was defined as the individual designated by the patient who has consistently<br />
assumed responsibility for the patient s housing health or safety The California Supreme Court has ruled that<br />
a person whose responsibili ies consist principally <strong>of</strong> supplying cannabis and instructing on its use and who<br />
othenvise only sporadically takes a patient to medical appointments cannot qualify as a primary caregiver<br />
under the CCUA The Cour concluded that a primary caregiver must prove at a minimum that he or she<br />
consistently provided caregiving independent <strong>of</strong> any assistance in taking medical marijuana at or before he<br />
time he or she assumed responsibili y for assisting with medical marijuana A primary caregiver must be the<br />
principal lead or central person responsible for rendering assistance in the provision <strong>of</strong> daily life necessities<br />
In 2003 he California sta e legislature enacted the Medical Marijuana Program MMP The MMP clarified<br />
but did not modify or expand the reach <strong>of</strong> the CCUA The MMP acknowledges that patients and their primary<br />
caregivers may associate in order to cultivate cannabis cooperatively or collec ively for medical purposes<br />
without becoming subject to criminal sanctions solely because <strong>of</strong> that fact<br />
This language does not establishagreen light for cannabis dispensaries The California Attorney General has<br />
recognized that this provision was intended to be quite narrow<br />
issued guidelines to iden ify legitimate cooperatives and collectives<br />
In August zoo8 the State Attorney General<br />
The guidelines stressed that neither<br />
cooperatives nor collec ives should purchase cannabis from or sell tonon members instead they should only<br />
provide a means for facilitating or coordinating transactions between members<br />
eoth types <strong>of</strong> entities must<br />
carefully monitor their members and both should documen each member s contribution <strong>of</strong> labor resources<br />
or money as well as racking and recording the source <strong>of</strong> the cannabis Neither type <strong>of</strong> entity should pr<strong>of</strong>it<br />
from the sale or distribution <strong>of</strong> cannabis<br />
These guidelines allow for small groups <strong>of</strong> patients and primary caregivers to share the labor expenses and<br />
other responsibilities <strong>of</strong> cultivation on a common piece <strong>of</strong> land oroher facility This description does not<br />
apply to the vas2 majori y <strong>of</strong> cannabis dispensaries in California which have hundreds or even thousands <strong>of</strong><br />
members<br />
10 People v Mentch z008 45 Cal 4th 274 85CaI Rp r3d 480<br />
n CaliE Health<br />
Safety Code jfj111362J 11362 83<br />
1i Under Califomia law he legislature cannot amend an initiative such as he CCUA unless the initiative gran s he<br />
legisla ure auchority to do so CaliE Const art 1 10 subd The CCUA does not give the legislature authority to amend<br />
it without voter approval<br />
13 California Department <strong>of</strong> Justice Guidelines for the Security and Non diversion <strong>of</strong> Marijuana Grown for Medical<br />
Use Aug zoo8 hereinafter Attorney General Guidelineshttp ag ca gov cros<br />
attachmena press pdfs ni6oi<br />
medicalmarijuanaguidelines pdf<br />
14 Members also may reimburse the collec ive or cooperative for marijuana that has been allocated co them Any<br />
monetary reimbursement that members provide to the collec ive or cooperative should oniy be an amount necessary to<br />
cover overhead costs and operating expenses Id<br />
zoo9 Marijuana Dispensaries<br />
and the Federat Government 9
In California dispensaries have had 13 years to flourish and it is in California that their abuses have become<br />
evident<br />
Most dispensaries are merely retail storefronts that distribute cannabis to customers The California<br />
Attorney General has made clear that such dispensaries are operating outside the boundaries <strong>of</strong> state law<br />
dispensaries that merely require a<br />
patient to complete a form summarily designating the business owner as<br />
their primary caregiver and hen <strong>of</strong>fering cannabis in exchange for cash donation are likely unlawfal s<br />
Nevertheless dispensaries have proliferated across California s<br />
It is the current system and practices <strong>of</strong> inedical marijuana dispensaries in California and<br />
not the DEA s<br />
disruption <strong>of</strong> their merchandising operations that circumvent state law both medical marijuana laws and<br />
laws prohibiting the sale or possession <strong>of</strong> cannabis for non medical purposes<br />
The Operation <strong>of</strong> Cannabis Dispensaries Will Not Generate Scientific Data Leading to<br />
a<br />
Meaningful Assessment <strong>of</strong> Cannabis based Medications<br />
The practices <strong>of</strong> cannabis dispensaries will not enable this country to answer the pivotal ques ion what are<br />
the scientific data which demonstrate the risks and benefits <strong>of</strong> cannabis or cannabis derived medications<br />
Without such data no new medical product can gain acceptance by the medical pr<strong>of</strong>ession policymakers and<br />
an informed public California s cannabis dispensaries <strong>of</strong>fer a broad menu <strong>of</strong> cannabis products to a wide and<br />
shifting range <strong>of</strong> customers<br />
extracts and edibles are available<br />
Different strains <strong>of</strong> herbal materials as well as capsules highly concentrated<br />
Herbal material may be smoked or otherwise inhaled by means <strong>of</strong> a wide<br />
variety <strong>of</strong> devices Patients may try one product or one dispensary then another Some patients will have<br />
adverse reactions or will obtain no benefit<br />
Those individuals will simply not make further purchases their<br />
experiences will not be recorded or otherwise captured for medical benefit risk analysis<br />
Such practices cannot generate reliable controlled data that could lead to a<br />
meaningful assessment <strong>of</strong> the<br />
future <strong>of</strong> cannabis or wnnabis based medical products certainly not data on the myriad different cannabinoid<br />
prepara ions and dosage forms Acceptable and usable scientific data can be genera ed only by ransforming<br />
crude herbal material into standardized formulations <strong>of</strong> known and reproducible composition and dose<br />
incorporating those into appropriate delivery forms and testing such combinations through the modern<br />
regulatory system<br />
15 Attorney General Guidelines a p 11<br />
16 See the partial listing <strong>of</strong> publidy advertised dispensaries athctp www canorml org prop cbclist htmi<br />
io<br />
zoog Marrjuana Dispensaries and the Federal Government
Cannabis Dispensaries May Put Seriously III Patients at Risk<br />
State medical marijuana laws themselves recognize that cannabis is notaharmless herb akin to a dietary<br />
supplement or a home remedy These laws treat cannabis more like a prescription medication making a<br />
licensed physician the gatekeeper to a<br />
patient s access to cannabis the physician however is not required<br />
to be federally registered despite the fact tha cannabis holds Schedule I status under the CSA Despite this<br />
quasi prescrip ion status there isli tle assurance <strong>of</strong> quality consistency safety or efficacy Canna6is in herbal<br />
form or contained in crude preparations is not a homogeneous substance Depending on the concentration<br />
<strong>of</strong> various cannabinoids and other plant components use <strong>of</strong> inert excipients and delivery system or dosage<br />
form pa ients may be exposed to a variety <strong>of</strong> active ingredients with qui e different pharmacological effects<br />
Increasingly cannabis cultivated in North America and Europe is being bred to express very high concentrations<br />
<strong>of</strong> tetrahydrocannabinol THC s By contrast cannabidiol CBD anon<br />
prychoactive cannabinoid that dampens<br />
down he effec s including he psychoactive effecis <strong>of</strong> THC and whkh was presenT in significant amounu in<br />
cannabis used centuries ago has been bred out <strong>of</strong> modern cannabis<br />
The delivery system also enormously afiFects he impact that a cannabinoid product has on a patient If<br />
inhaled as in smoking or vaporizing THC blood levels rise rapidly and then fall dramatically which is likely<br />
to cause undesirable psychoac ive side effects Indeed when smoked cannabis is compared with standardized<br />
cannabis derived product containing equal amounts <strong>of</strong> THC and CBD and delivered by a sublingual method<br />
the patients using smoked cannabis report more significant adverse events In addition in a recent small<br />
sudy examining the effects <strong>of</strong> cannabis delivered inanon FDA approved vaporizer the subjects experienced<br />
17 For example patients cannotself diagnose as they do when purchasing dietary supplements nor can pa ients seek<br />
a physician<br />
approval only after their use <strong>of</strong> cannabis in an effort retroactively to validate suchself diagnosis See eg<br />
People v Rigo i999 69Cal App qth 409<br />
18 This is also true <strong>of</strong> op um Different strains <strong>of</strong> the opium poppy may be rich in morphine thebaine or oripavine<br />
These substances in turn are used co prepare very difFerent medications See DEA Authorized Sources <strong>of</strong> Narcotic Raw<br />
Materials 73 Fed Reg 6843 Feb 6 zo08<br />
19 Pot er DJ Clark P Brown MB Potency <strong>of</strong> Delta9THC and Other Cannabinoids in Cannabis in England in zoOS<br />
Implications for Psychoactivity and Pharmamlogy JournaloFore sic Sciences 2008 Jan 531904 Mehmedi Z Mar in<br />
J Foster S ElSohly MA editors Delta 9TNC and Other Cannabinoids Content <strong>of</strong> Confiscated Marijuana Pocency 7rends<br />
i993 Z003In ernational Association <strong>of</strong> Canna6is as Medicine 2005 September 10 Leiden Netherlands Intemational<br />
Association <strong>of</strong> Cannabis as Medicine ElSohly MA Ross SA Mehmedic Z Arafat R Vi B Banahan Bf 3rd Porency Trends<br />
<strong>of</strong> Delta9 7HC and Other Cannabinoids in Confiscated Marijuana from1980 1997 Journol <strong>of</strong> Forensic Sciences 200045124<br />
30 a complete description <strong>of</strong> the adverse health effects <strong>of</strong> high potency inhaled herbal cannabis is beyond he scope <strong>of</strong><br />
this documen<br />
20 Russo EB History <strong>of</strong> Cannabis and its Preparations in Saga Science and Sobriquet Chemistry Biodiversity 2007<br />
4S2624 45 Periwee RG Cannbidiol as a Potential Medicine 47 65 in Mechoulam R ed Cannobinoids os 7herapeutics<br />
Basel Switzerland Birkhauser Verlag zoo5<br />
2i Russo EB The Solution to the Medicinal Cannabis Problem in Schatman ME and Gan BL eds Ethicallssues in<br />
Chronic Pain Mpnagement 765 176 181 Boca Ra on FL Taylor<br />
Francis<br />
zz The Volcanon is produced by Storz Bickel GmbH Co in Germany A description and drawing can be found in Abrams<br />
D infra It has limited portability In use outside the climcal trial setting the dose <strong>of</strong> cannabinoids and the extent <strong>of</strong><br />
zoo9 Marijuana Dispensaries and the Federal Government 11
i<br />
s<br />
h<br />
YtaW nP<br />
i<br />
JF<br />
y<br />
4 4 3bY1<br />
1 n<br />
Y er<br />
er<br />
1<br />
t<br />
J<br />
m<br />
y<br />
E 2u4<br />
ce<br />
n<br />
rw3a<br />
Pm<br />
ma<br />
t er C n<br />
tkM<br />
r w<br />
s<br />
uns<br />
WELCGME To b 2 J<br />
I w<br />
f<br />
l<br />
ci<br />
L<br />
ry t t v<br />
a<br />
r<br />
p r ty<br />
1<br />
i<br />
p<br />
i<br />
r<br />
i<br />
S<br />
t<br />
pt<br />
ht 1<br />
1<br />
w<br />
Ti5 M satl<br />
F rS<br />
1<br />
rtrw i5L8e<br />
m14<br />
k<br />
qy<br />
n eve<br />
a<br />
t<br />
y k<br />
u<br />
n<br />
notable intoxication they found the cannabis with an intermediate THC concentration34 more tolerable<br />
than the higherTHC concentration68 material Oral consumption has delayed and unpredictable effccts<br />
This varia6ility and unreliability <strong>of</strong> effect may be particularly harmful o seriously ill patients who are <strong>of</strong>ten<br />
debilitated and likely to be taking a range <strong>of</strong> other prescription medications<br />
Cannabis distributed by dispensaries also poses other even more serious risks for patien s It may be<br />
contaminated by pesticides heavy metals or fungus For example in the Netherlands cannabis is grown<br />
for medical use by cwo cultivators who are licensed by he government s Office <strong>of</strong> Medicinal Cannabis The<br />
cannabis has such high microbial content that it must be irradiated before it can be distributed to patients<br />
pyroly ic products will vary with the temperature setting and the patient s inhalation practices<br />
23 Abrams D et al Vaporization as a Smokeless Cannabis Delivery System q pilo Study Clinical Pharmacology<br />
Therapeutics April zoo7 at p 4http www namre comJcpt<br />
2q Joy J Wa son SJ Benson JA Jc Norijuano and Medicine Aasessing the Science Bose Washington DC Ins itute <strong>of</strong><br />
Medicine 1999 at p zo3 Variation in individual responses is highest for oral THC and bioavailability is lowest<br />
z5 There is no requirement in Iocal legislation that cannabis sold in dispensaries must be organic indeed one<br />
dispensary in San Francisco advertises itself as the only dispensary<strong>of</strong>ering organic cannabis in the <strong>City</strong> http www<br />
sanfranciscocannabisdubs com directory<br />
sarnfrancisco al ernative patient w regivers hm<br />
26 Schol en W Therapeutic Cannabis in the Netherlands Drug Informanon Association Annual Meeting June i7 2004<br />
presen ation Hazekamp A An Evaluation <strong>of</strong> the Quality <strong>of</strong> Medicinal Grade Cannabis in he Netherlands Cannobinoids<br />
12 2009 Marijuana Dispensaries<br />
and the Federa Government
i<br />
r<br />
c<br />
i Nxx 9 3 r4i in k L<br />
r<br />
w<br />
x<br />
LEW Y<br />
a<br />
r<br />
a<br />
9<br />
r<br />
e<br />
s<br />
nt<br />
t Ar<br />
ri s<br />
r<br />
a<br />
I Y<br />
i<br />
I<br />
g<br />
ti<br />
in enor <strong>of</strong> a San Diego cannabis dispensary<br />
Decercber zoo5<br />
7 T J<br />
i<br />
F<br />
tr<br />
n r<br />
rW<br />
Yv Ji 4 a<br />
N v<br />
4<br />
In a US cannabis dispensary however there is no such quality control If seriously ill patients sufrer harm<br />
from such contamination they will receive no compensation there will be no product recall or governmental<br />
investigation and there is no tool to deter future malfeasance In short none <strong>of</strong> the federal and state regulatory<br />
protections are in place and the cannabis distributed by dispensaries is not subject to reliable oversight<br />
2006i9 Canada also has a small governmen sponsored and licensed cultivation program There too the cannabis<br />
must be irradiated before it is distribu ed to patients See Health Canada Product Information Sheet on Dried Marihuana<br />
http www ho sc gcca dhp mps marihuana supply approvis dried information sechee eng php Certain hlgh technology<br />
cultivation practices eg a computervcontrolled greenhouse opera ed by a pharmaceutical company under scnct standard<br />
operating procedures can preven such fungal growthhttp www gwpharm com<br />
17 One scienust has scressed that certain pathogens such as aflatoxins are not destroyed by heat as in smo ing or<br />
vaporizing and are Increasingly being recognized as an underestimated source <strong>of</strong> neurological toxicity or infections such<br />
asaspergillosrs Individualswhoareusinganti<br />
infammarorysteroidsorhavecompromisedimmunesystemsareespeually<br />
vulnerable to such infections See Hazekamp supra at p 6<br />
i8 Smoking also produces harmful pyrolytic products that can impair a patient S pulmonary function and cause other<br />
harm Tashkin DP Smolced Marijuana as a Gause <strong>of</strong> Lung Injury Monaldi Arch Ches Dis 2oo5 June63293 l00 In<br />
addition many dispensaries permit cannabis consumption on the premises However if cannabis jmnts or vaporizers are<br />
sfiared dangerous pathogens can be spread 2mongs senously ill patients Zanocco V Meningowccal Cases Linked by<br />
SharingJoints Vancouver BC Canada VancouverCoas aI Health 2005 Apri181ht pwww vch ca news docs 2oo5 o4 07<br />
mening oints pdf<br />
zoo9 Marijuana Dispensaries and the Federal Government 13
Cannabis Dispensaries May Take Advantage <strong>of</strong> Desperate Patients<br />
Reverend Scott Imler one <strong>of</strong> the early California proponents <strong>of</strong> medical marijuanaco author <strong>of</strong> Proposition<br />
zi5 and a founder <strong>of</strong> one <strong>of</strong> the original dispensaries has voiced concern that dispensaries can be preda ory<br />
taking economic advantage <strong>of</strong> desperate and vulnerable patients<br />
We created Prop z15 so that patients would not have to deal with black market pr<strong>of</strong>iteers But today it<br />
is all about the money Most <strong>of</strong> the dispensaries operating in California are little more than dope dealers<br />
with store fronts<br />
There is little doubt as to why cannabis dispensaries are multiplying at such a rate The price <strong>of</strong> cannabis in<br />
dispensaries ranges from i2 5o to z5 per gram z8 grams per ounce The average medical user with<br />
a chronic medical condition may consume from 15 to 3o grams per day Therefore the monthly cost to<br />
patients ranges from 56z 15 grams day atiz 5o gm to z5o 3 grams day atz5 gm Since the herbal<br />
cannabis which is <strong>of</strong> varying strains and quality has not received FDA approval none <strong>of</strong> this expense is covered<br />
by a patient s health insurance and there is no assurance <strong>of</strong> quality control or accurate dosage information<br />
This system actualiy impedes access by patients to cannabis derived medications<br />
If a medication has gone<br />
through the FDA process there is at leastan opportunity for itto be covered by public or private health insurance<br />
Given its exclusion from health insurance plans its cost exceeds that which most seriously ill patiencs many <strong>of</strong><br />
whom may not be working can afford to purchase<br />
are not in fact patients who require cannabis for medical purposes<br />
are pr<strong>of</strong>iting some dispensaries take in over 20 00o per day<br />
This cost in turn implies that the majority <strong>of</strong> purchasers<br />
In the meantime cannabis dispensaries<br />
i9 Office <strong>of</strong> National Drug Control Policy Medical Marijuana Realiry Checkhitp Jwww<br />
whitehousedrugpolicy gov<br />
drugfact<br />
sht medical marijuana html Accessed Feb z7 zoo9 Alterna ives Magazine FaII 1oo61ssue 39<br />
30 CNBC A Gallery <strong>of</strong> Medical Marijuanahttp Jwww cnbc com id 285618g6 Accessed March i 2009<br />
3i People v Mencch 2008 45 CalAth 274 85Ca Rptr 3d 480 patient using 3 grams per day<br />
3z In Califomia for example state law does not require a govemmen private or any other health insurance provider or<br />
health care service plan to be liable for any daim for reimbursement for he use <strong>of</strong> inedicinal cannabis Calif Heal h<br />
Safety Code 11362 785 dj<br />
33 CNBC A Gallery <strong>of</strong> Medical Marijuanahttp www cnbccom<br />
idjz856i896 Accessed March 1 2009<br />
America s Pot Industry Jan z2 zoo9<br />
CNBC Inside<br />
14 2oog Marijuana Dispensaries and the Federal Government
THE NEED FOR REGULATORY PROTECTIONS<br />
Allowing a Proliferation <strong>of</strong> Cannabis Dispensaries Will Seriously Undercut the FDA<br />
Drug Approval System and Deprive Patients <strong>of</strong> important Regulatory Protections<br />
President Obama has expressed his desire to ensure that the US provides continued global leadership in<br />
scientific discoveries and technological breakthroughs<br />
He has assured the public that modern scientific<br />
developments will guide the Administration<br />
policy decisions A proliferation <strong>of</strong> cannabis dispensaries in<br />
states across the country would have the opposite efFect seriously undermining the FDA approval system The<br />
federal Food Drug and Cosmetic Act FDCAp and the federal Controlled SubsTances Act CSA work in synergy<br />
to form this impressive regulatory fabric<br />
The FDCA requires that rigorous scientific data determine which<br />
medications may enter the marketplace and thereafter be prescribed and distribu ed o patients<br />
The CSA<br />
establishes a process scheduli g through which those scientific data can be used to ensure that controlled<br />
substances are made available for and limited to appropriate medical and scientific use hrough a closed<br />
system <strong>of</strong>dis ribution thac includes proper registration security recordkeeping reporting quota and other<br />
requirements<br />
The Requirements <strong>of</strong> the Food Drug and Cosmetic Act Reduce the Likelihood that<br />
Patients Will be Exposed to Harmful or Ineffective Products<br />
The FDCA has been developed over more than a century to protect the health and safety <strong>of</strong> vulnerable patients<br />
It enforces rigorous standards at all stages in the development <strong>of</strong> a new medicine<br />
Before a<br />
medical product may be approved by he FDA and be released for marketing it must be assessed in<br />
various nonclinical and preclinica laboratory tests including drug and drug food interaction tests<br />
final formulation must be analyzed for ba ch consistency stability and absence <strong>of</strong> dangerous contaminants Is<br />
manufacturing process must be validated and quality controlled<br />
Its<br />
Even after extensive predinical studies have demonstrated the likely safety <strong>of</strong> he product for human use<br />
several phases <strong>of</strong> clinical human research must be conducted If a product is intended to be used for a chronic<br />
condition carcinogenicity and reproduc ive toxicity tests must be performed Adverse events must be reported<br />
34 Montopoli B Obama Announces Stem Cell Decision CBS News Political Hotsheet March 9 2009 President Obama<br />
remarks in full at p 3<br />
35 zlUS0 ffj 3oi 399a<br />
36 uUS0 dJ 801 971<br />
37 Even at the research stage an investigational product may be tested in actual patients only if the physician<br />
investigator<br />
has preliminary evidence <strong>of</strong> safety and a protocol approved by the FDA The pro ocol must undergo careful scrutiny from<br />
an Institutional Review Board IRB<br />
zoo9 Marijuana Dispensaries<br />
and the federal Gavernment i5
and described in the product label The research is pubifshed in peer reviewed journals enabling physicians to<br />
judge the quality <strong>of</strong> the research as well as the relative safety and efficacy <strong>of</strong> the product<br />
The FDA also inspects and supervises he pharmaceutical manufacturer s facility If a flaw exists in the<br />
manufacturing process the FDA can withhold marketing approval Subsequent to approval if the FDA receives<br />
reports <strong>of</strong> serious unrecognized side effects a product s label can be amended to indude heigh ened warnings<br />
or the product can be removed from the market entirely<br />
This thorough and dynamic process reduces the likelihood that patients will be exposed to dangerous or<br />
ineffective products and provides important data to allow physicians to conduct meaningful dialogues with<br />
and give informed advice to patients regarding treatment options<br />
The Controlled Substances Act Plays a Critical Role in Ensuring that Properly Tested<br />
Medications are Made Available for Appropriate Medical Use<br />
The CSA and the Drug Enforcement Administration DEA piay important roles in this system <strong>of</strong> inedication<br />
development When medications contain controlled substances and herefore pose a potential risk <strong>of</strong> abuse<br />
or addiction the regulatory system is even more cautious Mere FDA approval <strong>of</strong> such a medication is not<br />
sufficient the product must also undergo review through an administrative process under the CSA<br />
scheduling process<br />
the<br />
Cannabis proponents <strong>of</strong>ten contend that herbal cannabis should be moved from Schedule I to Schedule II in<br />
order to increase its availability to patients through cannabis dispensaries This argument however reFlects<br />
a misunderstanding <strong>of</strong> the scheduling process as it relates to the ultimate FDA approval and marketing <strong>of</strong> a<br />
medication That process must be viewed in the context <strong>of</strong> the larger FDAjDEA regulatory scheme<br />
When Congress enacted the CSA it established five categories known as schedules to which different levels<br />
<strong>of</strong> requirements restrictions and prohibitions are attached A drug s dassifica ion in a specific schedule is<br />
determined by its abuse and dependence potentials on the one hand and by the evidence <strong>of</strong> its safety and<br />
therapeutic effectiveness on the other The scheduling process involves indepe dent but complementary roles<br />
for the DEA Deparcment <strong>of</strong> Health and Human Services the FDA and the National Institute on Drug Abuse<br />
NIDA in particular<br />
38 Congress placed most <strong>of</strong> these substances in their respec ive schedules as part <strong>of</strong> the CSA s enactment in 197o but new<br />
substances are continually scheduled and exis ing substances are moved between schedules as new scientific data become<br />
avai able DEA Controlled Substanre Schedules Chronological Orderhtp www<br />
deadiversion usdoj gov schedules<br />
schedules htm<br />
i6<br />
z009 Marijuana Dispensaries<br />
and the Federal Government
THE<br />
UNITED STATES INTERNATIONAL OBLIGATIONS<br />
Good Science Should Also Guide Decisions Implementing Our Obligations Under<br />
International Drug Control Treaties<br />
President Obama has announced his intention to trust science and research when designing our international<br />
as well as domestic policies Sound science shouid inform and guide this Administration as it implements<br />
our international responsibilities in the field <strong>of</strong> drug control policy The US and thereby he Department <strong>of</strong><br />
Justice has an obligation under our international drug control treaties to control strictly the manufacture<br />
and distribution <strong>of</strong> controlled substances including the cultivation and distribution <strong>of</strong> cannabis within our<br />
borders<br />
In particular if the US permits the cultivation <strong>of</strong> cannabis plants for medical use i must apply the same<br />
provisions as are imposed for the cultivation <strong>of</strong> the opium poppy for medical use<br />
controls must be maintained by a single government agency<br />
over the prolifera ion <strong>of</strong> cannabis dispensaries<br />
This rigorous system <strong>of</strong><br />
States therefore cannot have sole jurisdiction<br />
The United States is a signatory to the Single Convention on Narcotic Drugs 1961 Single Convention This<br />
treaty was intended to ensure that the production and use <strong>of</strong> narcotic substances are limited exclusively to<br />
bona fide medical and scientific purposes Accordingly the Single Convention requires a party to impose strict<br />
controls not merely on international trade but also on domestic manufacture distribution import export<br />
and possession <strong>of</strong> botanically derived controlled subs ances such as coca opium and cannabis<br />
The phrase medical and scientific purposes has a clear meaning The treaty was promulgated at a time<br />
when governments around the world were developing regulatory procedures to ensure the quality and safety<br />
<strong>of</strong> inedical products Crude narcotic plant material was not considered suitabie for direct medical use For<br />
example under the treaty opium smoking was not an accepted method for delivering the therapeutically useful<br />
components contained within the herbal material<br />
102 Single Convention on Narco ic Drugs March 30 1961 18 UST 1407<br />
io3 Single Convention preamble Art 4c<br />
104 The need for the prectice <strong>of</strong> inedicine to be evidence based had become wel6established particularly in the Western<br />
worid For several decades scientists had been conducting randomized placebo controlled dinical trials to imestigate the<br />
safety and efficacy <strong>of</strong> irnestigational medical products Chow S and Liu J Design andAnatysrs <strong>of</strong> Ginical Triats p4i998<br />
Then as now the results <strong>of</strong> such clinical trials formed the basis both <strong>of</strong> governmental regulators marketing approvals and<br />
physicians prescribing practices See Guyatt G et al Evidence Based Medicine Principles for Applying the Users Guides<br />
o Patient Care 284Joumal <strong>of</strong> the Ame ican Medical Association 1290 Sept 13 2000<br />
I<br />
1o5 Cannabis and cannabis resin were placed in Schedule IV he treaty s most restrictive schedule whereas oral cannabis<br />
preparationsie tincwres and extracts were placed in Schedule I along with most other narcotic drugs The Single<br />
Convention s schedule structure does not parallel that <strong>of</strong> the Convolled Substances Act in which Schedule is the most<br />
restric ive<br />
zoo9 Marijuana Dispensaries and the FederaJ Government 31
The Single Convention recognized that different coun ries may have different regulatory systemslo However<br />
the treaty expected that each party would in good faith adhere to modern scientific standards that is employ<br />
conventional<br />
regulatory standards when determining whether when and which narcotic substances and<br />
products could be made available for medical use<br />
Nowhere in the treaty is there any suggestion that a Par y<br />
may allow a diluted or informal medical system solely for a specific controlled substance such as cannabis<br />
In response to the activities <strong>of</strong> inedical cannabis proponents the International Narcotics Control eoard INCB<br />
stressed that a party may not allow cannabis to be cultivated manufactured and used for medical purposes<br />
uniess such products have satisfied the rigorous regulatory standards that apply to oher medical products<br />
Such use must 6e supported by objective scientific data from properly conducted research studies and must<br />
otherwise accord with principles <strong>of</strong> modern medicine<br />
The Singie Convention places parcicularly severe restrictions on the cultivation <strong>of</strong> cannabis opium and coca<br />
bush Artfde 23 requires that if a<br />
must establish and maintain a<br />
party permits cultivation <strong>of</strong> opium poppies within its borders the Party<br />
national Agency to carry out the Party s obligations<br />
Articles z6 and z8 apply<br />
those requirements o he cultivation <strong>of</strong> the coca bush and the cannabis plant respectively Article 23 requires<br />
that only nationally licensed cultivators whose license specifically identifies the precise extent and location<br />
<strong>of</strong> the land that they are authorized to cultivate may grow such narcotic plants They must deliver their<br />
total crops to the Agency and only the national Agency may deal with such crops The Agency must have the<br />
exdusive right <strong>of</strong> imporcing exporting wholesale trading and maintaining stocks<br />
iob See Secretary General <strong>of</strong> the United Nations Commenmry on the Single Convention on Norcotic Drugs i96i i973 pare<br />
ii pmlegitimate existing systems <strong>of</strong> indigenous medicine may be taken into account hereafter Commencary<br />
107 The INCB is the United Na ions organ created by the Single Conven ion to implement and monitor compliance with<br />
the Convention See Single Convention arts 59i5 19 zo<br />
108 INCB Report 1002 a p 21 2003<br />
io9 The treaty imposes other very specific restrictions on the cultivation <strong>of</strong> cannabis opium and coca Anide zz requires<br />
a Party to prohibit cultivation if the Party condudes in good fai h that the prevailing conditions in the country make such<br />
prohibition the most sui able measure <strong>of</strong> protecting the public health and safety Fur hermore a Party that prohibits such<br />
cultivation must take appropriate measures to seize and destroy any planu that are illegallycul ivated ezcept for small<br />
quantities that the Parry itself may need for scientific or research purposes<br />
uo The Commentary also indicates that under the Single Convention all licensed cultivators should to the greatest<br />
extent possible be located in the same part <strong>of</strong> the country and be contiguous in order to facilitate more effective control<br />
Commentary at p 280<br />
locations all over the US<br />
This provision would not permit the establishment <strong>of</strong> cannabis cultivation si es in<br />
numerous<br />
111 Preparations <strong>of</strong> cannabis such as pharmaceutical grade extracts and tinc ures are exempt from the government<br />
monopoly on wholesale distribution Single Convencion art z3 paraie The treaty also does not extend the governmenCs<br />
exclusive rights to medicinal opium and opium prepara ions d at art z3 paraie Medicinal opium is a form <strong>of</strong><br />
opium powder to which lactose has been added o reduce the morphine concent o the standard <strong>of</strong> about io percen<br />
Commentary at p zi 1z In other words the term referred to a product which had not only been extracted from the opium<br />
poppy but had also undergone severa further processes to prepare it for use in other drugs and to obtain a specific and<br />
standardized content <strong>of</strong> morphine iis primary active ingredienL DEA Lyle E Craker Denial <strong>of</strong> Applica ion 74 Fed Reg<br />
zio1 21o4 1an 14 zoo9 at p i116 Tlhere were recognized standards for the substance<br />
manufacwre and composition<br />
and the drug had an accepted medical use in humans Id ey contrast there are no recognized standards with respect<br />
3z<br />
zoo9 Marijuana Dispensories and the Federal Government
The National Institute on Drug Abuse NIDA serves as the US national Agency under the Single Convention<br />
Underthe auspices <strong>of</strong> NIDA the US maintains a domestic cultivation facility in which research grade cannabis<br />
is cultivated by the National Center for Natural Products Research at the University <strong>of</strong> Mississippi under<br />
contract with NIDA This wnnabis is supplied to investigators who have research protocols that have been<br />
approved by the FDA and by an expert committee <strong>of</strong> the Public Heaith Service and who have obtained research<br />
registrations from the DEA As <strong>of</strong> April 2004 the University <strong>of</strong> Mississippi with the approval <strong>of</strong> NIDA and the<br />
PHS committee had provided cannabis to more than 17 clinical and preclinical studies funded by the Center<br />
<strong>of</strong> Medicinal Cannabis Research CMCR at the University <strong>of</strong> California San Diego ve<br />
If in he future cannabis derived medications were to be developed and approved for marketing it would<br />
not be necessary for the cannabis cultivation production <strong>of</strong> starting materials to take place in the United<br />
States<br />
The herbal material or the Botanical Drug Substance extracts could be imported into the US for<br />
further formulation<br />
For over 85 years it has been the policy <strong>of</strong> the US no to cultivace or produce narcotic<br />
raw material NRM such as opium poppy straw and concentrate <strong>of</strong> poppysraw CPS By long standing<br />
international policy he US is a<br />
country that imports and consumes rather than one that produces and<br />
m herbal marijuana Id Therefore cannabis even if intended for medical use does not fall outeide <strong>of</strong> the jurisdittion <strong>of</strong><br />
a national Agenty<br />
11z NIDA Provision <strong>of</strong> Marijuana and Other Compounds Por Scientific Research<br />
Recommendations <strong>of</strong> he National Institute<br />
on Drug Abuse National Advisory Councilht pJwww nida nih gov about<br />
organization nacda<br />
marijuanastatement html<br />
113 See DEA Lyle E Craker Denial <strong>of</strong> Application 74 ied Reg 2101 Ilo4 Qan 14 2009 hereinafter Craker ApplicationJ<br />
Pr<strong>of</strong>essor Lyle Craker a plant scientist at the University <strong>of</strong> Massachusetts sought to be registered as a bulk manufacturer<br />
to cultiva e herbal wnnabis which he<br />
intended to provide to researchers with FDA approved INDS and DEA<br />
research<br />
registrations The DEA Deputy Admmistrator denied his application on a number <strong>of</strong> bases 1 there was no evidence<br />
that the quality or supply <strong>of</strong> NIDA cannabis was inadequate nor its cost excessive 2 Pr<strong>of</strong> Creker and his sponsor he<br />
Multidisciplinary Association for Psychedelic Studies MAPS were seeking to dismantle the existing Government control<br />
over the distribu ion <strong>of</strong> cannabis produced by growers and avoid the governmental monopoly over the wholesale<br />
distribution <strong>of</strong> marijuana that is mandated by the Single Convention by distribucing it oucside <strong>of</strong> the HHS system id at pp<br />
ii14 i117 i1z2 3 Pr<strong>of</strong> Craker unlike Dr Mahmoud ElSohiy the Principal Investiga or <strong>of</strong> the Na ional Center project had<br />
no experience in Che manufacture <strong>of</strong> controlled substances and could not demonstrate that he was capable <strong>of</strong> producing<br />
cannabls with any degree <strong>of</strong> quality rontrol id at p z1z1 fn 74 a there was no evidence chat MAPS had the knowledge or<br />
ezper ise to use such wnnabis to develop an FDA approved produc id at p 2i06 ui3 This case leaves open the question<br />
<strong>of</strong> whether the DEA might agree to register an additional bulk manufacmrer who possessed che appropriate expertise and<br />
who was willing to abide by the provisions <strong>of</strong> the Single Convention See fn ll5 below The DEA no ed tha he UK has<br />
gran ed GW Pharmaceuticals a license to grow cannabis far the limited purpose <strong>of</strong> producing extract for a pharmaceutical<br />
product Id at p 2115 fn 55<br />
114 TheNa<br />
ionalCenrerholdsanadditional regisvation to manufacturecannabisandTHCundertheterms<strong>of</strong>a Memorandum<br />
<strong>of</strong> Agreement with the DEA in ig99 The purpose <strong>of</strong> this registration is to allow the Cen er o develop a new product<br />
formulation for effecting delivery <strong>of</strong>lTHt in a pharmaceutically acceptable dosage form suppository and to provide crude<br />
THC extract to a DEA registered manufatturer <strong>of</strong> THC for further purification Id at 21o4 fn 1<br />
n5 In i999 the National Institu es <strong>of</strong> Health announced new procedures for making research grade cannabis available to<br />
researchers induding those whose research is privately fundedhttp www nih gov news<br />
medmarijuana hhsfact htm<br />
u6 Craker Application at p uo5<br />
117 See DEA Authorized Sources <strong>of</strong> Narcotic Raw Materials 73 Fed Reg 6843 Feb 6 2oo8<br />
zoo9 Marijuano Dispensaries<br />
and the Federal Government 33
supplies NRM The US relies on a specific list <strong>of</strong> councries authorized to import NRM inio the US in order<br />
to mee the legitimate medical needs <strong>of</strong> the US This list is deliberately kept very short in order to prevent a<br />
proliferation <strong>of</strong> NRM producing countries<br />
Furthermore the treaty imposes additional controls on all manufacture and distribution <strong>of</strong> cannabis derived<br />
and other controlled substances Such activities must be conducted by federally licensed and regulated en ities<br />
that are producing standardized products for medical or research purposes<br />
Therefore were the US to<br />
permit dispensaries in various states across the country to distribute or cultivate cannabis for medical use<br />
the US would be in viola ion <strong>of</strong> these unmistakably clear treaty obligations<br />
position<br />
The INCB has confirmed this<br />
The control measures applied in California for the cultivation production and use <strong>of</strong> cannabis do not<br />
meet the control standards set in the 1961 Convention to prevent diversion <strong>of</strong> narcotic drugs for illicit use<br />
Such standards require inter alia the control <strong>of</strong> cultivation and production <strong>of</strong> cannabis by a national<br />
cannabis agency and detailed record keeping and reporting on the activities with cannabis including<br />
reporting to INCB<br />
118 44 Fed Reg 33696 June 1i 1979<br />
119 Those countries are India Turlcey France Poland Hungary Aus ralia and Spain See<br />
Narcotic Raw Materials 73 Fed Reg 6843 feb 6 2008<br />
DEA Au horized Sourcei <strong>of</strong><br />
1zo The treary obligates he US and other parties to license and control all persons and encities engaged in he manufacture<br />
<strong>of</strong> narcotic substances and products as well as to control under Iicense the premises where such manufacture akes<br />
place In addi ion those manufac urers must ob ain periodical permits indicating the kinds and amounts <strong>of</strong> drugs they<br />
are authorized o manufacture Art ig The Party must control all persons and entities distributing suth subs ances<br />
and license the premises in which such distribution takes place Art 30 Finally the Parties must require all licensees to<br />
have adequa<br />
qualifications Art 34a They mus require all mawfacturers traders scientists scientifit institu ions<br />
and hospitals to keep records for two years showing 1 the quantities <strong>of</strong> each drug manufacwred and z each individual<br />
acquisition and disposal <strong>of</strong> drugs Arc 34 b The Parties are obligated to impose spetific requirements and res rictions<br />
on the labeling and import export <strong>of</strong> a mediwtion Art 3o 31 The provisions <strong>of</strong> the CSA in conjunction with those <strong>of</strong> the<br />
Food Drug Cosmetic Act satisfy these obligations<br />
i2i In addition to these controls the Single Convention in an effort to prevent Iegitimate medical products from being<br />
diverted co ilhcit use imposes strict requirements on Parcies co provide annual estimaces regarding quantities <strong>of</strong> drugs<br />
utilized or held for specific purposes Art i9 as well as statistical retums conceming among other things production<br />
manufacture consumption imports exporcs seizures disposals and year end ecocks Art zo These requirements apply<br />
even to substances used in research INCB Narcotic Drugs iooz atp97 003 recognizing appropriateness <strong>of</strong> UK reporting<br />
<strong>of</strong> amounts <strong>of</strong> wnnabis extracts used for medicai research Even if an individual practitioner or scientist wishes to conduct<br />
a small study using cannabis or some other narcotic substance the Party must ensure that those small amounts are<br />
accounted for through he estimate and statistical rewm rystem if distributors or dispensers in any State authorizing<br />
it could cultivace and distribute cannabis on a physician<br />
advice this entire system would rapidly become disrupted and<br />
meaningless<br />
1i2 INCB press release feb 8 2D08j<br />
34 zoo9 Marijuana Dispensarres and the Federal Government
The Controlled Substances Act Was Enacted in Part to Fulfill Our Obligations Under<br />
the Single Convention and the Proliferation <strong>of</strong> Cannabis Dispensaries Cannot be Left<br />
Solely to State Control<br />
The federal CSA was enacted in part to fulfill the United States obligations underthe Single Convention The<br />
CSA and its implementing regulations have two prongs They are designed<br />
i to ensure that there is a sufficient supply <strong>of</strong> controlled substances for legitimate medical scientific<br />
research and industrial purposes and<br />
z to prohibit deter and punish the sale and use <strong>of</strong> controlled substances to illegal purposes<br />
These goals parallel hose <strong>of</strong> the Single Convention to ensure that narcotic and other psychoactive substances<br />
are manufactured traded and used only for legitimateie evidence based medical and scientific purposes If<br />
the DEA were prohibited from shuttering cannabis dispensaries and seizing the materials purveyed herein the<br />
US would have failed to comply with its international responsibilities<br />
If the US does not abide by its treaty<br />
obligations other countries will be unlikely to adhere to theirs As in other arenas the US should seek to be a<br />
leader with respect to modern medical science and its responsibilities under internationai agreements<br />
The CSA achieves its purposes by<br />
1 establishing a process scheduling through which scientific and oiher data may be used to ensure<br />
appropriate levels <strong>of</strong> control <strong>of</strong> abuseable substances and the adequate availability <strong>of</strong> inedications<br />
containing them and<br />
z creatingaclosed system in which every importer exporter manufacturer distributor dispenser<br />
and researcher handling a controlled substance must meetsrict licensing recordkeeping and security<br />
requirements which are consistent with those required by the Single Convention<br />
Cannabis dispensaries operate entirely outside <strong>of</strong> this system <strong>of</strong> controls It is hard to see the logic or merit<br />
<strong>of</strong> any position that would relieve cannabis dispensaries from federal oversight despite the fac that cannabis<br />
is a Schedule I substance while requiring manufacturers and distributors <strong>of</strong> Schedule II substances to secure<br />
DEA registrations adhere to quotas keep accurate records and instituLe strict security measures The DEA has<br />
iz3 See ziUS0 Q<br />
Soi 7 findings<br />
iia Congress has recognized that our intemational treaty obliga ions can actually trump the normal scheduling process<br />
Generally in that process the Attorney General delegaxed to the DEA is bound by DHHS s and FDA s medical and scientific<br />
evaluation <strong>of</strong> and recommendations upon certain statu ory criteria relating to scientific knowledge pharmacological<br />
effect and abuse potential However if control is required by the United States obligations under intemational treaties<br />
theAttomey General must issue an order controlling the drug under the schedule he or she deems most appropriate to carry<br />
out such obligations without regard to any <strong>of</strong> the findings described above uUSC d8u<br />
2009 Marijuana Dispensaries and he federal Government 35
I<br />
am xmvazt t<br />
x<br />
r<br />
a tirri3<br />
kim<br />
y<br />
i 3 Kk<br />
8 S 3w<br />
o<br />
4 K<br />
YVy Y<br />
pgy i<br />
v<br />
r<br />
pi<br />
Pj<br />
rC<br />
y<br />
r<br />
l<br />
Y<br />
My<br />
F A<br />
n<br />
h<br />
Mn<br />
i 4<br />
wAl<br />
ti L<br />
1<br />
1 I<br />
Y<br />
y1<br />
F A<br />
ry1j<br />
Fyy Vt<br />
uSG<br />
yb pl I I<br />
4<br />
both the power s and the obligation to curb the proliferation <strong>of</strong> cannabis dispensaries It cannot abdicate this<br />
responsibility in the name <strong>of</strong> deferring to states rights<br />
Under the Single Convention the United States must in good faith strive to prevent the non medical sale and<br />
use <strong>of</strong> controlled substances A decision by the Administration to prevent the DEA from intervening in cannabis<br />
dispensaries if they are authorized under state law will effectively prevent he agency from enforcing the CSA<br />
against cannabis retail storefronts that are merely subterfuges for non medical distribution <strong>of</strong> cannabis<br />
State and local law enforcement do not alone possess adequate resources to stem the proliferation <strong>of</strong> dispensaries<br />
that distribute cannabis fornon medical use Moreover local law enforcement needs the assistance <strong>of</strong> the DEA<br />
in combating these operations These entities do not have access to the highly efficient law enforrement tools<br />
that the DEA has at its disposal For example local law enforcement cannot utilize federal asset Forfeiture laws<br />
to deter landlords from permitting cannabis distribution activities to take place on their property Indeed<br />
i25 Gonzales v Raich 545 US12005<br />
i16 It should 6e noted tha the federal government first intervened in cannabis dispensaries under President Clinton s<br />
administracion See US v Oak ond Connabis 6uyers Cooperotive zool 53 US 483 no exception for medical necessity<br />
under the CSA for distribution <strong>of</strong> cannabis for medi al purposes<br />
iz7 In aoo7 the DEA sent notices to landlords in CaliPomia waming them that their property could be seized if it were being<br />
used for the purpose <strong>of</strong> marijuana distribu ionhttp Jwwwsafeaccessnow org downloads DEA Landlord Letter pdf<br />
36 zoo9 Marijuana Dispensaries<br />
and the Federal Government
attempting to require the DEA selectively to halt only non medical distribution centers will require the DEA to<br />
dissipate its limited resources in a futileline drawing exercise<br />
The process <strong>of</strong> identifying canna6is dispensaries that distribute cannabis for non medical use<br />
extremely onerous for a federal agency<br />
would be<br />
In order to fulfillis unquestioned obligation to enforce the CSA s and<br />
Single Convention s prohibitions against non medical distribution the DEA would be required to examine the<br />
records <strong>of</strong> dispensaries to make the followirtg assessments the true non pr<strong>of</strong>it nature <strong>of</strong> the entity the means<br />
by which physician recommendations are verified the bona fides <strong>of</strong> inembers and the relative labor monetary<br />
or other resource contributions <strong>of</strong> those members to the non pr<strong>of</strong>it enterprise the source <strong>of</strong> the cannabis and<br />
whether it can be determined to have been cultivated in all cases by legitimate members etc s<br />
Moreover the DEA s resource intensive struggle to disxinguish between legitimate under state law and unlawful<br />
under state law dispensaries would be compounded by the fact that increasingly cannabis dispensaries have<br />
delivery services Such delivery services would make it even more difficult for the DEA to track and evaluate<br />
cannabis distribution ac ivities for compliance with state law<br />
Even for local jurisdictions detailed state guidelines such as those issued by the California Attorney General are<br />
difficult enough to interpret and enforce To require the DEA to take a hands <strong>of</strong>f approach to any dispensarythat<br />
may be operating in accordance with such state guidelines would effectively ban the DEA from any significant<br />
cannabis interdiction leading to a free for all <strong>of</strong> cannabis dispensaries across the state and potentially across<br />
the nation As a result cannabis would become readily available for any use both medical and recreational<br />
128 Some dispensaries boasamembership <strong>of</strong> 20 o00 with hundreds <strong>of</strong> new customers signing up monthly Manhattan<br />
Project supra<br />
1z9 See eg The Green Crosshttp<br />
wwwsanfranciscocannabisdubs com directory<br />
green cross htm<br />
130 Even the mayor <strong>of</strong> San francisco does not support the legalization and regulation <strong>of</strong> cannabis for non medical use<br />
See Legal Pot is Not Mayor s Cup <strong>of</strong> Tea San Francisco Chronide Feb z7 2009<br />
2009 Marifuana Dispensaries<br />
and the Federal Government 37
CONCLUSION<br />
For the reasons sta ed above the Obama Administration must take a measured approach in addressing<br />
marijuana dispensaries maintaining the commitment to enforcing the CSA that the Department <strong>of</strong> Justice has<br />
recently reiterated 7his commitment must be met even in states that authorize medical use <strong>of</strong> marijuana<br />
and especially where illegal distributors attempt to use state medicai marijuana laws as a pretex We recognize<br />
that the Department <strong>of</strong> Justice and the DEA have limited resources and those resources must be spent wisely<br />
The United States however also has both domestic and international responsibilities to protect the health and<br />
safety <strong>of</strong> patients and to promote the responsible development <strong>of</strong> modern medications A fixed Administration<br />
ruling against DEA intervention into the operations <strong>of</strong> cannabis dispensaries would allow informal quasi<br />
medical networks to spring up across the nation thereby putting at risk the critical protec ions so carefully<br />
crafted under the national food and drug legislation <strong>of</strong> the 2oth and 2ist centuries<br />
38 zoog Marijuana Dispensaries<br />
and the Federal Government
NOTES<br />
2009 Marijuana Dispensaries and the Federal Government 39
Friends <strong>of</strong> the DEA<br />
2009N14th Sireet<br />
Suite 414<br />
Arlington Virginia zzzoi<br />
www<br />
friends<strong>of</strong>thedea org<br />
x<br />
Ima9<br />
es pp 12 13p19 ond p 26 O Copyright 2009 County <strong>of</strong>San Diego District Attorney Used with permission
MARI UANA CHILDREN<br />
THE WORK PLACE AND MEDICINE<br />
ur<br />
Presentation to<br />
National Marijuana Initiative NMI<br />
Campaign Against Marijuana Planting CAMP<br />
2010 Conference<br />
California<br />
May 10 2010<br />
BARRY R McCAFFREY<br />
GENERAL USA RETIRED<br />
2900 South Quincy Street Suite 300A 2900 Soulh Quincy SUeel Suite 300A<br />
Adington VA 22206<br />
GEN 3arry R McCaf ey OSA Ret Alington VA 22206<br />
bm<br />
QmccafTreyacsociates com 10 May 2010 brm@mccaffreyassocia 703 824 5160 www<br />
mccatUeyassociates com 703 624 5160
90 OF AMERICANS DID NOT<br />
USE MARI UANA LAST YEAR<br />
Marijuana is the most commonly used illicit drug According to the 2008 National<br />
Survey on Drug Use and Health 102 million Americans aged 12 or older have tried<br />
marijuana at least once in their lifetimes 41 <strong>of</strong> the US population<br />
The number <strong>of</strong> past year marijuana users in 2008 was approximately 258M103 <strong>of</strong><br />
the population the number <strong>of</strong> past month marijuana users was 15 2M61<br />
Among 12 17 year olds67 reported past month marijuana use 165 <strong>of</strong> 18 25<br />
year olds and42 <strong>of</strong> those aged 26 or older reported past month use <strong>of</strong> marijuana<br />
In 2008 there were 2M persons aged 12 or older who had used marijuana for the<br />
first time within the past 12 months this averages to about6000 initiates per day<br />
A 2002 SAMHSA report concludes that the younger children are when they first use<br />
marijuana the more likely they are to use cocaine and heroin and become dependent<br />
on drugs as adults<br />
Results <strong>of</strong> the 2008 Monitoring the Future survey indicate that 146 <strong>of</strong> eighth<br />
graders 29 <strong>of</strong> tenth graders and 426 <strong>of</strong> twelfth graders reported lifetime use <strong>of</strong><br />
marijuana<br />
GEN 6arry R McCaffrcy USA RcL<br />
10 May 2010<br />
www mccalt<br />
ryassociates com 2 Of 16
80 OF STUDENTS DID NOT<br />
USE MARI UANA LAST MONTH<br />
The 2007 Youth Risk Behavior Surveillance System YRBSS study by the<br />
Centers for Disease Control and Prevention CDC survey indicates that<br />
381 <strong>of</strong> high school students reported using marijuana at some point in<br />
their lifetimes<br />
Additional YRBSS results indicate that 197 <strong>of</strong> students reported current<br />
past month use <strong>of</strong> marijuana<br />
Approximately 475 <strong>of</strong> college students and 567 <strong>of</strong> young adults ages<br />
19 28 surveyed in 2007 reported lifetime use <strong>of</strong> marijuana<br />
According to data from the Bureau <strong>of</strong> Justice Statistics approximately 776<br />
<strong>of</strong> State prisoners and 712 <strong>of</strong> Federal prisoners surveyed in 2004 indicated<br />
that they used marijuana hashish at some point in their lives<br />
GHN 6arry R McCa Trey USA Re<br />
10 May 2010<br />
www meca teyassocia es com 3 Of 16
C C<br />
IF YOUR LIFE REQUIRES CLEAR THINKING<br />
CHRONIC MARI UANA USE WILL BE A PROBLEM<br />
Marijuana abuse is associated with many detrimental health efFects These efFects can<br />
include respiratory illnesses problems with learning and memory increased heart rate<br />
and impaired coordination<br />
A number <strong>of</strong> studies have also shown an association between chronic marijuana use<br />
and increased rates <strong>of</strong> anxiety depression suicidal ideation and schizophrenia<br />
Long term marijuana abuse can lead to addiction Withdrawal symptoms may include<br />
irritability sleeplessness decreased appetite anxiety and drug craving<br />
Someone who smokes marijuana regularly may have many <strong>of</strong> the same respiratory<br />
problems that tobacco smokers do such as daily cough and phlegm production more<br />
frequent acute chest illnesses a heightened risk <strong>of</strong> lung infections and a greater<br />
tendency toward obstructed airways<br />
Cancer <strong>of</strong> the respiratory tract and lungs may also be promoted by marijuana smoke<br />
Marijuana has the potential to promote cancer <strong>of</strong> the lungs and other parts <strong>of</strong> the<br />
respiratory tract because marijuana smoke contains 50 percent to 70 percent more<br />
carcinogenic hydrocarbons than does tobacco smoke<br />
Marijuana s damage to short term memory seems to occur because THC alters the way<br />
in which information is processed by the hippocampus a brain area responsible for<br />
memory formation<br />
EBa<br />
10 May 2010<br />
www<br />
mccafUeyassociates com 4 Of 16
MARI UANA USE CARRIES<br />
SIGNIFICANT HEALTH RISKS WHICH INCREASE<br />
AS THE DRUG S USEIN CREAS ES<br />
In one study researchers compared marijuana smoking and nonsmoking<br />
12th graders scores on standardized tests <strong>of</strong> verbal and mathematical skills<br />
Those who were heavy marijuana smokersie those who used marijuana<br />
seven or more times per week scored significantly lower in 12th grade than<br />
nonsmokers<br />
A study <strong>of</strong> college students found that among heavy users <strong>of</strong> marijuana<br />
critical skills related to attention memory and learning were significantly<br />
impaired even after they had not used the drug for at least 24 hours<br />
Of an estimated 113 million emergency department ED visits in the US<br />
during 2006 the Drug Abuse Warning Network DAWN estimates that<br />
1742 887 were drug related DAWN data indicate that marijuana was<br />
involved in 290 563 ED visits<br />
From 1997 to 2007 the number <strong>of</strong> admissions to treatment in which<br />
marijuana was the primary drug <strong>of</strong> abuse increased from 197 840 in 1997 to<br />
287 933 in 2007 Marijuana admissions represented 123 <strong>of</strong> the total drug<br />
alcohol admissions to treatment during 1997 and 158 <strong>of</strong> the treatment<br />
admissions in 2007<br />
fi<br />
GEN Barry R McCn lcy USA Re<br />
I O May 2010<br />
www<br />
mccatFreynssociates com 5 <strong>of</strong> 16
IF YOU GOT LOCKED UP FOR<br />
MARI UANA OFFENSES<br />
YOU WERE MOST LIKELY<br />
DOING SOME SIGNIFICCRIMINAL ACTIVITY<br />
T<br />
a<br />
According to the FBI there were an estimated total <strong>of</strong>1841 182 state and<br />
local arrests for drug abuse violations in the United States during 2007 Of<br />
these drug abuse violation arrests53 were for thesale<br />
manufacture <strong>of</strong><br />
marijuana and 421 were for marijuana possession<br />
According to the National Drug Intelligence Center there were5039 Federal<br />
marijuana related arrests during 2006<br />
During FY 2008 there were6337 Federal <strong>of</strong>fenders sentenced for marijuana<br />
related charges in US Courts Approximateiy 978 <strong>of</strong> these cases involved<br />
trafficking and 16 <strong>of</strong> cases involved simple possession<br />
The Arrestee Drug Abuse Monitoring ADAM program is designed to gather<br />
information on drug use and related matters from adult male <strong>of</strong>Fenders in 10<br />
US locations within 48 hours <strong>of</strong> arrest In 9 out <strong>of</strong> the 10 sites in 2008 45<br />
or more <strong>of</strong> the arrestees reported using marijuana within the past year<br />
GEN 6arry R McCalTrey USA ReL<br />
10 May 2010<br />
wwwmccalTmyassociamscom 6 Of 16
MARI UANA PRODUCTION AND<br />
TRAFFICKING IS DANGEROUS CRIMINAL<br />
AC TI VI TY DOMI NATED BY MEXICAN CARTELS<br />
sY<br />
The threat associated with marijuana trafficking and abuse is rising which is<br />
largely the result <strong>of</strong> a growing demand forhigh potency marijuana and a<br />
related increase in the drug s availability<br />
Most foreign source marijuana smuggled into the United States enters<br />
through or between points <strong>of</strong> entry at theUSMexico border During 2006<br />
more than 1 million KGs <strong>of</strong> marijuana were seized along the Southwest<br />
Border Cannabis cultivation in Mexico remains high and most <strong>of</strong> the<br />
marijuana produced in that country is destined for US drug markets<br />
There have been recent increases in cannabis cultivation and marijuana<br />
production within the United States<br />
According to <strong>of</strong>Ficers with the Forest Service and other agencies many <strong>of</strong><br />
California s illegal marijuana fields are controlled not by peace loving flower<br />
children but by employees <strong>of</strong> Mexican drug trafficking organizations carrying<br />
high powered assault weapons<br />
GHN 6arry R McCaffrey USA Ret<br />
IO May Z6 0<br />
www<br />
mccaRreyassociatescom 7 Of 16
x 1<br />
P<br />
e<br />
DRUG USE IS NOT INEVITABLE<br />
Dru prevention is a must and it must start at the kitchen table be on the<br />
curriculum in schools and be reinforced in athletic programs religious<br />
programs pediatric <strong>of</strong>fices and in extra curricular activities<br />
Kids that are busy are less likely to abuse drugs the most dangerous time<br />
for kids is when they are home unsupervised after school<br />
Prevention programs must be fact based<br />
have been demonstrated to be effective<br />
there are lots <strong>of</strong> programs that<br />
Parent led and community supported programs are essential<br />
Californians for Drug Free YouthDARE Illinois Drug Education Alliance<br />
and many other prevention organizations are determined to keep our kids<br />
drug free<br />
GEN Barry R McCa Frey USA Ret<br />
10 Muy 2010<br />
www<br />
mccafGeyussuciates com 8 Of 16
1<br />
MARI UANA DOES NOT HAVE SCIENTIFICALLY<br />
DEMONSTRATED MEDICAL VALUE<br />
Marijuana is a Schedule I substance under the Controlled Substances Act Schedule I<br />
drugs are classified as having a high potential for abuse no currently accepted medical<br />
use in treatment in the United States and a lack <strong>of</strong> accepted safety for use <strong>of</strong> the drug<br />
under medical supervision<br />
In the case <strong>of</strong> United States v Oakland Cannabis Club the US Supreme Court ruled<br />
that marijuana has no medical value as determined by Congress The opinion <strong>of</strong> the<br />
court stated that In the case <strong>of</strong> the Controlled Substances Act the statute reflects a<br />
determination that marijuana has no medical benefits worthy <strong>of</strong> an exception outside<br />
the confines <strong>of</strong> a government approved research project The case reached the US<br />
Supreme Court after the federal government sought an injunction in 1998 against the<br />
Oakland Cannabis Buyers Cooperative and five other marijuana distributors in<br />
California<br />
The United States Court <strong>of</strong> Appeals for the District <strong>of</strong> Columbia Circuit issued a ruling<br />
on May 24 2002 upholding DEA s determination that marijuana must remain a<br />
schedule I controlled substance The Court <strong>of</strong> Appeals rejected an appeal that<br />
contended that marijuana does not meet the legal criteria for classification in the most<br />
restrictive schedule I<br />
GEN Barry R McCaffrey USA Ret<br />
10 May 2010<br />
www<br />
mccatTreyassocia es com 9 <strong>of</strong> 16
A<br />
k x<br />
i J<br />
INHALED MARI7UANA SMOKE IS DANGEROUS<br />
Marijuana as a smoked product has never proven to be medically beneficial Marijuana<br />
smoke is a crude THC delivery system that also sends many harmful substances into<br />
the body<br />
In 1999 the Institute <strong>of</strong> Medicine IOM published a review <strong>of</strong> the available scientific<br />
evidence in an effort to assess the potential health benefits <strong>of</strong> marijuana The review<br />
concluded that smoking marijuana is not recommended for any long term medical use<br />
and marijuana is not a modern medicine<br />
Pot advocates claim that marijuana can alleviate numerous maladies including vaginal<br />
pain genital herpes writer s cramp impotence nightmares color blindness<br />
constipation and diarrhea<br />
Medicines should not approved in this country by popular vote Before any drugs can<br />
be released for public use they must undergo rigorous clinical trials to demonstrate<br />
they are both safe and effective and then be approved by the Food and Drug<br />
Administration Our investment and confidence in medical science will be seriously<br />
undermined if we do not defend the proven process by which medicines are brought to<br />
market<br />
GEN Barry R McCa irey USA ReL<br />
10 Muy 2010<br />
wwwmccallieyassocia es com 10 Of 16
MEDICAL POT HAS BEEN A STALKING HORSE<br />
FOR THE NORMALIZATION OF MARI UANA USE<br />
7<br />
In California there is no state regulation or standard <strong>of</strong> the cultivation and or<br />
distribution <strong>of</strong> inedical marijuana Establishment <strong>of</strong> guidelines is up to local<br />
jurisdictions which can widely vary Marin County allows up to six mature<br />
plants and or a half pound dried mariJuana Its neighbor Sonoma County<br />
permits possession <strong>of</strong> three pounds <strong>of</strong> marijuana and allows cultivation up to<br />
99 plants and doctors may recommend more for exceptional patients<br />
Local and state law enforcement counterparts cannot distinguish between<br />
illegal marijuana grows and rows that qualify as medical exemptions Most<br />
self designated medical mari uana growers are in fact growing mari uana for<br />
ilegal recreational use<br />
Elected law enforcement <strong>of</strong>ficialsie Sheriffs and District Attorneys in<br />
California have been targeted by the marijuana lobby<br />
Law enforcement agencies routinely report that large scale drug traffickers<br />
hide behind and invoke Proposition 215 even when there is no evidence <strong>of</strong><br />
any medical claim<br />
GEN 6arry R McCalTrey USA RCt<br />
10 Mag 2010<br />
www mccnEF eyassocia es com 11 <strong>of</strong> 16
THE MEDICAL AND SCIENTIFIC<br />
COMMUNITIES SAY NO<br />
The DEA and the federal government have strong scientific support to view smoked marijuana as<br />
having no documented medical value<br />
The American Cancer Society does not advocate inhaling smoke nor the legalization <strong>of</strong> marijuana<br />
The American Academy <strong>of</strong> Pediatrics AAP believes that a change in the lega status <strong>of</strong> marijuana<br />
even if limited to adults could affect the prevalence <strong>of</strong> use among adolescents<br />
The National Multiple Sclerosis Society NMSS states that studies done to date have not provided<br />
convincing evidence that marijuana benefits people with MS<br />
The British Medical Association BMA voiced extreme concern that down grading the criminal<br />
status <strong>of</strong> marijuana would mislead the public into believing that the drug is safe The BMA<br />
maintains that mariJ uana has been linked to greater risk <strong>of</strong> heart disease lung cancer bronchitis<br />
and emphysema The 2004 Deputy Chairman <strong>of</strong> the BMA s Board <strong>of</strong> Science said that the public<br />
must be made aware <strong>of</strong> the harmful effects we know result from smoking this drug<br />
The American Academ <strong>of</strong> Pediatrics asserted that from a public health perspective even a small<br />
increase in fmarijuana use whether attributable to increased availability or decreased perception<br />
<strong>of</strong> risk would have significant ramifications<br />
The Institute <strong>of</strong> Medicine IOM reported that smoked marijuana<br />
is a crude THC delivery<br />
system that also delivers harmful substances The study concluded that there is little future in<br />
smoked marijuana as a medically approved medication<br />
GHN Barry R McCafTrey USA Re<br />
I O May 20I0<br />
www mcwll<br />
reyassociates com 12 Of 16
C<br />
MARINOL IS MEDICINE<br />
POT IS NOT<br />
Medical marijuana already exists It s called Marinol a pharmaceutical product<br />
Marinol is widely available through prescription<br />
It comes in pill form Alternate means<br />
<strong>of</strong> delivery such as an inhaler or patch are being studied Its active ingredient is<br />
synthetic THC which can relieve the nausea and vomiting associated with<br />
chemotherapy and assist with loss <strong>of</strong> appetite<br />
Unlike smoked marijuana which contains more than 400 different chemicals<br />
including most <strong>of</strong> the hazardous chemicals found in tobacco smoke Marinol has been<br />
studied and approved by the medical community and the Food and Drug Administration<br />
FDA<br />
Since the passage <strong>of</strong> the 1906 Pure Food and Drug Act any drug that is marketed in<br />
the United States must undergo rigorous scientific testing This approva process<br />
verifies claims <strong>of</strong> drug safety and therapeutic value<br />
There are no FDA approved medications that are smoked Smoking is a poor way to<br />
deliver medicine The harmful chemicals and carcinogens that are byproducts <strong>of</strong><br />
smoking create entirely new health problems There are four times the levei <strong>of</strong> tar in a<br />
marijuana cigarette than in a tobacco cigarette<br />
GEN Barry R McCa ftey USA Ret<br />
10 May Z010<br />
www<br />
mccaCGeyassociates cum 13 Of 16
LAW ENFORCEMENT AGENCIES AND<br />
COALITIONS MUST PROTECT OUR COMMUNITIES<br />
FROM ILLEGAL DRUGS AND DRUG TRAFFICKERS<br />
f<br />
The mission <strong>of</strong> the National Mari uana Initiative NMI is to detect deter<br />
disrupt and dismantle drug trafFicking organizations DTO responsible or<br />
domestic marijuana production<br />
NMI coordinates investigative interdiction and intelligence operations among<br />
federal state and local law enforcement agencies to promote a unified<br />
strategy identify best practices and provide oversight and expertise<br />
Since its inception in FY01 the NMI has provided funding training and<br />
intelligence support to 220 federal state and local law enforcement and land<br />
mana ement agencies to advance their efforts to combat the DTOs These<br />
agencies have dedicated personnel to establish multi agency task forces<br />
The results are that over 36 million marijuana plants with an estimated street<br />
value <strong>of</strong> 72 billion dollars have been eradicated and 43 DTOs have been<br />
dismantled<br />
GEN 6zrry R McCatGey USA Ret<br />
10 May 2010<br />
www mcca lreyassociates rom 14 Of 16
a<br />
CAM P MAKES OU R SOCIETY<br />
SAFER AND BETTER<br />
The goal <strong>of</strong> the California Campaign Against Marijuana Planting CAMP<br />
program is to eradicate marijuana illegally cultivated and trafficked in<br />
California<br />
CAMP seizes more marijuana than any other single organization in the United<br />
States 4m plants worth 17 8B seized in 2009 This phenomenal<br />
success is attributable to its partnership with the National Guard DEA<br />
ONDCP and more than 75 federal state and local agencies<br />
In addition to eradicating marijuana plants CAMP provides critical training to<br />
law enforcement agencies throughout California including federal agencies<br />
CAMP also educates the public about the dangers <strong>of</strong> marijuana cultivation<br />
and its devastating impact on our environment<br />
OEN Barry R McCaffrey USA Ret<br />
10 May 2010<br />
www<br />
mccaCGeyassociates com 15 Of 16
k<br />
POT AND THE POLITICAL PROCESS<br />
California has 30 plus years <strong>of</strong> experience for better or worse with referendum<br />
propositions that fundamentally affect how society is organized and governed<br />
Passionate well funded advocates can hijack the system to attain goals that are<br />
unachievable through other channels<br />
The ballot box should not be the vehicle for determining what is a safe and effective<br />
medicine<br />
Pro pot advocates did not seek to legalize marijuana possession and usage 10 or 15<br />
years ago via proposition 215 because they knew they would not succeed<br />
There were more marijuana dispensaries in San Francisco than Starbucks c<strong>of</strong>fee shops<br />
i n 2008<br />
Marijuana legalization legislation will soon be a reality unless concerned Californians act<br />
now<br />
Drugs are not harmful because they are illegal<br />
harmful<br />
they are illegal because they are<br />
GEN ea ry R McCaffrey USA Ret<br />
10 May 2010<br />
www mceati<br />
reyassociateacom 16 Of 16
Substances in both Schedules I and I I are su6ject to the greatest restrictions because they haveahigh potential<br />
for abuse For the most part these restrictions are similar for example bulk manufacturers <strong>of</strong> Schedule I or<br />
II substances are subject to produc ion quotas manufacturers <strong>of</strong> finished dosage forms produc s containing<br />
Schedule I or II substances are subject to procurement quotas eecause they have no accepted medical<br />
use Schedule I<br />
research programs<br />
substances are subject to some additional restrictions and may only be used in FDA approved<br />
Under the CSA Schedule II Placement Does Not Make a Substance Available for<br />
Direct Use By Patients<br />
The CSA schedules contain basic types or classes <strong>of</strong> substances such as oxycodone not specific products<br />
such as OxyContin0 or Fentora0 although each new branded medication undergoes a scheduling analysis<br />
as part <strong>of</strong> the FDA approval process Placement <strong>of</strong> a substance in Schedule II is not sufficien to allow a specific<br />
79 Examples <strong>of</strong> Schedule I botanical materials dassified as hallucinogens are marijuana cannabis psilocybin and<br />
ibogaine Pure synthetic THC is also in Schedule L<br />
u GER I13o8 11<br />
40 A drug s potential for abuse is a threshold issue in determining the schedule into which he drug may be placed The<br />
term is not defined in the CSA but the legislative history demonsirates that the following factors are indicators that a drug<br />
or other substance has a potential for abuse<br />
There is evidence ha individuals are taking he drug or other substance in amoun s sufficient to veate a hazard to<br />
their health or to the safety <strong>of</strong> other individuals or to the community<br />
There is significant diversion <strong>of</strong> fie drug or other subs ance from legitimate drugs channels<br />
Individuals are taking che drug or other substance on cheir own iniciacive rather than on the basis <strong>of</strong> inedical advice<br />
from a practitioner licensed by law to administer such drugs or<br />
The drug is a new drug so related in its action to a drug or other subscance already listed as having a potential for abuse<br />
to make it likely chatthe drugwill have che same poteneial for abuse as such drugs thus malcing it reasonable to assume<br />
that there may be significant diversions from legitimate channels signifiwnt use contrary to or without medical advice<br />
or that it has a substantial capability <strong>of</strong> creating hazards to the heal<br />
<strong>of</strong> the user or to the safety <strong>of</strong> he community<br />
Of course evidence <strong>of</strong> acival abuse <strong>of</strong> a substance is indicative that a drug has a potential for abuse<br />
H R Rep No 1444 91st Cong zd Sess 1970 reprinted in 1970 US Code Cong Ad News 4566 4601<br />
41 u CFR 13o3 u the registration application <strong>of</strong> a bulk manufacturer must pass through a noiice publication in the<br />
Federal Register and commen procedure 21 CF R 1301 33<br />
4 zlCFR 130312<br />
43 Substances in Schedule IIV have an accepted medical use Substances in schedules III V also have lower abuse potential<br />
and are subjec to fewer restrictions Interestingly in California wnnabis remains in Schedule I <strong>of</strong> the sta e controlled<br />
substances law despite the fact that it has been decriminalized for imited medical use Calif Health Safeiy Code<br />
uosa di3<br />
zoo9 Marijuana Dispensaries<br />
and the Federal Government i7
product containing the substance to be marketed and distributed directly o patients The latter requires FDA<br />
approval<br />
In order for a substance to move from Schedule I to Schedule 11 che DEA must determine that it has an accepted<br />
medical use In order for a substance to have an accepted medical use the following criteria must be met<br />
1 Its chemistry must be known and reproducible<br />
z There must be adequate safety studies<br />
3 There must be adequate andwell controlled studies proving efficacy<br />
4 It must be accepted by qualified experts and<br />
5 The scientific evidence must be widely available<br />
These criteria can only be me by data <strong>of</strong> very high scientific quality essentially equivalent to the data that must<br />
be generated in order for a specific finished product to achieve FDA approval Ae a practical matter therefore<br />
the scheduling <strong>of</strong> new controlled substances generally occurs only after or simultaneously with FDA approval<br />
<strong>of</strong> products containing those substances<br />
FDA Approval is Required in Order for a Specific Finished Medication to be Marketed<br />
and Distributed to Patients<br />
By contrast to the CSA s scheduling <strong>of</strong> substances rather than individual products the FDA approves only specific<br />
products for marketing and distribution to patients<br />
The FDA does not approve pure active pharmaceutical<br />
ingredien s APIs nor crude herbal substances such as narcotic raw materials NRM Only a finished dosage<br />
form containing a specific type <strong>of</strong> controlled substance can obtain FDA approval and become a<br />
prescription<br />
medication<br />
44 See 57 Fed Reg 10499 10506 March 26 1992 See Alliance forCannabrs Theropeutics v DEA i5 F3d ii3i DC Cir i994<br />
The DEA originally developed these criteria during the scheduling <strong>of</strong> MDMA 53 Fed Reg Si56 Feb zz i98S Grinspoon v<br />
Drug EnforcementAdministratioq 8z8 Fid 881 ls Cir 1987<br />
45 Hence FDA approval <strong>of</strong> a specific finished product is generally sufficient m establish an accepted medical use for the<br />
substance contained therein There are rare exceptions See eg dronabinol synthetic in sesame oiI and encapsulated<br />
in a s<strong>of</strong>t gela in wpsule in a US Food and Drug Administtation approved producY is in Schedule III and has a Drug Code <strong>of</strong><br />
7369 Zi GER jli3oS i3g whereas pure synthetic THC remains in Schedule I with a Drug Code <strong>of</strong> 7370 2iCFR jii3o8<br />
d<br />
See Si Fed Reg 1746 May 13 1986 64 fed Reg 359z8 Quly 2 i999 dronabinol product FDA approved products con aining<br />
GHB are in Schedule III while stree GHB is in Schedule I 65 Ped Reg1i35 March 13 2000 Pub L 106 172 GHB Hence<br />
a formulated cannabis derived produc tould be placed in Schedule II or III after FDA approval while crude herbal annabis<br />
could remain in Schedule I<br />
46 FDA approval is not techniwlly a legal precondition to rescheduling Grinspoon supro at p 8991<br />
47 See eg tapentadol The finished pharmaceutical product manufacmred by Johnson Johnson was approved by the<br />
FDA in November 2008 DEA has issued a proposed rule placing tapentadoi into Schedule 11 74 Fed Reg 7386 Feb i7 zoo9<br />
The finished product does noc yet have a tradeie branded name<br />
18 2009 Marijuana Dispensaries and the Federal Government
u<br />
r<br />
pr s<br />
jr cd vdx IM ti7TrArs<br />
INW7c Mmrf<br />
7fR<br />
r<br />
k<br />
5<br />
M<br />
w<br />
Frs9d<br />
s<br />
zbaui<br />
yfJH a<br />
l<br />
r<br />
Candy bars rontaining cannabis seized as<br />
eviGente From dispensarics in San Dic o<br />
December 2005<br />
This applies to cannabis as well as to other controlled substance plant materials In ig7o at the time it enacted<br />
the CSA Congress placed opium and coca leaves in Schedule II <strong>of</strong> the CSA because modem standardized<br />
and refined medical products derived from these substances were already oo the market Such schedule II<br />
placement did not put crude opium or coca leaves on the pharmacy shelves Opium and concentrate <strong>of</strong> poppy<br />
straw CPS contain different concentrations <strong>of</strong> alkaloids such as morphine hebaine and oripavine These<br />
alkaloids are themselves considered Schedule II substances from which final pharmaceutical products are<br />
developed If a dispensary were to attempt to cultivate and distribute crude opium or coca leaves it is beyond<br />
doubt that the DEA would have both the authority and the obligation to ake action against such conduct<br />
whether or not that activity was decriminalized under state law<br />
48 Under the CPS method used by all cultivating countries except India the plant is allowed to go ro seed purtiorts <strong>of</strong><br />
the plani are then processed into a concentrate It is generally believed that CPS is less divertible than opium CPS may be<br />
rich in morphine hebaine or oripavine See DEA AUthorized Sources <strong>of</strong> Narcotit Raw Materials 73 Fed Reg 6843 Feb<br />
6 2008<br />
49 Thebaine is used to manufacture oxycodone which in wm can be used to manufacture hydromorphone oripavme is<br />
used to make buprenorphine as well as naloxone an opioid antagonistJ id See 7z Fed Reg 54ZO8 Sept 24 Zoo7 oripavine<br />
scheduted separately in Schedule 71 rather than as a derivative <strong>of</strong> thebaine to comply with ihe USs obligations under<br />
the Single Convention<br />
2009 Marijuana Dispensaries<br />
and the Federal Government 19
THE SCIENTIFIC PROCESS<br />
Crude Herbal Cannabis and Unstandardized Cannabis Preparations Do Not Meet the<br />
Standards <strong>of</strong> Modern Medicine<br />
The Institute <strong>of</strong> Medicine IOM has recognized that crude herbal cannabis has little future as a true<br />
medication<br />
Although marijuana smoked delivers THC and other cannanbinoids to the body it also delivers harmful<br />
substances including most <strong>of</strong> those found in tobacco smoke<br />
In addition plants contain a variable<br />
mix ure <strong>of</strong> biologically active compounds and cannot be expected to provide a precisely defined drug<br />
efFect<br />
For those reasons there is little future in smoked marijuana as a medically approved medication<br />
If there is any future in cannabinoid drugs i lies with agents <strong>of</strong> more cercain not less certain<br />
composition<br />
The IOM stressed that the purpose <strong>of</strong> clinical trials <strong>of</strong> smoked marijuana would not be to develop marijuana as a<br />
licensed drug but rather to serve as a first step toward the development <strong>of</strong> nonsmoked rapid onset cannabinoid<br />
delivery systems<br />
The FDA agrees hat crude herbal cannabis is not a medication The California Medfcal Association recently<br />
announced its intention tore examine the need for continued research on smoked herbal cannabis in light <strong>of</strong><br />
So Joy JE Watson SJ Benson A r eds Marijuona and Medicine Assessing he Science Base Washington DC Ins itute <strong>of</strong><br />
Medicine 1999 atpp 177 78 hereafter Marijuana and Medicine<br />
Si CurrenNy popular vaporizers eliminate some but no all potentially harmful polyaromatic hydrocarbons Gieringer<br />
D St LaurentJ Goodrich S Cannabis Vaporizer Combines Efficient Delivery <strong>of</strong> THC with Efrective Suppression <strong>of</strong> Pyrolytic<br />
Compounds Joumal <strong>of</strong> Cannobis Theropeutics z004417i7 Vaporizers are also not efficient as a delivery devite<br />
Hazekamp A Ruhaak R Zuurman L van Gerven J Verpoorte R Evaluation <strong>of</strong> a Vaporizing Device Volcano for the<br />
Pulmonary Administration <strong>of</strong> Tetrahydrocannabinol Joumol <strong>of</strong> Pharm Sci zo06 une956i3o8 i7 See also McCarberg<br />
W Cannabinoids Their Role in Pain and Pallia ion fournpl <strong>of</strong> Pain G PoHip ive Cpre PharmpcoCherapy 2oo7 213 19 28<br />
vaporiza ion provides no assurance <strong>of</strong> consistency <strong>of</strong> dose or quality with unstandardized plant material Id at p 11<br />
Sz In zooi in rejecting a pecition for che rescheduling <strong>of</strong> marijuana<br />
the FDA stressed<br />
The agency cannot condude hat marijuana has an acceptable level <strong>of</strong> safety without assurance <strong>of</strong> a consistent and<br />
predictable potency and without pro<strong>of</strong> that the substance is free <strong>of</strong> contamination If marijuana is to be investigated<br />
more widely for medical use informacion and data regarding the chemistry manufacturing and specifications <strong>of</strong><br />
marijuana must be developed<br />
DEA Notice <strong>of</strong> Denial <strong>of</strong> Petition 66 Fed Reg 20038 20045 April 18 z0oi The agency more recently confirmed its posi ion<br />
FDA Interagency Advisory Regarding Claims That Smoked Marijuana is a Medicine April ioo4 http www fda gov bbs<br />
topics news 2oo6 newoi36z html<br />
zo<br />
zoo9 Marijuana Dispensaries<br />
and the Federal Government
ecent research on its benefits and harm and the long term prospect <strong>of</strong> smoked herbal canna6is as a medicine<br />
The DEA also acknowledges the need for standardized product<br />
Herbal cannabis should comprise only the starting material from which a bono fide medical product<br />
is ultimately derived f5ltandardizing herbal statting material represen<br />
only the first <strong>of</strong> manyseps<br />
necessary o create a modern medicine that is safe and effective for use in specific medical conditions<br />
A1 final medical product must also be delivered in a dosage form that is consis ent in composition and<br />
that allows the patien o obtain an identifiable and reliable amount <strong>of</strong> inedication<br />
Only Recently Has Technology Made Possible the Development <strong>of</strong> Modern Cannabis<br />
derived and Cannabinoid Medications<br />
There are good reasons why the development <strong>of</strong> cannabis derived medications has<br />
<strong>of</strong> synthetic and naturaliy derived opioids and other modern medicatians<br />
lagged far behind that<br />
Given that the active ingredients<br />
morphine codeine <strong>of</strong> opium are water soluble it was relatively simple in the 19th and early 2oh centuries<br />
to isolate them and develop standardized and purified medications with the technologies that existed at tha<br />
time<br />
The story <strong>of</strong> cannabis is quite different Cannabinoids especially THC are lipophilicie not water soluble<br />
and unstable making it difficult for early scientists to identify and isolate the active ingredients Consequentiy<br />
potentially therapeutic appiications were limited to oral preparation <strong>of</strong> cannabis tinctures and extracts<br />
which could not be adequately standardized Patient response was variable and unpredictable As more<br />
modern medicines became available these unreliable extracts and tinctures fell ou <strong>of</strong> favor with the medical<br />
pr<strong>of</strong>ession<br />
53 California Medical Association ON CALL document 1315Jn 2009ht pJwww cmanet org<br />
54 DEA Lyle E Craker Denial <strong>of</strong> Application 74 Fed Reg 2101 2105 Jan i4 2009 citing Letter from Alice P Mead GW<br />
Pharmaceuticals PLC o Christine V 8eato Acting Asst Sec for Heal h HHS Apr 12 2005<br />
SS As technologies advanceA syn hetic medicines appeared neceesitating he promulgation <strong>of</strong> a<br />
Psychotropic Convention <strong>of</strong> i971<br />
subsequen treaty the<br />
56 Cannabis was generally not smoked at that time for medical purposes<br />
57 Unlike cannabis the medicinal and reveational forms <strong>of</strong> opium were dearly distinct Had medical technology been<br />
advanced enough at chat time to allow cannabinoids to be identified formulated and delivered he medicol marijuana<br />
movement would probobly not hove occurred As with the opium poppy prescription cannabinoid medications and crude<br />
herbalcannabiswouldhavebeenusedinverydifferentvenues McCarberg<br />
WHand6arkinRL TheFU<br />
ure<strong>of</strong>Cannabinoids<br />
as Analgesic Agents A Pharmacologic Pharmacokinetic and Pharmacodynamic Overview 200 American Joumal <strong>of</strong><br />
Theropeutics i45 475 483 476 emphasis added<br />
Zoo9 Marijuana Dispensaries and the federal Government 21
The modern era <strong>of</strong> cannabinoid research was in its infancy in 1964 When the primary psychoactive ingredient <strong>of</strong><br />
cannabis THC was isolated and then synthesized a Beginning in 1989 a robus body <strong>of</strong> cannabinoid research<br />
began o develop foliowing scientists discovery <strong>of</strong> the human cannabinoid receptor system This delay in<br />
the development <strong>of</strong> modern cannabinoid and cannabis derived medicationshas therefore been caused more<br />
by past technological limitations than by governmental obstructionism That development gap is now slowly<br />
closing and there is no justification for affording a<br />
cannabis<br />
non scientific accelerationieafree pass to herbal<br />
This evolution has followed the same principles as the evolution <strong>of</strong> drug therapy in general The<br />
direction has been away from crude substances <strong>of</strong> variable composition stability and potency toward<br />
the development <strong>of</strong> progressively more specific or selectively active pure compounds chat permic more<br />
precise dosage and reduced risk <strong>of</strong> unwanted side effects<br />
This is<br />
not to say that complex botanically derived preparations cannot pass FDA muster<br />
There is strong<br />
evidence that some properly tested and standardized plant preparations including those derived from cannabis<br />
may <strong>of</strong>fer different and better pharmacological efFects than a pure synthesized cannabinoid alone<br />
The FDA has recognized that there is burgeoning scientific and public interestin botanically based products<br />
and that modern technology makes it possible to develop medications <strong>of</strong> botanical origin in order to guide the<br />
development <strong>of</strong> such products the agency has set forth the criteria that must be met to achieve FDA approval b<br />
While allowing some Flexibility at the early stages <strong>of</strong> inedication developmen the guidance specifically states<br />
that by the time <strong>of</strong> Phase 3<br />
clinical studies b the requirements for a<br />
botanical drug product are virtuaNy<br />
the same as to those that apply to a new chemical entity NCE Botanical Raw Material BRM such as<br />
herbal cannabis has no been formula ed incorporated into a specific dosage form and tested through his<br />
demanding NCE process The FDA guidelines make it quite clear that even if crude herbal cannabis were moved<br />
to Schedule II it could no thereby be marketed and distributed directly to patients<br />
58 Gaoni Y Mechoulam R ISOlation Siruc ure and Partial Synihesis <strong>of</strong> an Active Constituen <strong>of</strong> Hashish JournalAm Chem<br />
Soc 196486 1646 7<br />
S9 Devane WA Hanus L 6reuer A Pertwee RG Stevenson LA Griffin G et al Isolation and Structure <strong>of</strong> a<br />
Brain Consti uent<br />
hat Binds to he Cannabinoid Receptor Science 199zZ58 5090 1946<br />
Howle t AC Johnson MR Melvin LS Milne GM<br />
NOndassical Cannabinoid Analgetics Inhibit Adenylate Cydase Development <strong>of</strong> a Cannabinoid Receptor Model Molecular<br />
Pharmacology i988 Mar33Z97 3o2<br />
6o Kalant H Smoked Marijuana as Medicine Not Much Future Clinica Phormpcology G Therppeutics April 2008 834<br />
517 519 517<br />
61MPartland JM Russo EB Cannabis and Gannabis Extracts Greater Than the sum <strong>of</strong> Their Parts7 JournaloConnobis<br />
Therapeutics 2ooii34io3 i3Z<br />
6z FDA Guidance for Industry Botanical Drug Products 2o04htp www fda gov cder guidance 459zfnl pdf hereinafter<br />
Botanical Guidance at p 34<br />
botanical product submitted for marketing approval as a drugwill be treated like any other<br />
new drug under developmentPrevious human experience may be insufficient to demonstrate the safery <strong>of</strong> a botanical<br />
product especially when it is indicated for chronic herapy<br />
63 This is the last stage <strong>of</strong> human research before the submission <strong>of</strong> a marketing application or NDA<br />
zz<br />
zoo9 Marijuana Dispensaries and the Federal Government
The Administration Should Respect and Support the Proper Workings <strong>of</strong> the Scientific<br />
Process<br />
As a<br />
result <strong>of</strong> modern technologies and as demonstrated by the receptor research mentioned above there<br />
is significant interest wi hin the scientific and medical communities in cannabinoid research<br />
Scien ists are<br />
moving as expedi iously as possible to bring new cannabinoid products to market Time is required however for<br />
such research to be conducted in accordance with modern medical standards In keeping withis commitment<br />
to science his Administration should do nothing 2o discourage these efforts As Presiden Obama has stated<br />
Medical miracles do not happen simply by accident They result from painstaking and costly research<br />
from years <strong>of</strong> lonely trial and error much <strong>of</strong> which never bears fruit and from a government willing to<br />
support that work<br />
The United States is indeed supporting such work in this area For example the FDA has allowed a cannabis<br />
derived produa to enter into advanced clinical trials in the US For the pas ten years research has been<br />
underway in the Uni ed Kingdom by GW Pharmaceuticals to develop a range <strong>of</strong> prescription medications derived<br />
from the components <strong>of</strong> the cannabis plant GW cul ivates particular strains <strong>of</strong> cannabis that have been<br />
bred to express specific ratios <strong>of</strong> cannabinoids<br />
in order to maintain the consistency <strong>of</strong> the plants chemical<br />
composition they are grown by clones cuttings underhighly<br />
standardized and computer controlled conditions<br />
in secure glasshouses GW exvacts the pharmacologically active components <strong>of</strong> the plant removes waxes and<br />
other unwanted constituents and formulates the resulting botanical drug substance into a final dosage form<br />
<strong>of</strong> specified composition which is characterized by various standard chromatographic techniques<br />
The company s lead product Sativex0 is an oromucosal inside <strong>of</strong> the mouth spray composed primarily <strong>of</strong> THC<br />
and CBD<br />
It is believed that this combination has distinct and important pharmacological activity The product<br />
has already been approved in Canada for neuropathic pain in multiple sderosis and for cancer pain The DEA<br />
has licensed the importer b ar d the research sites<br />
A number <strong>of</strong> other companies including Alexa Pharmaceuticais Inc THC aerosol producq Aphios naturally<br />
derived THC producq and Insys Therapeutia Inc are also developing cannabinoid products in the US All<br />
64 Montopoli B Obama Announ es Stem Cell Decision CBS News PoliUCal Hotsheet Mar 9 20o9 President Obama<br />
remarks in full at p 2<br />
65 GW Pharmaceuticals Research Development Cannabis Cultivationhttp www gwpharm com research cultivation<br />
asp<br />
66 The origina reg rstration was originally granted in 2006 71 Fed Reg 64298 NOV 1 2006 and waS recently renewed 73<br />
Ped Reg 9589 Feb u zo08 Clinical rials began in November zoo7http www gwpharm com states asp<br />
67 Such efforts are not confined to the US see eg Echo Pharmaceuticals the Netheriands Namisol a naturally<br />
derived THC in sublingual cablet form The US through NIDA has also provided research grade cannabis to a number<br />
<strong>of</strong> researchers whose studies have been funded by grants from the Center <strong>of</strong> Medicinal Cannabis Research which is based<br />
at the University <strong>of</strong> California San Diego The results <strong>of</strong> a<br />
number <strong>of</strong> these studies have been published www cmcr ucsd<br />
zoo9 Marijuana Dispensaries<br />
and the Federal Government z3
<strong>of</strong> these research programs are moving through the conventional domestic regulatory process sF<br />
None is<br />
attempting to distribute crude herbal cannabis ornon<br />
standardized botanical preparations to pharmacies<br />
and patients<br />
These research programs indicate that cannabis derived medications can and therefore should<br />
be developed within che parameters <strong>of</strong> modern regulatory oversight Allowing a proliferation <strong>of</strong> cannabis<br />
dispensaries would undermine these efforts o bring properiy tested medications to market a<br />
with this Administration<br />
position tha its policies should be based on sound science<br />
result at odds<br />
Developing properly standardized and<br />
tested cannabis derived or cannabinoid medications is not an easy<br />
matter it requires patience perseverance and a commitment <strong>of</strong> substantial resources But numerous medical<br />
cragedies have proven that shortcuts to the FDA process do a disservice to patient safety and well being The<br />
FDA drug approval process is not perfect as demonstrated by recent news about previously unknown dangers<br />
<strong>of</strong> marketed medications such as VioxxOO<br />
The lesson <strong>of</strong> these experiences however is not tha we should<br />
do less testing or lower our current standards for prescription medicines Indeed those incidents have led to<br />
demands for greater oversight by the FDA and recently for the establishment <strong>of</strong> an independent ins itute o<br />
examine the comparative safety and effectiveness <strong>of</strong> inedica ions<br />
eduJgeninfo marijuana htm and reepond o the IOM ssatemens that such dinical trials serve as a first step oward the<br />
development <strong>of</strong> nonsmoked rapid onset cannabinoid delivery systems Marijuana and Medicine supra at p 11<br />
68 Indeed even che scaunchest herbal cannabis advocates are recognizing the need to develop seandardized cannabis<br />
pharmaceutical products with innovative formulationshttp www phytiva com<br />
69 The path <strong>of</strong> Cannasa is instructive Cannasat the only firm in Canada devoted to the development <strong>of</strong> cannabinoid<br />
medications initially extolled the benefrts <strong>of</strong> herbal cannabis plant material Recently it sold <strong>of</strong>f its ownership interests in<br />
the cannabis cultivation program operated under con ract from Health Canada and is developing synthetic cannabinoids<br />
with proprietary formulations and drug delivery technologieshttp www<br />
cannasaccom news Shtml http www<br />
cannasat com<br />
70 The Instiw e <strong>of</strong> Medicine has described the many financial and oher challenges that would be faced by a developer<br />
<strong>of</strong> fegitimace cannabis derived pharmaceutical products even iF a parallel informal rystertt <strong>of</strong> dispensaries did not exist<br />
To allow such dispensaries would increase these disincentives and poten ially prevent the US from responding mhe<br />
IOM s call for the development <strong>of</strong> rapid onset altemative delivery systems for cannabis or cannabinoid based products<br />
Marijuana and Medicine supra at pp 193 zi9<br />
i For example the Elixir Sulfanilamide disaster led to the enac ment <strong>of</strong> the 1938 Food Drug Cosmetic Act PDCA June<br />
15 1938 c675 SZ Stat 1040 which required among other hings that new drugs be tested for safety before marketing<br />
The chalidomide vagedy in Europe led co the passage <strong>of</strong> the Drug Amendments <strong>of</strong> i962 Pub L 87 78i sec i Oct io i962<br />
76 Stat 780 also known as the Kefauver Harris Amendmen s which required that produca be proved to be both safe and<br />
effective before marketing<br />
7Zhttp www fda gov<br />
cderJdrugJinfopageJCOX2 defaulLhtm FDA Estimates Vioxx Caused 27J85 Deaths Nov 4 2ooq<br />
hxtp www cons u m eraffa irs com newso4 vioxx esti mates htmI<br />
73 Walker EP5imulus 8ill Gives 1 8illion for Comparative Efiectiveness Research MedPage Today feb 19 2009<br />
24 zoo9 Marijuana Dispensaries and the FeQeral Government
The FDA Has Limited Power to Protect Patients Who Seek Medical Treatment and<br />
Advice From Cannabis Dispensaries<br />
The FDA has limited jurisdiction to address the dangers posed by cannabis dispensaries<br />
The provisions <strong>of</strong><br />
he FDCA govern only products that have been introduced into interstate com merce Therefore it can be<br />
argued that the activities <strong>of</strong> intra state cannabis dispensary operations are beyond the reach <strong>of</strong> the FDA<br />
Ironically the FDA has greater power over dietary supplements which have generally passed through interstate<br />
commerce and over health food stores han it does over cannabis dispensaries and their operators Indeed<br />
the manufacturers <strong>of</strong> herbs and other dietary supplements and Yhe reiail establishments that sell them are<br />
prohibited by federal law from making claims regarding the product s medical usefulness or specific health<br />
effects Cannabis dispensaries however do give out advice and provide books and pamphlets containing<br />
such medical claims<br />
The DEA therefore plays a critical part in protecting patients from dangerous ineffective and federally<br />
unapproved cannabis products<br />
The CSA and therefore the DEA s authority extends to produc s containing<br />
controlled substances and activities that may affect interstate commerce even if the specific products have<br />
been manufactured and distributed solely within the state If this Administration ties the DEA s hands with<br />
regard to dispensaries patients will lose altogether any avenue <strong>of</strong> federal protection<br />
States Laws and Regulatory Bodies Should Enhance RatherThan Undermine the<br />
Protections Provided by the FDA System<br />
In cases other than medical marijuana the FDA and DEA are able to rely to a large extent on state regulatory<br />
and law enforcement systems to support and augment the federal structures<br />
States have generally accepted<br />
his responsibility enacting their own food and drug laws to fili the gap in the FDA s jurisdiction These state<br />
laws are for the mosi part modeled after the federal FDCA<br />
In California for example the Sherman Food<br />
Drug and Cosmetic Law Sherman Law establishes rigorous scientific standards that must be met before a<br />
74 Dietary supplements are already subject co a lower standard <strong>of</strong> requlatory scrutiny because they are presumed to be less<br />
dangerous than prescription medications and because they are not intended and cannot be Iabeled or advercised as for<br />
use in diagnosingmi iga ing Veating or curing disease See the Dietary Supplement Health and Education Act <strong>of</strong> 1994<br />
DSHEA nUSC 3z1 f Dietary supplemen<br />
are orally ingested FDA Botanical Guidance at p 3<br />
75 See The Dietary Supplement Health and Education Act <strong>of</strong> i994 DSHEA Pub L 1o3 4i7http www fda gov opacom<br />
Iaws DSHEA html Whether a product is a drug under the fDCA turns on its intended use intended use in turn is<br />
created by daims made by or on behalf <strong>of</strong> a manufacturer or distributor <strong>of</strong> che item to prospective purchasers such<br />
as in advertising labefing or ora scatements zi US0 p3u gJ 1J B Botanical Gutdance at p z Dietary supplemen<br />
manufacturers distributors or retailers cannot make specific health clalms See eg US v z4 Bottles SterlingVinegarand<br />
HoneyAged in Wood Cider elended With Finest Honey Con ents i Pint ProductoSterling Cider Col Inc Sterling Mass 338 F2d<br />
i5J nd Cir z964 Kordel e US 335 US 345 1948<br />
76 See eg Califomia Law Enforcement Investiga ing POt Docs July 8 008http www <strong>of</strong>ficeccom web online iop<br />
News Stories Ca I ifo rnia Law Enforce m e ntI nves i gati ngPot Docs 131450<br />
77 Gonzales v Raich 545 US12005<br />
zoo9 Marijuana Dispensaries and the Federal Government<br />
z5
mc nr crwm uu wwiws<br />
t<br />
MEDfI<br />
m6p6ZW<br />
PHYSICIAN<br />
SfATEh1ENP<br />
I<br />
t<br />
rnnu2m xm cnb ma ammc vma rydAd ia<br />
naucauxvu m waw<br />
mnlwn mrnmlin<br />
uumamibi<br />
mu mc mcac<br />
Ph y sician<br />
recommendation from the records <strong>of</strong> a<br />
riwmm<br />
7wuam eub<br />
ivmnnnvrwn<br />
San Diego cannabis dispensary December 2005<br />
i<br />
sis Fl rn<br />
um cua<br />
wum h ia1 7 JnN<br />
rlFer<br />
e a<br />
S<br />
A uacxn<br />
r u<br />
4<br />
n<br />
r<br />
r<br />
1<br />
new drug may be marlceted for medical use<br />
The Sherman Law states that a new drug generally may not be<br />
sold delivered or given away unless a new drug application has been filed with and approved by the state or<br />
federel governmentl<br />
State regulatory boards and agencies similarly enhance the efFectiveness <strong>of</strong> the FDA and DEA<br />
State boards <strong>of</strong><br />
medicine nursing pharmacy etc supervise the education training and practices <strong>of</strong> all health care providers<br />
who examine or advise patients or dispense or distribute medications Health care providers who do not adhere<br />
to accepted standards <strong>of</strong> inedical practice may incur sanctions from these boards as well as risl potential civil<br />
liabilityforinappropriateprescribingorotherconductfallingbelowthestandard<strong>of</strong>care Healthcarefacilities<br />
are monitored and licensed by state departments <strong>of</strong> health services State tort systems allow patients who have<br />
suffered injury from a medication to seek damages from the manufacturer even if that medication has been<br />
FDA approved<br />
These state mechanisms when they operate effectively provide patients with additional or<br />
greater avenues <strong>of</strong> redress and protection and thereby complement federal food and drug provisions<br />
78 Calif Health Safety Code ll155o<br />
79 If physicians prescribe unapproved medica ions those that are not approved by the state or federel regulatory agenty<br />
and a patient suffers harm as a result he physician<br />
pr<strong>of</strong>essional Ilabi iiy policy may not cover a daim for damages See<br />
Educating Voices The Potential Medical Liabiliry for Physicians Recommending Marijuana as a Medicine white paper<br />
http www<br />
educatingvoices org EVl<br />
WhicePaperl pdf<br />
So Wyeth v Levine 555 US Mar 4 2009<br />
z6<br />
zo04 Marrjupna Dispensaries and the Federal Government
By contrast when states utilize their food and drug laws or enact other state legislation for the purpose<br />
<strong>of</strong> circumventing the FDCA patien health and safety is jeopardized<br />
controversy paralleis the Laetrile controversy <strong>of</strong> the i97os<br />
In many ways the current cannabis<br />
At that time Laetrile amygdalin was vigorously<br />
promoted as a cancer treatment and preventative Despite efForts by its supporters to characterize it as a<br />
dietary supplement Vitamin B17 the FDA determined that Laetrile was a new drug since it was intended<br />
for medical use and was subject to premarketing approval 8 Since it had not been proven safe and effective<br />
for medical use the FDCA precluded Laetrile s shipment in interstate commerce<br />
spurred on by anecdotal reporcs <strong>of</strong> efficacy contended that they had a<br />
Desperate cancer patiencs<br />
right to use Laetrile despite evidence<br />
<strong>of</strong> cyanide toxicity Laetrile advocates claimed that the FDA the American Medical Association the American<br />
Cancer Society the pharmaceutical companies and others were conspiring against Laetrile s This political<br />
pressure rather than scientific evidence caused twenty seven state legislatures to pass laws allowing the<br />
sale and use <strong>of</strong> Laetrile within heir borders<br />
manufacture Laetrile within each state<br />
These state laws had little effect since it was not feasible to<br />
Proponents hoped however that if enough states legalized its use<br />
within the states Congress would change the federal law as well Ultimately the National Cancer Institute<br />
conducted clinical testing and determined that Laetrile was not efFective as a cancer treatment<br />
The lesson <strong>of</strong><br />
Laetrile is that state legislation should only be used to enhance rather than undermine he protections <strong>of</strong> the<br />
federai regulatory system<br />
The same is true with regard to controlled substances<br />
Many states have adopted the Uniform Controlled<br />
Substances Act a the provisions <strong>of</strong> which parallel those <strong>of</strong> the federal CSA States can serve as an early warning<br />
system and have the flexibility to respond more quickly to abuses <strong>of</strong> controlled substances<br />
substances with abuse potential<br />
or <strong>of</strong> uncontrolled<br />
within their borders sb For example as an added layer <strong>of</strong> protection states<br />
may require that individuals who conduct research into controlled substances must be independently inspected<br />
81 4 Fed Reg39 768<br />
795 1977<br />
82 Bone M MD laetrile Drug Never Proved to be EfFective Cancer 7reatment The Polm Beach Post Mar 20 2008<br />
83 Wilson B MD The Rise and Fall <strong>of</strong> Laetrilehttp Jwww quackwa ch org<br />
olQuackeryRelatedTOpics<br />
CancerJlaetrile<br />
hml<br />
84 Moer el CG et al A Clinical Trial <strong>of</strong> Amygdalin Laetrile in the Treatment <strong>of</strong> Human Cancer New EnglondJournal <strong>of</strong><br />
Medicine 198i 306 4z01<br />
Nevertheless even at present companies continue o promote and sell Laetrile as a cancer<br />
Vea ment Chrough interne web sites See eg FDA Talk Paper FDA Takes Ac ion Against Firms Marke ing Unapproved<br />
Drugs Sept 6 z000http www fda gov bbs topics<br />
ANSWERS ANSOlo3z html<br />
85 See National Conference <strong>of</strong> Commissioners on Uniform State Lawshttp www<br />
org nccusl uniformact<br />
summariesJuniformaccsucsa9o asp Calif Health Safety Code pfjii000 i1651<br />
86 For example Salvio divinorum whose active constituent is salvinorin A is an herb that is increasingly used by the public<br />
for its hallucinogenic effeccs Salvia is not currently controlled under the CSA although the DEA is observing It dosely As<br />
<strong>of</strong> November iooS thirteen states had enacted legislation placing regulatory controls on Salvia divinorum andJor salvinorin<br />
A a number <strong>of</strong> those states placed he subs ances in schedule I <strong>of</strong> state law Proposed legislation is pending in a number <strong>of</strong><br />
other states DEA Drugs and Chemicals <strong>of</strong> Concern Nov ioo8http www<br />
deadiversion usdoj govJdrugs<br />
concernJindex<br />
html<br />
zoo9 Marijuana Dispensaries and the Federal Government 27
licensed and or approved by state agencies in addition to obtaining DEA registrations States may enact<br />
prescription monitoring programs to track physicians who prescribe controlled substances in order to identify<br />
and stop inappropriate prescribing practices by physicians as well as doctor shopping by patients obtaining<br />
prescriptions from multiple doctors simultaneously<br />
States also have greater flexibility in cheir scheduling<br />
actions If a state believes that a new substance has abuse potential and poses a threat to patient safety or<br />
public health the state need not wait on the DEA it may schedule that substance more restrictively or prohibit<br />
its sale and use altogether<br />
Cannabis Dispensaries Are Not Subject to State Laws and Regulations Applicable to<br />
Entities Operating in the Health Care Area<br />
Cannabis dispensaries starkly conflict with this robus state system <strong>of</strong> patient oriented controls<br />
Pot docs<br />
for cash payments <strong>of</strong> several hundred dollars provide recommendations to patients including minors<br />
with whom they have vir ually no physician patient relationship to enable them to use cannabis for a wide<br />
variety <strong>of</strong> inedical conditions ss Patients purchase cannabis from dispensaries with which they have only a<br />
retailer consumer relationship Dispensary personnei need not be licensed as health care providers nor are<br />
they required to follow proper sterile techniques to protect against on site bacterial or other contamination<br />
<strong>of</strong> the herbal materiaf although it is intended for consumption diredly by patients Despite their lack <strong>of</strong><br />
raining and accreditation such personnel freely <strong>of</strong>fer medical information and advice to patients about the<br />
87 The Research Advisory Panel RAP <strong>of</strong> the CaliforniaAorney General s <strong>of</strong>fice must approve all Schedule I and II research<br />
projects and protocois Calif Heal h Safety Code pIIn48o 8ihctp wagstace ca us research<br />
88 DEA State Prescription Drug Monitoring Programshtp www<br />
deadiversion usdoj gov faq nc monitor htm When<br />
controlled substances are at issue Che federal government also has authority to regulate direcdy some aspec<br />
<strong>of</strong> a physician<br />
medical practice Under the CSA physicians who prescribe or dispense controlled substances must hold a registration from<br />
the DEA and such conV011ed subs ances must be prescribed for a legitimate medical purpose and in the course <strong>of</strong> regular<br />
pr<strong>of</strong>essional practice u CFR jf1306 04a US v Moore 4Z3 US 1i 137 140 42 1975 Although states bear he primary<br />
responsibility for preventing and punishing he diversion <strong>of</strong> prescription controlled drugs by health care providers the DEA<br />
in egregious cases may investigate and revoke the registracion <strong>of</strong> and even criminally prosecute a physician orother health<br />
care provider who facilitaces and or promotes drug abuse and addiction<br />
89 See eg Califomia Law Enforcemen Investigating POt Docs puly 8 008ht pwww <strong>of</strong>ficeccom web oniine iop<br />
News Stories California Law<br />
Enforcement<br />
Investigating POt DOCS 131450 The Medical Board <strong>of</strong> Califomia has promulgated<br />
guidelines for physicians who recommend cannabis however here has been very limited enforcement http www medbd<br />
gov Medical Marijuana html Physicians who recommend cannabis can avoid the need for a DEA registration if they do<br />
not prescribe other controlled substances<br />
90 Salmonella and E coli are common baccerial contaminants that can be transmitted to botanical material through<br />
improper handling rechniques<br />
9i San Francisco regulations state that dispensaryoperators must require employees only to wash hands and use sanitary<br />
utensils when handling cannabis rather than use sterile gloves and instruments Sec 33iz b3<br />
9z AS one dispensary advertises We are also experienced and knowlecgeable about the various medications and how they<br />
workforvariousailments sowecans<br />
eeryoutowardananswer<br />
notjustanotherdeadendhttp<br />
greendragoncoop com<br />
default him gdid<br />
CKWtgr6wj5kCFRBbagodxhFTZg http Jwww mlive om news<br />
flinyindexssf z0o9 o3 group to <strong>of</strong>fer<br />
28 2004 Marijuana Dispensaries and Che Federal Government
panoply <strong>of</strong> cannabis products including extracts capsules tablets and various types <strong>of</strong> edibles Some <strong>of</strong> these<br />
products can reach THC concentrations as high as 80 which could produce significant side efFects especially<br />
in seriously ill patients or those who have not used cannabis before<br />
At best cannabis dispensaries are regulated at the local IeveL Where they are permi ted by local legislation<br />
as in San francisco such dispensaries are not regulated as<br />
or pharmacies answerable to the state department <strong>of</strong> health services<br />
if they were health care facilities eg dinics<br />
Nor are the employees who provide<br />
direct patient serviceeg distributing medlcal marijuana or medlcal advice subject to the scope <strong>of</strong> practice<br />
restrictions and requirements supervised by the state boards <strong>of</strong> pharmacy nursing and medicine<br />
Rather<br />
dispensaries are regulated as if they were retail establishments subject only to the Building Planning Housing<br />
Police Fire and Health codes <strong>of</strong> the local jurisdiction<br />
Cannabis and Cannabis Derived Products Should be Governed by the Quality Control<br />
and Other Testing Procedures Applicable to All Modern Medications<br />
Gradually even some cannabis dispensaries have begun to voice concern that these unregulated distribution<br />
practices may be placing patients in danger<br />
One operator has acknowledged that if cannabis is going to<br />
become an accepted mainstream medicine there must be quality assurance and dosage information<br />
fA dog wall s in the grow room and wags itstail anything can be coming <strong>of</strong>f that dog s tail IYs gross<br />
Fertilizers with E coli Compost<br />
that they don t make right anaerobic tea that has elevated levels <strong>of</strong><br />
E coli and salmonella It has to come There s no way that this is sustainable AII it takes is one story <strong>of</strong><br />
immune<br />
compromised people dying from Aspergillus infection<br />
marijuana advichtmlhtp www<br />
sanfranciscocannabisdubs mm directory<br />
sarnfrancisco green door hm patients can<br />
expect to deal wi h know edgeable staR membercJ<br />
93 Downs D The Manhattan Project <strong>of</strong> Mari uana Eas Bay Express Mar 4 2009http jwww<br />
eastbayexpress om ebx<br />
PrintFriendly oid 96926 Hereinafter<br />
ManhattanPro ect<br />
94 Many cities have no reg aions and indeed have issued bans or mora oriahttp Jnwwscribd com dci94869i MedicaP<br />
Mari uana moratorium map<br />
95 Medical Cannabis Ac mvisions Of cial San<br />
ordi nanceso9 o0015 09 Pdf<br />
Franc sco We6sitehttp wvwsfgov org<br />
uploadedfilesJbdsupvrs<br />
96 Cannabis is a highly abuseable substance and if determined to have an accepted medical use in treatment in the<br />
US would remain sub ect to he dosed system <strong>of</strong> distribution required by Me CSA State regulation does not fulfill this<br />
reqwrement<br />
97 Manhattan Projec supro<br />
zoo9 Marijuana Dispensaries and the Federal Government 9
This operator has affiliated with an informal laboratory and envisions a testing program using such instruments<br />
as a gas chromatograph and mass spearometer<br />
He also no es however that IYs expensive to test every<br />
single thing tha comes through the door thaYs the price you pay with a decentralized supply system five<br />
pounds coming from here and two from there It is far from certain whether other dispensaries would<br />
voluntarily join such an effort<br />
These rudimentary laboratory testing efforts merely confirm the imporcance <strong>of</strong> adhering to the exis ing body <strong>of</strong><br />
tecf nological toois and methodoiogies mandated by state and federal regulatory agencies There is no need to<br />
recreate the wheel for cannabis or cannabis derived preparations Drug manufacturers are already required to<br />
institute extensive testing procedures to ensure that their products are quality controlled during manufacture<br />
and that their formulations and dosage forms are standardized and reproducible Testing procedures mus be<br />
validated instruments must be calibrated equipment operators must be appropnately educated and trained<br />
careful records must be kept and practices must be sterile<br />
Finished medical products must be analyzed<br />
for to batch consistency and any degradants and minorcon aminants must be identified and strictly<br />
limited<br />
Should a sys em <strong>of</strong> cannabis testing laboratories ultimately develop at all it is hard to imagine that it would<br />
be allowed to operate at a different or inferior level to the current US medication<br />
development system<br />
cannabis dispensaries are allowed o proliferate across he country our current regulatory system to which<br />
the American Medical Association and all other major US medical associations give their unwavering support<br />
may be seriously undermined<br />
If<br />
If there were only a single state with a few dispensaries the risk might not be as significant At present<br />
however 13 states have laws decriminalizing the use <strong>of</strong> cannabis for medical purposes and bills are pending<br />
in many more states If such cultivation and distribution activities are deemed to be beyond the reach <strong>of</strong> the<br />
DEA dispensaries are likely to emerge all over the country<br />
98 Of coursehis<br />
9aborecory is a far cry from currendy acceptable scientific standards ooks Iike a bachelor pad with a<br />
Iocked room in che back ld<br />
99 d<br />
100 For example bills are pending in Illinois Minnesota New Hampshire and New York among others to decriminalize<br />
cannabis for medical usehtcp www mpp org legislation<br />
ioi For example a bill is currently pending in the Rhode Island legislature to amend the existing medical marijuana<br />
law to authorize cannabis dispensaries This bill has gained more force following Attorney General Eric Holder s remarks<br />
alchough it failed in the state House <strong>of</strong> Representatives last year Members <strong>of</strong> the House have stated that the Attorney<br />
General s comments have caused them to view the proposal much more fawrably than lastyear Needham C Bill Would<br />
License Dispensaries o Sell Medical Marijuana Mar 5 2009http Jwww projo com news con ent MARI UANA BILL 03<br />
OS O9 U N DH M 3Nv17 37894c1 htm I<br />
3a<br />
2009 Marijuana Dispensaries and the Federal Government